Genworth Financial
Annual Report 2023

Plain-text annual report

Annual Report Genworth Financial Inc. 2023UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K È ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ‘ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32195 GENWORTH FINANCIAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 6620 West Broad Street Richmond, Virginia (Address of principal executive offices) 80-0873306 (I.R.S. Employer Identification No.) 23230 (Zip Code) (804) 281-6000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act Title of Each Class Class A Common Stock, par value $.001 per share Trading Symbol GNW Name of each exchange on which registered New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes È No ‘ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ‘ No È Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes È No ‘ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes È No ‘ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer È Non-accelerated filer ‘ Accelerated filer ‘ Smaller reporting company ‘ Emerging growth company ‘ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ‘ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. È If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ‘ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ‘ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ‘ No È As of February 15, 2024, 442,625,464 shares of Class A Common Stock, par value $0.001 per share were outstanding. The aggregate market value of the common equity (based on the closing price of the Class A Common Stock on the New York Stock Exchange) held by non-affiliates of the registrant on June 30, 2023, the last business day of the registrant’s most recently completed second fiscal quarter, was approximately $2.3 billion. All executive officers and directors of the registrant have been deemed, solely for the purpose of the foregoing calculation, to be “affiliates” of the registrant. Certain portions of the registrant’s definitive proxy statement pursuant to Regulation 14A of the Securities Exchange Act of 1934 in connection with the 2024 annual meeting of the registrant’s stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K. DOCUMENTS INCORPORATED BY REFERENCE Table of Contents Cautionary Note Regarding Forward-looking Statements PART I Item 1. Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 1A. Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 1B. Unresolved Staff Comments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 1C. Cybersecurity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 2. Properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Legal Proceedings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 3. Item 4. Mine Safety Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . PART II Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 6. Reserved . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations . . . . . Item 7A. Quantitative and Qualitative Disclosures About Market Risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . Financial Statements and Supplementary Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 8. Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure . . . . Item 9A. Controls and Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 9B. Other Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections . . . . . . . . . . . . . . . . . . . . . . PART III Item 10. Directors, Executive Officers and Corporate Governance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 11. Executive Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 13. Certain Relationships and Related Transactions, and Director Independence . . . . . . . . . . . . . . . . Item 14. Principal Accountant Fees and Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . PART IV Item 15. Exhibits and Financial Statement Schedules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Page 4 32 63 63 65 66 66 67 68 69 126 129 277 277 280 280 281 286 286 286 286 287 This Annual Report on Form 10-K, including Management’s Discussion and Analysis of Financial Condition and Results of Operations, contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “expects,” “intends,” “anticipates,” “plans,” “believes,” “seeks,” “estimates,” “will” or words of similar meaning and include, but are not limited to, statements regarding the outlook for our future business and financial performance. Examples of forward-looking statements include statements we make relating to potential dividends or share repurchases; future return of capital by Enact Holdings, Inc. (“Enact Holdings”), including share repurchases, and quarterly and special dividends; the cumulative economic benefit of approved and future rate actions contemplated in our long-term care insurance multi-year in-force rate action plan; future financial performance and condition of our businesses; liquidity and new lines of business or new products and services, such as those we are pursuing with our CareScout business (“CareScout”); as well as statements we make regarding the potential occurrence of a recession. Forward-looking statements are based on management’s current expectations and assumptions, which are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from those in the forward-looking statements due to global political, economic, inflation, business, competitive, market, regulatory and other factors and risks, including but not limited to, the items identified under “Part I—Item 1A—Risk Factors.” We therefore caution you against relying on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise. 2 3 Table of Contents Cautionary Note Regarding Forward-looking Statements This Annual Report on Form 10-K, including Management’s Discussion and Analysis of Financial Condition and Results of Operations, contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “expects,” “intends,” “anticipates,” “plans,” “believes,” “seeks,” “estimates,” “will” or words of similar meaning and include, but are not limited to, statements regarding the outlook for our future business and financial performance. Examples of forward-looking statements include statements we make relating to potential dividends or share repurchases; future return of capital by Enact Holdings, Inc. (“Enact Holdings”), including share repurchases, and quarterly and special dividends; the cumulative economic benefit of approved and future rate actions contemplated in our long-term care insurance multi-year in-force rate action plan; future financial performance and condition of our businesses; liquidity and new lines of business or new products and services, such as those we are pursuing with our CareScout business (“CareScout”); as well as statements we make regarding the potential occurrence of a recession. Forward-looking statements are based on management’s current expectations and assumptions, which are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from those in the forward-looking statements due to global political, economic, inflation, business, competitive, market, regulatory and other factors and risks, including but not limited to, the items identified under “Part I—Item 1A—Risk Factors.” We therefore caution you against relying on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise. Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 1A. Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 1B. Unresolved Staff Comments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 1C. Cybersecurity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Legal Proceedings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mine Safety Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 6. Reserved . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations . . . . . Item 7A. Quantitative and Qualitative Disclosures About Market Risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 8. Item 9. Financial Statements and Supplementary Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Changes in and Disagreements With Accountants on Accounting and Financial Disclosure . . . . Item 9A. Controls and Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 9B. Other Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections . . . . . . . . . . . . . . . . . . . . . . Item 10. Directors, Executive Officers and Corporate Governance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 11. Executive Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 13. Certain Relationships and Related Transactions, and Director Independence . . . . . . . . . . . . . . . . Item 14. Principal Accountant Fees and Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . PART I Item 1. Item 2. Item 3. Item 4. PART II PART III PART IV Item 15. Exhibits and Financial Statement Schedules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 287 Page 4 32 63 63 65 66 66 67 68 69 126 129 277 277 280 280 281 286 286 286 286 2 3 In this Annual Report on Form 10-K, unless the context otherwise requires, “Genworth,” the “Company,” “we,” “us” and “our” refer to Genworth Financial, Inc. on a consolidated basis. References to “Genworth Financial” refer solely to Genworth Financial, Inc., and not to any of its consolidated subsidiaries. PART I Item 1. Business Overview Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s U.S. life insurance subsidiaries offer long-term care insurance and also manage in-force blocks of life insurance and annuity products that are no longer sold. Genworth Financial also has a start-up business whereby it offers fee-based services, advice, consulting and other products and services through CareScout, its indirect subsidiary. Beginning in the first quarter of 2023, we changed our operating segments to better align with how we manage our business. The changes allow us to sharpen our focus on common aspects of products within each segment and enhance understanding of business performance. All prior period financial information has been re-presented to reflect the reorganized segment reporting structure. Under the new reporting structure, we operate our business through three operating segments: Enact; Long-Term Care Insurance; and Life and Annuities. In addition to our three operating segments, we report certain of our results of operations in Corporate and Other. On September 20, 2021, Genworth Financial, through its wholly owned subsidiary Genworth Holdings, Inc. (“Genworth Holdings”), completed a minority initial public offering (“IPO”) of 18.4% of Enact Holdings. The minority IPO resulted in Enact Holdings becoming a separate, standalone public company traded on the Nasdaq Global Select Market exchange under the ticker symbol “ACT.” Genworth Financial maintains control of Enact Holdings through an indirect majority voting interest and accordingly, Enact Holdings remains a consolidated subsidiary of Genworth Financial in this Annual Report on Form 10-K. Enact Holdings and its mortgage insurance subsidiaries comprise, and can therefore generally be viewed as, our Enact segment, or commonly referred to as “Enact.” Strategic Priorities We have advanced Genworth’s strategy to drive shareholder value over the past several years, culminating in several major achievements in 2022 and 2023. We reduced Genworth Holdings’ debt to less than $1.0 billion, enhanced the value of Enact, received multiple upgrades from rating agencies, continued to make progress on our multi-year long-term care insurance in-force rate action plan and began returning capital to shareholders for the first time in over 13 years. Building on this progress and the improvement in Genworth’s financial position over the past few years, we have refocused our strategic priorities to three areas: • • • further strengthen our legacy long-term care insurance financial and operational capabilities to address customer needs; allocate capital from Enact to drive Genworth Financial’s long-term shareholder value; and leverage our unparalleled long-term care expertise to develop innovative aging care services and solutions. We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multiyear in-force rate action plan from 2012 through 2023 was approximately $28.0 billion, on a net present value basis. We will continue to execute our first strategic objective primarily through our in-force rate action plan, which is critical to the business. We manage our U.S. life insurance subsidiaries on a standalone basis. Accordingly, the U.S. life insurance subsidiaries will continue to rely on their statutory capital, significant reserves, prudent management of the in-force blocks and long-term care insurance in-force rate actions to satisfy policyholder obligations. For additional information regarding our in-force rate actions, see “Part II—Item 7— Management’s Discussion and Analysis of Financial Condition and Results of Operations—Long-Term Care Insurance segment.” Enact continues to be a significant driver of value for Genworth. Effective March 1, 2023, the government- sponsored enterprises (“GSEs”) removed the additional capital restrictions that had been imposed on Enact. This was an important milestone as Enact is no longer subject to more stringent capital requirements than its mortgage insurance peers. Genworth Holdings received $245 million of capital returns from Enact Holdings in 2023. We believe capital returns from Enact will continue to benefit our shareholders by funding our strategic initiatives, including new CareScout products and services as well as share repurchases. In July 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under the existing share repurchase program. Since the initial authorization in May 2022 and through February 13, 2024, we have repurchased $384 million worth of shares of Genworth Financial’s common stock. For additional information on our share repurchase program, see “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources.” We are focused on advancing Genworth’s senior care growth initiatives and see meaningful opportunities to provide the products and services offered by CareScout to address the needs of elderly Americans, as well as their caregivers and families. We launched the initial phase of our CareScout services business in March 2023. This business includes a digital platform, where we hope to curate a broad marketplace that matches consumers’ long-term care needs with a network of quality providers that we are building. In addition to the digital platform and quality network offerings to consumers, employers and long-term care insurers, the discounts available through the network are expected to have the potential to further mitigate risk in our legacy long-term care insurance block by reducing claims costs. Our CareScout services business is currently focused on home care providers as the majority of our initial long-term care insurance claims begin with care in the home. While the initial focus for the quality network has been with Genworth’s long-term care insurance policyholders in certain states, we believe we can accelerate our efforts to build a national quality network of care providers, which we expect could allow a high-quality experience and discounted fees for more existing Genworth policyholders and broaden the scope of our CareScout services business to new consumer markets. We are also working to build the foundation necessary to re-enter the long-term care insurance market through our CareScout insurance business. As we expand CareScout, there may be other potential future growth opportunities, such as expanding CareScout’s products and services to international markets. We will strive to maintain a disciplined approach in Genworth’s capital allocation strategy, balancing investments in CareScout growth initiatives with returning value to shareholders. Enact Segment Through Enact Holdings and its mortgage insurance subsidiaries, we have been providing private mortgage insurance products and services in the United States since 1981 and operate in all 50 states and the District of Columbia. Enact is engaged in the business of writing and assuming residential mortgage guaranty insurance. The insurance covers a portion of the unpaid principal balance of mortgage loans where the loan amount exceeds 80% of the value of the home (“low down payment mortgages” or “high loan-to-value mortgages”) and protects lenders and investors against certain losses resulting from nonpayment of loans secured by mortgages, deeds of trust or other instruments constituting a first lien on residential real estate. Private mortgage insurance facilitates the sale of mortgages to the secondary market, including to private investors as well as the Federal National Mortgage Association (“Fannie Mae”) and the Federal Home Loan Mortgage Corporation (“Freddie Mac”). Fannie Mae and Freddie Mac are government-sponsored enterprises and are collectively referred to as the “GSEs.” Credit protection and liquidity through secondary market sales allow mortgage lenders to increase their lending capacity, manage risk and expand financing access to prospective homeowners, many of whom are first time home buyers. At present, mortgage insurance products are primarily geared towards secondary market sales to the GSEs. Enact’s mortgage insurance products predominantly insure prime-based, individually underwritten residential mortgage loans. 4 5 In this Annual Report on Form 10-K, unless the context otherwise requires, “Genworth,” the “Company,” “we,” “us” and “our” refer to Genworth Financial, Inc. on a consolidated basis. References to “Genworth Financial” refer solely to Genworth Financial, Inc., and not to any of its consolidated subsidiaries. PART I Item 1. Business Overview Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s U.S. life insurance subsidiaries offer long-term care insurance and also manage in-force blocks of life insurance and annuity products that are no longer sold. Genworth Financial also has a start-up business whereby it offers fee-based services, advice, consulting and other products and services through CareScout, its indirect subsidiary. Beginning in the first quarter of 2023, we changed our operating segments to better align with how we manage our business. The changes allow us to sharpen our focus on common aspects of products within each segment and enhance understanding of business performance. All prior period financial information has been re-presented to reflect the reorganized segment reporting structure. Under the new reporting structure, we operate our business through three operating segments: Enact; Long-Term Care Insurance; and Life and Annuities. In addition to our three operating segments, we report certain of our results of operations in Corporate and Other. On September 20, 2021, Genworth Financial, through its wholly owned subsidiary Genworth Holdings, Inc. (“Genworth Holdings”), completed a minority initial public offering (“IPO”) of 18.4% of Enact Holdings. The minority IPO resulted in Enact Holdings becoming a separate, standalone public company traded on the Nasdaq Global Select Market exchange under the ticker symbol “ACT.” Genworth Financial maintains control of Enact Holdings through an indirect majority voting interest and accordingly, Enact Holdings remains a consolidated subsidiary of Genworth Financial in this Annual Report on Form 10-K. Enact Holdings and its mortgage insurance subsidiaries comprise, and can therefore generally be viewed as, our Enact segment, or commonly referred to as “Enact.” Strategic Priorities We have advanced Genworth’s strategy to drive shareholder value over the past several years, culminating in several major achievements in 2022 and 2023. We reduced Genworth Holdings’ debt to less than $1.0 billion, enhanced the value of Enact, received multiple upgrades from rating agencies, continued to make progress on our multi-year long-term care insurance in-force rate action plan and began returning capital to shareholders for the first time in over 13 years. Building on this progress and the improvement in Genworth’s financial position over the past few years, we have refocused our strategic priorities to three areas: further strengthen our legacy long-term care insurance financial and operational capabilities to address allocate capital from Enact to drive Genworth Financial’s long-term shareholder value; and leverage our unparalleled long-term care expertise to develop innovative aging care services and • • • customer needs; solutions. We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multiyear in-force rate action plan from 2012 through 2023 was approximately $28.0 billion, on a net present value basis. We will continue to execute our first strategic objective primarily through our in-force rate action plan, which is critical to the business. We manage our U.S. life insurance subsidiaries on a standalone basis. Accordingly, the U.S. life insurance subsidiaries will continue to rely on their statutory capital, significant reserves, prudent management of the in-force blocks and long-term care insurance in-force rate actions to satisfy policyholder obligations. For additional information regarding our in-force rate actions, see “Part II—Item 7— Management’s Discussion and Analysis of Financial Condition and Results of Operations—Long-Term Care Insurance segment.” Enact continues to be a significant driver of value for Genworth. Effective March 1, 2023, the government- sponsored enterprises (“GSEs”) removed the additional capital restrictions that had been imposed on Enact. This was an important milestone as Enact is no longer subject to more stringent capital requirements than its mortgage insurance peers. Genworth Holdings received $245 million of capital returns from Enact Holdings in 2023. We believe capital returns from Enact will continue to benefit our shareholders by funding our strategic initiatives, including new CareScout products and services as well as share repurchases. In July 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under the existing share repurchase program. Since the initial authorization in May 2022 and through February 13, 2024, we have repurchased $384 million worth of shares of Genworth Financial’s common stock. For additional information on our share repurchase program, see “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources.” We are focused on advancing Genworth’s senior care growth initiatives and see meaningful opportunities to provide the products and services offered by CareScout to address the needs of elderly Americans, as well as their caregivers and families. We launched the initial phase of our CareScout services business in March 2023. This business includes a digital platform, where we hope to curate a broad marketplace that matches consumers’ long-term care needs with a network of quality providers that we are building. In addition to the digital platform and quality network offerings to consumers, employers and long-term care insurers, the discounts available through the network are expected to have the potential to further mitigate risk in our legacy long-term care insurance block by reducing claims costs. Our CareScout services business is currently focused on home care providers as the majority of our initial long-term care insurance claims begin with care in the home. While the initial focus for the quality network has been with Genworth’s long-term care insurance policyholders in certain states, we believe we can accelerate our efforts to build a national quality network of care providers, which we expect could allow a high-quality experience and discounted fees for more existing Genworth policyholders and broaden the scope of our CareScout services business to new consumer markets. We are also working to build the foundation necessary to re-enter the long-term care insurance market through our CareScout insurance business. As we expand CareScout, there may be other potential future growth opportunities, such as expanding CareScout’s products and services to international markets. We will strive to maintain a disciplined approach in Genworth’s capital allocation strategy, balancing investments in CareScout growth initiatives with returning value to shareholders. Enact Segment Through Enact Holdings and its mortgage insurance subsidiaries, we have been providing private mortgage insurance products and services in the United States since 1981 and operate in all 50 states and the District of Columbia. Enact is engaged in the business of writing and assuming residential mortgage guaranty insurance. The insurance covers a portion of the unpaid principal balance of mortgage loans where the loan amount exceeds 80% of the value of the home (“low down payment mortgages” or “high loan-to-value mortgages”) and protects lenders and investors against certain losses resulting from nonpayment of loans secured by mortgages, deeds of trust or other instruments constituting a first lien on residential real estate. Private mortgage insurance facilitates the sale of mortgages to the secondary market, including to private investors as well as the Federal National Mortgage Association (“Fannie Mae”) and the Federal Home Loan Mortgage Corporation (“Freddie Mac”). Fannie Mae and Freddie Mac are government-sponsored enterprises and are collectively referred to as the “GSEs.” Credit protection and liquidity through secondary market sales allow mortgage lenders to increase their lending capacity, manage risk and expand financing access to prospective homeowners, many of whom are first time home buyers. At present, mortgage insurance products are primarily geared towards secondary market sales to the GSEs. Enact’s mortgage insurance products predominantly insure prime-based, individually underwritten residential mortgage loans. 4 5 The overall U.S. residential mortgage market encompasses both primary and secondary markets. The primary market consists of lenders originating home loans to borrowers to support home purchases, which are referred to as purchase originations, and loans made to refinance existing mortgages, which are referred to as refinancing originations. The secondary market includes institutions buying and selling mortgages in the form of whole loans or securitized assets, such as mortgage-backed securities. The GSEs are the largest participants in the secondary mortgage market, buying residential mortgages from banks and other primary lenders as part of their governmental mandate to provide access, liquidity and stability in the U.S. housing finance system. The GSE charters generally require credit enhancement for low down payment mortgages to be eligible for purchase by the GSEs. Such credit enhancement can be satisfied if a loan is insured by a GSE-qualified insurer, the mortgage seller retains at least a 10% participation in the loan, or the seller agrees to repurchase or replace the loan in the event of a default. Private mortgage insurance satisfies the GSEs’ credit enhancement requirement and historically has been the preferred method lenders have utilized to meet this GSE charter requirement. As a result, the nature of the private mortgage insurance industry in the United States is driven in large part by the business practices and mortgage insurance requirements of the GSEs. In furtherance of their respective charter requirements, each GSE maintains eligibility criteria to establish when a mortgage insurer is qualified to issue coverage that will be acceptable to the GSEs for their portfolio. For more information about the financial and other requirements of the GSEs for Enact Holdings and its mortgage insurance subsidiaries, see “—Regulation— Enact—Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.” Selected financial information and operating performance measures regarding our Enact segment are included under “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment.” Products and services Enact offers the following mortgage insurance products: Primary mortgage insurance Substantially all of Enact’s policies are primary mortgage insurance, which provides protection on individual loans at specified coverage percentages. Primary mortgage insurance is placed on individual loans at the time of origination and is typically delivered to Enact on a loan-by-loan basis. Primary mortgage insurance can also be delivered to Enact on an aggregated basis, whereby each mortgage in a given loan portfolio is insured in a single transaction after the point of origination. Customers who purchase primary mortgage insurance select a specific coverage level for each insured loan. A customer may choose the coverage percentage established by a GSE in order to be eligible for purchase by that particular GSE or for loans not sold to the GSEs, the customer determines its desired coverage percentage. Generally, Enact’s risk across all policies written is approximately 25% of the underlying primary insurance in-force, but may vary from policy to policy, typically between 6% and 35% coverage. The loan amount and coverage percentage determine Enact’s risk in-force on each insured loan. Enact files premium rates, as required, with the insurance departments of U.S. states and the District of Columbia. Premium rates cannot be changed after the issuance of coverage. Premium payments for primary mortgage insurance coverage are typically made by the borrower and are referred to as borrower-paid mortgage insurance. Loans for which premiums are paid by the lender are referred to as lender-paid mortgage insurance. In either case, the payment of premium to Enact is generally the responsibility of the insured. Premiums are generally calculated as a percentage of the original principal balance and may be paid on a monthly or annual basis, as a single premium paid at the time of mortgage origination or split, where an initial lump sum premium is paid at the time of mortgage origination in addition to subsequent monthly payments. Pool mortgage insurance Pool mortgage insurance transactions provide coverage on a finite set of individual loans identified by the pool policy. Pool policies contain coverage percentages and provisions limiting the insurer’s obligation to pay claims until a threshold amount is reached (known as a “deductible”) or capping the insurer’s potential aggregate liability for claims payments (known as a “stop loss”) or a combination of both provisions. Pool mortgage insurance is typically used to provide additional credit enhancement for certain secondary market mortgage transactions. Pool insurance generally covers the excess of the loss on a defaulted mortgage loan that exceeds the claim payment under the primary coverage, if such loan has primary coverage, as well as the total loss on a defaulted mortgage loan that did not have primary coverage. In another variation, generally referred to as modified pool insurance, policies are structured to include both an exposure limit for each individual loan, as well as an aggregate loss limit or a deductible for the entire pool. Currently, Enact has an insignificant amount of pool insurance in-force. Enact also performs fee-based contract underwriting services for its customers. Contract underwriting services provide customers outsourced scalable capacity to underwrite mortgage loans. Enact’s underwriters can underwrite the loan on behalf of its customers for both investor compliance and mortgage insurance, thus reducing duplicative activities and increasing Enact’s ability to write mortgage insurance for these loans. Under contract underwriting agreement terms, Enact agrees to indemnify its customers against losses incurred in the event it makes material errors in determining whether loans underwritten by its contract underwriters meet specified underwriting or purchase criteria, subject to contractual limitations. As a result, Enact assumes credit and processing risk in connection with its contract underwriting services. Underwriting and pricing Enact establishes and maintains underwriting guidelines based on its risk appetite. Enact’s guidelines require borrowers to have a verified capacity and willingness to support their obligation and a well-supported valuation of the collateral. Enact’s underwriting guidelines incorporate credit eligibility requirements that, among other things, limit its coverage to mortgages that meet its thresholds with respect to borrower Fair Isaac Company (“FICO”) scores, maximum loan-to-value ratios, documentation requirements and maximum debt-to-income ratios. All loans must pass through its eligibility rules to ensure proper discharge of loans not meeting its guidelines and to maintain thorough underwriting standards. Enact’s underwriting guidelines are largely consistent with those of the GSEs. Many of its customers use the GSEs’ automated loan underwriting systems for making credit determinations. Enact generally accepts the underwriting decisions and documentation requirements made by the GSEs’ underwriting systems, subject to its review as well as certain limitations and requirements. FICO developed the FICO credit scoring model to calculate a score based upon a borrower’s credit history. Enact uses the FICO credit score as one indicator of a borrower’s credit quality. Typically, a borrower with a higher credit score has a lower likelihood of defaulting on a loan. FICO credit scores range up to 850, with a score of 620 or more generally viewed as a “prime” loan and a score below 620 generally viewed as a “sub-prime” loan. Generally, “A minus” loans are loans where the borrowers have FICO credit scores between 575 and 660 and have a blemished credit history. The weighted average FICO score of Enact’s primary insurance in-force was 744 as of December 31, 2023. Loan applications for primary mortgage insurance are either directly reviewed by Enact (or its contract underwriters), or as noted below, by lenders under delegated authority. In either case, automated underwriting systems may be utilized. For non-delegated underwriting, customers submit loan files to Enact and Enact individually underwrites each application to determine whether it will insure the loan. Enact uses its mortgage insurance underwriting system to perform non-delegated underwriting evaluations, and its underwriting staff is dispersed throughout the United States. In addition to its employees, Enact uses domestically based contract underwriters to assist with underwriting capacity and drive efficiency. 6 7 The overall U.S. residential mortgage market encompasses both primary and secondary markets. The primary market consists of lenders originating home loans to borrowers to support home purchases, which are referred to as purchase originations, and loans made to refinance existing mortgages, which are referred to as refinancing originations. The secondary market includes institutions buying and selling mortgages in the form of whole loans or securitized assets, such as mortgage-backed securities. The GSEs are the largest participants in the secondary mortgage market, buying residential mortgages from banks and other primary lenders as part of their governmental mandate to provide access, liquidity and stability in the U.S. housing finance system. The GSE charters generally require credit enhancement for low down payment mortgages to be eligible for purchase by the GSEs. Such credit enhancement can be satisfied if a loan is insured by a GSE-qualified insurer, the mortgage seller retains at least a 10% participation in the loan, or the seller agrees to repurchase or replace the loan in the event of a default. Private mortgage insurance satisfies the GSEs’ credit enhancement requirement and historically has been the preferred method lenders have utilized to meet this GSE charter requirement. As a result, the nature of the private mortgage insurance industry in the United States is driven in large part by the business practices and mortgage insurance requirements of the GSEs. In furtherance of their respective charter requirements, each GSE maintains eligibility criteria to establish when a mortgage insurer is qualified to issue coverage that will be acceptable to the GSEs for their portfolio. For more information about the financial and other requirements of the GSEs for Enact Holdings and its mortgage insurance subsidiaries, see “—Regulation— Enact—Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.” Selected financial information and operating performance measures regarding our Enact segment are included under “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment.” Products and services Enact offers the following mortgage insurance products: Primary mortgage insurance Substantially all of Enact’s policies are primary mortgage insurance, which provides protection on individual loans at specified coverage percentages. Primary mortgage insurance is placed on individual loans at the time of origination and is typically delivered to Enact on a loan-by-loan basis. Primary mortgage insurance can also be delivered to Enact on an aggregated basis, whereby each mortgage in a given loan portfolio is insured in a single transaction after the point of origination. Customers who purchase primary mortgage insurance select a specific coverage level for each insured loan. A customer may choose the coverage percentage established by a GSE in order to be eligible for purchase by that particular GSE or for loans not sold to the GSEs, the customer determines its desired coverage percentage. Generally, Enact’s risk across all policies written is approximately 25% of the underlying primary insurance in-force, but may vary from policy to policy, typically between 6% and 35% coverage. The loan amount and coverage percentage determine Enact’s risk in-force on each insured loan. Enact files premium rates, as required, with the insurance departments of U.S. states and the District of Columbia. Premium rates cannot be changed after the issuance of coverage. Premium payments for primary mortgage insurance coverage are typically made by the borrower and are referred to as borrower-paid mortgage insurance. Loans for which premiums are paid by the lender are referred to as lender-paid mortgage insurance. In either case, the payment of premium to Enact is generally the responsibility of the insured. Premiums are generally calculated as a percentage of the original principal balance and may be paid on a monthly or annual basis, as a single premium paid at the time of mortgage origination or split, where an initial lump sum premium is paid at the time of mortgage origination in addition to subsequent monthly payments. Pool mortgage insurance Pool mortgage insurance transactions provide coverage on a finite set of individual loans identified by the pool policy. Pool policies contain coverage percentages and provisions limiting the insurer’s obligation to pay claims until a threshold amount is reached (known as a “deductible”) or capping the insurer’s potential aggregate liability for claims payments (known as a “stop loss”) or a combination of both provisions. Pool mortgage insurance is typically used to provide additional credit enhancement for certain secondary market mortgage transactions. Pool insurance generally covers the excess of the loss on a defaulted mortgage loan that exceeds the claim payment under the primary coverage, if such loan has primary coverage, as well as the total loss on a defaulted mortgage loan that did not have primary coverage. In another variation, generally referred to as modified pool insurance, policies are structured to include both an exposure limit for each individual loan, as well as an aggregate loss limit or a deductible for the entire pool. Currently, Enact has an insignificant amount of pool insurance in-force. Enact also performs fee-based contract underwriting services for its customers. Contract underwriting services provide customers outsourced scalable capacity to underwrite mortgage loans. Enact’s underwriters can underwrite the loan on behalf of its customers for both investor compliance and mortgage insurance, thus reducing duplicative activities and increasing Enact’s ability to write mortgage insurance for these loans. Under contract underwriting agreement terms, Enact agrees to indemnify its customers against losses incurred in the event it makes material errors in determining whether loans underwritten by its contract underwriters meet specified underwriting or purchase criteria, subject to contractual limitations. As a result, Enact assumes credit and processing risk in connection with its contract underwriting services. Underwriting and pricing Enact establishes and maintains underwriting guidelines based on its risk appetite. Enact’s guidelines require borrowers to have a verified capacity and willingness to support their obligation and a well-supported valuation of the collateral. Enact’s underwriting guidelines incorporate credit eligibility requirements that, among other things, limit its coverage to mortgages that meet its thresholds with respect to borrower Fair Isaac Company (“FICO”) scores, maximum loan-to-value ratios, documentation requirements and maximum debt-to-income ratios. All loans must pass through its eligibility rules to ensure proper discharge of loans not meeting its guidelines and to maintain thorough underwriting standards. Enact’s underwriting guidelines are largely consistent with those of the GSEs. Many of its customers use the GSEs’ automated loan underwriting systems for making credit determinations. Enact generally accepts the underwriting decisions and documentation requirements made by the GSEs’ underwriting systems, subject to its review as well as certain limitations and requirements. FICO developed the FICO credit scoring model to calculate a score based upon a borrower’s credit history. Enact uses the FICO credit score as one indicator of a borrower’s credit quality. Typically, a borrower with a higher credit score has a lower likelihood of defaulting on a loan. FICO credit scores range up to 850, with a score of 620 or more generally viewed as a “prime” loan and a score below 620 generally viewed as a “sub-prime” loan. Generally, “A minus” loans are loans where the borrowers have FICO credit scores between 575 and 660 and have a blemished credit history. The weighted average FICO score of Enact’s primary insurance in-force was 744 as of December 31, 2023. Loan applications for primary mortgage insurance are either directly reviewed by Enact (or its contract underwriters), or as noted below, by lenders under delegated authority. In either case, automated underwriting systems may be utilized. For non-delegated underwriting, customers submit loan files to Enact and Enact individually underwrites each application to determine whether it will insure the loan. Enact uses its mortgage insurance underwriting system to perform non-delegated underwriting evaluations, and its underwriting staff is dispersed throughout the United States. In addition to its employees, Enact uses domestically based contract underwriters to assist with underwriting capacity and drive efficiency. 6 7 Enact delegates to eligible lender customers the ability to underwrite mortgage insurance based on its delegated underwriting guidelines. To perform delegated underwriting, customers must be approved by Enact’s risk management team. Enact regularly performs quality assurance reviews on a statistically significant sample of delegated loans to assess compliance with its guidelines. Enact also offers a post-closing underwriting review when requested by customers for both non-delegated and delegated loans. Upon satisfactory completion of this review, Enact agrees to waive its right to rescind coverage under certain circumstances. Pricing is highly competitive in the mortgage insurance industry, with industry participants competing for market share, customer relationships and overall value. To appropriately align price and risk, dynamic pricing engines utilize granular pricing models based on a number of loan, borrower, lender and property risk attributes. Enact’s risk-based pricing engine was developed to evaluate returns and volatility under both the private mortgage insurer eligibility requirements (“PMIERs”) capital framework and its internal economic capital framework, which is sensitive to economic cycles and current housing market conditions. The model assesses the performance of new business under expected and stress scenarios on an individualized loan basis, which is used to determine pricing and inform Enact’s risk selection strategy that seeks to optimize economic value by balancing return and volatility. Enact seeks to charge premium rates commensurate with the underlying risk of each loan insured. Enact’s proprietary pricing platform provides a flexible, granular and analytical approach to selecting and pricing risk and its use allows Enact to adjust its risk tolerance by quickly changing prices in response to evolving economic conditions, new analytical insights or industry pricing trends. Loss mitigation Enact’s loss mitigation and claims department is led by seasoned personnel who are supported by default tracking and claims processing capabilities within their integrated platform. Enact’s loss mitigation staff is also actively engaged with the GSEs and servicers regarding appropriate servicing and loss mitigation practices. Enact has granted loss mitigation delegation to the GSEs and servicers, whereby they perform certain loss mitigation efforts on Enact’s behalf. Moreover, the Consumer Financial Protection Bureau’s (“CFPB”) mortgage servicing rule obligates servicers to engage in early intervention and loss mitigation efforts with a borrower prior to foreclosure. These efforts have traditionally involved loan modifications intended to enable qualified borrowers to make restructured loan payments or sell the property, thereby potentially reducing claim amounts. Borrower forbearance plans offered by the GSEs, including as a result of the coronavirus pandemic (“COVID-19”), allow deferred or reduced payments for borrowers experiencing financial hardship under certain circumstances. At the conclusion of the forbearance term, a borrower may either bring the loan current, defer any missed payments until the end of the loan, or modify the loan through a repayment plan or extension of the mortgage term. Enact’s goal is to keep borrowers in their homes. If a loan becomes delinquent, Enact works closely with the customer, investor and servicer to attempt to cure the delinquency and allow the homeowner to retain ownership of the property. Claims result from delinquencies that are not cured, or from losses on short sales, other third-party sales or deeds-in-lieu of foreclosure that Enact approves. Under the terms of Enact’s primary insurance master policy, customers are required to file claims within 60 days of the earliest of: (i) the date the customer acquired title to the underlying property (typically through foreclosure); (ii) the date of an approved short sale (or other third- party sale of the underlying property); or (iii) the date a request is made by Enact to file a claim. Upon review and determination that a filed claim is valid, Enact may pay the coverage percentage specified in the certificate of insurance and related expenses, pay the amount of the claim required to make the customer whole, commonly referred to as the “actual loss amount,” following the approved sale or pay the full claim amount and acquire title to the property. Claim activity is not evenly spread across the coverage period of loans Enact insures. The number of delinquencies may not correlate directly with the number of claims received because the rate at which delinquencies are cured is influenced by borrowers’ financial resources and circumstances, as well as regional economic differences. For those loans that fail to cure, whether delinquency leads to a claim principally depends upon the borrower’s equity at the time of delinquency and the borrower’s or the insured’s ability to sell the home for an amount sufficient to satisfy all amounts due under the mortgage loan. When claim notices are received, Enact reviews the loan and servicing files to determine the appropriateness of a claim amount. Failure to deliver the required documentation or Enact’s review of such documentation may result in a rescission, cancellation or claim denial. Enact’s insurance policies allow for the reduction or denial of a claim if the servicer does not materially comply with its obligations under Enact’s policies, including the requirement to pursue reasonable loss mitigation actions. Enact also periodically receives claim notices that request coverage for costs and expenses associated with items not covered under its policies, such as losses resulting from property damage to a covered home. Enact actively reviews claim notices to ensure it pays only for covered expenses. A reduction in the claim amount paid relative to the amount requested in the claim notice is deemed to be a curtailment. When reviewing loan and servicing files in connection with the delinquency or claims process, Enact may also decide to rescind coverage of the underlying mortgages or deny payment of claims. Enact’s ability to rescind coverage is limited by the terms of its master policies. Enact may rescind coverage in situations where, among other things, (i) fraudulent misrepresentations were made or materially inaccurate information was provided regarding a borrower’s income, debts, intention to occupy a property or property value or (ii) a loan was originated in material violation of Enact’s underwriting guidelines. Consideration is given to an insured’s appeal of rescinded coverage. If Enact agrees with the appeal, it takes the necessary steps to reinstate insurance coverage and reactivate the loan certificate or otherwise address the issues raised in the appeal. If the parties are unable to agree on the outcome of the appeal, the insured may choose to pursue arbitration or litigation under the terms of the applicable master policy and challenge the results. Subject to applicable limitations in Enact’s policies and by state law, legal challenges to Enact’s actions may be brought several years after the disposal of a claim. From time to time, Enact enters into agreements with policyholders to accelerate claims and negotiate an agreed-upon payment amount for claims on an identified group of delinquent loans. In exchange for the accelerated claim payment, mortgage insurance is canceled, and Enact is discharged from any further liability on the identified loans. Distribution and customers Enact distributes its mortgage insurance products through a dedicated sales force located throughout the United States, including in-house sales representatives. Enact’s sales force utilizes a digital marketing program designed to expand its customer reach beyond traditional sales. Enact’s sales force primarily markets to financial institutions and mortgage originators that impose a requirement for mortgage insurance as part of the borrower’s financing. Enact’s industry presence has enabled it to build active customer relationships with mortgage lenders across the United States. Enact’s customers are broadly diversified by size, type and geography and include large money center banks, non-bank lenders, national and local mortgage bankers, community banks and credit unions. Enact’s principal mortgage insurance customers are originators of residential mortgage loans who typically determine which mortgage insurer or insurers they will use for the placement of mortgage insurance written on loans they originate. For the year ended December 31, 2023, approximately 33% of Enact’s new insurance written was attributable to its largest five lender customers, of which 19% was attributable to its largest customer. Earned premiums from Enact’s largest customer accounted for 10% of Enact’s total revenues for the year ended December 31, 2023. No other customer exceeded 10% of Enact’s new insurance written during 2023 or had earned premiums that accounted for 10% or more of Enact’s total revenues for the year ended December 31, 8 9 Enact delegates to eligible lender customers the ability to underwrite mortgage insurance based on its delegated underwriting guidelines. To perform delegated underwriting, customers must be approved by Enact’s risk management team. Enact regularly performs quality assurance reviews on a statistically significant sample of delegated loans to assess compliance with its guidelines. Enact also offers a post-closing underwriting review when requested by customers for both non-delegated and delegated loans. Upon satisfactory completion of this review, Enact agrees to waive its right to rescind coverage under certain circumstances. Pricing is highly competitive in the mortgage insurance industry, with industry participants competing for market share, customer relationships and overall value. To appropriately align price and risk, dynamic pricing engines utilize granular pricing models based on a number of loan, borrower, lender and property risk attributes. Enact’s risk-based pricing engine was developed to evaluate returns and volatility under both the private mortgage insurer eligibility requirements (“PMIERs”) capital framework and its internal economic capital framework, which is sensitive to economic cycles and current housing market conditions. The model assesses the performance of new business under expected and stress scenarios on an individualized loan basis, which is used to determine pricing and inform Enact’s risk selection strategy that seeks to optimize economic value by balancing return and volatility. Enact seeks to charge premium rates commensurate with the underlying risk of each loan insured. Enact’s proprietary pricing platform provides a flexible, granular and analytical approach to selecting and pricing risk and its use allows Enact to adjust its risk tolerance by quickly changing prices in response to evolving economic conditions, new analytical insights or industry pricing trends. Loss mitigation Enact’s loss mitigation and claims department is led by seasoned personnel who are supported by default tracking and claims processing capabilities within their integrated platform. Enact’s loss mitigation staff is also actively engaged with the GSEs and servicers regarding appropriate servicing and loss mitigation practices. Enact has granted loss mitigation delegation to the GSEs and servicers, whereby they perform certain loss mitigation efforts on Enact’s behalf. Moreover, the Consumer Financial Protection Bureau’s (“CFPB”) mortgage servicing rule obligates servicers to engage in early intervention and loss mitigation efforts with a borrower prior to foreclosure. These efforts have traditionally involved loan modifications intended to enable qualified borrowers to make restructured loan payments or sell the property, thereby potentially reducing claim amounts. Borrower forbearance plans offered by the GSEs, including as a result of the coronavirus pandemic (“COVID-19”), allow deferred or reduced payments for borrowers experiencing financial hardship under certain circumstances. At the conclusion of the forbearance term, a borrower may either bring the loan current, defer any missed payments until the end of the loan, or modify the loan through a repayment plan or extension of the mortgage term. Enact’s goal is to keep borrowers in their homes. If a loan becomes delinquent, Enact works closely with the customer, investor and servicer to attempt to cure the delinquency and allow the homeowner to retain ownership of the property. Claims result from delinquencies that are not cured, or from losses on short sales, other third-party sales or deeds-in-lieu of foreclosure that Enact approves. Under the terms of Enact’s primary insurance master policy, customers are required to file claims within 60 days of the earliest of: (i) the date the customer acquired title to the underlying property (typically through foreclosure); (ii) the date of an approved short sale (or other third- party sale of the underlying property); or (iii) the date a request is made by Enact to file a claim. Upon review and determination that a filed claim is valid, Enact may pay the coverage percentage specified in the certificate of insurance and related expenses, pay the amount of the claim required to make the customer whole, commonly referred to as the “actual loss amount,” following the approved sale or pay the full claim amount and acquire title to the property. Claim activity is not evenly spread across the coverage period of loans Enact insures. The number of delinquencies may not correlate directly with the number of claims received because the rate at which delinquencies are cured is influenced by borrowers’ financial resources and circumstances, as well as regional economic differences. For those loans that fail to cure, whether delinquency leads to a claim principally depends upon the borrower’s equity at the time of delinquency and the borrower’s or the insured’s ability to sell the home for an amount sufficient to satisfy all amounts due under the mortgage loan. When claim notices are received, Enact reviews the loan and servicing files to determine the appropriateness of a claim amount. Failure to deliver the required documentation or Enact’s review of such documentation may result in a rescission, cancellation or claim denial. Enact’s insurance policies allow for the reduction or denial of a claim if the servicer does not materially comply with its obligations under Enact’s policies, including the requirement to pursue reasonable loss mitigation actions. Enact also periodically receives claim notices that request coverage for costs and expenses associated with items not covered under its policies, such as losses resulting from property damage to a covered home. Enact actively reviews claim notices to ensure it pays only for covered expenses. A reduction in the claim amount paid relative to the amount requested in the claim notice is deemed to be a curtailment. When reviewing loan and servicing files in connection with the delinquency or claims process, Enact may also decide to rescind coverage of the underlying mortgages or deny payment of claims. Enact’s ability to rescind coverage is limited by the terms of its master policies. Enact may rescind coverage in situations where, among other things, (i) fraudulent misrepresentations were made or materially inaccurate information was provided regarding a borrower’s income, debts, intention to occupy a property or property value or (ii) a loan was originated in material violation of Enact’s underwriting guidelines. Consideration is given to an insured’s appeal of rescinded coverage. If Enact agrees with the appeal, it takes the necessary steps to reinstate insurance coverage and reactivate the loan certificate or otherwise address the issues raised in the appeal. If the parties are unable to agree on the outcome of the appeal, the insured may choose to pursue arbitration or litigation under the terms of the applicable master policy and challenge the results. Subject to applicable limitations in Enact’s policies and by state law, legal challenges to Enact’s actions may be brought several years after the disposal of a claim. From time to time, Enact enters into agreements with policyholders to accelerate claims and negotiate an agreed-upon payment amount for claims on an identified group of delinquent loans. In exchange for the accelerated claim payment, mortgage insurance is canceled, and Enact is discharged from any further liability on the identified loans. Distribution and customers Enact distributes its mortgage insurance products through a dedicated sales force located throughout the United States, including in-house sales representatives. Enact’s sales force utilizes a digital marketing program designed to expand its customer reach beyond traditional sales. Enact’s sales force primarily markets to financial institutions and mortgage originators that impose a requirement for mortgage insurance as part of the borrower’s financing. Enact’s industry presence has enabled it to build active customer relationships with mortgage lenders across the United States. Enact’s customers are broadly diversified by size, type and geography and include large money center banks, non-bank lenders, national and local mortgage bankers, community banks and credit unions. Enact’s principal mortgage insurance customers are originators of residential mortgage loans who typically determine which mortgage insurer or insurers they will use for the placement of mortgage insurance written on loans they originate. For the year ended December 31, 2023, approximately 33% of Enact’s new insurance written was attributable to its largest five lender customers, of which 19% was attributable to its largest customer. Earned premiums from Enact’s largest customer accounted for 10% of Enact’s total revenues for the year ended December 31, 2023. No other customer exceeded 10% of Enact’s new insurance written during 2023 or had earned premiums that accounted for 10% or more of Enact’s total revenues for the year ended December 31, 8 9 2023. For more information on the potential impacts due to customer concentration, see “Item 1A—Risk Factors—Enact Holdings’ reliance on key customers or distribution relationships could cause a loss of significant sales if one or more of those relationships terminate or are reduced.” Competition Enact’s principal sources of competition are U.S. federal, state and local government agencies and other private mortgage insurers. Enact also competes with mortgage lenders and other investors, the GSEs, portfolio lenders who self-insure, reinsurers, and other capital markets participants who may utilize financial instruments designed to mitigate risk. U.S. federal, state and local government agencies Enact and other private mortgage insurers compete for mortgage insurance business directly with U.S. federal agencies, principally the Federal Housing Administration (“FHA”) and the U.S. Department of Veterans Affairs (“VA”), and to a lesser extent, state and local housing finance agencies. Enact’s competition with government agencies is principally on the basis of price and underwriting guidelines. In contrast to private mortgage insurers, government agencies generally have less restrictive guidelines and apply a flat pricing structure regardless of an individual borrower’s credit profile. As a result, we believe borrowers with lower FICO scores are more likely to secure mortgage loans with coverage by government agencies and borrowers with higher FICO scores are more likely to secure mortgage loans with coverage by private mortgage insurers. Private mortgage insurers The U.S. private mortgage insurance industry is highly competitive. Enact competes on pricing, underwriting guidelines, customer relationships, service levels, policy terms, loss mitigation practices, perceived financial strength (including comparative financial strength ratings), reputation, product features, and effective use and ease of technology. There are currently six active mortgage insurers in the United States, including Enact. GSEs, portfolio lenders, reinsurers and other capital markets participants Enact also competes with various participants in the mortgage finance industry including the GSEs, portfolio lenders, reinsurers and other participants in the capital markets. Enact competes with these participants primarily based on pricing, policy terms and perceived financial strength. The GSEs enter into risk sharing transactions with financial institutions designed to reduce the risk of their mortgage portfolios. Competition also comes from portfolio lenders that are willing to hold credit risk on their balance sheets without credit enhancement. In addition, investors can make use of risk-sharing structures designed to mitigate the impact of mortgage defaults in place of private mortgage insurance. Finally, although their presence is a fraction of what it was in the past, there are products designed to eliminate the need for private mortgage insurance, such as “simultaneous seconds,” which combine a first lien loan with a second lien loan in order to meet the 80% loan-to-value threshold required for sale to the GSEs without certain credit protections. Long-Term Care Insurance Segment Our Long-Term Care Insurance segment includes long-term care insurance products that are intended to protect against the significant and escalating costs of long-term care services provided in the insured’s home or assisted living or nursing facilities. We currently offer individual long-term care insurance policies to customers who contact us directly (subject to state availability); however, we no longer accept applications for new group long-term care insurance policies but will accept new applications and issue new coverage certificates on current open group cases on certain group policy forms. We established ourselves as a leader in long-term care insurance over 40 years ago and remain a leading insurer. As part of our strategy for our long-term care insurance business, and in connection with our strategic priority to further strengthen our legacy long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions on older generation blocks of business in order to ensure the continued self-sustainability of this business over time and reduce the strain on its earnings and capital. We are also requesting premium rate increases and associated benefit reductions on newer blocks of business, as needed, some of which will be significant, to help bring these blocks closer to their original pricing. For certain risks related to our long-term care insurance business and in-force rate actions, see “Item 1A—Risk Factors—The inability to obtain in-force rate action increases (including increased premiums and associated benefit reductions) in our long-term care insurance business could have a material adverse impact on our business, including our results of operations and financial condition.” See “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Long-Term Care Insurance segment” for selected operating performance measures related to our long-term care insurance in-force rate actions. Life and Annuities Segment We service a variety of protection and retirement income products through our principal U.S. life insurance subsidiaries. Our Life and Annuities segment includes traditional and non-traditional life insurance (term, universal and term universal life insurance as well as corporate-owned life insurance and funding agreements), fixed annuities and variable annuities. We have not actively sold our life insurance and fixed annuity products since 2016 and our variable annuity products since 2011. Corporate and Other Corporate and Other includes debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other businesses that are reported outside of our operating segments, such as certain international businesses and discontinued operations. Corporate and Other also includes startup results of our CareScout business related to our senior care growth initiatives. See “Item 1—Business—Strategic Priorities” for additional details. On March 3, 2021, we completed a sale of our entire ownership interest of approximately 52% in Genworth Mortgage Insurance Australia Limited, our former Australian mortgage insurance business. This business is reported as discontinued operations and its results of operations and cash flows are separately reported for the year ended December 31, 2021. See note 28 in our consolidated financial statements under “Part II—Item 8— Financial Statements and Supplementary Data” for additional information. Risk Management Risk management is a critical part of all of our businesses. We have an enterprise risk management framework that includes risk management processes relating to strategic priorities and risks (including emerging risks), product development and pricing, management of in-force business, including certain mitigating strategies and claims risk management, credit risk management, asset-liability management, liquidity management, investment activities (including derivatives), model risk management, portfolio diversification, underwriting and loss mitigation, information systems, information technology risk management, data security and cybersecurity, business acquisitions and dispositions, operational risk assessment capabilities and overall operational risk management. For additional information regarding cybersecurity risk management, see “Item 1C— Cybersecurity.” We have identified the following as the most significant risk types to our business: credit risk, market risk, insurance risk, housing risk, model risk, operational risk and information technology risk. In addition, we have processes in place to identify, understand and manage emerging risks (such as artificial intelligence), with the 10 11 2023. For more information on the potential impacts due to customer concentration, see “Item 1A—Risk Factors—Enact Holdings’ reliance on key customers or distribution relationships could cause a loss of significant sales if one or more of those relationships terminate or are reduced.” Competition Enact’s principal sources of competition are U.S. federal, state and local government agencies and other private mortgage insurers. Enact also competes with mortgage lenders and other investors, the GSEs, portfolio lenders who self-insure, reinsurers, and other capital markets participants who may utilize financial instruments designed to mitigate risk. U.S. federal, state and local government agencies Enact and other private mortgage insurers compete for mortgage insurance business directly with U.S. federal agencies, principally the Federal Housing Administration (“FHA”) and the U.S. Department of Veterans Affairs (“VA”), and to a lesser extent, state and local housing finance agencies. Enact’s competition with government agencies is principally on the basis of price and underwriting guidelines. In contrast to private mortgage insurers, government agencies generally have less restrictive guidelines and apply a flat pricing structure regardless of an individual borrower’s credit profile. As a result, we believe borrowers with lower FICO scores are more likely to secure mortgage loans with coverage by government agencies and borrowers with higher FICO scores are more likely to secure mortgage loans with coverage by private mortgage insurers. Private mortgage insurers The U.S. private mortgage insurance industry is highly competitive. Enact competes on pricing, underwriting guidelines, customer relationships, service levels, policy terms, loss mitigation practices, perceived financial strength (including comparative financial strength ratings), reputation, product features, and effective use and ease of technology. There are currently six active mortgage insurers in the United States, including Enact. GSEs, portfolio lenders, reinsurers and other capital markets participants Enact also competes with various participants in the mortgage finance industry including the GSEs, portfolio lenders, reinsurers and other participants in the capital markets. Enact competes with these participants primarily based on pricing, policy terms and perceived financial strength. The GSEs enter into risk sharing transactions with financial institutions designed to reduce the risk of their mortgage portfolios. Competition also comes from portfolio lenders that are willing to hold credit risk on their balance sheets without credit enhancement. In addition, investors can make use of risk-sharing structures designed to mitigate the impact of mortgage defaults in place of private mortgage insurance. Finally, although their presence is a fraction of what it was in the past, there are products designed to eliminate the need for private mortgage insurance, such as “simultaneous seconds,” which combine a first lien loan with a second lien loan in order to meet the 80% loan-to-value threshold required for sale to the GSEs without certain credit protections. Long-Term Care Insurance Segment Our Long-Term Care Insurance segment includes long-term care insurance products that are intended to protect against the significant and escalating costs of long-term care services provided in the insured’s home or assisted living or nursing facilities. We currently offer individual long-term care insurance policies to customers who contact us directly (subject to state availability); however, we no longer accept applications for new group long-term care insurance policies but will accept new applications and issue new coverage certificates on current open group cases on certain group policy forms. We established ourselves as a leader in long-term care insurance over 40 years ago and remain a leading insurer. As part of our strategy for our long-term care insurance business, and in connection with our strategic priority to further strengthen our legacy long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions on older generation blocks of business in order to ensure the continued self-sustainability of this business over time and reduce the strain on its earnings and capital. We are also requesting premium rate increases and associated benefit reductions on newer blocks of business, as needed, some of which will be significant, to help bring these blocks closer to their original pricing. For certain risks related to our long-term care insurance business and in-force rate actions, see “Item 1A—Risk Factors—The inability to obtain in-force rate action increases (including increased premiums and associated benefit reductions) in our long-term care insurance business could have a material adverse impact on our business, including our results of operations and financial condition.” See “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Long-Term Care Insurance segment” for selected operating performance measures related to our long-term care insurance in-force rate actions. Life and Annuities Segment We service a variety of protection and retirement income products through our principal U.S. life insurance subsidiaries. Our Life and Annuities segment includes traditional and non-traditional life insurance (term, universal and term universal life insurance as well as corporate-owned life insurance and funding agreements), fixed annuities and variable annuities. We have not actively sold our life insurance and fixed annuity products since 2016 and our variable annuity products since 2011. Corporate and Other Corporate and Other includes debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other businesses that are reported outside of our operating segments, such as certain international businesses and discontinued operations. Corporate and Other also includes startup results of our CareScout business related to our senior care growth initiatives. See “Item 1—Business—Strategic Priorities” for additional details. On March 3, 2021, we completed a sale of our entire ownership interest of approximately 52% in Genworth Mortgage Insurance Australia Limited, our former Australian mortgage insurance business. This business is reported as discontinued operations and its results of operations and cash flows are separately reported for the year ended December 31, 2021. See note 28 in our consolidated financial statements under “Part II—Item 8— Financial Statements and Supplementary Data” for additional information. Risk Management Risk management is a critical part of all of our businesses. We have an enterprise risk management framework that includes risk management processes relating to strategic priorities and risks (including emerging risks), product development and pricing, management of in-force business, including certain mitigating strategies and claims risk management, credit risk management, asset-liability management, liquidity management, investment activities (including derivatives), model risk management, portfolio diversification, underwriting and loss mitigation, information systems, information technology risk management, data security and cybersecurity, business acquisitions and dispositions, operational risk assessment capabilities and overall operational risk management. For additional information regarding cybersecurity risk management, see “Item 1C— Cybersecurity.” We have identified the following as the most significant risk types to our business: credit risk, market risk, insurance risk, housing risk, model risk, operational risk and information technology risk. In addition, we have processes in place to identify, understand and manage emerging risks (such as artificial intelligence), with the 10 11 goal of mitigating adverse impacts to our business. Related to these identified risk types and our process for emerging risks, we have classified both our top and emerging risks and report these risks to both senior management and the risk committee of Genworth Financial’s Board of Directors. Our risk management framework includes seven key components: risk type key attributes (to ensure full coverage); identification of risk exposures to identify top risks; business strategy and planning; governance; risk assessment (both qualitative and quantitative); risk appetite and limits; and stress testing. Our risk management framework also includes an assessment and implementation of company and business risk appetites, the identification and assessment of risks, a proactive decision process to determine which risks are acceptable to be retained (based on risk and reward considerations, among other factors) and the ongoing management, monitoring and reporting of material risks. Our long-term care insurance business continues to pursue significant premium rate increases and associated benefit reductions on its insurance in-force. In support of this initiative, we have developed processes that include experience studies to analyze emerging experience, reviews of in-force product performance, an assumption review process, and comprehensive monitoring and reporting. In connection with these processes, our risk management team works closely with our long-term care insurance business to ensure proper governance and to better align the development of assumptions with the identified risks. As part of our evaluation of overall in-force product performance, new product initiatives and service offerings, and risk mitigation alternatives, we monitor regulatory and rating agency capital models as well as internal economic capital models to determine the appropriate level of risk-adjusted capital requirements. We utilize a stress testing framework to assess the risk of loss to our capital resources based upon the portfolio of risks we underwrite and retain and upon our asset and operational risk profiles. Our commitment to risk management involves the ongoing review and expansion of internal risk management capabilities aligned with industry best practices. Operations and Technology Service and support Enact Holdings and its U.S. mortgage insurance subsidiaries have introduced technology enabled services to help their customers (lenders and servicers) as well as consumers (borrowers and homeowners). Enact Holdings heavily relies upon information technology, and a number of critical aspects are highly automated. Our U.S. life insurance subsidiaries heavily rely upon information technology to support and improve their overall operations. Enact Holdings and our U.S. life insurance subsidiaries both accept insurance applications, issue approvals, process claims and reconcile premium remittance through electronic submissions. For Enact Holdings, in order to facilitate these processes, direct connections have been established with many of its customers’ and servicers’ systems to enable the selection of its mortgage insurance products and to allow for direct communication. Enact Holdings and our U.S. life insurance subsidiaries also provide their customers secure access to their web-based portals to facilitate transactions and provide customers with access to their account information. Enact Holdings and our U.S. life insurance subsidiaries regularly upgrade and enhance their systems and technology in an effort to achieve their goals of expanding their capabilities, improve productivity and enhance the customer experience. Operating centers We have established scalable, efficient operating centers for our U.S. life insurance subsidiaries in Virginia and for Enact Holdings in North Carolina. In addition, through an arrangement with an outsourcing provider, we have a team of professionals in India and the Philippines who provide a variety of services primarily to our U.S. life insurance subsidiaries and certain corporate functions, including data entry, transaction processing and functional support. In June 2022, we outsourced operational servicing of our life insurance and fixed annuity blocks to a third- party servicer. In connection with the outsourcing, we will convert certain administrative systems to those used by the third-party servicer over the next few years, with a targeted completion date in 2026. There was no impact to the servicing of our long-term care insurance products because they were not a part of the third-party outsourcing agreement. Reinsurance We reinsure a portion of our annuities, life insurance, long-term care insurance and mortgage insurance with unaffiliated reinsurers, and beginning in 2023, also established an affiliated reinsurer, Enact Re Ltd. (“Enact Re”). In a reinsurance transaction, a reinsurer agrees to indemnify another insurer for part or all of its liability under a policy or policies it has issued for an agreed upon premium. We participate in reinsurance activities in order to minimize exposure to significant risks, limit losses and provide additional capacity for future growth. We also obtain reinsurance to reduce certain capital requirements, including sometimes utilizing intercompany reinsurance agreements to manage our statutory capital positions. However, these intercompany agreements do not have an effect on our consolidated U.S. generally accepted accounting principles (“U.S. GAAP”) financial statements as they eliminate in consolidation. We enter into various agreements with reinsurers that cover individual risks, group risks or defined blocks of business, primarily on a coinsurance, yearly renewable term, excess of loss or quota share basis. Under the terms of the reinsurance agreements, the reinsurer agrees to reimburse us for the ceded amount in the event a claim is paid. Cessions under reinsurance agreements do not discharge our obligations as the primary insurer. In the event that reinsurers do not meet their obligations under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. Our amounts recoverable from reinsurers represent receivables from and/or reserves ceded to reinsurers. The amounts recoverable from reinsurers, net of allowance for credit losses, were $19.0 billion as of December 31, 2023 and 2022. We focus on obtaining reinsurance from a diverse group of highly rated reinsurers. We regularly evaluate the financial condition of our reinsurers and monitor concentration risk with our reinsurers at least annually. U.S. life insurance subsidiaries Our U.S. life insurance subsidiaries have established standards and criteria for our use and selection of reinsurers. In order for a new reinsurer to participate in our current program, without collateralization, we require the reinsurer to have a S&P Global Rating (“S&P”) rating of “A-” or better or a Moody’s Investors Service, Inc. (“Moody’s”) rating of “A3” or better and a minimum capital and surplus level of $350 million. If the reinsurer does not have these ratings, our U.S. life insurance subsidiaries generally require it to post collateral as described below. In addition, our U.S. life insurance subsidiaries may require collateral from a reinsurer to mitigate credit/ collectability risk. Typically, in such cases, the reinsurer must either maintain minimum specified ratings and risk-based capital (“RBC”) ratios or provide the specified quality and quantity of collateral. Similarly, our U.S. life insurance subsidiaries have also required collateral in connection with books of business sold pursuant to indemnity reinsurance agreements and have been required to post collateral when purchasing books of business. Reinsurers that are not licensed, accredited or authorized in the state of domicile of the reinsured (“ceding company”) are required to post statutorily prescribed forms of collateral for the ceding company to receive reinsurance credit. The three primary forms of collateral are: (i) qualifying assets held in a reserve credit trust; (ii) irrevocable, unconditional, evergreen letters of credit issued by a qualified U.S. financial institution; and (iii) assets held by the ceding company in a segregated funds withheld account. Collateral must be maintained in accordance with the rules of the ceding company’s state of domicile and must be readily accessible by the ceding company to cover claims under the reinsurance agreement. Accordingly, our U.S. life insurance subsidiaries require unauthorized reinsurers that are not so licensed, accredited or authorized to post acceptable forms of collateral to support their reinsurance obligations. 12 13 goal of mitigating adverse impacts to our business. Related to these identified risk types and our process for emerging risks, we have classified both our top and emerging risks and report these risks to both senior management and the risk committee of Genworth Financial’s Board of Directors. by the third-party servicer over the next few years, with a targeted completion date in 2026. There was no impact to the servicing of our long-term care insurance products because they were not a part of the third-party outsourcing agreement. Our risk management framework includes seven key components: risk type key attributes (to ensure full coverage); identification of risk exposures to identify top risks; business strategy and planning; governance; risk assessment (both qualitative and quantitative); risk appetite and limits; and stress testing. Our risk management framework also includes an assessment and implementation of company and business risk appetites, the identification and assessment of risks, a proactive decision process to determine which risks are acceptable to be retained (based on risk and reward considerations, among other factors) and the ongoing management, monitoring and reporting of material risks. Our long-term care insurance business continues to pursue significant premium rate increases and associated benefit reductions on its insurance in-force. In support of this initiative, we have developed processes that include experience studies to analyze emerging experience, reviews of in-force product performance, an assumption review process, and comprehensive monitoring and reporting. In connection with these processes, our risk management team works closely with our long-term care insurance business to ensure proper governance and to better align the development of assumptions with the identified risks. As part of our evaluation of overall in-force product performance, new product initiatives and service offerings, and risk mitigation alternatives, we monitor regulatory and rating agency capital models as well as internal economic capital models to determine the appropriate level of risk-adjusted capital requirements. We utilize a stress testing framework to assess the risk of loss to our capital resources based upon the portfolio of risks we underwrite and retain and upon our asset and operational risk profiles. Our commitment to risk management involves the ongoing review and expansion of internal risk management capabilities aligned with industry best practices. Operations and Technology Service and support Enact Holdings and its U.S. mortgage insurance subsidiaries have introduced technology enabled services to help their customers (lenders and servicers) as well as consumers (borrowers and homeowners). Enact Holdings heavily relies upon information technology, and a number of critical aspects are highly automated. Our U.S. life insurance subsidiaries heavily rely upon information technology to support and improve their overall operations. Enact Holdings and our U.S. life insurance subsidiaries both accept insurance applications, issue approvals, process claims and reconcile premium remittance through electronic submissions. For Enact Holdings, in order to facilitate these processes, direct connections have been established with many of its customers’ and servicers’ systems to enable the selection of its mortgage insurance products and to allow for direct communication. Enact Holdings and our U.S. life insurance subsidiaries also provide their customers secure access to their web-based portals to facilitate transactions and provide customers with access to their account information. Enact Holdings and our U.S. life insurance subsidiaries regularly upgrade and enhance their systems and technology in an effort to achieve their goals of expanding their capabilities, improve productivity and enhance the customer experience. Operating centers We have established scalable, efficient operating centers for our U.S. life insurance subsidiaries in Virginia and for Enact Holdings in North Carolina. In addition, through an arrangement with an outsourcing provider, we have a team of professionals in India and the Philippines who provide a variety of services primarily to our U.S. life insurance subsidiaries and certain corporate functions, including data entry, transaction processing and functional support. In June 2022, we outsourced operational servicing of our life insurance and fixed annuity blocks to a third- party servicer. In connection with the outsourcing, we will convert certain administrative systems to those used Reinsurance We reinsure a portion of our annuities, life insurance, long-term care insurance and mortgage insurance with unaffiliated reinsurers, and beginning in 2023, also established an affiliated reinsurer, Enact Re Ltd. (“Enact Re”). In a reinsurance transaction, a reinsurer agrees to indemnify another insurer for part or all of its liability under a policy or policies it has issued for an agreed upon premium. We participate in reinsurance activities in order to minimize exposure to significant risks, limit losses and provide additional capacity for future growth. We also obtain reinsurance to reduce certain capital requirements, including sometimes utilizing intercompany reinsurance agreements to manage our statutory capital positions. However, these intercompany agreements do not have an effect on our consolidated U.S. generally accepted accounting principles (“U.S. GAAP”) financial statements as they eliminate in consolidation. We enter into various agreements with reinsurers that cover individual risks, group risks or defined blocks of business, primarily on a coinsurance, yearly renewable term, excess of loss or quota share basis. Under the terms of the reinsurance agreements, the reinsurer agrees to reimburse us for the ceded amount in the event a claim is paid. Cessions under reinsurance agreements do not discharge our obligations as the primary insurer. In the event that reinsurers do not meet their obligations under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. Our amounts recoverable from reinsurers represent receivables from and/or reserves ceded to reinsurers. The amounts recoverable from reinsurers, net of allowance for credit losses, were $19.0 billion as of December 31, 2023 and 2022. We focus on obtaining reinsurance from a diverse group of highly rated reinsurers. We regularly evaluate the financial condition of our reinsurers and monitor concentration risk with our reinsurers at least annually. U.S. life insurance subsidiaries Our U.S. life insurance subsidiaries have established standards and criteria for our use and selection of reinsurers. In order for a new reinsurer to participate in our current program, without collateralization, we require the reinsurer to have a S&P Global Rating (“S&P”) rating of “A-” or better or a Moody’s Investors Service, Inc. (“Moody’s”) rating of “A3” or better and a minimum capital and surplus level of $350 million. If the reinsurer does not have these ratings, our U.S. life insurance subsidiaries generally require it to post collateral as described below. In addition, our U.S. life insurance subsidiaries may require collateral from a reinsurer to mitigate credit/ collectability risk. Typically, in such cases, the reinsurer must either maintain minimum specified ratings and risk-based capital (“RBC”) ratios or provide the specified quality and quantity of collateral. Similarly, our U.S. life insurance subsidiaries have also required collateral in connection with books of business sold pursuant to indemnity reinsurance agreements and have been required to post collateral when purchasing books of business. Reinsurers that are not licensed, accredited or authorized in the state of domicile of the reinsured (“ceding company”) are required to post statutorily prescribed forms of collateral for the ceding company to receive reinsurance credit. The three primary forms of collateral are: (i) qualifying assets held in a reserve credit trust; (ii) irrevocable, unconditional, evergreen letters of credit issued by a qualified U.S. financial institution; and (iii) assets held by the ceding company in a segregated funds withheld account. Collateral must be maintained in accordance with the rules of the ceding company’s state of domicile and must be readily accessible by the ceding company to cover claims under the reinsurance agreement. Accordingly, our U.S. life insurance subsidiaries require unauthorized reinsurers that are not so licensed, accredited or authorized to post acceptable forms of collateral to support their reinsurance obligations. 12 13 The following table sets forth our exposure, represented by the amount of reinsurance recoverable measured loss reinsurance relating to GSE credit risk transfer and reinsured EMICO’s new and existing insurance in-force at the locked-in discount rate owed by the principal reinsurers to our U.S. life insurance subsidiaries as of December 31, 2023: (Amounts in millions) UFLIC (1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . RGA Reinsurance Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . General Reinsurance Corporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Riversource Life Insurance Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . SCOR Global Life USA Reinsurance Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Reinsurance recoverable $13,020 2,262 656 348 333 (1) We have several significant reinsurance transactions with Union Fidelity Life Insurance Company (“UFLIC”), an affiliate of General Electric Company (“GE”), which results in a significant concentration of reinsurance risk. UFLIC’s obligations to us are secured by trust accounts. See note 9 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional details. External new business reinsurance is dependent on a number of factors, including price, availability, risk tolerance and capital levels. For additional information on our reinsurance agreements and the associated risks and impacts on our business, see “Item 1A—Risk Factors—Reinsurance may not be available, affordable or adequate to protect us against losses.” Enact Enact Holdings, through Enact Mortgage Insurance Corporation (“EMICO”), its principal U.S. mortgage insurance subsidiary, cedes a portion of its mortgage insurance risk to reduce the risk of loss and to obtain capital credit towards the financial requirements of the GSEs’ PMIERs. Enact Holdings’ credit risk transfer program distributes risk to highly rated counterparties through its traditional reinsurance program, as well as to insurance- linked note investors via fully collateralized special purpose reinsurance vehicles. Its traditional reinsurance program utilizes excess of loss and quota share insurance coverage. Enact Holdings’ excess of loss reinsurance transactions generally cover a subset of loans in a given book year where typically both the attachment and detachment points of the ceded risk tier are within the PMIERs capital requirements at inception, providing both loss volatility protection and PMIERs capital credit. Each reinsurance treaty has a term of ten years or more and provides a unilateral right to commute prior to the full term, subject to certain performance triggers. Enact Holdings selects the type and structure of the credit risk transfer transactions based on a variety of factors including, but not limited to, capacity, cost, flexibility, sustainability and diversification. Under Enact Holdings’ quota share reinsurance agreements, the reinsurer receives a premium in exchange for covering an agreed-upon portion of incurred losses. Since 2015 and through December 31, 2023, Enact Holdings has executed $5.0 billion of excess of loss transactions across both traditional reinsurance arrangements and insurance-linked note transactions and $1.9 billion of ceded risk in-force through quota share transactions. Enact Holdings’ credit risk transfer program provided an estimated aggregate of $1.7 billion of PMIERs capital credit as of December 31, 2023. Enact Holdings’ traditional reinsurance coverage is provided by a panel of reinsurance partners each currently rated “A-” or better by Moody’s, S&P or A.M. Best Company, Inc. (“A.M. Best”). These reinsurers are contractually required to collateralize a portion (typically 20% to 30%) of the reinsurance exposures consistent with PMIERs. In 2023, EMICO contributed $500 million into Enact Re, its wholly owned Bermuda-based subsidiary. Enact Re is expected to create value by addressing the opportunity for favorable risk-adjusted returns in the GSE credit risk transfer market and leverage affiliate quota share reinsurance for ratings and capital efficiency. Enact Re is expected to have a minimal impact on Enact’s overall expense structure and is anticipated to contribute to Enact’s increasing statutory dividend capacity over time. As of December 31, 2023, Enact Re assumed excess of under quota share reinsurance agreements. For additional information related to reinsurance, see note 9 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Ratings Financial Strength Ratings Ratings with respect to the financial strength of operating subsidiaries are an important factor in establishing the competitive position of insurance companies. Ratings are important to maintaining public confidence in us and our ability to market our products. Rating organizations review the financial performance and condition of most insurers and provide opinions regarding financial strength, operating performance and ability to meet obligations to policyholders. As of February 27, 2024, EMICO was rated in terms of financial strength as follows: Rating Agency Rating Rating categories S&P . . . . . . . . . . . . . . . . . . . . . . . . . . Moody’s . . . . . . . . . . . . . . . . . . . . . . . Fitch Ratings, Inc. (“Fitch”) . . . . . . . A.M. Best . . . . . . . . . . . . . . . . . . . . . . A- (7th highest of 21) A3 (7th highest of 21) A- (7th highest of 21) A- (4th highest of 13) AAA to D Aaa to C AAA to C A++ to D As of February 27, 2024, our principal life insurance subsidiaries were rated in terms of financial strength by A.M. Best as follows: Company Genworth Life Insurance Company (“GLIC”) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C++ (9th highest of 13) Genworth Life and Annuity Insurance Company (“GLAIC”) . . . . . . . . . . . . . . . . . . . . . B- (8th highest of 13) Genworth Life Insurance Company of New York (“GLICNY”) . . . . . . . . . . . . . . . . . . . C++ (9th highest of 13) The financial strength ratings of our operating companies are not designed to be, and do not serve as, measures of protection or valuation offered to investors. These financial strength ratings should not be relied on with respect to making an investment in our securities. A.M. Best rating Credit Ratings In addition to the financial strength ratings for our operating subsidiaries, rating agencies also assign credit ratings to the debt issued by our intermediate holding company, Genworth Holdings. In addition, S&P and A.M. Best assign credit ratings to Genworth Financial. These ratings are typically notched lower than the financial strength ratings of our primary operating subsidiaries, reflecting Genworth Holdings’ reliance on dividends from the operating subsidiaries to service its debt obligations. The unsecured debt ratings may be used in evaluating Genworth Holdings’ debt as a fixed-income investment and are only disclosed by us given their potential impact on our business, including their potential to affect, among other things, our ability to raise capital through the issuance of debt and other forms of credit. These credit ratings may change at any time and should not be relied on as a recommendation with respect to making an investment in our securities. As of February 27, 2024, Genworth Holdings’ senior unsecured debt was assigned the following credit ratings: Rating Agency S&P . . . . . . . . . . . . . . . . . . . . . . . . . . Moody’s . . . . . . . . . . . . . . . . . . . . . . . A.M. Best . . . . . . . . . . . . . . . . . . . . . . BB- (13th highest of 21) Ba1 (11th highest of 21) b+ (14th highest of 21) AAA to D Aaa to C aaa to c Rating Rating categories 14 15 December 31, 2023: (Amounts in millions) UFLIC (1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $13,020 RGA Reinsurance Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,262 General Reinsurance Corporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Riversource Life Insurance Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . SCOR Global Life USA Reinsurance Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 656 348 333 (1) We have several significant reinsurance transactions with Union Fidelity Life Insurance Company (“UFLIC”), an affiliate of General Electric Company (“GE”), which results in a significant concentration of reinsurance risk. UFLIC’s obligations to us are secured by trust accounts. See note 9 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional External new business reinsurance is dependent on a number of factors, including price, availability, risk tolerance and capital levels. For additional information on our reinsurance agreements and the associated risks and impacts on our business, see “Item 1A—Risk Factors—Reinsurance may not be available, affordable or adequate to protect us against losses.” details. Enact Enact Holdings, through Enact Mortgage Insurance Corporation (“EMICO”), its principal U.S. mortgage insurance subsidiary, cedes a portion of its mortgage insurance risk to reduce the risk of loss and to obtain capital credit towards the financial requirements of the GSEs’ PMIERs. Enact Holdings’ credit risk transfer program distributes risk to highly rated counterparties through its traditional reinsurance program, as well as to insurance- linked note investors via fully collateralized special purpose reinsurance vehicles. Its traditional reinsurance program utilizes excess of loss and quota share insurance coverage. Enact Holdings’ excess of loss reinsurance transactions generally cover a subset of loans in a given book year where typically both the attachment and detachment points of the ceded risk tier are within the PMIERs capital requirements at inception, providing both loss volatility protection and PMIERs capital credit. Each reinsurance treaty has a term of ten years or more and provides a unilateral right to commute prior to the full term, subject to certain performance triggers. Enact Holdings selects the type and structure of the credit risk transfer transactions based on a variety of factors including, but not limited to, capacity, cost, flexibility, sustainability and diversification. Under Enact Holdings’ quota share reinsurance agreements, the reinsurer receives a premium in exchange for covering an agreed-upon portion of incurred losses. Since 2015 and through December 31, 2023, Enact Holdings has executed $5.0 billion of excess of loss transactions across both traditional reinsurance arrangements and insurance-linked note transactions and $1.9 billion of ceded risk in-force through quota share transactions. Enact Holdings’ credit risk transfer program provided an estimated aggregate of $1.7 billion of PMIERs capital credit as of December 31, 2023. Enact Holdings’ traditional reinsurance coverage is provided by a panel of reinsurance partners each currently rated “A-” or better by Moody’s, S&P or A.M. Best Company, Inc. (“A.M. Best”). These reinsurers are contractually required to collateralize a portion (typically 20% to 30%) of the reinsurance exposures consistent with PMIERs. In 2023, EMICO contributed $500 million into Enact Re, its wholly owned Bermuda-based subsidiary. Enact Re is expected to create value by addressing the opportunity for favorable risk-adjusted returns in the GSE credit risk transfer market and leverage affiliate quota share reinsurance for ratings and capital efficiency. Enact Re is expected to have a minimal impact on Enact’s overall expense structure and is anticipated to contribute to Enact’s increasing statutory dividend capacity over time. As of December 31, 2023, Enact Re assumed excess of The following table sets forth our exposure, represented by the amount of reinsurance recoverable measured at the locked-in discount rate owed by the principal reinsurers to our U.S. life insurance subsidiaries as of loss reinsurance relating to GSE credit risk transfer and reinsured EMICO’s new and existing insurance in-force under quota share reinsurance agreements. Reinsurance recoverable For additional information related to reinsurance, see note 9 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Ratings Financial Strength Ratings Ratings with respect to the financial strength of operating subsidiaries are an important factor in establishing the competitive position of insurance companies. Ratings are important to maintaining public confidence in us and our ability to market our products. Rating organizations review the financial performance and condition of most insurers and provide opinions regarding financial strength, operating performance and ability to meet obligations to policyholders. As of February 27, 2024, EMICO was rated in terms of financial strength as follows: Rating Agency Rating Rating categories S&P . . . . . . . . . . . . . . . . . . . . . . . . . . Moody’s . . . . . . . . . . . . . . . . . . . . . . . Fitch Ratings, Inc. (“Fitch”) . . . . . . . A.M. Best . . . . . . . . . . . . . . . . . . . . . . A- (7th highest of 21) A3 (7th highest of 21) A- (7th highest of 21) A- (4th highest of 13) AAA to D Aaa to C AAA to C A++ to D As of February 27, 2024, our principal life insurance subsidiaries were rated in terms of financial strength by A.M. Best as follows: Company A.M. Best rating Genworth Life Insurance Company (“GLIC”) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C++ (9th highest of 13) Genworth Life and Annuity Insurance Company (“GLAIC”) . . . . . . . . . . . . . . . . . . . . . B- (8th highest of 13) Genworth Life Insurance Company of New York (“GLICNY”) . . . . . . . . . . . . . . . . . . . C++ (9th highest of 13) The financial strength ratings of our operating companies are not designed to be, and do not serve as, measures of protection or valuation offered to investors. These financial strength ratings should not be relied on with respect to making an investment in our securities. Credit Ratings In addition to the financial strength ratings for our operating subsidiaries, rating agencies also assign credit ratings to the debt issued by our intermediate holding company, Genworth Holdings. In addition, S&P and A.M. Best assign credit ratings to Genworth Financial. These ratings are typically notched lower than the financial strength ratings of our primary operating subsidiaries, reflecting Genworth Holdings’ reliance on dividends from the operating subsidiaries to service its debt obligations. The unsecured debt ratings may be used in evaluating Genworth Holdings’ debt as a fixed-income investment and are only disclosed by us given their potential impact on our business, including their potential to affect, among other things, our ability to raise capital through the issuance of debt and other forms of credit. These credit ratings may change at any time and should not be relied on as a recommendation with respect to making an investment in our securities. As of February 27, 2024, Genworth Holdings’ senior unsecured debt was assigned the following credit ratings: Rating Agency Rating Rating categories S&P . . . . . . . . . . . . . . . . . . . . . . . . . . Moody’s . . . . . . . . . . . . . . . . . . . . . . . A.M. Best . . . . . . . . . . . . . . . . . . . . . . BB- (13th highest of 21) Ba1 (11th highest of 21) b+ (14th highest of 21) AAA to D Aaa to C aaa to c 14 15 Ratings actions regularly evaluating our asset class mix and pursuing additional investment classes when prudent; and • On February 27, 2024, S&P affirmed the credit rating of “BB-” of Genworth Financial and Genworth continuously monitoring asset quality and market conditions that could affect our assets. Holdings with an outlook of stable. • On January 8, 2024, S&P upgraded the financial strength rating of EMICO to “A-” from “BBB+” with an outlook of stable. • On August 1, 2023, A.M. Best assigned an initial public financial strength rating of “A-” to EMICO, with an outlook of stable. • On April 25, 2023, Fitch upgraded the financial strength rating of EMICO to “A-” from “BBB+” with an outlook of stable. • On March 1, 2023, Moody’s upgraded the credit rating of Genworth Holdings to “Ba1” from “Ba2” and upgraded the financial strength rating of EMICO to “A3” from “Baa1.” The outlooks for the ratings are stable. • On February 16, 2023, S&P upgraded the credit rating of Genworth Financial and Genworth Holdings to “BB-” from “B+” with an outlook of stable and upgraded the financial strength rating of EMICO to “BBB+” from “BBB.” S&P, Moody’s, Fitch, and A.M. Best review their ratings periodically and we cannot assure you that we will maintain our current ratings in the future. These and other agencies may also rate our holding companies or insurance subsidiaries on a solicited or an unsolicited basis. We do not provide non-public information to agencies issuing unsolicited ratings and cannot ensure that any agencies that rate our holding companies or insurance subsidiaries on an unsolicited basis will continue to do so. For information on adverse credit rating actions related to Genworth and the potential impact of credit ratings on our business, see “Item 1A—Risk Factors—Adverse rating agency actions have in the past resulted in a loss of business and adversely affected our results of operations, financial condition and business, and future adverse rating actions could have a further and more significant adverse impact on us.” Investments Under the direction of our Chief Investment Officer, our investments department is responsible for managing the assets in our various portfolios, including establishing investment and derivatives policies and strategies, reviewing asset-liability management, performing asset allocations and setting risk limits. We manage our assets to meet diversification, credit quality, yield and liquidity requirements of our policy and contract liabilities by investing primarily in fixed maturity securities, including government, municipal and corporate bonds and mortgage-backed and other asset-backed securities. We also hold commercial mortgage loans, limited partnerships and other invested assets, which includes derivatives, bank loans and short-term investments. Investments for our insurance company subsidiaries are required to comply with our risk management requirements, as well as applicable insurance laws and regulations. Investment strategies, policy and risk management are closely monitored by Genworth Financial’s management investment committee and the risk committee of Genworth Financial’s Board of Directors. Our primary investment objective is to meet our obligations to policyholders and contractholders while increasing value to our stockholders by investing in a diversified, high-quality portfolio, comprised primarily of income producing securities and other assets. Our investment strategy focuses on: • managing interest rate risk, as appropriate, through monitoring asset durations relative to policyholder and contractholder obligations; selecting assets based on fundamental, research-driven strategies; emphasizing fixed-income, low-volatility assets while pursuing active strategies to enhance yield; • • • maintaining sufficient liquidity to meet financial obligations; 16 17 • • Supplementary Data.” Regulation General For further information related to our invested assets, see “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Investments and Derivative Instruments” and notes 5, 6 and 21 to our consolidated financial statements under “Part II—Item 8—Financial Statements and Our insurance operations are subject to a wide variety of laws and regulations. U.S. state insurance laws and regulations (“Insurance Laws”) regulate most aspects of our U.S. insurance businesses, and our U.S. insurers are regulated by the insurance departments of the states in which they are domiciled and licensed. Our non-U.S. insurance operations are principally regulated by insurance regulatory authorities in the jurisdictions in which they are domiciled. Our insurance products and businesses are also affected by U.S. federal, state and local tax laws, and the tax laws of non-U.S. jurisdictions. Our securities operations, including our insurance products that are regulated as securities, such as variable annuities, are subject to U.S. federal and state and non-U.S. securities laws and regulations. The U.S. Securities and Exchange Commission (“SEC”), U.S. Financial Industry Regulatory Authority, state securities authorities and similar non-U.S. authorities regulate and supervise these products. The primary purpose of the Insurance Laws regulating our insurance businesses and their equivalents in the other countries in which we operate, and the securities laws affecting certain of our products and our broker/ dealer, is to protect our policyholders, contractholders and clients, not our stockholders. These laws and regulations are regularly re-examined and any changes to these laws or new laws may be more restrictive or otherwise adversely affect our operations. Insurance and securities regulatory authorities (including state law enforcement agencies and attorneys general or their non-U.S. equivalents) periodically make inquiries regarding compliance with insurance, securities and other laws and regulations, and we cooperate with such inquiries and take corrective action when warranted. U.S. Insurance Regulation Our U.S. insurers are licensed and regulated in all jurisdictions in which they conduct insurance business. The extent of this regulation varies but Insurance Laws generally govern the financial condition of insurers, including standards of solvency, types and concentrations of permissible investments, establishment and maintenance of reserves, credit for reinsurance and requirements of capital adequacy. Insurance Laws also govern the business conduct of insurers, including marketplace activities, affecting the form and content of disclosure to consumers, product illustrations, advertising, product replacement, sales and underwriting practices, and complaint and claims handling, and these provisions are generally enforced through periodic market conduct examinations. In addition, Insurance Laws usually require the licensing of insurers and agents, the filing or approval of policy forms and related materials prior to their use, and approval of premium rates for certain lines of insurance. Our U.S. insurers must file periodic reports, including detailed annual financial statements, with insurance regulatory authorities in each jurisdiction in which they do business, and their operations and accounts are subject to periodic examination by such authorities. Insurance departments in U.S. jurisdictions conduct periodic detailed examinations of the books, records, accounts and business practices of domestic insurers. These examinations generally are conducted in cooperation with insurance departments of two or three other states or Ratings actions • On February 27, 2024, S&P affirmed the credit rating of “BB-” of Genworth Financial and Genworth Holdings with an outlook of stable. • On January 8, 2024, S&P upgraded the financial strength rating of EMICO to “A-” from “BBB+” with • On August 1, 2023, A.M. Best assigned an initial public financial strength rating of “A-” to EMICO, • On April 25, 2023, Fitch upgraded the financial strength rating of EMICO to “A-” from “BBB+” with • On March 1, 2023, Moody’s upgraded the credit rating of Genworth Holdings to “Ba1” from “Ba2” and upgraded the financial strength rating of EMICO to “A3” from “Baa1.” The outlooks for the • On February 16, 2023, S&P upgraded the credit rating of Genworth Financial and Genworth Holdings to “BB-” from “B+” with an outlook of stable and upgraded the financial strength rating of EMICO to an outlook of stable. with an outlook of stable. an outlook of stable. ratings are stable. “BBB+” from “BBB.” S&P, Moody’s, Fitch, and A.M. Best review their ratings periodically and we cannot assure you that we will maintain our current ratings in the future. These and other agencies may also rate our holding companies or insurance subsidiaries on a solicited or an unsolicited basis. We do not provide non-public information to agencies issuing unsolicited ratings and cannot ensure that any agencies that rate our holding companies or insurance subsidiaries on an unsolicited basis will continue to do so. For information on adverse credit rating actions related to Genworth and the potential impact of credit ratings on our business, see “Item 1A—Risk Factors—Adverse rating agency actions have in the past resulted in a loss of business and adversely affected our results of operations, financial condition and business, and future adverse rating actions could have a further and more significant adverse impact on us.” Investments Under the direction of our Chief Investment Officer, our investments department is responsible for managing the assets in our various portfolios, including establishing investment and derivatives policies and strategies, reviewing asset-liability management, performing asset allocations and setting risk limits. We manage our assets to meet diversification, credit quality, yield and liquidity requirements of our policy and contract liabilities by investing primarily in fixed maturity securities, including government, municipal and corporate bonds and mortgage-backed and other asset-backed securities. We also hold commercial mortgage loans, limited partnerships and other invested assets, which includes derivatives, bank loans and short-term investments. Investments for our insurance company subsidiaries are required to comply with our risk management requirements, as well as applicable insurance laws and regulations. Investment strategies, policy and risk management are closely monitored by Genworth Financial’s management investment committee and the risk committee of Genworth Financial’s Board of Directors. Our primary investment objective is to meet our obligations to policyholders and contractholders while increasing value to our stockholders by investing in a diversified, high-quality portfolio, comprised primarily of income producing securities and other assets. Our investment strategy focuses on: • managing interest rate risk, as appropriate, through monitoring asset durations relative to policyholder and contractholder obligations; selecting assets based on fundamental, research-driven strategies; • • emphasizing fixed-income, low-volatility assets while pursuing active strategies to enhance yield; • maintaining sufficient liquidity to meet financial obligations; • • regularly evaluating our asset class mix and pursuing additional investment classes when prudent; and continuously monitoring asset quality and market conditions that could affect our assets. For further information related to our invested assets, see “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Investments and Derivative Instruments” and notes 5, 6 and 21 to our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Regulation General Our insurance operations are subject to a wide variety of laws and regulations. U.S. state insurance laws and regulations (“Insurance Laws”) regulate most aspects of our U.S. insurance businesses, and our U.S. insurers are regulated by the insurance departments of the states in which they are domiciled and licensed. Our non-U.S. insurance operations are principally regulated by insurance regulatory authorities in the jurisdictions in which they are domiciled. Our insurance products and businesses are also affected by U.S. federal, state and local tax laws, and the tax laws of non-U.S. jurisdictions. Our securities operations, including our insurance products that are regulated as securities, such as variable annuities, are subject to U.S. federal and state and non-U.S. securities laws and regulations. The U.S. Securities and Exchange Commission (“SEC”), U.S. Financial Industry Regulatory Authority, state securities authorities and similar non-U.S. authorities regulate and supervise these products. The primary purpose of the Insurance Laws regulating our insurance businesses and their equivalents in the other countries in which we operate, and the securities laws affecting certain of our products and our broker/ dealer, is to protect our policyholders, contractholders and clients, not our stockholders. These laws and regulations are regularly re-examined and any changes to these laws or new laws may be more restrictive or otherwise adversely affect our operations. Insurance and securities regulatory authorities (including state law enforcement agencies and attorneys general or their non-U.S. equivalents) periodically make inquiries regarding compliance with insurance, securities and other laws and regulations, and we cooperate with such inquiries and take corrective action when warranted. U.S. Insurance Regulation Our U.S. insurers are licensed and regulated in all jurisdictions in which they conduct insurance business. The extent of this regulation varies but Insurance Laws generally govern the financial condition of insurers, including standards of solvency, types and concentrations of permissible investments, establishment and maintenance of reserves, credit for reinsurance and requirements of capital adequacy. Insurance Laws also govern the business conduct of insurers, including marketplace activities, affecting the form and content of disclosure to consumers, product illustrations, advertising, product replacement, sales and underwriting practices, and complaint and claims handling, and these provisions are generally enforced through periodic market conduct examinations. In addition, Insurance Laws usually require the licensing of insurers and agents, the filing or approval of policy forms and related materials prior to their use, and approval of premium rates for certain lines of insurance. Our U.S. insurers must file periodic reports, including detailed annual financial statements, with insurance regulatory authorities in each jurisdiction in which they do business, and their operations and accounts are subject to periodic examination by such authorities. Insurance departments in U.S. jurisdictions conduct periodic detailed examinations of the books, records, accounts and business practices of domestic insurers. These examinations generally are conducted in cooperation with insurance departments of two or three other states or 16 17 jurisdictions representing each of the National Association of Insurance Commissioners (“NAIC”) zones, under guidelines promulgated by the NAIC. State insurance departments may also conduct examinations of non-domiciliary insurers licensed in their states. The Insurance Laws applicable to us and our U.S. insurers are described below. Our U.S. mortgage insurers are also subject to additional Insurance Laws applicable specifically to mortgage insurers discussed below under “—Enact—Mortgage Insurance Regulation.” Insurance holding company regulation Our primary U.S. insurance companies are domiciled in the following states: Delaware, New York, North Carolina and Virginia and (except for our captive insurers) they are required to register as members of an insurance holding company system under their domiciliary state’s insurance holding company act. They are also required to submit annual reports to the state insurance regulatory authority identifying the members of the insurance holding company system and describing certain transactions between the insurer and any member of its insurance group that may materially affect the operations, management or financial condition of the insurers within the system. All transactions between an insurer and an affiliate must be fair and reasonable, and certain transactions are subject to prior approval by the domiciliary state insurance regulator. In addition, most states have adopted insurance regulations setting forth detailed requirements for cost sharing and management agreements between an insurer and its affiliates. Our U.S. insurers’ ability to pay dividends or other distributions is regulated by their domiciliary state insurance regulators. Our U.S. life insurance subsidiaries had negative unassigned surplus as of December 31, 2023, and as a result, we do not expect these subsidiaries to pay dividends for the foreseeable future. Our principal U.S. mortgage insurance subsidiaries may pay dividends only from unassigned surplus; payments made from other sources, such as paid-in and contributed surplus, are categorized as distributions. Notice of all dividends must be submitted to the commissioner within five business days after declaration of the dividend, and at least 30 days before payment thereof. No dividend may be paid unless the commissioner has not disapproved or has approved the payment within that 30-day period. Any distribution, regardless of amount, requires that same 30-day notice to the commissioner, but also requires the commissioner’s affirmative approval before being paid. Under the insurance laws of the State of North Carolina (our mortgage insurance subsidiaries’ primary state of domicile), an “extraordinary” dividend or distribution is defined as a dividend or distribution that, together with other dividends and distributions made within the preceding 12 months, exceeds the greater of: (i) 10% of the mortgage insurer’s statutory surplus as of the immediately prior year end; or (ii) the statutory net income during the prior calendar year. In addition, insurance regulators may prohibit the payment of ordinary dividends and distributions or other payments by our insurers to group affiliates (such as a payment under a tax sharing agreement or for employment or other services) if they determine that such payment could be adverse to policyholders or contractholders. Acquisition or change of control of a U.S. insurer requires the prior approval of the insurer’s domiciliary state insurance regulator. The domiciliary states of our U.S. insurers also require prior notice of a divestiture of control. Control is generally presumed to exist if any person, directly or indirectly, owns, controls, holds with the power to vote, or holds proxies representing 10% or more of the voting securities of the insurer or any parent company of the insurer. Certain state provisions may not require acquisition approval but can lead to imposition of conditions on an acquisition that could delay or prevent its consummation. Such laws may discourage potential acquisition proposals and may delay, deter or prevent an investment in or a change of control involving us, or one or more of our regulated subsidiaries, including transactions that our management and some or all of our stockholders might consider desirable. The NAIC Risk Management and Own Risk and Solvency Assessment (“ORSA”) Model Act requires an insurer to regularly, and at least annually, undertake a confidential internal assessment of material and relevant risks and upon an insurance regulator’s request, submit a confidential, high-level summary assessment of the material and relevant risks associated with an insurer or insurance group’s current business plan and the sufficiency of capital and liquidity resources to support those risks. We file an ORSA summary report annually with Virginia, our lead domiciliary state. The NAIC Corporate Governance Annual Disclosure Model Act and Corporate Governance Annual Disclosure Model Regulation require insurers to provide detailed information regarding their corporate governance practices to their lead state and/or domestic regulator. The NAIC implemented a regulatory framework through an actuarial guideline (“AG 48”) applicable to the use of captive insurers in connection with Regulation XXX and Regulation AXXX transactions. Among other things, the framework calls for more disclosure of an insurer’s use of captives in its statutory financial statements and narrows the types of assets permitted to back statutory reserves that are required to support the insurer’s future obligations. AG 48 requires the actuary of the ceding insurer that opines on the insurer’s reserves to issue a qualified opinion if the framework is not followed. The NAIC adopted an amended version of AG 48, which applies to new policies issued and new reinsurance transactions entered into on or after January 1, 2017. AG 48 does not affect reinsurance arrangements that were pre-existing as of January 1, 2015, and the changes set forth in the amended version do not affect reinsurance arrangements that were pre-existing as of January 1, 2017. The NAIC also adopted the Term and Universal Life Insurance Reserve Financing Model Regulation, which contains the same substantive requirements as the amended version of AG 48. States must either adopt the model regulation or use AG 48 to satisfy the NAIC accreditation requirement. Virginia, the domestic state regulator for GLAIC, one of our principal life insurance subsidiaries, has adopted the model regulation. The NAIC developed a group capital calculation (“GCC”) tool using an RBC aggregation methodology for all entities within the insurance holding company system, including non-U.S. entities. The GCC provides regulators with an additional tool for conducting group-wide supervision and enhances transparency into how capital is allocated. In December 2020, the NAIC adopted a Group Capital Calculation Template and Instructions, and it amended the Holding Company System Model Act and Regulation to implement an annual GCC filing requirement. Virginia, our insurance holding company group’s lead state, adopted the amendments in 2022, and we submitted our first annual filing in 2023. It is unclear how the development of a group capital tool by the NAIC will interact with existing capital requirements for U.S. insurance companies. Long-term care insurance rate increase regulation In general, we implement rate increases on our long-term care insurance policies in accordance with the laws of the state in which a policy was issued. In 2019, the NAIC established the Long-Term Care Insurance Task Force to address efforts to create a national standard for reviewing and approving long-term care insurance rate increase requests. This task force was charged with developing a consistent national approach for reviewing rate increase requests that results in actuarially appropriate increases being granted by the states in a timely manner and eliminates cross-state rate subsidization, among others. In April 2022, the NAIC adopted the Long- Term Care Insurance Multistate Rate Review Framework, and as of December 2023, the task force is monitoring and evaluating the progress of the rate review process, including how to address large rate increase requests, as outlined in the framework. We continue to work closely with state regulators on our in-force long-term care insurance rate action plan (including increased premiums and associated benefit reductions) to achieve a shared goal of ensuring that our U.S. life insurance subsidiaries can honor their policyholder commitments in the future. Guaranty associations and similar arrangements Most jurisdictions in which our U.S. insurers are licensed require those insurers to participate in guaranty associations which pay contractual benefits owed under the policies of impaired or insolvent insurers. These associations levy assessments, up to prescribed limits, on each member insurer in a jurisdiction on the basis of the proportionate share of the premiums written by such insurer in the lines of business in which the impaired, 18 19 jurisdictions representing each of the National Association of Insurance Commissioners (“NAIC”) zones, under guidelines promulgated by the NAIC. State insurance departments may also conduct examinations of non-domiciliary insurers licensed in their states. The Insurance Laws applicable to us and our U.S. insurers are described below. Our U.S. mortgage insurers are also subject to additional Insurance Laws applicable specifically to mortgage insurers discussed below under “—Enact—Mortgage Insurance Regulation.” Insurance holding company regulation Our primary U.S. insurance companies are domiciled in the following states: Delaware, New York, North Carolina and Virginia and (except for our captive insurers) they are required to register as members of an insurance holding company system under their domiciliary state’s insurance holding company act. They are also required to submit annual reports to the state insurance regulatory authority identifying the members of the insurance holding company system and describing certain transactions between the insurer and any member of its insurance group that may materially affect the operations, management or financial condition of the insurers within the system. All transactions between an insurer and an affiliate must be fair and reasonable, and certain transactions are subject to prior approval by the domiciliary state insurance regulator. In addition, most states have adopted insurance regulations setting forth detailed requirements for cost sharing and management agreements between an insurer and its affiliates. Our U.S. insurers’ ability to pay dividends or other distributions is regulated by their domiciliary state insurance regulators. Our U.S. life insurance subsidiaries had negative unassigned surplus as of December 31, 2023, and as a result, we do not expect these subsidiaries to pay dividends for the foreseeable future. Our principal U.S. mortgage insurance subsidiaries may pay dividends only from unassigned surplus; payments made from other sources, such as paid-in and contributed surplus, are categorized as distributions. Notice of all dividends must be submitted to the commissioner within five business days after declaration of the dividend, and at least 30 days before payment thereof. No dividend may be paid unless the commissioner has not disapproved or has approved the payment within that 30-day period. Any distribution, regardless of amount, requires that same 30-day notice to the commissioner, but also requires the commissioner’s affirmative approval before being paid. Under the insurance laws of the State of North Carolina (our mortgage insurance subsidiaries’ primary state of domicile), an “extraordinary” dividend or distribution is defined as a dividend or distribution that, together with other dividends and distributions made within the preceding 12 months, exceeds the greater of: (i) 10% of the mortgage insurer’s statutory surplus as of the immediately prior year end; or (ii) the statutory net income during the prior calendar year. In addition, insurance regulators may prohibit the payment of ordinary dividends and distributions or other payments by our insurers to group affiliates (such as a payment under a tax sharing agreement or for employment or other services) if they determine that such payment could be adverse to policyholders or contractholders. Acquisition or change of control of a U.S. insurer requires the prior approval of the insurer’s domiciliary state insurance regulator. The domiciliary states of our U.S. insurers also require prior notice of a divestiture of control. Control is generally presumed to exist if any person, directly or indirectly, owns, controls, holds with the power to vote, or holds proxies representing 10% or more of the voting securities of the insurer or any parent company of the insurer. Certain state provisions may not require acquisition approval but can lead to imposition of conditions on an acquisition that could delay or prevent its consummation. Such laws may discourage potential acquisition proposals and may delay, deter or prevent an investment in or a change of control involving us, or one or more of our regulated subsidiaries, including transactions that our management and some or all of our stockholders might consider desirable. The NAIC Risk Management and Own Risk and Solvency Assessment (“ORSA”) Model Act requires an insurer to regularly, and at least annually, undertake a confidential internal assessment of material and relevant risks and upon an insurance regulator’s request, submit a confidential, high-level summary assessment of the material and relevant risks associated with an insurer or insurance group’s current business plan and the sufficiency of capital and liquidity resources to support those risks. We file an ORSA summary report annually with Virginia, our lead domiciliary state. The NAIC Corporate Governance Annual Disclosure Model Act and Corporate Governance Annual Disclosure Model Regulation require insurers to provide detailed information regarding their corporate governance practices to their lead state and/or domestic regulator. The NAIC implemented a regulatory framework through an actuarial guideline (“AG 48”) applicable to the use of captive insurers in connection with Regulation XXX and Regulation AXXX transactions. Among other things, the framework calls for more disclosure of an insurer’s use of captives in its statutory financial statements and narrows the types of assets permitted to back statutory reserves that are required to support the insurer’s future obligations. AG 48 requires the actuary of the ceding insurer that opines on the insurer’s reserves to issue a qualified opinion if the framework is not followed. The NAIC adopted an amended version of AG 48, which applies to new policies issued and new reinsurance transactions entered into on or after January 1, 2017. AG 48 does not affect reinsurance arrangements that were pre-existing as of January 1, 2015, and the changes set forth in the amended version do not affect reinsurance arrangements that were pre-existing as of January 1, 2017. The NAIC also adopted the Term and Universal Life Insurance Reserve Financing Model Regulation, which contains the same substantive requirements as the amended version of AG 48. States must either adopt the model regulation or use AG 48 to satisfy the NAIC accreditation requirement. Virginia, the domestic state regulator for GLAIC, one of our principal life insurance subsidiaries, has adopted the model regulation. The NAIC developed a group capital calculation (“GCC”) tool using an RBC aggregation methodology for all entities within the insurance holding company system, including non-U.S. entities. The GCC provides regulators with an additional tool for conducting group-wide supervision and enhances transparency into how capital is allocated. In December 2020, the NAIC adopted a Group Capital Calculation Template and Instructions, and it amended the Holding Company System Model Act and Regulation to implement an annual GCC filing requirement. Virginia, our insurance holding company group’s lead state, adopted the amendments in 2022, and we submitted our first annual filing in 2023. It is unclear how the development of a group capital tool by the NAIC will interact with existing capital requirements for U.S. insurance companies. Long-term care insurance rate increase regulation In general, we implement rate increases on our long-term care insurance policies in accordance with the laws of the state in which a policy was issued. In 2019, the NAIC established the Long-Term Care Insurance Task Force to address efforts to create a national standard for reviewing and approving long-term care insurance rate increase requests. This task force was charged with developing a consistent national approach for reviewing rate increase requests that results in actuarially appropriate increases being granted by the states in a timely manner and eliminates cross-state rate subsidization, among others. In April 2022, the NAIC adopted the Long- Term Care Insurance Multistate Rate Review Framework, and as of December 2023, the task force is monitoring and evaluating the progress of the rate review process, including how to address large rate increase requests, as outlined in the framework. We continue to work closely with state regulators on our in-force long-term care insurance rate action plan (including increased premiums and associated benefit reductions) to achieve a shared goal of ensuring that our U.S. life insurance subsidiaries can honor their policyholder commitments in the future. Guaranty associations and similar arrangements Most jurisdictions in which our U.S. insurers are licensed require those insurers to participate in guaranty associations which pay contractual benefits owed under the policies of impaired or insolvent insurers. These associations levy assessments, up to prescribed limits, on each member insurer in a jurisdiction on the basis of the proportionate share of the premiums written by such insurer in the lines of business in which the impaired, 18 19 insolvent or failed insurer is engaged. Some jurisdictions permit member insurers to recover assessments paid through full or partial premium tax offsets. Aggregate assessments levied against our U.S. insurers were not significant to our consolidated financial statements for the years ended December 31, 2023, 2022 and 2021. Policy and contract reserve sufficiency analysis The Insurance Laws of our U.S. life insurers’ domiciliary jurisdictions require each such insurer to conduct an annual analysis of the sufficiency of their life and health insurance and annuity reserves. Other jurisdictions where insurers are licensed may have certain reserve requirements that differ from those of their domiciliary jurisdictions. In each case, a qualified actuary must submit an opinion stating that the aggregate statutory reserves, when considered in light of the assets held with respect to such reserves, make good and sufficient provision for the insurer’s associated contractual obligations and related expenses. If such an opinion cannot be provided, the insurer must establish additional reserves by transferring funds from surplus. Our U.S. life insurers submit these opinions annually to their insurance regulatory authorities, and each year they conduct a statutory cash flow testing process to support these opinions. Different reserve requirements exist for our U.S. mortgage insurance subsidiaries. See “—Enact—Mortgage Insurance Regulation—State regulation—Reserves.” Surplus and capital requirements Insurance regulators have the discretionary authority, in connection with maintaining the licensing of our U.S. insurers, to limit or restrict insurers from issuing new policies, or policies having a dollar value over certain thresholds, if, in the regulators’ judgment, the insurer is not maintaining a sufficient amount of surplus or is in a hazardous financial condition. We seek to maintain capital management and new business strategies to support meeting related regulatory requirements. Risk-based capital The NAIC has established RBC standards for U.S. life insurers, as well as a Risk-Based Capital for Insurers Model Act (“RBC Model Act”). All 50 states and the District of Columbia have adopted the RBC Model Act or a substantially similar law or regulation. The RBC Model Act requires that life insurers annually submit a report to state regulators regarding their RBC based upon four categories of risk: asset risk, insurance risk, interest rate risk and business risk. The capital requirement for each is generally determined by applying factors which vary based upon the degree of risk to various asset, premium and reserve items. The formula is an early warning tool to identify possible weakly capitalized companies for purposes of initiating further regulatory action. Regulatory compliance is determined by a ratio of a company’s total adjusted capital (“TAC”) to its authorized control level RBC (“ACL RBC”). The minimum level of TAC before corrective action commences (“Company Action Level”) is two times the ACL RBC or three times the ACL RBC with a negative trend. If an insurer’s ACL RBC falls below specified levels, it would be subject to different degrees of regulatory action depending upon the level, ranging from requiring the insurer to propose actions to correct the capital deficiency to placing the insurer under regulatory control. Our U.S. life insurance subsidiaries’ reported RBC ratio measures the ratio of TAC to our Company Action Level. As of December 31, 2023, the RBC of each of our U.S. life insurance subsidiaries exceeded the level of RBC that would require any of them to take or become subject to any corrective action in their respective domiciliary state. For additional information on the RBC of our U.S. life insurance subsidiaries, see note 22 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Statutory accounting principles U.S. insurance regulators developed statutory accounting principles (“SAP”) as a basis of accounting used to monitor and regulate the solvency of insurers. Since insurance regulators are primarily concerned with ensuring an insurer’s ability to pay its current and future obligations to policyholders, statutory accounting conservatively values the assets and liabilities of insurers, generally in accordance with standards specified by the insurer’s domiciliary jurisdiction. Uniform statutory accounting practices are established by the NAIC and are generally adopted by regulators in the various U.S. jurisdictions. Due to differences in methodology between SAP and U.S. GAAP, the values for assets, liabilities and equity reflected in financial statements prepared in accordance with U.S. GAAP are materially different from those reflected in financial statements prepared under SAP. Regulation of investments Each of our U.S. insurers is subject to Insurance Laws that require diversification of its investment portfolio and limit the proportion of investments in different asset categories. Assets invested contrary to such regulatory limitations must be treated as non-admitted assets for purposes of measuring surplus, and in some instances, regulations require divestiture of such non-complying investments. We believe the investments made by our U.S. insurers comply with these Insurance Laws. Enact—Mortgage Insurance Regulation Forbearance programs For mortgages insured by the federal government (including those purchased by Fannie Mae and Freddie Mac), forbearance allowed borrowers impacted by COVID-19 to temporarily suspend mortgage payments up to 18 months subject to certain limits. However, the Biden Administration ended the national emergency for COVID-19 in April 2023, and as a result, the deadline for requesting a COVID-19 related forbearance under the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act ended in August 2023. In addition, the GSEs retired their COVID-19 servicing-related policies including with respect to forbearance in November 2023 and reverted to standard forbearance policies as a loss mitigation option for borrowers that meet general hardship and program guidelines. In March 2023, the GSEs announced new loss mitigation programs that would allow six-month payment deferrals for borrowers facing financial hardship and encouraged servicers to start evaluating borrowers for these programs as early as July 1, 2023, but no later than October 1, 2023. Even though most foreclosure moratoriums expired at the end of 2021, federal laws and regulations continue to require servicers to discuss loss mitigation options with borrowers before proceeding with foreclosures. These requirements could further extend the foreclosure timeline, which could negatively impact the severity of loss on loans that go to claim. State regulation General Mortgage insurers generally are limited by Insurance Laws to directly writing only mortgage guaranty insurance business to the exclusion of other types of insurance. Mortgage insurers are not subject to the NAIC’s RBC requirements, but certain states and other regulators impose another form of capital requirement on mortgage insurers, requiring maintenance of a risk-to-capital ratio not to exceed 25:1. Each of Enact Holdings’ mortgage insurance subsidiaries met its capital requirements as of December 31, 2023. See note 22 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information. The North Carolina Department of Insurance’s (“NCDOI”) current regulatory framework by which EMICO’s risk-to-capital ratio is calculated differs from the capital requirements of the GSEs as discussed under “—Other U.S. Regulation and Agency Qualification Requirements.” 20 21 insolvent or failed insurer is engaged. Some jurisdictions permit member insurers to recover assessments paid through full or partial premium tax offsets. Aggregate assessments levied against our U.S. insurers were not significant to our consolidated financial statements for the years ended December 31, 2023, 2022 and 2021. Policy and contract reserve sufficiency analysis The Insurance Laws of our U.S. life insurers’ domiciliary jurisdictions require each such insurer to conduct an annual analysis of the sufficiency of their life and health insurance and annuity reserves. Other jurisdictions where insurers are licensed may have certain reserve requirements that differ from those of their domiciliary jurisdictions. In each case, a qualified actuary must submit an opinion stating that the aggregate statutory reserves, when considered in light of the assets held with respect to such reserves, make good and sufficient provision for the insurer’s associated contractual obligations and related expenses. If such an opinion cannot be provided, the insurer must establish additional reserves by transferring funds from surplus. Our U.S. life insurers submit these opinions annually to their insurance regulatory authorities, and each year they conduct a statutory cash flow testing process to support these opinions. Different reserve requirements exist for our U.S. mortgage insurance subsidiaries. See “—Enact—Mortgage Insurance Regulation—State regulation—Reserves.” Surplus and capital requirements Insurance regulators have the discretionary authority, in connection with maintaining the licensing of our U.S. insurers, to limit or restrict insurers from issuing new policies, or policies having a dollar value over certain thresholds, if, in the regulators’ judgment, the insurer is not maintaining a sufficient amount of surplus or is in a hazardous financial condition. We seek to maintain capital management and new business strategies to support meeting related regulatory requirements. Risk-based capital The NAIC has established RBC standards for U.S. life insurers, as well as a Risk-Based Capital for Insurers Model Act (“RBC Model Act”). All 50 states and the District of Columbia have adopted the RBC Model Act or a substantially similar law or regulation. The RBC Model Act requires that life insurers annually submit a report to state regulators regarding their RBC based upon four categories of risk: asset risk, insurance risk, interest rate risk and business risk. The capital requirement for each is generally determined by applying factors which vary based upon the degree of risk to various asset, premium and reserve items. The formula is an early warning tool to identify possible weakly capitalized companies for purposes of initiating further regulatory action. Regulatory compliance is determined by a ratio of a company’s total adjusted capital (“TAC”) to its authorized control level RBC (“ACL RBC”). The minimum level of TAC before corrective action commences (“Company Action Level”) is two times the ACL RBC or three times the ACL RBC with a negative trend. If an insurer’s ACL RBC falls below specified levels, it would be subject to different degrees of regulatory action depending upon the level, ranging from requiring the insurer to propose actions to correct the capital deficiency to placing the insurer under regulatory control. Our U.S. life insurance subsidiaries’ reported RBC ratio measures the ratio of TAC to our Company Action Level. As of December 31, 2023, the RBC of each of our U.S. life insurance subsidiaries exceeded the level of RBC that would require any of them to take or become subject to any corrective action in their respective domiciliary state. For additional information on the RBC of our U.S. life insurance subsidiaries, see note 22 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Statutory accounting principles U.S. insurance regulators developed statutory accounting principles (“SAP”) as a basis of accounting used to monitor and regulate the solvency of insurers. Since insurance regulators are primarily concerned with ensuring an insurer’s ability to pay its current and future obligations to policyholders, statutory accounting conservatively values the assets and liabilities of insurers, generally in accordance with standards specified by the insurer’s domiciliary jurisdiction. Uniform statutory accounting practices are established by the NAIC and are generally adopted by regulators in the various U.S. jurisdictions. Due to differences in methodology between SAP and U.S. GAAP, the values for assets, liabilities and equity reflected in financial statements prepared in accordance with U.S. GAAP are materially different from those reflected in financial statements prepared under SAP. Regulation of investments Each of our U.S. insurers is subject to Insurance Laws that require diversification of its investment portfolio and limit the proportion of investments in different asset categories. Assets invested contrary to such regulatory limitations must be treated as non-admitted assets for purposes of measuring surplus, and in some instances, regulations require divestiture of such non-complying investments. We believe the investments made by our U.S. insurers comply with these Insurance Laws. Enact—Mortgage Insurance Regulation Forbearance programs For mortgages insured by the federal government (including those purchased by Fannie Mae and Freddie Mac), forbearance allowed borrowers impacted by COVID-19 to temporarily suspend mortgage payments up to 18 months subject to certain limits. However, the Biden Administration ended the national emergency for COVID-19 in April 2023, and as a result, the deadline for requesting a COVID-19 related forbearance under the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act ended in August 2023. In addition, the GSEs retired their COVID-19 servicing-related policies including with respect to forbearance in November 2023 and reverted to standard forbearance policies as a loss mitigation option for borrowers that meet general hardship and program guidelines. In March 2023, the GSEs announced new loss mitigation programs that would allow six-month payment deferrals for borrowers facing financial hardship and encouraged servicers to start evaluating borrowers for these programs as early as July 1, 2023, but no later than October 1, 2023. Even though most foreclosure moratoriums expired at the end of 2021, federal laws and regulations continue to require servicers to discuss loss mitigation options with borrowers before proceeding with foreclosures. These requirements could further extend the foreclosure timeline, which could negatively impact the severity of loss on loans that go to claim. State regulation General Mortgage insurers generally are limited by Insurance Laws to directly writing only mortgage guaranty insurance business to the exclusion of other types of insurance. Mortgage insurers are not subject to the NAIC’s RBC requirements, but certain states and other regulators impose another form of capital requirement on mortgage insurers, requiring maintenance of a risk-to-capital ratio not to exceed 25:1. Each of Enact Holdings’ mortgage insurance subsidiaries met its capital requirements as of December 31, 2023. See note 22 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information. The North Carolina Department of Insurance’s (“NCDOI”) current regulatory framework by which EMICO’s risk-to-capital ratio is calculated differs from the capital requirements of the GSEs as discussed under “—Other U.S. Regulation and Agency Qualification Requirements.” 20 21 In August 2023, the NAIC adopted amendments to the Mortgage Guaranty Insurance Model Act (the “MGI Model Act”) and is in the process of making conforming revisions to the Statement of Statutory Accounting Principles No. 58—Mortgage Guaranty Insurance. The revisions to the MGI Model Act are extensive, including with respect to risk concentration limits, capital and reserve requirements, reinsurance, underwriting practices and quality assurance. For a discussion of the potential risks to our business associated with these amendments, see “Item 1A—Risk Factors—Enact Holdings’ U.S. mortgage insurance subsidiaries are subject to minimum statutory capital requirements, which if not met or waived, would result in restrictions or prohibitions on them doing business and could have a material adverse impact on our business, financial condition and results of operations.” Reserves Insurance Laws require our U.S. mortgage insurers to establish a special statutory contingency reserve in their statutory financial statements to provide for claims and other expenses in the event of significant economic declines. Annual additions to the statutory contingency reserve must be at least 50% of net earned premiums as defined by Insurance Laws. These contingency reserves generally are held until the earlier of (i) 10 years or (ii) when loss ratios exceed 35%, in which case the amount above 35% can be released under certain circumstances, although regulators have granted discretionary releases from time to time. However, approval by the NCDOI, the primary domiciliary regulator for our U.S. mortgage insurers, is required for contingency reserve releases when loss ratios exceed 35%. The establishment of the statutory contingency reserve is funded by premiums that would otherwise generate net earnings that would be reflected in policyholder surplus. This reserve reduces the policyholder surplus of our U.S. mortgage insurers, and therefore, their ability to pay dividends to our holding companies. See note 22 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for information on the statutory contingency reserve for our U.S. mortgage insurers. Premium rates In most states where our U.S. mortgage insurance subsidiaries are licensed, premium rates are required to be filed before the authorization is granted to charge premiums. In some states, these premium rates must be approved before their use. Likewise, changes in premium rates must be filed and receive approval. In general, states may require actuarial justification on the basis of the insurer’s loss experience, expenses and future projections. In addition, states may consider general default experience in the mortgage insurance industry in assessing the premium rates charged by U.S. mortgage insurers. Federal regulation In addition to federal laws directly applicable to mortgage insurers, the laws and regulations applicable to mortgage originators and lenders, purchasers of mortgage loans such as the GSEs, and governmental insurers such as the FHA and VA indirectly affect mortgage insurers. Moreover, mortgage origination and servicing transactions are subject to compliance with various state and federal laws. Changes in federal housing legislation and other laws and regulations that affect the demand for private mortgage insurance, or the way in which such laws and regulations are interpreted or applied, may have a material effect on private mortgage insurers. For example, the Enterprise Capital Framework of the Federal Housing Finance Agency (“FHFA”) that became effective in 2021 includes significantly higher regulatory capital requirements for the GSEs over current requirements. Higher GSE capital requirements could ultimately lead to increased costs to borrowers of GSE loans, which in turn could shift the market away from the GSEs to the FHA or lender portfolios. Such a shift could result in a smaller market for private mortgage insurance. See “Item 1A—Risk Factors—Changes to the role of the GSEs or to the charters or business practices of the GSEs, including actions or decisions to decrease or discontinue the use of mortgage insurance, could adversely affect our business, financial condition and results of operations.” The Homeowners Protection Act of 1998 (“HOPA”) provides for the automatic termination, or cancellation upon a borrower’s request, of the borrower’s obligation to pay for private mortgage insurance upon satisfaction of certain conditions, although mortgage servicers may continue to keep the coverage in place at their expense. HOPA applies to owner-occupied residential mortgage loans regardless of lien priority and to borrower-paid mortgage insurance closed after July 29, 1999. HOPA requires lenders to automatically terminate a borrower’s obligation to pay for mortgage insurance coverage once the loan-to-value ratio reaches 78% of the original value. A borrower generally may also request cancellation of mortgage insurance from the lender once the actual payments reduce the loan balance to 80% of the home’s original value. For borrower-initiated cancellation of mortgage insurance, the borrower must have a “good payment history” as defined by HOPA. The Real Estate Settlement Procedures Act of 1974 (“RESPA”) applies to most residential mortgages insured by private mortgage insurers. Mortgage insurance is considered a “settlement service” for purposes of loans subject to RESPA. Subject to limited exceptions, RESPA precludes our U.S. mortgage insurance subsidiaries from providing services to mortgage lenders or other settlement service providers free of charge, charging fees for services that are lower than their reasonable or fair market value, and paying fees for services that others provide that are higher than their reasonable or fair market value. In addition, RESPA prohibits persons from giving or accepting any portion or percentage of a charge for a real estate settlement service, other than for services actually performed. Although many states prohibit mortgage insurers from giving rebates, RESPA has been interpreted to cover many non-fee services as well. Mortgage insurers and their customers are subject to the possible sanctions of this law, which may be enforced by the CFPB, state insurance departments, state attorneys general and other enforcement authorities. The Fair Housing Act and the Fair Credit Reporting Act (“FCRA”) also affect the business of mortgage insurance in various ways. The Fair Housing Act generally prohibits discrimination in the terms, conditions or privileges in residential real estate-related transactions on the basis of race, color, religion, sex, familial status or national origin. Numerous courts have held that the Fair Housing Act prohibits discriminatory insurance practices. The FCRA governs the access and use of consumer credit information in credit transactions and requires notices to consumers in certain circumstances. It imposes restrictions on the permissible use of credit report information and requires mortgage insurance companies to provide adverse action notices to consumers in the event an application for mortgage insurance is declined or offered at less than the best available rate for the loan program applied for due to information contained in a consumer’s credit report. Other U.S. Regulation and Agency Qualification Requirements The GSEs impose eligibility requirements that private mortgage insurers must satisfy in order to be approved to insure loans purchased by the GSEs. The PMIERs aim to ensure that approved insurers possess the financial and operational capacity to serve as strong counterparties to the GSEs throughout various market conditions. The PMIERs are comprehensive, covering virtually all aspects of our U.S. mortgage insurance subsidiaries’ business and operations as private mortgage insurers of GSE loans, including internal risk management and quality controls, underwriting, claim processing and loss mitigation, among other aspects. In addition, the PMIERs require private mortgage insurers to obtain the prior consent of the GSEs before taking certain actions, which may include entering into various intercompany agreements and commuting or reinsuring risk, among others. The financial requirements of PMIERs mandate that a mortgage insurer’s “Available Assets” (generally only the most liquid assets of an insurer) must meet or exceed “Minimum Required Assets” (which are based on an insurer’s risk in-force and are calculated from tables of factors with several risk dimensions and are subject to a floor amount). During 2020 and 2021, the GSEs issued several amendments to PMIERs. Many of the provisions are no longer applicable, but for loans that became non-performing due to a COVID-19 hardship, PMIERs was temporarily amended with respect to each non-performing loan that (i) had an initial missed monthly payment occurring on or after March 1, 2020 and prior to April 1, 2021 or (ii) is subject to a forbearance plan granted in response to a financial hardship related to COVID-19, the terms of which are materially consistent with terms of 22 23 In August 2023, the NAIC adopted amendments to the Mortgage Guaranty Insurance Model Act (the “MGI Model Act”) and is in the process of making conforming revisions to the Statement of Statutory Accounting Principles No. 58—Mortgage Guaranty Insurance. The revisions to the MGI Model Act are extensive, including with respect to risk concentration limits, capital and reserve requirements, reinsurance, underwriting practices and quality assurance. For a discussion of the potential risks to our business associated with these amendments, see “Item 1A—Risk Factors—Enact Holdings’ U.S. mortgage insurance subsidiaries are subject to minimum statutory capital requirements, which if not met or waived, would result in restrictions or prohibitions on them doing business and could have a material adverse impact on our business, financial condition and results of operations.” Reserves Insurance Laws require our U.S. mortgage insurers to establish a special statutory contingency reserve in their statutory financial statements to provide for claims and other expenses in the event of significant economic declines. Annual additions to the statutory contingency reserve must be at least 50% of net earned premiums as defined by Insurance Laws. These contingency reserves generally are held until the earlier of (i) 10 years or (ii) when loss ratios exceed 35%, in which case the amount above 35% can be released under certain circumstances, although regulators have granted discretionary releases from time to time. However, approval by the NCDOI, the primary domiciliary regulator for our U.S. mortgage insurers, is required for contingency reserve releases when loss ratios exceed 35%. The establishment of the statutory contingency reserve is funded by premiums that would otherwise generate net earnings that would be reflected in policyholder surplus. This reserve reduces the policyholder surplus of our U.S. mortgage insurers, and therefore, their ability to pay dividends to our holding companies. See note 22 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for information on the statutory contingency reserve for our U.S. mortgage insurers. Premium rates In most states where our U.S. mortgage insurance subsidiaries are licensed, premium rates are required to be filed before the authorization is granted to charge premiums. In some states, these premium rates must be approved before their use. Likewise, changes in premium rates must be filed and receive approval. In general, states may require actuarial justification on the basis of the insurer’s loss experience, expenses and future projections. In addition, states may consider general default experience in the mortgage insurance industry in assessing the premium rates charged by U.S. mortgage insurers. Federal regulation In addition to federal laws directly applicable to mortgage insurers, the laws and regulations applicable to mortgage originators and lenders, purchasers of mortgage loans such as the GSEs, and governmental insurers such as the FHA and VA indirectly affect mortgage insurers. Moreover, mortgage origination and servicing transactions are subject to compliance with various state and federal laws. Changes in federal housing legislation and other laws and regulations that affect the demand for private mortgage insurance, or the way in which such laws and regulations are interpreted or applied, may have a material effect on private mortgage insurers. For example, the Enterprise Capital Framework of the Federal Housing Finance Agency (“FHFA”) that became effective in 2021 includes significantly higher regulatory capital requirements for the GSEs over current requirements. Higher GSE capital requirements could ultimately lead to increased costs to borrowers of GSE loans, which in turn could shift the market away from the GSEs to the FHA or lender portfolios. Such a shift could result in a smaller market for private mortgage insurance. See “Item 1A—Risk Factors—Changes to the role of the GSEs or to the charters or business practices of the GSEs, including actions or decisions to decrease or discontinue the use of mortgage insurance, could adversely affect our business, financial condition and results of operations.” The Homeowners Protection Act of 1998 (“HOPA”) provides for the automatic termination, or cancellation upon a borrower’s request, of the borrower’s obligation to pay for private mortgage insurance upon satisfaction of certain conditions, although mortgage servicers may continue to keep the coverage in place at their expense. HOPA applies to owner-occupied residential mortgage loans regardless of lien priority and to borrower-paid mortgage insurance closed after July 29, 1999. HOPA requires lenders to automatically terminate a borrower’s obligation to pay for mortgage insurance coverage once the loan-to-value ratio reaches 78% of the original value. A borrower generally may also request cancellation of mortgage insurance from the lender once the actual payments reduce the loan balance to 80% of the home’s original value. For borrower-initiated cancellation of mortgage insurance, the borrower must have a “good payment history” as defined by HOPA. The Real Estate Settlement Procedures Act of 1974 (“RESPA”) applies to most residential mortgages insured by private mortgage insurers. Mortgage insurance is considered a “settlement service” for purposes of loans subject to RESPA. Subject to limited exceptions, RESPA precludes our U.S. mortgage insurance subsidiaries from providing services to mortgage lenders or other settlement service providers free of charge, charging fees for services that are lower than their reasonable or fair market value, and paying fees for services that others provide that are higher than their reasonable or fair market value. In addition, RESPA prohibits persons from giving or accepting any portion or percentage of a charge for a real estate settlement service, other than for services actually performed. Although many states prohibit mortgage insurers from giving rebates, RESPA has been interpreted to cover many non-fee services as well. Mortgage insurers and their customers are subject to the possible sanctions of this law, which may be enforced by the CFPB, state insurance departments, state attorneys general and other enforcement authorities. The Fair Housing Act and the Fair Credit Reporting Act (“FCRA”) also affect the business of mortgage insurance in various ways. The Fair Housing Act generally prohibits discrimination in the terms, conditions or privileges in residential real estate-related transactions on the basis of race, color, religion, sex, familial status or national origin. Numerous courts have held that the Fair Housing Act prohibits discriminatory insurance practices. The FCRA governs the access and use of consumer credit information in credit transactions and requires notices to consumers in certain circumstances. It imposes restrictions on the permissible use of credit report information and requires mortgage insurance companies to provide adverse action notices to consumers in the event an application for mortgage insurance is declined or offered at less than the best available rate for the loan program applied for due to information contained in a consumer’s credit report. Other U.S. Regulation and Agency Qualification Requirements The GSEs impose eligibility requirements that private mortgage insurers must satisfy in order to be approved to insure loans purchased by the GSEs. The PMIERs aim to ensure that approved insurers possess the financial and operational capacity to serve as strong counterparties to the GSEs throughout various market conditions. The PMIERs are comprehensive, covering virtually all aspects of our U.S. mortgage insurance subsidiaries’ business and operations as private mortgage insurers of GSE loans, including internal risk management and quality controls, underwriting, claim processing and loss mitigation, among other aspects. In addition, the PMIERs require private mortgage insurers to obtain the prior consent of the GSEs before taking certain actions, which may include entering into various intercompany agreements and commuting or reinsuring risk, among others. The financial requirements of PMIERs mandate that a mortgage insurer’s “Available Assets” (generally only the most liquid assets of an insurer) must meet or exceed “Minimum Required Assets” (which are based on an insurer’s risk in-force and are calculated from tables of factors with several risk dimensions and are subject to a floor amount). During 2020 and 2021, the GSEs issued several amendments to PMIERs. Many of the provisions are no longer applicable, but for loans that became non-performing due to a COVID-19 hardship, PMIERs was temporarily amended with respect to each non-performing loan that (i) had an initial missed monthly payment occurring on or after March 1, 2020 and prior to April 1, 2021 or (ii) is subject to a forbearance plan granted in response to a financial hardship related to COVID-19, the terms of which are materially consistent with terms of 22 23 forbearance plans offered by the GSEs. The risk-based required asset amount factor for the non-performing loan is the greater of (a) the applicable risk-based required asset amount factor for a performing loan were it not delinquent, and (b) the product of a 0.30 multiplier and the applicable risk-based required asset amount factor for a non-performing loan. In the case of (i) above, absent the loan being subject to a forbearance plan described in (ii) above, the 0.30 multiplier is applicable for no longer than three calendar months beginning with the month in which the loan became a non-performing loan due to having missed two monthly payments. Loans subject to a forbearance plan described in (ii) above include those that are either in a repayment plan or loan modification trial period following the forbearance plan unless reported to the approved insurer that the loan is no longer in such forbearance plan, repayment plan, or loan modification trial period. In addition, the PMIERs amendments made permanent revisions to the risk-based required asset amount factor for non-performing loans for properties located in future Federal Emergency Management Agency Declared Major Disaster Areas eligible for individual assistance. In their respective letters approving credit for reinsurance and other credit risk transfer transactions against PMIERs financial requirements, the GSEs require U.S. mortgage insurers not to exceed a maximum statutory risk-to-capital ratio of 18:1 or they reserve the right to re-evaluate the amount of PMIERs credit indicated in their approval letters. Freddie Mac has also imposed additional requirements on our option to commute these reinsurance agreements. Both GSEs reserved the right to periodically review the reinsurance and credit risk transfer transactions for treatment under PMIERs. In September 2020, subsequent to the issuance of Enact Holdings’ senior notes due in 2025, the GSEs imposed certain restrictions (the “GSE Restrictions”) on Enact with respect to capital. In May 2021, in connection with their conditional approval of the partial sale of Enact Holdings, the GSEs confirmed the GSE Restrictions would remain in effect until certain conditions (the “GSE Conditions”) were met for two consecutive quarters. These conditions were met as of December 31, 2022 and in March 2023, the GSEs confirmed that Enact is no longer subject to the GSE Restrictions and the GSE Conditions. Each approved mortgage insurer is required to provide the GSEs with an annual certification and a quarterly report as to its compliance with PMIERs. As of December 31, 2023, Enact met the PMIERs financial and operational requirements. For additional information, see note 22 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Although we expect Enact will continue to retain its eligibility status with the GSEs, there can be no assurance these conditions will continue, see “Item 1A—Risk Factors—If Enact is unable to continue to meet the requirements mandated by PMIERs because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition.” Non-U.S. Insurance Regulation We operate in and have certain subsidiaries domiciled in countries outside the United States, principally including Mexico, Bermuda and India. Generally, our subsidiaries conducting business in these countries must obtain licenses from local regulatory authorities and satisfy local regulatory requirements, including those relating to rates, forms, capital, reserves and financial reporting. Enact Re is subject to regulation by the Bermuda Monetary Authority. This includes required filing of financial and capital information as well as certain restrictions on its ability to pay dividends and distributions. stringent regulation. 24 25 Other Laws and Regulations Changes in tax laws On August 16, 2022, the U.S. federal government enacted the Inflation Reduction Act (“IRA”) which, among other things, implemented a 15% corporate alternative minimum tax (“CAMT”) based on adjusted financial statement income and imposed a 1% excise tax on corporate stock repurchases, effective January 1, 2023. The enactment of the CAMT did not have a material impact on our financial statements for the year ended December 31, 2023. Excise tax incurred on our share repurchases is recognized as part of the cost basis of the treasury stock acquired and not reported as part of income tax expense, and it did not have a material impact on our financial position for the year ended December 31, 2023. There was no other U.S. federal income tax-related legislation or administrative guidance issued in 2023 or 2022 that had a significant impact on our results of operations or financial condition. Dodd-Frank Act and other federal initiatives Although the federal government generally does not directly regulate the insurance business, federal initiatives often have an impact on the business in a variety of ways, including through regulation of financial services. The Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) made extensive changes to the laws regulating financial services firms and required various federal agencies to adopt a broad range of rules and regulations. In the case of Enact Holdings, the Dodd-Frank Act prohibits a creditor from making a residential mortgage loan unless the creditor makes a reasonable and good faith determination that, at the time the loan is consummated, the consumer has a reasonable ability to repay the loan. In addition, the Dodd-Frank Act created the CFPB, which regulates certain aspects of the offering and provision of consumer financial products or services but not the business of insurance. Certain rules and regulations established by the CFPB require mortgage lenders to demonstrate that they have effectively considered the consumer’s ability to repay a mortgage loan, establish when a mortgage may be classified as a Qualified Mortgage (“QM”) and determine when a lender is eligible for a safe harbor as a presumption that the lender has complied with the ability-to-repay requirements. The Financial Stability Oversight Council (“FSOC”) is authorized to designate certain financial companies, which may include insurance companies, as non-bank systemically important financial institutions (“SIFIs”). The FSOC is authorized to subject SIFIs to stricter prudential standards, including a special orderly liquidation process outside the federal Bankruptcy Code, among other requirements. On November 3, 2023, the FSOC adopted new guidance that no longer requires the FSOC to conduct a cost-benefit analysis and assessment of the likelihood of a non-bank financial company’s material financial distress before designating the company as a non-bank SIFI. The new guidance could have the effect of simplifying and shortening the FSOC’s procedures for designating certain financial companies as non-bank SIFIs. We have not been, nor do we believe we will be, designated as systemically significant by the FSOC. A future determination that we or our counterparties are systemically significant could impose significant burdens on us, impact the way we conduct our business, increase compliance costs, duplicate state regulation and result in a competitive disadvantage. The Dodd-Frank Act established a Federal Insurance Office (“FIO”) within the U.S. Department of the Treasury. While not having a general supervisory or regulatory authority over the business of insurance, the director of this office performs various functions with respect to insurance, including serving as a non-voting member of the FSOC and making recommendations to the FSOC regarding insurers to be designated for more The Dodd-Frank Act established a framework of regulation of over-the-counter (“OTC”) derivatives markets which requires us to pledge highly liquid securities or cash to meet initial and variation margin requirements for most interest rate derivatives we trade. In addition, federal bank regulations require certain bank-regulated counterparties to include in certain derivatives contracts terms that delay or restrict the rights of forbearance plans offered by the GSEs. The risk-based required asset amount factor for the non-performing loan is the greater of (a) the applicable risk-based required asset amount factor for a performing loan were it not delinquent, and (b) the product of a 0.30 multiplier and the applicable risk-based required asset amount factor for a non-performing loan. In the case of (i) above, absent the loan being subject to a forbearance plan described in (ii) above, the 0.30 multiplier is applicable for no longer than three calendar months beginning with the month in which the loan became a non-performing loan due to having missed two monthly payments. Loans subject to a forbearance plan described in (ii) above include those that are either in a repayment plan or loan modification trial period following the forbearance plan unless reported to the approved insurer that the loan is no longer in such forbearance plan, repayment plan, or loan modification trial period. In addition, the PMIERs amendments made permanent revisions to the risk-based required asset amount factor for non-performing loans for properties located in future Federal Emergency Management Agency Declared Major Disaster Areas eligible for individual assistance. In their respective letters approving credit for reinsurance and other credit risk transfer transactions against PMIERs financial requirements, the GSEs require U.S. mortgage insurers not to exceed a maximum statutory risk-to-capital ratio of 18:1 or they reserve the right to re-evaluate the amount of PMIERs credit indicated in their approval letters. Freddie Mac has also imposed additional requirements on our option to commute these reinsurance agreements. Both GSEs reserved the right to periodically review the reinsurance and credit risk transfer transactions for treatment under PMIERs. In September 2020, subsequent to the issuance of Enact Holdings’ senior notes due in 2025, the GSEs imposed certain restrictions (the “GSE Restrictions”) on Enact with respect to capital. In May 2021, in connection with their conditional approval of the partial sale of Enact Holdings, the GSEs confirmed the GSE Restrictions would remain in effect until certain conditions (the “GSE Conditions”) were met for two consecutive quarters. These conditions were met as of December 31, 2022 and in March 2023, the GSEs confirmed that Enact is no longer subject to the GSE Restrictions and the GSE Conditions. Each approved mortgage insurer is required to provide the GSEs with an annual certification and a quarterly report as to its compliance with PMIERs. As of December 31, 2023, Enact met the PMIERs financial and operational requirements. For additional information, see note 22 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Although we expect Enact will continue to retain its eligibility status with the GSEs, there can be no assurance these conditions will continue, see “Item 1A—Risk Factors—If Enact is unable to continue to meet the requirements mandated by PMIERs because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition.” Non-U.S. Insurance Regulation We operate in and have certain subsidiaries domiciled in countries outside the United States, principally including Mexico, Bermuda and India. Generally, our subsidiaries conducting business in these countries must obtain licenses from local regulatory authorities and satisfy local regulatory requirements, including those relating to rates, forms, capital, reserves and financial reporting. Enact Re is subject to regulation by the Bermuda Monetary Authority. This includes required filing of financial and capital information as well as certain restrictions on its ability to pay dividends and distributions. Other Laws and Regulations Changes in tax laws On August 16, 2022, the U.S. federal government enacted the Inflation Reduction Act (“IRA”) which, among other things, implemented a 15% corporate alternative minimum tax (“CAMT”) based on adjusted financial statement income and imposed a 1% excise tax on corporate stock repurchases, effective January 1, 2023. The enactment of the CAMT did not have a material impact on our financial statements for the year ended December 31, 2023. Excise tax incurred on our share repurchases is recognized as part of the cost basis of the treasury stock acquired and not reported as part of income tax expense, and it did not have a material impact on our financial position for the year ended December 31, 2023. There was no other U.S. federal income tax-related legislation or administrative guidance issued in 2023 or 2022 that had a significant impact on our results of operations or financial condition. Dodd-Frank Act and other federal initiatives Although the federal government generally does not directly regulate the insurance business, federal initiatives often have an impact on the business in a variety of ways, including through regulation of financial services. The Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) made extensive changes to the laws regulating financial services firms and required various federal agencies to adopt a broad range of rules and regulations. In the case of Enact Holdings, the Dodd-Frank Act prohibits a creditor from making a residential mortgage loan unless the creditor makes a reasonable and good faith determination that, at the time the loan is consummated, the consumer has a reasonable ability to repay the loan. In addition, the Dodd-Frank Act created the CFPB, which regulates certain aspects of the offering and provision of consumer financial products or services but not the business of insurance. Certain rules and regulations established by the CFPB require mortgage lenders to demonstrate that they have effectively considered the consumer’s ability to repay a mortgage loan, establish when a mortgage may be classified as a Qualified Mortgage (“QM”) and determine when a lender is eligible for a safe harbor as a presumption that the lender has complied with the ability-to-repay requirements. The Financial Stability Oversight Council (“FSOC”) is authorized to designate certain financial companies, which may include insurance companies, as non-bank systemically important financial institutions (“SIFIs”). The FSOC is authorized to subject SIFIs to stricter prudential standards, including a special orderly liquidation process outside the federal Bankruptcy Code, among other requirements. On November 3, 2023, the FSOC adopted new guidance that no longer requires the FSOC to conduct a cost-benefit analysis and assessment of the likelihood of a non-bank financial company’s material financial distress before designating the company as a non-bank SIFI. The new guidance could have the effect of simplifying and shortening the FSOC’s procedures for designating certain financial companies as non-bank SIFIs. We have not been, nor do we believe we will be, designated as systemically significant by the FSOC. A future determination that we or our counterparties are systemically significant could impose significant burdens on us, impact the way we conduct our business, increase compliance costs, duplicate state regulation and result in a competitive disadvantage. The Dodd-Frank Act established a Federal Insurance Office (“FIO”) within the U.S. Department of the Treasury. While not having a general supervisory or regulatory authority over the business of insurance, the director of this office performs various functions with respect to insurance, including serving as a non-voting member of the FSOC and making recommendations to the FSOC regarding insurers to be designated for more stringent regulation. The Dodd-Frank Act established a framework of regulation of over-the-counter (“OTC”) derivatives markets which requires us to pledge highly liquid securities or cash to meet initial and variation margin requirements for most interest rate derivatives we trade. In addition, federal bank regulations require certain bank-regulated counterparties to include in certain derivatives contracts terms that delay or restrict the rights of 24 25 counterparties, which could adversely affect our ability to terminate, or realize amounts to be received under, such derivatives agreements. As the marketplace continues to evolve, we may have to alter or limit the way we use derivatives in the future, which could have an adverse effect on our results of operations and financial condition. On December 13, 2023, the SEC adopted rules to require that covered clearing agencies have policies and procedures reasonably designed to require every direct participant of the agency to submit for clearing eligible secondary market transactions in U.S. Treasury securities. The rule effectively requires such participants to clear eligible cash transactions in U.S. Treasury securities by December 31, 2025, and eligible repurchase transactions in U.S. Treasury securities by June 30, 2026. The rule’s potential effect on the U.S. Treasury markets is uncertain. On October 26, 2022, the SEC adopted a final rule to implement Section 954 of the Dodd-Frank Act titled “Listing Standards for Recovery of Erroneously Awarded Compensation.” The final rule added Section 10D to the Exchange Act, which requires national security exchanges to adopt listing standards that mandate issuers of securities listed on an exchange to develop and implement a policy for recovering erroneously awarded incentive-based compensation paid to executive officers in connection with a financial restatement, regardless of fault or misconduct, on or after October 2, 2023 (commonly referred to as a “clawback” policy). We revised our Incentive-Based Compensation Recovery Policy to include the applicable provisions of the final rule, see “—Part IV—Item 15—Exhibits and Financial Statement Schedules” for additional details. We cannot predict the effect of all the regulations or legislation adopted under the Dodd-Frank Act on financial markets generally, or on our businesses specifically, the additional costs associated with compliance with such regulations or legislation, or any changes to our operations that may be necessary to comply with the Dodd-Frank Act and the regulations thereunder, any of which could have a material adverse effect on our business, results of operations, cash flows or financial condition. We also cannot predict whether other federal initiatives will be adopted or what impact, if any, such initiatives, if adopted as laws, may have on our business, financial condition or results of operations. Environmental considerations As an owner and operator of real property, we are subject to extensive U.S. federal and state and non-U.S. environmental laws and regulations. Potential environmental liabilities and costs in connection with any required remediation of our properties is also an inherent risk in property ownership and operation. In addition, we hold equity interests in companies, and have made loans secured by properties, which could potentially be subject to environmental liabilities. We routinely have environmental assessments performed with respect to real estate being acquired for investment and real property to be acquired through foreclosure. Based upon information currently available to us, we believe that any costs associated with compliance with environmental laws and regulations, or any remediation of such properties will not have a material adverse effect on our business, financial condition or results of operations. Climate change and financial risks The topic of climate risk has come under increased scrutiny by the NAIC and insurance regulators. The NAIC has adopted a new standard for insurance companies to report their climate-related risks as part of its annual Climate Risk Disclosure Survey, which applies to insurers that meet the reporting threshold of $100 million in countrywide direct premium and are licensed in one of the participating jurisdictions. The new disclosure standard is consistent with the international Task Force on Climate-Related Financial Disclosures’ framework for reporting climate-related financial information. NYDFS expects insurers to integrate financial risks related to climate change into their governance frameworks, risk management processes and business strategies, and that insurers should develop their approach to climate related financial disclosure. We have initiated and continue to build upon a multi-phase climate risk management process. On November 15, 2021, the NYDFS issued additional guidance for New York domestic insurers (the “2021 Guidance”), applicable to GLICNY, related to the management of financial risks from climate change. Such insurers are expected to manage these risks by outlining actions that are proportionate to the nature, scale and complexity of their businesses. For instance, the 2021 Guidance states that an insurer should: (i) incorporate climate risk into its financial risk management, including its ORSA; (ii) manage climate risk through its enterprise risk management functions and ensure that its organizational structure clearly defines roles and responsibilities related to managing such risk; (iii) use scenario analysis when developing business strategies and identifying risks; and (iv) incorporate the management of climate risk into its corporate governance structure at the group or insurer entity level. As of August 15, 2022, insurers were required to implement certain corporate governance changes and develop plans to implement the organizational structure changes. We complied with this requirement and provided our plan to the NYDFS. Insurers are encouraged to work on additional changes that may take longer to implement, although the NYDFS will issue further guidance with more specific timelines. The NYDFS also amended the regulation that governs enterprise risk management, effective as of August 13, 2021, that requires an insurance group to include certain additional risks, such as climate change risk, in its enterprise risk management function. In addition, the FIO is authorized to monitor the U.S. insurance industry under the Dodd-Frank Act. Pursuant to its statutory authority, the FIO is assessing how the insurance sector may mitigate climate risks and help achieve national climate-related goals. On June 27, 2023, the FIO released a report titled, Insurance Supervision and Regulation of Climate-Related Risks, which evaluates climate-related issues and gaps in insurer regulation. The report urges insurance regulators to adopt climate-related risk-monitoring guidance in order to enhance their regulation and supervision of insurers. On October 7, 2023, California enacted two climate disclosure laws that will require entities that do business in the state and meet certain annual revenue thresholds to provide climate-related disclosures. Insurance companies are specifically excluded from the disclosure requirements of the Climate-Related Financial Risk Act (“SB 261”); however, it is expected that thousands of public and private companies will be subject to the disclosure requirements of the Climate Corporate Data Accountability Act (“SB 253”), including Genworth. SB 253 requires entities with more than $1.0 billion in annual revenue to annually disclose their Scope 1, Scope 2 and Scope 3 emissions in accordance with the Greenhouse Gas Protocol and obtain limited assurance over those disclosures beginning in 2026 and reasonable assurance beginning in 2030. SB 253 requires disclosures of Scope 1 and Scope 2 emissions beginning in 2026 (using fiscal year ended 2025 data), and Scope 3 emissions disclosures beginning in 2027. The California legislature continues to review implementation details under the new climate laws, including deadlines, as well as the potential impacts of the law on business entities; therefore, we cannot predict at this time whether there will be changes in how and when the laws are applied or the impact on our business, results of operations and financial condition. Diversity and corporate governance The NAIC and state insurance regulators are also focused on the topic of race, diversity and inclusion within the insurance industry. In New York, the NYDFS expects the insurers it regulates to make diversity of their leadership a business priority and a key element of their corporate governance. Privacy and cybersecurity The New York State Department of Financial Services (“NYDFS”) issued a circular letter in 2020 to New York domestic and foreign authorized insurers, which applies to certain of our subsidiaries, stating that the In the United States, federal and state laws and regulations require financial institutions, including insurance companies, to protect the privacy and security of consumer financial information and to notify consumers about 26 27 counterparties, which could adversely affect our ability to terminate, or realize amounts to be received under, such derivatives agreements. As the marketplace continues to evolve, we may have to alter or limit the way we use derivatives in the future, which could have an adverse effect on our results of operations and financial On December 13, 2023, the SEC adopted rules to require that covered clearing agencies have policies and procedures reasonably designed to require every direct participant of the agency to submit for clearing eligible secondary market transactions in U.S. Treasury securities. The rule effectively requires such participants to clear eligible cash transactions in U.S. Treasury securities by December 31, 2025, and eligible repurchase transactions in U.S. Treasury securities by June 30, 2026. The rule’s potential effect on the U.S. Treasury markets is condition. uncertain. On October 26, 2022, the SEC adopted a final rule to implement Section 954 of the Dodd-Frank Act titled “Listing Standards for Recovery of Erroneously Awarded Compensation.” The final rule added Section 10D to the Exchange Act, which requires national security exchanges to adopt listing standards that mandate issuers of securities listed on an exchange to develop and implement a policy for recovering erroneously awarded incentive-based compensation paid to executive officers in connection with a financial restatement, regardless of fault or misconduct, on or after October 2, 2023 (commonly referred to as a “clawback” policy). We revised our Incentive-Based Compensation Recovery Policy to include the applicable provisions of the final rule, see “—Part IV—Item 15—Exhibits and Financial Statement Schedules” for additional details. We cannot predict the effect of all the regulations or legislation adopted under the Dodd-Frank Act on financial markets generally, or on our businesses specifically, the additional costs associated with compliance with such regulations or legislation, or any changes to our operations that may be necessary to comply with the Dodd-Frank Act and the regulations thereunder, any of which could have a material adverse effect on our business, results of operations, cash flows or financial condition. We also cannot predict whether other federal initiatives will be adopted or what impact, if any, such initiatives, if adopted as laws, may have on our business, financial condition or results of operations. Environmental considerations As an owner and operator of real property, we are subject to extensive U.S. federal and state and non-U.S. environmental laws and regulations. Potential environmental liabilities and costs in connection with any required remediation of our properties is also an inherent risk in property ownership and operation. In addition, we hold equity interests in companies, and have made loans secured by properties, which could potentially be subject to environmental liabilities. We routinely have environmental assessments performed with respect to real estate being acquired for investment and real property to be acquired through foreclosure. Based upon information currently available to us, we believe that any costs associated with compliance with environmental laws and regulations, or any remediation of such properties will not have a material adverse effect on our business, financial condition or results of operations. Climate change and financial risks The topic of climate risk has come under increased scrutiny by the NAIC and insurance regulators. The NAIC has adopted a new standard for insurance companies to report their climate-related risks as part of its annual Climate Risk Disclosure Survey, which applies to insurers that meet the reporting threshold of $100 million in countrywide direct premium and are licensed in one of the participating jurisdictions. The new disclosure standard is consistent with the international Task Force on Climate-Related Financial Disclosures’ framework for reporting climate-related financial information. NYDFS expects insurers to integrate financial risks related to climate change into their governance frameworks, risk management processes and business strategies, and that insurers should develop their approach to climate related financial disclosure. We have initiated and continue to build upon a multi-phase climate risk management process. On November 15, 2021, the NYDFS issued additional guidance for New York domestic insurers (the “2021 Guidance”), applicable to GLICNY, related to the management of financial risks from climate change. Such insurers are expected to manage these risks by outlining actions that are proportionate to the nature, scale and complexity of their businesses. For instance, the 2021 Guidance states that an insurer should: (i) incorporate climate risk into its financial risk management, including its ORSA; (ii) manage climate risk through its enterprise risk management functions and ensure that its organizational structure clearly defines roles and responsibilities related to managing such risk; (iii) use scenario analysis when developing business strategies and identifying risks; and (iv) incorporate the management of climate risk into its corporate governance structure at the group or insurer entity level. As of August 15, 2022, insurers were required to implement certain corporate governance changes and develop plans to implement the organizational structure changes. We complied with this requirement and provided our plan to the NYDFS. Insurers are encouraged to work on additional changes that may take longer to implement, although the NYDFS will issue further guidance with more specific timelines. The NYDFS also amended the regulation that governs enterprise risk management, effective as of August 13, 2021, that requires an insurance group to include certain additional risks, such as climate change risk, in its enterprise risk management function. In addition, the FIO is authorized to monitor the U.S. insurance industry under the Dodd-Frank Act. Pursuant to its statutory authority, the FIO is assessing how the insurance sector may mitigate climate risks and help achieve national climate-related goals. On June 27, 2023, the FIO released a report titled, Insurance Supervision and Regulation of Climate-Related Risks, which evaluates climate-related issues and gaps in insurer regulation. The report urges insurance regulators to adopt climate-related risk-monitoring guidance in order to enhance their regulation and supervision of insurers. On October 7, 2023, California enacted two climate disclosure laws that will require entities that do business in the state and meet certain annual revenue thresholds to provide climate-related disclosures. Insurance companies are specifically excluded from the disclosure requirements of the Climate-Related Financial Risk Act (“SB 261”); however, it is expected that thousands of public and private companies will be subject to the disclosure requirements of the Climate Corporate Data Accountability Act (“SB 253”), including Genworth. SB 253 requires entities with more than $1.0 billion in annual revenue to annually disclose their Scope 1, Scope 2 and Scope 3 emissions in accordance with the Greenhouse Gas Protocol and obtain limited assurance over those disclosures beginning in 2026 and reasonable assurance beginning in 2030. SB 253 requires disclosures of Scope 1 and Scope 2 emissions beginning in 2026 (using fiscal year ended 2025 data), and Scope 3 emissions disclosures beginning in 2027. The California legislature continues to review implementation details under the new climate laws, including deadlines, as well as the potential impacts of the law on business entities; therefore, we cannot predict at this time whether there will be changes in how and when the laws are applied or the impact on our business, results of operations and financial condition. Diversity and corporate governance The NAIC and state insurance regulators are also focused on the topic of race, diversity and inclusion within the insurance industry. In New York, the NYDFS expects the insurers it regulates to make diversity of their leadership a business priority and a key element of their corporate governance. Privacy and cybersecurity The New York State Department of Financial Services (“NYDFS”) issued a circular letter in 2020 to New York domestic and foreign authorized insurers, which applies to certain of our subsidiaries, stating that the In the United States, federal and state laws and regulations require financial institutions, including insurance companies, to protect the privacy and security of consumer financial information and to notify consumers about 26 27 policies and practices relating to the collection, use and disclosure of consumer information, as well as policies relating to protecting the confidentiality, integrity and availability of that information. Similarly, federal and state laws and regulations govern the disclosure and security of consumer health information. In particular, regulations promulgated by the U.S. Department of Health and Human Services pursuant to the Health Insurance Portability and Accountability Act and various states regulate the disclosure and use of protected health information by health insurers and other covered entities, the physical and procedural safeguards employed to protect the security of that information, and the electronic transmission of such information. From time to time, Congress and state legislatures consider additional legislation relating to privacy and other aspects of consumer information. We cannot predict whether such legislation will be enacted, or what impact, if any, such legislation may have on our business, financial condition or results of operations. The California Consumer Privacy Act of 2018 (the “CCPA”) is applicable to portions of our business and was significantly amended by the California Privacy Rights Act of 2020 (“CPRA”). The CCPA, as amended by the CPRA, grants California residents the right to know what information a business has collected about them and the sourcing and sharing of that information, as well as the right to access and correct their personal information, and (subject to certain exemptions) the right to have a business delete their personal information. The CPRA created the California Privacy Protection Agency to enforce the CCPA and to promulgate regulations thereunder, imposed additional obligations regarding the privacy notice and service provider contracts, created new requirements around the protection of sensitive personal information and eliminated certain exemptions for personal information collected in employment or business-to-business contexts. The majority of the CPRA provisions went into effect on January 1, 2023. Failure to comply with the CCPA risks regulatory fines, and the law grants a private right of action for any unauthorized disclosure of certain personal information not subject to an exemption as a result of failure to maintain reasonable security procedures and practices. Other states have enacted, or are considering enacting, similar comprehensive data privacy laws. These laws generally include entity-wide exemptions for financial institutions subject to Title V of the Gramm-Leach-Bliley Act. However, such new laws and regulations vary by jurisdiction, and adapting our data privacy practices may increase the risk of noncompliance, along with our compliance costs. The NAIC’s Privacy Protections (H) Working Group (“PPWG”) is also developing a new Insurance Consumer Privacy Protections Model Law (Model 674) to replace the NAIC’s Insurance Information and Privacy Protection Model Act and the Privacy of Consumer Financial and Health Information Regulation. Due to the large number of comments received on a revised draft of Model 674, the PPWG received an extension until December 31, 2024 to develop the new model law. Cybersecurity continues to be an area of significant and increasing focus of legislatures and regulators. For example, on November 1, 2023, the NYDFS adopted amendments to its cybersecurity regulation specific to financial services institutions, including banking and insurance entities, under its jurisdiction. The regulation requires a company’s cybersecurity program to be reasonably designed to protect consumers’ private data and to include robust controls regarding access privileges, application security, policies and procedures for the disposal of nonpublic information, regular cybersecurity awareness training, encryption of nonpublic information, third- party due diligence and an incident response plan. The amendments expand requirements for notification to the NYDFS of cybersecurity events, including related to ransomware attacks, and expand technical requirements around system penetration testing, vulnerability assessments, risk assessments and audits. The amendments also add new requirements related to cybersecurity plans and expand cybersecurity governance requirements, among other things. We are required to file an annual certification of compliance with the NYDFS regarding our cybersecurity program. In addition, the NAIC’s Insurance Data Security Model Law (the “Cybersecurity Model Law”), which is similar to New York’s cybersecurity regulation, establishes standards for data security and for the investigation of and notification to insurance commissioners of cybersecurity events involving unauthorized access to, or the misuse of, certain nonpublic information. The Cybersecurity Model Law provides requirements to protect the confidentiality, integrity and availability of covered information systems and the sensitive or business information thereon. Approximately 23 states have adopted a version of the Cybersecurity Model Law, including Delaware and Virginia. Finally, effective as of June 2023, the Federal Trade Commission (“FTC”) amended the “Standards for Safeguarding Customer Information Rules” (known as the “Safeguards Rule”) to add requirements for certain covered financial institutions to implement and maintain certain data security practices in their information security programs. In November 2023, the FTC published a final rule further amending the Safeguards Rule to require notification to the FTC of certain data breach events. These additional amendments take effect in May For additional information regarding our cybersecurity risk management and governance, see “Item 1C— We are committed to helping families become more financially secure, self-reliant and prepared for the future, and that philosophy extends to our employees. We take a holistic approach to human capital management, including attracting and retaining talent with comprehensive benefits and compensation packages, providing professional development and learning opportunities, facilitating access to dedicated resources that foster an equitable and inclusive environment and encouraging a sincere commitment to community service and 2024. Cybersecurity.” Human Capital Management involvement. Total rewards and well-being • Our compensation package, including salary, bonus and long-term incentives, aligns employee and stockholder interests. In 2023, we introduced a new rewards and recognition platform that encourages our employees to recognize one another for exemplifying our values to make it human, make it about others, make it happen and make it better as they serve our current and future customers. • In addition to a competitive compensation program, we also offer our employees benefits such as life and health insurance, paid time off, paid family leave, identity theft protection, financial planning and a retirement savings plan. • To further support our employees, we continue to provide additional financial, health and wellbeing resources, as well as a flexible work schedule to allow employees additional time for self-care and the care of family members. We are currently operating under a hybrid approach organizationally, allowing flexibility to work remotely or in the office. Learning and development • We offer a multitude of professional development and career enrichment opportunities, including building leadership skills, professional skills training and industry-specific matters, as well as education reimbursement benefits and student loan repayment to aid career progression. • Additionally, we facilitate an annual organization-wide talent management process to support career development, progression and succession planning. Diversity and inclusion • We are committed to fostering an inclusive work environment that encourages employees to be their authentic selves. Our executive leadership established a diversity, equity, and inclusion executive steering committee to emphasize the importance of Genworth’s diversity philosophy. We have built 28 29 policies and practices relating to the collection, use and disclosure of consumer information, as well as policies relating to protecting the confidentiality, integrity and availability of that information. Similarly, federal and state laws and regulations govern the disclosure and security of consumer health information. In particular, regulations promulgated by the U.S. Department of Health and Human Services pursuant to the Health Insurance Portability and Accountability Act and various states regulate the disclosure and use of protected health information by health insurers and other covered entities, the physical and procedural safeguards employed to protect the security of that information, and the electronic transmission of such information. From time to time, Congress and state legislatures consider additional legislation relating to privacy and other aspects of consumer information. We cannot predict whether such legislation will be enacted, or what impact, if any, such legislation may have on our business, financial condition or results of operations. The California Consumer Privacy Act of 2018 (the “CCPA”) is applicable to portions of our business and was significantly amended by the California Privacy Rights Act of 2020 (“CPRA”). The CCPA, as amended by the CPRA, grants California residents the right to know what information a business has collected about them and the sourcing and sharing of that information, as well as the right to access and correct their personal information, and (subject to certain exemptions) the right to have a business delete their personal information. The CPRA created the California Privacy Protection Agency to enforce the CCPA and to promulgate regulations thereunder, imposed additional obligations regarding the privacy notice and service provider contracts, created new requirements around the protection of sensitive personal information and eliminated certain exemptions for personal information collected in employment or business-to-business contexts. The majority of the CPRA provisions went into effect on January 1, 2023. Failure to comply with the CCPA risks regulatory fines, and the law grants a private right of action for any unauthorized disclosure of certain personal information not subject to an exemption as a result of failure to maintain reasonable security procedures and practices. Other states have enacted, or are considering enacting, similar comprehensive data privacy laws. These laws generally include entity-wide exemptions for financial institutions subject to Title V of the Gramm-Leach-Bliley Act. However, such new laws and regulations vary by jurisdiction, and adapting our data privacy practices may increase the risk of noncompliance, along with our compliance costs. The NAIC’s Privacy Protections (H) Working Group (“PPWG”) is also developing a new Insurance Consumer Privacy Protections Model Law (Model 674) to replace the NAIC’s Insurance Information and Privacy Protection Model Act and the Privacy of Consumer Financial and Health Information Regulation. Due to the large number of comments received on a revised draft of Model 674, the PPWG received an extension until December 31, 2024 to develop the new model law. Cybersecurity continues to be an area of significant and increasing focus of legislatures and regulators. For example, on November 1, 2023, the NYDFS adopted amendments to its cybersecurity regulation specific to financial services institutions, including banking and insurance entities, under its jurisdiction. The regulation requires a company’s cybersecurity program to be reasonably designed to protect consumers’ private data and to include robust controls regarding access privileges, application security, policies and procedures for the disposal of nonpublic information, regular cybersecurity awareness training, encryption of nonpublic information, third- party due diligence and an incident response plan. The amendments expand requirements for notification to the NYDFS of cybersecurity events, including related to ransomware attacks, and expand technical requirements around system penetration testing, vulnerability assessments, risk assessments and audits. The amendments also add new requirements related to cybersecurity plans and expand cybersecurity governance requirements, among other things. We are required to file an annual certification of compliance with the NYDFS regarding our cybersecurity program. In addition, the NAIC’s Insurance Data Security Model Law (the “Cybersecurity Model Law”), which is similar to New York’s cybersecurity regulation, establishes standards for data security and for the investigation of and notification to insurance commissioners of cybersecurity events involving unauthorized access to, or the misuse of, certain nonpublic information. The Cybersecurity Model Law provides requirements to protect the confidentiality, integrity and availability of covered information systems and the sensitive or business information thereon. Approximately 23 states have adopted a version of the Cybersecurity Model Law, including Delaware and Virginia. Finally, effective as of June 2023, the Federal Trade Commission (“FTC”) amended the “Standards for Safeguarding Customer Information Rules” (known as the “Safeguards Rule”) to add requirements for certain covered financial institutions to implement and maintain certain data security practices in their information security programs. In November 2023, the FTC published a final rule further amending the Safeguards Rule to require notification to the FTC of certain data breach events. These additional amendments take effect in May 2024. For additional information regarding our cybersecurity risk management and governance, see “Item 1C— Cybersecurity.” Human Capital Management We are committed to helping families become more financially secure, self-reliant and prepared for the future, and that philosophy extends to our employees. We take a holistic approach to human capital management, including attracting and retaining talent with comprehensive benefits and compensation packages, providing professional development and learning opportunities, facilitating access to dedicated resources that foster an equitable and inclusive environment and encouraging a sincere commitment to community service and involvement. Total rewards and well-being • Our compensation package, including salary, bonus and long-term incentives, aligns employee and stockholder interests. In 2023, we introduced a new rewards and recognition platform that encourages our employees to recognize one another for exemplifying our values to make it human, make it about others, make it happen and make it better as they serve our current and future customers. • In addition to a competitive compensation program, we also offer our employees benefits such as life and health insurance, paid time off, paid family leave, identity theft protection, financial planning and a retirement savings plan. • To further support our employees, we continue to provide additional financial, health and wellbeing resources, as well as a flexible work schedule to allow employees additional time for self-care and the care of family members. We are currently operating under a hybrid approach organizationally, allowing flexibility to work remotely or in the office. Learning and development • We offer a multitude of professional development and career enrichment opportunities, including building leadership skills, professional skills training and industry-specific matters, as well as education reimbursement benefits and student loan repayment to aid career progression. • Additionally, we facilitate an annual organization-wide talent management process to support career development, progression and succession planning. Diversity and inclusion • We are committed to fostering an inclusive work environment that encourages employees to be their authentic selves. Our executive leadership established a diversity, equity, and inclusion executive steering committee to emphasize the importance of Genworth’s diversity philosophy. We have built 28 29 Our website also includes the charters of our audit committee, nominating and corporate governance committee, risk committee, and management development and compensation committee, any key practices of these committees, our governance principles, and the Company’s code of ethics. Copies of these materials also are available, without charge, from Genworth Investor Relations, at the above address. Within the time period required by the SEC and the New York Stock Exchange, we will post on our website any amendment to our code of ethics and any waiver applicable to any of our directors, executive officers or senior financial officers. On May 30, 2023, our President and Chief Executive Officer certified to the New York Stock Exchange that he was not aware of any violation by us of the New York Stock Exchange’s corporate governance listing standards. Transfer Agent and Registrar Our transfer agent and registrar is Computershare, P.O. Box 505000, Louisville, KY 40233-5000. Telephone: 866-229-8413; 201-680-6578 (outside the United States and Canada may call collect); and 800-231-5469 (for hearing impaired). and continue to actively engage strong community connections and partnerships with diverse organizations to promote equitable opportunities and have implemented training initiatives to enhance employee inclusivity and self-awareness. • We empower our employees to embrace their differences and commonalities to contribute to a culture of belonging. To help in this important work, all employees are encouraged to participate in our 13 Employee Resource Groups (“ERGs”) and Toastmasters, a communication and leadership club. These ERGs and Toastmasters are central to Genworth’s identity, driving allyship, education, resources and positive change throughout our workforce. Social responsibility • We use our outreach platforms, including the Genworth Foundation, to extend our very purposeful impact in our communities through grants, program sponsorships, paid volunteer time for our employees and employee-directed charitable giving. We align philanthropic efforts with our primary business focus areas, our commitment to sustainability and other programs that are important to our employees. • Please read our Sustainability Report to learn more about our collective accomplishments and plans to continue serving our customers, our colleagues, and our community. Workforce demographics • We are proud to embrace a future where the diversity of our associates, leadership and executives contribute to a culture of belonging and inclusion. • As of December 31, 2023, we employed approximately 2,700 full-time and part-time employees globally, none of which are subject to a collective bargaining agreement. Women comprised approximately 61% of our total U.S. employee population, while 34% of our employees in the U.S. were ethnically diverse. Among people leaders in the U.S., 46% were women and 24% were ethnically diverse and for our senior management, which we designate based on internal human resource compensation levels, 32% were women and 22% were ethnically diverse. With respect to the eight members of our non-management Board of Directors, four are women and two are ethnically diverse. In addition, as of January 1, 2024, of the five senior leaders of our top business lines and our investments group, three are women and four are ethnically diverse. Information posted on our website, including our Sustainability Report, is not incorporated by reference into and does not form part of this Annual Report on Form 10-K. Directors and Executive Officers See Part III, Item 10 of this Annual Report on Form 10-K for information about our directors and executive officers. Available Information Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act are available, without charge, on our website, www.genworth.com, as soon as reasonably practicable after we file or furnish such reports with the SEC. The public may read and copy any electronic materials we file or furnish with the SEC at the SEC’s website, www.sec.gov. Copies of our SEC filed or furnished reports are also available, without charge, from Genworth Investor Relations, 6620 West Broad Street, Richmond, VA 23230. 30 31 Our website also includes the charters of our audit committee, nominating and corporate governance committee, risk committee, and management development and compensation committee, any key practices of these committees, our governance principles, and the Company’s code of ethics. Copies of these materials also are available, without charge, from Genworth Investor Relations, at the above address. Within the time period required by the SEC and the New York Stock Exchange, we will post on our website any amendment to our code of ethics and any waiver applicable to any of our directors, executive officers or senior financial officers. On May 30, 2023, our President and Chief Executive Officer certified to the New York Stock Exchange that he was not aware of any violation by us of the New York Stock Exchange’s corporate governance listing standards. Transfer Agent and Registrar Our transfer agent and registrar is Computershare, P.O. Box 505000, Louisville, KY 40233-5000. Telephone: 866-229-8413; 201-680-6578 (outside the United States and Canada may call collect); and 800-231-5469 (for hearing impaired). and continue to actively engage strong community connections and partnerships with diverse organizations to promote equitable opportunities and have implemented training initiatives to enhance employee inclusivity and self-awareness. • We empower our employees to embrace their differences and commonalities to contribute to a culture of belonging. To help in this important work, all employees are encouraged to participate in our 13 Employee Resource Groups (“ERGs”) and Toastmasters, a communication and leadership club. These ERGs and Toastmasters are central to Genworth’s identity, driving allyship, education, resources and positive change throughout our workforce. Social responsibility • We use our outreach platforms, including the Genworth Foundation, to extend our very purposeful impact in our communities through grants, program sponsorships, paid volunteer time for our employees and employee-directed charitable giving. We align philanthropic efforts with our primary business focus areas, our commitment to sustainability and other programs that are important to our employees. • Please read our Sustainability Report to learn more about our collective accomplishments and plans to continue serving our customers, our colleagues, and our community. Workforce demographics • We are proud to embrace a future where the diversity of our associates, leadership and executives contribute to a culture of belonging and inclusion. • As of December 31, 2023, we employed approximately 2,700 full-time and part-time employees globally, none of which are subject to a collective bargaining agreement. Women comprised approximately 61% of our total U.S. employee population, while 34% of our employees in the U.S. were ethnically diverse. Among people leaders in the U.S., 46% were women and 24% were ethnically diverse and for our senior management, which we designate based on internal human resource compensation levels, 32% were women and 22% were ethnically diverse. With respect to the eight members of our non-management Board of Directors, four are women and two are ethnically diverse. In addition, as of January 1, 2024, of the five senior leaders of our top business lines and our investments group, three are women and four are ethnically diverse. Information posted on our website, including our Sustainability Report, is not incorporated by reference into and does not form part of this Annual Report on Form 10-K. See Part III, Item 10 of this Annual Report on Form 10-K for information about our directors and executive Directors and Executive Officers officers. Available Information Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act are available, without charge, on our website, www.genworth.com, as soon as reasonably practicable after we file or furnish such reports with the SEC. The public may read and copy any electronic materials we file or furnish with the SEC at the SEC’s website, www.sec.gov. Copies of our SEC filed or furnished reports are also available, without charge, from Genworth Investor Relations, 6620 West Broad Street, Richmond, VA 23230. 30 31 Item 1A. Risk Factors You should carefully consider the following risks. These risks could materially affect our business, results of operations or financial condition, cause the trading price of our common stock to decline materially or cause our actual results to differ materially from those expected or those expressed in any forward-looking statements made by us or on our behalf. These risks are not exclusive, and additional risks to which we are subject include, but are not limited to, the factors mentioned under “Cautionary note regarding forward-looking statements” and the risks of our businesses described elsewhere in this Annual Report on Form 10-K for the year ended December 31, 2023. Risk Factor Summary The following summarizes material risks to the Company and is qualified by the full description contained below. The occurrence of any of the following risks or of unknown risks and uncertainties may adversely affect our business, operating results and financial condition. Risks Relating to Our Ability to Grow Our New Business, Products or Services • New lines of business or new products and services, such as those we are pursuing with CareScout, may not be successful or may subject us to additional risks. Risks Relating to Estimates, Assumptions and Valuations • We may be required to increase our reserves as a result of deviations from our estimates and actuarial assumptions or other reasons, which could have a material adverse effect on our business, results of operations and financial condition. • If the models used in our businesses are inaccurate, it could have a material adverse impact on our business, results of operations and financial condition. • Our valuation of fixed maturity and equity securities uses methodologies, estimations and assumptions that are subject to change and differing interpretations which could result in changes to investment valuations that may materially adversely affect our business, results of operations and financial condition. Liquidity, Financial Strength and Credit Ratings, and Counterparty and Credit Risks • Genworth Financial and Genworth Holdings depend on the ability of Enact Holdings and its subsidiaries to pay dividends and make other payments and distributions to each of them and to meet their obligations. • Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms. • Adverse rating agency actions have in the past resulted in a loss of business and adversely affected our results of operations, financial condition and business, and future adverse rating actions could have a further and more significant adverse impact on us. • Defaults by counterparties to our reinsurance arrangements or to derivative instruments we use to hedge our business risks, or defaults by us on agreements we have with these counterparties, may expose us to risks we sought to mitigate, which could have a material adverse effect on our business, results of operations and financial condition. • Defaults or other events impacting the value of our fixed maturity securities portfolio may reduce our income. Risks Relating to Economic and Market Conditions • Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability. • A deterioration in economic conditions, a severe recession or a decline in home prices, all of which could be driven by many potential factors, may adversely affect Enact Holdings’ loss experience. Regulatory and Legal Risks • Changes in accounting and reporting standards issued by the Financial Accounting Standards Board or other standard-setting bodies and insurance regulators could materially adversely affect our business, financial condition and results of operations. • The inability to obtain in-force rate action increases (including increased premiums and associated benefit reductions) in our long-term care insurance business could have a material adverse impact on our business, including our results of operations and financial condition. • Our insurance businesses are extensively regulated and changes in regulation may reduce our profitability and limit our growth. • Litigation and regulatory investigations or other actions are common in the insurance business and may result in financial losses and harm our reputation. • An adverse change in the regulatory requirements on our U.S. life insurance subsidiaries, including risk- based capital requirements, could have a material adverse impact on our business, results of operations and financial condition. 32 33 Item 1A. Risk Factors You should carefully consider the following risks. These risks could materially affect our business, results of operations or financial condition, cause the trading price of our common stock to decline materially or cause our actual results to differ materially from those expected or those expressed in any forward-looking statements made by us or on our behalf. These risks are not exclusive, and additional risks to which we are subject include, but are not limited to, the factors mentioned under “Cautionary note regarding forward-looking statements” and the risks of our businesses described elsewhere in this Annual Report on Form 10-K for the year ended December 31, 2023. Risk Factor Summary The following summarizes material risks to the Company and is qualified by the full description contained below. The occurrence of any of the following risks or of unknown risks and uncertainties may adversely affect our business, operating results and financial condition. Risks Relating to Our Ability to Grow Our New Business, Products or Services • New lines of business or new products and services, such as those we are pursuing with CareScout, may not be successful or may subject us to additional risks. Risks Relating to Estimates, Assumptions and Valuations • We may be required to increase our reserves as a result of deviations from our estimates and actuarial assumptions or other reasons, which could have a material adverse effect on our business, results of operations and financial condition. If the models used in our businesses are inaccurate, it could have a material adverse impact on our business, results of operations and financial condition. • • Our valuation of fixed maturity and equity securities uses methodologies, estimations and assumptions that are subject to change and differing interpretations which could result in changes to investment valuations that may materially adversely affect our business, results of operations and financial condition. Liquidity, Financial Strength and Credit Ratings, and Counterparty and Credit Risks • Genworth Financial and Genworth Holdings depend on the ability of Enact Holdings and its subsidiaries to pay dividends and make other payments and distributions to each of them and to meet their obligations. • Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms. • Adverse rating agency actions have in the past resulted in a loss of business and adversely affected our results of operations, financial condition and business, and future adverse rating actions could have a further and more significant adverse impact on us. • Defaults by counterparties to our reinsurance arrangements or to derivative instruments we use to hedge our business risks, or defaults by us on agreements we have with these counterparties, may expose us to risks we sought to mitigate, which could have a material adverse effect on our business, results of operations and financial condition. • Defaults or other events impacting the value of our fixed maturity securities portfolio may reduce our income. Risks Relating to Economic and Market Conditions • Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability. • A deterioration in economic conditions, a severe recession or a decline in home prices, all of which could be driven by many potential factors, may adversely affect Enact Holdings’ loss experience. Regulatory and Legal Risks • Changes in accounting and reporting standards issued by the Financial Accounting Standards Board or other standard-setting bodies and insurance regulators could materially adversely affect our business, financial condition and results of operations. • The inability to obtain in-force rate action increases (including increased premiums and associated benefit reductions) in our long-term care insurance business could have a material adverse impact on our business, including our results of operations and financial condition. • Our insurance businesses are extensively regulated and changes in regulation may reduce our profitability and limit our growth. • Litigation and regulatory investigations or other actions are common in the insurance business and may result in financial losses and harm our reputation. • An adverse change in the regulatory requirements on our U.S. life insurance subsidiaries, including risk- based capital requirements, could have a material adverse impact on our business, results of operations and financial condition. 32 33 • Changes to the role of the GSEs or to the charters or business practices of the GSEs, including actions or decisions to decrease or discontinue the use of mortgage insurance, could adversely affect our business, financial condition and results of operations. • If Enact is unable to continue to meet the requirements mandated by PMIERs because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition. • Enact Holdings’ U.S. mortgage insurance subsidiaries are subject to minimum statutory capital requirements, which if not met or waived, would result in restrictions or prohibitions on them doing business and could have a material adverse impact on our business, financial condition and results of operations. • Changes in regulations that adversely affect the mortgage insurance markets in which Enact Holdings operates could affect its operations significantly and could reduce the demand for mortgage insurance. • Our U.S. life insurance subsidiaries may not be able to continue to mitigate the impact of Regulations XXX or AXXX and, therefore, they may incur higher operating costs that could have a material adverse effect on our business, financial condition and results of operations. Operational Risks • If we are unable to retain, attract and motivate qualified employees or senior management, our results of operations, financial condition and business operations may be adversely impacted. • Enact Holdings’ reliance on key customers or distribution relationships could cause a loss of significant sales if one or more of those relationships terminate or are reduced. • Our businesses could be adversely impacted from deficiencies in our disclosure controls and procedures or internal control over financial reporting. • Our computer systems and those of our third-party service providers have in the past and may in the future fail or be compromised, including through cybersecurity breaches; we may experience issues from new and complex information technology methodologies such as artificial intelligence; and unanticipated problems could materially adversely impact our disaster recovery systems and business continuity plans, any of which could damage our reputation, impair our ability to conduct business effectively, result in enforcement action or litigation, and materially adversely affect our business, financial condition and results of operations. • We rely upon third-party vendors who may be unable or unwilling to meet their obligations to us. Insurance and Product-Related Risks • Enact Holdings may be unable to maintain or increase capital in its mortgage insurance subsidiaries in a timely manner, on anticipated terms or at all, including through improved business performance, reinsurance or similar transactions, securities offerings or otherwise, in each case as and when required. • Reinsurance may not be available, affordable or adequate to protect us against losses. • A decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations could result in a decline in Enact Holdings’ revenue. • The amount of mortgage insurance written by Enact Holdings could decline significantly if alternatives to private mortgage insurance are used or lower coverage levels of mortgage insurance are selected. • Enact Holdings’ delegated underwriting program may subject its mortgage insurance subsidiaries to unanticipated claims. • Medical advances, such as genetic research and diagnostic imaging, emerging new technology, including artificial intelligence and related legislation, could materially adversely affect the financial performance of our life insurance, long-term care insurance and annuity businesses. Other Emerging Risks • Other emerging risks, such as the occurrence of natural or man-made disasters, including geopolitical tensions and war; a public health emergency, including pandemics; climate change; or unknown risks and uncertainties associated with artificial intelligence could materially adversely affect our business, financial condition and results of operations. Risks Relating to Our Ability to Grow Our New Business, Products or Services New lines of business or new products and services, such as those we are pursuing with CareScout, may not be successful or may subject us to additional risks. Our senior care growth initiatives, which include fee-based services, advice and consulting along with traditional insurance products, including long-term care insurance offered by CareScout, constitute a new line of business we are pursuing. There are risks and uncertainties associated with any new line of business. In developing and marketing new lines of business and new products and services, we expect to invest significant time and resources, including capital, and the attention of management and our Board of Directors could be diverted from other business operations. Our planned timeline for the development and introduction of new products or services may not be achieved, our expenditures may exceed revenues for longer than we anticipate, and our price and profitability targets may not prove feasible. Our ability to achieve anticipated business performance and financial results from CareScout could be adversely impacted for a variety of reasons and unforeseen events, including but not limited to, lower than anticipated customer demand, higher capital needs, staffing shortages and continued workflow disruptions, and impediments to Genworth Holdings’ liquidity caused by, among other things, downturns in the U.S. economy that reduce its strategic investments in CareScout. Furthermore, if customers do not perceive our new offerings as providing significant value, they may fail to accept our new products and services in the way we anticipate. External factors, such as competitive alternatives, commercial and/or regulatory challenges and shifting market preferences, may also impact the successful implementation of a new line of business or a new product or service. Failure to successfully manage these risks in the development and implementation of our new lines of business or new products or services, specifically our inability to achieve anticipated business performance and financial results from CareScout, could have a material adverse effect on our business, results of operations and financial condition. Risks Relating to Estimates, Assumptions and Valuations We may be required to increase our reserves as a result of deviations from our estimates and actuarial assumptions or other reasons, which could have a material adverse effect on our business, results of operations and financial condition. We calculate and maintain reserves for estimated future payments of claims to our policyholders and contractholders in accordance with U.S. GAAP and industry accounting practices. We release these reserves as those future obligations are paid, experience changes or policies lapse. The reserves we establish reflect estimates and actuarial assumptions with regard to our future experience. These estimates and actuarial assumptions involve the exercise of significant judgment. Our future financial results depend significantly upon the extent to which our actual future experience is consistent with the assumptions and methodologies we have used in pricing our products and calculating our reserves. Many factors, and changes in these factors, can affect future experience, including but not limited to: interest rates; investment returns and volatility; economic and social conditions, such as inflation, unemployment, home price appreciation or depreciation, and health care experience (including the type of care and cost of care); policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next); insured mortality (i.e., life expectancy or longevity); insured morbidity (i.e., frequency and severity of claim, including claim termination rates, claim incidence, duration of claim and benefit utilization rates); future premium rate increases and associated benefit reductions; expenses; and doctrines of legal liability and damage awards in litigation. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. At least annually, as part of our ongoing assessment of our business performance and risks, we review our assumptions to determine the adequacy of reserves. Generally, we do not anticipate trends in actual versus expected experience to change significantly in the short-term and, to the extent these trends may change, we 34 35 • Changes to the role of the GSEs or to the charters or business practices of the GSEs, including actions or decisions to decrease or discontinue the use of mortgage insurance, could adversely affect our business, financial condition and results of operations. • If Enact is unable to continue to meet the requirements mandated by PMIERs because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition. • Enact Holdings’ U.S. mortgage insurance subsidiaries are subject to minimum statutory capital requirements, which if not met or waived, would result in restrictions or prohibitions on them doing business and could have a material adverse impact on our business, financial condition and results of operations. • Changes in regulations that adversely affect the mortgage insurance markets in which Enact Holdings operates could affect its operations significantly and could reduce the demand for mortgage insurance. • Our U.S. life insurance subsidiaries may not be able to continue to mitigate the impact of Regulations XXX or AXXX and, therefore, they may incur higher operating costs that could have a material adverse effect on our business, financial condition and results of operations. Operational Risks • If we are unable to retain, attract and motivate qualified employees or senior management, our results of operations, financial condition and business operations may be adversely impacted. • Enact Holdings’ reliance on key customers or distribution relationships could cause a loss of significant sales if one or more of those relationships terminate or are reduced. • Our businesses could be adversely impacted from deficiencies in our disclosure controls and procedures or internal control over financial reporting. • Our computer systems and those of our third-party service providers have in the past and may in the future fail or be compromised, including through cybersecurity breaches; we may experience issues from new and complex information technology methodologies such as artificial intelligence; and unanticipated problems could materially adversely impact our disaster recovery systems and business continuity plans, any of which could damage our reputation, impair our ability to conduct business effectively, result in enforcement action or litigation, and materially adversely affect our business, financial condition and results of operations. • We rely upon third-party vendors who may be unable or unwilling to meet their obligations to us. Insurance and Product-Related Risks • Enact Holdings may be unable to maintain or increase capital in its mortgage insurance subsidiaries in a timely manner, on anticipated terms or at all, including through improved business performance, reinsurance or similar transactions, securities offerings or otherwise, in each case as and when required. • Reinsurance may not be available, affordable or adequate to protect us against losses. • A decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations could result in a decline in Enact Holdings’ revenue. • The amount of mortgage insurance written by Enact Holdings could decline significantly if alternatives to private mortgage insurance are used or lower coverage levels of mortgage insurance are selected. • Enact Holdings’ delegated underwriting program may subject its mortgage insurance subsidiaries to unanticipated claims. • Medical advances, such as genetic research and diagnostic imaging, emerging new technology, including artificial intelligence and related legislation, could materially adversely affect the financial performance of our life insurance, long-term care insurance and annuity businesses. Other Emerging Risks • Other emerging risks, such as the occurrence of natural or man-made disasters, including geopolitical tensions and war; a public health emergency, including pandemics; climate change; or unknown risks and uncertainties associated with artificial intelligence could materially adversely affect our business, financial condition and results of operations. Risks Relating to Our Ability to Grow Our New Business, Products or Services New lines of business or new products and services, such as those we are pursuing with CareScout, may not be successful or may subject us to additional risks. Our senior care growth initiatives, which include fee-based services, advice and consulting along with traditional insurance products, including long-term care insurance offered by CareScout, constitute a new line of business we are pursuing. There are risks and uncertainties associated with any new line of business. In developing and marketing new lines of business and new products and services, we expect to invest significant time and resources, including capital, and the attention of management and our Board of Directors could be diverted from other business operations. Our planned timeline for the development and introduction of new products or services may not be achieved, our expenditures may exceed revenues for longer than we anticipate, and our price and profitability targets may not prove feasible. Our ability to achieve anticipated business performance and financial results from CareScout could be adversely impacted for a variety of reasons and unforeseen events, including but not limited to, lower than anticipated customer demand, higher capital needs, staffing shortages and continued workflow disruptions, and impediments to Genworth Holdings’ liquidity caused by, among other things, downturns in the U.S. economy that reduce its strategic investments in CareScout. Furthermore, if customers do not perceive our new offerings as providing significant value, they may fail to accept our new products and services in the way we anticipate. External factors, such as competitive alternatives, commercial and/or regulatory challenges and shifting market preferences, may also impact the successful implementation of a new line of business or a new product or service. Failure to successfully manage these risks in the development and implementation of our new lines of business or new products or services, specifically our inability to achieve anticipated business performance and financial results from CareScout, could have a material adverse effect on our business, results of operations and financial condition. Risks Relating to Estimates, Assumptions and Valuations We may be required to increase our reserves as a result of deviations from our estimates and actuarial assumptions or other reasons, which could have a material adverse effect on our business, results of operations and financial condition. We calculate and maintain reserves for estimated future payments of claims to our policyholders and contractholders in accordance with U.S. GAAP and industry accounting practices. We release these reserves as those future obligations are paid, experience changes or policies lapse. The reserves we establish reflect estimates and actuarial assumptions with regard to our future experience. These estimates and actuarial assumptions involve the exercise of significant judgment. Our future financial results depend significantly upon the extent to which our actual future experience is consistent with the assumptions and methodologies we have used in pricing our products and calculating our reserves. Many factors, and changes in these factors, can affect future experience, including but not limited to: interest rates; investment returns and volatility; economic and social conditions, such as inflation, unemployment, home price appreciation or depreciation, and health care experience (including the type of care and cost of care); policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next); insured mortality (i.e., life expectancy or longevity); insured morbidity (i.e., frequency and severity of claim, including claim termination rates, claim incidence, duration of claim and benefit utilization rates); future premium rate increases and associated benefit reductions; expenses; and doctrines of legal liability and damage awards in litigation. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. At least annually, as part of our ongoing assessment of our business performance and risks, we review our assumptions to determine the adequacy of reserves. Generally, we do not anticipate trends in actual versus expected experience to change significantly in the short-term and, to the extent these trends may change, we 34 35 expect such changes to be gradual over the long-term. However, this may not prove to be the case. If we conclude that our reserves are insufficient to cover actual or expected policy and contract benefits and claim payments as a result of changes in experience, assumptions or otherwise, we would be required to increase our reserves and record a charge through earnings in the period in which we make the determination. The amounts of such increases to reserves and charges to earnings may be significant, and this could materially adversely affect our results of operations and financial condition. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The long-term profitability of our products depends upon the accuracy of our long-term assumptions used to calculate our reserves and how our actual experience compares with our expected experience. If any of our long- term assumptions prove to be inaccurate, our reserves may be inadequate. See “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates” and notes 10, 11, 12 and 15 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information. Significant increases to our reserves may, among other things, limit our ability to execute on our business initiatives and adversely impact our credit or financial strength ratings. Any of these results could have a material adverse impact on our business, results of operations and financial condition. We also perform cash flow testing or “asset adequacy analysis” separately for each of our U.S. life insurance subsidiaries on a statutory accounting basis. To the extent that the cash flow testing margin is negative in any of our U.S. life insurance subsidiaries, we would need to increase statutory reserves in that company, which would decrease our RBC ratios. For additional information regarding impacts to statutory capital as a result of reserve increases, see “—An adverse change in the regulatory requirements on our U.S. life insurance subsidiaries, including risk-based capital requirements, could have a material adverse impact on our business, results of operations and financial condition.” Long-Term Care Insurance Segment Long-term care insurance policies provide for long-duration coverage and, therefore, our actual claims experience will emerge over many years, or decades. The prices and expected future profitability of our long- term care insurance products are based in part upon expected patterns of premiums, expenses and benefits, using a number of assumptions, including, but not limited to, persistency, morbidity, and future premium rate increases and associated benefit reductions. For our long-term care insurance policies, actual persistency in later policy durations that is higher than our expected persistency assumptions could have a negative impact on profitability. If these policies remain in-force longer than we assumed, then we could be required to make greater benefit payments than we anticipated. A significant number of our long-term care insurance policies have experienced higher persistency than we had originally assumed, which has resulted in higher claims and an adverse effect on profitability. In addition, if morbidity rates are higher or mortality rates are lower than our valuation assumptions, we could be required to make greater payments and thus establish more reserves under our long-term care insurance policies than we had expected, and such amounts could be significant. Among other factors, changes in economic and interest rate risk, socio-demographics, behavioral trends (e.g., location of care and level of benefit use) and medical advances, may also have a material adverse impact on our future claims trends. For example, the impact of inflation on claims could be more pronounced for our long-term care insurance business than our other businesses given the “long tail” nature of this business. To the extent inflation or other factors causes health care costs to increase more than we anticipated, we will be required to increase our reserves which could negatively impact our profitability. Although we consider the potential effects of inflation when setting premium rates, our premiums may not fully offset the effects of inflation and may result in our underpricing of the risks we insure. Given these inherent challenges, our ability to precisely forecast future claim costs for long-term care insurance is limited. For additional information on our long-term care insurance reserves, see “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates— Liability for future policy benefits.” Long-duration Targeted Improvements (“LDTI”) Under LDTI, we use best estimate assumptions for our long-term care insurance business and the impacts of assumption updates are reflected as remeasurement gains or losses in the income statement based on issue-year cohorts. As a result, assumption updates as well as actual versus expected experience on these long-duration products will continue to drive volatility in our long-term care insurance results. Approximately 50% of our cohorts currently have net premium ratios capped at 100%. The net premium ratio represents the portion of the gross premiums required to provide for all benefits and certain expenses in our long-term care insurance business. These capped cohorts are generally our older long-term care insurance policies, largely sold prior to 2003. The other 50% of our cohorts have a net premium ratio of less than 100% and are currently expected to be profitable. We would expect ongoing income statement impacts and volatility related to assumption updates and variances between actual and expected experience in our older, unprofitable capped cohorts going forward. Conversely, we currently expect the profitable uncapped cohorts to have a more modest earnings impact related to assumption updates and variances between actual and expected experience, with a portion of the impact reflected in current period results and the remaining majority of the impact recognized over the life of the cohort. While quarterly variations are typically expected to be relatively small compared to the overall size of our liability for future policy benefits of $42.2 billion, at the locked-in discount rate, for our long-term care insurance business as of December 31, 2023, these variations have had, and may in the future have, a material impact on our quarterly results of operations and can result in material losses in our long-term care insurance business. See “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Long-Term Care Insurance segment” for the impacts of assumption updates and actual versus expected experience. In-force rate actions The adequacy of our current long-term care insurance reserves depends significantly on our assumptions regarding our continuing ability to successfully execute our multi-year in-force rate action plan through premium rate increases and associated benefit reductions. In measuring our long-term care insurance reserves under U.S. GAAP, our in-force rate action assumptions include significant future premium rate increases and associated benefit reductions resulting from rate actions that have been approved and related legal settlements, as well as rate actions that are anticipated to be approved (including premium rate increases and associated benefit reductions not yet filed) under our in-force rate action plan. As part of our cash flow testing process for our U.S. life insurance subsidiaries, we also consider incremental benefits from expected future in-force rate actions in our long-term care insurance products that help mitigate the impact of deteriorating experience. We may not be able to obtain regulatory approval for the future in-force rate actions we assumed in connection with our cash flow testing for our life insurance subsidiaries. If we do not obtain regulatory approval, we may be required to significantly further increase statutory reserves which could have a material adverse effect on our business, statutory results of operations and financial condition. The NYDFS, which regulates GLICNY, our New York insurance subsidiary, also requires specific adequacy testing scenarios that are generally more severe than those deemed acceptable in other states. Moreover, the required testing scenarios by the NYDFS have a disproportionate impact on our long-term care insurance products. In addition, we use New York specific experience for setting assumptions in our long-term care insurance products in GLICNY. While the NYDFS generally does not permit in-force rate increases for long-term care insurance to be used in asset adequacy analysis until such increases have been approved, it has allowed GLICNY to incorporate recently filed in-force rate actions in its asset adequacy analysis prior to 36 37 expect such changes to be gradual over the long-term. However, this may not prove to be the case. If we conclude that our reserves are insufficient to cover actual or expected policy and contract benefits and claim payments as a result of changes in experience, assumptions or otherwise, we would be required to increase our reserves and record a charge through earnings in the period in which we make the determination. The amounts of such increases to reserves and charges to earnings may be significant, and this could materially adversely affect our results of operations and financial condition. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The long-term profitability of our products depends upon the accuracy of our long-term assumptions used to calculate our reserves and how our actual experience compares with our expected experience. If any of our long- term assumptions prove to be inaccurate, our reserves may be inadequate. See “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates” and notes 10, 11, 12 and 15 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information. Significant increases to our reserves may, among other things, limit our ability to execute on our business initiatives and adversely impact our credit or financial strength ratings. Any of these results could have a material adverse impact on our business, results of operations and financial condition. We also perform cash flow testing or “asset adequacy analysis” separately for each of our U.S. life insurance subsidiaries on a statutory accounting basis. To the extent that the cash flow testing margin is negative in any of our U.S. life insurance subsidiaries, we would need to increase statutory reserves in that company, which would decrease our RBC ratios. For additional information regarding impacts to statutory capital as a result of reserve increases, see “—An adverse change in the regulatory requirements on our U.S. life insurance subsidiaries, including risk-based capital requirements, could have a material adverse impact on our business, results of operations and financial condition.” Long-Term Care Insurance Segment Long-term care insurance policies provide for long-duration coverage and, therefore, our actual claims experience will emerge over many years, or decades. The prices and expected future profitability of our long- term care insurance products are based in part upon expected patterns of premiums, expenses and benefits, using a number of assumptions, including, but not limited to, persistency, morbidity, and future premium rate increases and associated benefit reductions. For our long-term care insurance policies, actual persistency in later policy durations that is higher than our expected persistency assumptions could have a negative impact on profitability. If these policies remain in-force longer than we assumed, then we could be required to make greater benefit payments than we anticipated. A significant number of our long-term care insurance policies have experienced higher persistency than we had originally assumed, which has resulted in higher claims and an adverse effect on profitability. In addition, if morbidity rates are higher or mortality rates are lower than our valuation assumptions, we could be required to make greater payments and thus establish more reserves under our long-term care insurance policies than we had expected, and such amounts could be significant. Among other factors, changes in economic and interest rate risk, socio-demographics, behavioral trends (e.g., location of care and level of benefit use) and medical advances, may also have a material adverse impact on our future claims trends. For example, the impact of inflation on claims could be more pronounced for our long-term care insurance business than our other businesses given the “long tail” nature of this business. To the extent inflation or other factors causes health care costs to increase more than we anticipated, we will be required to increase our reserves which could negatively impact our profitability. Although we consider the potential effects of inflation when setting premium rates, our premiums may not fully offset the effects of inflation and may result in our underpricing of the risks we insure. Given these inherent challenges, our ability to precisely forecast future claim costs for long-term care insurance is limited. For additional information on our long-term care insurance reserves, see “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates— Liability for future policy benefits.” Long-duration Targeted Improvements (“LDTI”) Under LDTI, we use best estimate assumptions for our long-term care insurance business and the impacts of assumption updates are reflected as remeasurement gains or losses in the income statement based on issue-year cohorts. As a result, assumption updates as well as actual versus expected experience on these long-duration products will continue to drive volatility in our long-term care insurance results. Approximately 50% of our cohorts currently have net premium ratios capped at 100%. The net premium ratio represents the portion of the gross premiums required to provide for all benefits and certain expenses in our long-term care insurance business. These capped cohorts are generally our older long-term care insurance policies, largely sold prior to 2003. The other 50% of our cohorts have a net premium ratio of less than 100% and are currently expected to be profitable. We would expect ongoing income statement impacts and volatility related to assumption updates and variances between actual and expected experience in our older, unprofitable capped cohorts going forward. Conversely, we currently expect the profitable uncapped cohorts to have a more modest earnings impact related to assumption updates and variances between actual and expected experience, with a portion of the impact reflected in current period results and the remaining majority of the impact recognized over the life of the cohort. While quarterly variations are typically expected to be relatively small compared to the overall size of our liability for future policy benefits of $42.2 billion, at the locked-in discount rate, for our long-term care insurance business as of December 31, 2023, these variations have had, and may in the future have, a material impact on our quarterly results of operations and can result in material losses in our long-term care insurance business. See “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Long-Term Care Insurance segment” for the impacts of assumption updates and actual versus expected experience. In-force rate actions The adequacy of our current long-term care insurance reserves depends significantly on our assumptions regarding our continuing ability to successfully execute our multi-year in-force rate action plan through premium rate increases and associated benefit reductions. In measuring our long-term care insurance reserves under U.S. GAAP, our in-force rate action assumptions include significant future premium rate increases and associated benefit reductions resulting from rate actions that have been approved and related legal settlements, as well as rate actions that are anticipated to be approved (including premium rate increases and associated benefit reductions not yet filed) under our in-force rate action plan. As part of our cash flow testing process for our U.S. life insurance subsidiaries, we also consider incremental benefits from expected future in-force rate actions in our long-term care insurance products that help mitigate the impact of deteriorating experience. We may not be able to obtain regulatory approval for the future in-force rate actions we assumed in connection with our cash flow testing for our life insurance subsidiaries. If we do not obtain regulatory approval, we may be required to significantly further increase statutory reserves which could have a material adverse effect on our business, statutory results of operations and financial condition. The NYDFS, which regulates GLICNY, our New York insurance subsidiary, also requires specific adequacy testing scenarios that are generally more severe than those deemed acceptable in other states. Moreover, the required testing scenarios by the NYDFS have a disproportionate impact on our long-term care insurance products. In addition, we use New York specific experience for setting assumptions in our long-term care insurance products in GLICNY. While the NYDFS generally does not permit in-force rate increases for long-term care insurance to be used in asset adequacy analysis until such increases have been approved, it has allowed GLICNY to incorporate recently filed in-force rate actions in its asset adequacy analysis prior to 36 37 approval in the past. As a result, after discussions with the NYDFS and through the exercise of professional actuarial judgment, GLICNY incorporated in its 2023 and 2022 asset adequacy analysis assumptions for future in-force rate actions for long-term care insurance products to offset the emerging adverse experience for these products. With these assumption updates, GLICNY’s 2023 and 2022 asset adequacy analysis produced a negative margin. To address the negative margin, GLICNY recorded an incremental $87 million and $98 million of additional statutory reserves in 2023 and 2022, respectively, which resulted in RBC of 202% and 201% for GLICNY as of December 31, 2023 and 2022, respectively. For additional information on GLICNY asset adequacy testing, see note 22 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” If the NYDFS no longer allows GLICNY to incorporate assumptions for future in-force rate actions in its asset adequacy analysis, this would result in a material decrease in GLICNY’s cash flow testing margin and would require GLICNY to further significantly increase its statutory reserves. This would have a material adverse effect on GLICNY’s financial condition and RBC ratio. For additional information on our in-force rate actions in our long-term care insurance business, see “—The inability to obtain in-force rate action increases (including increased premiums and associated benefit reductions) in our long-term care insurance business could have a material adverse impact on our business, including our results of operations and financial condition.” Life and Annuities Segment The prices and expected future profitability of our life insurance and annuity products are based in part upon expected patterns of premiums, expenses and benefits, using a number of assumptions, including mortality, persistency and lapse. For example, if mortality rates are higher than our pricing and valuation assumptions, we could be required to make greater payments under our life insurance policies and annuity contracts with guaranteed minimum death benefits (“GMDBs”) than we had projected. Conversely, if mortality rates are lower than our valuation assumptions, we could be required to make greater payments and thus establish additional reserves under our annuity contracts without GMDBs and such amounts could be significant. For our universal life insurance contracts, increased persistency that is the result of the sale of contracts by the insured to third parties that continue to make premium payments on contracts that would otherwise have lapsed, also known as life settlements, could have an adverse impact on profitability because of the higher claims rate associated with settled contracts. For our deferred annuity products with GMWBs and guaranteed annuitization benefits, actual persistency that is higher than our persistency assumptions could have an adverse impact on profitability because we could be required to make withdrawal or annuitization payments for a longer period of time than the account value would support. The risk that our lapse experience may differ significantly from our valuation assumptions is also significant for our term life and term universal life insurance products. These products generally have a level premium period for a specified period of years (e.g., 10 years to 30 years) after which the premium increases, which may be significant. If the frequency of lapses is higher than our expected reserve assumption, we would experience lower premiums and could experience higher benefit costs. In addition, it may be that healthy policyholders are the ones who lapse (as they can more easily replace coverage), creating adverse selection where less healthy policyholders remain in our portfolio. We have experienced both a greater frequency of policyholder lapses and more severe adverse selection after the level premium period, and this experience could continue or worsen. If lapse experience continues or worsens on future 10-, 15-and 20-year level premium period blocks, we would expect volatility in premiums and mortality experience, which would reduce profitability in our term life insurance products, in amounts that could be material, if persistency is lower than our original assumptions. For additional information on our term life insurance reserves, including select sensitivities, see “Part II—Item 7— Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates—Liability for future policy benefits.” LDTI also introduced market risk benefits (“MRBs”), the valuation of which is subject to capital market risks, primarily through equity market and interest rate volatility. We attempt to mitigate some of these risks through hedging strategies; however, adverse changes in equity market performance or interest rate fluctuations could devalue the expected benefits to contractholders resulting in the need to increase our MRB reserves, which may have a material adverse effect on our financial condition and results of operations. Enact Segment The establishment of loss reserves for Enact Holdings and its mortgage insurance subsidiaries is subject to inherent uncertainty and requires significant judgment and numerous assumptions. Enact Holdings establishes loss reserves using its best estimate of the rates at which delinquencies go to claim (“claim rates”) and claim severity to calculate estimated losses on loans reported as being in default as of the end of each reporting period. Enact Holdings also establishes incurred but not reported (“IBNR”) reserves for estimated losses incurred on loans in default that have not yet been reported by servicers. The sources of uncertainty affecting estimates are numerous and include both internal and external factors. Internal factors include, but are not limited to, changes in the mix of exposures, loss mitigation activities and claim settlement practices. Significant external factors include changes in general economic conditions, such as home prices, unemployment/underemployment, interest rates, tax policy, credit availability, government housing policies, government and GSE loss mitigation and mortgage forbearance programs, state foreclosure timelines, GSE and state foreclosure moratoriums and types of mortgage products. For example, during recessionary periods in the past, accompanied by increased unemployment and declining home prices, Enact Holdings has experienced higher delinquencies and increased losses. Because assumptions related to these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, Enact Holdings cannot determine with precision the ultimate amounts it will pay for actual claims or the timing of those payments. Even in a stable economic environment, the actual claim payments made may be substantially different and even materially exceed the amount of the corresponding loss reserves for such claims. Enact Holdings regularly reviews its reserves and associated assumptions as part of its ongoing assessment of business performance and risks. If Enact Holdings concludes its reserves are insufficient to cover actual or expected claim payments as a result of changes in experience, assumptions or otherwise, it would be required to increase its reserves and incur charges in the period in which the determination was made. The amounts of such increases could be significant, and this may materially adversely affect our results of operations, financial condition and liquidity. In addition, sudden and/or unexpected deterioration of economic conditions may cause estimates of loss reserves to be materially understated. To the extent actual losses are greater than current loss reserves or if loans in default ultimately become delinquent and go to claim more than expected, it could materially adversely impact our results of operations and financial condition and restrict Enact Holdings’ ability to distribute dividends to Genworth Holdings, thereby negatively impacting our liquidity. Furthermore, consistent with industry practice, Enact Holdings does not record losses on insured loans that are not in default. Therefore, future potential losses may develop from loans not currently in default and may have a materially adverse impact on our results of operations, financial condition and liquidity. Enact Holdings depends on the reliability of third-party servicing of the loans that it insures. If a servicer were to experience adverse effects to its business, such servicer could experience delays in its reporting and premium payment requirements. Without reliable, consistent third-party servicing, Enact Holdings may be unable to properly recognize and establish reserves on loans when a delinquency exists or occurs but is not reported. In addition, if these servicers fail to limit and mitigate losses when appropriate, Enact Holdings’ losses may unexpectedly increase. Enact Holdings establishes premium rates for the duration of a mortgage insurance certificate upon issuance and cannot adjust the premiums after a certificate is issued. As a result, Enact Holdings cannot offset the impact of unanticipated claims with premium increases on coverage in-force. Enact Holdings’ premium rates vary with the perceived risk of a claim and prepayment on the insured loan and are developed using models based on long term historical experience, which takes into account a number of factors including, but not limited to, the loan-to-value ratio, whether the mortgage provides for fixed payments or variable payments, the term of the mortgage, the borrower’s credit history, the borrower’s income and assets, and home price appreciation. In the 38 39 approval in the past. As a result, after discussions with the NYDFS and through the exercise of professional actuarial judgment, GLICNY incorporated in its 2023 and 2022 asset adequacy analysis assumptions for future in-force rate actions for long-term care insurance products to offset the emerging adverse experience for these products. With these assumption updates, GLICNY’s 2023 and 2022 asset adequacy analysis produced a negative margin. To address the negative margin, GLICNY recorded an incremental $87 million and $98 million of additional statutory reserves in 2023 and 2022, respectively, which resulted in RBC of 202% and 201% for GLICNY as of December 31, 2023 and 2022, respectively. For additional information on GLICNY asset adequacy testing, see note 22 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” If the NYDFS no longer allows GLICNY to incorporate assumptions for future in-force rate actions in its asset adequacy analysis, this would result in a material decrease in GLICNY’s cash flow testing margin and would require GLICNY to further significantly increase its statutory reserves. This would have a material adverse effect on GLICNY’s financial condition and RBC ratio. For additional information on our in-force rate actions in our long-term care insurance business, see “—The inability to obtain in-force rate action increases (including increased premiums and associated benefit reductions) in our long-term care insurance business could have a material adverse impact on our business, including our results of operations and financial condition.” Life and Annuities Segment The prices and expected future profitability of our life insurance and annuity products are based in part upon expected patterns of premiums, expenses and benefits, using a number of assumptions, including mortality, persistency and lapse. For example, if mortality rates are higher than our pricing and valuation assumptions, we could be required to make greater payments under our life insurance policies and annuity contracts with guaranteed minimum death benefits (“GMDBs”) than we had projected. Conversely, if mortality rates are lower than our valuation assumptions, we could be required to make greater payments and thus establish additional reserves under our annuity contracts without GMDBs and such amounts could be significant. For our universal life insurance contracts, increased persistency that is the result of the sale of contracts by the insured to third parties that continue to make premium payments on contracts that would otherwise have lapsed, also known as life settlements, could have an adverse impact on profitability because of the higher claims rate associated with settled contracts. For our deferred annuity products with GMWBs and guaranteed annuitization benefits, actual persistency that is higher than our persistency assumptions could have an adverse impact on profitability because we could be required to make withdrawal or annuitization payments for a longer period of time than the account value would support. The risk that our lapse experience may differ significantly from our valuation assumptions is also significant for our term life and term universal life insurance products. These products generally have a level premium period for a specified period of years (e.g., 10 years to 30 years) after which the premium increases, which may be significant. If the frequency of lapses is higher than our expected reserve assumption, we would experience lower premiums and could experience higher benefit costs. In addition, it may be that healthy policyholders are the ones who lapse (as they can more easily replace coverage), creating adverse selection where less healthy policyholders remain in our portfolio. We have experienced both a greater frequency of policyholder lapses and more severe adverse selection after the level premium period, and this experience could continue or worsen. If lapse experience continues or worsens on future 10-, 15-and 20-year level premium period blocks, we would expect volatility in premiums and mortality experience, which would reduce profitability in our term life insurance products, in amounts that could be material, if persistency is lower than our original assumptions. For additional information on our term life insurance reserves, including select sensitivities, see “Part II—Item 7— Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates—Liability for future policy benefits.” LDTI also introduced market risk benefits (“MRBs”), the valuation of which is subject to capital market risks, primarily through equity market and interest rate volatility. We attempt to mitigate some of these risks through hedging strategies; however, adverse changes in equity market performance or interest rate fluctuations could devalue the expected benefits to contractholders resulting in the need to increase our MRB reserves, which may have a material adverse effect on our financial condition and results of operations. Enact Segment The establishment of loss reserves for Enact Holdings and its mortgage insurance subsidiaries is subject to inherent uncertainty and requires significant judgment and numerous assumptions. Enact Holdings establishes loss reserves using its best estimate of the rates at which delinquencies go to claim (“claim rates”) and claim severity to calculate estimated losses on loans reported as being in default as of the end of each reporting period. Enact Holdings also establishes incurred but not reported (“IBNR”) reserves for estimated losses incurred on loans in default that have not yet been reported by servicers. The sources of uncertainty affecting estimates are numerous and include both internal and external factors. Internal factors include, but are not limited to, changes in the mix of exposures, loss mitigation activities and claim settlement practices. Significant external factors include changes in general economic conditions, such as home prices, unemployment/underemployment, interest rates, tax policy, credit availability, government housing policies, government and GSE loss mitigation and mortgage forbearance programs, state foreclosure timelines, GSE and state foreclosure moratoriums and types of mortgage products. For example, during recessionary periods in the past, accompanied by increased unemployment and declining home prices, Enact Holdings has experienced higher delinquencies and increased losses. Because assumptions related to these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, Enact Holdings cannot determine with precision the ultimate amounts it will pay for actual claims or the timing of those payments. Even in a stable economic environment, the actual claim payments made may be substantially different and even materially exceed the amount of the corresponding loss reserves for such claims. Enact Holdings regularly reviews its reserves and associated assumptions as part of its ongoing assessment of business performance and risks. If Enact Holdings concludes its reserves are insufficient to cover actual or expected claim payments as a result of changes in experience, assumptions or otherwise, it would be required to increase its reserves and incur charges in the period in which the determination was made. The amounts of such increases could be significant, and this may materially adversely affect our results of operations, financial condition and liquidity. In addition, sudden and/or unexpected deterioration of economic conditions may cause estimates of loss reserves to be materially understated. To the extent actual losses are greater than current loss reserves or if loans in default ultimately become delinquent and go to claim more than expected, it could materially adversely impact our results of operations and financial condition and restrict Enact Holdings’ ability to distribute dividends to Genworth Holdings, thereby negatively impacting our liquidity. Furthermore, consistent with industry practice, Enact Holdings does not record losses on insured loans that are not in default. Therefore, future potential losses may develop from loans not currently in default and may have a materially adverse impact on our results of operations, financial condition and liquidity. Enact Holdings depends on the reliability of third-party servicing of the loans that it insures. If a servicer were to experience adverse effects to its business, such servicer could experience delays in its reporting and premium payment requirements. Without reliable, consistent third-party servicing, Enact Holdings may be unable to properly recognize and establish reserves on loans when a delinquency exists or occurs but is not reported. In addition, if these servicers fail to limit and mitigate losses when appropriate, Enact Holdings’ losses may unexpectedly increase. Enact Holdings establishes premium rates for the duration of a mortgage insurance certificate upon issuance and cannot adjust the premiums after a certificate is issued. As a result, Enact Holdings cannot offset the impact of unanticipated claims with premium increases on coverage in-force. Enact Holdings’ premium rates vary with the perceived risk of a claim and prepayment on the insured loan and are developed using models based on long term historical experience, which takes into account a number of factors including, but not limited to, the loan-to-value ratio, whether the mortgage provides for fixed payments or variable payments, the term of the mortgage, the borrower’s credit history, the borrower’s income and assets, and home price appreciation. In the 38 39 event the premiums Enact Holdings charges do not adequately compensate for the risks and costs associated with the provided coverage, including costs associated with unforeseen higher claims, it may have a material adverse effect on our business, results of operations and financial condition. If the models used in our businesses are inaccurate, it could have a material adverse impact on our business, results of operations and financial condition. We employ models to, among other uses, price products, calculate reserves, value assets, make investment decisions and generate projections used to estimate future pre-tax income, as well as to evaluate risk, determine internal capital requirements and perform stress testing. These models rely on estimates and projections that are inherently uncertain, may use data and/or assumptions that do not adequately reflect recent experience and relevant industry data, and may not operate as intended. In addition, from time to time we seek to improve certain actuarial and financial models, and the conversion process may result in material changes to assumptions and financial results. The models we employ are complex, which increases our risk of error in their design, implementation or use. Also, the associated input data, assumptions and calculations and the controls we have in place to mitigate these risks may not be effective in all cases. The risks related to our models often increase when we change assumptions and/or methodologies, add or change modeling platforms or implement model changes under time constraints. These risks are exacerbated when the process for assumption changes strains our overall governance and timing around our financial reporting. We intend to continue developing our modeling capabilities, including new and emerging artificial intelligence methodologies. During or after the implementation of model updates or enhancements, we may discover errors, risks or other deficiencies in existing models, assumptions and/or methodologies. Moreover, we may use additional, more granular and detailed information through enhancements in our reserving and other processes or we may employ more simplified approaches in the future, either of which may cause us to refine or otherwise change existing assumptions and/or methodologies and thus associated reserve levels, which in turn could have a material adverse impact on our business, results of operations and financial condition. Specific to Enact Holdings, models may prove to be less predictive than expected for a variety of reasons, including changes in credit scoring and reporting processes, economic conditions that develop differently than forecasted, unique conditions for which we do not have good historical comparators, unexpected economic and unemployment conditions that arise, changes in the law or in PMIERs and the use of short-term financial metrics that do not reveal long-term trends. Our valuation of fixed maturity and equity securities uses methodologies, estimations and assumptions that are subject to change and differing interpretations which could result in changes to investment valuations that may materially adversely affect our business, results of operations and financial condition. We report fixed maturity and equity securities at fair value in our consolidated balance sheets. These securities represent the majority of our total cash, cash equivalents and invested assets. Our portfolio of fixed maturity securities consists primarily of investment grade securities. Valuations use inputs and assumptions that are less observable or require greater estimation, as well as valuation methods that are more complex or require greater estimation, thereby resulting in values that are less certain and may vary significantly from the value at which the investments may be ultimately sold. The methodologies, estimates and assumptions we use in valuing our investment securities evolve over time and are subject to different interpretation (including based on developments in relevant accounting literature), all of which can lead to changes in the value of our investment securities. Rapidly changing and unanticipated interest rate, external macroeconomic, credit and equity market conditions could materially impact the valuation of investment securities as reported within our consolidated financial statements, and the period-to-period changes in value could vary significantly. Decreases in value may have a material adverse effect on our results of operations or financial condition. Liquidity, Financial Strength and Credit Ratings, and Counterparty and Credit Risks Genworth Financial and Genworth Holdings depend on the ability of Enact Holdings and its subsidiaries to pay dividends and make other payments and distributions to each of them and to meet their obligations. Genworth Financial and Genworth Holdings each act as a holding company and do not have business operations of their own. Dividends from Enact Holdings and its subsidiaries, permitted payments to Genworth Financial and Genworth Holdings under tax sharing and expense reimbursement arrangements with their subsidiaries and proceeds from borrowings are their principal sources of cash to meet their obligations. These obligations principally include operating expenses and interest and principal payments on current and future borrowings. If the cash Genworth Financial or Genworth Holdings receives pursuant to dividends and tax sharing and expense reimbursement arrangements is insufficient to fund any of their obligations, or if a subsidiary is unable or unwilling for any reason to pay dividends to either of them, our liquidity would be materially adversely impacted which would likely have a material adverse effect on our financial condition and overall business. Moreover, if Genworth Financial or Genworth Holdings do not receive sufficient cash to fund their obligations, they may be forced to raise cash through unfavorable arrangements or terms, including but not limited to, the incurrence of debt (including convertible or exchangeable debt), the sale of assets or the issuance of equity. See “—Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms” for additional details. We began paying federal taxes in 2023 due to projected taxable income and the utilization of our remaining foreign tax credits; therefore, we expect intercompany cash tax payments retained by Genworth Holdings from its subsidiaries to be lower starting in 2024. Our holding companies’ liquidity and capital positions are highly dependent on the performance of Enact Holdings and its ability to pay future dividends. Our principal U.S. life insurance subsidiaries had negative unassigned surplus of approximately $563 million under statutory accounting as of December 31, 2023, and as a result, we do not expect these subsidiaries to have the ability to pay dividends for the foreseeable future. Enact Holdings’ evaluation of future dividend payments to Genworth Holdings and our holding companies’ overall resulting liquidity plans are subject to and dependent on, among other things, current and future market conditions, Enact Holdings’ business performance and capital preservation, corporate law restrictions, insurance laws and regulations, Enact Holdings’ ability to maintain adequate capital to meet its current and future requirements mandated by PMIERs or other GSE requirements, and business and regulatory approvals. For additional details on PMIERs and risks associated with an inability to meet its requirements, see “—If Enact is unable to continue to meet the requirements mandated by PMIERs because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition” and “Regulation—Enact— Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.” In general, dividends are required to be submitted to an insurer’s domiciliary department of insurance for review, and distributions from sources other than unassigned surplus require affirmative approval before being paid. In addition, insurance regulators may prohibit the payment of dividends and distributions or other payments by the insurance subsidiaries (such as a payment under a tax sharing agreement or for employee or other services, including expense reimbursements) if they determine that such payment could be adverse to policyholders. Genworth Financial has the right to appoint a majority of directors to the board of directors of Enact Holdings; however, actions taken by Enact Holdings and its board of directors (including in the case of the payment of dividends, the approval of Enact Holdings’ independent capital committee) are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms. Although Genworth Financial and Genworth Holdings continue to significantly improve their overall financial condition, they still need liquidity to pay operating expenses, debt servicing costs and other obligations. 40 41 event the premiums Enact Holdings charges do not adequately compensate for the risks and costs associated with the provided coverage, including costs associated with unforeseen higher claims, it may have a material adverse effect on our business, results of operations and financial condition. If the models used in our businesses are inaccurate, it could have a material adverse impact on our business, results of operations and financial condition. We employ models to, among other uses, price products, calculate reserves, value assets, make investment decisions and generate projections used to estimate future pre-tax income, as well as to evaluate risk, determine internal capital requirements and perform stress testing. These models rely on estimates and projections that are inherently uncertain, may use data and/or assumptions that do not adequately reflect recent experience and relevant industry data, and may not operate as intended. In addition, from time to time we seek to improve certain actuarial and financial models, and the conversion process may result in material changes to assumptions and financial results. The models we employ are complex, which increases our risk of error in their design, implementation or use. Also, the associated input data, assumptions and calculations and the controls we have in place to mitigate these risks may not be effective in all cases. The risks related to our models often increase when we change assumptions and/or methodologies, add or change modeling platforms or implement model changes under time constraints. These risks are exacerbated when the process for assumption changes strains our overall governance and timing around our financial reporting. We intend to continue developing our modeling capabilities, including new and emerging artificial intelligence methodologies. During or after the implementation of model updates or enhancements, we may discover errors, risks or other deficiencies in existing models, assumptions and/or methodologies. Moreover, we may use additional, more granular and detailed information through enhancements in our reserving and other processes or we may employ more simplified approaches in the future, either of which may cause us to refine or otherwise change existing assumptions and/or methodologies and thus associated reserve levels, which in turn could have a material adverse impact on our business, results of operations and financial condition. Specific to Enact Holdings, models may prove to be less predictive than expected for a variety of reasons, including changes in credit scoring and reporting processes, economic conditions that develop differently than forecasted, unique conditions for which we do not have good historical comparators, unexpected economic and unemployment conditions that arise, changes in the law or in PMIERs and the use of short-term financial metrics that do not reveal long-term trends. Our valuation of fixed maturity and equity securities uses methodologies, estimations and assumptions that are subject to change and differing interpretations which could result in changes to investment valuations that may materially adversely affect our business, results of operations and financial condition. We report fixed maturity and equity securities at fair value in our consolidated balance sheets. These securities represent the majority of our total cash, cash equivalents and invested assets. Our portfolio of fixed maturity securities consists primarily of investment grade securities. Valuations use inputs and assumptions that are less observable or require greater estimation, as well as valuation methods that are more complex or require greater estimation, thereby resulting in values that are less certain and may vary significantly from the value at which the investments may be ultimately sold. The methodologies, estimates and assumptions we use in valuing our investment securities evolve over time and are subject to different interpretation (including based on developments in relevant accounting literature), all of which can lead to changes in the value of our investment securities. Rapidly changing and unanticipated interest rate, external macroeconomic, credit and equity market conditions could materially impact the valuation of investment securities as reported within our consolidated financial statements, and the period-to-period changes in value could vary significantly. Decreases in value may have a material adverse effect on our results of operations or financial condition. Liquidity, Financial Strength and Credit Ratings, and Counterparty and Credit Risks Genworth Financial and Genworth Holdings depend on the ability of Enact Holdings and its subsidiaries to pay dividends and make other payments and distributions to each of them and to meet their obligations. Genworth Financial and Genworth Holdings each act as a holding company and do not have business operations of their own. Dividends from Enact Holdings and its subsidiaries, permitted payments to Genworth Financial and Genworth Holdings under tax sharing and expense reimbursement arrangements with their subsidiaries and proceeds from borrowings are their principal sources of cash to meet their obligations. These obligations principally include operating expenses and interest and principal payments on current and future borrowings. If the cash Genworth Financial or Genworth Holdings receives pursuant to dividends and tax sharing and expense reimbursement arrangements is insufficient to fund any of their obligations, or if a subsidiary is unable or unwilling for any reason to pay dividends to either of them, our liquidity would be materially adversely impacted which would likely have a material adverse effect on our financial condition and overall business. Moreover, if Genworth Financial or Genworth Holdings do not receive sufficient cash to fund their obligations, they may be forced to raise cash through unfavorable arrangements or terms, including but not limited to, the incurrence of debt (including convertible or exchangeable debt), the sale of assets or the issuance of equity. See “—Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms” for additional details. We began paying federal taxes in 2023 due to projected taxable income and the utilization of our remaining foreign tax credits; therefore, we expect intercompany cash tax payments retained by Genworth Holdings from its subsidiaries to be lower starting in 2024. Our holding companies’ liquidity and capital positions are highly dependent on the performance of Enact Holdings and its ability to pay future dividends. Our principal U.S. life insurance subsidiaries had negative unassigned surplus of approximately $563 million under statutory accounting as of December 31, 2023, and as a result, we do not expect these subsidiaries to have the ability to pay dividends for the foreseeable future. Enact Holdings’ evaluation of future dividend payments to Genworth Holdings and our holding companies’ overall resulting liquidity plans are subject to and dependent on, among other things, current and future market conditions, Enact Holdings’ business performance and capital preservation, corporate law restrictions, insurance laws and regulations, Enact Holdings’ ability to maintain adequate capital to meet its current and future requirements mandated by PMIERs or other GSE requirements, and business and regulatory approvals. For additional details on PMIERs and risks associated with an inability to meet its requirements, see “—If Enact is unable to continue to meet the requirements mandated by PMIERs because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition” and “Regulation—Enact— Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.” In general, dividends are required to be submitted to an insurer’s domiciliary department of insurance for review, and distributions from sources other than unassigned surplus require affirmative approval before being paid. In addition, insurance regulators may prohibit the payment of dividends and distributions or other payments by the insurance subsidiaries (such as a payment under a tax sharing agreement or for employee or other services, including expense reimbursements) if they determine that such payment could be adverse to policyholders. Genworth Financial has the right to appoint a majority of directors to the board of directors of Enact Holdings; however, actions taken by Enact Holdings and its board of directors (including in the case of the payment of dividends, the approval of Enact Holdings’ independent capital committee) are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms. Although Genworth Financial and Genworth Holdings continue to significantly improve their overall financial condition, they still need liquidity to pay operating expenses, debt servicing costs and other obligations. 40 41 As of December 31, 2023, Genworth Holdings had approximately $856 million of outstanding debt that matures starting in 2034. Given our expectation that we will not receive dividends from our U.S. life insurance subsidiaries for the foreseeable future, we are reliant on dividends from Enact Holdings to fund holding company obligations. Absent receiving dividends from Enact Holdings as anticipated, we would likely need to access additional liquidity through third party sources. However, we may not be able to raise capital and/or borrowings on favorable terms based on our credit ratings and current business prospects, particularly given the aforementioned risks associated with launching new business initiatives offered by CareScout. There is no guarantee that any of these factors will improve in the future when we would seek additional capital. Disruptions, volatility and uncertainty in the financial markets and downgrades in our credit ratings may force us to delay raising capital, issue shorter term securities than would be optimal, bear an unattractive cost of capital or be unable to raise capital at any price. Furthermore, the availability of raising additional capital, including through additional minority equity offerings of Enact Holdings or the issuance of equity or debt, could depend on a variety of factors such as market conditions, regulatory considerations, the general availability of credit, the level of activity and availability of reinsurance, our credit ratings and credit capacity and the performance of and outlook for Enact Holdings. Market conditions and a variety of other factors may make it difficult or impracticable to generate additional liquidity on favorable terms or at all. Similarly, market conditions and a variety of other factors may make it difficult or impracticable to generate additional liquidity through asset sales or the issuance of additional equity, and any issuance of equity in such circumstances could be highly dilutive to our stockholders. Any failure to meet our financial obligations as they become due would have a material adverse effect on our business, financial condition and results of operations. We do not currently have a revolving credit facility at the Genworth Holdings level to provide liquidity. To the extent we need additional funding to satisfy our additional liquidity needs, we may not be able to enter into a new credit facility on terms (or at targeted amounts) acceptable to us or at all. For a further discussion of our liquidity, see “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources.” Adverse rating agency actions have in the past resulted in a loss of business and adversely affected our results of operations, financial condition and business, and future adverse rating actions could have a further and more significant adverse impact on us. Financial strength ratings, which various rating agencies publish as measures of an insurance company’s ability to meet contractholder and policyholder obligations, are important to maintaining public confidence in our products, the ability to market our products and our competitive position. Credit ratings, which rating agencies publish as measures of an entity’s ability to repay its indebtedness, are important to our ability to raise capital through the issuance of debt and other forms of credit and to the cost of such financing. Over the course of the last several years prior to 2021, the ratings of our holding companies and all our insurance subsidiaries were downgraded, placed on negative outlook and/or put on review for potential downgrade on various occasions. A ratings downgrade, negative outlook or review could occur again for a variety of reasons, including reasons specifically related to our company, generally related to our industry or the broader financial services industry or as a result of changes by the rating agencies in their methodologies or rating criteria. A negative outlook on our ratings or a downgrade in any of our financial strength or credit ratings, the announcement of a potential downgrade, negative outlook or review, or customer, investor, regulator or other concerns about the possibility of a downgrade, negative outlook or review, could have a material adverse effect on our results of operations, financial condition and business. See “Item 1—Business—Ratings” for information regarding the current financial strength ratings of our principal insurance subsidiaries. The direct or indirect effects of such adverse ratings actions or any future actions could include, but are not limited to: • ceasing and/or reducing new sales of our products or limiting the business opportunities we are presented with; • • • • • • • • • • • adversely affecting our relationships with distributors, including the loss of exclusivity under certain agreements with our independent sales intermediaries and distribution partners; causing us to lose key distributors that have ratings requirements that we may no longer satisfy (or resulting in our renegotiation of new, less favorable arrangements with those distributors); requiring us to modify some of our existing products or services to remain competitive, including reducing premiums we charge, or introduce new products or services; • materially increasing the number or amount of policy surrenders, withdrawals and loans by contractholders and policyholders; requiring us to post additional collateral for our derivatives or hedging agreements tied to the credit ratings of our holding companies; requiring us to provide support, or to arrange for third-party support, in the form of collateral, capital contributions or letters of credit under the terms of certain of our reinsurance and other agreements, or otherwise securing our commercial counterparties for the perceived risk of our financial strength; adversely affecting our ability to maintain reinsurance or obtain new reinsurance or obtain it on reasonable pricing and other terms; increasing the capital charge associated with affiliated investments within certain of our U.S. life insurance subsidiaries thereby lowering capital and RBC of these subsidiaries and negatively impacting our financial flexibility; regulators requiring certain of our subsidiaries to maintain additional capital, limiting thereby our financial flexibility and requiring us to raise additional capital; adversely affecting our ability to raise capital; increased scrutiny by the GSEs and/or by customers, potentially resulting in a decrease in the amount of new insurance written; or enter into a credit agreement; and increasing our cost of borrowing and making it more difficult to borrow in the public debt markets • making it more difficult to execute on CareScout initiatives. Under PMIERs, the GSEs require maintenance of at least one rating with a rating agency acceptable to the respective GSEs. The current PMIERs do not include a specific ratings requirement with respect to eligibility, but if this were to change in the future, Enact may become subject to a ratings requirement in order to retain its eligibility status under PMIERs. Ratings downgrades that result in the inability of Enact to insure new mortgage loans sold to the GSEs, or the transfer by the GSEs of its existing policies to an alternative mortgage insurer, would have a material adverse effect on our business, results of operations and financial condition. See “—If Enact is unable to continue to meet the requirements mandated by PMIERs because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition” for additional information regarding the requirements under PMIERs. Relationships with mortgage insurance customers may be adversely affected by the ratings assigned to Genworth Holdings or our principal insurance subsidiaries which could have a material adverse effect on our business, financial condition and results of operations. EMICO, our principal U.S. mortgage insurance subsidiary, has financial strength ratings that are relatively consistent with its competitors. However, any assigned financial strength rating that is below other private mortgage insurers could hinder our competitiveness in the marketplace and could result in an adverse impact to our business. Moreover, any future downgrade in the financial strength ratings of EMICO or the announcement of a potential downgrade could have a material adverse impact on our business, results of operations and financial condition. 42 43 As of December 31, 2023, Genworth Holdings had approximately $856 million of outstanding debt that matures starting in 2034. Given our expectation that we will not receive dividends from our U.S. life insurance subsidiaries for the foreseeable future, we are reliant on dividends from Enact Holdings to fund holding company obligations. Absent receiving dividends from Enact Holdings as anticipated, we would likely need to access additional liquidity through third party sources. However, we may not be able to raise capital and/or borrowings on favorable terms based on our credit ratings and current business prospects, particularly given the aforementioned risks associated with launching new business initiatives offered by CareScout. There is no guarantee that any of these factors will improve in the future when we would seek additional capital. Disruptions, volatility and uncertainty in the financial markets and downgrades in our credit ratings may force us to delay raising capital, issue shorter term securities than would be optimal, bear an unattractive cost of capital or be unable to raise capital at any price. Furthermore, the availability of raising additional capital, including through additional minority equity offerings of Enact Holdings or the issuance of equity or debt, could depend on a variety of factors such as market conditions, regulatory considerations, the general availability of credit, the level of activity and availability of reinsurance, our credit ratings and credit capacity and the performance of and outlook for Enact Holdings. Market conditions and a variety of other factors may make it difficult or impracticable to generate additional liquidity on favorable terms or at all. Similarly, market conditions and a variety of other factors may make it difficult or impracticable to generate additional liquidity through asset sales or the issuance of additional equity, and any issuance of equity in such circumstances could be highly dilutive to our stockholders. Any failure to meet our financial obligations as they become due would have a material adverse effect on our business, financial condition and results of operations. We do not currently have a revolving credit facility at the Genworth Holdings level to provide liquidity. To the extent we need additional funding to satisfy our additional liquidity needs, we may not be able to enter into a new credit facility on terms (or at targeted amounts) acceptable to us or at all. For a further discussion of our liquidity, see “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources.” Adverse rating agency actions have in the past resulted in a loss of business and adversely affected our results of operations, financial condition and business, and future adverse rating actions could have a further and more significant adverse impact on us. Financial strength ratings, which various rating agencies publish as measures of an insurance company’s ability to meet contractholder and policyholder obligations, are important to maintaining public confidence in our products, the ability to market our products and our competitive position. Credit ratings, which rating agencies publish as measures of an entity’s ability to repay its indebtedness, are important to our ability to raise capital through the issuance of debt and other forms of credit and to the cost of such financing. Over the course of the last several years prior to 2021, the ratings of our holding companies and all our insurance subsidiaries were downgraded, placed on negative outlook and/or put on review for potential downgrade on various occasions. A ratings downgrade, negative outlook or review could occur again for a variety of reasons, including reasons specifically related to our company, generally related to our industry or the broader financial services industry or as a result of changes by the rating agencies in their methodologies or rating criteria. A negative outlook on our ratings or a downgrade in any of our financial strength or credit ratings, the announcement of a potential downgrade, negative outlook or review, or customer, investor, regulator or other concerns about the possibility of a downgrade, negative outlook or review, could have a material adverse effect on our results of operations, financial condition and business. See “Item 1—Business—Ratings” for information regarding the current financial strength ratings of our principal insurance subsidiaries. limited to: presented with; The direct or indirect effects of such adverse ratings actions or any future actions could include, but are not • ceasing and/or reducing new sales of our products or limiting the business opportunities we are • • • adversely affecting our relationships with distributors, including the loss of exclusivity under certain agreements with our independent sales intermediaries and distribution partners; causing us to lose key distributors that have ratings requirements that we may no longer satisfy (or resulting in our renegotiation of new, less favorable arrangements with those distributors); requiring us to modify some of our existing products or services to remain competitive, including reducing premiums we charge, or introduce new products or services; • materially increasing the number or amount of policy surrenders, withdrawals and loans by contractholders and policyholders; • • • • • • • • requiring us to post additional collateral for our derivatives or hedging agreements tied to the credit ratings of our holding companies; requiring us to provide support, or to arrange for third-party support, in the form of collateral, capital contributions or letters of credit under the terms of certain of our reinsurance and other agreements, or otherwise securing our commercial counterparties for the perceived risk of our financial strength; adversely affecting our ability to maintain reinsurance or obtain new reinsurance or obtain it on reasonable pricing and other terms; increasing the capital charge associated with affiliated investments within certain of our U.S. life insurance subsidiaries thereby lowering capital and RBC of these subsidiaries and negatively impacting our financial flexibility; regulators requiring certain of our subsidiaries to maintain additional capital, limiting thereby our financial flexibility and requiring us to raise additional capital; adversely affecting our ability to raise capital; increased scrutiny by the GSEs and/or by customers, potentially resulting in a decrease in the amount of new insurance written; increasing our cost of borrowing and making it more difficult to borrow in the public debt markets or enter into a credit agreement; and • making it more difficult to execute on CareScout initiatives. Under PMIERs, the GSEs require maintenance of at least one rating with a rating agency acceptable to the respective GSEs. The current PMIERs do not include a specific ratings requirement with respect to eligibility, but if this were to change in the future, Enact may become subject to a ratings requirement in order to retain its eligibility status under PMIERs. Ratings downgrades that result in the inability of Enact to insure new mortgage loans sold to the GSEs, or the transfer by the GSEs of its existing policies to an alternative mortgage insurer, would have a material adverse effect on our business, results of operations and financial condition. See “—If Enact is unable to continue to meet the requirements mandated by PMIERs because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition” for additional information regarding the requirements under PMIERs. Relationships with mortgage insurance customers may be adversely affected by the ratings assigned to Genworth Holdings or our principal insurance subsidiaries which could have a material adverse effect on our business, financial condition and results of operations. EMICO, our principal U.S. mortgage insurance subsidiary, has financial strength ratings that are relatively consistent with its competitors. However, any assigned financial strength rating that is below other private mortgage insurers could hinder our competitiveness in the marketplace and could result in an adverse impact to our business. Moreover, any future downgrade in the financial strength ratings of EMICO or the announcement of a potential downgrade could have a material adverse impact on our business, results of operations and financial condition. 42 43 Defaults by counterparties to our reinsurance arrangements or to derivative instruments we use to hedge our business risks, or defaults by us on agreements we have with these counterparties, may expose us to risks we sought to mitigate, which could have a material adverse effect on our business, results of operations and financial condition. We routinely execute reinsurance and derivative transactions with reinsurers, brokers/dealers, commercial banks, investment banks and other institutional counterparties to mitigate our risks in various circumstances and to hedge various business risks. Many of these transactions expose us to credit risk in the event of default of our counterparty or client or change in collateral value. Reinsurance does not relieve us of our direct liability to our policyholders, even when the reinsurer is liable to us. Accordingly, we bear credit risk with respect to our reinsurers. We cannot be sure that our reinsurers will pay the reinsurance recoverable owed to us now or in the future or that they will pay these recoverables on a timely basis. A reinsurer’s insolvency, inability or unwillingness to make payments under the terms of its reinsurance agreement with us could have a material adverse effect on our financial condition and results of operations. Collateral is often posted by the counterparty to offset this risk; however, we bear the risk that the collateral declines in value or otherwise is inadequate to fully compensate us in the event of a default. We also enter into a variety of derivative instruments, including options, swaps, forwards, and interest rate and currency swaps with a number of counterparties. If our counterparties fail or refuse to honor their obligations under the derivative instruments, and collateral posted, if any, is inadequate, our hedges of the related risk will be ineffective. In addition, if we trigger downgrade provisions on risk-hedging or reinsurance arrangements, the counterparties to these arrangements may be able to terminate our arrangements with them or require us to take other measures, such as post additional collateral, contribute capital or provide letters of credit. We have agreed to new terms with almost all of our counterparties concerning our collateral arrangements given our low ratings and, in most cases, agreed to post excess collateral to maintain our existing derivative agreements. Moreover, the new terms also removed the credit downgrade provisions from all of the insurance company master swap agreements and replaced them with a provision that allows the counterparty to terminate the derivative transaction if the RBC ratio of the applicable insurance company goes below a certain threshold. Although we believe this has allowed us to maintain effective hedging relationships with our counterparties, it has added additional strain on liquidity and collateral sufficiency. Furthermore, we may not be able to maintain these current arrangements in the foreseeable future or at all. If counterparties exercise their rights to terminate transactions, we may be required to make cash payments to the counterparty based on the current contract value, which would hinder our ability to manage future risks. We ceded to UFLIC our in-force structured settlements block of business issued prior to 2004, certain variable annuity business issued prior to 2004 and the long-term care insurance business assumed from legal entities now a part of Brighthouse Life Insurance Company. UFLIC has established trust accounts for our benefit to secure its obligations under the reinsurance arrangements. GE is obligated to maintain UFLIC’s RBC above a specified minimum level pursuant to a Capital Maintenance Agreement. If UFLIC becomes insolvent notwithstanding this agreement, and the amounts in the trust accounts are insufficient to pay UFLIC’s obligations to us, it could have a material adverse effect on our financial condition and results of operations. The loss of material risk-hedging or reinsurance arrangements could have a material adverse effect on our financial condition and results of operations. For additional information on UFLIC reinsurance, see note 9 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Defaults or other events impacting the value of our fixed maturity securities portfolio may reduce our income. We are subject to the risk that the issuers or guarantors of investment securities we own may default on principal or interest payments they owe us. As of December 31, 2023, fixed maturity securities of $46.8 billion in our investment portfolio represented 75% of our total cash, cash equivalents and invested assets. Events reducing the value of our investment portfolio other than on a temporary basis could have a material adverse effect on our business, results of operations and financial condition. Levels of write-downs or expected credit losses are impacted by our assessment of the financial condition of the issuer, whether or not the issuer is expected to pay its principal and interest obligations, and our expected recoveries in the event of a default or circumstances that would require us to sell securities that have declined in value. Risks Relating to Economic and Market Conditions Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability. Insurance Products and Investments Our products and investment portfolio are impacted by interest rate fluctuations. We have experienced significant declines in investment valuations as a result of elevated interest rates, and we may experience further declines if credit deteriorates resulting in credit losses and/or if interest rates continue to rise. During periods of increasing interest rates, market values of lower-yielding assets will decline resulting in unrealized losses on our investment portfolio. The rise in interest rates during 2022 and 2023 had an adverse impact on our financial position, and if interest rates continue to climb, we may experience a further decline in our stockholders’ equity in future periods. Rising interest rates erode the value of our investment portfolio and reduce our unrealized investment gains. Any material reduction in unrealized gains or increase in unrealized losses on our investment portfolio or forward starting swap derivatives due to higher interest rates could impede our ability to utilize certain deferred tax assets and/or result in the need to establish higher tax valuation allowances, either of which could materially adversely impact our results of operations and financial position. During periods of increasing market interest rates, we may increase crediting rates on interest-sensitive in-force products, such as universal life insurance and fixed annuities. Rapidly rising interest rates may lead to increased policy surrenders, withdrawals from life insurance policies and annuity contracts and requests for policy loans, as policyholders and contractholders shift assets into higher yielding investments. Increases in crediting rates, as well as surrenders and withdrawals, could have a material adverse effect on our financial condition and results of operations, including the requirement to liquidate fixed-income investments in an unrealized loss position to satisfy surrenders or withdrawals. Our insurance and investment products, such as those included in our policyholder account balances and separate accounts, are sensitive to interest rate fluctuations and expose us to the risk that declines in interest rates or tightening credit spreads will reduce our interest rate margin or net spreads (the difference between the returns we earn on the investments that support our obligations under these products and the amounts that we pay to policyholders and contractholders). We may reduce the interest rates we credit on most of these products only at limited, pre-established intervals, and some contracts have guaranteed minimum interest crediting rates. As a result of historic low interest rates prior to 2022 and declines in our interest rate margin on these products, our business and profitability have been adversely impacted. During 2023, we continued to experience lower net spreads on our annuity products due to crediting rates outpacing investment returns, coupled with lower annuity account values driven by block runoff. This unfavorable trend occurred in spite of the higher interest rate environment, and if it persists, could result in further net spread compression and an adverse impact to our results of operations. Prior to the significant rise in interest rates in 2022, sustained low interest rates adversely impacted our prior business results, reserves and profitability. For additional information, including the financial impact of annual assumption reviews, see “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates—Liability for future policy benefits.” If interest rates were to return to historic lows, our financial condition, most notably stockholders’ equity, and our results of operations and overall business could be materially adversely impacted. In addition, our insurance reserves are sensitive to movements in interest rates as we are required under LDTI to remeasure our liability for future policy benefits and related reinsurance recoverables at the current discount rate, commonly interpreted to be a single-A rated bond rate. This will likely result in volatility to our stockholders’ equity. For example, if the U.S. Federal Reserve reverses its monetary tightening by reducing interest rates, our insurance reserves would increase and our stockholders’ equity would decrease by amounts that could be material, which may have a material adverse effect on our financial condition. See note 2 in “Part II—Item 8—Financial Statements and Supplementary Data” for additional details on the measurement of our insurance reserves. 44 45 Defaults by counterparties to our reinsurance arrangements or to derivative instruments we use to hedge our business risks, or defaults by us on agreements we have with these counterparties, may expose us to risks we sought to mitigate, which could have a material adverse effect on our business, results of operations and financial condition. We routinely execute reinsurance and derivative transactions with reinsurers, brokers/dealers, commercial banks, investment banks and other institutional counterparties to mitigate our risks in various circumstances and to hedge various business risks. Many of these transactions expose us to credit risk in the event of default of our counterparty or client or change in collateral value. Reinsurance does not relieve us of our direct liability to our policyholders, even when the reinsurer is liable to us. Accordingly, we bear credit risk with respect to our reinsurers. We cannot be sure that our reinsurers will pay the reinsurance recoverable owed to us now or in the future or that they will pay these recoverables on a timely basis. A reinsurer’s insolvency, inability or unwillingness to make payments under the terms of its reinsurance agreement with us could have a material adverse effect on our financial condition and results of operations. Collateral is often posted by the counterparty to offset this risk; however, we bear the risk that the collateral declines in value or otherwise is inadequate to fully compensate us in the event of a default. We also enter into a variety of derivative instruments, including options, swaps, forwards, and interest rate and currency swaps with a number of counterparties. If our counterparties fail or refuse to honor their obligations under the derivative instruments, and collateral posted, if any, is inadequate, our hedges of the related risk will be ineffective. In addition, if we trigger downgrade provisions on risk-hedging or reinsurance arrangements, the counterparties to these arrangements may be able to terminate our arrangements with them or require us to take other measures, such as post additional collateral, contribute capital or provide letters of credit. We have agreed to new terms with almost all of our counterparties concerning our collateral arrangements given our low ratings and, in most cases, agreed to post excess collateral to maintain our existing derivative agreements. Moreover, the new terms also removed the credit downgrade provisions from all of the insurance company master swap agreements and replaced them with a provision that allows the counterparty to terminate the derivative transaction if the RBC ratio of the applicable insurance company goes below a certain threshold. Although we believe this has allowed us to maintain effective hedging relationships with our counterparties, it has added additional strain on liquidity and collateral sufficiency. Furthermore, we may not be able to maintain these current arrangements in the foreseeable future or at all. If counterparties exercise their rights to terminate transactions, we may be required to make cash payments to the counterparty based on the current contract value, which would hinder our ability to manage future risks. We ceded to UFLIC our in-force structured settlements block of business issued prior to 2004, certain variable annuity business issued prior to 2004 and the long-term care insurance business assumed from legal entities now a part of Brighthouse Life Insurance Company. UFLIC has established trust accounts for our benefit to secure its obligations under the reinsurance arrangements. GE is obligated to maintain UFLIC’s RBC above a specified minimum level pursuant to a Capital Maintenance Agreement. If UFLIC becomes insolvent notwithstanding this agreement, and the amounts in the trust accounts are insufficient to pay UFLIC’s obligations to us, it could have a material adverse effect on our financial condition and results of operations. The loss of material risk-hedging or reinsurance arrangements could have a material adverse effect on our financial condition and results of operations. For additional information on UFLIC reinsurance, see note 9 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Defaults or other events impacting the value of our fixed maturity securities portfolio may reduce our income. We are subject to the risk that the issuers or guarantors of investment securities we own may default on principal or interest payments they owe us. As of December 31, 2023, fixed maturity securities of $46.8 billion in our investment portfolio represented 75% of our total cash, cash equivalents and invested assets. Events reducing the value of our investment portfolio other than on a temporary basis could have a material adverse effect on our business, results of operations and financial condition. Levels of write-downs or expected credit losses are impacted by our assessment of the financial condition of the issuer, whether or not the issuer is expected to pay its principal and interest obligations, and our expected recoveries in the event of a default or circumstances that would require us to sell securities that have declined in value. Risks Relating to Economic and Market Conditions Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability. Insurance Products and Investments Our products and investment portfolio are impacted by interest rate fluctuations. We have experienced significant declines in investment valuations as a result of elevated interest rates, and we may experience further declines if credit deteriorates resulting in credit losses and/or if interest rates continue to rise. During periods of increasing interest rates, market values of lower-yielding assets will decline resulting in unrealized losses on our investment portfolio. The rise in interest rates during 2022 and 2023 had an adverse impact on our financial position, and if interest rates continue to climb, we may experience a further decline in our stockholders’ equity in future periods. Rising interest rates erode the value of our investment portfolio and reduce our unrealized investment gains. Any material reduction in unrealized gains or increase in unrealized losses on our investment portfolio or forward starting swap derivatives due to higher interest rates could impede our ability to utilize certain deferred tax assets and/or result in the need to establish higher tax valuation allowances, either of which could materially adversely impact our results of operations and financial position. During periods of increasing market interest rates, we may increase crediting rates on interest-sensitive in-force products, such as universal life insurance and fixed annuities. Rapidly rising interest rates may lead to increased policy surrenders, withdrawals from life insurance policies and annuity contracts and requests for policy loans, as policyholders and contractholders shift assets into higher yielding investments. Increases in crediting rates, as well as surrenders and withdrawals, could have a material adverse effect on our financial condition and results of operations, including the requirement to liquidate fixed-income investments in an unrealized loss position to satisfy surrenders or withdrawals. Our insurance and investment products, such as those included in our policyholder account balances and separate accounts, are sensitive to interest rate fluctuations and expose us to the risk that declines in interest rates or tightening credit spreads will reduce our interest rate margin or net spreads (the difference between the returns we earn on the investments that support our obligations under these products and the amounts that we pay to policyholders and contractholders). We may reduce the interest rates we credit on most of these products only at limited, pre-established intervals, and some contracts have guaranteed minimum interest crediting rates. As a result of historic low interest rates prior to 2022 and declines in our interest rate margin on these products, our business and profitability have been adversely impacted. During 2023, we continued to experience lower net spreads on our annuity products due to crediting rates outpacing investment returns, coupled with lower annuity account values driven by block runoff. This unfavorable trend occurred in spite of the higher interest rate environment, and if it persists, could result in further net spread compression and an adverse impact to our results of operations. Prior to the significant rise in interest rates in 2022, sustained low interest rates adversely impacted our prior business results, reserves and profitability. For additional information, including the financial impact of annual assumption reviews, see “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates—Liability for future policy benefits.” If interest rates were to return to historic lows, our financial condition, most notably stockholders’ equity, and our results of operations and overall business could be materially adversely impacted. In addition, our insurance reserves are sensitive to movements in interest rates as we are required under LDTI to remeasure our liability for future policy benefits and related reinsurance recoverables at the current discount rate, commonly interpreted to be a single-A rated bond rate. This will likely result in volatility to our stockholders’ equity. For example, if the U.S. Federal Reserve reverses its monetary tightening by reducing interest rates, our insurance reserves would increase and our stockholders’ equity would decrease by amounts that could be material, which may have a material adverse effect on our financial condition. See note 2 in “Part II—Item 8—Financial Statements and Supplementary Data” for additional details on the measurement of our insurance reserves. 44 45 Enact—Mortgage Insurance The mortgage origination market has been negatively impacted by elevated interest rates and housing affordability pressure, which could cause new insurance written by Enact Holdings to decline materially, and could thereby pressure earnings and lead to an adverse effect on our results of operations and financial condition. The U.S. housing market experienced a dramatic decline in the volume of mortgage originations in 2022 and 2023 due largely to rising interest rates, resulting in lower new insurance written at Enact Holdings. While the decrease in new insurance written was generally offset by higher persistency on Enact Holdings’ existing insured loans, the ultimate impact on Enact Holdings’ premiums and future new insurance written is difficult to predict. We could experience a future adverse impact to our results of operations if the volume of new insurance written remains suppressed for a prolonged period of time. While the terms of recent vintages of adjustable-rate mortgages (“ARMs”) have changed to limit the frequency and severity of shocks, rising interest rates can also increase the monthly mortgage payments for homeowners with insured loans that have ARMs that could have the effect of increasing default rates on ARM loans. Higher interest rates can lead to an increase in defaults, as borrowers who default will find it harder to qualify for a replacement loan. Rising interest rates can also have a negative impact on home prices, which increases our risk of loss. Home price appreciation slowed temporarily in 2022 as a result of rising interest rates but regained its upward trend in 2023 as the low supply of homes more than offset higher borrowing costs. Any significant decline in home values, either due to rising rates or otherwise, particularly if accompanied by increased unemployment in a recessionary environment, could increase delinquencies and foreclosures at Enact Holdings, which could have a material adverse effect on our business, results of operations and financial condition. See “—A deterioration in economic conditions, a severe recession or a decline in home prices, all of which could be driven by many potential factors, may adversely affect Enact Holdings’ loss experience.” As seen prior to 2022, declining interest rates historically have increased the rate at which borrowers refinance their existing mortgages, resulting in cancellations of the mortgage insurance covering the refinanced loans. Declining interest rates have also contributed to home price appreciation, which may provide borrowers in the United States with the option of cancelling their mortgage insurance coverage earlier than we anticipated when pricing that coverage. In addition, during 2021 and 2020, as a result of the low interest rate environment, Enact Holdings experienced a decline in persistency rates. Lower persistency rates can result in reduced insurance in-force and earned premiums, which could have a significant adverse impact on our results of operations. See “—A decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations could result in a decline in our revenue in our mortgage insurance subsidiaries.” See “Part II—Item 7A—Quantitative and Qualitative Disclosures About Market Risk” for additional information about interest rate risk. A deterioration in economic conditions, a severe recession or a decline in home prices, all of which could be driven by many potential factors, may adversely affect Enact Holdings’ loss experience. Loss experience in Enact Holdings generally results from adverse economic events, such as a borrower’s reduction of income, unemployment, underemployment, divorce, illness, inability to manage credit, or a change in interest rate levels or home values, that reduce a borrower’s willingness or ability to continue to make mortgage payments. Rising unemployment rates and deterioration in economic conditions across the United States or in specific regional economies generally increase the likelihood of borrower defaults and can also adversely affect housing values, which increases our risk of loss. Economic uncertainty persisted throughout 2023. Variability in consumer confidence due in part to elevated inflation and interest rates, along with developments related to the U.S. federal debt ceiling and geopolitical tensions, continue to create a backdrop of uncertainty in the overall macroeconomic environment. Some economists still predict a recession in 2024. Unfavorable or uncertain economic conditions, such as those described above, could also impact home prices. A decline in home values typically makes it more difficult for borrowers to sell or refinance their homes, results of operations. 46 47 increasing the likelihood of a default followed by a claim if borrowers experience a job loss or other life events that reduce their incomes or increase their expenses. In addition, declines in home values may also decrease the willingness of borrowers with sufficient financial resources to make mortgage payments when their mortgage balances exceed the values of their homes. Declines in home values typically increase the severity of claims Enact Holdings may pay. A decline in home prices, whether or not in conjunction with deteriorating economic conditions, may increase the risk of loss. Generally, home prices steadily rose over the past decade, and in many geographic locations, home price appreciation outpaced borrower incomes. Home price appreciation coupled with rising interest rates and a low supply of available homes has placed pressure on housing affordability in recent years, most notably beginning in 2022. Home prices temporarily declined in late 2022 but regained an upward trend in 2023 as the low supply of homes more than offset the higher borrowing costs. Housing supply remains depressed as homeowners are reluctant to sell their house and pay significantly higher mortgage rates for a new one. We are uncertain as to whether and to what extent the higher interest rate environment will affect home values, but it is possible the housing market could experience a sharp price correction if the U.S. Federal Reserve maintains its current policy of keeping rates higher for longer to combat inflation. We could experience a higher frequency and severity of defaults on more recent book years should home values decline. Declining home values erode the value of the underlying collateral and reduce the likelihood that foreclosed homes can be sold for an amount sufficient to offset the unpaid principal and interest which may adversely impact Enact Holdings’ loss mitigation activities. Furthermore, Enact Holdings’ estimates of claims-paying resources and claim obligations are based on various assumptions, including but not limited to, the timing of receipt of claims on delinquent loans, estimates of future claims that will ultimately be received, the ultimate resolution of borrower forbearance plans, including whether loans in forbearance cure or result in a claim payment, anticipated loss mitigation activities, premiums, housing prices and unemployment rates. These assumptions are subject to inherent uncertainty and require judgment. Any of these events may have a material adverse effect on Enact Holdings which could result in a material adverse effect on our business, results of operations and financial condition. The ultimate amount of the loss suffered depends, in part, on whether the home of a borrower who defaults on a mortgage can be sold for an amount that will cover the unpaid principal balance, interest and the expenses of the sale. In previous economic slowdowns in the United States, a pronounced weakness in the housing market ensued, as well as declines in home prices. If we experience a future economic slowdown or an economic recession in the United States that impacts the housing market in a similar way as compared to past economic slowdowns, we would expect higher levels of delinquencies in Enact Holdings. Mortgage forbearance programs and any delays in foreclosure processes could cause Enact Holdings’ losses to increase as expenses accrue for longer periods or if the value of foreclosed homes further declines during such delays. If Enact Holdings experiences a higher number and/or severity of delinquencies than expected, including as a result of borrowers’ exit from forbearance programs upon reaching the maximum forbearance term, our business, results of operations and financial condition could be adversely affected. In response to COVID-19, the federal government and the GSEs offered programs to support borrowers through economic hardship including mortgage payment forbearance options and foreclosure and eviction moratoriums. The pandemic initially resulted in a material increase in new defaults as borrowers failed to make timely payments on their mortgages, primarily as a result of these forbearance programs. These delinquencies have largely cured at rates favorable to Enact Holdings’ initial expectations; however, there is still uncertainty as to the timing and ultimate severity of the COVID-19 delinquencies that remain. Though the ability to take advantage of COVID-19-specific forbearance for new delinquencies ended in 2023, Enact Holdings has seen limited claims emerge from this population of loans. Further, in March 2023, the GSEs announced new loss mitigation programs that would allow six-month payment deferrals for borrowers facing financial hardship, including hardship unrelated to COVID-19. As a result of the continued availability of forbearance and lack of foreclosure experience, the impact this will have on our business, results of operations and financial condition remains uncertain. If Enact Holdings experiences an increase in claim severity resulting in claim amounts that are higher than expected, it would adversely affect Enact Holdings and consequently our financial position and Enact—Mortgage Insurance The mortgage origination market has been negatively impacted by elevated interest rates and housing affordability pressure, which could cause new insurance written by Enact Holdings to decline materially, and could thereby pressure earnings and lead to an adverse effect on our results of operations and financial condition. The U.S. housing market experienced a dramatic decline in the volume of mortgage originations in 2022 and 2023 due largely to rising interest rates, resulting in lower new insurance written at Enact Holdings. While the decrease in new insurance written was generally offset by higher persistency on Enact Holdings’ existing insured loans, the ultimate impact on Enact Holdings’ premiums and future new insurance written is difficult to predict. We could experience a future adverse impact to our results of operations if the volume of new insurance written remains suppressed for a prolonged period of time. While the terms of recent vintages of adjustable-rate mortgages (“ARMs”) have changed to limit the frequency and severity of shocks, rising interest rates can also increase the monthly mortgage payments for homeowners with insured loans that have ARMs that could have the effect of increasing default rates on ARM loans. Higher interest rates can lead to an increase in defaults, as borrowers who default will find it harder to qualify for a replacement loan. Rising interest rates can also have a negative impact on home prices, which increases our risk of loss. Home price appreciation slowed temporarily in 2022 as a result of rising interest rates but regained its upward trend in 2023 as the low supply of homes more than offset higher borrowing costs. Any significant decline in home values, either due to rising rates or otherwise, particularly if accompanied by increased unemployment in a recessionary environment, could increase delinquencies and foreclosures at Enact Holdings, which could have a material adverse effect on our business, results of operations and financial condition. See “—A deterioration in economic conditions, a severe recession or a decline in home prices, all of which could be driven by many potential factors, may adversely affect Enact Holdings’ loss experience.” As seen prior to 2022, declining interest rates historically have increased the rate at which borrowers refinance their existing mortgages, resulting in cancellations of the mortgage insurance covering the refinanced loans. Declining interest rates have also contributed to home price appreciation, which may provide borrowers in the United States with the option of cancelling their mortgage insurance coverage earlier than we anticipated when pricing that coverage. In addition, during 2021 and 2020, as a result of the low interest rate environment, Enact Holdings experienced a decline in persistency rates. Lower persistency rates can result in reduced insurance in-force and earned premiums, which could have a significant adverse impact on our results of operations. See “—A decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations could result in a decline in our revenue in our mortgage insurance subsidiaries.” information about interest rate risk. See “Part II—Item 7A—Quantitative and Qualitative Disclosures About Market Risk” for additional A deterioration in economic conditions, a severe recession or a decline in home prices, all of which could be driven by many potential factors, may adversely affect Enact Holdings’ loss experience. Loss experience in Enact Holdings generally results from adverse economic events, such as a borrower’s reduction of income, unemployment, underemployment, divorce, illness, inability to manage credit, or a change in interest rate levels or home values, that reduce a borrower’s willingness or ability to continue to make mortgage payments. Rising unemployment rates and deterioration in economic conditions across the United States or in specific regional economies generally increase the likelihood of borrower defaults and can also adversely affect housing values, which increases our risk of loss. Economic uncertainty persisted throughout 2023. Variability in consumer confidence due in part to elevated inflation and interest rates, along with developments related to the U.S. federal debt ceiling and geopolitical tensions, continue to create a backdrop of uncertainty in the overall macroeconomic environment. Some economists still predict a recession in 2024. Unfavorable or uncertain economic conditions, such as those described above, could also impact home prices. A decline in home values typically makes it more difficult for borrowers to sell or refinance their homes, increasing the likelihood of a default followed by a claim if borrowers experience a job loss or other life events that reduce their incomes or increase their expenses. In addition, declines in home values may also decrease the willingness of borrowers with sufficient financial resources to make mortgage payments when their mortgage balances exceed the values of their homes. Declines in home values typically increase the severity of claims Enact Holdings may pay. A decline in home prices, whether or not in conjunction with deteriorating economic conditions, may increase the risk of loss. Generally, home prices steadily rose over the past decade, and in many geographic locations, home price appreciation outpaced borrower incomes. Home price appreciation coupled with rising interest rates and a low supply of available homes has placed pressure on housing affordability in recent years, most notably beginning in 2022. Home prices temporarily declined in late 2022 but regained an upward trend in 2023 as the low supply of homes more than offset the higher borrowing costs. Housing supply remains depressed as homeowners are reluctant to sell their house and pay significantly higher mortgage rates for a new one. We are uncertain as to whether and to what extent the higher interest rate environment will affect home values, but it is possible the housing market could experience a sharp price correction if the U.S. Federal Reserve maintains its current policy of keeping rates higher for longer to combat inflation. We could experience a higher frequency and severity of defaults on more recent book years should home values decline. Declining home values erode the value of the underlying collateral and reduce the likelihood that foreclosed homes can be sold for an amount sufficient to offset the unpaid principal and interest which may adversely impact Enact Holdings’ loss mitigation activities. Furthermore, Enact Holdings’ estimates of claims-paying resources and claim obligations are based on various assumptions, including but not limited to, the timing of receipt of claims on delinquent loans, estimates of future claims that will ultimately be received, the ultimate resolution of borrower forbearance plans, including whether loans in forbearance cure or result in a claim payment, anticipated loss mitigation activities, premiums, housing prices and unemployment rates. These assumptions are subject to inherent uncertainty and require judgment. Any of these events may have a material adverse effect on Enact Holdings which could result in a material adverse effect on our business, results of operations and financial condition. The ultimate amount of the loss suffered depends, in part, on whether the home of a borrower who defaults on a mortgage can be sold for an amount that will cover the unpaid principal balance, interest and the expenses of the sale. In previous economic slowdowns in the United States, a pronounced weakness in the housing market ensued, as well as declines in home prices. If we experience a future economic slowdown or an economic recession in the United States that impacts the housing market in a similar way as compared to past economic slowdowns, we would expect higher levels of delinquencies in Enact Holdings. Mortgage forbearance programs and any delays in foreclosure processes could cause Enact Holdings’ losses to increase as expenses accrue for longer periods or if the value of foreclosed homes further declines during such delays. If Enact Holdings experiences a higher number and/or severity of delinquencies than expected, including as a result of borrowers’ exit from forbearance programs upon reaching the maximum forbearance term, our business, results of operations and financial condition could be adversely affected. In response to COVID-19, the federal government and the GSEs offered programs to support borrowers through economic hardship including mortgage payment forbearance options and foreclosure and eviction moratoriums. The pandemic initially resulted in a material increase in new defaults as borrowers failed to make timely payments on their mortgages, primarily as a result of these forbearance programs. These delinquencies have largely cured at rates favorable to Enact Holdings’ initial expectations; however, there is still uncertainty as to the timing and ultimate severity of the COVID-19 delinquencies that remain. Though the ability to take advantage of COVID-19-specific forbearance for new delinquencies ended in 2023, Enact Holdings has seen limited claims emerge from this population of loans. Further, in March 2023, the GSEs announced new loss mitigation programs that would allow six-month payment deferrals for borrowers facing financial hardship, including hardship unrelated to COVID-19. As a result of the continued availability of forbearance and lack of foreclosure experience, the impact this will have on our business, results of operations and financial condition remains uncertain. If Enact Holdings experiences an increase in claim severity resulting in claim amounts that are higher than expected, it would adversely affect Enact Holdings and consequently our financial position and results of operations. 46 47 Regulatory and Legal Risks Our insurance businesses are extensively regulated and changes in regulation may reduce our profitability Changes in accounting and reporting standards issued by the Financial Accounting Standards Board or other standard-setting bodies and insurance regulators could materially adversely affect our business, financial condition and results of operations. Our financial statements are subject to the application of U.S. GAAP, which is periodically revised and/or expanded. Accordingly, from time to time, we are required to adopt new or revised accounting standards issued by recognized authoritative bodies, including the Financial Accounting Standards Board. It is possible that future accounting and reporting standards we are required to adopt could change the current accounting treatment that we apply to our financial statements and that such changes could have a material adverse effect on our financial condition and results of operations. In addition, the required adoption of future accounting and reporting standards, including certain proposals by the SEC related to climate-related disclosures, may result in significant costs to implement. These requirements would also likely require us to make significant changes to systems and add additional resources, either of which may be material to our business and results of operations. The inability to obtain in-force rate action increases (including increased premiums and associated benefit reductions) in our long-term care insurance business could have a material adverse impact on our business, including our results of operations and financial condition. The continued sustainability of our long-term care insurance business, as well as that of GLIC and GLICNY, is based on our ability to obtain significant premium rate increases and associated benefit reductions on our in-force long-term care insurance products. Although the terms of our long-term care insurance policies permit us to increase premiums under certain circumstances during the premium-paying period, these increases generally require regulatory approval, which can often take a long time to obtain and may not be obtained in all relevant jurisdictions or for the full amounts requested. In addition, some states have adopted or are considering adopting laws that would further limit increases in long-term care insurance premium rates beyond the statutes and regulations previously adopted in certain states, which would adversely impact our ability to achieve anticipated rate increases. Furthermore, some states have refused to approve actuarially justified rate actions or have required that approved rate actions be phased in over an extended period of time. Regulators may be unwilling to approve premium rates we seek to charge. We cannot predict how regulators may react to any in-force rate increases, nor can we predict if regulators will approve requested in-force rate increases. We will not be able to realize our future premium rate increases and associated benefit reductions in the future if we cannot obtain the required regulatory approvals. In this event, we would have to increase our long- term care insurance reserves by amounts that would likely be material and would result in a material adverse impact to earnings. Moreover, we may not be able to sufficiently mitigate the impact of unexpected adverse experience through premium rate increases and associated benefit reductions. Given the claims history in our long-term care insurance business and its related pressure to reserve levels and earnings, and the expectation that claims will continue to rise due to the aging of the block and from higher incidence and severity, among other factors, our results of operations, capital levels, RBC and financial condition would be materially adversely affected absent future premium rate increases and associated benefit reductions. We cannot predict how our policyholders may react to any in-force rate increases. In certain circumstances, our policyholders have brought legal action against us due to alleged misleading and inadequate disclosures regarding premium rate increases. See “—Litigation and regulatory investigations or other actions are common in the insurance business and may result in financial losses and harm our reputation” and note 25 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information. and limit our growth. Our insurance operations are subject to a wide variety of laws and regulations and are extensively regulated. State insurance laws regulate most aspects of our U.S. insurance businesses, and our insurance subsidiaries are regulated by the insurance departments of the states in which they are domiciled and licensed. Our international operations, predominantly located in Mexico as well as a new subsidiary of Enact Holdings domiciled in Bermuda, are principally regulated by insurance regulatory authorities in the jurisdictions in which they are domiciled. Failure to comply with applicable regulations or to obtain or maintain appropriate authorizations or exemptions under any applicable laws could result in restrictions on our ability to do business or engage in activities regulated in one or more jurisdictions in which we operate and could subject us to fines and other sanctions which could have a material adverse effect on our business. In addition, the nature and extent of regulation of our activities in applicable jurisdictions could materially change causing a material adverse effect on our business. Although future regulatory changes are unknown, we expect our regulators to continue to pursue new regulation in the areas of environmental, social and corporate governance, as well as cybersecurity and artificial intelligence. Insurance regulatory authorities have broad administrative powers, which at times, are coordinated and communicated across regulatory bodies. These administrative powers include, but are not limited to: licensing companies and agents to transact business; calculating the value of assets and determining the eligibility of assets to determine compliance with statutory requirements; • mandating certain insurance benefits; regulating certain premium rates; reviewing and approving policy forms; regulating discrimination in pricing, coverage terms and other insurance practices, as well as unfair trade and claims practices, including through the imposition of restrictions on marketing and sales practices, distribution arrangements and payment of inducements; establishing and revising statutory capital and reserve requirements and solvency standards; fixing maximum interest rates on insurance policy loans and minimum rates for guaranteed crediting rates on life insurance policies and annuity contracts; approving premium increases and associated benefit reductions; evaluating enterprise risk to an insurer; approving changes in control of insurance companies; restricting the payment of dividends and other transactions between affiliates; regulating the types, amounts and valuation of investments; restricting the types of insurance products that may be offered; and imposing insurance eligibility criteria. State insurance regulators and the NAIC regularly re-examine existing laws and regulations, specifically focusing on modifications to SAP, interpretations of existing laws and the development of new laws and regulations applicable to insurance companies and their products. Any adopted future legislation or NAIC regulations may be more restrictive on our ability to conduct business than current regulatory requirements or may result in higher costs or increased statutory capital and reserve requirements. Further, because laws and regulations can be complex and sometimes inexact, there is also a risk that any particular regulator’s or enforcement authority’s interpretation of a legal, accounting or reserving issue may change over time to our detriment or expose us to different or additional regulatory risks. The application of these regulations and guidelines by insurers involves interpretations and judgments that may differ from those of state insurance • • • • • • • • • • • • • • 48 49 Regulatory and Legal Risks Changes in accounting and reporting standards issued by the Financial Accounting Standards Board or other standard-setting bodies and insurance regulators could materially adversely affect our business, financial condition and results of operations. Our financial statements are subject to the application of U.S. GAAP, which is periodically revised and/or expanded. Accordingly, from time to time, we are required to adopt new or revised accounting standards issued by recognized authoritative bodies, including the Financial Accounting Standards Board. It is possible that future accounting and reporting standards we are required to adopt could change the current accounting treatment that we apply to our financial statements and that such changes could have a material adverse effect on our financial condition and results of operations. In addition, the required adoption of future accounting and reporting standards, including certain proposals by the SEC related to climate-related disclosures, may result in significant costs to implement. These requirements would also likely require us to make significant changes to systems and add additional resources, either of which may be material to our business and results of operations. The inability to obtain in-force rate action increases (including increased premiums and associated benefit reductions) in our long-term care insurance business could have a material adverse impact on our business, including our results of operations and financial condition. The continued sustainability of our long-term care insurance business, as well as that of GLIC and GLICNY, is based on our ability to obtain significant premium rate increases and associated benefit reductions on our in-force long-term care insurance products. Although the terms of our long-term care insurance policies permit us to increase premiums under certain circumstances during the premium-paying period, these increases generally require regulatory approval, which can often take a long time to obtain and may not be obtained in all relevant jurisdictions or for the full amounts requested. In addition, some states have adopted or are considering adopting laws that would further limit increases in long-term care insurance premium rates beyond the statutes and regulations previously adopted in certain states, which would adversely impact our ability to achieve anticipated rate increases. Furthermore, some states have refused to approve actuarially justified rate actions or have required that approved rate actions be phased in over an extended period of time. Regulators may be unwilling to approve premium rates we seek to charge. We cannot predict how regulators may react to any in-force rate increases, nor can we predict if regulators will approve requested in-force rate increases. We will not be able to realize our future premium rate increases and associated benefit reductions in the future if we cannot obtain the required regulatory approvals. In this event, we would have to increase our long- term care insurance reserves by amounts that would likely be material and would result in a material adverse impact to earnings. Moreover, we may not be able to sufficiently mitigate the impact of unexpected adverse experience through premium rate increases and associated benefit reductions. Given the claims history in our long-term care insurance business and its related pressure to reserve levels and earnings, and the expectation that claims will continue to rise due to the aging of the block and from higher incidence and severity, among other factors, our results of operations, capital levels, RBC and financial condition would be materially adversely affected absent future premium rate increases and associated benefit reductions. We cannot predict how our policyholders may react to any in-force rate increases. In certain circumstances, our policyholders have brought legal action against us due to alleged misleading and inadequate disclosures regarding premium rate increases. See “—Litigation and regulatory investigations or other actions are common in the insurance business and may result in financial losses and harm our reputation” and note 25 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information. Our insurance businesses are extensively regulated and changes in regulation may reduce our profitability and limit our growth. Our insurance operations are subject to a wide variety of laws and regulations and are extensively regulated. State insurance laws regulate most aspects of our U.S. insurance businesses, and our insurance subsidiaries are regulated by the insurance departments of the states in which they are domiciled and licensed. Our international operations, predominantly located in Mexico as well as a new subsidiary of Enact Holdings domiciled in Bermuda, are principally regulated by insurance regulatory authorities in the jurisdictions in which they are domiciled. Failure to comply with applicable regulations or to obtain or maintain appropriate authorizations or exemptions under any applicable laws could result in restrictions on our ability to do business or engage in activities regulated in one or more jurisdictions in which we operate and could subject us to fines and other sanctions which could have a material adverse effect on our business. In addition, the nature and extent of regulation of our activities in applicable jurisdictions could materially change causing a material adverse effect on our business. Although future regulatory changes are unknown, we expect our regulators to continue to pursue new regulation in the areas of environmental, social and corporate governance, as well as cybersecurity and artificial intelligence. Insurance regulatory authorities have broad administrative powers, which at times, are coordinated and communicated across regulatory bodies. These administrative powers include, but are not limited to: • • licensing companies and agents to transact business; calculating the value of assets and determining the eligibility of assets to determine compliance with statutory requirements; • mandating certain insurance benefits; • • • • • • • • • • • • regulating certain premium rates; reviewing and approving policy forms; regulating discrimination in pricing, coverage terms and other insurance practices, as well as unfair trade and claims practices, including through the imposition of restrictions on marketing and sales practices, distribution arrangements and payment of inducements; establishing and revising statutory capital and reserve requirements and solvency standards; fixing maximum interest rates on insurance policy loans and minimum rates for guaranteed crediting rates on life insurance policies and annuity contracts; approving premium increases and associated benefit reductions; evaluating enterprise risk to an insurer; approving changes in control of insurance companies; restricting the payment of dividends and other transactions between affiliates; regulating the types, amounts and valuation of investments; restricting the types of insurance products that may be offered; and imposing insurance eligibility criteria. State insurance regulators and the NAIC regularly re-examine existing laws and regulations, specifically focusing on modifications to SAP, interpretations of existing laws and the development of new laws and regulations applicable to insurance companies and their products. Any adopted future legislation or NAIC regulations may be more restrictive on our ability to conduct business than current regulatory requirements or may result in higher costs or increased statutory capital and reserve requirements. Further, because laws and regulations can be complex and sometimes inexact, there is also a risk that any particular regulator’s or enforcement authority’s interpretation of a legal, accounting or reserving issue may change over time to our detriment or expose us to different or additional regulatory risks. The application of these regulations and guidelines by insurers involves interpretations and judgments that may differ from those of state insurance 48 49 departments. Such differences of opinion may result in regulatory, tax or other challenges to the actions we have taken to date. The result of those potential challenges could require us to increase levels of statutory capital and reserves or incur higher operating costs and/or have implications on certain tax positions. Litigation and regulatory investigations or other actions are common in the insurance business and may result in financial losses and harm our reputation. We face the risk of litigation and regulatory investigations or other actions in the ordinary course of operating our businesses, including the risk of class action lawsuits. Our pending legal and regulatory actions include proceedings specific to us and others generally applicable to business practices in the industries in which we operate. In our insurance operations, we are, have been, or may become subject to class actions and individual suits alleging, among other things, issues relating to sales or underwriting practices, increases to in-force long-term care insurance premiums, payment of contingent or other sales commissions, claims payments and procedures, product design, product disclosure, product administration, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, recommending unsuitable products to customers, our pricing structures and business practices in our mortgage insurance subsidiaries, such as captive reinsurance arrangements with lenders and contract underwriting services, violations of RESPA or related state anti-inducement laws, mortgage insurance policy rescissions and curtailments, and breaching fiduciary or other duties to customers, including but not limited to cybersecurity breaches of customer information. In our investment-related operations, we are subject to litigation involving commercial disputes with counterparties. We may also have disputes with reinsurance partners relating to the parties’ rights and obligations under reinsurance treaties and/or related administration agreements. In addition, we are also subject to various regulatory inquiries, such as information requests, subpoenas, books and record examinations and market conduct and financial examinations from state, federal and international regulators and other authorities. Plaintiffs in class action and other lawsuits against us, as well as regulators, may seek very large or indeterminate amounts, which may remain unknown for substantial periods of time. We are also subject to litigation arising out of our general business activities such as our contractual and employment relationships, including claims under the Employee Retirement Income Security Act of 1974, and we are also subject to shareholder putative class action lawsuits alleging securities law violations. A substantial legal liability or a significant regulatory action (including uncertainty about the outcome of pending legal and regulatory investigations and actions) against us could have a material adverse effect on our business, financial condition and results of operations. Moreover, even if we ultimately prevail in the litigation, regulatory action or investigation, we could suffer significant reputational harm and incur significant legal expenses, which could have a material adverse effect on our business, financial condition or results of operations. At this time, it is not feasible to predict, nor determine, the ultimate outcomes of any pending investigations and legal proceedings, nor to provide reasonable ranges of possible losses other than those that have been disclosed. For a further discussion of certain current investigations and proceedings in which we are involved, see note 25 in “Part II—Item 8—Financial Statements and Supplementary Data.” These investigations and proceedings could have a material adverse effect on our liquidity, business, financial condition or results of operations. It is also possible that we could become subject to further investigations and have lawsuits filed or enforcement actions initiated against us. In addition, increased regulatory scrutiny and any resulting investigations or legal proceedings could result in new legal precedents and industry-wide regulations or practices that could materially adversely affect our business, financial condition and results of operations. An adverse change in the regulatory requirements on our U.S. life insurance subsidiaries, including risk- based capital requirements, could have a material adverse impact on our business, results of operations and financial condition. insurance subsidiaries to meet applicable RBC requirements or minimum statutory capital and surplus requirements could subject our insurance subsidiaries to further examination or corrective action imposed by state insurance regulators, including limitations on their ability to write additional business, or the addition of state regulatory supervision, rehabilitation, seizure or liquidation. As of December 31, 2023, the RBC of each of our U.S. life insurance subsidiaries exceeded the level of RBC that would require any of them to take or become subject to any corrective action in their respective domiciliary state. However, we continue to face challenges in our principal life insurance subsidiaries, particularly those subsidiaries that rely heavily on in-force rate actions as a source of earnings and capital. We may see variability in statutory results and a decline in the RBC ratios of these subsidiaries given the time lag between the approval of in-force rate actions versus when the benefits from the in-force rate actions (including increased premiums and associated benefit reductions) are fully realized in our financial results. Additionally, the RBC ratio of our U.S. life insurance subsidiaries would be negatively impacted by future increases in our statutory reserves, including results of Actuarial Guideline 38, cash flow testing and assumption reviews, particularly in our long-term care and life insurance products. An adverse change in our U.S. life insurance subsidiaries’ RBC or our ability to meet other minimum regulatory requirements could cause rating agencies to downgrade the financial strength ratings of our insurance subsidiaries and the credit ratings of Genworth Holdings, which could have an adverse impact on our ability to execute our strategic priorities, including stabilizing the legacy long-term care insurance in-force block and advancing CareScout’s new lines of business or new products and services, and would further restrict our ability to retain and write new business. Furthermore, it may cause regulators to take regulatory or supervisory actions with respect to our U.S. life insurance subsidiaries, thereby limiting the financial flexibility of our holding company, all of which could have a material adverse effect on our results of operations, financial condition and business. Changes to the role of the GSEs or to the charters or business practices of the GSEs, including actions or decisions to decrease or discontinue the use of mortgage insurance, could adversely affect our business, financial condition and results of operations. The requirements and practices of the GSEs impact the operating results and financial performance of approved mortgage insurers, including Enact Holdings. Changes in the charters or business practices of Freddie Mac or Fannie Mae could materially reduce the number of mortgages they purchase that are insured by Enact Holdings and consequently diminish the value of our business. The GSEs could be directed to make such changes by the FHFA, which was appointed as their conservator in September 2008 and has the authority to control and direct the operations of the GSEs. Congress may legislate, or the administration may implement through administrative reform, structural and other changes to the GSEs and the functioning of the secondary mortgage market. In the absence of legislation, the FHFA continues to move forward on administrative reform efforts to prepare the GSEs for the end of conservatorship, once fully and adequately capitalized. Effective February 16, 2021, the FHFA enacted the Enterprise Capital Framework, which imposes a capital framework on the GSEs, including risk-based and leverage capital requirements and capital buffers in excess of regulatory minimums that can be drawn down in periods of financial stress. However, the GSEs will not be subject to any requirement under the Enterprise Capital Framework until (i) the date of termination of the conservatorship of a GSE or (ii) any later compliance date provided in a consent order or other transition order applicable to such GSE. The Enterprise Capital Framework significantly increases capital requirements and reduces capital credit on credit risk transfer transactions as compared to the previous framework. This rule could accelerate the recent diversification of the GSEs’ risk transfer programs to encompass a broader array of instruments beyond private mortgage insurance, which could adversely impact Enact Holdings and our business. Likewise, legislation or regulation that changes the role of the GSEs, ends the GSEs’ conservatorship or increases the number of people eligible for FHA or VA mortgages could have a material adverse effect on Enact Holdings and limit its ability to compete with the FHA or VA thereby adversely impacting our business. Our U.S. life insurance subsidiaries are subject to the NAIC’s RBC standards and other minimum statutory capital and surplus requirements imposed under the laws of their respective states of domicile. The failure of our On January 14, 2021, the FHFA and the Treasury Department agreed to amend the PSPAs between the Treasury Department and each of the GSEs to increase the amount of capital each GSE may retain. Among other 50 51 departments. Such differences of opinion may result in regulatory, tax or other challenges to the actions we have taken to date. The result of those potential challenges could require us to increase levels of statutory capital and reserves or incur higher operating costs and/or have implications on certain tax positions. Litigation and regulatory investigations or other actions are common in the insurance business and may result in financial losses and harm our reputation. We face the risk of litigation and regulatory investigations or other actions in the ordinary course of operating our businesses, including the risk of class action lawsuits. Our pending legal and regulatory actions include proceedings specific to us and others generally applicable to business practices in the industries in which we operate. In our insurance operations, we are, have been, or may become subject to class actions and individual suits alleging, among other things, issues relating to sales or underwriting practices, increases to in-force long-term care insurance premiums, payment of contingent or other sales commissions, claims payments and procedures, product design, product disclosure, product administration, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, recommending unsuitable products to customers, our pricing structures and business practices in our mortgage insurance subsidiaries, such as captive reinsurance arrangements with lenders and contract underwriting services, violations of RESPA or related state anti-inducement laws, mortgage insurance policy rescissions and curtailments, and breaching fiduciary or other duties to customers, including but not limited to cybersecurity breaches of customer information. In our investment-related operations, we are subject to litigation involving commercial disputes with counterparties. We may also have disputes with reinsurance partners relating to the parties’ rights and obligations under reinsurance treaties and/or related administration agreements. In addition, we are also subject to various regulatory inquiries, such as information requests, subpoenas, books and record examinations and market conduct and financial examinations from state, federal and international regulators and other authorities. Plaintiffs in class action and other lawsuits against us, as well as regulators, may seek very large or indeterminate amounts, which may remain unknown for substantial periods of time. We are also subject to litigation arising out of our general business activities such as our contractual and employment relationships, including claims under the Employee Retirement Income Security Act of 1974, and we are also subject to shareholder putative class action lawsuits alleging securities law violations. A substantial legal liability or a significant regulatory action (including uncertainty about the outcome of pending legal and regulatory investigations and actions) against us could have a material adverse effect on our business, financial condition and results of operations. Moreover, even if we ultimately prevail in the litigation, regulatory action or investigation, we could suffer significant reputational harm and incur significant legal expenses, which could have a material adverse effect on our business, financial condition or results of operations. At this time, it is not feasible to predict, nor determine, the ultimate outcomes of any pending investigations and legal proceedings, nor to provide reasonable ranges of possible losses other than those that have been disclosed. For a further discussion of certain current investigations and proceedings in which we are involved, see note 25 in “Part II—Item 8—Financial Statements and Supplementary Data.” These investigations and proceedings could have a material adverse effect on our liquidity, business, financial condition or results of operations. It is also possible that we could become subject to further investigations and have lawsuits filed or enforcement actions initiated against us. In addition, increased regulatory scrutiny and any resulting investigations or legal proceedings could result in new legal precedents and industry-wide regulations or practices that could materially adversely affect our business, financial condition and results of operations. An adverse change in the regulatory requirements on our U.S. life insurance subsidiaries, including risk- based capital requirements, could have a material adverse impact on our business, results of operations and financial condition. insurance subsidiaries to meet applicable RBC requirements or minimum statutory capital and surplus requirements could subject our insurance subsidiaries to further examination or corrective action imposed by state insurance regulators, including limitations on their ability to write additional business, or the addition of state regulatory supervision, rehabilitation, seizure or liquidation. As of December 31, 2023, the RBC of each of our U.S. life insurance subsidiaries exceeded the level of RBC that would require any of them to take or become subject to any corrective action in their respective domiciliary state. However, we continue to face challenges in our principal life insurance subsidiaries, particularly those subsidiaries that rely heavily on in-force rate actions as a source of earnings and capital. We may see variability in statutory results and a decline in the RBC ratios of these subsidiaries given the time lag between the approval of in-force rate actions versus when the benefits from the in-force rate actions (including increased premiums and associated benefit reductions) are fully realized in our financial results. Additionally, the RBC ratio of our U.S. life insurance subsidiaries would be negatively impacted by future increases in our statutory reserves, including results of Actuarial Guideline 38, cash flow testing and assumption reviews, particularly in our long-term care and life insurance products. An adverse change in our U.S. life insurance subsidiaries’ RBC or our ability to meet other minimum regulatory requirements could cause rating agencies to downgrade the financial strength ratings of our insurance subsidiaries and the credit ratings of Genworth Holdings, which could have an adverse impact on our ability to execute our strategic priorities, including stabilizing the legacy long-term care insurance in-force block and advancing CareScout’s new lines of business or new products and services, and would further restrict our ability to retain and write new business. Furthermore, it may cause regulators to take regulatory or supervisory actions with respect to our U.S. life insurance subsidiaries, thereby limiting the financial flexibility of our holding company, all of which could have a material adverse effect on our results of operations, financial condition and business. Changes to the role of the GSEs or to the charters or business practices of the GSEs, including actions or decisions to decrease or discontinue the use of mortgage insurance, could adversely affect our business, financial condition and results of operations. The requirements and practices of the GSEs impact the operating results and financial performance of approved mortgage insurers, including Enact Holdings. Changes in the charters or business practices of Freddie Mac or Fannie Mae could materially reduce the number of mortgages they purchase that are insured by Enact Holdings and consequently diminish the value of our business. The GSEs could be directed to make such changes by the FHFA, which was appointed as their conservator in September 2008 and has the authority to control and direct the operations of the GSEs. Congress may legislate, or the administration may implement through administrative reform, structural and other changes to the GSEs and the functioning of the secondary mortgage market. In the absence of legislation, the FHFA continues to move forward on administrative reform efforts to prepare the GSEs for the end of conservatorship, once fully and adequately capitalized. Effective February 16, 2021, the FHFA enacted the Enterprise Capital Framework, which imposes a capital framework on the GSEs, including risk-based and leverage capital requirements and capital buffers in excess of regulatory minimums that can be drawn down in periods of financial stress. However, the GSEs will not be subject to any requirement under the Enterprise Capital Framework until (i) the date of termination of the conservatorship of a GSE or (ii) any later compliance date provided in a consent order or other transition order applicable to such GSE. The Enterprise Capital Framework significantly increases capital requirements and reduces capital credit on credit risk transfer transactions as compared to the previous framework. This rule could accelerate the recent diversification of the GSEs’ risk transfer programs to encompass a broader array of instruments beyond private mortgage insurance, which could adversely impact Enact Holdings and our business. Likewise, legislation or regulation that changes the role of the GSEs, ends the GSEs’ conservatorship or increases the number of people eligible for FHA or VA mortgages could have a material adverse effect on Enact Holdings and limit its ability to compete with the FHA or VA thereby adversely impacting our business. Our U.S. life insurance subsidiaries are subject to the NAIC’s RBC standards and other minimum statutory capital and surplus requirements imposed under the laws of their respective states of domicile. The failure of our On January 14, 2021, the FHFA and the Treasury Department agreed to amend the PSPAs between the Treasury Department and each of the GSEs to increase the amount of capital each GSE may retain. Among other 50 51 things, the amendments to the PSPAs limit the number of certain mortgages the GSEs may acquire with two or more prescribed risk factors, including certain mortgages with combined loan-to-value ratios above 90%. However, on September 14, 2021, the FHFA and Treasury Department suspended certain provisions of the amendments to the PSPAs, including the limit on the number of mortgages with two or more risk factors that the GSEs may acquire. Such suspensions end six months after the Treasury Department notifies the GSEs of termination. The limit on the number of mortgages with two or more risk factors was based on the market size at the time. While Enact Holdings does not expect any material impact to the private mortgage market, changes in the provisions or enforcement of this rule could impact our results of operations. The adoption of any GSE reform, whether through legislation or administrative action, could impact the current role of private mortgage insurance as a credit enhancement, including its reduction or elimination, which would have an adverse effect on our business, revenue, results of operations and financial condition. As a result, it is uncertain what role private capital, including mortgage insurance, will play in the U.S. residential housing finance system in the future or the impact any such changes could have on our business. Passage and timing of any comprehensive GSE reform or incremental change (legislative or administrative) is uncertain, making the actual impact on Enact Holdings and the private mortgage insurance industry difficult to predict. Any such changes that occur could have a significant impact on our business, results of operations and financial condition. The FHFA has set goals for the GSEs to transfer significant portions of the GSEs’ mortgage credit risk to the private sector. This mandate builds upon the goal established by the GSEs to increase the role of private capital through experimenting with different forms of transactions and structures. Enact Holdings participates in credit risk transfer programs developed by Fannie Mae and Freddie Mac. The GSEs have in the past piloted and may in the future attempt to launch alternative products or transactions. To the extent these credit risk products evolve in a manner that displaces primary mortgage insurance coverage, the amount of insurance Enact Holdings writes may be reduced. It is difficult to predict the impact of alternative credit risk transfer products that are developed to meet the goals established by the FHFA. Fannie Mae and Freddie Mac also possess substantial market power, which enables them to influence Enact Holdings and the mortgage insurance industry in general. Although Enact Holdings actively monitors and develops its relationship with Fannie Mae and Freddie Mac, a deterioration in any of these relationships, or the loss of business or opportunities for new business, could have a material adverse effect on our business, financial condition and results of operations. If Enact is unable to continue to meet the requirements mandated by PMIERs because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition. In furtherance of Fannie Mae and Freddie Mac’s respective charter requirements, each GSE adopted PMIERs effective December 31, 2015. The GSEs have in the past and may in the future amend or waive PMIERs at their discretion or impose additional conditions or restrictions, and the GSEs have broad discretion to interpret PMIERs, any of which could impact the calculation of Available Assets and/or Minimum Required Assets or require an increase in assets held to remain compliant. For a discussion of PMIERs requirements and recent amendments to PMIERs, see “Regulation—Enact—Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.” The amount of capital that may be required in the future to maintain the Minimum Required Assets, as defined in PMIERs, is dependent upon, among other things: (i) the way PMIERs are applied and interpreted by the GSEs and the FHFA; (ii) the future performance of the U.S. housing market; (iii) Enact Holdings’ generation of earnings, available assets and risk-based required assets, reducing risk in-force and reducing delinquencies as anticipated, and writing anticipated amounts and types of new mortgage insurance business; and (iv) Enact Holdings’ overall financial performance, capital and liquidity levels. Depending on actual experience, the amount of capital required under PMIERs for Enact Holdings’ subsidiaries may be higher than currently anticipated. In the absence of a premium increase on new business, if Enact Holdings’ subsidiaries hold more capital relative to their insured loans, their returns will be lower. Enact Holdings may be unable to increase premium rates on new business for various reasons, principally due to competition. Enact Holdings’ inability to increase its capital as required in the anticipated timeframes and on anticipated terms, and realize the anticipated benefits, could have a material adverse impact on our business, results of operations and financial condition. More specifically, Enact Holdings’ subsidiaries’ ability to continue to meet the PMIERs financial requirements and maintain a prudent amount of capital in excess of those requirements, given the dynamic nature of asset valuations and requirement changes over time, is dependent upon, among other things: (i) Enact Holdings’ ability to complete credit risk transfer transactions on its anticipated terms and timetable, which as applicable, are subject to market conditions, third-party approvals and other actions (including approval by regulators and the GSEs), and other factors that are outside its control; and (ii) Enact Holdings’ ability to contribute its holding company cash or other sources of capital to satisfy the portion of the financial requirements that are not satisfied through credit risk transfer transactions. In addition, another potential capital source includes, but is not limited to, the issuance of securities by Genworth Financial, Genworth Holdings or Enact Holdings, which could materially adversely impact our business, shareholders and debtholders. Enact Holdings’ assessment of PMIERs compliance is based on a number of factors, including its understanding of the GSEs’ interpretation of the PMIERs financial requirements. Although we believe Enact Holdings has sufficient capital as required under PMIERs and it remains an approved insurer, it is possible these conditions may not continue. In addition, Enact Holdings may not continue to meet the conditions contained in the GSE letters granting PMIERs credit for reinsurance and other credit risk transfer transactions including, but not limited to, its ability to remain below a statutory risk-to-capital ratio of 18:1. The GSEs also reserve the right to re-evaluate the credit for reinsurance and other credit risk transfer transactions available under PMIERs. If Enact is unable to continue to meet the requirements mandated by PMIERs or the GSEs, whether because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition. Additionally, compliance with PMIERs requires Enact Holdings to seek the GSEs’ prior approval before taking many actions, including implementing certain new products or services or entering into intercompany agreements among others. PMIERs’ approval requirements could prohibit, materially modify or delay Enact Holdings’ intended course of action. Further, the GSEs may modify or change their interpretation of terms they require Enact Holdings to include in its mortgage insurance coverage for loans purchased by the GSEs, requiring Enact Holdings to modify its terms of coverage or operational procedures to remain an approved insurer, and such changes could have a material adverse impact on our financial position and operating results. It is possible the GSEs could, at their own discretion, require additional limitations and/or conditions on Enact Holdings’ activities and practices that are not currently in PMIERs in order for Enact Holdings to remain an approved insurer. Additional requirements or conditions imposed by the GSEs could limit Enact Holdings’ operating flexibility and the areas in which it may write new business. Any of these events would have a material adverse effect on our business, results of operations and financial condition. Enact Holdings’ U.S. mortgage insurance subsidiaries are subject to minimum statutory capital requirements, which if not met or waived, would result in restrictions or prohibitions on them doing business and could have a material adverse impact on our business, financial condition and results of operations. In addition to PMIERs, mortgage insurers are required by certain states and other regulators to maintain a minimum amount of statutory capital relative to their level of risk in-force. While formulations of minimum capital vary in certain states, the most common measure applied allows for a maximum permitted risk-to-capital ratio of 25:1. If one of Enact Holdings’ U.S. mortgage insurance subsidiaries that is writing business in a particular state fails to maintain that state’s required minimum capital level, it would generally be required to 52 53 things, the amendments to the PSPAs limit the number of certain mortgages the GSEs may acquire with two or more prescribed risk factors, including certain mortgages with combined loan-to-value ratios above 90%. However, on September 14, 2021, the FHFA and Treasury Department suspended certain provisions of the amendments to the PSPAs, including the limit on the number of mortgages with two or more risk factors that the GSEs may acquire. Such suspensions end six months after the Treasury Department notifies the GSEs of termination. The limit on the number of mortgages with two or more risk factors was based on the market size at the time. While Enact Holdings does not expect any material impact to the private mortgage market, changes in the provisions or enforcement of this rule could impact our results of operations. The adoption of any GSE reform, whether through legislation or administrative action, could impact the current role of private mortgage insurance as a credit enhancement, including its reduction or elimination, which would have an adverse effect on our business, revenue, results of operations and financial condition. As a result, it is uncertain what role private capital, including mortgage insurance, will play in the U.S. residential housing finance system in the future or the impact any such changes could have on our business. Passage and timing of any comprehensive GSE reform or incremental change (legislative or administrative) is uncertain, making the actual impact on Enact Holdings and the private mortgage insurance industry difficult to predict. Any such changes that occur could have a significant impact on our business, results of operations and financial condition. The FHFA has set goals for the GSEs to transfer significant portions of the GSEs’ mortgage credit risk to the private sector. This mandate builds upon the goal established by the GSEs to increase the role of private capital through experimenting with different forms of transactions and structures. Enact Holdings participates in credit risk transfer programs developed by Fannie Mae and Freddie Mac. The GSEs have in the past piloted and may in the future attempt to launch alternative products or transactions. To the extent these credit risk products evolve in a manner that displaces primary mortgage insurance coverage, the amount of insurance Enact Holdings writes may be reduced. It is difficult to predict the impact of alternative credit risk transfer products that are developed to meet the goals established by the FHFA. Fannie Mae and Freddie Mac also possess substantial market power, which enables them to influence Enact Holdings and the mortgage insurance industry in general. Although Enact Holdings actively monitors and develops its relationship with Fannie Mae and Freddie Mac, a deterioration in any of these relationships, or the loss of business or opportunities for new business, could have a material adverse effect on our business, financial condition and results of operations. If Enact is unable to continue to meet the requirements mandated by PMIERs because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition. In furtherance of Fannie Mae and Freddie Mac’s respective charter requirements, each GSE adopted PMIERs effective December 31, 2015. The GSEs have in the past and may in the future amend or waive PMIERs at their discretion or impose additional conditions or restrictions, and the GSEs have broad discretion to interpret PMIERs, any of which could impact the calculation of Available Assets and/or Minimum Required Assets or require an increase in assets held to remain compliant. For a discussion of PMIERs requirements and recent amendments to PMIERs, see “Regulation—Enact—Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.” The amount of capital that may be required in the future to maintain the Minimum Required Assets, as defined in PMIERs, is dependent upon, among other things: (i) the way PMIERs are applied and interpreted by the GSEs and the FHFA; (ii) the future performance of the U.S. housing market; (iii) Enact Holdings’ generation of earnings, available assets and risk-based required assets, reducing risk in-force and reducing delinquencies as anticipated, and writing anticipated amounts and types of new mortgage insurance business; and (iv) Enact Holdings’ overall financial performance, capital and liquidity levels. Depending on actual experience, the amount of capital required under PMIERs for Enact Holdings’ subsidiaries may be higher than currently anticipated. In the absence of a premium increase on new business, if Enact Holdings’ subsidiaries hold more capital relative to their insured loans, their returns will be lower. Enact Holdings may be unable to increase premium rates on new business for various reasons, principally due to competition. Enact Holdings’ inability to increase its capital as required in the anticipated timeframes and on anticipated terms, and realize the anticipated benefits, could have a material adverse impact on our business, results of operations and financial condition. More specifically, Enact Holdings’ subsidiaries’ ability to continue to meet the PMIERs financial requirements and maintain a prudent amount of capital in excess of those requirements, given the dynamic nature of asset valuations and requirement changes over time, is dependent upon, among other things: (i) Enact Holdings’ ability to complete credit risk transfer transactions on its anticipated terms and timetable, which as applicable, are subject to market conditions, third-party approvals and other actions (including approval by regulators and the GSEs), and other factors that are outside its control; and (ii) Enact Holdings’ ability to contribute its holding company cash or other sources of capital to satisfy the portion of the financial requirements that are not satisfied through credit risk transfer transactions. In addition, another potential capital source includes, but is not limited to, the issuance of securities by Genworth Financial, Genworth Holdings or Enact Holdings, which could materially adversely impact our business, shareholders and debtholders. Enact Holdings’ assessment of PMIERs compliance is based on a number of factors, including its understanding of the GSEs’ interpretation of the PMIERs financial requirements. Although we believe Enact Holdings has sufficient capital as required under PMIERs and it remains an approved insurer, it is possible these conditions may not continue. In addition, Enact Holdings may not continue to meet the conditions contained in the GSE letters granting PMIERs credit for reinsurance and other credit risk transfer transactions including, but not limited to, its ability to remain below a statutory risk-to-capital ratio of 18:1. The GSEs also reserve the right to re-evaluate the credit for reinsurance and other credit risk transfer transactions available under PMIERs. If Enact is unable to continue to meet the requirements mandated by PMIERs or the GSEs, whether because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition. Additionally, compliance with PMIERs requires Enact Holdings to seek the GSEs’ prior approval before taking many actions, including implementing certain new products or services or entering into intercompany agreements among others. PMIERs’ approval requirements could prohibit, materially modify or delay Enact Holdings’ intended course of action. Further, the GSEs may modify or change their interpretation of terms they require Enact Holdings to include in its mortgage insurance coverage for loans purchased by the GSEs, requiring Enact Holdings to modify its terms of coverage or operational procedures to remain an approved insurer, and such changes could have a material adverse impact on our financial position and operating results. It is possible the GSEs could, at their own discretion, require additional limitations and/or conditions on Enact Holdings’ activities and practices that are not currently in PMIERs in order for Enact Holdings to remain an approved insurer. Additional requirements or conditions imposed by the GSEs could limit Enact Holdings’ operating flexibility and the areas in which it may write new business. Any of these events would have a material adverse effect on our business, results of operations and financial condition. Enact Holdings’ U.S. mortgage insurance subsidiaries are subject to minimum statutory capital requirements, which if not met or waived, would result in restrictions or prohibitions on them doing business and could have a material adverse impact on our business, financial condition and results of operations. In addition to PMIERs, mortgage insurers are required by certain states and other regulators to maintain a minimum amount of statutory capital relative to their level of risk in-force. While formulations of minimum capital vary in certain states, the most common measure applied allows for a maximum permitted risk-to-capital ratio of 25:1. If one of Enact Holdings’ U.S. mortgage insurance subsidiaries that is writing business in a particular state fails to maintain that state’s required minimum capital level, it would generally be required to 52 53 immediately stop writing new business in the state until the insurer re-establishes the required level of capital or receives a waiver of the requirement from the state’s insurance regulator, or until it establishes an alternative source of underwriting capacity acceptable to the regulator. If Enact Holdings’ insurance subsidiaries exceed required risk-to-capital levels in the future, Enact Holdings and Genworth Financial would seek required regulatory and GSE forbearance and approvals or seek approval for the utilization of alternative insurance vehicles. However, such forbearance and approvals may not be obtained or may be obtained on unfavorable terms. In August 2023, the NAIC adopted amendments to the MGI Model Act and is in the process of making corresponding revisions to the Statement of Statutory Accounting Principles No. 58—Mortgage Guaranty Insurance. The revisions to the MGI Model Act are extensive, including with respect to risk concentration limits, capital and reserve requirements, reinsurance, underwriting practices and quality assurance. At this time, we cannot predict which states, if any, will adopt the amended MGI Model Act or any of its specific provisions, the effect changes will have on the mortgage guaranty insurance market generally, or on our business specifically, the additional costs associated with compliance with any such changes, or any changes to our operations that may be necessary to comply, any of which could have a material adverse effect on our business, results of operations and financial condition. We also cannot predict whether other regulatory initiatives will be adopted or what impact, if any, such initiatives, if adopted as laws, may have on our business, results of operations and financial condition. Changes in regulations that adversely affect the mortgage insurance markets in which Enact Holdings operates could affect its operations significantly and could reduce the demand for mortgage insurance. In addition to the general regulatory risks that are described under “—Our insurance businesses are extensively regulated and changes in regulation may reduce our profitability and limit our growth,” we are also affected, through our ownership of Enact Holdings, by various additional regulations related specifically to mortgage insurance operations. Federal and state regulations affect the scope of competitor operations, which influences the size of the mortgage insurance market and the intensity of the competition. This competition includes not only other private mortgage insurers, but also U.S. federal and state governmental and quasi-governmental agencies, principally the FHA and the VA, which are governed by federal regulations. Increases in the maximum loan amount that the FHA can insure, and reductions in the mortgage insurance premiums the FHA charges, such as the reduction implemented in 2023, can reduce the demand for private mortgage insurance. Decreases in the maximum loan amounts or maximum loan-to-value ratio of loans the GSEs will purchase or guarantee or increases in GSE fees can also reduce demand for private mortgage insurance. Legislative, regulatory or administrative changes could cause demand for private mortgage insurance to decrease. Enact Holdings and its U.S. mortgage insurance subsidiaries, as credit enhancement providers in the residential mortgage lending industry, are also subject to compliance with various federal and state consumer protection and insurance laws, including RESPA, the ECOA, the Fair Housing Act, the Dodd-Frank Act (including the adoption of the QM Rule), HOPA, the FCRA and the Fair Debt Collection Practices Act, among others. These laws prohibit payments for referrals of settlement service business, providing services to lenders for no or reduced fees, or payments for services not actually performed; require cancellation of insurance and refund of unearned premiums under certain circumstances; and govern the circumstances under which companies may obtain and use consumer credit information. Changes in these laws or regulations, changes in the appropriate regulator’s interpretation of these laws or regulations or heightened enforcement activity could materially adversely affect the operations and profitability of Enact Holdings. Basel Framework Following the financial crisis of 2008, the Basel Committee on Banking Supervision issued Basel III that established RBC and leverage capital requirements for most U.S. banking organizations (although banking organizations with less than $10.0 billion in total assets may now choose to comply with an alternative community bank leverage ratio framework established by the Federal Banking Agencies in 2019). In 2013, the U.S. federal banking regulators confirmed the role of mortgage insurance as a component of prudential bank regulation for high loan-to-value mortgages. More recently, in July 2023, the U.S. Federal Reserve, the Federal Deposit Insurance Corporation and the Office of the Comptroller of the Currency proposed for comment the Basel III Endgame rule. Under the proposed rule, commercial banks with total assets greater than $100.0 billion would no longer receive the 50% capital relief for high loan-to-value portfolio loans with mortgage insurance. If adopted as proposed, this rule could decrease the demand for mortgage insurance. The federal banking regulators are currently in the review process and it remains unclear whether there will be changes to the final rule ahead of its planned implementation in 2025. Our U.S. life insurance subsidiaries may not be able to continue to mitigate the impact of Regulations XXX or AXXX and, therefore, they may incur higher operating costs that could have a material adverse effect on our business, financial condition and results of operations. We have increased term and universal life insurance statutory reserves in response to Regulations XXX and AXXX and have taken steps to mitigate the impact these regulations have had on our business, including increasing premium rates and implementing reserve funding structures. One way that we and other insurance companies have mitigated the impact of these regulations is through captive reinsurance companies. If we were to discontinue our use of captive life reinsurance subsidiaries to finance statutory reserves in response to regulatory changes on a prospective basis, the reasonably likely impact would be increased costs related to alternative financing, such as third-party reinsurance, which would adversely impact our consolidated results of operations and financial condition. In addition, we cannot be certain that affordable alternative financing would be available. While we are no longer writing new life insurance business, we may not be able to continue to implement actions to mitigate the impacts of Regulations XXX or AXXX on our in-force term and universal life insurance products which are not currently part of reserve funding structures, or which may be part of existing reserve arrangements and need refinancing. Additionally, there may be future regulatory, tax or other impacts to existing reserve funding structures and/ or future refinancing, which could require us to increase statutory reserves or incur higher operating and/or tax costs. Operational Risks If we are unable to retain, attract and motivate qualified employees or senior management, our results of operations, financial condition and business operations may be adversely impacted. Our success is largely dependent on our ability to retain, attract and motivate qualified employees and senior management. We face intense competition in our industry for key employees with demonstrated ability, including actuarial, finance, legal, investment, risk, compliance and other professional skills. Our ability to retain, attract and motivate experienced and qualified employees and senior management has been more challenging in light of our previous financial difficulties, announcements concerning expense reductions and from the demands being placed on our employees, as well as recruitment challenges due to the ongoing labor shortage and low labor participation rate. In addition, our ability to attract, recruit, retain and motivate current and prospective employees may be adversely impacted due to uncertainty and/or the Company changing its strategic direction. Furthermore, should work arrangements, such as remote work environments, become more flexible and commonplace, our ability to compete for qualified employees could be further challenged. A remote work environment has expanded competition among employers, which has likely exacerbated the battle for talent in an already tight labor market. We cannot be sure we will be able to attract, retain and motivate the desired 54 55 immediately stop writing new business in the state until the insurer re-establishes the required level of capital or receives a waiver of the requirement from the state’s insurance regulator, or until it establishes an alternative source of underwriting capacity acceptable to the regulator. If Enact Holdings’ insurance subsidiaries exceed required risk-to-capital levels in the future, Enact Holdings and Genworth Financial would seek required regulatory and GSE forbearance and approvals or seek approval for the utilization of alternative insurance vehicles. However, such forbearance and approvals may not be obtained or may be obtained on unfavorable terms. In August 2023, the NAIC adopted amendments to the MGI Model Act and is in the process of making corresponding revisions to the Statement of Statutory Accounting Principles No. 58—Mortgage Guaranty Insurance. The revisions to the MGI Model Act are extensive, including with respect to risk concentration limits, capital and reserve requirements, reinsurance, underwriting practices and quality assurance. At this time, we cannot predict which states, if any, will adopt the amended MGI Model Act or any of its specific provisions, the effect changes will have on the mortgage guaranty insurance market generally, or on our business specifically, the additional costs associated with compliance with any such changes, or any changes to our operations that may be necessary to comply, any of which could have a material adverse effect on our business, results of operations and financial condition. We also cannot predict whether other regulatory initiatives will be adopted or what impact, if any, such initiatives, if adopted as laws, may have on our business, results of operations and financial condition. Changes in regulations that adversely affect the mortgage insurance markets in which Enact Holdings operates could affect its operations significantly and could reduce the demand for mortgage insurance. In addition to the general regulatory risks that are described under “—Our insurance businesses are extensively regulated and changes in regulation may reduce our profitability and limit our growth,” we are also affected, through our ownership of Enact Holdings, by various additional regulations related specifically to mortgage insurance operations. Federal and state regulations affect the scope of competitor operations, which influences the size of the mortgage insurance market and the intensity of the competition. This competition includes not only other private mortgage insurers, but also U.S. federal and state governmental and quasi-governmental agencies, principally the FHA and the VA, which are governed by federal regulations. Increases in the maximum loan amount that the FHA can insure, and reductions in the mortgage insurance premiums the FHA charges, such as the reduction implemented in 2023, can reduce the demand for private mortgage insurance. Decreases in the maximum loan amounts or maximum loan-to-value ratio of loans the GSEs will purchase or guarantee or increases in GSE fees can also reduce demand for private mortgage insurance. Legislative, regulatory or administrative changes could cause demand for private mortgage insurance to decrease. Enact Holdings and its U.S. mortgage insurance subsidiaries, as credit enhancement providers in the residential mortgage lending industry, are also subject to compliance with various federal and state consumer protection and insurance laws, including RESPA, the ECOA, the Fair Housing Act, the Dodd-Frank Act (including the adoption of the QM Rule), HOPA, the FCRA and the Fair Debt Collection Practices Act, among others. These laws prohibit payments for referrals of settlement service business, providing services to lenders for no or reduced fees, or payments for services not actually performed; require cancellation of insurance and refund of unearned premiums under certain circumstances; and govern the circumstances under which companies may obtain and use consumer credit information. Changes in these laws or regulations, changes in the appropriate regulator’s interpretation of these laws or regulations or heightened enforcement activity could materially adversely affect the operations and profitability of Enact Holdings. Basel Framework Following the financial crisis of 2008, the Basel Committee on Banking Supervision issued Basel III that established RBC and leverage capital requirements for most U.S. banking organizations (although banking organizations with less than $10.0 billion in total assets may now choose to comply with an alternative community bank leverage ratio framework established by the Federal Banking Agencies in 2019). In 2013, the U.S. federal banking regulators confirmed the role of mortgage insurance as a component of prudential bank regulation for high loan-to-value mortgages. More recently, in July 2023, the U.S. Federal Reserve, the Federal Deposit Insurance Corporation and the Office of the Comptroller of the Currency proposed for comment the Basel III Endgame rule. Under the proposed rule, commercial banks with total assets greater than $100.0 billion would no longer receive the 50% capital relief for high loan-to-value portfolio loans with mortgage insurance. If adopted as proposed, this rule could decrease the demand for mortgage insurance. The federal banking regulators are currently in the review process and it remains unclear whether there will be changes to the final rule ahead of its planned implementation in 2025. Our U.S. life insurance subsidiaries may not be able to continue to mitigate the impact of Regulations XXX or AXXX and, therefore, they may incur higher operating costs that could have a material adverse effect on our business, financial condition and results of operations. We have increased term and universal life insurance statutory reserves in response to Regulations XXX and AXXX and have taken steps to mitigate the impact these regulations have had on our business, including increasing premium rates and implementing reserve funding structures. One way that we and other insurance companies have mitigated the impact of these regulations is through captive reinsurance companies. If we were to discontinue our use of captive life reinsurance subsidiaries to finance statutory reserves in response to regulatory changes on a prospective basis, the reasonably likely impact would be increased costs related to alternative financing, such as third-party reinsurance, which would adversely impact our consolidated results of operations and financial condition. In addition, we cannot be certain that affordable alternative financing would be available. While we are no longer writing new life insurance business, we may not be able to continue to implement actions to mitigate the impacts of Regulations XXX or AXXX on our in-force term and universal life insurance products which are not currently part of reserve funding structures, or which may be part of existing reserve arrangements and need refinancing. Additionally, there may be future regulatory, tax or other impacts to existing reserve funding structures and/ or future refinancing, which could require us to increase statutory reserves or incur higher operating and/or tax costs. Operational Risks If we are unable to retain, attract and motivate qualified employees or senior management, our results of operations, financial condition and business operations may be adversely impacted. Our success is largely dependent on our ability to retain, attract and motivate qualified employees and senior management. We face intense competition in our industry for key employees with demonstrated ability, including actuarial, finance, legal, investment, risk, compliance and other professional skills. Our ability to retain, attract and motivate experienced and qualified employees and senior management has been more challenging in light of our previous financial difficulties, announcements concerning expense reductions and from the demands being placed on our employees, as well as recruitment challenges due to the ongoing labor shortage and low labor participation rate. In addition, our ability to attract, recruit, retain and motivate current and prospective employees may be adversely impacted due to uncertainty and/or the Company changing its strategic direction. Furthermore, should work arrangements, such as remote work environments, become more flexible and commonplace, our ability to compete for qualified employees could be further challenged. A remote work environment has expanded competition among employers, which has likely exacerbated the battle for talent in an already tight labor market. We cannot be sure we will be able to attract, retain and motivate the desired 54 55 workforce, and our failure to do so could have a material adverse effect on our results of operations, financial condition and business operations. In addition, we may not be able to meet regulatory requirements relating to required expertise in various professional positions. Managing key employee succession and retention is also critical to our success. We would be adversely affected if we fail to adequately plan for the succession of our senior management and other key employees. While we have succession plans and long-term compensation plans, including retention programs, designed to retain our employees, our succession plans may not operate effectively, and our compensation plans cannot guarantee that the services of these employees will continue to be available to us. Enact Holdings’ reliance on key customers or distribution relationships could cause a loss of significant sales if one or more of those relationships terminate or are reduced. Our businesses depend on our relationships with our customers, and in particular, our relationships with our largest lending customers in Enact Holdings. Customers place private mortgage insurance provided by Enact Holdings directly on loans that they originate and indirectly through purchases of loans that already have mortgage insurance coverage provided by Enact Holdings. Customer relationships may influence the amount of business written with Enact Holdings and the customers’ willingness to continue to approve Enact Holdings as a mortgage insurance provider for loans that they purchase. In 2023, Enact Holdings’ largest customer accounted for 19% of its total new insurance written and 10% of its total revenues. Its top five customers generated 33% of its new insurance written in 2023. An inability to maintain a relationship with one or more of these customers could have an adverse effect on the amount of new business Enact Holdings is able to write and consequently, our financial condition and results of operations. Enact Holdings’ ability to maintain business relationships and business volumes with its largest lending customers remains critical to the success of our business. In addition, customer concentration may adversely affect our financial condition if a significant customer chooses to increase its use of other mortgage insurers, merges with a competitor or exits the mortgage finance business, chooses alternatives to mortgage insurance or experiences a decrease in its business. We cannot be certain that any loss of business from significant customers, or any single lender, would be replaced by other customers, existing or new. As a result of current market conditions and increased regulatory requirements, Enact Holdings’ lending customers may decide to write business only with a limited number of mortgage insurers or only with certain mortgage insurers based on their views of an insurer’s pricing, service levels, underwriting guidelines, loss mitigation practices, financial strength, ratings, mechanisms of credit enhancements or other factors. Our businesses could be adversely impacted from deficiencies in our disclosure controls and procedures or internal control over financial reporting. The design and effectiveness of our disclosure controls and procedures and internal control over financial reporting, including incremental controls added to implement LDTI, may not prevent all errors, misstatements or misrepresentations. While management continually reviews the effectiveness of our disclosure controls and procedures and internal control over financial reporting, there can be no guarantee that our internal control over financial reporting will be effective in accomplishing all control objectives all of the time. Any material weaknesses in internal control over financial reporting, such as those we have reported in the past, or any other failure to maintain effective disclosure controls and procedures could result in material errors or restatements in our historical financial statements or untimely filings, which could cause investors to lose confidence in our reported financial information, that would result in a material adverse impact on our business and financial condition. Our computer systems and those of our third-party service providers have in the past and may in the future fail or be compromised, including through cybersecurity breaches; we may experience issues from new and complex information technology methodologies such as artificial intelligence; and unanticipated problems could materially adversely impact our disaster recovery systems and business continuity plans, any of which could damage our reputation, impair our ability to conduct business effectively, result in enforcement action or litigation, and materially adversely affect our business, financial condition and results of operations. Our business is highly dependent upon the effective operation of our computer systems. We also have arrangements in place with our partners and other third-party service providers through which we share and receive information. We rely on these systems throughout our business for a variety of functions, including processing claims and applications, providing information to customers and distributors, performing actuarial analyses and maintaining financial records. We have implemented and maintain what we believe to be reasonable security controls and back-up measures, but despite this, our computer systems and those of our partners and third-party service providers have been, and may be in the future, vulnerable to physical or electronic intrusions, computer malware, malicious code or other attacks, system failures, programming errors, employee and third- party errors or wrongdoing, and similar disruption or adverse outcomes. The failure of these systems for any reason could cause significant interruptions to our operations, which could result in a material adverse effect on our business, financial condition or results of operations. Technology continues to expand and plays an ever-increasing role in our business. While it is our goal to safeguard information assets from physical theft and cybersecurity threats, our information security measures may not detect, and protect information assets from, or fully mitigate, these ever-increasing risks. Information assets include both information itself in the form of computer data, written materials, knowledge and supporting processes, and the information technology systems, networks, other electronic devices and storage media used to store, process, retrieve and transmit that information. As more information is used and shared by our employees, customers and suppliers, both within and outside our company, cybersecurity threats become expansive in nature. Additionally, cybersecurity threats have continued to grow in sophistication, in part through the deployment of artificial intelligence technologies. The confidentiality, integrity, security and availability of information are essential to maintaining our reputation and ability to conduct our operations. Although we have implemented controls and continue to train our employees, a cybersecurity event could still occur which would cause damage to our reputation with our customers, distributors and other stakeholders, could have a material adverse effect on our business, financial condition or results of operations, or expose us to litigation or other enforcement actions. For example, during the second quarter of 2023, we were notified by PBI Research Services (“PBI”), a third-party vendor, that PBI was subject to the widely reported security events involving the MOVEit file transfer system, which PBI uses in the performance of its services (the “MOVEit Cybersecurity Incident”). The MOVEit Cybersecurity Incident resulted in the unauthorized acquisition of data by a third party from PBI as well as several organizations and governmental agencies. After being notified of the security event, we, together with PBI, promptly launched an investigation to determine to whether and to what extent personal information had been unlawfully accessed. Approximately 2.5 to 2.7 million of our policyholders’ or other customers’ personal information, including social security numbers, was exposed to and obtained by the threat actor as a result of the MOVEit Cybersecurity Incident. We do not currently believe this incident will have a material adverse effect on our business, results of operations or financial condition. However, there could be a material adverse effect in the future, especially if the amount of insurance coverage we maintain is not sufficient to cover claims or liabilities relating to this or a future incident. We retain confidential information in our computer systems, and we rely on commercial technologies to maintain the security of those systems, including computers or mobile devices. Anyone who is able to circumvent our security measures and penetrate our computer systems or misuse authorized access could access, view, misappropriate, alter, delete or disclose any information in the systems, including personal information, personal health information and proprietary business information. Our employees, distribution partners and other vendors use portable computers or mobile devices which may contain similar information to that in our computer 56 57 workforce, and our failure to do so could have a material adverse effect on our results of operations, financial condition and business operations. In addition, we may not be able to meet regulatory requirements relating to required expertise in various professional positions. Managing key employee succession and retention is also critical to our success. We would be adversely affected if we fail to adequately plan for the succession of our senior management and other key employees. While we have succession plans and long-term compensation plans, including retention programs, designed to retain our employees, our succession plans may not operate effectively, and our compensation plans cannot guarantee that the services of these employees will continue to be available to us. Enact Holdings’ reliance on key customers or distribution relationships could cause a loss of significant sales if one or more of those relationships terminate or are reduced. Our businesses depend on our relationships with our customers, and in particular, our relationships with our largest lending customers in Enact Holdings. Customers place private mortgage insurance provided by Enact Holdings directly on loans that they originate and indirectly through purchases of loans that already have mortgage insurance coverage provided by Enact Holdings. Customer relationships may influence the amount of business written with Enact Holdings and the customers’ willingness to continue to approve Enact Holdings as a mortgage insurance provider for loans that they purchase. In 2023, Enact Holdings’ largest customer accounted for 19% of its total new insurance written and 10% of its total revenues. Its top five customers generated 33% of its new insurance written in 2023. An inability to maintain a relationship with one or more of these customers could have an adverse effect on the amount of new business Enact Holdings is able to write and consequently, our financial condition and results of operations. Enact Holdings’ ability to maintain business relationships and business volumes with its largest lending customers remains critical to the success of our business. In addition, customer concentration may adversely affect our financial condition if a significant customer chooses to increase its use of other mortgage insurers, merges with a competitor or exits the mortgage finance business, chooses alternatives to mortgage insurance or experiences a decrease in its business. We cannot be certain that any loss of business from significant customers, or any single lender, would be replaced by other customers, existing or new. As a result of current market conditions and increased regulatory requirements, Enact Holdings’ lending customers may decide to write business only with a limited number of mortgage insurers or only with certain mortgage insurers based on their views of an insurer’s pricing, service levels, underwriting guidelines, loss mitigation practices, financial strength, ratings, mechanisms of credit enhancements or other factors. Our businesses could be adversely impacted from deficiencies in our disclosure controls and procedures or internal control over financial reporting. The design and effectiveness of our disclosure controls and procedures and internal control over financial reporting, including incremental controls added to implement LDTI, may not prevent all errors, misstatements or misrepresentations. While management continually reviews the effectiveness of our disclosure controls and procedures and internal control over financial reporting, there can be no guarantee that our internal control over financial reporting will be effective in accomplishing all control objectives all of the time. Any material weaknesses in internal control over financial reporting, such as those we have reported in the past, or any other failure to maintain effective disclosure controls and procedures could result in material errors or restatements in our historical financial statements or untimely filings, which could cause investors to lose confidence in our reported financial information, that would result in a material adverse impact on our business and financial condition. Our computer systems and those of our third-party service providers have in the past and may in the future fail or be compromised, including through cybersecurity breaches; we may experience issues from new and complex information technology methodologies such as artificial intelligence; and unanticipated problems could materially adversely impact our disaster recovery systems and business continuity plans, any of which could damage our reputation, impair our ability to conduct business effectively, result in enforcement action or litigation, and materially adversely affect our business, financial condition and results of operations. Our business is highly dependent upon the effective operation of our computer systems. We also have arrangements in place with our partners and other third-party service providers through which we share and receive information. We rely on these systems throughout our business for a variety of functions, including processing claims and applications, providing information to customers and distributors, performing actuarial analyses and maintaining financial records. We have implemented and maintain what we believe to be reasonable security controls and back-up measures, but despite this, our computer systems and those of our partners and third-party service providers have been, and may be in the future, vulnerable to physical or electronic intrusions, computer malware, malicious code or other attacks, system failures, programming errors, employee and third- party errors or wrongdoing, and similar disruption or adverse outcomes. The failure of these systems for any reason could cause significant interruptions to our operations, which could result in a material adverse effect on our business, financial condition or results of operations. Technology continues to expand and plays an ever-increasing role in our business. While it is our goal to safeguard information assets from physical theft and cybersecurity threats, our information security measures may not detect, and protect information assets from, or fully mitigate, these ever-increasing risks. Information assets include both information itself in the form of computer data, written materials, knowledge and supporting processes, and the information technology systems, networks, other electronic devices and storage media used to store, process, retrieve and transmit that information. As more information is used and shared by our employees, customers and suppliers, both within and outside our company, cybersecurity threats become expansive in nature. Additionally, cybersecurity threats have continued to grow in sophistication, in part through the deployment of artificial intelligence technologies. The confidentiality, integrity, security and availability of information are essential to maintaining our reputation and ability to conduct our operations. Although we have implemented controls and continue to train our employees, a cybersecurity event could still occur which would cause damage to our reputation with our customers, distributors and other stakeholders, could have a material adverse effect on our business, financial condition or results of operations, or expose us to litigation or other enforcement actions. For example, during the second quarter of 2023, we were notified by PBI Research Services (“PBI”), a third-party vendor, that PBI was subject to the widely reported security events involving the MOVEit file transfer system, which PBI uses in the performance of its services (the “MOVEit Cybersecurity Incident”). The MOVEit Cybersecurity Incident resulted in the unauthorized acquisition of data by a third party from PBI as well as several organizations and governmental agencies. After being notified of the security event, we, together with PBI, promptly launched an investigation to determine to whether and to what extent personal information had been unlawfully accessed. Approximately 2.5 to 2.7 million of our policyholders’ or other customers’ personal information, including social security numbers, was exposed to and obtained by the threat actor as a result of the MOVEit Cybersecurity Incident. We do not currently believe this incident will have a material adverse effect on our business, results of operations or financial condition. However, there could be a material adverse effect in the future, especially if the amount of insurance coverage we maintain is not sufficient to cover claims or liabilities relating to this or a future incident. We retain confidential information in our computer systems, and we rely on commercial technologies to maintain the security of those systems, including computers or mobile devices. Anyone who is able to circumvent our security measures and penetrate our computer systems or misuse authorized access could access, view, misappropriate, alter, delete or disclose any information in the systems, including personal information, personal health information and proprietary business information. Our employees, distribution partners and other vendors use portable computers or mobile devices which may contain similar information to that in our computer 56 57 systems, and these devices have been and can be lost, stolen or damaged, and therefore subject to the same risks as our other computer systems. In addition, an increasing number of states and foreign countries require that affected parties be notified or other actions be taken (which could involve significant costs to us) if a security breach results in the unlawful disclosure of personal information. We have experienced occasional, actual or attempted breaches of our cybersecurity, although to date, none of these breaches has had a material effect on our business, operations or reputation. Any compromise of the security of our computer systems or those of our partners and third-party service providers that results in the unauthorized disclosure of customer personal information, like the one involving PBI and MOVEit discussed above, could damage our reputation in the marketplace, deter people from purchasing our products, subject us to significant civil and criminal liability and require us to incur significant technical, legal and other expenses. Cybersecurity, data privacy and artificial intelligence risks and uncertainties have come under increased scrutiny in recent years, with various countries, government agencies and insurance regulators introducing and/or passing legislation in an attempt to safeguard personal information from escalating cybersecurity threats and other unknown risks and uncertainties. For additional details, see “Regulation—Other Laws and Regulations— Privacy and cybersecurity.” We have implemented internal policies, practices and controls designed to comply with applicable data privacy and security laws. Failure, by us or any third-party on which we rely, to comply with these laws, regulations and rules may result in enforcement action, litigation, monetary fines, or other penalties, which could have a material adverse effect on our business, financial condition, and reputation. For additional details on our cybersecurity risk management, strategy and governance, see “Item 1C—Cybersecurity.” In addition, unanticipated problems with, or failures of, our disaster recovery systems and business continuity plans could have a material adverse impact on our ability to conduct business and on our results of operations and financial condition, particularly if those problems affect our information technology systems and destroy, lose or otherwise compromise the integrity or availability of valuable data. Furthermore, in the event that a significant number of our employees were unavailable in the event of a disaster or a pandemic, our ability to effectively conduct business could be severely compromised. The failure of our disaster recovery systems and business continuity plans could adversely impact our profitability and our business. We rely upon third-party vendors who may be unable or unwilling to meet their obligations to us. We rely on third-party vendors to efficiently execute in-house processes and other outsourcing arrangements, as well as to provide unique or cost-efficient products or services. We rely on the controls and risk management processes of these third parties. While we have certain contractual protections and perform third- party vendor due diligence procedures, it is possible that third-party vendors may not provide accurate and complete information to us, maintain adequate internal controls, meet their obligations on a timely basis and adhere to the provisions of our agreements. If any third-party provider (or such third-party’s supplier, vendor or subcontractor) experiences any deficiency in internal controls, determines that its practices and procedures used in providing services to us (including administering any of our policies) require review, or it otherwise fails to provide services to us in accordance with appropriate standards, we could incur expenses and experience other adverse effects as a result. Additionally, if a third-party vendor is unable to source and maintain a capable workforce or supply us with contractors during times of peak volume, then we may be unable to satisfy our customer obligations and/or regulatory reporting requirements. In addition, some third-party vendors may provide unique services and the loss of those services may be difficult to replace and/or the cost to receive the third-party services may be significant, including conversion costs to establish the appropriate technology infrastructure. Any of the above scenarios could lead to reputational damage and/or an adverse financial impact, including the imposition of penalties or being subject to litigation costs. Insurance and Product-Related Risks Enact Holdings may be unable to maintain or increase capital in its mortgage insurance subsidiaries in a timely manner, on anticipated terms or at all, including through improved business performance, reinsurance or similar transactions, securities offerings or otherwise, in each case as and when required. Enact Holdings may require incremental capital to support its growth, meet regulatory or GSE capital requirements, comply with rating agency criteria to maintain ratings, repay its debt due in 2025, operate and meet unexpected cash flow obligations. Our ability to support the capital needs of Enact Holdings is limited. Accordingly, we are largely reliant on Enact Holdings to support its own capital needs. Furthermore, our current plans do not include any additional minority sales resulting in Genworth owning less than 80% of Enact Holdings, and accordingly, Enact Holdings’ ability to raise additional capital by issuing its stock to third parties is limited. Enact Holdings’ inability to fund or raise the capital required in the anticipated timeframes and on the anticipated terms could cause a reduction in its business levels or subject it to a variety of regulatory actions, which would have a material adverse impact on our business, results of operations and financial condition. Specifically, as Enact Holdings’ outstanding debt matures, Enact Holdings may face challenges in refinancing or extending the debt on favorable terms. Unfavorable market conditions, changes in Enact Holdings’ financial position or changes to its ratings could limit its ability to refinance the debt, potentially impacting our liquidity. In addition, the implementation of any further credit risk transfer transactions or other transactions with third parties to provide additional capital depends on a number of factors, including but not limited to, market conditions, necessary third-party approvals (including approval by regulators and the GSEs) and other factors which are outside Enact Holdings’ control. Therefore, Enact Holdings may not be able to successfully implement these actions on the anticipated timetable and terms, or at all. Even if Enact Holdings is able to successfully implement these actions, it may not be able to achieve the anticipated benefits from the actions. Reinsurance may not be available, affordable or adequate to protect us against losses. As part of our overall risk and capital management strategy, we purchase reinsurance from external reinsurers, use credit risk transfer transactions and provide internal reinsurance support for certain risks underwritten by our various business segments. These reinsurance arrangements and credit risk transfer transactions are intended to enable our businesses to transfer risks in exchange for some of the associated economic benefits and, as a result, improve our statutory capital position, manage risk to within our tolerance level and improve the PMIERs position of Enact Holdings. The availability and cost of reinsurance protection are impacted by our operating and financial performance, including ratings, as well as conditions beyond our control, including changes in regulation. For example, our U.S. life insurance subsidiaries’ low financial strength ratings may reduce the availability of certain types of reinsurance and have made it more costly when it is available, as reinsurers have been less willing to take on credit risk in the volatile market. Accordingly, we may continue to be forced into incurring additional expenses for reinsurance and/or we may not be able to obtain new reinsurance or renew existing reinsurance arrangements on acceptable terms, or at all, which could increase our risk and adversely affect our ability to obtain statutory capital credit for new reinsurance or could require us to make capital contributions to maintain regulatory capital requirements. Moreover, absent the availability and affordability to enter into new credit risk transfer transactions, the ability of Enact Holdings to obtain PMIERs or statutory credit for new transactions would be adversely impacted. See “—If Enact is unable to continue to meet the requirements mandated by PMIERs because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition.” We also manage risk and capital allocated to our long-term care insurance business through utilization of external reinsurance in the form of coinsurance. Our U.S. life insurance subsidiaries have executed external reinsurance agreements to reinsure sales of some of their older blocks of long-term care insurance products (10% of new business issued from 2003 to 2008; 20% to 30% of new business issued from 2009 to 2011; and 40% of 58 59 systems, and these devices have been and can be lost, stolen or damaged, and therefore subject to the same risks as our other computer systems. In addition, an increasing number of states and foreign countries require that affected parties be notified or other actions be taken (which could involve significant costs to us) if a security breach results in the unlawful disclosure of personal information. We have experienced occasional, actual or attempted breaches of our cybersecurity, although to date, none of these breaches has had a material effect on our business, operations or reputation. Any compromise of the security of our computer systems or those of our partners and third-party service providers that results in the unauthorized disclosure of customer personal information, like the one involving PBI and MOVEit discussed above, could damage our reputation in the marketplace, deter people from purchasing our products, subject us to significant civil and criminal liability and require us to incur significant technical, legal and other expenses. Cybersecurity, data privacy and artificial intelligence risks and uncertainties have come under increased scrutiny in recent years, with various countries, government agencies and insurance regulators introducing and/or passing legislation in an attempt to safeguard personal information from escalating cybersecurity threats and other unknown risks and uncertainties. For additional details, see “Regulation—Other Laws and Regulations— Privacy and cybersecurity.” We have implemented internal policies, practices and controls designed to comply with applicable data privacy and security laws. Failure, by us or any third-party on which we rely, to comply with these laws, regulations and rules may result in enforcement action, litigation, monetary fines, or other penalties, which could have a material adverse effect on our business, financial condition, and reputation. For additional details on our cybersecurity risk management, strategy and governance, see “Item 1C—Cybersecurity.” In addition, unanticipated problems with, or failures of, our disaster recovery systems and business continuity plans could have a material adverse impact on our ability to conduct business and on our results of operations and financial condition, particularly if those problems affect our information technology systems and destroy, lose or otherwise compromise the integrity or availability of valuable data. Furthermore, in the event that a significant number of our employees were unavailable in the event of a disaster or a pandemic, our ability to effectively conduct business could be severely compromised. The failure of our disaster recovery systems and business continuity plans could adversely impact our profitability and our business. We rely upon third-party vendors who may be unable or unwilling to meet their obligations to us. We rely on third-party vendors to efficiently execute in-house processes and other outsourcing arrangements, as well as to provide unique or cost-efficient products or services. We rely on the controls and risk management processes of these third parties. While we have certain contractual protections and perform third- party vendor due diligence procedures, it is possible that third-party vendors may not provide accurate and complete information to us, maintain adequate internal controls, meet their obligations on a timely basis and adhere to the provisions of our agreements. If any third-party provider (or such third-party’s supplier, vendor or subcontractor) experiences any deficiency in internal controls, determines that its practices and procedures used in providing services to us (including administering any of our policies) require review, or it otherwise fails to provide services to us in accordance with appropriate standards, we could incur expenses and experience other adverse effects as a result. Additionally, if a third-party vendor is unable to source and maintain a capable workforce or supply us with contractors during times of peak volume, then we may be unable to satisfy our customer obligations and/or regulatory reporting requirements. In addition, some third-party vendors may provide unique services and the loss of those services may be difficult to replace and/or the cost to receive the third-party services may be significant, including conversion costs to establish the appropriate technology infrastructure. Any of the above scenarios could lead to reputational damage and/or an adverse financial impact, including the imposition of penalties or being subject to litigation costs. Insurance and Product-Related Risks Enact Holdings may be unable to maintain or increase capital in its mortgage insurance subsidiaries in a timely manner, on anticipated terms or at all, including through improved business performance, reinsurance or similar transactions, securities offerings or otherwise, in each case as and when required. Enact Holdings may require incremental capital to support its growth, meet regulatory or GSE capital requirements, comply with rating agency criteria to maintain ratings, repay its debt due in 2025, operate and meet unexpected cash flow obligations. Our ability to support the capital needs of Enact Holdings is limited. Accordingly, we are largely reliant on Enact Holdings to support its own capital needs. Furthermore, our current plans do not include any additional minority sales resulting in Genworth owning less than 80% of Enact Holdings, and accordingly, Enact Holdings’ ability to raise additional capital by issuing its stock to third parties is limited. Enact Holdings’ inability to fund or raise the capital required in the anticipated timeframes and on the anticipated terms could cause a reduction in its business levels or subject it to a variety of regulatory actions, which would have a material adverse impact on our business, results of operations and financial condition. Specifically, as Enact Holdings’ outstanding debt matures, Enact Holdings may face challenges in refinancing or extending the debt on favorable terms. Unfavorable market conditions, changes in Enact Holdings’ financial position or changes to its ratings could limit its ability to refinance the debt, potentially impacting our liquidity. In addition, the implementation of any further credit risk transfer transactions or other transactions with third parties to provide additional capital depends on a number of factors, including but not limited to, market conditions, necessary third-party approvals (including approval by regulators and the GSEs) and other factors which are outside Enact Holdings’ control. Therefore, Enact Holdings may not be able to successfully implement these actions on the anticipated timetable and terms, or at all. Even if Enact Holdings is able to successfully implement these actions, it may not be able to achieve the anticipated benefits from the actions. Reinsurance may not be available, affordable or adequate to protect us against losses. As part of our overall risk and capital management strategy, we purchase reinsurance from external reinsurers, use credit risk transfer transactions and provide internal reinsurance support for certain risks underwritten by our various business segments. These reinsurance arrangements and credit risk transfer transactions are intended to enable our businesses to transfer risks in exchange for some of the associated economic benefits and, as a result, improve our statutory capital position, manage risk to within our tolerance level and improve the PMIERs position of Enact Holdings. The availability and cost of reinsurance protection are impacted by our operating and financial performance, including ratings, as well as conditions beyond our control, including changes in regulation. For example, our U.S. life insurance subsidiaries’ low financial strength ratings may reduce the availability of certain types of reinsurance and have made it more costly when it is available, as reinsurers have been less willing to take on credit risk in the volatile market. Accordingly, we may continue to be forced into incurring additional expenses for reinsurance and/or we may not be able to obtain new reinsurance or renew existing reinsurance arrangements on acceptable terms, or at all, which could increase our risk and adversely affect our ability to obtain statutory capital credit for new reinsurance or could require us to make capital contributions to maintain regulatory capital requirements. Moreover, absent the availability and affordability to enter into new credit risk transfer transactions, the ability of Enact Holdings to obtain PMIERs or statutory credit for new transactions would be adversely impacted. See “—If Enact is unable to continue to meet the requirements mandated by PMIERs because the GSEs amend them or the GSEs’ interpretation of the financial requirements requires Enact to hold amounts of capital that are higher than planned or otherwise, Enact may not be eligible to write new insurance on loans acquired by the GSEs, which would have a material adverse effect on our business, results of operations and financial condition.” We also manage risk and capital allocated to our long-term care insurance business through utilization of external reinsurance in the form of coinsurance. Our U.S. life insurance subsidiaries have executed external reinsurance agreements to reinsure sales of some of their older blocks of long-term care insurance products (10% of new business issued from 2003 to 2008; 20% to 30% of new business issued from 2009 to 2011; and 40% of 58 59 new business issued from 2011 to early 2013). We also have external reinsurance on some older blocks of business which includes a treaty on a yearly renewable term basis on business that was written between 1998 and 2003. This yearly renewable term reinsurance provides coverage for claims on those policies for 15 years after the policy was written. After 15 years, reinsurance coverage ends for policies not on claim, while reinsurance coverage continues for policies on claim until the claim ends. The 15-year coverage on the policies written in 2003 expired in 2018; therefore, any new claims will not have reinsurance coverage under this treaty. Since 2013, we have seen, and may continue to see, an increase in our benefit costs as policies with reinsurance coverage exhaust their benefits or terminate and policies which are not covered by reinsurance go on claim. Over time, affordable or any reinsurance may not continue to be available. A decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations could result in a decline in Enact Holdings’ revenue. Enact Holdings provides mortgage insurance primarily for high loan-to-value mortgages. Factors that could lead to a decrease in the volume of high loan-to-value mortgage originations include, but are not limited to: • • • • • • • • • • • an increase in home mortgage interest rates; limitations on the tax benefits of homeownership and mortgage interest; implementation of more rigorous mortgage lending regulation; a decline in economic conditions generally, or in conditions in regional and local economies; events outside of Enact Holdings’ control, including natural and man-made disasters and pandemics adversely affecting housing markets and home buying; the level of consumer confidence, which may be adversely affected by economic instability, war or terrorist events; an increase in the price of homes relative to income levels; a lack of housing supply at lower home prices; adverse population trends, including lower homeownership rates; high rates of home price appreciation, which for refinancings affect whether refinanced loans have loan-to-value ratios that require mortgage insurance; and changes in government housing policy encouraging loans to first-time home buyers. A decline in the volume of high loan-to-value mortgage originations would reduce the demand for mortgage insurance and, therefore, could have a material adverse effect on Enact Holdings and our financial condition and results of operations. In addition, each year, Enact Holdings recognizes a significant percentage of its earned premiums from renewal premiums on insurance policies written in previous years. As a result, the length of time insurance remains in-force is an important determinant of Genworth’s mortgage insurance revenues. Fannie Mae, Freddie Mac and many other mortgage investors generally permit a homeowner to ask the loan servicer to cancel the borrower’s obligation to pay for mortgage insurance when the principal amount of the mortgage falls below 80% of the home’s value. Factors that tend to reduce the length of time our mortgage insurance remains in-force include: • • declining interest rates, which may result in the refinancing of the mortgages underlying the insurance policies with new mortgage loans that may not require mortgage insurance or that Enact Holdings does not insure; customer concentration levels with certain customers that actively market refinancing opportunities to their existing borrowers; • • • • • • • • significant appreciation in the value of homes, which causes the unpaid balance of the mortgage to decrease below 80% of the value of the home and enables the borrower to request cancellation of the mortgage insurance; and applicable law. changes in mortgage insurance cancellation requirements or procedures of the GSEs or under Any change in the methodology by which servicers determine the cancellation dates of mortgage insurance under HOPA; GSE requirements or otherwise, including as a result of changes in law or regulation; GSE rules or guidance, including changes in response to COVID-19 or homeowner affordability initiatives; and/or for any other reason, could reduce the amount of Enact Holdings’ insurance in-force and may have a material adverse effect on our financial condition and results of operations. Enact Holdings experienced elevated persistency in 2023 and 2022 primarily as a result of the rising interest rate environment in response to inflationary pressures. A decrease in persistency generally would reduce the amount of Enact Holdings’ insurance in-force and could have a material adverse effect on our financial condition and results of operations. Conversely, higher persistency on certain higher-risk products could have a material adverse effect if claims generated by such products remain elevated or increase. The amount of mortgage insurance written by Enact Holdings could decline significantly if alternatives to private mortgage insurance are used or lower coverage levels of mortgage insurance are selected. There are a variety of alternatives to private mortgage insurance that may reduce the amount of mortgage insurance written by Enact Holdings. These alternatives include: originating mortgages that consist of two simultaneous loans, known as “simultaneous seconds,” comprising a first mortgage with a loan-to-value ratio of 80% and a simultaneous second mortgage for the excess portion of the loan, instead of a single mortgage with a loan-to-value ratio of more than 80%; using government mortgage insurance programs; holding mortgages in the lenders’ own loan portfolios and self-insuring; using programs, such as those offered by Fannie Mae and Freddie Mac in the United States, requiring lower mortgage insurance coverage levels; originating and securitizing loans in mortgage-backed securities whose underlying mortgages are not insured with private mortgage insurance or which are structured so that the risk of default lies with the investor, rather than a private mortgage insurer; and using risk-sharing insurance programs, credit default swaps or similar instruments, instead of private mortgage insurance, to transfer credit risk on mortgages. The degree to which lenders or borrowers may select these alternatives now, or in the future, is difficult to predict. The performance and resiliency of the private mortgage insurance industry could impact the perception of the industry and private mortgage insurance execution as the primary choice of first-loss credit protection, which could influence the popularity of alternative forms of mortgage insurance in the future. As one or more of the alternatives described above, or new alternatives that enter the market, are chosen over private mortgage insurance, Enact Holdings’ revenue could be adversely impacted. The loss of business in general or the specific loss of more profitable business in Enact Holdings could have a material adverse effect on our results of operations and financial condition. Additionally, Enact Holdings competes with the FHA and the VA, as well as certain local-and state-level housing finance agencies. Separately, the government-owned and government-sponsored enterprises, including Fannie Mae and Freddie Mac, compete with Enact Holdings through certain of their risk-sharing insurance programs. Those competitors may establish pricing terms and business practices that may be influenced by 60 61 new business issued from 2011 to early 2013). We also have external reinsurance on some older blocks of business which includes a treaty on a yearly renewable term basis on business that was written between 1998 and 2003. This yearly renewable term reinsurance provides coverage for claims on those policies for 15 years after the policy was written. After 15 years, reinsurance coverage ends for policies not on claim, while reinsurance coverage continues for policies on claim until the claim ends. The 15-year coverage on the policies written in 2003 expired in 2018; therefore, any new claims will not have reinsurance coverage under this treaty. Since 2013, we have seen, and may continue to see, an increase in our benefit costs as policies with reinsurance coverage exhaust their benefits or terminate and policies which are not covered by reinsurance go on claim. Over time, affordable or any reinsurance may not continue to be available. A decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations could result in a decline in Enact Holdings’ revenue. Enact Holdings provides mortgage insurance primarily for high loan-to-value mortgages. Factors that could lead to a decrease in the volume of high loan-to-value mortgage originations include, but are not limited to: an increase in home mortgage interest rates; limitations on the tax benefits of homeownership and mortgage interest; implementation of more rigorous mortgage lending regulation; a decline in economic conditions generally, or in conditions in regional and local economies; events outside of Enact Holdings’ control, including natural and man-made disasters and pandemics adversely affecting housing markets and home buying; the level of consumer confidence, which may be adversely affected by economic instability, war or terrorist events; an increase in the price of homes relative to income levels; a lack of housing supply at lower home prices; adverse population trends, including lower homeownership rates; high rates of home price appreciation, which for refinancings affect whether refinanced loans have loan-to-value ratios that require mortgage insurance; and changes in government housing policy encouraging loans to first-time home buyers. A decline in the volume of high loan-to-value mortgage originations would reduce the demand for mortgage insurance and, therefore, could have a material adverse effect on Enact Holdings and our financial condition and results of operations. In addition, each year, Enact Holdings recognizes a significant percentage of its earned premiums from renewal premiums on insurance policies written in previous years. As a result, the length of time insurance remains in-force is an important determinant of Genworth’s mortgage insurance revenues. Fannie Mae, Freddie Mac and many other mortgage investors generally permit a homeowner to ask the loan servicer to cancel the borrower’s obligation to pay for mortgage insurance when the principal amount of the mortgage falls below 80% of the home’s value. Factors that tend to reduce the length of time our mortgage insurance remains in-force include: declining interest rates, which may result in the refinancing of the mortgages underlying the insurance policies with new mortgage loans that may not require mortgage insurance or that Enact Holdings does not insure; their existing borrowers; customer concentration levels with certain customers that actively market refinancing opportunities to • • • • • • • • • • • • • • • significant appreciation in the value of homes, which causes the unpaid balance of the mortgage to decrease below 80% of the value of the home and enables the borrower to request cancellation of the mortgage insurance; and changes in mortgage insurance cancellation requirements or procedures of the GSEs or under applicable law. Any change in the methodology by which servicers determine the cancellation dates of mortgage insurance under HOPA; GSE requirements or otherwise, including as a result of changes in law or regulation; GSE rules or guidance, including changes in response to COVID-19 or homeowner affordability initiatives; and/or for any other reason, could reduce the amount of Enact Holdings’ insurance in-force and may have a material adverse effect on our financial condition and results of operations. Enact Holdings experienced elevated persistency in 2023 and 2022 primarily as a result of the rising interest rate environment in response to inflationary pressures. A decrease in persistency generally would reduce the amount of Enact Holdings’ insurance in-force and could have a material adverse effect on our financial condition and results of operations. Conversely, higher persistency on certain higher-risk products could have a material adverse effect if claims generated by such products remain elevated or increase. The amount of mortgage insurance written by Enact Holdings could decline significantly if alternatives to private mortgage insurance are used or lower coverage levels of mortgage insurance are selected. There are a variety of alternatives to private mortgage insurance that may reduce the amount of mortgage insurance written by Enact Holdings. These alternatives include: • • • • • • originating mortgages that consist of two simultaneous loans, known as “simultaneous seconds,” comprising a first mortgage with a loan-to-value ratio of 80% and a simultaneous second mortgage for the excess portion of the loan, instead of a single mortgage with a loan-to-value ratio of more than 80%; using government mortgage insurance programs; holding mortgages in the lenders’ own loan portfolios and self-insuring; using programs, such as those offered by Fannie Mae and Freddie Mac in the United States, requiring lower mortgage insurance coverage levels; originating and securitizing loans in mortgage-backed securities whose underlying mortgages are not insured with private mortgage insurance or which are structured so that the risk of default lies with the investor, rather than a private mortgage insurer; and using risk-sharing insurance programs, credit default swaps or similar instruments, instead of private mortgage insurance, to transfer credit risk on mortgages. The degree to which lenders or borrowers may select these alternatives now, or in the future, is difficult to predict. The performance and resiliency of the private mortgage insurance industry could impact the perception of the industry and private mortgage insurance execution as the primary choice of first-loss credit protection, which could influence the popularity of alternative forms of mortgage insurance in the future. As one or more of the alternatives described above, or new alternatives that enter the market, are chosen over private mortgage insurance, Enact Holdings’ revenue could be adversely impacted. The loss of business in general or the specific loss of more profitable business in Enact Holdings could have a material adverse effect on our results of operations and financial condition. Additionally, Enact Holdings competes with the FHA and the VA, as well as certain local-and state-level housing finance agencies. Separately, the government-owned and government-sponsored enterprises, including Fannie Mae and Freddie Mac, compete with Enact Holdings through certain of their risk-sharing insurance programs. Those competitors may establish pricing terms and business practices that may be influenced by 60 61 motives such as advancing social housing policy or stabilizing the mortgage lending industry, which may not be consistent with maximizing return on capital or other profitability measures. In addition, those governmental enterprises typically do not have the same capital requirements or cost of capital that Enact Holdings and other mortgage insurance companies have and therefore may have financial flexibility in their pricing and capacity that could put Enact Holdings at a competitive disadvantage. In the event that a government-owned or sponsored entity decides to change prices significantly or alter the terms and conditions of its mortgage insurance or other credit enhancement products in furtherance of social or other goals rather than a profit or risk management motive, Enact Holdings may be unable to compete effectively, which could have a material adverse effect on our business, financial condition and results of operations. Enact Holdings’ delegated underwriting program may subject its mortgage insurance subsidiaries to unanticipated claims. Certain of Enact Holdings’ customers commit Enact Holdings to insure loans that use its pre-established guidelines under delegated underwriting authority. Delegated underwriting represented approximately 70% and 71% of Enact Holdings’ total new insurance written by loan count for the years ended December 31, 2023 and 2022, respectively. Once a customer is accepted into Enact Holdings’ delegated underwriting program, a loan originated by that customer is generally insured without validating the accuracy of the data submitted, investigating for fraud or reviewing to ensure the customer followed the pre-established guidelines for delegated underwriting. Under this program, it is possible a customer could commit Enact Holdings to insure a material number of loans that would fail Enact Holdings’ pre-established guidelines for delegated underwriting but pass its model, among other criteria, before Enact Holdings discovers the problem and terminates the customer’s delegated underwriting authority. Although coverage on such loans may be rescindable or otherwise limited under the terms of Enact Holdings’ master policies, the burden of establishing the right to rescind or deny coverage lies with the insurer. To the extent that Enact Holdings’ customers exceed their delegated underwriting authorities, our business, results of operations and financial condition could be materially adversely affected. Medical advances, such as genetic research and diagnostic imaging, emerging new technology, including artificial intelligence and related legislation, could materially adversely affect the financial performance of our life insurance, long-term care insurance and annuity businesses. Genetic testing research and discovery is advancing at a rapid pace. In addition, future reliance on new artificial intelligence methodologies may drastically change medical research and science. Though some of this medical research is focused on identifying the genes associated with rare diseases, much of the research is focused on identifying the genes associated with an increased risk of various common diseases such as diabetes, heart disease, cancer and Alzheimer’s disease. Diagnostic testing utilizing various blood panels or imaging techniques, including the use of artificial intelligence, may allow clinicians to detect similar diseases during an earlier treatment phase and prescribe more acute medicine or treatments. We believe that if an individual learns through such testing that they are predisposed to a condition that may reduce their life expectancy or increase their chances of requiring long-term care, they potentially will be more likely to purchase life and long-term care insurance policies or avoid lapsing their existing policy. In contrast, if an individual learns that they lack the genetic predisposition to develop the conditions that reduce longevity or require long-term care, they potentially will be less likely to purchase life and long-term care insurance products or allow their life and long-term care insurance policies to lapse but would be more likely to purchase certain annuity products. Being able to access and use the medical information (including the results of genetic research, diagnostic testing and artificial intelligence methodologies) known to our prospective policyholders is important to ensure that an underwriting risk assessment matches the anticipated risk priced into our life and long-term care insurance products, as well as our annuity products. Currently, there are some state level restrictions related to an insurer’s access and use of genetic information, and periodically new genetic testing legislation is being introduced. However, further restrictions on the access and use of such medical information could create a mismatch between an assessed risk and the product pricing. Such a mismatch has the potential to increase product pricing causing a decrease in sales to lower risk individuals resulting in higher risk individuals becoming the more likely buyer. In addition, it is possible that regulators may enforce anti-discrimination provisions even when medical information is available that indicates a purchaser is at higher risk. The net result of this could cause a deterioration in the risk profile of our portfolio which could lead to payments to our policyholders and contractholders that are materially higher than anticipated. Any of these events could materially adversely affect our business, results of operations and financial condition. In addition to earlier diagnosis or knowledge of disease risk, medical advances may also lead to newer forms of preventive care which could improve an individual’s overall health and/or longevity. If this were to occur, the duration of payments made by us under certain forms of life insurance policies or annuity contracts would likely increase thereby reducing our profitability on those products. Conversely, slower progressing medical advances, particularly in the areas of cognitive decline, could adversely impact our long-term care insurance business as policyholders may remain on claim for a long period of time resulting in higher severity and duration of claims. Other Emerging Risks Other emerging risks, such as the occurrence of natural or man-made disasters, including geopolitical tensions and war; a public health emergency, including pandemics; climate change; or unknown risks and uncertainties associated with artificial intelligence could materially adversely affect our business, financial condition and results of operations. We are exposed to various risks arising out of natural disasters, including fires, earthquakes, hurricanes, floods and tornadoes, many of which could be exacerbated by climate change. Increasing geopolitical tensions and war (including the Russian invasion of Ukraine and the Israel-Hamas conflict) could impact the economic environment and reduce available resources or increase costs due to supply chain impacts, including restricting oil supply and/or increasing the price of oil. The risk of a public health emergency, including from a pandemic, exposes us to risks similar to those experienced during COVID-19. A future natural or man-made disaster could disrupt our computer systems and our ability to conduct or process business, as well as lead to unexpected changes in mortgage borrower, policyholder and contractholder behavior. We are also exposed to the continued threat of terrorism, military actions and other man-made disasters, which may cause significant volatility in global financial markets and could trigger an economic downturn in the areas directly or indirectly affected by the disaster. These consequences could, among other things, result in a decline in business and increased claims from those areas, as well as an adverse effect on home prices in those areas, which could result in increased loss experience in our mortgage insurance subsidiaries. Disasters or a public health emergency, including a pandemic, could also disrupt public and private infrastructure, including communications and financial services, which could disrupt our normal business operations. Our inability to anticipate and leverage new technology developments, such as artificial intelligence, could adversely affect the future success of our business. We may not be successful in anticipating or responding to these developments on a timely and cost-effective basis, and our investments in these capabilities may not deliver the benefits anticipated or perform as expected. Poor implementation of new technologies, including artificial intelligence, by us or our third-party service providers, could subject us to additional risks we cannot adequately mitigate, which could have a material adverse impact to our business, results of operations and financial condition. Item 1B. Unresolved Staff Comments We have no unresolved comments from the staff of the SEC. Item 1C. Cybersecurity We have identified information technology and cybersecurity risk as some of the most significant risk types to our business. Related to these identified risk types, we have classified our top risks and report these risks to 62 63 motives such as advancing social housing policy or stabilizing the mortgage lending industry, which may not be consistent with maximizing return on capital or other profitability measures. In addition, those governmental enterprises typically do not have the same capital requirements or cost of capital that Enact Holdings and other mortgage insurance companies have and therefore may have financial flexibility in their pricing and capacity that could put Enact Holdings at a competitive disadvantage. In the event that a government-owned or sponsored entity decides to change prices significantly or alter the terms and conditions of its mortgage insurance or other credit enhancement products in furtherance of social or other goals rather than a profit or risk management motive, Enact Holdings may be unable to compete effectively, which could have a material adverse effect on our business, financial condition and results of operations. Enact Holdings’ delegated underwriting program may subject its mortgage insurance subsidiaries to unanticipated claims. Certain of Enact Holdings’ customers commit Enact Holdings to insure loans that use its pre-established guidelines under delegated underwriting authority. Delegated underwriting represented approximately 70% and 71% of Enact Holdings’ total new insurance written by loan count for the years ended December 31, 2023 and 2022, respectively. Once a customer is accepted into Enact Holdings’ delegated underwriting program, a loan originated by that customer is generally insured without validating the accuracy of the data submitted, investigating for fraud or reviewing to ensure the customer followed the pre-established guidelines for delegated underwriting. Under this program, it is possible a customer could commit Enact Holdings to insure a material number of loans that would fail Enact Holdings’ pre-established guidelines for delegated underwriting but pass its model, among other criteria, before Enact Holdings discovers the problem and terminates the customer’s delegated underwriting authority. Although coverage on such loans may be rescindable or otherwise limited under the terms of Enact Holdings’ master policies, the burden of establishing the right to rescind or deny coverage lies with the insurer. To the extent that Enact Holdings’ customers exceed their delegated underwriting authorities, our business, results of operations and financial condition could be materially adversely affected. Medical advances, such as genetic research and diagnostic imaging, emerging new technology, including artificial intelligence and related legislation, could materially adversely affect the financial performance of our life insurance, long-term care insurance and annuity businesses. Genetic testing research and discovery is advancing at a rapid pace. In addition, future reliance on new artificial intelligence methodologies may drastically change medical research and science. Though some of this medical research is focused on identifying the genes associated with rare diseases, much of the research is focused on identifying the genes associated with an increased risk of various common diseases such as diabetes, heart disease, cancer and Alzheimer’s disease. Diagnostic testing utilizing various blood panels or imaging techniques, including the use of artificial intelligence, may allow clinicians to detect similar diseases during an earlier treatment phase and prescribe more acute medicine or treatments. We believe that if an individual learns through such testing that they are predisposed to a condition that may reduce their life expectancy or increase their chances of requiring long-term care, they potentially will be more likely to purchase life and long-term care insurance policies or avoid lapsing their existing policy. In contrast, if an individual learns that they lack the genetic predisposition to develop the conditions that reduce longevity or require long-term care, they potentially will be less likely to purchase life and long-term care insurance products or allow their life and long-term care insurance policies to lapse but would be more likely to purchase certain annuity products. Being able to access and use the medical information (including the results of genetic research, diagnostic testing and artificial intelligence methodologies) known to our prospective policyholders is important to ensure that an underwriting risk assessment matches the anticipated risk priced into our life and long-term care insurance products, as well as our annuity products. Currently, there are some state level restrictions related to an insurer’s access and use of genetic information, and periodically new genetic testing legislation is being introduced. However, further restrictions on the access and use of such medical information could create a mismatch between an assessed risk and the product pricing. Such a mismatch has the potential to increase product pricing causing a decrease in sales to lower risk individuals resulting in higher risk individuals becoming the more likely buyer. In addition, it is possible that regulators may enforce anti-discrimination provisions even when medical information is available that indicates a purchaser is at higher risk. The net result of this could cause a deterioration in the risk profile of our portfolio which could lead to payments to our policyholders and contractholders that are materially higher than anticipated. Any of these events could materially adversely affect our business, results of operations and financial condition. In addition to earlier diagnosis or knowledge of disease risk, medical advances may also lead to newer forms of preventive care which could improve an individual’s overall health and/or longevity. If this were to occur, the duration of payments made by us under certain forms of life insurance policies or annuity contracts would likely increase thereby reducing our profitability on those products. Conversely, slower progressing medical advances, particularly in the areas of cognitive decline, could adversely impact our long-term care insurance business as policyholders may remain on claim for a long period of time resulting in higher severity and duration of claims. Other Emerging Risks Other emerging risks, such as the occurrence of natural or man-made disasters, including geopolitical tensions and war; a public health emergency, including pandemics; climate change; or unknown risks and uncertainties associated with artificial intelligence could materially adversely affect our business, financial condition and results of operations. We are exposed to various risks arising out of natural disasters, including fires, earthquakes, hurricanes, floods and tornadoes, many of which could be exacerbated by climate change. Increasing geopolitical tensions and war (including the Russian invasion of Ukraine and the Israel-Hamas conflict) could impact the economic environment and reduce available resources or increase costs due to supply chain impacts, including restricting oil supply and/or increasing the price of oil. The risk of a public health emergency, including from a pandemic, exposes us to risks similar to those experienced during COVID-19. A future natural or man-made disaster could disrupt our computer systems and our ability to conduct or process business, as well as lead to unexpected changes in mortgage borrower, policyholder and contractholder behavior. We are also exposed to the continued threat of terrorism, military actions and other man-made disasters, which may cause significant volatility in global financial markets and could trigger an economic downturn in the areas directly or indirectly affected by the disaster. These consequences could, among other things, result in a decline in business and increased claims from those areas, as well as an adverse effect on home prices in those areas, which could result in increased loss experience in our mortgage insurance subsidiaries. Disasters or a public health emergency, including a pandemic, could also disrupt public and private infrastructure, including communications and financial services, which could disrupt our normal business operations. Our inability to anticipate and leverage new technology developments, such as artificial intelligence, could adversely affect the future success of our business. We may not be successful in anticipating or responding to these developments on a timely and cost-effective basis, and our investments in these capabilities may not deliver the benefits anticipated or perform as expected. Poor implementation of new technologies, including artificial intelligence, by us or our third-party service providers, could subject us to additional risks we cannot adequately mitigate, which could have a material adverse impact to our business, results of operations and financial condition. Item 1B. Unresolved Staff Comments We have no unresolved comments from the staff of the SEC. Item 1C. Cybersecurity We have identified information technology and cybersecurity risk as some of the most significant risk types to our business. Related to these identified risk types, we have classified our top risks and report these risks to 62 63 both senior management and the risk committee of Genworth Financial’s Board of Directors. For additional information regarding the risks associated with these matters, see “Item 1A—Risk Factors.” Governance Risk Management Genworth’s risk management framework recognizes the significant operational risk, including risk of losses, from cyber incidents and the importance of a strong cybersecurity program for effective risk management. As part of our risk management, we have implemented a Data Security and Cybersecurity Program (the “DSCP”) which sets policy expectations, ensures broad coverage over information technology risks, integrates the Information Security and Information Technology Risk Management Framework into our broader risk management systems, establishes clear roles and governance, and aligns control expectations to the National Institute of Standards and Technology (“NIST”). Under the DSCP, we have processes for identifying, assessing and managing technology and cybersecurity risk. The DSCP employs various controls and policies to secure our operations and information, which include monitoring, reporting, managing and remediating cybersecurity threats. Key features of the DSCP include access controls, security training, system security testing, dedicated security personnel, security event monitoring, and when necessary, consultation with third-party data security experts. Through a cross-functional team, we assess and mitigate risks associated with our third-party providers and have processes in place to regularly monitor and evaluate cybersecurity risks and threats associated with the use of third-party providers. Our information security team, overseen by our Chief Information Security Officer (“CISO”), conducts annual information security awareness training for employees involved in our systems and processes that handle customer data. We have conducted cybersecurity awareness training with management, including a tabletop exercise to simulate a response to a cybersecurity incident, and used these findings to improve our processes and technologies. In addition, the DSCP includes an incident response plan, which coordinates the activities we take to prepare for, detect, respond to and recover from cybersecurity incidents, which include processes to assess the materiality of the incident, escalate, contain, investigate and remediate the incident, as well as to comply with potentially applicable legal reporting and other obligations and mitigate reputational damage. We also carry insurance that provides protection against the potential losses arising from a cybersecurity incident. Additionally, we have procedures set forth in the DSCP for reporting and responding to potential security incidents as well as determining applicable disclosure requirements, including timely incident reporting. For example, as disclosed in our Form 8-K filed on June 22, 2023, we were notified by PBI, a third-party vendor, that PBI was subject to the widely reported security events involving the MOVEit file transfer system, which PBI uses in the performance of its services. The MOVEit Cybersecurity Incident resulted in the unauthorized acquisition of data by a third party from PBI as well as several organizations and governmental agencies. After being notified of the security event, we, together with PBI, promptly launched an investigation to determine whether and to what extent personal information had been unlawfully accessed. Approximately 2.5 to 2.7 million of our policyholders’ or other customers’ personal information, including social security numbers, was exposed to and obtained by the threat actor as a result of the MOVEit Cybersecurity Incident. We believe that the MOVEit Cybersecurity Incident has not had any impact on any of our information systems, including our financial systems, and that there has not been any material interruption of our business operations. While we are continuing to measure the impact, including certain remediation expenses and other potential liabilities, we do not currently believe this incident or other known risks from cybersecurity threats are reasonably likely to have a material adverse effect on our business, results of operations or financial condition. See “Item 1A—Risk Factors—Our computer systems and those of our third-party service providers have in the past and may in the future fail or be compromised, including through cybersecurity breaches; we may experience issues from new and complex information technology methodologies such as artificial intelligence; and unanticipated problems could materially adversely impact our disaster recovery systems and business continuity plans, any of which could damage our reputation, impair our ability to conduct business effectively, result in enforcement action or litigation, and materially adversely affect our business, financial condition and results of operations.” Our Board of Directors recognizes the importance of maintaining the privacy and security of customer information, as well as the availability of our systems, and consequently dedicates meaningful time and attention to oversight of cybersecurity risk. In light of these risks, our Board of Directors is actively engaged in the oversight of the Company’s information technology, which includes periodic briefings on cybersecurity threats and participation in cybersecurity preparedness exercises. Furthermore, under its charter, the Board’s risk committee has primary responsibility for cybersecurity oversight. In this capacity, the risk committee oversees the Company’s processes for identifying, assessing and managing technology and cybersecurity risk. In connection with the MOVEit Cybersecurity Incident, the risk committee was immediately notified by management and regularly briefed on the matter, and worked with management, including Genworth’s CISO and Chief Risk Officer (“CRO”), to assess and manage the risk and implement the Company’s response to the incident. Genworth’s CISO and CRO, both members of management, support the cybersecurity risk oversight responsibilities of the Board and the risk committee and involve applicable management personnel in cybersecurity risk management. The risk committee receives periodic reports from the CISO and CRO on the Company’s technology and cybersecurity risk profiles, information security program and key cybersecurity initiatives. Additionally, the CISO and CRO follow a risk-based escalation process to notify the risk committee outside of the regular reporting cycle when they identify potential substantive cybersecurity risks or issues. Genworth’s CISO is an information technology and security professional with 23 years of experience and 11 years of service at Genworth. In his 23 years of experience, he has held roles in information technology infrastructure administration, information technology infrastructure, security consulting and security administration. He received a Bachelor of Science Degree in Business Administration from Regent University and is a Certified Information Systems Security Professional (CISSP). Genworth’s CRO has served in information technology and risk management leadership roles for over twenty years, including oversight of enterprise risk management and operational risk, as well as oversight for financial reporting systems, operational and technology platforms, and testing and quality assurance programs. He received a Bachelor of Science Degree in Decision Support Systems from Virginia Polytechnic Institute (Virginia Tech) and graduated from the Tuck Global Executive Leadership Program through Dartmouth in 2020. For more information about our CRO, see “Part III—Item 10—Directors, Executive Officers and Corporate Governance.” Item 2. Properties Genworth owns a campus facility in Richmond, Virginia, which previously served as its headquarters, consisting of approximately 450,000 square feet in four buildings, as well as one facility in Lynchburg, Virginia with approximately 210,000 square feet. Genworth has leased and is currently renovating a 174,000 square foot facility in Richmond, Virginia for use as its new headquarters office. Genworth has leased 89,000 square feet of office space in Richmond, Virginia to use as its interim headquarters until the new space is ready. In addition, Genworth leases 11,000 square feet in Lynchburg, Virginia, and another 61,000 square feet of office space in four locations throughout the United States. One of Genworth’s international subsidiaries leases office space in Mexico. Enact Holdings leases its headquarters facility in Raleigh, North Carolina, which consists of approximately 130,000 square feet, and also leases one other office space of approximately 2,000 square feet in Washington, D.C. Genworth has entered into a contract to sell its owned campus facility in Richmond, Virginia. The contract purchaser is conducting its due diligence as permitted under the contract. 64 65 both senior management and the risk committee of Genworth Financial’s Board of Directors. For additional information regarding the risks associated with these matters, see “Item 1A—Risk Factors.” Risk Management Genworth’s risk management framework recognizes the significant operational risk, including risk of losses, from cyber incidents and the importance of a strong cybersecurity program for effective risk management. As part of our risk management, we have implemented a Data Security and Cybersecurity Program (the “DSCP”) which sets policy expectations, ensures broad coverage over information technology risks, integrates the Information Security and Information Technology Risk Management Framework into our broader risk management systems, establishes clear roles and governance, and aligns control expectations to the National Institute of Standards and Technology (“NIST”). Under the DSCP, we have processes for identifying, assessing and managing technology and cybersecurity risk. The DSCP employs various controls and policies to secure our operations and information, which include monitoring, reporting, managing and remediating cybersecurity threats. Key features of the DSCP include access controls, security training, system security testing, dedicated security personnel, security event monitoring, and when necessary, consultation with third-party data security experts. Through a cross-functional team, we assess and mitigate risks associated with our third-party providers and have processes in place to regularly monitor and evaluate cybersecurity risks and threats associated with the use of third-party providers. Our information security team, overseen by our Chief Information Security Officer (“CISO”), conducts annual information security awareness training for employees involved in our systems and processes that handle customer data. We have conducted cybersecurity awareness training with management, including a tabletop exercise to simulate a response to a cybersecurity incident, and used these findings to improve our processes and technologies. In addition, the DSCP includes an incident response plan, which coordinates the activities we take to prepare for, detect, respond to and recover from cybersecurity incidents, which include processes to assess the materiality of the incident, escalate, contain, investigate and remediate the incident, as well as to comply with potentially applicable legal reporting and other obligations and mitigate reputational damage. We also carry insurance that provides protection against the potential losses arising from a cybersecurity incident. Additionally, we have procedures set forth in the DSCP for reporting and responding to potential security incidents as well as determining applicable disclosure requirements, including timely incident reporting. For example, as disclosed in our Form 8-K filed on June 22, 2023, we were notified by PBI, a third-party vendor, that PBI was subject to the widely reported security events involving the MOVEit file transfer system, which PBI uses in the performance of its services. The MOVEit Cybersecurity Incident resulted in the unauthorized acquisition of data by a third party from PBI as well as several organizations and governmental agencies. After being notified of the security event, we, together with PBI, promptly launched an investigation to determine whether and to what extent personal information had been unlawfully accessed. Approximately 2.5 to 2.7 million of our policyholders’ or other customers’ personal information, including social security numbers, was exposed to and obtained by the threat actor as a result of the MOVEit Cybersecurity Incident. We believe that the MOVEit Cybersecurity Incident has not had any impact on any of our information systems, including our financial systems, and that there has not been any material interruption of our business operations. While we are continuing to measure the impact, including certain remediation expenses and other potential liabilities, we do not currently believe this incident or other known risks from cybersecurity threats are reasonably likely to have a material adverse effect on our business, results of operations or financial condition. See “Item 1A—Risk Factors—Our computer systems and those of our third-party service providers have in the past and may in the future fail or be compromised, including through cybersecurity breaches; we may experience issues from new and complex information technology methodologies such as artificial intelligence; and unanticipated problems could materially adversely impact our disaster recovery systems and business continuity plans, any of which could damage our reputation, impair our ability to conduct business effectively, result in enforcement action or litigation, and materially adversely affect our business, financial condition and results of operations.” Governance Our Board of Directors recognizes the importance of maintaining the privacy and security of customer information, as well as the availability of our systems, and consequently dedicates meaningful time and attention to oversight of cybersecurity risk. In light of these risks, our Board of Directors is actively engaged in the oversight of the Company’s information technology, which includes periodic briefings on cybersecurity threats and participation in cybersecurity preparedness exercises. Furthermore, under its charter, the Board’s risk committee has primary responsibility for cybersecurity oversight. In this capacity, the risk committee oversees the Company’s processes for identifying, assessing and managing technology and cybersecurity risk. In connection with the MOVEit Cybersecurity Incident, the risk committee was immediately notified by management and regularly briefed on the matter, and worked with management, including Genworth’s CISO and Chief Risk Officer (“CRO”), to assess and manage the risk and implement the Company’s response to the incident. Genworth’s CISO and CRO, both members of management, support the cybersecurity risk oversight responsibilities of the Board and the risk committee and involve applicable management personnel in cybersecurity risk management. The risk committee receives periodic reports from the CISO and CRO on the Company’s technology and cybersecurity risk profiles, information security program and key cybersecurity initiatives. Additionally, the CISO and CRO follow a risk-based escalation process to notify the risk committee outside of the regular reporting cycle when they identify potential substantive cybersecurity risks or issues. Genworth’s CISO is an information technology and security professional with 23 years of experience and 11 years of service at Genworth. In his 23 years of experience, he has held roles in information technology infrastructure administration, information technology infrastructure, security consulting and security administration. He received a Bachelor of Science Degree in Business Administration from Regent University and is a Certified Information Systems Security Professional (CISSP). Genworth’s CRO has served in information technology and risk management leadership roles for over twenty years, including oversight of enterprise risk management and operational risk, as well as oversight for financial reporting systems, operational and technology platforms, and testing and quality assurance programs. He received a Bachelor of Science Degree in Decision Support Systems from Virginia Polytechnic Institute (Virginia Tech) and graduated from the Tuck Global Executive Leadership Program through Dartmouth in 2020. For more information about our CRO, see “Part III—Item 10—Directors, Executive Officers and Corporate Governance.” Item 2. Properties Genworth owns a campus facility in Richmond, Virginia, which previously served as its headquarters, consisting of approximately 450,000 square feet in four buildings, as well as one facility in Lynchburg, Virginia with approximately 210,000 square feet. Genworth has leased and is currently renovating a 174,000 square foot facility in Richmond, Virginia for use as its new headquarters office. Genworth has leased 89,000 square feet of office space in Richmond, Virginia to use as its interim headquarters until the new space is ready. In addition, Genworth leases 11,000 square feet in Lynchburg, Virginia, and another 61,000 square feet of office space in four locations throughout the United States. One of Genworth’s international subsidiaries leases office space in Mexico. Enact Holdings leases its headquarters facility in Raleigh, North Carolina, which consists of approximately 130,000 square feet, and also leases one other office space of approximately 2,000 square feet in Washington, D.C. Genworth has entered into a contract to sell its owned campus facility in Richmond, Virginia. The contract purchaser is conducting its due diligence as permitted under the contract. 64 65 Item 3. Legal Proceedings See note 25 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for a description of material pending litigation and regulatory matters affecting us. Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of PART II Item 4. Mine Safety Disclosures Not applicable. Equity Securities Market for Common Stock Our Class A Common Stock is listed on the New York Stock Exchange under the symbol “GNW.” As of February 15, 2024, we had 272 holders of record of our Class A Common Stock. Common Stock Performance Graph The following performance graph and related information shall not be deemed “soliciting material” nor to be “filed” with the SEC, nor shall such information be incorporated by reference into any future filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, each as amended, except to the extent we specifically incorporate it by reference into such filing. In April 2021, we were included in the S&P SmallCap 600 Index, which is more representative of our total market capitalization. The following graph compares the cumulative total stockholder return on our Class A Common Stock with the cumulative total stockholder return on the S&P 500 Stock Index, S&P 500 Insurance Index, S&P SmallCap 600 Index and S&P SmallCap 600 Insurance Index. Comparison of Cumulative Five Year Total Return $250 $200 $150 $100 $50 $0 12/31/18 12/31/19 12/31/20 12/31/21 12/31/22 12/31/23 Genworth Financial S&P 500 Insurance Index S&P SmallCap 600 Insurance Index S&P 500 Index S&P SmallCap 600 Index 2018 2019 2020 2021 2022 2023 Genworth Financial, Inc. . . . . . . . . . . . . . . . . . . . . $100.00 $ 94.42 $ 81.12 $ 86.91 $113.52 $143.35 S&P 500® . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $100.00 $131.49 $155.68 $200.37 $164.08 $207.21 S&P 500 Insurance Index . . . . . . . . . . . . . . . . . . . $100.00 $129.38 $128.81 $170.19 $187.42 $204.78 S&P SmallCap 600 Index . . . . . . . . . . . . . . . . . . . $100.00 $122.78 $136.64 $173.29 $145.39 $168.73 S&P SmallCap 600 Insurance Index . . . . . . . . . . . $100.00 $114.89 $117.89 $123.81 $103.30 $112.17 66 67 Item 3. Legal Proceedings See note 25 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for a description of material pending litigation and regulatory matters affecting us. Item 4. Mine Safety Disclosures Not applicable. Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of PART II Equity Securities Market for Common Stock Our Class A Common Stock is listed on the New York Stock Exchange under the symbol “GNW.” As of February 15, 2024, we had 272 holders of record of our Class A Common Stock. Common Stock Performance Graph The following performance graph and related information shall not be deemed “soliciting material” nor to be “filed” with the SEC, nor shall such information be incorporated by reference into any future filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, each as amended, except to the extent we specifically incorporate it by reference into such filing. In April 2021, we were included in the S&P SmallCap 600 Index, which is more representative of our total market capitalization. The following graph compares the cumulative total stockholder return on our Class A Common Stock with the cumulative total stockholder return on the S&P 500 Stock Index, S&P 500 Insurance Index, S&P SmallCap 600 Index and S&P SmallCap 600 Insurance Index. Comparison of Cumulative Five Year Total Return $250 $200 $150 $100 $50 $0 12/31/18 12/31/19 12/31/20 12/31/21 12/31/22 12/31/23 Genworth Financial S&P 500 Insurance Index S&P SmallCap 600 Insurance Index S&P 500 Index S&P SmallCap 600 Index 2018 2019 2020 2021 2022 2023 Genworth Financial, Inc. . . . . . . . . . . . . . . . . . . . . S&P 500® . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S&P 500 Insurance Index . . . . . . . . . . . . . . . . . . . S&P SmallCap 600 Index . . . . . . . . . . . . . . . . . . . S&P SmallCap 600 Insurance Index . . . . . . . . . . . $100.00 $ 94.42 $ 81.12 $ 86.91 $113.52 $143.35 $100.00 $131.49 $155.68 $200.37 $164.08 $207.21 $100.00 $129.38 $128.81 $170.19 $187.42 $204.78 $100.00 $122.78 $136.64 $173.29 $145.39 $168.73 $100.00 $114.89 $117.89 $123.81 $103.30 $112.17 66 67 Dividends In November 2008, Genworth Financial’s Board of Directors suspended the payment of dividends to its shareholders indefinitely. In 2022, Genworth Financial’s Board of Directors approved a new share repurchase program. Any amounts used for the purpose of returning capital to Genworth Financial’s shareholders, including share repurchases or dividends if a new dividend policy is ultimately approved, will be dependent on many factors. These factors will include, in addition to any other factors that may arise in the future, the receipt of dividends and/or other returns of capital from Enact Holdings, Genworth’s operating results and financial condition, the capital requirements of our subsidiaries, legal requirements, regulatory constraints, debt obligations of Genworth Holdings and Enact Holdings, our credit and financial strength ratings, the capital needs of our subsidiaries for future growth and other factors Genworth Financial’s Board of Directors deems relevant. In addition, we cannot assure you when, whether or at what level we will resume paying dividends on Genworth Financial’s common stock. See “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” for additional information. Issuer Purchases of Common Stock The following table sets forth information regarding Genworth Financial’s share repurchases during the three months ended December 31, 2023: (Dollar amounts in millions, except per share amounts) Total number of shares purchased as part of publicly announced program Approximate dollar amount of shares that may yet be purchased under the program (1) Total number of shares purchased Average price paid per share October 1, 2023 through October 31, 2023 . . . . . . . . . . . . . 1,717,825 $5.82 1,717,825 November 1, 2023 through November 30, 2023 . . . . . . . . . 2,581,077 $5.81 2,581,077 December 1, 2023 through December 31, 2023 . . . . . . . . . 1,600,446 $6.14 1,600,446 $366 $351 $341 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,899,348 5,899,348 (1) On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial could repurchase up to $350 million of its outstanding Class A common stock. On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under the existing share repurchase program. Under the program, share repurchases may be made at the Company’s discretion from time to time in open market transactions, privately negotiated transactions, or other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time. For additional information on the share repurchase program, see “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources.” Item 6. Reserved Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes included in “Item 8—Financial Statements and Supplementary Data.” Item 7 of our Annual Report on Form 10-K generally discusses year-to-year comparisons between the years ended December 31, 2023 and 2022. In addition, with the exception of our Enact segment, this Form 10-K also includes discussions of information related to 2021 and year-to-year comparisons between 2022 and 2021, which have been re-presented to reflect the adoption of LDTI and the change in our operating segments. Detailed comparative discussions between 2022 and 2021 for our Enact segment, which was not impacted by the new accounting guidance or change in operating segments, can be found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” in our Annual Report on Form 10-K for the year ended December 31, 2022. Overview Our business Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s U.S. life insurance subsidiaries offer long-term care insurance and also manage in-force blocks of life insurance and annuity products which are no longer sold. We report our business results through three operating business segments: Enact; Long-Term Care Insurance; and Life and Annuities. In addition to our three operating segments, we report certain of our results of operations in Corporate and Other. Our financial information financial statements. The financial information in this Annual Report on Form 10-K has been derived from our consolidated Revenues and expenses Our revenues consist primarily of the following: • Premiums. Premiums consist primarily of premiums earned on insurance products for mortgage, long- term care and term life insurance. • Net investment income. Net investment income represents the income earned on our investments. For discussion of the change in net investment income, see the comparison for this line item under “—Investments and Derivative Instruments.” • Net investment gains (losses). Net investment gains (losses) consist primarily of realized gains and losses from the sale of our investments, credit losses, unrealized and realized gains and losses from our equity securities, limited partnership investments and derivative instruments. For discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” • Policy fees and other income. Policy fees and other income consists primarily of fees assessed against policyholder and contractholder account values, surrender charges, cost of insurance assessed on universal and term universal life insurance policies, advisory and administration service fees assessed on investment contractholder account values, broker/dealer commission revenues, fee revenue from contract underwriting services and other fees. 68 69 Dividends In November 2008, Genworth Financial’s Board of Directors suspended the payment of dividends to its shareholders indefinitely. In 2022, Genworth Financial’s Board of Directors approved a new share repurchase program. Any amounts used for the purpose of returning capital to Genworth Financial’s shareholders, including share repurchases or dividends if a new dividend policy is ultimately approved, will be dependent on many factors. These factors will include, in addition to any other factors that may arise in the future, the receipt of dividends and/or other returns of capital from Enact Holdings, Genworth’s operating results and financial condition, the capital requirements of our subsidiaries, legal requirements, regulatory constraints, debt obligations of Genworth Holdings and Enact Holdings, our credit and financial strength ratings, the capital needs of our subsidiaries for future growth and other factors Genworth Financial’s Board of Directors deems relevant. In addition, we cannot assure you when, whether or at what level we will resume paying dividends on Genworth See “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” for Financial’s common stock. additional information. Issuer Purchases of Common Stock three months ended December 31, 2023: The following table sets forth information regarding Genworth Financial’s share repurchases during the Total Approximate number of shares purchased as part of publicly announced program dollar amount of shares that may yet be purchased under the program (1) Total number of shares purchased Average price paid per share (Dollar amounts in millions, except per share amounts) October 1, 2023 through October 31, 2023 . . . . . . . . . . . . . 1,717,825 $5.82 1,717,825 November 1, 2023 through November 30, 2023 . . . . . . . . . 2,581,077 $5.81 2,581,077 December 1, 2023 through December 31, 2023 . . . . . . . . . 1,600,446 $6.14 1,600,446 $366 $351 $341 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,899,348 5,899,348 (1) On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial could repurchase up to $350 million of its outstanding Class A common stock. On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under the existing share repurchase program. Under the program, share repurchases may be made at the Company’s discretion from time to time in open market transactions, privately negotiated transactions, or other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time. For additional information on the share repurchase program, see “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources.” Item 6. Reserved Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes included in “Item 8—Financial Statements and Supplementary Data.” Item 7 of our Annual Report on Form 10-K generally discusses year-to-year comparisons between the years ended December 31, 2023 and 2022. In addition, with the exception of our Enact segment, this Form 10-K also includes discussions of information related to 2021 and year-to-year comparisons between 2022 and 2021, which have been re-presented to reflect the adoption of LDTI and the change in our operating segments. Detailed comparative discussions between 2022 and 2021 for our Enact segment, which was not impacted by the new accounting guidance or change in operating segments, can be found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” in our Annual Report on Form 10-K for the year ended December 31, 2022. Overview Our business Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s U.S. life insurance subsidiaries offer long-term care insurance and also manage in-force blocks of life insurance and annuity products which are no longer sold. We report our business results through three operating business segments: Enact; Long-Term Care Insurance; and Life and Annuities. In addition to our three operating segments, we report certain of our results of operations in Corporate and Other. Our financial information The financial information in this Annual Report on Form 10-K has been derived from our consolidated financial statements. Revenues and expenses Our revenues consist primarily of the following: • Premiums. Premiums consist primarily of premiums earned on insurance products for mortgage, long- term care and term life insurance. • Net investment income. Net investment income represents the income earned on our investments. For discussion of the change in net investment income, see the comparison for this line item under “—Investments and Derivative Instruments.” • Net investment gains (losses). Net investment gains (losses) consist primarily of realized gains and losses from the sale of our investments, credit losses, unrealized and realized gains and losses from our equity securities, limited partnership investments and derivative instruments. For discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” • Policy fees and other income. Policy fees and other income consists primarily of fees assessed against policyholder and contractholder account values, surrender charges, cost of insurance assessed on universal and term universal life insurance policies, advisory and administration service fees assessed on investment contractholder account values, broker/dealer commission revenues, fee revenue from contract underwriting services and other fees. 68 69 Our expenses consist primarily of the following: Consolidated Results of Operations • Benefits and other changes in policy reserves. Benefits and other changes in policy reserves consist primarily of benefits paid, interest accretion expense and other reserve activity related to current claims, as well as future policy benefits on insurance and investment products for long-term care insurance, life insurance, fixed and variable annuities, and claim costs incurred related to mortgage insurance products. • Liability remeasurement (gains) losses. Liability remeasurement (gains) losses represent changes to the net premium ratio for actual versus expected experience and updates to cash flow assumptions used to measure long-duration traditional and limited-payment insurance contracts. • Changes in fair value of market risk benefits and associated hedges. Changes in fair value of market risk benefits and associated hedges consist of fair value changes of market risk benefits (other than changes attributable to instrument-specific credit risk), net of changes in the fair value of non-qualified derivative instruments associated with our market risk benefits. • Interest credited. Interest credited represents interest credited on behalf of policyholder and contractholder general account balances. • Acquisition and operating expenses, net of deferrals. Acquisition and operating expenses, net of deferrals, represent costs and expenses related to the acquisition and ongoing maintenance of insurance and investment contracts, including commissions, policy issuance expenses and other underwriting and general operating costs. These costs and expenses are net of amounts that are capitalized and deferred, which are costs and expenses that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts, such as first-year commissions in excess of ultimate renewal commissions and other policy issuance expenses. We allocate corporate expenses to each of our operating segments using various methodologies. • Amortization of deferred acquisition costs and intangibles. Amortization of deferred acquisition costs (“DAC”) and intangibles consists primarily of the amortization of acquisition costs that are capitalized, present value of future profits and capitalized software. • Interest expense. Interest expense represents interest related to our borrowings that are incurred at Genworth Holdings or Enact Holdings, and certain reinsurance arrangements being accounted for as deposits. • Provision (benefit) for income taxes. We tax our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other. The effective tax rates disclosed herein are calculated using whole numbers. As a result, the percentages shown may differ from an effective tax rate calculated using rounded numbers. • Net income from continuing operations attributable to noncontrolling interests. Net income from continuing operations attributable to noncontrolling interests represents the portion of income from continuing operations in a subsidiary attributable to third parties. The following table sets forth the consolidated results of operations for the periods indicated: Years ended December 31, Increase (decrease) and percentage change 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 (Amounts in millions) Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,636 $3,680 $3,406 $ Net investment income . . . . . . . . . . . . . . . . . . . . . . 3,183 3,146 3,370 Net investment gains (losses) . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . 23 646 (2) 671 322 724 (44) 37 (1)% $ 274 1% (224) 25 NM(1) (324) (101)% (25) (4)% (53) Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . 7,488 7,495 7,822 (7) — % (327) 8% (7)% (7)% (4)% Benefits and expenses: Benefits and other changes in policy reserves . . . . Liability remeasurement (gains) losses . . . . . . . . . 4,783 587 4,303 (290) 4,575 242 480 11% 877 NM(1) (272) (6)% (532) NM(1) Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition and operating expenses, net of (12) 503 (104) 504 (160) 511 92 88% (1) — % 56 (7) 35% (1)% deferrals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 942 1,285 998 (343) (27)% 287 29% Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . 264 118 326 106 384 160 Total benefits and expenses . . . . . . . . . . . . . . 7,185 6,130 6,710 1,055 (62) (19)% 12 11% 17% (58) (54) (15)% (34)% (580) (9)% Income from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision for income taxes . . . . . . . . . . . . . . . . . . . Income from continuing operations . . . . . . . . . . . . Income from discontinued operations, net of taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations Less: net income from discontinued operations 303 104 199 — 199 1,365 319 1,046 — 1,046 1,112 (1,062) (78)% (67)% (215) (847) (81)% 253 71 182 23% 29% 21% — — % (27) (100)% (847) (81)% 155 17% 248 864 27 891 33 8 attributable to noncontrolling interests . . . . . . . . 123 130 (7) (5)% 97 NM(1) attributable to noncontrolling interests . . . . . . . . — — — — % (8) (100)% Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . $ 76 $ 916 $ 850 $ (840) (92)% $ 66 8% Net income available to Genworth Financial, Inc.’s common stockholders: Income from continuing operations available to Genworth Financial, Inc.’s common Income from discontinued operations available to Genworth Financial, Inc.’s stockholders . . . . . . . . . . . . . . . . . . . . . . . . $ 76 $ 916 $ 831 $ (840) (92)% $ 85 10% common stockholders . . . . . . . . . . . . . . . . . — — 19 — — % (19) (100)% Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . $ 76 $ 916 $ 850 $ (840) (92)% $ 66 8% (1) We define “NM” as not meaningful for increases or decreases greater than 200%. 70 71 Our expenses consist primarily of the following: Consolidated Results of Operations • Benefits and other changes in policy reserves. Benefits and other changes in policy reserves consist primarily of benefits paid, interest accretion expense and other reserve activity related to current claims, as well as future policy benefits on insurance and investment products for long-term care insurance, life insurance, fixed and variable annuities, and claim costs incurred related to mortgage insurance products. • Liability remeasurement (gains) losses. Liability remeasurement (gains) losses represent changes to the net premium ratio for actual versus expected experience and updates to cash flow assumptions used to measure long-duration traditional and limited-payment insurance contracts. • Changes in fair value of market risk benefits and associated hedges. Changes in fair value of market risk benefits and associated hedges consist of fair value changes of market risk benefits (other than changes attributable to instrument-specific credit risk), net of changes in the fair value of non-qualified derivative instruments associated with our market risk benefits. • Interest credited. Interest credited represents interest credited on behalf of policyholder and contractholder general account balances. • Acquisition and operating expenses, net of deferrals. Acquisition and operating expenses, net of deferrals, represent costs and expenses related to the acquisition and ongoing maintenance of insurance and investment contracts, including commissions, policy issuance expenses and other underwriting and general operating costs. These costs and expenses are net of amounts that are capitalized and deferred, which are costs and expenses that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts, such as first-year commissions in excess of ultimate renewal commissions and other policy issuance expenses. We allocate corporate expenses to each of our operating segments using various methodologies. • Amortization of deferred acquisition costs and intangibles. Amortization of deferred acquisition costs (“DAC”) and intangibles consists primarily of the amortization of acquisition costs that are capitalized, present value of future profits and capitalized software. • Interest expense. Interest expense represents interest related to our borrowings that are incurred at Genworth Holdings or Enact Holdings, and certain reinsurance arrangements being accounted for as deposits. • Provision (benefit) for income taxes. We tax our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other. The effective tax rates disclosed herein are calculated using whole numbers. As a result, the percentages shown may differ from an effective tax rate calculated using rounded numbers. • Net income from continuing operations attributable to noncontrolling interests. Net income from continuing operations attributable to noncontrolling interests represents the portion of income from continuing operations in a subsidiary attributable to third parties. The following table sets forth the consolidated results of operations for the periods indicated: Years ended December 31, Increase (decrease) and percentage change (Amounts in millions) 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment income . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . $3,636 $3,680 $3,406 $ 3,146 3,183 (2) 23 671 646 3,370 322 724 8% (1)% $ 274 (44) (224) 37 (7)% 1% (324) (101)% 25 NM(1) (7)% (53) (4)% (25) Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . 7,488 7,495 7,822 (7) — % (327) (4)% Benefits and expenses: Benefits and other changes in policy reserves . . . . Liability remeasurement (gains) losses . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest credited Acquisition and operating expenses, net of 4,783 587 4,303 (290) 4,575 242 11% 480 877 NM(1) (6)% (272) (532) NM(1) (12) 503 (104) 504 (160) 511 92 88% (1) — % 56 (7) 35% (1)% deferrals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 942 1,285 998 (343) (27)% 287 29% Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . 264 118 326 106 384 160 (62) 12 (19)% 11% (58) (54) (15)% (34)% Total benefits and expenses . . . . . . . . . . . . . . 7,185 6,130 6,710 1,055 17% (580) (9)% Income from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision for income taxes . . . . . . . . . . . . . . . . . . . Income from continuing operations . . . . . . . . . . . . Income from discontinued operations, net of taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations 303 104 199 — 199 1,365 319 1,046 — 1,046 attributable to noncontrolling interests . . . . . . . . 123 130 Less: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . — — Net income available to Genworth Financial, 1,112 248 (1,062) (215) (78)% (67)% 864 (847) (81)% 253 71 182 23% 29% 21% 27 891 33 8 — — % (27) (100)% (847) (81)% 155 17% (7) (5)% 97 NM(1) — — % (8) (100)% Inc.’s common stockholders . . . . . . . . . . . . . . . . $ 76 $ 916 $ 850 $ (840) (92)% $ 66 8% Net income available to Genworth Financial, Inc.’s common stockholders: Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . $ 76 $ 916 $ 831 $ (840) (92)% $ 85 10% — — 19 — — % (19) (100)% $ 76 $ 916 $ 850 $ (840) (92)% $ 66 8% (1) We define “NM” as not meaningful for increases or decreases greater than 200%. 70 71 Unless otherwise stated, all references to net income (loss), net income (loss) per share, adjusted operating income (loss) and adjusted operating income (loss) per share found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read as net income (loss) available to Genworth Financial, Inc.’s common stockholders, net income (loss) available to Genworth Financial, Inc.’s common stockholders per share, adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders and adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share, respectively. Use of non-GAAP measures Reconciliation of net income (loss) to adjusted operating income (loss) Management uses non-GAAP financial measures entitled “adjusted operating income (loss)” and “adjusted operating income (loss) per share” to evaluate performance and allocate resources. Adjusted operating income (loss) per share is derived from adjusted operating income (loss). We define adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) from continuing operations attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. We exclude net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) because, in our opinion, they are not indicative of overall operating performance. While some of these items may be significant components of net income (loss) in accordance with U.S. GAAP, we believe that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), including adjusted operating income (loss) per share on a basic and diluted basis, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss), among other key performance indicators, as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) and adjusted operating income (loss) per share on a basic and diluted basis are not substitutes for net income (loss) or net income (loss) per share on a basic and diluted basis determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) may differ from the definitions used by other companies. Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments. The following table presents a reconciliation of net income to adjusted operating income for the years ended December 31: (Amounts in millions) 2023 2022 2021 Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 76 $ 916 $ 850 Add: net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 130 33 Add: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: income from discontinued operations, net of taxes . . . . . . . . . . . . . . . Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to noncontrolling — 199 — 199 — 1,046 — 1,046 8 891 27 864 interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 130 33 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76 916 831 Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: Net investment (gains) losses, net (1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (25) 2 (322) Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges (2) . . . . . . . . . . . . . . . . . . . . . . . . . (142) (210) (Gains) losses on early extinguishment of debt (3) . . . . . . . . . . . . . . . . . . . . Expenses related to restructuring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Pension plan termination costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Taxes on adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjusted operating income available to Genworth Financial, Inc.’s (22) (2) 4 — 10 6 2 8 26 45 34 — 96 common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 41 $ 818 $ 474 (1) For the year ended December 31, 2023, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $2 million. (2) Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(10) million, $(38) million and $(50) million for the years ended December 31, 2023, 2022 and 2021, respectively. (3) See note 17 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information on (gains) losses on early extinguishment of debt during 2023 and 2022. During 2021, we paid pre-tax make-whole premiums of $26 million and incurred pre-tax losses of $19 million in connection with the early redemption and repurchase of certain of Genworth Holdings’ senior notes. Other than pension plan termination costs incurred in 2022 related to one of our defined benefit pension plans, there were no infrequent or unusual items excluded from adjusted operating income during the periods presented. 72 73 Unless otherwise stated, all references to net income (loss), net income (loss) per share, adjusted operating income (loss) and adjusted operating income (loss) per share found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read as net income (loss) available to Genworth Financial, Inc.’s common stockholders, net income (loss) available to Genworth Financial, Inc.’s common stockholders per share, adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders and adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share, respectively. Use of non-GAAP measures Reconciliation of net income (loss) to adjusted operating income (loss) Management uses non-GAAP financial measures entitled “adjusted operating income (loss)” and “adjusted operating income (loss) per share” to evaluate performance and allocate resources. Adjusted operating income (loss) per share is derived from adjusted operating income (loss). We define adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) from continuing operations attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. We exclude net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) because, in our opinion, they are not indicative of overall operating performance. While some of these items may be significant components of net income (loss) in accordance with U.S. GAAP, we believe that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), including adjusted operating income (loss) per share on a basic and diluted basis, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss), among other key performance indicators, as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) and adjusted operating income (loss) per share on a basic and diluted basis are not substitutes for net income (loss) or net income (loss) per share on a basic and diluted basis determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) may differ from the definitions used by other companies. Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments. The following table presents a reconciliation of net income to adjusted operating income for the years ended December 31: (Amounts in millions) Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Add: net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Add: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: income from discontinued operations, net of taxes . . . . . . . . . . . . . . . Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: 2023 2022 2021 $ 76 $ 916 $ 850 123 — 199 — 199 123 130 33 — 1,046 — 1,046 8 891 27 864 130 33 76 916 831 Net investment (gains) losses, net (1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges (2) . . . . . . . . . . . . . . . . . . . . . . . . . (Gains) losses on early extinguishment of debt (3) . . . . . . . . . . . . . . . . . . . . Expenses related to restructuring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Pension plan termination costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Taxes on adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (25) (22) (2) 4 — 10 2 (322) (142) 6 2 8 26 (210) 45 34 — 96 Adjusted operating income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 41 $ 818 $ 474 (1) For the year ended December 31, 2023, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $2 million. (2) Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(10) million, $(38) million and $(50) million for the years ended December 31, 2023, 2022 and 2021, respectively. (3) See note 17 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information on (gains) losses on early extinguishment of debt during 2023 and 2022. During 2021, we paid pre-tax make-whole premiums of $26 million and incurred pre-tax losses of $19 million in connection with the early redemption and repurchase of certain of Genworth Holdings’ senior notes. Other than pension plan termination costs incurred in 2022 related to one of our defined benefit pension plans, there were no infrequent or unusual items excluded from adjusted operating income during the periods presented. 72 73 Earnings per share Executive Summary of Consolidated Financial Results The following table provides basic and diluted earnings per common share for the periods indicated: (Amounts in millions, except per share amounts) 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Years ended December 31, Increase (decrease) and percentage change Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Below is an executive summary of our consolidated financial results for the periods indicated. Amounts included within this “Executive Summary of Consolidated Financial Results” are net of taxes, unless otherwise indicated. After-tax amounts assume a tax rate of 21%. For a discussion of selected financial information and detailed descriptions of operating performance measures, see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment.” Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.82 $ 1.64 $(1.66) (91)% $0.18 11% Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.79 $ 1.61 $(1.63) (91)% $0.18 11% 2023 compared to 2022 Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.82 $ 1.68 $(1.66) (91)% $0.14 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.79 $ 1.65 $(1.63) (91)% $0.14 8% 8% Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.09 $ 1.62 $ 0.93 $(1.53) (94)% $0.69 74% Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.09 $ 1.60 $ 0.92 $(1.51) (94)% $0.68 74% Weighted-average common shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 468.8 504.4 506.9 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 474.9 510.9 514.7 Diluted weighted-average common shares outstanding reflect the effects of potentially dilutive securities including performance stock units, restricted stock units and other equity-based awards. The following table presents a summary of adjusted operating income (loss) for our segments and Corporate • We also experienced higher operating costs and lower premiums in 2023. and Other for the periods indicated: (Amounts in millions) Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance segment . . . . . . . . . . . . . . . . . Life and Annuities segment: Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Variable annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . Life and Annuities segment . . . . . . . . . . . . . . . . . . . . . . . . Corporate and Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjusted operating income available to Genworth Years ended December 31, 2022 2021 2023 Increase (decrease) and percentage change 2023 vs. 2022 2022 vs. 2021 $ 552 $ 578 $ 520 $ (26) (242) 11% (4)% $ 58 (562) (176)% 194 154% 320 126 (275) 50 37 (188) (81) (111) 62 21 (28) (52) (201) 83 22 (164) (148)% (19)% (12) 76% 16 90 45% (21) (25)% (5)% (1) (96) (160) NM(1) (76) (29) (56)% 68 24 71% 32% Financial, Inc.’s common stockholders . . . . . . . . . . . . . $ 41 $ 818 $ 474 $(777) (95)% $344 73% (1) We define “NM” as not meaningful for increases or decreases greater than 200%. • Adjusted operating income increased predominantly due to aging of our in-force block, partially offset by a decrease in fee income driven by lower account value in 74 75 • Net income in 2023 and 2022 was $76 million and $916 million, respectively, and adjusted operating income was $41 million and $818 million, respectively. Adjusted operating income (loss) highlights were as follows: • Enact segment • Adjusted operating income decreased primarily attributable to higher losses on new delinquencies and lower favorable reserve adjustments, partially offset by higher net investment income, higher premiums and lower operating costs in 2023. • Long-Term Care Insurance segment • The change to an adjusted operating loss in 2023 from adjusted operating income in 2022 was largely driven by unfavorable cash flow assumption updates in 2023 compared to favorable updates in 2022. • The change was also driven by adverse actual versus expected experience in 2023 primarily related to higher claims and unfavorable timing impacts related to a legal settlement. • The adjusted operating loss increased largely from $179 million of unfavorable updates to our persistency and mortality assumptions, as well as lower premiums reflecting runoff of our in-force blocks in 2023. • These adverse developments were partially offset by lower DAC amortization related to higher lapses in 2022 and a $20 million legal settlement expense in 2022 • Adjusted operating income decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality experience • Life and Annuities segment • Life insurance: that did not recur. • Fixed annuities: in 2023. • Variable annuities: 2023. Earnings per share Executive Summary of Consolidated Financial Results The following table provides basic and diluted earnings per common share for the periods indicated: (Amounts in millions, except per share amounts) 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Years ended December 31, Increase (decrease) and percentage change Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Below is an executive summary of our consolidated financial results for the periods indicated. Amounts included within this “Executive Summary of Consolidated Financial Results” are net of taxes, unless otherwise indicated. After-tax amounts assume a tax rate of 21%. For a discussion of selected financial information and detailed descriptions of operating performance measures, see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment.” Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.82 $ 1.64 $(1.66) (91)% $0.18 11% Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.79 $ 1.61 $(1.63) (91)% $0.18 11% 2023 compared to 2022 • Net income in 2023 and 2022 was $76 million and $916 million, respectively, and adjusted operating income was $41 million and $818 million, respectively. Adjusted operating income (loss) highlights were as follows: • Enact segment • Adjusted operating income decreased primarily attributable to higher losses on new delinquencies and lower favorable reserve adjustments, partially offset by higher net investment income, higher premiums and lower operating costs in 2023. • Long-Term Care Insurance segment • The change to an adjusted operating loss in 2023 from adjusted operating income in 2022 was largely driven by unfavorable cash flow assumption updates in 2023 compared to favorable updates in 2022. • The change was also driven by adverse actual versus expected experience in 2023 primarily related to higher claims and unfavorable timing impacts related to a legal settlement. The following table presents a summary of adjusted operating income (loss) for our segments and Corporate • We also experienced higher operating costs and lower premiums in 2023. • Life and Annuities segment • Life insurance: • The adjusted operating loss increased largely from $179 million of unfavorable updates to our persistency and mortality assumptions, as well as lower premiums reflecting runoff of our in-force blocks in 2023. • These adverse developments were partially offset by lower DAC amortization related to higher lapses in 2022 and a $20 million legal settlement expense in 2022 that did not recur. • Fixed annuities: • Adjusted operating income decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality experience in 2023. • Variable annuities: • Adjusted operating income increased predominantly due to aging of our in-force block, partially offset by a decrease in fee income driven by lower account value in 2023. 74 75 Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.82 $ 1.68 $(1.66) (91)% $0.14 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.79 $ 1.65 $(1.63) (91)% $0.14 8% 8% Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.09 $ 1.62 $ 0.93 $(1.53) (94)% $0.69 74% Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.09 $ 1.60 $ 0.92 $(1.51) (94)% $0.68 74% Weighted-average common shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 468.8 504.4 506.9 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 474.9 510.9 514.7 Diluted weighted-average common shares outstanding reflect the effects of potentially dilutive securities including performance stock units, restricted stock units and other equity-based awards. and Other for the periods indicated: Years ended December 31, Increase (decrease) and percentage change (Amounts in millions) 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 552 $ 578 $ 520 $ (26) (4)% $ 58 11% Long-Term Care Insurance segment . . . . . . . . . . . . . . . . . (242) 320 126 (562) (176)% 194 154% Life and Annuities segment: Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (275) (111) (201) (164) (148)% 90 45% Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Variable annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50 37 83 22 (12) (19)% (21) (25)% 16 76% (1) (5)% Life and Annuities segment . . . . . . . . . . . . . . . . . . . . . . . . (188) (96) (160) NM(1) Corporate and Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (81) (76) (29) (56)% 68 24 71% 32% 62 21 (28) (52) Adjusted operating income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . $ 41 $ 818 $ 474 $(777) (95)% $344 73% (1) We define “NM” as not meaningful for increases or decreases greater than 200%. • Corporate and Other • The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives and higher interest expense attributable to Genworth Holdings’ junior subordinated notes, partially offset by higher net investment income in 2023. 2022 compared to 2021 • Net income in 2022 and 2021 was $916 million and $850 million, respectively, and adjusted operating income was $818 million and $474 million, respectively. Adjusted operating income (loss) highlights were as follows: • Enact segment • Adjusted operating income increased primarily attributable to lower losses largely driven by net favorable reserve adjustments of $212 million, consisting of reserve releases of $248 million primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations, partially offset by reserve strengthening of $36 million related to 2022 delinquencies given uncertainty in the economic environment. • This improvement was partially offset by the minority initial public offering of Enact Holdings that closed in September 2021, which reduced Genworth Financial’s ownership percentage to 81.6%. • The improvement was also partially offset by lower premiums in 2022. • Long-Term Care Insurance segment • Adjusted operating income increased largely driven by favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of a legal settlement, partially offset by lower net investment income in 2022. • Life and Annuities segment • Life insurance: • The adjusted operating loss decreased largely from favorable cash flow assumption updates in our universal and term universal life insurance products in 2022 related to higher interest rates compared to unfavorable cash flow assumption updates in 2021 primarily driven by unfavorable pre-COVID-19 mortality. • The decrease was also attributable to lower DAC amortization primarily driven by lapse experience in our term life insurance products. • Fixed annuities: • Adjusted operating income decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality in 2022. • Corporate and Other • The adjusted operating loss decreased primarily related to lower interest expense in 2022, partially offset by tax benefits of $21 million in 2021 from a reduction in uncertain tax positions due to the expiration of certain statute of limitations that did not recur. Significant Developments and Strategic Highlights Enact segment • Mortgage insurance portfolio. Enact’s primary persistency rate was 85% during 2023 compared to 80% during 2022. Elevated persistency continued to offset a decline in new insurance written, contributing to insurance in-force growth in 2023. New insurance written decreased 20% during 2023 compared to 2022 mostly from a decline in originations due to elevated interest rates. • Loss performance. Enact recorded favorable pre-tax reserve releases of $241 million in 2023 primarily related to favorable cure performance on 2022 and prior delinquencies, including those related to COVID-19. New primary delinquencies in 2023 increased compared to 2022 largely due to the aging of large, new books of business. • Capital. Enact’s PMIERs sufficiency ratio was 161% or $1,887 million above the PMIERs requirements as of December 31, 2023. • Capital returns. Genworth Holdings received $245 million of capital returns from Enact Holdings during 2023. Long-Term Care Insurance segment • In-force rate actions. We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan from 2012 through 2023 was approximately $28.0 billion, on a net present value basis, which includes our current updated assumptions regarding future premiums and benefit reductions from approved rate actions and legal settlements as described in “Results of Operations and Selected Financial and Operating Performance Measures by Segment.” This estimated cumulative economic benefit reflects progress of approximately 84% toward our latest estimate of approximately $33.3 billion total net present value of premium increases and benefit reductions contemplated in our multi-year in-force rate action plan, which also takes into account our current updated assumptions. As a result, based on current assumptions, the remaining estimated amount to be achieved through future rate action approvals under our in-force rate action plan was reduced by $1.5 billion in 2023 to approximately $5.3 billion. • Claims. We expect higher paid claims in our long-term care insurance business as our blocks age with peak claim years over a decade away. Paid claims on newer products continue to increase as policyholders approach peak claim age, while claims on our older products decline as those policyholders are past peak claim age. We also expect overall claim costs to continue to increase as the approximately 625,000 insured individuals in our two largest blocks, Choice I and Choice II, with average attained ages of 77 and 74, respectively, reach their peak claim years, which are over age 85. • Actual to expected experience. Unfavorable pre-tax actual versus expected experience of $269 million in 2023 was primarily driven by higher claims and unfavorable timing impacts related to a legal settlement. • Annual assumption review. As part of our annual review of assumptions in the fourth quarter of 2023, our long-term care insurance business had unfavorable pre-tax impacts of $61 million from cash flow assumption updates. We made unfavorable updates to our healthy life assumptions to better reflect near-term experience for cost of care, mortality, incidence and lapse rates, partially offset by a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. See “—Critical Accounting Estimates— Liability for future policy benefits” for additional information on the impact of changes in our long- term care insurance cash flow assumptions. Assumption updates also included changes for future in-force rate action approvals and benefit reductions based on recent favorable experience and reflect a recent legal settlement that primarily impacted uncapped cohorts. Life and Annuities segment • As part of our annual review of assumptions in the fourth quarter of 2023, our life insurance business had unfavorable pre-tax impacts of $226 million from cash flow assumption updates. We made 76 77 • Corporate and Other • The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives and higher interest expense attributable to Genworth Holdings’ junior subordinated notes, partially offset by higher net investment income in 2023. 2022 compared to 2021 • Net income in 2022 and 2021 was $916 million and $850 million, respectively, and adjusted operating income was $818 million and $474 million, respectively. Adjusted operating income (loss) highlights were as follows: • Enact segment • Adjusted operating income increased primarily attributable to lower losses largely driven by net favorable reserve adjustments of $212 million, consisting of reserve releases of $248 million primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations, partially offset by reserve strengthening of $36 million related to 2022 delinquencies given uncertainty in the economic environment. • This improvement was partially offset by the minority initial public offering of Enact Holdings that closed in September 2021, which reduced Genworth Financial’s ownership percentage to 81.6%. • The improvement was also partially offset by lower premiums in 2022. • Long-Term Care Insurance segment • Adjusted operating income increased largely driven by favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of a legal settlement, partially offset by lower net investment income in 2022. • Life and Annuities segment • Life insurance: • The adjusted operating loss decreased largely from favorable cash flow assumption updates in our universal and term universal life insurance products in 2022 related to higher interest rates compared to unfavorable cash flow assumption updates in 2021 primarily driven by unfavorable pre-COVID-19 mortality. • The decrease was also attributable to lower DAC amortization primarily driven by lapse experience in our term life insurance products. • Fixed annuities: • Corporate and Other • Adjusted operating income decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality in 2022. • The adjusted operating loss decreased primarily related to lower interest expense in 2022, partially offset by tax benefits of $21 million in 2021 from a reduction in uncertain tax positions due to the expiration of certain statute of limitations that did not recur. Significant Developments and Strategic Highlights Enact segment • Mortgage insurance portfolio. Enact’s primary persistency rate was 85% during 2023 compared to 80% during 2022. Elevated persistency continued to offset a decline in new insurance written, contributing to insurance in-force growth in 2023. New insurance written decreased 20% during 2023 compared to 2022 mostly from a decline in originations due to elevated interest rates. • Loss performance. Enact recorded favorable pre-tax reserve releases of $241 million in 2023 primarily related to favorable cure performance on 2022 and prior delinquencies, including those related to COVID-19. New primary delinquencies in 2023 increased compared to 2022 largely due to the aging of large, new books of business. • Capital. Enact’s PMIERs sufficiency ratio was 161% or $1,887 million above the PMIERs requirements as of December 31, 2023. • Capital returns. Genworth Holdings received $245 million of capital returns from Enact Holdings during 2023. Long-Term Care Insurance segment • In-force rate actions. We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan from 2012 through 2023 was approximately $28.0 billion, on a net present value basis, which includes our current updated assumptions regarding future premiums and benefit reductions from approved rate actions and legal settlements as described in “Results of Operations and Selected Financial and Operating Performance Measures by Segment.” This estimated cumulative economic benefit reflects progress of approximately 84% toward our latest estimate of approximately $33.3 billion total net present value of premium increases and benefit reductions contemplated in our multi-year in-force rate action plan, which also takes into account our current updated assumptions. As a result, based on current assumptions, the remaining estimated amount to be achieved through future rate action approvals under our in-force rate action plan was reduced by $1.5 billion in 2023 to approximately $5.3 billion. • Claims. We expect higher paid claims in our long-term care insurance business as our blocks age with peak claim years over a decade away. Paid claims on newer products continue to increase as policyholders approach peak claim age, while claims on our older products decline as those policyholders are past peak claim age. We also expect overall claim costs to continue to increase as the approximately 625,000 insured individuals in our two largest blocks, Choice I and Choice II, with average attained ages of 77 and 74, respectively, reach their peak claim years, which are over age 85. • Actual to expected experience. Unfavorable pre-tax actual versus expected experience of $269 million in 2023 was primarily driven by higher claims and unfavorable timing impacts related to a legal settlement. • Annual assumption review. As part of our annual review of assumptions in the fourth quarter of 2023, our long-term care insurance business had unfavorable pre-tax impacts of $61 million from cash flow assumption updates. We made unfavorable updates to our healthy life assumptions to better reflect near-term experience for cost of care, mortality, incidence and lapse rates, partially offset by a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. See “—Critical Accounting Estimates— Liability for future policy benefits” for additional information on the impact of changes in our long- term care insurance cash flow assumptions. Assumption updates also included changes for future in-force rate action approvals and benefit reductions based on recent favorable experience and reflect a recent legal settlement that primarily impacted uncapped cohorts. Life and Annuities segment • As part of our annual review of assumptions in the fourth quarter of 2023, our life insurance business had unfavorable pre-tax impacts of $226 million from cash flow assumption updates. We made 76 77 unfavorable cash flow assumption updates to our persistency assumptions in our universal life insurance products with secondary guarantees to better reflect emerging experience. We also made unfavorable updates to our mortality assumptions in our term universal, universal and term life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term post- COVID-19, similar to long-term care insurance. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in our life insurance cash flow assumptions. Capital of U.S. life insurance subsidiaries • As of December 31, 2023 and 2022, the consolidated RBC ratio on a company action level basis of our U.S. domiciled life insurance subsidiaries was approximately 303% and 291%, respectively. The increase was primarily driven by earnings in our annuity products, including a net benefit to variable annuities from the impact of equity market and interest rate performance, as well as a net favorable impact from assumption updates primarily in our life insurance products in 2023. Genworth Financial share repurchase program • Genworth Financial executed $295 million in share repurchases, excluding excise taxes and other associated costs, during 2023. Results of Operations and Selected Financial and Operating Performance Measures by Segment Management’s discussion and analysis by segment contains selected operating performance measures including “sales” and “insurance in-force” or “risk in-force” which are commonly used in the insurance industry as measures of operating performance. Management regularly monitors and reports sales metrics as a measure of volume of new business generated in a period. Sales refer to new insurance written for mortgage insurance products included in our Enact segment. We consider new insurance written to be a measure of our Enact segment’s operating performance because it represents a measure of new sales of insurance policies during a specified period, rather than a measure of revenues or profitability during that period. Management also regularly monitors and reports insurance in-force and risk in-force for our Enact segment. Insurance in-force is a measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by our U.S. mortgage insurance subsidiaries. Risk in-force is based on the coverage percentage applied to the estimated current outstanding loan balance. We consider insurance in-force and risk in-force to be measures of our Enact segment’s operating performance because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period. These metrics are presented on a direct basis and exclude reinsurance. Management also regularly monitors and reports a loss ratio for our Enact segment. The loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums, and we consider it to be a measure of underwriting performance and helps to enhance the understanding of the operating performance of our Enact segment. Management regularly monitors and reports on in-force rate actions, including state filing approvals; impacted in-force premiums; weighted-average percentage rate increases approved; and gross incremental premiums approved in our Long-Term Care Insurance segment. We also estimate the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan on a net present value basis, discounted at our investment portfolio yield. This is defined as the net present value of historical and future expected premium increases and benefit reductions as a result of rate increases approved on individual and group long-term care insurance policies and reserve reductions related to legal settlements less cash payments made to policyholders who elect certain reduced benefit options in connection with the legal settlements, referred to as settlement payments. We monitor these selected operating performance measures for in-force rate actions to track our progress on ensuring the continued self-sustainability of our long-term care insurance business over time. We consider these in-force rate actions metrics to be measures of financial performance and help to enhance the understanding of the operating performance of our Long-Term Care Insurance segment. These operating performance measures enable us to compare our operating performance across periods without regard to revenues or profitability related to policies or contracts sold in prior periods or from investments or other sources. Enact segment Trends and conditions Results of our Enact segment are affected primarily by the following factors: competitor actions; unemployment or underemployment levels; other economic and housing market trends, including interest rates, home prices, the number of first-time homebuyers, and mortgage origination volume mix and practices; the size of the overall private mortgage insurance market and the effect of regulatory actions thereon; the levels and aging of mortgage delinquencies; the effect of seasonal variations; the inventory of unsold homes; loan modification and other servicing efforts; and litigation, among other items. References to “Enact” included herein “Item 7— Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” are, unless the context otherwise requires, to our Enact segment. Macroeconomic environment Mortgage origination activity remained slow throughout 2023 in response to elevated mortgage rates and sustained low housing supply. Housing affordability continued to deteriorate due to high interest rates and elevated home prices, only marginally offset by rising median family income, according to the National Association of Realtors Housing Affordability Index. National home prices rose modestly throughout 2023, according to the FHFA Monthly Purchase-Only House Price Index. The unemployment rate increased to 3.7% in December 2023, compared to 3.5% in December 2022. As of December 31, 2023, the number of unemployed Americans was approximately 6.3 million, and the number of long term unemployed over 26 weeks was approximately 1.2 million. Both metrics remain relatively in line with pre-pandemic levels in February 2020. Forbearance and loss mitigation programs For mortgages insured by the federal government (including those purchased by Fannie Mae and Freddie Mac), COVID-19 forbearance allowed borrowers impacted by COVID-19 to temporarily suspend mortgage payments up to 18 months subject to certain limits. However, the Biden Administration ended the national emergency for COVID-19 in April 2023, and as a result, the deadline for requesting a COVID-19 related forbearance under the CARES Act ended in August 2023. The GSEs retired their COVID-19 servicing-related policies including with respect to forbearance effective November 1, 2023 and reverted to standard forbearance policies as a loss mitigation option for borrowers that meet general hardship and program guidelines. In March 2023, the GSEs announced new loss mitigation programs that allow six-month payment deferrals for borrowers facing financial hardship and encouraged servicers to start evaluating borrowers for these programs as early as July 1, 2023 but no later than October 1, 2023. Even though most foreclosure moratoriums expired at the end of 2021, federal laws and regulations continue to require servicers to discuss loss mitigation options with borrowers before proceeding with foreclosures. These requirements could further extend foreclosure timelines, which could negatively impact the severity of loss on loans that go to claim. 78 79 unfavorable cash flow assumption updates to our persistency assumptions in our universal life insurance products with secondary guarantees to better reflect emerging experience. We also made unfavorable updates to our mortality assumptions in our term universal, universal and term life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term post- COVID-19, similar to long-term care insurance. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in our life insurance cash flow assumptions. Capital of U.S. life insurance subsidiaries • As of December 31, 2023 and 2022, the consolidated RBC ratio on a company action level basis of our U.S. domiciled life insurance subsidiaries was approximately 303% and 291%, respectively. The increase was primarily driven by earnings in our annuity products, including a net benefit to variable annuities from the impact of equity market and interest rate performance, as well as a net favorable impact from assumption updates primarily in our life insurance products in 2023. Genworth Financial share repurchase program • Genworth Financial executed $295 million in share repurchases, excluding excise taxes and other associated costs, during 2023. Results of Operations and Selected Financial and Operating Performance Measures by Segment Management’s discussion and analysis by segment contains selected operating performance measures including “sales” and “insurance in-force” or “risk in-force” which are commonly used in the insurance industry as measures of operating performance. Management regularly monitors and reports sales metrics as a measure of volume of new business generated in a period. Sales refer to new insurance written for mortgage insurance products included in our Enact segment. We consider new insurance written to be a measure of our Enact segment’s operating performance because it represents a measure of new sales of insurance policies during a specified period, rather than a measure of revenues or profitability during that period. Management also regularly monitors and reports insurance in-force and risk in-force for our Enact segment. Insurance in-force is a measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by our U.S. mortgage insurance subsidiaries. Risk in-force is based on the coverage percentage applied to the estimated current outstanding loan balance. We consider insurance in-force and risk in-force to be measures of our Enact segment’s operating performance because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period. These metrics are presented on a direct basis and exclude reinsurance. Management also regularly monitors and reports a loss ratio for our Enact segment. The loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums, and we consider it to be a measure of underwriting performance and helps to enhance the understanding of the operating performance of our Enact segment. Management regularly monitors and reports on in-force rate actions, including state filing approvals; impacted in-force premiums; weighted-average percentage rate increases approved; and gross incremental premiums approved in our Long-Term Care Insurance segment. We also estimate the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan on a net present value basis, discounted at our investment portfolio yield. This is defined as the net present value of historical and future expected premium increases and benefit reductions as a result of rate increases approved on individual and group long-term care insurance policies and reserve reductions related to legal settlements less cash payments made to policyholders who elect certain reduced benefit options in connection with the legal settlements, referred to as settlement payments. We monitor these selected operating performance measures for in-force rate actions to track our progress on ensuring the continued self-sustainability of our long-term care insurance business over time. We consider these in-force rate actions metrics to be measures of financial performance and help to enhance the understanding of the operating performance of our Long-Term Care Insurance segment. These operating performance measures enable us to compare our operating performance across periods without regard to revenues or profitability related to policies or contracts sold in prior periods or from investments or other sources. Enact segment Trends and conditions Results of our Enact segment are affected primarily by the following factors: competitor actions; unemployment or underemployment levels; other economic and housing market trends, including interest rates, home prices, the number of first-time homebuyers, and mortgage origination volume mix and practices; the size of the overall private mortgage insurance market and the effect of regulatory actions thereon; the levels and aging of mortgage delinquencies; the effect of seasonal variations; the inventory of unsold homes; loan modification and other servicing efforts; and litigation, among other items. References to “Enact” included herein “Item 7— Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” are, unless the context otherwise requires, to our Enact segment. Macroeconomic environment Mortgage origination activity remained slow throughout 2023 in response to elevated mortgage rates and sustained low housing supply. Housing affordability continued to deteriorate due to high interest rates and elevated home prices, only marginally offset by rising median family income, according to the National Association of Realtors Housing Affordability Index. National home prices rose modestly throughout 2023, according to the FHFA Monthly Purchase-Only House Price Index. The unemployment rate increased to 3.7% in December 2023, compared to 3.5% in December 2022. As of December 31, 2023, the number of unemployed Americans was approximately 6.3 million, and the number of long term unemployed over 26 weeks was approximately 1.2 million. Both metrics remain relatively in line with pre-pandemic levels in February 2020. Forbearance and loss mitigation programs For mortgages insured by the federal government (including those purchased by Fannie Mae and Freddie Mac), COVID-19 forbearance allowed borrowers impacted by COVID-19 to temporarily suspend mortgage payments up to 18 months subject to certain limits. However, the Biden Administration ended the national emergency for COVID-19 in April 2023, and as a result, the deadline for requesting a COVID-19 related forbearance under the CARES Act ended in August 2023. The GSEs retired their COVID-19 servicing-related policies including with respect to forbearance effective November 1, 2023 and reverted to standard forbearance policies as a loss mitigation option for borrowers that meet general hardship and program guidelines. In March 2023, the GSEs announced new loss mitigation programs that allow six-month payment deferrals for borrowers facing financial hardship and encouraged servicers to start evaluating borrowers for these programs as early as July 1, 2023 but no later than October 1, 2023. Even though most foreclosure moratoriums expired at the end of 2021, federal laws and regulations continue to require servicers to discuss loss mitigation options with borrowers before proceeding with foreclosures. These requirements could further extend foreclosure timelines, which could negatively impact the severity of loss on loans that go to claim. 78 79 Although it is difficult to predict the future level of reported forbearance and how many of the loans in a forbearance plan that remain current on their monthly mortgage payment will go delinquent, servicer reported forbearances have generally declined. As of December 31, 2023, approximately 1.2% or 11,536 of Enact’s active primary policies were reported in a forbearance plan, of which approximately 31% were reported as delinquent. The full impact of COVID-19 and its associated economic effects on Enact’s future business results are difficult to predict. Given the maximum length of forbearance plans, the resolution of a delinquency in a plan still may not be known for several quarters or longer. Enact continues to monitor regulatory and government actions and the resolution of forbearance delinquencies. While the associated risks have moderated and delinquencies related to COVID-19 have declined, it is possible that ancillary economic effects of COVID-19 could have an adverse impact on Enact’s future results of operations and financial condition. Regulatory developments Private mortgage insurance market penetration and overall market size are affected in part by actions that impact housing or housing finance policy taken by the GSEs and the U.S. government, including but not limited to, the FHA and the FHFA. In the past, these actions have included announced changes, or potential changes, to underwriting standards, including changes to the GSEs’ automated underwriting systems, FHA pricing, GSE guaranty fees, loan limits and alternative products. On October 24, 2022, the FHFA announced targeted changes to the GSEs’ guarantee fee pricing by eliminating upfront fees for certain first-time home buyers with income at or below area median income and for certain GSE affordable mortgage products, while implementing targeted increases to the upfront fees for most cash-out refinance loans. The fee reductions went into effect in the fourth quarter of 2022 while the new fees on cash-out refinance loans began February 1, 2023. Enact has seen a limited impact from these price changes on the private mortgage insurance market. The FHFA also announced in October 2022 its validation and approval of certain credit score models for use by the GSEs and changed the required number of credit reports provided by lenders from all three nationwide consumer reporting agencies to only two. The validation of the new credit scores requires lenders to deliver both credit scores for each loan sold to the GSEs. The FHFA has announced preliminary implementation expectations, but this is expected to be a multiple year process that will require system and process updates. In January 2023, the FHFA announced additional updates to its upfront fee structure and pricing matrix. The changes marked the third iteration of the FHFA’s ongoing pricing review since early 2022 and impact purchase and rate-term refinance loans. Pricing grids are now broken out by loan purpose and are recalibrated to new credit score and loan-to-value ratio categories, along with associated loan attributes. The new pricing matrix initially included new upfront fees for loans with debt-to-income ratios greater than 40% but those fees were rescinded prior to implementation. The remaining changes became effective May 1, 2023. In February 2023, the Department of Housing and Urban Development announced a 30 basis point reduction of the annual insurance premium charged to borrowers with FHA-insured mortgages in order to reduce the cost of borrowing for eligible lower and middle class homebuyers. This price reduction, which went into effect on March 20, 2023, is expected to have a negative impact on the U.S. private mortgage insurance market but will be partially offset by the effects of the recent FHFA pricing changes referenced above. Enact does not believe this net impact has been or will be material. Competitive environment The U.S. private mortgage insurance industry is highly competitive. Enact Holdings’ market share is influenced by the execution of its go to market strategy, including but not limited to, pricing competitiveness relative to its peers and its selective participation in forward commitment transactions. Enact continues to manage the quality of new business through pricing and its underwriting guidelines, which are modified from time to time when circumstances warrant. The market and underwriting conditions, including the mortgage insurance pricing environment, are within Enact’s risk adjusted return appetite enabling it to write new business at returns it views as attractive. Mortgage insurance portfolio New insurance written of $53.1 billion in 2023 decreased 20% compared to 2022 mostly from a smaller estimated private mortgage insurance market as originations were impacted by elevated interest rates. Enact’s primary persistency rate was 85% for the year ended December 31, 2023 compared to 80% for the year ended December 31, 2022. The increase in persistency was primarily driven by a decline in the percentage of in-force policies with mortgage rates above current mortgage rates and offset the decline in new insurance written in 2023, contributing to an increase in insurance in-force of $14.7 billion during 2023. Net earned premiums increased in 2023 compared to 2022 primarily driven by insurance in-force growth, partially offset by the lapse of older, higher priced policies and lower single premium policy cancellations in 2023. The total number of delinquent loans has declined from the COVID-19 peak in the second quarter of 2020 as borrowers continued to exit forbearance plans and new forbearances declined. During this time and consistent with prior years, servicers continued the practice of remitting premiums during the early stages of default, and Enact refunds the post-delinquent premiums to the insured party if the delinquent loan goes to claim. Enact records a liability and a reduction to net earned premiums for the post-delinquent premiums it expects to refund. The post-delinquent premium liability recorded since the beginning of COVID-19 in the second quarter of 2020 through December 31, 2023 was not significant to the change in earned premiums for those periods. Loss experience Enact’s loss ratio was 3% for the year ended December 31, 2023, compared to (10)% for the year ended December 31, 2022. Enact recorded favorable reserve adjustments of $241 million in 2023 primarily related to favorable cure performance on delinquencies from 2022 and earlier, including those related to COVID-19. During the peak of COVID-19, Enact experienced elevated new delinquencies subject to forbearance plans, and those delinquencies have continued to cure at levels above Enact’s reserve expectations. In addition, cure performance on delinquencies from 2022 has not been negatively impacted by uncertainty in the economic environment to the extent initially expected. During 2022, Enact recorded net favorable reserve adjustments of $268 million primarily related to favorable cure performance on COVID-19 delinquencies from 2020 and 2021, partially offset by reserve strengthening on certain 2022 delinquencies. Borrowers who have experienced a financial hardship including, but not limited to, the loss of income due to the closing of a business or the loss of a job continue to take advantage of available loss mitigation options, including forbearance programs, payment deferral options and other modifications. Loss reserves recorded on these delinquencies require a high degree of estimation due to the level of uncertainty regarding whether delinquencies in forbearance will ultimately cure or result in claim payments, as well as the timing and severity of those payments. The severity of loss on loans that do go to claim may be negatively impacted by the extended forbearance and foreclosure timelines, the associated elevated expenses and the higher loan amount of the recent new delinquencies. These negative influences on loss severity could be mitigated in part by embedded home price appreciation. For loans insured on or after October 1, 2014, Enact’s mortgage insurance policies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months. New primary delinquencies in 2023 increased compared to 2022 primarily due to the aging of large, new books of business. New primary delinquencies of 41,617 contributed $265 million of loss expense in 2023, while Enact incurred $171 million of losses from 35,996 new primary delinquencies in 2022. In determining the loss expense estimate, considerations were given to recent cure and claim experience and the prevailing and 80 81 Although it is difficult to predict the future level of reported forbearance and how many of the loans in a forbearance plan that remain current on their monthly mortgage payment will go delinquent, servicer reported forbearances have generally declined. As of December 31, 2023, approximately 1.2% or 11,536 of Enact’s active primary policies were reported in a forbearance plan, of which approximately 31% were reported as delinquent. manage the quality of new business through pricing and its underwriting guidelines, which are modified from time to time when circumstances warrant. The market and underwriting conditions, including the mortgage insurance pricing environment, are within Enact’s risk adjusted return appetite enabling it to write new business at returns it views as attractive. The full impact of COVID-19 and its associated economic effects on Enact’s future business results are difficult to predict. Given the maximum length of forbearance plans, the resolution of a delinquency in a plan still may not be known for several quarters or longer. Enact continues to monitor regulatory and government actions and the resolution of forbearance delinquencies. While the associated risks have moderated and delinquencies related to COVID-19 have declined, it is possible that ancillary economic effects of COVID-19 could have an adverse impact on Enact’s future results of operations and financial condition. Regulatory developments Private mortgage insurance market penetration and overall market size are affected in part by actions that impact housing or housing finance policy taken by the GSEs and the U.S. government, including but not limited to, the FHA and the FHFA. In the past, these actions have included announced changes, or potential changes, to underwriting standards, including changes to the GSEs’ automated underwriting systems, FHA pricing, GSE guaranty fees, loan limits and alternative products. On October 24, 2022, the FHFA announced targeted changes to the GSEs’ guarantee fee pricing by eliminating upfront fees for certain first-time home buyers with income at or below area median income and for certain GSE affordable mortgage products, while implementing targeted increases to the upfront fees for most cash-out refinance loans. The fee reductions went into effect in the fourth quarter of 2022 while the new fees on cash-out refinance loans began February 1, 2023. Enact has seen a limited impact from these price changes on the private mortgage insurance market. The FHFA also announced in October 2022 its validation and approval of certain credit score models for use by the GSEs and changed the required number of credit reports provided by lenders from all three nationwide consumer reporting agencies to only two. The validation of the new credit scores requires lenders to deliver both credit scores for each loan sold to the GSEs. The FHFA has announced preliminary implementation expectations, but this is expected to be a multiple year process that will require system and process updates. In January 2023, the FHFA announced additional updates to its upfront fee structure and pricing matrix. The changes marked the third iteration of the FHFA’s ongoing pricing review since early 2022 and impact purchase and rate-term refinance loans. Pricing grids are now broken out by loan purpose and are recalibrated to new credit score and loan-to-value ratio categories, along with associated loan attributes. The new pricing matrix initially included new upfront fees for loans with debt-to-income ratios greater than 40% but those fees were rescinded prior to implementation. The remaining changes became effective May 1, 2023. In February 2023, the Department of Housing and Urban Development announced a 30 basis point reduction of the annual insurance premium charged to borrowers with FHA-insured mortgages in order to reduce the cost of borrowing for eligible lower and middle class homebuyers. This price reduction, which went into effect on March 20, 2023, is expected to have a negative impact on the U.S. private mortgage insurance market but will be partially offset by the effects of the recent FHFA pricing changes referenced above. Enact does not believe this net impact has been or will be material. Competitive environment The U.S. private mortgage insurance industry is highly competitive. Enact Holdings’ market share is influenced by the execution of its go to market strategy, including but not limited to, pricing competitiveness relative to its peers and its selective participation in forward commitment transactions. Enact continues to Mortgage insurance portfolio New insurance written of $53.1 billion in 2023 decreased 20% compared to 2022 mostly from a smaller estimated private mortgage insurance market as originations were impacted by elevated interest rates. Enact’s primary persistency rate was 85% for the year ended December 31, 2023 compared to 80% for the year ended December 31, 2022. The increase in persistency was primarily driven by a decline in the percentage of in-force policies with mortgage rates above current mortgage rates and offset the decline in new insurance written in 2023, contributing to an increase in insurance in-force of $14.7 billion during 2023. Net earned premiums increased in 2023 compared to 2022 primarily driven by insurance in-force growth, partially offset by the lapse of older, higher priced policies and lower single premium policy cancellations in 2023. The total number of delinquent loans has declined from the COVID-19 peak in the second quarter of 2020 as borrowers continued to exit forbearance plans and new forbearances declined. During this time and consistent with prior years, servicers continued the practice of remitting premiums during the early stages of default, and Enact refunds the post-delinquent premiums to the insured party if the delinquent loan goes to claim. Enact records a liability and a reduction to net earned premiums for the post-delinquent premiums it expects to refund. The post-delinquent premium liability recorded since the beginning of COVID-19 in the second quarter of 2020 through December 31, 2023 was not significant to the change in earned premiums for those periods. Loss experience Enact’s loss ratio was 3% for the year ended December 31, 2023, compared to (10)% for the year ended December 31, 2022. Enact recorded favorable reserve adjustments of $241 million in 2023 primarily related to favorable cure performance on delinquencies from 2022 and earlier, including those related to COVID-19. During the peak of COVID-19, Enact experienced elevated new delinquencies subject to forbearance plans, and those delinquencies have continued to cure at levels above Enact’s reserve expectations. In addition, cure performance on delinquencies from 2022 has not been negatively impacted by uncertainty in the economic environment to the extent initially expected. During 2022, Enact recorded net favorable reserve adjustments of $268 million primarily related to favorable cure performance on COVID-19 delinquencies from 2020 and 2021, partially offset by reserve strengthening on certain 2022 delinquencies. Borrowers who have experienced a financial hardship including, but not limited to, the loss of income due to the closing of a business or the loss of a job continue to take advantage of available loss mitigation options, including forbearance programs, payment deferral options and other modifications. Loss reserves recorded on these delinquencies require a high degree of estimation due to the level of uncertainty regarding whether delinquencies in forbearance will ultimately cure or result in claim payments, as well as the timing and severity of those payments. The severity of loss on loans that do go to claim may be negatively impacted by the extended forbearance and foreclosure timelines, the associated elevated expenses and the higher loan amount of the recent new delinquencies. These negative influences on loss severity could be mitigated in part by embedded home price appreciation. For loans insured on or after October 1, 2014, Enact’s mortgage insurance policies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months. New primary delinquencies in 2023 increased compared to 2022 primarily due to the aging of large, new books of business. New primary delinquencies of 41,617 contributed $265 million of loss expense in 2023, while Enact incurred $171 million of losses from 35,996 new primary delinquencies in 2022. In determining the loss expense estimate, considerations were given to recent cure and claim experience and the prevailing and 80 81 Capital returns and other transactions In April 2023 and November 2023, EMICO completed distributions to Enact Holdings that support its ability to pay a quarterly dividend. Enact Holdings intends to use these proceeds and future EMICO distributions to fund the quarterly dividend as well as to bolster its financial flexibility and potentially return additional capital to shareholders. Future dividend payments are subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial. In addition to Enact’s quarterly dividend program, in November 2022, Enact Holdings announced approval by its board of directors of a share repurchase program under which it could repurchase up to $75 million of its outstanding common stock, and on August 1, 2023, announced the authorization of an additional $100 million of common stock repurchases under a new share repurchase program. Genworth Holdings has agreed to participate in order to maintain its overall ownership at its current level. As the majority shareholder, Genworth Holdings received $245 million of capital returns from Enact Holdings during 2023 comprised of $82 million of quarterly dividends, a special dividend of $92 million and $71 million of share repurchases. In May 2023, EMICO contributed $250 million to Enact Re, which enabled Enact Re to participate in the assumption of excess of loss reinsurance relating to GSE credit risk transfer and to reinsure EMICO’s new and existing insurance in-force under quota share reinsurance agreements. EMICO contributed an additional $250 million to Enact Re in November 2023, which will support an increase to the ceding percentage of affiliate quota share agreements, along with assumed new insurance written and new business opportunities, including the continued execution of GSE credit risk transfer. Returning capital to shareholders, balanced with growth and risk management priorities, remains a key commitment for Enact Holdings, as it looks to enhance shareholder value through time. Future return of capital will be shaped by Enact Holdings’ capital prioritization framework, including: supporting its existing policyholders; growing its mortgage insurance business; funding attractive new business opportunities; and returning capital to shareholders. Enact Holdings’ total return of capital will also be based on its view of the prevailing and prospective macroeconomic conditions, regulatory landscape and business performance. prospective economic conditions. Approximately 13% of Enact’s primary new delinquencies in 2023 were subject to a forbearance plan compared to 21% in 2022. Due to the declining number of new delinquencies in forbearance, Enact no longer differentiates the expected claim rates applied to new delinquencies in forbearance versus those not in forbearance. Capital requirements As of December 31, 2023, EMICO’s risk-to-capital ratio under the current regulatory framework as established under North Carolina law and enforced by the NCDOI, EMICO’s domestic insurance regulator, was approximately 11.6:1, compared with a risk-to-capital ratio of 12.9:1 as of December 31, 2022. EMICO’s risk-to-capital ratio remains below the NCDOI’s maximum risk-to-capital ratio of 25:1. North Carolina’s calculation of risk-to-capital excludes the risk in-force for delinquent loans given the established loss reserves against all delinquencies. EMICO’s ongoing risk-to-capital ratio will depend principally on the magnitude of future losses incurred by EMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, the impact of quota share reinsurance, the amount of policy lapses and the amount of additional capital that is generated or distributed by the business. Under PMIERs, Enact is subject to operational and financial requirements that private mortgage insurers must meet in order to remain eligible to insure loans that are purchased by the GSEs. In addition, in September 2020, subsequent to the issuance of Enact Holdings’ senior notes due in 2025, the GSEs imposed certain restrictions on Enact with respect to capital. In May 2021, in connection with their conditional approval of the then potential partial sale of Enact Holdings, the GSEs confirmed the GSE Restrictions would remain in effect until certain conditions were met. These conditions were met as of December 31, 2022, and Enact is no longer subject to the GSE Restrictions and the GSE Conditions. As of December 31, 2023, Enact had estimated available assets of $5,006 million against $3,119 million net required assets under PMIERs compared to available assets of $5,206 million against $3,156 million net required assets as of December 31, 2022. The sufficiency ratio as of December 31, 2023 was 161% or $1,887 million above the PMIERs requirements, compared to 165% or $2,050 million above the published PMIERS requirements as of December 31, 2022. Enact’s PMIERs required assets as of December 31, 2023 and 2022 benefited from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing loans. The application of the 0.30 multiplier to all eligible delinquencies provided $73 million and $132 million of benefit to Enact’s PMIERs required assets as of December 31, 2023 and 2022, respectively. These amounts are gross of any incremental reinsurance benefit from the elimination of the 0.30 multiplier. During 2023, Enact executed excess of loss reinsurance transactions that provide up to $428 million of reinsurance coverage on a portion of its new insurance written for the 2022 and 2023 book years. Enact also executed a quota share reinsurance agreement under which it cedes 16.125% of a portion of new insurance written in the 2023 book year. Enact’s third-party reinsurance transactions provided an aggregate of approximately $1,714 million and $1,578 million of PMIERs capital credit as of December 31, 2023 and 2022, respectively. On January 3, 2024, Enact entered into a quota share reinsurance agreement under which it will cede approximately 21% of a portion of its new insurance written in the 2024 book year. On January 30, 2024, Enact executed an excess of loss reinsurance transaction which provides up to $255 million of reinsurance coverage on a portion of current and expected new insurance written for the 2024 book year, effective January 1, 2024. See note 9 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional details on Enact’s reinsurance transactions. Enact may execute future credit risk transfer transactions to maintain a prudent level of financial flexibility in excess of the PMIERs capital requirements in response to potential changes in performance and PMIERs requirements over time. 82 83 Capital returns and other transactions In April 2023 and November 2023, EMICO completed distributions to Enact Holdings that support its ability to pay a quarterly dividend. Enact Holdings intends to use these proceeds and future EMICO distributions to fund the quarterly dividend as well as to bolster its financial flexibility and potentially return additional capital to shareholders. Future dividend payments are subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial. In addition to Enact’s quarterly dividend program, in November 2022, Enact Holdings announced approval by its board of directors of a share repurchase program under which it could repurchase up to $75 million of its outstanding common stock, and on August 1, 2023, announced the authorization of an additional $100 million of common stock repurchases under a new share repurchase program. Genworth Holdings has agreed to participate in order to maintain its overall ownership at its current level. As the majority shareholder, Genworth Holdings received $245 million of capital returns from Enact Holdings during 2023 comprised of $82 million of quarterly dividends, a special dividend of $92 million and $71 million of share repurchases. In May 2023, EMICO contributed $250 million to Enact Re, which enabled Enact Re to participate in the assumption of excess of loss reinsurance relating to GSE credit risk transfer and to reinsure EMICO’s new and existing insurance in-force under quota share reinsurance agreements. EMICO contributed an additional $250 million to Enact Re in November 2023, which will support an increase to the ceding percentage of affiliate quota share agreements, along with assumed new insurance written and new business opportunities, including the continued execution of GSE credit risk transfer. Returning capital to shareholders, balanced with growth and risk management priorities, remains a key commitment for Enact Holdings, as it looks to enhance shareholder value through time. Future return of capital will be shaped by Enact Holdings’ capital prioritization framework, including: supporting its existing policyholders; growing its mortgage insurance business; funding attractive new business opportunities; and returning capital to shareholders. Enact Holdings’ total return of capital will also be based on its view of the prevailing and prospective macroeconomic conditions, regulatory landscape and business performance. prospective economic conditions. Approximately 13% of Enact’s primary new delinquencies in 2023 were subject to a forbearance plan compared to 21% in 2022. Due to the declining number of new delinquencies in forbearance, Enact no longer differentiates the expected claim rates applied to new delinquencies in forbearance versus those not in forbearance. Capital requirements As of December 31, 2023, EMICO’s risk-to-capital ratio under the current regulatory framework as established under North Carolina law and enforced by the NCDOI, EMICO’s domestic insurance regulator, was approximately 11.6:1, compared with a risk-to-capital ratio of 12.9:1 as of December 31, 2022. EMICO’s risk-to-capital ratio remains below the NCDOI’s maximum risk-to-capital ratio of 25:1. North Carolina’s calculation of risk-to-capital excludes the risk in-force for delinquent loans given the established loss reserves against all delinquencies. EMICO’s ongoing risk-to-capital ratio will depend principally on the magnitude of future losses incurred by EMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, the impact of quota share reinsurance, the amount of policy lapses and the amount of additional capital that is generated or distributed by the business. Under PMIERs, Enact is subject to operational and financial requirements that private mortgage insurers must meet in order to remain eligible to insure loans that are purchased by the GSEs. In addition, in September 2020, subsequent to the issuance of Enact Holdings’ senior notes due in 2025, the GSEs imposed certain restrictions on Enact with respect to capital. In May 2021, in connection with their conditional approval of the then potential partial sale of Enact Holdings, the GSEs confirmed the GSE Restrictions would remain in effect until certain conditions were met. These conditions were met as of December 31, 2022, and Enact is no longer subject to the GSE Restrictions and the GSE Conditions. As of December 31, 2023, Enact had estimated available assets of $5,006 million against $3,119 million net required assets under PMIERs compared to available assets of $5,206 million against $3,156 million net required assets as of December 31, 2022. The sufficiency ratio as of December 31, 2023 was 161% or $1,887 million above the PMIERs requirements, compared to 165% or $2,050 million above the published PMIERS requirements as of December 31, 2022. Enact’s PMIERs required assets as of December 31, 2023 and 2022 benefited from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing loans. The application of the 0.30 multiplier to all eligible delinquencies provided $73 million and $132 million of benefit to Enact’s PMIERs required assets as of December 31, 2023 and 2022, respectively. These amounts are gross of any incremental reinsurance benefit from the elimination of the 0.30 multiplier. respectively. During 2023, Enact executed excess of loss reinsurance transactions that provide up to $428 million of reinsurance coverage on a portion of its new insurance written for the 2022 and 2023 book years. Enact also executed a quota share reinsurance agreement under which it cedes 16.125% of a portion of new insurance written in the 2023 book year. Enact’s third-party reinsurance transactions provided an aggregate of approximately $1,714 million and $1,578 million of PMIERs capital credit as of December 31, 2023 and 2022, On January 3, 2024, Enact entered into a quota share reinsurance agreement under which it will cede approximately 21% of a portion of its new insurance written in the 2024 book year. On January 30, 2024, Enact executed an excess of loss reinsurance transaction which provides up to $255 million of reinsurance coverage on a portion of current and expected new insurance written for the 2024 book year, effective January 1, 2024. See note 9 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional details on Enact’s reinsurance transactions. Enact may execute future credit risk transfer transactions to maintain a prudent level of financial flexibility in excess of the PMIERs capital requirements in response to potential changes in performance and PMIERs requirements over time. 82 83 Segment results of operations The following table sets forth the results of operations relating to our Enact segment for the periods For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” indicated: (Amounts in millions) Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . . . . . . . . . Years ended December 31, Increase (decrease) and percentage change 2023 2022 2021 2023 vs. 2022 $ 957 $ 940 $ 975 $ 17 141 53 (12) (2) 4 — 155 (2) 2 208 (14) 2 Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,153 1,095 1,118 58 Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . . . . . . . . Acquisition and operating expenses, net of deferrals . . . . . . . . . Amortization of deferred acquisition costs and intangibles . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total benefits and expenses . . . . . . . . . . . . . . . . . . . . . . . . Income from continuing operations before income taxes . . . . . Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to 27 212 11 52 302 851 186 665 (94) 227 12 52 197 898 194 704 121 125 (15) 230 15 (1) 51 — 421 697 148 549 105 (47) (8) (39) 2% 34% NM(1) — % 5% 129% (7)% (8)% — % 53% (5)% (4)% (6)% noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 130 33 (7) (5)% Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: 542 574 516 (32) (6)% Net investment (gains) losses, net (2) . . . . . . . . . . . . . . . . . . . . . Expenses related to restructuring . . . . . . . . . . . . . . . . . . . . . . . . Taxes on adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 — (2) 2 3 (1) 2 3 (1) 10 (3) (1) NM(1) (100)% (100)% Adjusted operating income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . $ 552 $ 578 $ 520 $ (26) (4)% (1) We define “NM” as not meaningful for increases or decreases greater than 200%. (2) Net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $2 million. 2023 compared to 2022 Adjusted operating income available to Genworth Financial, Inc.’s common stockholders New insurance written Adjusted operating income decreased primarily attributable to higher losses on new delinquencies and lower favorable reserve adjustments, partially offset by higher net investment income, higher premiums and lower operating costs in 2023. Revenues Premiums increased mostly from higher insurance in-force, partially offset by the lapse of older, higher priced policies, lower single premium policy cancellations and higher ceded premiums in 2023. New insurance written decreased primarily due to a smaller estimated private mortgage insurance market in 2023 as both refinancing and purchase originations were impacted by elevated mortgage rates. Loss and expense ratios The following table sets forth the loss and expense ratios for Enact for the dates indicated: Years ended December 31, Increase (decrease) 2023 2022 2021 2023 vs. 2022 Net investment income increased primarily from higher investment yields and higher average invested assets in 2023. Loss ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Expense ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3% 23% (10)% 13% 25% 25% 13% (2)% 84 85 Benefits and expenses Benefits and other changes in policy reserves increased largely from higher losses on new delinquencies and lower favorable reserve adjustments in 2023. Enact released $241 million of reserves in 2023 primarily related to favorable cure performance on delinquencies from 2022 and earlier, including those related to COVID-19, compared to net favorable reserve adjustments of $268 million in 2022. Acquisition and operating expenses, net of deferrals, decreased primarily attributable to lower operating costs in 2023. Provision for income taxes. The effective tax rate was 21.8% and 21.6% for the years ended December 31, 2023 and 2022, respectively, consistent with the U.S. corporate federal income tax rate. Enact selected operating performance measures The following table sets forth selected operating performance measures regarding Enact as of and for the dates indicated: (Amounts in millions) Risk in-force: Years ended December 31, 2023 2022 2021 2023 vs. 2022 Increase (decrease) and percentage change Primary insurance in-force . . . . . . . . . . . . . . . . . . . . . . . . . . . $262,937 $248,262 $226,514 $ 14,675 6% Primary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 67,529 $ 62,791 $ 56,881 $ 4,738 8% Pool . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69 79 105 (10) (13)% Total risk in-force . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 67,598 $ 62,870 $ 56,986 $ 4,728 8% New insurance written . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 53,081 $ 66,485 $ 97,004 $(13,404) (20)% 2023 compared to 2022 Primary insurance in-force and risk in-force Primary insurance in-force increased largely from new insurance written. In addition, lower lapses and cancellations drove higher primary persistency, largely as a result of suppressed refinancing activity due to a decline in the percentage of in-force policies with mortgage rates above current mortgage rates. Total risk in-force increased largely from higher primary insurance in-force. Segment results of operations indicated: (Amounts in millions) Revenues: The following table sets forth the results of operations relating to our Enact segment for the periods Years ended December 31, Increase (decrease) and percentage change 2023 2022 2021 2023 vs. 2022 Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 957 $ 940 $ 975 $ 17 Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . . . . . . . . . 208 (14) 2 155 (2) 2 141 (2) 53 (12) 4 — Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,153 1,095 1,118 58 Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . . . . . . . . Acquisition and operating expenses, net of deferrals . . . . . . . . . Amortization of deferred acquisition costs and intangibles . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total benefits and expenses . . . . . . . . . . . . . . . . . . . . . . . . Income from continuing operations before income taxes . . . . . Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to 27 212 11 52 302 851 186 665 51 — (94) 227 12 52 197 898 194 704 125 230 15 421 697 148 549 121 (15) (1) 105 (47) (8) (39) 2% 34% NM(1) — % 5% 129% (7)% (8)% — % 53% (5)% (4)% (6)% (5)% noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 130 33 (7) Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . 542 574 516 (32) (6)% Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: Net investment (gains) losses, net (2) . . . . . . . . . . . . . . . . . . . . . Expenses related to restructuring . . . . . . . . . . . . . . . . . . . . . . . . Taxes on adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 — (2) 2 3 (1) 2 3 (1) 10 (3) (1) NM(1) (100)% (100)% Adjusted operating income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . $ 552 $ 578 $ 520 $ (26) (4)% (1) We define “NM” as not meaningful for increases or decreases greater than 200%. (2) Net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $2 million. 2023 compared to 2022 operating costs in 2023. Revenues For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” Benefits and expenses Benefits and other changes in policy reserves increased largely from higher losses on new delinquencies and lower favorable reserve adjustments in 2023. Enact released $241 million of reserves in 2023 primarily related to favorable cure performance on delinquencies from 2022 and earlier, including those related to COVID-19, compared to net favorable reserve adjustments of $268 million in 2022. Acquisition and operating expenses, net of deferrals, decreased primarily attributable to lower operating costs in 2023. Provision for income taxes. The effective tax rate was 21.8% and 21.6% for the years ended December 31, 2023 and 2022, respectively, consistent with the U.S. corporate federal income tax rate. Enact selected operating performance measures The following table sets forth selected operating performance measures regarding Enact as of and for the dates indicated: (Amounts in millions) Primary insurance in-force . . . . . . . . . . . . . . . . . . . . . . . . . . . Risk in-force: Primary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Pool . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Years ended December 31, 2022 2023 2021 Increase (decrease) and percentage change 2023 vs. 2022 $262,937 $248,262 $226,514 $ 14,675 6% $ 67,529 $ 62,791 $ 56,881 $ 4,738 69 79 105 8% (10) (13)% Total risk in-force . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 67,598 $ 62,870 $ 56,986 $ 4,728 8% New insurance written . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 53,081 $ 66,485 $ 97,004 $(13,404) (20)% 2023 compared to 2022 Primary insurance in-force and risk in-force Primary insurance in-force increased largely from new insurance written. In addition, lower lapses and cancellations drove higher primary persistency, largely as a result of suppressed refinancing activity due to a decline in the percentage of in-force policies with mortgage rates above current mortgage rates. Total risk in-force increased largely from higher primary insurance in-force. Adjusted operating income available to Genworth Financial, Inc.’s common stockholders New insurance written Adjusted operating income decreased primarily attributable to higher losses on new delinquencies and lower favorable reserve adjustments, partially offset by higher net investment income, higher premiums and lower New insurance written decreased primarily due to a smaller estimated private mortgage insurance market in 2023 as both refinancing and purchase originations were impacted by elevated mortgage rates. Premiums increased mostly from higher insurance in-force, partially offset by the lapse of older, higher priced policies, lower single premium policy cancellations and higher ceded premiums in 2023. Loss and expense ratios The following table sets forth the loss and expense ratios for Enact for the dates indicated: Years ended December 31, Increase (decrease) 2023 2022 2021 2023 vs. 2022 Net investment income increased primarily from higher investment yields and higher average invested assets in 2023. Loss ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Expense ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3% 23% (10)% 13% 25% 25% 13% (2)% 84 85 The loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums. The expense ratio is the ratio of general expenses to net earned premiums. Enact’s general expenses consist of acquisition and operating expenses, net of deferrals, and amortization of DAC and intangibles. 2023 compared to 2022 The loss ratio increased largely from higher losses on new delinquencies and lower favorable reserve adjustments in 2023, as discussed above. The expense ratio decreased primarily attributable to lower operating costs in 2023. Mortgage insurance loan portfolio December 31: (Amounts in millions) The following table sets forth selected financial information regarding Enact’s loan portfolio as of 2023 2022 2021 Primary insurance in-force by loan-to-value ratio at origination: 95.01% and above . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90.01% to 95.00% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 44,955 109,227 $ 39,509 103,618 85.01% to 90.00% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85.00% and below . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77,887 30,868 72,132 33,003 $ 35,455 95,149 64,549 31,361 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $262,937 $248,262 $226,514 Primary risk in-force by loan-to-value ratio at origination: 95.01% and above . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 12,878 $ 11,136 $ 90.01% to 95.00% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85.01% to 90.00% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85.00% and below . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31,781 19,163 3,707 30,079 17,621 3,955 9,907 27,608 15,644 3,722 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 67,529 $ 62,791 $ 56,881 Primary insurance in-force by credit quality at origination: Over 760 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $110,635 $102,467 $ 89,982 740—759 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720—739 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 700—719 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 680—699 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 660—679(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 640—659 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 620—639 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . <620 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43,053 37,020 29,766 21,835 11,357 6,137 2,504 630 40,097 34,916 28,867 21,554 10,926 6,095 2,630 710 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $262,937 $248,262 $226,514 Primary risk in-force by credit quality at origination: Over 760 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 28,363 $ 25,807 $ 22,489 740—759 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,096 10,154 720—739 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 700—719 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 680—699 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 660—679(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 640—659 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 620—639 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . <620 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,621 7,623 5,557 2,908 1,565 635 161 8,931 7,317 5,428 2,767 1,540 665 182 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 67,529 $ 62,791 $ 56,881 35,874 31,730 27,359 21,270 10,549 6,124 2,783 843 9,009 8,055 6,907 5,334 2,638 1,530 702 217 (1) Loans with unknown FICO scores are included in the 660-679 category. The FICO credit score is one indicator of a borrower’s credit quality. Enact continues to underwrite predominantly prime loan new business. Based upon FICO at loan closing, the weighted average FICO score of Enact’s primary insurance in-force was 744 as of December 31, 2023. Delinquent loans and claims Enact’s delinquency management process begins with notification by the loan servicer of a delinquency on an insured loan. “Delinquency” is defined in Enact’s master policies as the borrower’s failure to pay when due an 86 87 The loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums. The expense ratio is the ratio of general expenses to net earned premiums. Enact’s general expenses consist of acquisition and operating expenses, net of deferrals, and amortization of DAC and intangibles. 2023 compared to 2022 The loss ratio increased largely from higher losses on new delinquencies and lower favorable reserve adjustments in 2023, as discussed above. The expense ratio decreased primarily attributable to lower operating costs in 2023. Mortgage insurance loan portfolio The following table sets forth selected financial information regarding Enact’s loan portfolio as of December 31: (Amounts in millions) 2023 2022 2021 Primary insurance in-force by loan-to-value ratio at origination: 95.01% and above . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90.01% to 95.00% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85.01% to 90.00% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85.00% and below . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 44,955 109,227 77,887 30,868 $ 39,509 103,618 72,132 33,003 $ 35,455 95,149 64,549 31,361 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $262,937 $248,262 $226,514 Primary risk in-force by loan-to-value ratio at origination: 95.01% and above . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90.01% to 95.00% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85.01% to 90.00% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85.00% and below . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 12,878 31,781 19,163 3,707 $ 11,136 30,079 17,621 3,955 $ 9,907 27,608 15,644 3,722 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 67,529 $ 62,791 $ 56,881 Primary insurance in-force by credit quality at origination: Over 760 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 740—759 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720—739 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 700—719 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 680—699 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 660—679(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 640—659 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 620—639 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . <620 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $110,635 43,053 37,020 29,766 21,835 11,357 6,137 2,504 630 $102,467 40,097 34,916 28,867 21,554 10,926 6,095 2,630 710 $ 89,982 35,874 31,730 27,359 21,270 10,549 6,124 2,783 843 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $262,937 $248,262 $226,514 Primary risk in-force by credit quality at origination: Over 760 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 740—759 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720—739 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 700—719 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 680—699 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 660—679(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 640—659 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 620—639 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . <620 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 28,363 11,096 9,621 7,623 5,557 2,908 1,565 635 161 $ 25,807 10,154 8,931 7,317 5,428 2,767 1,540 665 182 $ 22,489 9,009 8,055 6,907 5,334 2,638 1,530 702 217 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 67,529 $ 62,791 $ 56,881 (1) Loans with unknown FICO scores are included in the 660-679 category. The FICO credit score is one indicator of a borrower’s credit quality. Enact continues to underwrite predominantly prime loan new business. Based upon FICO at loan closing, the weighted average FICO score of Enact’s primary insurance in-force was 744 as of December 31, 2023. Delinquent loans and claims Enact’s delinquency management process begins with notification by the loan servicer of a delinquency on an insured loan. “Delinquency” is defined in Enact’s master policies as the borrower’s failure to pay when due an 86 87 amount equal to the scheduled monthly mortgage payment under the terms of the mortgage. Generally, the master policies require an insured to notify Enact of a delinquency if the borrower fails to make two consecutive monthly mortgage payments prior to the due date of the next mortgage payment. Enact generally considers a loan to be delinquent and establishes required reserves after the insured gives notification that the borrower has failed to make two scheduled mortgage payments. Borrowers default for a variety of reasons, including a reduction of income, unemployment, divorce, illness/death, inability to manage credit, falling home prices and interest rate levels. Borrowers may cure delinquencies by making all of the delinquent loan payments, agreeing to a loan modification or by selling the property in full satisfaction of all amounts due under the mortgage. In most cases, delinquencies that are not cured result in a claim under Enact’s policy. The following table sets forth the number of loans insured, the number of delinquent loans and the delinquency rate for Enact’s loan portfolio as of December 31: Primary insurance: Insured loans in-force . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Delinquent loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Percentage of delinquent loans (delinquency rate) . . . . . . 974,516 20,432 960,306 19,943 937,350 24,820 2.10% 2.08% 2.65% 2023 2022 2021 The delinquency rate as of December 31, 2023 increased compared to December 31, 2022 primarily from an increase in total delinquencies mostly driven by new delinquencies outpacing cures and paid claims. The delinquency rate as of December 31, 2023 decreased compared to December 31, 2021 primarily from a decline in total delinquencies as cures outpaced new delinquencies. The following tables set forth primary delinquencies, direct primary case reserves and risk in-force by aged missed payment status in Enact’s loan portfolio as of December 31: (Dollar amounts in millions) Payments in default: 3 payments or less . . . . . . . . . . . . . . . . . . . 4 – 11 payments . . . . . . . . . . . . . . . . . . . . . 12 payments or more . . . . . . . . . . . . . . . . . Total . . . . . . . . . . . . . . . . . . . . . . . . . . Delinquencies Direct primary case reserves(1) Risk in-force Reserves as % of risk in-force 2023 10,166 6,934 3,332 20,432 $ 88 205 184 $477 $ 629 469 200 $1,298 14% 44% 92% 37% (1) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. 2022 (Dollar amounts in millions) Delinquencies Direct primary case reserves(1) Risk in-force Reserves as % of risk in-force Payments in default: 3 payments or less . . . . . . . . . . . . . . . . . . . 4 – 11 payments . . . . . . . . . . . . . . . . . . . . . 12 payments or more . . . . . . . . . . . . . . . . . 8,920 6,466 4,557 Total . . . . . . . . . . . . . . . . . . . . . . . . . . 19,943 $ 69 166 244 $479 $ 509 390 248 $1,147 14% 43% 98% 42% (1) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. Reserves as a percentage of risk in-force as of December 31, 2023 decreased compared to December 31, 2022 as long-term delinquencies with higher reserves have continued to cure. The number of loans that are delinquent for 12 months or more has decreased since December 31, 2022 and is more in line with pre-COVID-19 levels. Due to continued forbearance options, foreclosure moratoriums and the uncertainty around the lack of progression through the foreclosure process, there is still uncertainty around the likelihood and timing of delinquencies going to claim. Primary insurance delinquency rates differ from region to region in the United States at any one time depending upon economic conditions and cyclical growth patterns. The tables below set forth the dispersion of direct primary case reserves and primary delinquency rates for the 10 largest states and the 10 largest Metropolitan Statistical Areas (“MSA”) or Metro Divisions (“MD”) by Enact’s primary risk in-force as of the dates indicated. Delinquency rates are shown by region based upon the location of the underlying property, rather than the location of the lender. Percent of primary Percent of direct primary risk in-force as of December 31, 2023 case reserves as of December 31, 2023(1) Delinquency rate as of December 31, 2023 2022 2021 By State: California . . . . . . . . . . . . . . . . . . . . . . . . . Texas . . . . . . . . . . . . . . . . . . . . . . . . . . . . Florida(2) . . . . . . . . . . . . . . . . . . . . . . . . . . New York(2) . . . . . . . . . . . . . . . . . . . . . . . Illinois(2) . . . . . . . . . . . . . . . . . . . . . . . . . . Arizona . . . . . . . . . . . . . . . . . . . . . . . . . . . Michigan . . . . . . . . . . . . . . . . . . . . . . . . . Georgia . . . . . . . . . . . . . . . . . . . . . . . . . . . North Carolina . . . . . . . . . . . . . . . . . . . . . Washington . . . . . . . . . . . . . . . . . . . . . . . By MSA or MD: Phoenix, AZ MSA . . . . . . . . . . . . . . . . . . Chicago-Naperville, IL MD . . . . . . . . . . . Atlanta, GA MSA . . . . . . . . . . . . . . . . . . . New York, NY MD . . . . . . . . . . . . . . . . . Washington-Arlington, DC MD . . . . . . . . Houston, TX MSA . . . . . . . . . . . . . . . . . . Los Angeles-Long Beach, CA MD . . . . . Dallas, TX MD . . . . . . . . . . . . . . . . . . . . . Riverside-San Bernardino, CA MSA . . . . Denver-Aurora-Lakewood, CO MSA . . . 13% 8% 8% 5% 4% 4% 4% 3% 3% 3% 3% 3% 3% 2% 2% 2% 2% 2% 2% 2% 12% 8% 9% 12% 6% 3% 3% 4% 2% 2% 2% 4% 3% 7% 2% 3% 3% 2% 3% 1% 2.22% 2.22% 2.39% 3.05% 2.61% 1.93% 1.94% 2.23% 1.56% 1.77% 2.09% 2.12% 2.54% 2.95% 2.54% 1.78% 1.79% 2.23% 1.59% 1.92% 3.17% 2.89% 2.97% 3.80% 3.09% 2.31% 1.87% 2.94% 2.18% 2.98% 2.01% 2.88% 2.40% 3.60% 2.01% 2.67% 2.39% 1.92% 2.83% 1.12% 1.83% 2.84% 2.42% 3.75% 1.85% 2.60% 2.18% 1.86% 2.89% 1.12% 2.36% 3.68% 3.28% 5.32% 2.96% 3.61% 3.95% 2.31% 3.42% 1.66% (1) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. (2) Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be completed. Percent of primary Percent of direct primary risk in-force as of December 31, 2023 case reserves as of December 31, 2023(1) Delinquency rate as of December 31, 2023 2022 2021 (1) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. The number of delinquencies may not correlate directly with the number of claims received because delinquencies may cure. The rate at which delinquencies cure is influenced by borrowers’ financial resources and circumstances and regional economic differences. Whether a delinquency leads to a claim correlates highly with the borrower’s equity at the time of delinquency, as it influences the borrower’s willingness to continue to make payments, and the borrower’s or the insured’s ability to sell the home for an amount sufficient to satisfy all amounts due under the mortgage loan, as well as the borrower’s financial ability to continue making payments. When Enact receives notice of a delinquency, it uses its proprietary model to determine whether a delinquent loan is a candidate for a modification. When the model identifies such a candidate, Enact’s loan workout 88 89 amount equal to the scheduled monthly mortgage payment under the terms of the mortgage. Generally, the master policies require an insured to notify Enact of a delinquency if the borrower fails to make two consecutive monthly mortgage payments prior to the due date of the next mortgage payment. Enact generally considers a loan to be delinquent and establishes required reserves after the insured gives notification that the borrower has failed to make two scheduled mortgage payments. Borrowers default for a variety of reasons, including a reduction of income, unemployment, divorce, illness/death, inability to manage credit, falling home prices and interest rate levels. Borrowers may cure delinquencies by making all of the delinquent loan payments, agreeing to a loan modification or by selling the property in full satisfaction of all amounts due under the mortgage. In most cases, delinquencies that are not cured result in a claim under Enact’s policy. The following table sets forth the number of loans insured, the number of delinquent loans and the delinquency rate for Enact’s loan portfolio as of December 31: Primary insurance: Insured loans in-force . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Delinquent loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 974,516 20,432 960,306 19,943 937,350 24,820 Percentage of delinquent loans (delinquency rate) . . . . . . 2.10% 2.08% 2.65% 2023 2022 2021 The delinquency rate as of December 31, 2023 increased compared to December 31, 2022 primarily from an increase in total delinquencies mostly driven by new delinquencies outpacing cures and paid claims. The delinquency rate as of December 31, 2023 decreased compared to December 31, 2021 primarily from a decline in total delinquencies as cures outpaced new delinquencies. The following tables set forth primary delinquencies, direct primary case reserves and risk in-force by aged missed payment status in Enact’s loan portfolio as of December 31: 2023 2022 Delinquencies Direct primary case reserves(1) Risk in-force Reserves as % of risk in-force (Dollar amounts in millions) Payments in default: 3 payments or less . . . . . . . . . . . . . . . . . . . 4 – 11 payments . . . . . . . . . . . . . . . . . . . . . 12 payments or more . . . . . . . . . . . . . . . . . Total . . . . . . . . . . . . . . . . . . . . . . . . . . 10,166 6,934 3,332 20,432 $ 88 205 184 $477 $ 629 469 200 $1,298 (1) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. Delinquencies Direct primary case reserves(1) Risk in-force Reserves as % of risk in-force (Dollar amounts in millions) Payments in default: 3 payments or less . . . . . . . . . . . . . . . . . . . 4 – 11 payments . . . . . . . . . . . . . . . . . . . . . 12 payments or more . . . . . . . . . . . . . . . . . 8,920 6,466 4,557 Total . . . . . . . . . . . . . . . . . . . . . . . . . . 19,943 $ 69 166 244 $479 $ 509 390 248 $1,147 (1) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. Reserves as a percentage of risk in-force as of December 31, 2023 decreased compared to December 31, 2022 as long-term delinquencies with higher reserves have continued to cure. The number of loans that are delinquent for 12 months or more has decreased since December 31, 2022 and is more in line with pre-COVID-19 levels. Due to continued forbearance options, foreclosure moratoriums and the uncertainty 14% 44% 92% 37% 14% 43% 98% 42% around the lack of progression through the foreclosure process, there is still uncertainty around the likelihood and timing of delinquencies going to claim. Primary insurance delinquency rates differ from region to region in the United States at any one time depending upon economic conditions and cyclical growth patterns. The tables below set forth the dispersion of direct primary case reserves and primary delinquency rates for the 10 largest states and the 10 largest Metropolitan Statistical Areas (“MSA”) or Metro Divisions (“MD”) by Enact’s primary risk in-force as of the dates indicated. Delinquency rates are shown by region based upon the location of the underlying property, rather than the location of the lender. Percent of primary risk in-force as of December 31, 2023 Percent of direct primary case reserves as of December 31, 2023(1) Delinquency rate as of December 31, 2023 2022 2021 By State: California . . . . . . . . . . . . . . . . . . . . . . . . . Texas . . . . . . . . . . . . . . . . . . . . . . . . . . . . Florida(2) . . . . . . . . . . . . . . . . . . . . . . . . . . New York(2) . . . . . . . . . . . . . . . . . . . . . . . Illinois(2) . . . . . . . . . . . . . . . . . . . . . . . . . . Arizona . . . . . . . . . . . . . . . . . . . . . . . . . . . Michigan . . . . . . . . . . . . . . . . . . . . . . . . . Georgia . . . . . . . . . . . . . . . . . . . . . . . . . . . North Carolina . . . . . . . . . . . . . . . . . . . . . Washington . . . . . . . . . . . . . . . . . . . . . . . 13% 8% 8% 5% 4% 4% 4% 3% 3% 3% 12% 8% 9% 12% 6% 3% 3% 4% 2% 2% 2.22% 2.22% 2.39% 3.05% 2.61% 1.93% 1.94% 2.23% 1.56% 1.77% 2.09% 2.12% 2.54% 2.95% 2.54% 1.78% 1.79% 2.23% 1.59% 1.92% 3.17% 2.89% 2.97% 3.80% 3.09% 2.31% 1.87% 2.94% 2.18% 2.98% (1) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. (2) Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be completed. Percent of primary risk in-force as of December 31, 2023 Percent of direct primary case reserves as of December 31, 2023(1) Delinquency rate as of December 31, 2022 2023 2021 By MSA or MD: Phoenix, AZ MSA . . . . . . . . . . . . . . . . . . Chicago-Naperville, IL MD . . . . . . . . . . . Atlanta, GA MSA . . . . . . . . . . . . . . . . . . . New York, NY MD . . . . . . . . . . . . . . . . . Washington-Arlington, DC MD . . . . . . . . Houston, TX MSA . . . . . . . . . . . . . . . . . . Los Angeles-Long Beach, CA MD . . . . . Dallas, TX MD . . . . . . . . . . . . . . . . . . . . . Riverside-San Bernardino, CA MSA . . . . Denver-Aurora-Lakewood, CO MSA . . . 3% 3% 3% 2% 2% 2% 2% 2% 2% 2% 2% 4% 3% 7% 2% 3% 3% 2% 3% 1% 2.01% 2.88% 2.40% 3.60% 2.01% 2.67% 2.39% 1.92% 2.83% 1.12% 1.83% 2.84% 2.42% 3.75% 1.85% 2.60% 2.18% 1.86% 2.89% 1.12% 2.36% 3.68% 3.28% 5.32% 2.96% 3.61% 3.95% 2.31% 3.42% 1.66% (1) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. The number of delinquencies may not correlate directly with the number of claims received because delinquencies may cure. The rate at which delinquencies cure is influenced by borrowers’ financial resources and circumstances and regional economic differences. Whether a delinquency leads to a claim correlates highly with the borrower’s equity at the time of delinquency, as it influences the borrower’s willingness to continue to make payments, and the borrower’s or the insured’s ability to sell the home for an amount sufficient to satisfy all amounts due under the mortgage loan, as well as the borrower’s financial ability to continue making payments. When Enact receives notice of a delinquency, it uses its proprietary model to determine whether a delinquent loan is a candidate for a modification. When the model identifies such a candidate, Enact’s loan workout 88 89 specialists prioritize cases for loss mitigation based upon the likelihood that the loan will result in a claim. Loss mitigation actions include loan modification, extension of credit to bring a loan current, foreclosure forbearance, pre-foreclosure sale and deed-in-lieu. These loss mitigation efforts often are an effective way to reduce Enact’s claim exposure and ultimate payouts. The following table sets forth the dispersion of Enact’s direct primary case reserves, primary insurance in-force and risk in-force by year of policy origination, weighted average mortgage interest rate and delinquency rate as of December 31, 2023: (Amounts in millions) Policy Year 2008 and prior . . . . . . . . . . . . . . . 2009 to 2015 . . . . . . . . . . . . . . . . 2016 . . . . . . . . . . . . . . . . . . . . . . . 2017 . . . . . . . . . . . . . . . . . . . . . . . 2018 . . . . . . . . . . . . . . . . . . . . . . . 2019 . . . . . . . . . . . . . . . . . . . . . . . 2020 . . . . . . . . . . . . . . . . . . . . . . . 2021 . . . . . . . . . . . . . . . . . . . . . . . 2022 . . . . . . . . . . . . . . . . . . . . . . . 2023 . . . . . . . . . . . . . . . . . . . . . . . Total portfolio . . . . . . . . . . . . . . . Weighted average rate (1) Percent of direct primary case reserves(2) Primary insurance in-force Percent of total Primary risk in-force Percent of total Delinquency rate 5.74% 4.34% 3.94% 4.30% 4.82% 4.25% 3.27% 3.11% 4.89% 6.68% 4.41% 18% 4 4 5 6 8 15 21 16 3 $ 5,621 3,383 4,659 5,321 5,750 13,773 44,486 70,045 59,267 50,632 2% $ 1,449 881 1 1,248 2 1,403 2 1,476 2 3,544 5 11,697 17 17,846 27 14,907 23 13,078 19 2% 1 2 2 2 5 17 27 22 20 100% $262,937 100% $67,529 100% 8.61% 4.55% 3.20% 3.59% 4.42% 2.77% 1.70% 1.65% 1.57% 0.47% 2.10% (1) Average annual mortgage interest rate weighted by insurance in-force. (2) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. Loss reserves in policy years 2008 and prior are outsized compared to their representation of risk in-force. The size of these policy years at origination combined with the significant decline in home prices led to significant losses in policy years prior to 2009. Although uncertainty remains with respect to the ultimate losses Enact will experience on these policy years, they have become a smaller percentage of its total mortgage insurance portfolio. Loss reserves have shifted to newer book years, largely 2020 and later given their significant representation of risk in-force. As of December 31, 2023, Enact’s 2016 and newer policy years represented approximately 97% of its primary risk in-force and 78% of its total direct primary case reserves. The ratio of the claim paid to the current risk in-force for a loan is referred to as “claim severity.” The current risk in-force is equal to the unpaid principal amount multiplied by the coverage percentage. The main determinants of claim severity are the age of the mortgage loan, the value of the underlying property, accrued interest on the loan, expenses advanced by the insured and foreclosure expenses. These amounts depend partly upon the time required to complete foreclosure, which varies depending upon state laws. Pre-foreclosure sales, acquisitions and other early workout and claim administration actions help to reduce overall claim severity. Enact’s average primary mortgage insurance claim severity was 97%, 94% and 103% for the years ended December 31, 2023, 2022 and 2021, respectively. The average claim severity for the years ended December 31, 2023 and 2022 was impacted by low claim volumes and lifetime home price appreciation. The average claim severities do not include the effects of agreements on non-performing loans. Long-Term Care Insurance segment Trends and conditions The long-term profitability of our long-term care insurance business depends upon how our actual experience compares with our valuation assumptions, including but not limited to in-force rate actions, morbidity, mortality and persistency. Estimates for in-force rate actions reflect certain simplifying assumptions that may vary materially from actual results, including but not limited to consistent policyholder behavior over time in addition to a uniform rate of coinsurance and premium taxes. Actual policyholder behavior may differ significantly from these assumptions. Results of our long-term care insurance business are also influenced by our ability to improve investment yields and manage expenses and reinsurance, among other factors. Changes in laws or government programs, including long-term care insurance rate action legislation, regulation and/or practices, could also impact our long-term care insurance business either positively or negatively. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments as our actual claims experience will emerge over many years, or decades. For example, average claim reserves for new claims have trended higher over time as the mix of claims continues to evolve, with an increasing number of policies with higher daily benefit amounts and higher inflation factors going on claim. Although new claim counts on our oldest long-term care insurance blocks of business will continue to decrease as the blocks run off, we are gaining more experience on our larger new blocks of business and fully expect continued overall growth in new claims as policyholders reach their peak claim years. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care principally attributable to elevated inflation. Increases in cost of care have resulted in higher claim payments in our long-term care insurance business, which could have a material adverse impact on our liquidity, results of operations and financial condition if it persists. We will continue to monitor our experience and make changes to our assumptions and methodologies, as appropriate, for our long-term care insurance products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Under LDTI, the impacts of assumption updates and actual versus expected experience will continue to drive volatility in our long-term care insurance results, particularly for our unprofitable capped cohorts. It is important to note that quarterly variations resulting from assumption updates and actual versus expected experience are typically expected to be relatively small compared to the overall size of our liability for future policy benefits of $42.2 billion, at the locked-in discount rate, for our long-term care insurance business as of December 31, 2023. For a discussion of potential impacts of assumption updates and actual versus expected experience on our results of operations, see “Item 1A—Risk Factors—We may be required to increase our reserves as a result of deviations from our estimates and actuarial assumptions or other reasons, which could have a material adverse effect on our business, results of operations and financial condition.” The financial condition of our long-term care insurance business is also impacted by interest rates. We remeasure our liability for future policy benefits and related reinsurance recoverables at the single-A bond rate each quarter. As a result, our reported insurance liabilities are sensitive to movements in interest rates, which will likely result in continued volatility to our reserve balances and equity. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability.” In-force rate actions and legal settlements Given the ongoing challenges in our long-term care insurance business, we continue to pursue initiatives to improve the risk and profitability profile of our business, including premium rate increases and associated benefit reductions on our in-force policies. Executing on our multi-year long-term care insurance in-force rate action plan with premium rate increases and associated benefit reductions on our legacy long-term care insurance policies is critical to the business. For an update on in-force rate actions, refer to the selected operating performance measures below. 90 91 specialists prioritize cases for loss mitigation based upon the likelihood that the loan will result in a claim. Loss mitigation actions include loan modification, extension of credit to bring a loan current, foreclosure forbearance, pre-foreclosure sale and deed-in-lieu. These loss mitigation efforts often are an effective way to reduce Enact’s claim exposure and ultimate payouts. The following table sets forth the dispersion of Enact’s direct primary case reserves, primary insurance in-force and risk in-force by year of policy origination, weighted average mortgage interest rate and delinquency rate as of December 31, 2023: (Amounts in millions) Policy Year 2008 and prior . . . . . . . . . . . . . . . 2009 to 2015 . . . . . . . . . . . . . . . . 2016 . . . . . . . . . . . . . . . . . . . . . . . 2017 . . . . . . . . . . . . . . . . . . . . . . . 2018 . . . . . . . . . . . . . . . . . . . . . . . 2019 . . . . . . . . . . . . . . . . . . . . . . . 2020 . . . . . . . . . . . . . . . . . . . . . . . 2021 . . . . . . . . . . . . . . . . . . . . . . . 2022 . . . . . . . . . . . . . . . . . . . . . . . 2023 . . . . . . . . . . . . . . . . . . . . . . . Weighted average rate (1) Percent of direct primary case reserves(2) Primary insurance in-force Percent of total Primary risk in-force Percent of total Delinquency rate 5.74% 4.34% 3.94% 4.30% 4.82% 4.25% 3.27% 3.11% 4.89% 6.68% 4.41% 18% $ 2% $ 1,449 2% 4 4 5 6 8 15 21 16 3 5,621 3,383 4,659 5,321 5,750 13,773 44,486 70,045 59,267 50,632 1 2 2 2 5 17 27 23 19 881 1,248 1,403 1,476 3,544 11,697 17,846 14,907 13,078 1 2 2 2 5 17 27 22 20 8.61% 4.55% 3.20% 3.59% 4.42% 2.77% 1.70% 1.65% 1.57% 0.47% 2.10% Total portfolio . . . . . . . . . . . . . . . 100% $262,937 100% $67,529 100% (1) Average annual mortgage interest rate weighted by insurance in-force. (2) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. Loss reserves in policy years 2008 and prior are outsized compared to their representation of risk in-force. The size of these policy years at origination combined with the significant decline in home prices led to significant losses in policy years prior to 2009. Although uncertainty remains with respect to the ultimate losses Enact will experience on these policy years, they have become a smaller percentage of its total mortgage insurance portfolio. Loss reserves have shifted to newer book years, largely 2020 and later given their significant representation of risk in-force. As of December 31, 2023, Enact’s 2016 and newer policy years represented approximately 97% of its primary risk in-force and 78% of its total direct primary case reserves. The ratio of the claim paid to the current risk in-force for a loan is referred to as “claim severity.” The current risk in-force is equal to the unpaid principal amount multiplied by the coverage percentage. The main determinants of claim severity are the age of the mortgage loan, the value of the underlying property, accrued interest on the loan, expenses advanced by the insured and foreclosure expenses. These amounts depend partly upon the time required to complete foreclosure, which varies depending upon state laws. Pre-foreclosure sales, acquisitions and other early workout and claim administration actions help to reduce overall claim severity. Enact’s average primary mortgage insurance claim severity was 97%, 94% and 103% for the years ended December 31, 2023, 2022 and 2021, respectively. The average claim severity for the years ended December 31, 2023 and 2022 was impacted by low claim volumes and lifetime home price appreciation. The average claim severities do not include the effects of agreements on non-performing loans. Long-Term Care Insurance segment Trends and conditions The long-term profitability of our long-term care insurance business depends upon how our actual experience compares with our valuation assumptions, including but not limited to in-force rate actions, morbidity, mortality and persistency. Estimates for in-force rate actions reflect certain simplifying assumptions that may vary materially from actual results, including but not limited to consistent policyholder behavior over time in addition to a uniform rate of coinsurance and premium taxes. Actual policyholder behavior may differ significantly from these assumptions. Results of our long-term care insurance business are also influenced by our ability to improve investment yields and manage expenses and reinsurance, among other factors. Changes in laws or government programs, including long-term care insurance rate action legislation, regulation and/or practices, could also impact our long-term care insurance business either positively or negatively. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments as our actual claims experience will emerge over many years, or decades. For example, average claim reserves for new claims have trended higher over time as the mix of claims continues to evolve, with an increasing number of policies with higher daily benefit amounts and higher inflation factors going on claim. Although new claim counts on our oldest long-term care insurance blocks of business will continue to decrease as the blocks run off, we are gaining more experience on our larger new blocks of business and fully expect continued overall growth in new claims as policyholders reach their peak claim years. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care principally attributable to elevated inflation. Increases in cost of care have resulted in higher claim payments in our long-term care insurance business, which could have a material adverse impact on our liquidity, results of operations and financial condition if it persists. We will continue to monitor our experience and make changes to our assumptions and methodologies, as appropriate, for our long-term care insurance products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Under LDTI, the impacts of assumption updates and actual versus expected experience will continue to drive volatility in our long-term care insurance results, particularly for our unprofitable capped cohorts. It is important to note that quarterly variations resulting from assumption updates and actual versus expected experience are typically expected to be relatively small compared to the overall size of our liability for future policy benefits of $42.2 billion, at the locked-in discount rate, for our long-term care insurance business as of December 31, 2023. For a discussion of potential impacts of assumption updates and actual versus expected experience on our results of operations, see “Item 1A—Risk Factors—We may be required to increase our reserves as a result of deviations from our estimates and actuarial assumptions or other reasons, which could have a material adverse effect on our business, results of operations and financial condition.” The financial condition of our long-term care insurance business is also impacted by interest rates. We remeasure our liability for future policy benefits and related reinsurance recoverables at the single-A bond rate each quarter. As a result, our reported insurance liabilities are sensitive to movements in interest rates, which will likely result in continued volatility to our reserve balances and equity. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability.” In-force rate actions and legal settlements Given the ongoing challenges in our long-term care insurance business, we continue to pursue initiatives to improve the risk and profitability profile of our business, including premium rate increases and associated benefit reductions on our in-force policies. Executing on our multi-year long-term care insurance in-force rate action plan with premium rate increases and associated benefit reductions on our legacy long-term care insurance policies is critical to the business. For an update on in-force rate actions, refer to the selected operating performance measures below. 90 91 insurance business in early 2022 was likely impacted by COVID-19. We expected the impacts to be temporary, with disabled life mortality remaining elevated over the near term. We saw mortality levels trending back to pre-pandemic levels in the latter half of 2022. In the first quarter of 2023, we experienced typical seasonally favorable mortality, but mortality was unfavorable for the remainder of 2023, consistent with seasonal trends. We also experienced lower than expected new claims incidence in our long-term care insurance business during COVID-19. However, we are seeing new claims incidence trending back to pre-pandemic levels. In addition, during the pandemic, a larger share of our claimants sought home care instead of facility-based care, and as the impacts of the pandemic subside, we have seen that trend reverse. We will continue to monitor long- term care insurance benefit utilization so that we can evaluate any long-term impact emerging from the pandemic. While the longer-term impacts of COVID-19 are very difficult to predict, the related outcomes and impact on our long-term care insurance business currently depend on the after-effects indirectly caused by the pandemic, including elevated inflation, the associated impacts to the cost of care and changes in policyholder behavior. We will continue to monitor COVID-19 associated impacts and evaluate all of our assumptions that may need updating as a result of longer-term trends related to the pandemic. In addition, we have reached certain legal settlements regarding alleged disclosure deficiencies in premium increases for long-term care insurance policies. The first legal settlement related to certain of our long-term care insurance policies, which represents approximately 20% of our block, was implemented beginning in 2021 and its implementation was materially completed in the second quarter of 2022. A second legal settlement on certain of our long-term care insurance policies, which represents 15% of our block, was implemented beginning in August 2022 and its implementation was materially completed in the fourth quarter of 2023. On March 27, 2023, a third similar settlement on certain of our long-term care insurance policies, which represents 35% of our block, became final. We began implementation of this settlement during the second quarter of 2023. While the legal settlements are similar, their ultimate impact will depend on the policyholder election rates and the types of reduced benefits elected. Given our experience with the first and second settlements, we expect the third legal settlement to result in an overall net favorable economic impact to our long-term care insurance business as it reduces tail risk on these long-duration liabilities. While we expect renewal premiums to decline over time, the settlements could accelerate that decline if policyholders continue to elect non-forfeiture and reduced benefit options, which have predominantly been the most prevalent policyholder elections for these legal settlements and which entitle the policyholder to reduced benefits in exchange for premiums already paid or a lower level of future premiums. Fourth quarter assumption review In the fourth quarter of 2023, our long-term care insurance products had an unfavorable pre-tax impact of $61 million from cash flow assumption updates, including updates to our healthy life assumptions to better reflect near-term experience for cost of care, mortality, incidence and lapse. For our 2023 assumption updates, we generally did not include data after 2019 in setting any long-term assumptions, as we do not have sufficient information around longer-term effects of the pandemic, which is consistent with the approach for our 2022 assumptions. However, we made a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. We also evaluated our assumptions regarding expectations of future premium rate increase approvals and benefit reductions and did not make significant changes to our multi-year in-force rate action plan. However, we did increase our assumption for future approvals and benefit reductions given our current plans for rate increase filings and our historical experience regarding approvals and regulatory support, as well as benefit reductions and legal settlement results. We also updated our assumptions for the third legal settlement in the fourth quarter of 2023; however, the changes had a muted favorable income statement impact as this settlement impacts profitable uncapped cohorts. In the fourth quarter of 2022, our long-term care insurance business had favorable assumption updates of $303 million, which reflected an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement. This settlement primarily impacts older, unprofitable capped cohorts; therefore, it had an immediate impact to the fourth quarter of 2022 earnings. Under statutory accounting, only changes to our claim reserve assumptions are reflected in statutory income. Assumption changes impacting active life reserves are included in cash flow testing margin, which only impacts statutory income if the margin falls below zero. We completed statutory cash flow testing for our life insurance subsidiaries in the fourth quarter of 2023 and concluded that the margin in GLIC was positive and within the $0.5 billion to $1.0 billion range. However, GLICNY had a negative margin and recorded additional statutory reserves of $87 million in 2023. COVID-19 impacts In our long-term care insurance products, we experienced a favorable impact on reserves and our operating results related to elevated mortality during COVID-19. Although it is not our practice to track cause of death for long-term care insurance policyholders and claimants, we believe the favorable mortality in our long-term care 92 93 insurance business in early 2022 was likely impacted by COVID-19. We expected the impacts to be temporary, with disabled life mortality remaining elevated over the near term. We saw mortality levels trending back to pre-pandemic levels in the latter half of 2022. In the first quarter of 2023, we experienced typical seasonally favorable mortality, but mortality was unfavorable for the remainder of 2023, consistent with seasonal trends. We also experienced lower than expected new claims incidence in our long-term care insurance business during COVID-19. However, we are seeing new claims incidence trending back to pre-pandemic levels. In addition, during the pandemic, a larger share of our claimants sought home care instead of facility-based care, and as the impacts of the pandemic subside, we have seen that trend reverse. We will continue to monitor long- term care insurance benefit utilization so that we can evaluate any long-term impact emerging from the pandemic. While the longer-term impacts of COVID-19 are very difficult to predict, the related outcomes and impact on our long-term care insurance business currently depend on the after-effects indirectly caused by the pandemic, including elevated inflation, the associated impacts to the cost of care and changes in policyholder behavior. We will continue to monitor COVID-19 associated impacts and evaluate all of our assumptions that may need updating as a result of longer-term trends related to the pandemic. In addition, we have reached certain legal settlements regarding alleged disclosure deficiencies in premium increases for long-term care insurance policies. The first legal settlement related to certain of our long-term care insurance policies, which represents approximately 20% of our block, was implemented beginning in 2021 and its implementation was materially completed in the second quarter of 2022. A second legal settlement on certain of our long-term care insurance policies, which represents 15% of our block, was implemented beginning in August 2022 and its implementation was materially completed in the fourth quarter of 2023. On March 27, 2023, a third similar settlement on certain of our long-term care insurance policies, which represents 35% of our block, became final. We began implementation of this settlement during the second quarter of 2023. While the legal settlements are similar, their ultimate impact will depend on the policyholder election rates and the types of reduced benefits elected. Given our experience with the first and second settlements, we expect the third legal settlement to result in an overall net favorable economic impact to our long-term care insurance business as it reduces tail risk on these long-duration liabilities. While we expect renewal premiums to decline over time, the settlements could accelerate that decline if policyholders continue to elect non-forfeiture and reduced benefit options, which have predominantly been the most prevalent policyholder elections for these legal settlements and which entitle the policyholder to reduced benefits in exchange for premiums already paid or a lower level of future premiums. Fourth quarter assumption review In the fourth quarter of 2023, our long-term care insurance products had an unfavorable pre-tax impact of $61 million from cash flow assumption updates, including updates to our healthy life assumptions to better reflect near-term experience for cost of care, mortality, incidence and lapse. For our 2023 assumption updates, we generally did not include data after 2019 in setting any long-term assumptions, as we do not have sufficient information around longer-term effects of the pandemic, which is consistent with the approach for our 2022 assumptions. However, we made a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. We also evaluated our assumptions regarding expectations of future premium rate increase approvals and benefit reductions and did not make significant changes to our multi-year in-force rate action plan. However, we did increase our assumption for future approvals and benefit reductions given our current plans for rate increase filings and our historical experience regarding approvals and regulatory support, as well as benefit reductions and legal settlement results. We also updated our assumptions for the third legal settlement in the fourth quarter of 2023; however, the changes had a muted favorable income statement impact as this settlement impacts profitable uncapped cohorts. In the fourth quarter of 2022, our long-term care insurance business had favorable assumption updates of $303 million, which reflected an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement. This settlement primarily impacts older, unprofitable capped cohorts; therefore, it had an immediate impact to the fourth quarter of 2022 earnings. Under statutory accounting, only changes to our claim reserve assumptions are reflected in statutory income. Assumption changes impacting active life reserves are included in cash flow testing margin, which only impacts statutory income if the margin falls below zero. We completed statutory cash flow testing for our life insurance subsidiaries in the fourth quarter of 2023 and concluded that the margin in GLIC was positive and within the $0.5 billion to $1.0 billion range. However, GLICNY had a negative margin and recorded additional statutory reserves of $87 million in 2023. COVID-19 impacts In our long-term care insurance products, we experienced a favorable impact on reserves and our operating results related to elevated mortality during COVID-19. Although it is not our practice to track cause of death for long-term care insurance policyholders and claimants, we believe the favorable mortality in our long-term care 92 93 2,027 257 1,900 19 — (1)% $ (61) (127) (238) (2)% (6)% (93)% (1) (100)% $2,463 $2,500 $2,561 $ (37) 1% 14 1,914 114 95 NM(1) 1 — — % — Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment income . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . Segment results of operations The following table sets forth the results of operations relating to our Long-Term Care Insurance segment for the periods indicated: (Amounts in millions) 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Years ended December 31, Increase (decrease) and percentage change Total revenues . . . . . . . . . . . . . . . . . . . . . . . 4,491 4,419 4,846 72 2% (427) (9)% terminations in 2023. Benefits and expenses: Benefits and other changes in policy reserves . . . Liability remeasurement (gains) losses . . . . . . . . Acquisition and operating expenses, net of 3,802 321 3,788 (317) 3,808 68 14 — % 638 NM(1) (20) (1)% (385) NM(1) deferrals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 452 413 451 39 9% (38) (8)% Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71 74 76 (3) (4)% (2) (3)% Total benefits and expenses . . . . . . . . . . . . . 4,646 3,958 4,403 688 17% (445) (10)% Income (loss) from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . Provision (benefit) for income taxes . . . . . . . . . . Income (loss) from continuing operations . . . . . . Adjustments to income (loss) from continuing operations: (155) (3) (152) 461 125 336 443 123 320 (616) (134)% (128) (102)% (488) (145)% 18 2 16 4% 2% 5% Net investment (gains) losses . . . . . . . . . . . . . . . Expenses related to restructuring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Taxes on adjustments (114) — 24 (19) (1) 4 (257) 12 51 (95) NM(1) 1 100% 20 NM(1) 238 93% (13) (108)% (92)% (47) Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . $ (242) $ 320 $ 126 $(562) (176)% $ 194 154% Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders (1) We define “NM” as not meaningful for increases or decreases greater than 200%. 2023 compared to 2022 Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders The change to an adjusted operating loss in 2023 from adjusted operating income in 2022 was largely driven by unfavorable cash flow assumption updates in 2023 compared to favorable updates in 2022. The change was also driven by adverse actual versus expected experience in 2023 primarily related to higher claims and unfavorable timing impacts related to the second legal settlement. We also experienced higher operating costs and lower premiums in 2023. Revenues Premiums decreased primarily driven by lower renewal premiums from policy terminations and policies entering paid-up status, partially offset by $70 million of higher premiums from newly implemented in-force rate actions in 2023. 94 95 Net investment income increased largely due to higher investment yields and higher income from limited partnerships and bank loans, partially offset by lower income from U.S. Government Treasury Inflation Protected Securities (“TIPS”). The increase was also partially offset by lower income from bond calls and commercial mortgage loan prepayments in 2023. For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” Benefits and expenses Benefits and other changes in policy reserves increased primarily due to aging of the in-force block, including higher interest accretion, as well as higher loss adjustment expenses, partially offset by policy The liability remeasurement loss in 2023 was largely driven by adverse actual versus expected experience primarily related to higher claims and unfavorable timing impacts from the second legal settlement. In addition, cash flow assumption updates were unfavorable in 2023 primarily driven by unfavorable updates to our healthy life assumptions to better reflect near-term experience related to cost of care, mortality, incidence and lapse. This was partially offset by a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. The liability remeasurement gain in 2022 resulted primarily from favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement. Acquisition and operating expenses, net of deferrals, increased principally from higher operating costs, partially offset by a lower accrual for legal settlement costs in 2023. Provision (benefit) for income taxes. The effective tax rate was 2.2% and 27.2% for the years ended December 31, 2023 and 2022, respectively. The decrease in the effective tax rate was primarily attributable to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income in relation to a pre-tax loss in 2023. 2022 compared to 2021 Revenues actions in 2022. Adjusted operating income increased largely driven by favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement, partially offset by lower net investment income in 2022. Premiums decreased primarily driven by lower renewal premiums from policy terminations and policies entering paid-up status, partially offset by $93 million of higher premiums from newly implemented in-force rate Net investment income decreased largely from lower income of $169 million in 2022 mostly attributable to limited partnerships, as well as bond calls and commercial mortgage loan prepayments. The decrease was partially offset by higher income of $18 million from TIPS and higher average invested assets in 2022. For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” Segment results of operations for the periods indicated: (Amounts in millions) Revenues: The following table sets forth the results of operations relating to our Long-Term Care Insurance segment Years ended December 31, Increase (decrease) and percentage change 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,463 $2,500 $2,561 $ (37) (1)% $ (61) Net investment income . . . . . . . . . . . . . . . . . . . . 1,914 1,900 Net investment gains (losses) . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . 114 — 19 — 2,027 257 14 1% 95 NM(1) (127) (238) 1 — — % (1) (100)% (2)% (6)% (93)% Total revenues . . . . . . . . . . . . . . . . . . . . . . . 4,491 4,419 4,846 72 2% (427) (9)% Benefits and expenses: Benefits and other changes in policy reserves . . . 3,802 3,788 3,808 14 — % (20) (1)% Liability remeasurement (gains) losses . . . . . . . . 321 (317) 68 638 NM(1) (385) NM(1) Acquisition and operating expenses, net of Amortization of deferred acquisition costs and deferrals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 452 413 451 39 9% (38) (8)% intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71 74 76 (3) (4)% (2) (3)% Total benefits and expenses . . . . . . . . . . . . . 4,646 3,958 4,403 688 17% (445) (10)% (155) (3) (152) 461 125 336 443 123 320 (616) (134)% (128) (102)% (488) (145)% 18 2 16 4% 2% 5% Net investment (gains) losses . . . . . . . . . . . . . . . (114) (257) (95) NM(1) 238 93% Expenses related to restructuring . . . . . . . . . . . . . Taxes on adjustments . . . . . . . . . . . . . . . . . . . . . — 24 12 51 1 100% 20 NM(1) (13) (108)% (47) (92)% (19) (1) 4 Income (loss) from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . Provision (benefit) for income taxes . . . . . . . . . . Income (loss) from continuing operations . . . . . . Adjustments to income (loss) from continuing operations: Adjusted operating income (loss) available to Genworth Financial, Inc.’s common (1) We define “NM” as not meaningful for increases or decreases greater than 200%. 2023 compared to 2022 Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders The change to an adjusted operating loss in 2023 from adjusted operating income in 2022 was largely driven by unfavorable cash flow assumption updates in 2023 compared to favorable updates in 2022. The change was also driven by adverse actual versus expected experience in 2023 primarily related to higher claims and unfavorable timing impacts related to the second legal settlement. We also experienced higher operating costs and lower premiums in 2023. Revenues actions in 2023. Premiums decreased primarily driven by lower renewal premiums from policy terminations and policies entering paid-up status, partially offset by $70 million of higher premiums from newly implemented in-force rate Net investment income increased largely due to higher investment yields and higher income from limited partnerships and bank loans, partially offset by lower income from U.S. Government Treasury Inflation Protected Securities (“TIPS”). The increase was also partially offset by lower income from bond calls and commercial mortgage loan prepayments in 2023. For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” Benefits and expenses Benefits and other changes in policy reserves increased primarily due to aging of the in-force block, including higher interest accretion, as well as higher loss adjustment expenses, partially offset by policy terminations in 2023. The liability remeasurement loss in 2023 was largely driven by adverse actual versus expected experience primarily related to higher claims and unfavorable timing impacts from the second legal settlement. In addition, cash flow assumption updates were unfavorable in 2023 primarily driven by unfavorable updates to our healthy life assumptions to better reflect near-term experience related to cost of care, mortality, incidence and lapse. This was partially offset by a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. The liability remeasurement gain in 2022 resulted primarily from favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement. Acquisition and operating expenses, net of deferrals, increased principally from higher operating costs, partially offset by a lower accrual for legal settlement costs in 2023. Provision (benefit) for income taxes. The effective tax rate was 2.2% and 27.2% for the years ended December 31, 2023 and 2022, respectively. The decrease in the effective tax rate was primarily attributable to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income in relation to a pre-tax loss in 2023. 2022 compared to 2021 stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . $ (242) $ 320 $ 126 $(562) (176)% $ 194 154% Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders Adjusted operating income increased largely driven by favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement, partially offset by lower net investment income in 2022. Revenues Premiums decreased primarily driven by lower renewal premiums from policy terminations and policies entering paid-up status, partially offset by $93 million of higher premiums from newly implemented in-force rate actions in 2022. Net investment income decreased largely from lower income of $169 million in 2022 mostly attributable to limited partnerships, as well as bond calls and commercial mortgage loan prepayments. The decrease was partially offset by higher income of $18 million from TIPS and higher average invested assets in 2022. For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” 94 95 Benefits and expenses Benefits and other changes in policy reserves decreased primarily due to policy terminations, partially offset by aging of the in-force block, including higher interest accretion, as well as higher loss adjustment expenses in 2022. The liability remeasurement gain in 2022 was largely related to favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement. The liability remeasurement loss in 2021 was primarily driven by unfavorable cash flow assumption updates largely related to an update to the benefit utilization trend to reflect expected future increases in cost of care, which drove significant updates to the in-force rate action plan and related assumptions. The unfavorable assumption updates in 2021 were partially offset by favorable actual to expected experience related to claim terminations and in-force rate actions. Acquisition and operating expenses, net of deferrals, decreased principally from lower operating costs in 2022 and restructuring costs of $12 million in 2021 that did not recur, partially offset by a $20 million accrual for legal settlement costs in 2022. Provision (benefit) for income taxes. The effective tax rate was 27.2% and 27.9% for the years ended December 31, 2022 and 2021, respectively. Long-Term Care Insurance selected operating performance measures Under LDTI, we now include expectations for benefit reductions related to in-force rate actions and legal settlements as well as settlement payments in our assumptions for the liability for future policy benefits, which have impacted and will continue to impact our reported U.S. GAAP financial results. There was no change in how we recognize premiums related to in-force rate actions due to the adoption of LDTI. We have experienced and may continue to experience quarterly fluctuations in earnings related to the legal settlements to the extent actual experience deviates from our assumptions. However, we expect the legal settlements to result in an overall net favorable economic impact to our long-term care insurance business as they reduce tail risk on these long-duration liabilities. Under LDTI, we elected to update the net premium ratio quarterly for actual versus expected experience; therefore, forecasted cash flow assumptions will be replaced with actual cash flows each quarter with any difference recorded in net income (loss). As a result, variances between actual experience and our expectations for benefit reductions and settlement payments will be reflected in liability remeasurement (gains) losses in our operating results on a quarterly basis. Remeasurement (gains) losses The following table sets forth the pre-tax components of the liability remeasurement (gains) losses for the For additional discussion of the change in liability remeasurement (gains) losses, see the comparison for this line item above in “—Segment results of operations.” In-force rate actions As part of our strategy for our long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions on older generation blocks of business in order to ensure the continued self-sustainability of our long-term care insurance business over time and reduce the strain on its earnings and capital. The following table sets forth filing approvals as part of our multi-year in-force rate action plan for the years ended December 31: (Dollar amounts in millions) 2023 2022 2021 State filings approved . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Impacted in-force premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117 $697 139 173 $1,143 $1,095 Weighted-average percentage rate increase approved . . . . . . . . 51% 48% 37% Gross incremental premiums approved . . . . . . . . . . . . . . . . . . . . $354 $ 549 $ 403 We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan from 2012 through December 31, 2023 was approximately $28.0 billion, on a net present value basis, which includes our current updated assumptions regarding future premiums and benefit reductions from approved rate actions and legal settlements. The $28.0 billion net present value of progress achieved has grown significantly since December 31, 2022, including $2.0 billion of value from rate action approvals and settlement implementations in 2023 and an increase of $2.5 billion of the value of benefit reductions connected with our previously achieved rate actions and settlements, including the impact of our assumption updates. During the year ended December 31, 2023, we also submitted 144 new filings on approximately $989 million in annualized in-force premiums. The approval process for in-force rate actions and the amount and timing of the premium rate increases and associated benefit reductions approved vary by state. In certain states, the decision to approve or disapprove a rate increase can take a significant amount of time, and the approved amount may be phased in over time. After approval, insureds are provided with written notice of the increase and increases are generally applied on the insured’s next policy anniversary date. As a result, the benefits of any rate increase are not fully realized until the implementation cycle is complete and are, therefore, expected to be realized over time. We continue to work closely with the NAIC and state regulators to demonstrate the broad-based need for actuarially justified rate increases in order to pay future claims. Because obtaining actuarially justified rate increases and associated benefit reductions is important to our ability to pay future claims, we will consider litigation against states that decline to approve those actuarially justified rate increases. In January 2022, we began litigation with two states that have refused to approve actuarially justified rate increases. periods indicated: (Amounts in millions) Years ended December 31 (Increase) decrease and percentage change 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Life and Annuities segment Trends and conditions Cash flow assumption updates . . . . . . . . . . . . . . . . . . . . . . . Actual to expected experience . . . . . . . . . . . . . . . . . . . . . . . $ 52 $(335) $ 227 $387 116% $(562) NM(1) 177 111% (159) 251 NM(1) 269 18 Total liability remeasurement (gains) losses . . . . . . . . . . . . $321 $(317) $ 68 $638 NM(1) $(385) NM(1) (1) We define “NM” as not meaningful for increases or decreases greater than 200%. Many factors can affect the results of our life insurance and annuity products, as further discussed below. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. We will continue to monitor our experience and assumptions closely and make changes to our assumptions and methodologies, as appropriate, for our life insurance and annuity products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the 96 97 Benefits and expenses 2022. Benefits and other changes in policy reserves decreased primarily due to policy terminations, partially offset by aging of the in-force block, including higher interest accretion, as well as higher loss adjustment expenses in The liability remeasurement gain in 2022 was largely related to favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement. The liability remeasurement loss in 2021 was primarily driven by unfavorable cash flow assumption updates largely related to an update to the benefit utilization trend to reflect expected future increases in cost of care, which drove significant updates to the in-force rate action plan and related assumptions. The unfavorable assumption updates in 2021 were partially offset by favorable actual to expected experience related to claim terminations and in-force rate actions. Acquisition and operating expenses, net of deferrals, decreased principally from lower operating costs in 2022 and restructuring costs of $12 million in 2021 that did not recur, partially offset by a $20 million accrual for legal settlement costs in 2022. Provision (benefit) for income taxes. The effective tax rate was 27.2% and 27.9% for the years ended December 31, 2022 and 2021, respectively. Long-Term Care Insurance selected operating performance measures Under LDTI, we now include expectations for benefit reductions related to in-force rate actions and legal settlements as well as settlement payments in our assumptions for the liability for future policy benefits, which have impacted and will continue to impact our reported U.S. GAAP financial results. There was no change in how we recognize premiums related to in-force rate actions due to the adoption of LDTI. We have experienced and may continue to experience quarterly fluctuations in earnings related to the legal settlements to the extent actual experience deviates from our assumptions. However, we expect the legal settlements to result in an overall net favorable economic impact to our long-term care insurance business as they reduce tail risk on these long-duration liabilities. Under LDTI, we elected to update the net premium ratio quarterly for actual versus expected experience; therefore, forecasted cash flow assumptions will be replaced with actual cash flows each quarter with any difference recorded in net income (loss). As a result, variances between actual experience and our expectations for benefit reductions and settlement payments will be reflected in liability remeasurement (gains) losses in our The following table sets forth the pre-tax components of the liability remeasurement (gains) losses for the operating results on a quarterly basis. Remeasurement (gains) losses periods indicated: (Amounts in millions) For additional discussion of the change in liability remeasurement (gains) losses, see the comparison for this line item above in “—Segment results of operations.” In-force rate actions As part of our strategy for our long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions on older generation blocks of business in order to ensure the continued self-sustainability of our long-term care insurance business over time and reduce the strain on its earnings and capital. The following table sets forth filing approvals as part of our multi-year in-force rate action plan for the years ended December 31: (Dollar amounts in millions) 2023 2022 2021 State filings approved . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Impacted in-force premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . Weighted-average percentage rate increase approved . . . . . . . . Gross incremental premiums approved . . . . . . . . . . . . . . . . . . . . 117 $697 139 $1,143 173 $1,095 51% 48% 37% $354 $ 549 $ 403 We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan from 2012 through December 31, 2023 was approximately $28.0 billion, on a net present value basis, which includes our current updated assumptions regarding future premiums and benefit reductions from approved rate actions and legal settlements. The $28.0 billion net present value of progress achieved has grown significantly since December 31, 2022, including $2.0 billion of value from rate action approvals and settlement implementations in 2023 and an increase of $2.5 billion of the value of benefit reductions connected with our previously achieved rate actions and settlements, including the impact of our assumption updates. During the year ended December 31, 2023, we also submitted 144 new filings on approximately $989 million in annualized in-force premiums. The approval process for in-force rate actions and the amount and timing of the premium rate increases and associated benefit reductions approved vary by state. In certain states, the decision to approve or disapprove a rate increase can take a significant amount of time, and the approved amount may be phased in over time. After approval, insureds are provided with written notice of the increase and increases are generally applied on the insured’s next policy anniversary date. As a result, the benefits of any rate increase are not fully realized until the implementation cycle is complete and are, therefore, expected to be realized over time. We continue to work closely with the NAIC and state regulators to demonstrate the broad-based need for actuarially justified rate increases in order to pay future claims. Because obtaining actuarially justified rate increases and associated benefit reductions is important to our ability to pay future claims, we will consider litigation against states that decline to approve those actuarially justified rate increases. In January 2022, we began litigation with two states that have refused to approve actuarially justified rate increases. Years ended December 31 (Increase) decrease and percentage change 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Life and Annuities segment Trends and conditions Cash flow assumption updates . . . . . . . . . . . . . . . . . . . . . . . $ 52 $(335) $ 227 $387 116% $(562) NM(1) Actual to expected experience . . . . . . . . . . . . . . . . . . . . . . . 269 18 (159) 251 NM(1) 177 111% Total liability remeasurement (gains) losses . . . . . . . . . . . . $321 $(317) $ 68 $638 NM(1) $(385) NM(1) (1) We define “NM” as not meaningful for increases or decreases greater than 200%. Many factors can affect the results of our life insurance and annuity products, as further discussed below. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. We will continue to monitor our experience and assumptions closely and make changes to our assumptions and methodologies, as appropriate, for our life insurance and annuity products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the 96 97 As part of our fourth quarter of 2023 review of our cash flow assumptions, we focused on mortality and lapse assumptions in our fixed annuity products and made modest updates based on recent experience. For fixed indexed annuities, equity market and interest rate performance and volatility could also result in additional gains or losses, although associated hedging activities are expected to partially mitigate these impacts. Variable annuities Results of our variable annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, surrenders and scheduled maturities. In addition, the results of our variable annuity products can significantly impact our regulatory capital requirements, distributable earnings and liquidity. We use hedging strategies as well as liquidity planning and asset-liability management to help mitigate the impacts. In addition, we have used reinsurance to help mitigate volatility in our variable annuity results. Equity market volatility and interest rate movements have caused fluctuations in the results of our variable annuity products and regulatory capital requirements. In the future, equity and interest rate market performance and volatility could result in additional gains or losses in these products although associated hedging activities are expected to partially mitigate these impacts. past have had, material impacts on our reserve levels, results of operations and financial condition. Results of our life insurance and annuity products depend significantly upon the extent to which our actual future experience is consistent with assumptions and methodologies we have used in calculating our reserves. Results of our life insurance and annuity products are also impacted by interest rates. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability.” Life insurance Results of our life insurance products are impacted primarily by mortality, persistency, investment yields, expenses, reinsurance and statutory reserve requirements, among other factors. Mortality levels may deviate each period from historical trends. Overall mortality experience was less unfavorable during 2023 as compared to 2022. In our life insurance products, COVID-19 deaths significantly declined during 2023 from the levels in 2022. We have experienced unfavorable mortality compared to our then- current and priced-for assumptions in recent years for our universal life insurance block. We have also been experiencing higher mortality related charges resulting in an increase in rates charged by our reinsurance partners reflecting natural block aging and unfavorable mortality compared to expectations. In the fourth quarter of 2023, our life insurance products had an unfavorable impact from cash flow assumption updates of $226 million reflecting updates to our persistency and mortality assumptions. We made an unfavorable update to our persistency assumptions particularly in certain universal life insurance products with secondary guarantees to better reflect emerging experience, consistent with others in the industry. However, given the relatively small size and characteristics of our closed block, we believe we experienced a smaller impact from our assumption updates relative to others in the industry with larger blocks. We also made unfavorable updates to our mortality assumption in our term universal, universal and term life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term post-COVID-19. Our 2023 assumption review considered trends during the pandemic years, but updates to our long-term assumptions generally excluded experience data after 2019, as we do not have sufficient information around the long-term effects of COVID-19. However, similar to our long-term care insurance products, we assessed near-term mortality trends as we continue to evaluate the long-term implications of COVID-19. In 2022, we made favorable cash flow assumption updates of $37 million in our universal and term universal life insurance products primarily related to higher interest rates. Certain of our universal life insurance products with secondary guarantees are subject to additional reserves on a statutory basis using a regulatory prescribed reinvestment rate. Given the increase in rates, we experienced a favorable benefit from the reinvestment rate in 2023, which more than offset negative assumption updates from a statutory income perspective. Fixed annuities Results of our fixed annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, persistency and expense and commission levels. We monitor and change crediting rates on fixed deferred annuities on a regular basis to maintain spreads and targeted returns, if applicable. However, we have seen and could continue to see declines in our fixed annuity spreads and margins as interest rates change, depending on the severity of the change. 98 99 As part of our fourth quarter of 2023 review of our cash flow assumptions, we focused on mortality and lapse assumptions in our fixed annuity products and made modest updates based on recent experience. For fixed indexed annuities, equity market and interest rate performance and volatility could also result in additional gains or losses, although associated hedging activities are expected to partially mitigate these impacts. Variable annuities Results of our variable annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, surrenders and scheduled maturities. In addition, the results of our variable annuity products can significantly impact our regulatory capital requirements, distributable earnings and liquidity. We use hedging strategies as well as liquidity planning and asset-liability management to help mitigate the impacts. In addition, we have used reinsurance to help mitigate volatility in our variable annuity results. Equity market volatility and interest rate movements have caused fluctuations in the results of our variable annuity products and regulatory capital requirements. In the future, equity and interest rate market performance and volatility could result in additional gains or losses in these products although associated hedging activities are expected to partially mitigate these impacts. past have had, material impacts on our reserve levels, results of operations and financial condition. Results of our life insurance and annuity products depend significantly upon the extent to which our actual future experience is consistent with assumptions and methodologies we have used in calculating our reserves. Results of our life insurance and annuity products are also impacted by interest rates. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability.” Life insurance Results of our life insurance products are impacted primarily by mortality, persistency, investment yields, expenses, reinsurance and statutory reserve requirements, among other factors. Mortality levels may deviate each period from historical trends. Overall mortality experience was less unfavorable during 2023 as compared to 2022. In our life insurance products, COVID-19 deaths significantly declined during 2023 from the levels in 2022. We have experienced unfavorable mortality compared to our then- current and priced-for assumptions in recent years for our universal life insurance block. We have also been experiencing higher mortality related charges resulting in an increase in rates charged by our reinsurance partners reflecting natural block aging and unfavorable mortality compared to expectations. In the fourth quarter of 2023, our life insurance products had an unfavorable impact from cash flow assumption updates of $226 million reflecting updates to our persistency and mortality assumptions. We made an unfavorable update to our persistency assumptions particularly in certain universal life insurance products with secondary guarantees to better reflect emerging experience, consistent with others in the industry. However, given the relatively small size and characteristics of our closed block, we believe we experienced a smaller impact from our assumption updates relative to others in the industry with larger blocks. We also made unfavorable updates to our mortality assumption in our term universal, universal and term life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term post-COVID-19. Our 2023 assumption review considered trends during the pandemic years, but updates to our long-term assumptions generally excluded experience data after 2019, as we do not have sufficient information around the long-term effects of COVID-19. However, similar to our long-term care insurance products, we assessed near-term mortality trends as we continue to evaluate the long-term implications of COVID-19. In 2022, we made favorable cash flow assumption updates of $37 million in our universal and term universal life insurance products primarily related to higher interest rates. Certain of our universal life insurance products with secondary guarantees are subject to additional reserves on a statutory basis using a regulatory prescribed reinvestment rate. Given the increase in rates, we experienced a favorable benefit from the reinvestment rate in 2023, which more than offset negative assumption updates from a statutory income perspective. Fixed annuities Results of our fixed annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, persistency and expense and commission levels. We monitor and change crediting rates on fixed deferred annuities on a regular basis to maintain spreads and targeted returns, if applicable. However, we have seen and could continue to see declines in our fixed annuity spreads and margins as interest rates change, depending on the severity of the change. 98 99 1,195 74 718 1,083 (4) 669 (12)% $ 370 NM(1) (9)% (4)% (112) (78) (105)% (7)% (49) $ 207 $ 234 $ (136) $ (27) (41) 1,042 (45) NM(1) (49) (3)% (23) 646 Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment income . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . Segment results of operations The following table sets forth the results of operations relating to our Life and Annuities segment for the periods indicated: Years ended December 31, Increase (decrease) and percentage change (Amounts in millions) 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 (Amounts in millions) 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,846 1,982 1,851 (136) (7)% 131 7% Benefits and expenses: Benefits and other changes in policy reserves . . . . . . Liability remeasurement (gains) losses . . . . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition and operating expenses, net of 963 266 620 27 648 174 343 55% 239 NM(1) (28) (147) (4)% (84)% (12) 503 (104) 504 (160) 511 88% 92 (1) —% 56 (7) 35% (1)% deferrals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 213 604 233 (391) (65)% 371 159% Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181 240 291 (59) (25)% (51) (18)% Total benefits and expenses . . . . . . . . . . . . . . . . 2,114 1,891 1,697 223 12% 194 11% Income (loss) from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision (benefit) for income taxes . . . . . . . . . . . . . . Income (loss) from continuing operations . . . . . . . . . Adjustments to income (loss) from continuing operations: Net investment (gains) losses . . . . . . . . . . . . . . . . . . . Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges(2) . . . . . . . . . . . . . . . . . . . . . . . . . Expenses related to restructuring . . . . . . . . . . . . . . . . Pension plan termination costs . . . . . . . . . . . . . . . . . . Taxes on adjustments . . . . . . . . . . . . . . . . . . . . . . . . . Adjusted operating loss available to Genworth (268) (59) (209) 91 16 75 154 30 124 (359) NM(1) (75) NM(1) (63) (14) (41)% (47)% (284) NM(1) (49) (40)% 49 4 (74) 45 NM(1) 78 105% Revenues (22) — — (6) (142) (1) 8 28 (210) 5 — 59 85% 120 1 100% (8) (100)% (34) (121)% 68 32% (6) (120)% 8 NM(1) (53)% (31) Financial, Inc.’s common stockholders . . . . . . . . . $ (188) $ (28) $ (96) $(160) NM(1) $ 68 71% (1) We define “NM” as not meaningful for increases or decreases greater than 200%. (2) For the years ended December 31, 2023, 2022 and 2021, changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(10) million, $(38) million and $(50) million, respectively. 100 101 The following table sets forth adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for the products included in our Life and Annuities segment for the periods indicated: Years ended December 31, Increase (decrease) and percentage change Increase (decrease) and percentage change Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(275) $(111) $(201) $(164) (148)% $ 90 45% Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Variable annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50 37 62 21 83 22 (12) (19)% (21) (25)% 16 76% (1) (5)% Total adjusted operating loss available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . $(188) $ (28) $ (96) $(160) NM(1) $ 68 71% (1) We define “NM” as not meaningful for increases or decreases greater than 200%. 2023 compared to 2022 Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders • The adjusted operating loss in our life insurance products increased largely from $179 million of unfavorable updates to our persistency and mortality assumptions, as well as lower premiums reflecting runoff of our in-force blocks in 2023. These adverse developments were partially offset by lower DAC amortization related to higher lapses in 2022 and a $20 million legal settlement expense in 2022 that did not recur. • Adjusted operating income in our fixed annuity products decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality experience in 2023. • Adjusted operating income in our variable annuity products increased predominantly due to aging of our in-force block, partially offset by a decrease in fee income driven by lower account value in 2023. Premiums. The decrease was driven by our life insurance products largely due to the continued runoff of our in-force blocks in 2023. Net investment income. The decrease was primarily attributable to lower average invested assets driven mostly by block runoff in our fixed annuity products, partially offset by higher investment yields in 2023. Net investment gains (losses). For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” Policy fees and other income. The decrease was principally from lower fee income due mostly to a decline in average account value in our variable annuity products and from lower product charges in our life insurance products due to the runoff of our in-force blocks in 2023. Benefits and expenses Benefits and other changes in policy reserves • Our fixed annuity products increased $352 million primarily from a third-party recapture of $372 million of certain single premium immediate annuity contracts in 2022 that did not recur, partially offset by favorable mortality in 2023. (1) 45% (21) (25)% (5)% $(275) $(111) $(201) $(164) (148)% $ 90 50 37 62 21 83 22 (12) 16 (19)% 76% Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Variable annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total adjusted operating loss available to Genworth The following table sets forth adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for the products included in our Life and Annuities segment for the periods indicated: (Amounts in millions) 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Years ended December 31, Increase (decrease) and percentage change Increase (decrease) and percentage change Segment results of operations periods indicated: (Amounts in millions) Revenues: The following table sets forth the results of operations relating to our Life and Annuities segment for the Years ended December 31, Increase (decrease) and percentage change 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 207 $ 234 $ (136) $ (27) (12)% $ 370 NM(1) Net investment income . . . . . . . . . . . . . . . . . . . . . . . . 1,042 1,083 1,195 (41) (4)% (112) (9)% Net investment gains (losses) . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . (49) 646 (4) 669 74 718 (45) NM(1) (78) (105)% (23) (3)% (49) (7)% Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,846 1,982 1,851 (136) (7)% 131 7% Benefits and expenses: Benefits and other changes in policy reserves . . . . . . Liability remeasurement (gains) losses . . . . . . . . . . . . 963 266 620 27 648 174 343 55% (28) (4)% 239 NM(1) (147) (84)% Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (12) 503 (104) 504 (160) 511 92 88% (1) —% 56 (7) 35% (1)% Acquisition and operating expenses, net of Amortization of deferred acquisition costs and deferrals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 213 604 233 (391) (65)% 371 159% intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181 240 291 (59) (25)% (51) (18)% Total benefits and expenses . . . . . . . . . . . . . . . . 2,114 1,891 1,697 223 12% 194 11% Income (loss) from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision (benefit) for income taxes . . . . . . . . . . . . . . Income (loss) from continuing operations . . . . . . . . . Adjustments to income (loss) from continuing operations: Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges(2) . . . . . . . . . . . . . . . . . . . . . . . . . Expenses related to restructuring . . . . . . . . . . . . . . . . Pension plan termination costs . . . . . . . . . . . . . . . . . . Taxes on adjustments . . . . . . . . . . . . . . . . . . . . . . . . . Adjusted operating loss available to Genworth (268) (59) (209) 91 16 75 154 30 124 (359) NM(1) (75) NM(1) (63) (14) (41)% (47)% (284) NM(1) (49) (40)% (22) — — (6) (142) (210) 120 (1) 8 28 5 — 59 85% 100% 1 68 32% (6) (120)% (8) (100)% 8 NM(1) (34) (121)% (31) (53)% Financial, Inc.’s common stockholders . . . . . . . . . $ (188) $ (28) $ (96) $(160) NM(1) $ 68 71% (1) We define “NM” as not meaningful for increases or decreases greater than 200%. (2) For the years ended December 31, 2023, 2022 and 2021, changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(10) million, $(38) million and $(50) million, respectively. Financial, Inc.’s common stockholders . . . . . . . . . . $(188) $ (28) $ (96) $(160) NM(1) $ 68 71% (1) We define “NM” as not meaningful for increases or decreases greater than 200%. 2023 compared to 2022 Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders • The adjusted operating loss in our life insurance products increased largely from $179 million of unfavorable updates to our persistency and mortality assumptions, as well as lower premiums reflecting runoff of our in-force blocks in 2023. These adverse developments were partially offset by lower DAC amortization related to higher lapses in 2022 and a $20 million legal settlement expense in 2022 that did not recur. • Adjusted operating income in our fixed annuity products decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality experience in 2023. • Adjusted operating income in our variable annuity products increased predominantly due to aging of our in-force block, partially offset by a decrease in fee income driven by lower account value in 2023. Net investment (gains) losses . . . . . . . . . . . . . . . . . . . 49 4 (74) 45 NM(1) 78 105% Revenues Premiums. The decrease was driven by our life insurance products largely due to the continued runoff of our in-force blocks in 2023. Net investment income. The decrease was primarily attributable to lower average invested assets driven mostly by block runoff in our fixed annuity products, partially offset by higher investment yields in 2023. Net investment gains (losses). For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” Policy fees and other income. The decrease was principally from lower fee income due mostly to a decline in average account value in our variable annuity products and from lower product charges in our life insurance products due to the runoff of our in-force blocks in 2023. Benefits and expenses Benefits and other changes in policy reserves • Our fixed annuity products increased $352 million primarily from a third-party recapture of $372 million of certain single premium immediate annuity contracts in 2022 that did not recur, partially offset by favorable mortality in 2023. 100 101 • Our life insurance products decreased $11 million primarily from less unfavorable mortality, partially offset by an increase in cost of reinsurance reserves related to a ceded reinsurance transaction in the fourth quarter of 2023. Net investment income. The decrease was primarily attributable to lower average invested assets driven mostly by block runoff in our fixed annuity products, as well as lower bond calls and commercial mortgage loan prepayments in 2022. Liability remeasurement (gains) losses. The increase in the liability remeasurement loss was largely attributable to a $244 million increase in our life insurance products principally driven by unfavorable updates to our persistency assumptions for certain universal life insurance products with secondary guarantees and unfavorable mortality updates, including more modest mortality improvement, in our term universal, universal and term life insurance products. The unfavorable assumption updates were partially offset by net favorable impacts related to a ceded reinsurance transaction in the fourth quarter of 2023. Changes in fair value of market risk benefits and associated hedges • Our variable annuity products had an unfavorable variance of $50 million principally driven by higher derivative losses and lower interest rate increases, partially offset by favorable equity market impacts as well as lower attributed fees and higher benefit payments due to aging of our in-force block in 2023. • Our fixed annuity products had an unfavorable variance of $42 million primarily attributable to lower interest rate increases, partially offset by favorable equity market impacts in 2023. Acquisition and operating expenses, net of deferrals • Our fixed annuity products decreased $363 million primarily due to a payment of $365 million in 2022 related to the recapture of certain single premium immediate annuity contracts by a third party. • Our life insurance products decreased $23 million primarily due to a legal settlement expense of $25 million and pension plan termination costs of $8 million in 2022 that did not recur. These decreases were partially offset by higher costs associated with an outsourcing arrangement in 2023. Amortization of deferred acquisition costs and intangibles. The decrease was primarily related to our life insurance products largely due to higher lapses in 2022 as our 20-year level premium period business written in 2002 entered its post-level premium period. Provision for income taxes. The effective tax rate was 22.1% and 18.2% for the years ended December 31, 2023 and 2022, respectively. The increase in the effective tax rate was primarily attributable to tax benefits from tax favored items in relation to a pre-tax loss in 2023. 2022 compared to 2021 Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders Changes in fair value of market risk benefits and associated hedges • The adjusted operating loss in our life insurance products decreased largely from favorable cash flow assumption updates in our universal and term universal life insurance products in 2022 related to higher interest rates compared to unfavorable cash flow assumption updates in 2021 primarily driven by unfavorable pre-COVID-19 mortality. The decrease was also attributable to lower DAC amortization primarily driven by lapse experience in our term life insurance products. • Adjusted operating income in our fixed annuity products decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality in 2022. • Adjusted operating income in our variable annuity products was relatively flat in 2022 compared to 2021. Revenues Premiums. The increase was driven by our life insurance products largely due to lower ceded premiums, partially offset by the continued runoff of our in-force blocks in 2022. In 2021, we ceded $360 million of certain term life insurance premiums in connection with a reinsurance transaction. 102 103 Net investment gains (losses). For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” Policy fees and other income. The decrease was principally from lower product charges in our life insurance products driven mostly by the runoff of our in-force blocks and lower fee income in our variable annuity products driven mostly by a decline in average account value in 2022. Benefits and expenses Benefits and other changes in policy reserves • Our fixed annuity products decreased $395 million primarily from a third-party recapture of $372 million of certain single premium immediate annuity contracts and from favorable mortality in 2022. • Our life insurance products increased $352 million primarily from higher ceded reinsurance in 2021, partially offset by favorable mortality experience in 2022. We ceded $360 million of certain term life insurance reserves in connection with a reinsurance transaction in 2021. • Our variable annuity products increased $15 million primarily from unfavorable equity market performance and aging of the in-force block in 2022. Liability remeasurement (gains) losses • The liability remeasurement loss in our life insurance products decreased $117 million mainly attributable to favorable cash flow assumption updates in our universal and term universal life insurance products in 2022 compared to unfavorable updates in 2021. The favorable cash flow assumption updates in 2022 were primarily related to higher interest rates. The unfavorable cash flow assumption updates in 2021 were primarily driven by unfavorable pre-COVID-19 mortality. • Our fixed annuity products had a liability remeasurement gain of $5 million in 2022 compared to a loss of $25 million in 2021. The liability remeasurement loss in 2021 was largely driven by unfavorable mortality assumption updates. • Our variable annuity products had an unfavorable variance of $75 million principally driven by unfavorable equity market impacts, partially offset by higher interest rates and derivative gains in 2022. • Our fixed annuity products had a favorable variance of $19 million primarily attributable to higher interest rates, partially offset by unfavorable equity market impacts in 2022. Acquisition and operating expenses, net of deferrals. The increase was largely attributable to our fixed annuity products primarily due to a payment of $365 million in 2022 related to the recapture of certain single premium immediate annuity contracts by a third party. Amortization of deferred acquisition costs and intangibles. The decrease was primarily driven by lapse experience in our term life insurance products. Provision for income taxes. The effective tax rate was 18.2% and 19.8% for the years ended December 31, 2022 and 2021, respectively. • Our life insurance products decreased $11 million primarily from less unfavorable mortality, partially offset by an increase in cost of reinsurance reserves related to a ceded reinsurance transaction in the fourth quarter of 2023. Net investment income. The decrease was primarily attributable to lower average invested assets driven mostly by block runoff in our fixed annuity products, as well as lower bond calls and commercial mortgage loan prepayments in 2022. Net investment gains (losses). For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” Policy fees and other income. The decrease was principally from lower product charges in our life insurance products driven mostly by the runoff of our in-force blocks and lower fee income in our variable annuity products driven mostly by a decline in average account value in 2022. Benefits and expenses Benefits and other changes in policy reserves • Our fixed annuity products decreased $395 million primarily from a third-party recapture of $372 million of certain single premium immediate annuity contracts and from favorable mortality in 2022. • Our life insurance products increased $352 million primarily from higher ceded reinsurance in 2021, partially offset by favorable mortality experience in 2022. We ceded $360 million of certain term life insurance reserves in connection with a reinsurance transaction in 2021. • Our variable annuity products increased $15 million primarily from unfavorable equity market performance and aging of the in-force block in 2022. Liability remeasurement (gains) losses • The liability remeasurement loss in our life insurance products decreased $117 million mainly attributable to favorable cash flow assumption updates in our universal and term universal life insurance products in 2022 compared to unfavorable updates in 2021. The favorable cash flow assumption updates in 2022 were primarily related to higher interest rates. The unfavorable cash flow assumption updates in 2021 were primarily driven by unfavorable pre-COVID-19 mortality. • Our fixed annuity products had a liability remeasurement gain of $5 million in 2022 compared to a loss of $25 million in 2021. The liability remeasurement loss in 2021 was largely driven by unfavorable mortality assumption updates. Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders Changes in fair value of market risk benefits and associated hedges • Our variable annuity products had an unfavorable variance of $75 million principally driven by unfavorable equity market impacts, partially offset by higher interest rates and derivative gains in 2022. • Our fixed annuity products had a favorable variance of $19 million primarily attributable to higher interest rates, partially offset by unfavorable equity market impacts in 2022. Acquisition and operating expenses, net of deferrals. The increase was largely attributable to our fixed annuity products primarily due to a payment of $365 million in 2022 related to the recapture of certain single premium immediate annuity contracts by a third party. Amortization of deferred acquisition costs and intangibles. The decrease was primarily driven by lapse experience in our term life insurance products. Provision for income taxes. The effective tax rate was 18.2% and 19.8% for the years ended December 31, 2022 and 2021, respectively. 102 103 Liability remeasurement (gains) losses. The increase in the liability remeasurement loss was largely attributable to a $244 million increase in our life insurance products principally driven by unfavorable updates to our persistency assumptions for certain universal life insurance products with secondary guarantees and unfavorable mortality updates, including more modest mortality improvement, in our term universal, universal and term life insurance products. The unfavorable assumption updates were partially offset by net favorable impacts related to a ceded reinsurance transaction in the fourth quarter of 2023. Changes in fair value of market risk benefits and associated hedges • Our variable annuity products had an unfavorable variance of $50 million principally driven by higher derivative losses and lower interest rate increases, partially offset by favorable equity market impacts as well as lower attributed fees and higher benefit payments due to aging of our in-force block in 2023. • Our fixed annuity products had an unfavorable variance of $42 million primarily attributable to lower interest rate increases, partially offset by favorable equity market impacts in 2023. Acquisition and operating expenses, net of deferrals • Our fixed annuity products decreased $363 million primarily due to a payment of $365 million in 2022 related to the recapture of certain single premium immediate annuity contracts by a third party. • Our life insurance products decreased $23 million primarily due to a legal settlement expense of $25 million and pension plan termination costs of $8 million in 2022 that did not recur. These decreases were partially offset by higher costs associated with an outsourcing arrangement in 2023. Amortization of deferred acquisition costs and intangibles. The decrease was primarily related to our life insurance products largely due to higher lapses in 2022 as our 20-year level premium period business written in 2002 entered its post-level premium period. Provision for income taxes. The effective tax rate was 22.1% and 18.2% for the years ended December 31, 2023 and 2022, respectively. The increase in the effective tax rate was primarily attributable to tax benefits from tax favored items in relation to a pre-tax loss in 2023. 2022 compared to 2021 • The adjusted operating loss in our life insurance products decreased largely from favorable cash flow assumption updates in our universal and term universal life insurance products in 2022 related to higher interest rates compared to unfavorable cash flow assumption updates in 2021 primarily driven by unfavorable pre-COVID-19 mortality. The decrease was also attributable to lower DAC amortization primarily driven by lapse experience in our term life insurance products. • Adjusted operating income in our fixed annuity products decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality in 2022. • Adjusted operating income in our variable annuity products was relatively flat in 2022 compared to 2021. Revenues Premiums. The increase was driven by our life insurance products largely due to lower ceded premiums, partially offset by the continued runoff of our in-force blocks in 2022. In 2021, we ceded $360 million of certain term life insurance premiums in connection with a reinsurance transaction. Life and Annuities selected operating performance measures Life insurance The following table sets forth selected operating performance measures regarding our life insurance The following table sets forth the results of operations relating to Corporate and Other for the periods products as of the dates indicated: (Amounts in millions) Term and whole life insurance Years ended December 31, Increase (decrease) and percentage change 2023 2022 2021 2023 vs. 2022 Years ended December 31, Increase (decrease) and percentage change 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Corporate and Other Results of operations indicated: (Amounts in millions) Revenues: Life insurance in-force, net of reinsurance . . . . . . . . Life insurance in-force, before reinsurance . . . . . . . . (8)% $ 44,121 $ 48,162 $ 47,297 $ (4,041) $270,950 $300,145 $332,793 $(29,195) (10)% Term universal life insurance Life insurance in-force, net of reinsurance . . . . . . . . Life insurance in-force, before reinsurance . . . . . . . . $ 90,427 $ 92,719 $ 99,471 $ (2,292) $ 91,024 $ 93,336 $100,119 $ (2,312) (2)% (2)% Universal life insurance Life insurance in-force, net of reinsurance . . . . . . . . Life insurance in-force, before reinsurance . . . . . . . . $ 28,710 $ 29,798 $ 31,117 $ (1,088) $ 32,199 $ 33,622 $ 35,228 $ (1,423) (4)% (4)% The decrease in insurance in-force in our life insurance products reflects the continued runoff of our in-force blocks. Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 9 $ 6 $ 6 $ 3 50% $ — — % Net investment income . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . . 19 (28) 8 (15) (2) — 11 (7) (13) 138% (87)% (2) NM(1) 1 14% (8) (114)% (1) (100)% Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . (2) (1) (1) (100)% (8) (114)% 7 1 7 Benefits and expenses: Acquisition and operating expenses, net of Benefits and other changes in policy reserves . . . . . . . (9) (11) (6) 2 18% (5) (83)% deferrals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 41 84 24 59% (43) (51)% Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 — Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total benefits and expenses . . . . . . . . . . . . . . . . . Loss from continuing operations before income 66 123 54 84 2 109 189 1 NM(1) 12 39 22% 46% (2) (100)% (55) (50)% (105) (56)% taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit for income taxes . . . . . . . . . . . . . . . . . . . . . . . (125) (20) (85) (16) (182) (53) (40) (4) (47)% (25)% Loss from continuing operations . . . . . . . . . . . . . . . . . (105) (69) (129) (36) (52)% 97 37 60 53% 70% 47% Adjustments to loss from continuing operations: Net investment (gains) losses . . . . . . . . . . . . . . . . . . . (Gains) losses on early extinguishment of debt . . . . . . Expenses related to restructuring . . . . . . . . . . . . . . . . . Taxes on adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . Adjusted operating loss available to Genworth 28 (2) 4 (6) 15 6 1 7 45 14 (5) (13) 13 87% (8) (133)% 3 NM(1) (1) (20)% 8 (39) (13) 8 114% (87)% (93)% 62% Financial, Inc.’s common stockholders . . . . . . . . . . $ (81) $ (52) $ (76) $(29) (56)% $ 24 32% (1) We define “NM” as not meaningful for increases or decreases greater than 200%. 2023 compared to 2022 Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives and higher interest expense attributable to Genworth Holdings’ junior subordinated notes, partially offset by higher net investment income in 2023. Revenues Net investment income increased largely from higher investment yields in 2023. For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” 104 105 Life insurance products as of the dates indicated: (Amounts in millions) Term and whole life insurance Term universal life insurance Universal life insurance Years ended December 31, Increase (decrease) and percentage change 2023 2022 2021 2023 vs. 2022 Life insurance in-force, net of reinsurance . . . . . . . . $ 44,121 $ 48,162 $ 47,297 $ (4,041) (8)% Life insurance in-force, before reinsurance . . . . . . . . $270,950 $300,145 $332,793 $(29,195) (10)% Life insurance in-force, net of reinsurance . . . . . . . . $ 90,427 $ 92,719 $ 99,471 $ (2,292) Life insurance in-force, before reinsurance . . . . . . . . $ 91,024 $ 93,336 $100,119 $ (2,312) Life insurance in-force, net of reinsurance . . . . . . . . $ 28,710 $ 29,798 $ 31,117 $ (1,088) Life insurance in-force, before reinsurance . . . . . . . . $ 32,199 $ 33,622 $ 35,228 $ (1,423) (2)% (2)% (4)% (4)% The decrease in insurance in-force in our life insurance products reflects the continued runoff of our in-force blocks. Life and Annuities selected operating performance measures Corporate and Other Results of operations The following table sets forth selected operating performance measures regarding our life insurance The following table sets forth the results of operations relating to Corporate and Other for the periods indicated: Years ended December 31, Increase (decrease) and percentage change (Amounts in millions) 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment income . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . . $ 6 $ 9 $ 8 19 (28) (15) (2) — 50% $ — — % 6 $ 3 138% 14% 1 11 7 (8) (114)% (13) (7) (87)% (1) (100)% (2) NM(1) 1 Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . (2) (1) 7 (1) (100)% (8) (114)% Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . Acquisition and operating expenses, net of (9) (11) (6) 2 18% (5) (83)% deferrals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 41 84 24 59% (43) (51)% Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 — 54 66 Total benefits and expenses . . . . . . . . . . . . . . . . . 123 84 Loss from continuing operations before income 2 109 189 1 NM(1) 22% 12 (2) (100)% (50)% (55) 39 46% (105) (56)% taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit for income taxes . . . . . . . . . . . . . . . . . . . . . . . (125) (20) (85) (16) (182) (53) (40) (4) (47)% (25)% Loss from continuing operations . . . . . . . . . . . . . . . . . Adjustments to loss from continuing operations: Net investment (gains) losses . . . . . . . . . . . . . . . . . . . (Gains) losses on early extinguishment of debt . . . . . . Expenses related to restructuring . . . . . . . . . . . . . . . . . Taxes on adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . Adjusted operating loss available to Genworth 97 37 60 53% 70% 47% (105) (69) (129) (36) (52)% 28 (2) 4 (6) 15 6 1 (5) 7 45 14 (13) 13 87% (8) (133)% 3 NM(1) (20)% (1) 8 (39) (13) 8 114% (87)% (93)% 62% Financial, Inc.’s common stockholders . . . . . . . . . . $ (81) $ (52) $ (76) $(29) (56)% $ 24 32% (1) We define “NM” as not meaningful for increases or decreases greater than 200%. 2023 compared to 2022 Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives and higher interest expense attributable to Genworth Holdings’ junior subordinated notes, partially offset by higher net investment income in 2023. Revenues Net investment income increased largely from higher investment yields in 2023. For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” 104 105 • During the fourth quarter of 2023, the ten-year U.S. Treasury yield rose to its highest level since 2007, but U.S. Treasury yields decreased compared to September 30, 2023. Although the two-year U.S. Treasury yield remained above the ten-year U.S. Treasury yield in 2023, the differential between the two-year yield and the ten-year yield declined compared to December 31, 2022. • Credit spreads tightened and credit market performance remained resilient as macroeconomic data continued to support market optimism for a soft economic landing in 2023. • Bank deposits stabilized in the second half of 2023 after three regional banks were taken into receivership by the Federal Deposit Insurance Corporation in early 2023. At this time, we believe our investment portfolio is well positioned and any risks to valuations as a result of the pressures in the regional banking system and commercial real estate are manageable. • As of December 31, 2023, our fixed maturity securities portfolio, which was 96% investment grade, comprised 75% of our total invested assets and cash. Derivatives • As of December 31, 2023, $1.3 billion notional of our derivatives portfolio was cleared through the Chicago Mercantile Exchange (“CME”). • The customer swap agreements that govern our cleared derivatives contain provisions that enable our clearing agents to request initial margin in excess of CME requirements. As of December 31, 2023, we posted initial margin of $79 million to our clearing agents, which represented $39 million more than was otherwise required by the clearinghouse. Because our clearing agents serve as guarantors of our obligations to the CME, the customer agreements contain broad termination provisions that are not specifically dependent on ratings. • As of December 31, 2023, $11.4 billion notional of our derivatives portfolio was in bilateral OTC derivative transactions pursuant to which we have posted aggregate independent amounts of $464 million and are holding collateral from counterparties in the amount of $19 million. Benefits and expenses Acquisition and operating expenses, net of deferrals, increased primarily from higher expenses related to CareScout growth initiatives and higher employee-related expenses, partially offset by gains on the early extinguishment of certain of Genworth Holdings’ debt in 2023 compared to losses in 2022. Interest expense increased largely driven by a higher floating rate of interest on Genworth Holdings’ junior subordinated notes in 2023, partially offset by the early redemption in 2022 of Genworth Holdings’ senior notes due in 2024. The benefit for income taxes increased primarily related to a higher pre-tax loss in 2023, partially offset by a state tax benefit in 2022 that did not recur. 2022 compared to 2021 Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders The adjusted operating loss decreased primarily related to lower interest expense in 2022, partially offset by tax benefits of $21 million in 2021 from a reduction in uncertain tax positions due to the expiration of certain statute of limitations that did not recur. Revenues For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” Benefits and expenses Benefits and other changes in policy reserves decreased primarily related to inter-segment transactions. Acquisition and operating expenses, net of deferrals, decreased mainly driven by $24 million of lower make-whole premiums on the early redemption of Genworth Holdings’ senior notes and $15 million of lower net losses related to the repurchase of Genworth Holdings’ senior notes in 2022, as well as $13 million of lower restructuring costs. These decreases were partially offset by higher expenses related to CareScout growth initiatives in 2022. Interest expense decreased largely driven by the early redemption and repurchase of Genworth Holdings’ senior notes due in September 2021, August 2023 and February 2024, partially offset by a higher floating rate of interest on Genworth Holdings’ junior subordinated notes in 2022. The decrease in the benefit for income taxes was primarily related to a reduction in uncertain tax positions due to the expiration of certain statute of limitations in 2021 that did not recur, as well as a lower pre-tax loss in 2022. Investments and Derivative Instruments Trends and conditions Investments During the year ended December 31, 2023, our investments portfolio was impacted, and we believe will continue to be impacted, by the following macroeconomic trends. • The U.S. Federal Reserve increased interest rates by 100 basis points, bringing the upper end of the target range to the highest level since 2001. 106 107 • During the fourth quarter of 2023, the ten-year U.S. Treasury yield rose to its highest level since 2007, but U.S. Treasury yields decreased compared to September 30, 2023. Although the two-year U.S. Treasury yield remained above the ten-year U.S. Treasury yield in 2023, the differential between the two-year yield and the ten-year yield declined compared to December 31, 2022. • Credit spreads tightened and credit market performance remained resilient as macroeconomic data continued to support market optimism for a soft economic landing in 2023. • Bank deposits stabilized in the second half of 2023 after three regional banks were taken into receivership by the Federal Deposit Insurance Corporation in early 2023. At this time, we believe our investment portfolio is well positioned and any risks to valuations as a result of the pressures in the regional banking system and commercial real estate are manageable. • As of December 31, 2023, our fixed maturity securities portfolio, which was 96% investment grade, comprised 75% of our total invested assets and cash. Derivatives • As of December 31, 2023, $1.3 billion notional of our derivatives portfolio was cleared through the Chicago Mercantile Exchange (“CME”). • The customer swap agreements that govern our cleared derivatives contain provisions that enable our clearing agents to request initial margin in excess of CME requirements. As of December 31, 2023, we posted initial margin of $79 million to our clearing agents, which represented $39 million more than was otherwise required by the clearinghouse. Because our clearing agents serve as guarantors of our obligations to the CME, the customer agreements contain broad termination provisions that are not specifically dependent on ratings. • As of December 31, 2023, $11.4 billion notional of our derivatives portfolio was in bilateral OTC derivative transactions pursuant to which we have posted aggregate independent amounts of $464 million and are holding collateral from counterparties in the amount of $19 million. Benefits and expenses Acquisition and operating expenses, net of deferrals, increased primarily from higher expenses related to CareScout growth initiatives and higher employee-related expenses, partially offset by gains on the early extinguishment of certain of Genworth Holdings’ debt in 2023 compared to losses in 2022. Interest expense increased largely driven by a higher floating rate of interest on Genworth Holdings’ junior subordinated notes in 2023, partially offset by the early redemption in 2022 of Genworth Holdings’ senior notes due in 2024. The benefit for income taxes increased primarily related to a higher pre-tax loss in 2023, partially offset by a state tax benefit in 2022 that did not recur. 2022 compared to 2021 Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders The adjusted operating loss decreased primarily related to lower interest expense in 2022, partially offset by tax benefits of $21 million in 2021 from a reduction in uncertain tax positions due to the expiration of certain statute of limitations that did not recur. For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” Revenues Benefits and expenses Benefits and other changes in policy reserves decreased primarily related to inter-segment transactions. Acquisition and operating expenses, net of deferrals, decreased mainly driven by $24 million of lower make-whole premiums on the early redemption of Genworth Holdings’ senior notes and $15 million of lower net losses related to the repurchase of Genworth Holdings’ senior notes in 2022, as well as $13 million of lower restructuring costs. These decreases were partially offset by higher expenses related to CareScout growth initiatives in 2022. Interest expense decreased largely driven by the early redemption and repurchase of Genworth Holdings’ senior notes due in September 2021, August 2023 and February 2024, partially offset by a higher floating rate of interest on Genworth Holdings’ junior subordinated notes in 2022. The decrease in the benefit for income taxes was primarily related to a reduction in uncertain tax positions due to the expiration of certain statute of limitations in 2021 that did not recur, as well as a lower pre-tax loss in 2022. Investments and Derivative Instruments Trends and conditions Investments During the year ended December 31, 2023, our investments portfolio was impacted, and we believe will continue to be impacted, by the following macroeconomic trends. • The U.S. Federal Reserve increased interest rates by 100 basis points, bringing the upper end of the target range to the highest level since 2001. 106 107 Investment results The following table sets forth net investment gains (losses) for the years ended December 31: The following table sets forth information about our investment income, excluding net investment gains (losses), for each component of our investment portfolio for the years ended December 31: (Amounts in millions) Fixed maturity securities— taxable . . . . . . . . . . . . . . . . Fixed maturity securities— non-taxable . . . . . . . . . . . . . Equity securities . . . . . . . . . . . Commercial mortgage 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Yield Amount Yield Amount Yield Amount Yield Amount Yield Amount Increase (decrease) 4.5% $ 2,244 4.5% $ 2,296 4.5% $ 2,411 — % $ (52) — % $(115) 4.2% 3.0% 3 11 4.7% 4.0% 5 10 5.6% 4.0% 7 9 (0.5)% (1.0)% (0.9)% (2) 1 — % (2) 1 loans . . . . . . . . . . . . . . . . . . 4.4% Policy loans . . . . . . . . . . . . . . 10.2% 4.5% Limited partnerships (1) . . . . . Other invested assets (2) . . . . . 50.5% Cash, cash equivalents, 302 4.6% 224 10.0% 4.7% 117 279 59.9% 5.5% 321 211 9.3% 99 15.7% 267 69.7% 376 189 223 241 (0.2)% 0.2% (0.2)% (9.4)% (19) 13 18 12 (0.9)% 0.7% (55) 22 (11.0)% (124) 26 (9.8)% restricted cash and short- term investments . . . . . . . . Gross investment income before expenses and fees . . Expenses and fees . . . . . . . . . Net investment income . . . . . . Average invested assets and cash . . . . . . . . . . . . . . . . . . . 4.7% 95 1.2% 20 — % 1 3.5% 75 1.2% 19 3,275 5.1% (0.2)% (92) 4.9% $ 3,183 3,229 5.0% (0.2)% (83) 4.8% $ 3,146 3,457 5.2% (0.1)% 5.1% $ 3,370 0.1% (87) — % 46 (9) 0.1% $ 37 (0.2)% (228) (0.1)% 4 (0.3)% $(224) $64,637 $65,160 $66,099 $(523) $(939) 2023 compared to 2022 (1) Limited partnership investments are primarily equity-based and do not have fixed returns by period. (2) Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation. Yields are based on net investment income as reported under U.S. GAAP and are consistent with how we measure our investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments and securities lending activity, which was included in other invested assets prior to the suspension of our securities lending program in the third quarter of 2021 and was calculated net of the corresponding securities lending liability. Gross annualized weighted-average investment yields increased in 2023 compared to 2022 primarily driven by higher investment income on lower average invested assets. Net investment income included higher returns of $75 million primarily on our short-term investments due to higher interest rates, $18 million of higher limited partnership income and $15 million of higher income from bank loans, partially offset by $41 million of lower income related to inflation-driven volatility on TIPS and $26 million of lower bond calls and commercial mortgage loan prepayments. Gross annualized weighted-average investment yields decreased in 2022 compared to 2021 primarily driven by lower net investment income on lower average invested assets. Net investment income included $124 million of lower limited partnership income and $106 million of lower bond calls and commercial mortgage loan prepayments, partially offset by $18 million of higher income related to inflation-driven volatility on TIPS in 2022. 108 109 (Amounts in millions) 2023 2022 2021 Realized investment gains (losses): Available-for-sale fixed maturity securities: Realized gains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Realized losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 29 (154) $ 28 (102) $ 67 (10) Net realized gains (losses) on available-for-sale fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net realized gains (losses) on equity securities sold . . . . . . . Net realized gains (losses) on limited partnerships . . . . . . . . Total net realized investment gains (losses) . . . . . . . . . . . . . . (125) (74) (1) — — (126) — (74) Net change in allowance for credit losses on available-for-sale fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (7) — Write-down of available-for-sale fixed maturity securities . . . . . . Net unrealized gains (losses) on equity securities still held . . . . . . Net unrealized gains (losses) on limited partnerships . . . . . . . . . . Commercial mortgage loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derivative instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1) 53 111 (5) 7 (9) (2) (35) 71 4 32 2 57 (7) 3 53 (6) (1) 1 264 (3) 13 1 Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . $ 23 $ (2) $322 • We recorded $125 million of net losses related to the sale of available-for-sale fixed maturity securities in 2023 compared to $74 million in 2022. The net losses in 2023 were primarily related to portfolio repositioning and liquidity management, as well as regional bank exposure management, including a $15 million loss related to the sale of First Republic Bank U.S. corporate bonds. • We recorded net unrealized gains on equity securities of $53 million in 2023 driven by favorable equity market performance compared to net unrealized losses of $35 million in 2022 from unfavorable performance. We recorded $40 million of higher net unrealized gains on limited partnerships driven by more favorable private equity market performance in 2023. We also recorded an allowance for credit losses on available-for-sale fixed maturity securities of $7 million in 2023. • Net investment gains related to derivatives decreased in 2023 primarily from losses on hedging programs that support our fixed indexed annuity products compared to gains in 2022, lower gains on hedging programs that support our indexed universal life insurance products and losses from forward bond purchase commitments in 2023. These decreases were partially offset by gains on equity index options in 2023 compared to losses in 2022. 2022 compared to 2021 • We recorded net realized losses related to the sale of available-for-sale fixed maturity securities of $74 million in 2022 compared to net realized gains of $57 million in 2021 primarily driven by sales of U.S. corporate securities to manage asset exposure and to optimize cash at Genworth Holdings in 2022. • We recorded $193 million of lower net unrealized gains on limited partnerships in 2022 compared to 2021 primarily from less favorable private equity market performance in 2022. We also recorded $35 million of net unrealized losses on equity securities during 2022 driven by unfavorable equity market performance. Investment results The following table sets forth information about our investment income, excluding net investment gains (losses), for each component of our investment portfolio for the years ended December 31: (Amounts in millions) Yield Amount Yield Amount Yield Amount Yield Amount Yield Amount 2023 2022 2021 2023 vs. 2022 2022 vs. 2021 Increase (decrease) 4.5% $ 2,244 4.5% $ 2,296 4.5% $ 2,411 — % $ (52) — % $(115) Fixed maturity securities— taxable . . . . . . . . . . . . . . . . Fixed maturity securities— non-taxable . . . . . . . . . . . . . Equity securities . . . . . . . . . . . Commercial mortgage 4.2% 3.0% 3 11 4.7% 4.0% loans . . . . . . . . . . . . . . . . . . 4.4% Policy loans . . . . . . . . . . . . . . 10.2% Limited partnerships (1) . . . . . 4.5% Other invested assets (2) . . . . . 50.5% 302 4.6% 224 10.0% 117 4.7% 279 59.9% 5 10 321 211 5.6% 4.0% 5.5% 9.3% 99 15.7% 267 69.7% 7 9 (0.5)% (1.0)% (2) (0.9)% 1 — % (2) 1 376 189 223 241 (0.2)% 0.2% (0.2)% (9.4)% (19) 13 18 12 (0.9)% 0.7% (55) 22 (11.0)% (124) (9.8)% 26 term investments . . . . . . . . 4.7% 95 1.2% 20 — % 1 3.5% 75 1.2% 19 Net investment income . . . . . . 4.9% $ 3,183 4.8% $ 3,146 5.1% $ 3,370 0.1% $ 37 (0.3)% $(224) 5.1% (0.2)% 3,275 5.0% 3,229 5.2% 3,457 0.1% (92) (0.2)% (83) (0.1)% (87) — % 46 (9) (0.2)% (228) (0.1)% 4 Cash, cash equivalents, restricted cash and short- Gross investment income before expenses and fees . . Expenses and fees . . . . . . . . . Average invested assets and cash . . . . . . . . . . . . . . . . . . . (1) Limited partnership investments are primarily equity-based and do not have fixed returns by period. (2) Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation. Yields are based on net investment income as reported under U.S. GAAP and are consistent with how we measure our investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments and securities lending activity, which was included in other invested assets prior to the suspension of our securities lending program in the third quarter of 2021 and was calculated net of the corresponding securities lending liability. Gross annualized weighted-average investment yields increased in 2023 compared to 2022 primarily driven by higher investment income on lower average invested assets. Net investment income included higher returns of $75 million primarily on our short-term investments due to higher interest rates, $18 million of higher limited partnership income and $15 million of higher income from bank loans, partially offset by $41 million of lower income related to inflation-driven volatility on TIPS and $26 million of lower bond calls and commercial mortgage loan prepayments. Gross annualized weighted-average investment yields decreased in 2022 compared to 2021 primarily driven by lower net investment income on lower average invested assets. Net investment income included $124 million of lower limited partnership income and $106 million of lower bond calls and commercial mortgage loan prepayments, partially offset by $18 million of higher income related to inflation-driven volatility on TIPS in 2022. The following table sets forth net investment gains (losses) for the years ended December 31: (Amounts in millions) 2023 2022 2021 Realized investment gains (losses): Available-for-sale fixed maturity securities: Realized gains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Realized losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 29 (154) $ 28 (102) $ 67 (10) Net realized gains (losses) on available-for-sale fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net realized gains (losses) on equity securities sold . . . . . . . Net realized gains (losses) on limited partnerships . . . . . . . . (125) (74) (1) — — — Total net realized investment gains (losses) . . . . . . . . . . . . . . (126) (74) Net change in allowance for credit losses on available-for-sale fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Write-down of available-for-sale fixed maturity securities . . . . . . Net unrealized gains (losses) on equity securities still held . . . . . . Net unrealized gains (losses) on limited partnerships . . . . . . . . . . Commercial mortgage loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derivative instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (7) — (2) (1) (35) 53 71 111 4 (5) 32 7 2 (9) 57 (7) 3 53 (6) (1) 1 264 (3) 13 1 $64,637 $65,160 $66,099 $(523) $(939) 2023 compared to 2022 Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . $ 23 $ (2) $322 • We recorded $125 million of net losses related to the sale of available-for-sale fixed maturity securities in 2023 compared to $74 million in 2022. The net losses in 2023 were primarily related to portfolio repositioning and liquidity management, as well as regional bank exposure management, including a $15 million loss related to the sale of First Republic Bank U.S. corporate bonds. • We recorded net unrealized gains on equity securities of $53 million in 2023 driven by favorable equity market performance compared to net unrealized losses of $35 million in 2022 from unfavorable performance. We recorded $40 million of higher net unrealized gains on limited partnerships driven by more favorable private equity market performance in 2023. We also recorded an allowance for credit losses on available-for-sale fixed maturity securities of $7 million in 2023. • Net investment gains related to derivatives decreased in 2023 primarily from losses on hedging programs that support our fixed indexed annuity products compared to gains in 2022, lower gains on hedging programs that support our indexed universal life insurance products and losses from forward bond purchase commitments in 2023. These decreases were partially offset by gains on equity index options in 2023 compared to losses in 2022. 2022 compared to 2021 • We recorded net realized losses related to the sale of available-for-sale fixed maturity securities of $74 million in 2022 compared to net realized gains of $57 million in 2021 primarily driven by sales of U.S. corporate securities to manage asset exposure and to optimize cash at Genworth Holdings in 2022. • We recorded $193 million of lower net unrealized gains on limited partnerships in 2022 compared to 2021 primarily from less favorable private equity market performance in 2022. We also recorded $35 million of net unrealized losses on equity securities during 2022 driven by unfavorable equity market performance. 108 109 Investment portfolio The following table sets forth our cash, cash equivalents and invested assets as of December 31: (Amounts in millions) Carrying value % of total Carrying value % of total 2023 2022 Available-for-sale fixed maturity securities: Public . . . . . . . . . . . . . . . . . . . . . . . . . . . Private . . . . . . . . . . . . . . . . . . . . . . . . . . . Equity securities . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage loans, net . . . . . . . . . . Policy loans . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . . . . . . . . Other invested assets . . . . . . . . . . . . . . . . . . . Cash, cash equivalents and restricted cash . . . Total cash, cash equivalents and $32,189 14,592 396 6,802 2,220 2,821 731 2,215 51% 24 1 10 4 5 1 4 $31,757 14,826 319 7,010 2,139 2,331 566 1,799 53% 24 1 11 3 4 1 3 invested assets . . . . . . . . . . . . . . . . . . $61,966 100% $60,747 100% For a discussion of the change in cash, cash equivalents and invested assets, see the comparison for these line items under “—Consolidated Balance Sheets.” See note 5 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to our investment portfolio. We hold fixed maturity and equity securities, limited partnerships, derivatives, embedded derivatives and certain other financial instruments, which are carried at fair value. Fair value is the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. As of December 31, 2023, approximately 7% of our investment holdings recorded at fair value was based on significant inputs that were not market observable and were classified as Level 3 measurements. See note 21 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to fair value. The following table presents our public, private and total fixed maturity securities by the Nationally Recognized Statistical Rating Organizations (“NRSRO”) designations and/or equivalent ratings, as well as the percentage, based upon fair value that each designation comprises. Certain fixed maturity securities that are not rated by an NRSRO are shown based upon internally prepared credit evaluations. (Amounts in millions) NRSRO designation Public fixed maturity securities As of December 31, 2023 2022 Amortized cost Fair value % of total Amortized cost Fair value % of total AAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2,779 $ 2,559 8% $ 6,394 $ 6,067 19% AA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,461 9,474 6,170 9,287 3,146 8,860 2,859 8,398 BBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,346 13,645 14,964 13,623 BB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . CCC and lower . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 518 32 — 498 30 — — — 839 37 — 776 34 — — — Total public fixed maturity securities . . . . . . . . . . . $33,610 $32,189 100% $34,240 $31,757 100% Private fixed maturity securities AAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 866 $ 6% $ 876 $ 6% AA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . BBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . BB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . CCC and lower . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Not rated . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,574 4,398 7,709 1,037 149 7 15 832 1,477 4,043 7,126 975 117 825 1,421 4,170 7,221 1,076 113 1,562 4,675 8,129 1,217 135 — — 7 — 15 — — — — — 9 27 43 2 10 28 48 7 1 19 29 42 2 10 28 48 7 1 Total private fixed maturity securities . . . . . . . . . . $15,755 $14,592 100% $16,594 $14,826 100% Total fixed maturity securities AAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,645 $ 3,391 7% $ 7,270 $ 6,892 15% AA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . BBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . BB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . CCC and lower . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Not rated . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,035 13,872 22,055 1,555 181 7 15 7,647 13,330 20,771 1,473 16 29 45 3 147 — 7 — 15 — 4,708 13,535 23,093 2,056 172 — — 4,280 12,568 20,844 1,852 9 27 45 4 147 — — — — — Total fixed maturity securities . . . . . . . . . . . . . . . . $49,365 $46,781 100% $50,834 $46,583 100% We invest in privately placed fixed maturity securities to increase diversification and obtain higher yields than can ordinarily be obtained with comparable public market securities. Generally, private placements provide us with protective covenants, call protection features and, where applicable, a higher level of collateral. However, our private placements are not as freely transferable as public securities because of restrictions imposed by federal and state securities laws, the terms of the securities and the characteristics of the private market. Based upon fair value, public fixed maturity securities represented 69% and 68%, respectively, of total fixed maturity securities as of December 31, 2023 and 2022. Private fixed maturity securities represented 31% and 32%, respectively, of total fixed maturity securities as of December 31, 2023 and 2022. We diversify our corporate securities by industry and issuer. As of December 31, 2023, our combined holdings in the 10 corporate issuers to which we had the greatest exposure was $1.8 billion, which was 110 111 Investment portfolio The following table sets forth our cash, cash equivalents and invested assets as of December 31: (Amounts in millions) Carrying value % of total Carrying value % of total 2023 2022 Available-for-sale fixed maturity securities: Public . . . . . . . . . . . . . . . . . . . . . . . . . . . Private . . . . . . . . . . . . . . . . . . . . . . . . . . . $32,189 14,592 Equity securities . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage loans, net . . . . . . . . . . Policy loans . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . . . . . . . . Other invested assets . . . . . . . . . . . . . . . . . . . Cash, cash equivalents and restricted cash . . . Total cash, cash equivalents and 396 6,802 2,220 2,821 731 2,215 51% 24 1 10 4 5 1 4 $31,757 14,826 319 7,010 2,139 2,331 566 1,799 53% 24 1 11 3 4 1 3 invested assets . . . . . . . . . . . . . . . . . . $61,966 100% $60,747 100% For a discussion of the change in cash, cash equivalents and invested assets, see the comparison for these line items under “—Consolidated Balance Sheets.” See note 5 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to our investment portfolio. We hold fixed maturity and equity securities, limited partnerships, derivatives, embedded derivatives and certain other financial instruments, which are carried at fair value. Fair value is the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. As of December 31, 2023, approximately 7% of our investment holdings recorded at fair value was based on significant inputs that were not market observable and were classified as Level 3 measurements. See note 21 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to fair value. The following table presents our public, private and total fixed maturity securities by the Nationally Recognized Statistical Rating Organizations (“NRSRO”) designations and/or equivalent ratings, as well as the percentage, based upon fair value that each designation comprises. Certain fixed maturity securities that are not rated by an NRSRO are shown based upon internally prepared credit evaluations. (Amounts in millions) NRSRO designation Public fixed maturity securities AAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . AA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . BBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . BB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . CCC and lower . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . As of December 31, 2023 2022 Amortized cost Fair value % of total Amortized cost Fair value % of total $ 2,779 $ 2,559 6,170 9,287 13,645 498 6,461 9,474 14,346 518 32 — 8% $ 6,394 $ 6,067 19% 2,859 19 9 8,398 29 27 13,623 42 43 2 776 2 34 — 30 — — — — — 3,146 8,860 14,964 839 37 — Total public fixed maturity securities . . . . . . . . . . . $33,610 $32,189 100% $34,240 $31,757 100% Private fixed maturity securities AAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . AA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . BBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . BB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . CCC and lower . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Not rated . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 866 $ 1,574 4,398 7,709 1,037 149 7 15 832 1,477 4,043 7,126 975 117 6% $ 10 28 48 7 1 7 — 15 — 876 $ 1,562 4,675 8,129 1,217 135 — — 6% 825 10 1,421 28 4,170 48 7,221 7 1,076 113 1 — — — — Total private fixed maturity securities . . . . . . . . . . $15,755 $14,592 100% $16,594 $14,826 100% Total fixed maturity securities AAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . AA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . BBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . BB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . CCC and lower . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Not rated . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,645 $ 3,391 7,647 13,330 20,771 1,473 8,035 13,872 22,055 1,555 181 7 15 7% $ 7,270 $ 6,892 4,280 16 12,568 29 20,844 45 1,852 3 147 — 7 — 15 — 4,708 13,535 23,093 2,056 172 — — 15% 9 27 45 4 147 — — — — — Total fixed maturity securities . . . . . . . . . . . . . . . . $49,365 $46,781 100% $50,834 $46,583 100% We invest in privately placed fixed maturity securities to increase diversification and obtain higher yields than can ordinarily be obtained with comparable public market securities. Generally, private placements provide us with protective covenants, call protection features and, where applicable, a higher level of collateral. However, our private placements are not as freely transferable as public securities because of restrictions imposed by federal and state securities laws, the terms of the securities and the characteristics of the private market. Based upon fair value, public fixed maturity securities represented 69% and 68%, respectively, of total fixed maturity securities as of December 31, 2023 and 2022. Private fixed maturity securities represented 31% and 32%, respectively, of total fixed maturity securities as of December 31, 2023 and 2022. We diversify our corporate securities by industry and issuer. As of December 31, 2023, our combined holdings in the 10 corporate issuers to which we had the greatest exposure was $1.8 billion, which was 110 111 approximately 3% of our total cash, cash equivalents and invested assets. The exposure to the largest single corporate issuer held as of December 31, 2023 was $273 million, which was less than 1% of our total cash, cash equivalents and invested assets. See note 5 to our consolidated financial statements under “Part II—Item 8— Financial Statements and Supplementary Data” for additional information on diversification by sector. Other invested assets The following table sets forth the carrying values of our other invested assets as of December 31: 2023 2022 (Amounts in millions) Carrying value % of total Carrying value % of total Bank loan investments . . . . . . . . . . . . . . . . . . Derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . Short-term investments . . . . . . . . . . . . . . . . . . Other investments . . . . . . . . . . . . . . . . . . . . . . Total other invested assets . . . . . . . . . . . $529 131 27 44 $731 72% 18 4 6 100% $467 50 3 46 $566 82% 9 1 8 100% Bank loan investments increased from funding of additional investments, partially offset by principal payments in 2023. Derivatives increased largely from higher contracted notional interest rates on forward bond purchase commitments in excess of current market rates. Derivatives The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for fixed indexed annuity and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated: Measurement 2022 Additions December 31, Maturities/ terminations December 31, 2023 (Notional in millions) Derivatives designated as hedges Cash flow hedges: Interest rate swaps . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . . . . . . . Forward bond purchase commitments . . . Notional Notional Notional Total cash flow hedges . . . . . . . . . . . . . . . Total derivatives designated as hedges . . . . . . . . . . . . . . . . . . . . . . Derivatives not designated as hedges $ 8,542 $1,857 $(1,424) $ 8,975 144 — 8,686 — 1,075 2,932 (13) — 131 1,075 (1,437) 10,181 8,686 2,932 (1,437) 10,181 Equity index options . . . . . . . . . . . . . . . . . . . . . Financial futures . . . . . . . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . Notional Notional Notional 936 1,403 — 729 5,488 500 (963) (5,640) — 702 1,251 500 Total derivatives not designated as hedges . . . . . . . . . . . . . . . . . . . . . . . . . . 2,339 6,717 (6,603) 2,453 Total derivatives . . . . . . . . . . . . . . . . $11,025 $9,649 $(8,040) $12,634 Measurement 2022 Additions December 31, Maturities/ terminations December 31, 2023 (Number of policies) Derivatives not designated as hedges Fixed indexed annuity embedded Indexed universal life embedded derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . Policies 7,315 (1,489) 5,826 derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . Policies 771 (22) 749 — — The increase in the notional value of derivatives was primarily attributable to the addition of forward bond purchase commitments and interest rate swaps that support our long-term care and universal life insurance businesses, partially offset by a decrease in equity index options used to support our fixed indexed annuity The number of policies with embedded derivatives decreased as these products are no longer being offered products. and continue to runoff. Critical Accounting Estimates The accounting estimates and assumptions (including sensitivities) discussed in this section are those that we consider to be critical to an understanding of our consolidated financial statements because their application places significant demands on our ability to judge the effect of inherently uncertain matters on our financial results. For all of these accounting estimates and assumptions (including sensitivities), we caution that future events seldom develop as estimated and management’s best estimates often require adjustment. See “Cautionary Note Regarding Forward-looking Statements.” For a detailed discussion of our significant accounting policies, see note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” 112 113 approximately 3% of our total cash, cash equivalents and invested assets. The exposure to the largest single corporate issuer held as of December 31, 2023 was $273 million, which was less than 1% of our total cash, cash equivalents and invested assets. See note 5 to our consolidated financial statements under “Part II—Item 8— Financial Statements and Supplementary Data” for additional information on diversification by sector. Other invested assets The following table sets forth the carrying values of our other invested assets as of December 31: (Amounts in millions) Carrying value % of total Carrying value % of total 2023 2022 Bank loan investments . . . . . . . . . . . . . . . . . . Derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . Short-term investments . . . . . . . . . . . . . . . . . . Other investments . . . . . . . . . . . . . . . . . . . . . . 72% 18 4 6 $467 50 3 46 82% 9 1 8 Total other invested assets . . . . . . . . . . . 100% $566 100% $529 131 27 44 $731 Bank loan investments increased from funding of additional investments, partially offset by principal payments in 2023. Derivatives increased largely from higher contracted notional interest rates on forward bond purchase commitments in excess of current market rates. Derivatives The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for fixed indexed annuity and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated: (Notional in millions) Derivatives designated as hedges Cash flow hedges: Measurement December 31, 2022 Additions Maturities/ terminations December 31, 2023 Interest rate swaps . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . . . . . . . Forward bond purchase commitments . . . Notional Notional Notional $ 8,542 144 — $1,857 — 1,075 $(1,424) (13) — $ 8,975 131 1,075 Total cash flow hedges . . . . . . . . . . . . . . . 8,686 2,932 (1,437) 10,181 Total derivatives designated as hedges . . . . . . . . . . . . . . . . . . . . . . Derivatives not designated as hedges Equity index options . . . . . . . . . . . . . . . . . . . . . Financial futures . . . . . . . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . Total derivatives not designated as hedges . . . . . . . . . . . . . . . . . . . . . . . . . . 8,686 2,932 (1,437) 10,181 Notional Notional Notional 936 1,403 — 729 5,488 500 (963) (5,640) — 702 1,251 500 2,339 6,717 (6,603) 2,453 Total derivatives . . . . . . . . . . . . . . . . $11,025 $9,649 $(8,040) $12,634 (Number of policies) Derivatives not designated as hedges Fixed indexed annuity embedded Measurement December 31, 2022 Additions Maturities/ terminations December 31, 2023 derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . Policies 7,315 Indexed universal life embedded derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . Policies 771 — — (1,489) 5,826 (22) 749 The increase in the notional value of derivatives was primarily attributable to the addition of forward bond purchase commitments and interest rate swaps that support our long-term care and universal life insurance businesses, partially offset by a decrease in equity index options used to support our fixed indexed annuity products. The number of policies with embedded derivatives decreased as these products are no longer being offered and continue to runoff. Critical Accounting Estimates The accounting estimates and assumptions (including sensitivities) discussed in this section are those that we consider to be critical to an understanding of our consolidated financial statements because their application places significant demands on our ability to judge the effect of inherently uncertain matters on our financial results. For all of these accounting estimates and assumptions (including sensitivities), we caution that future events seldom develop as estimated and management’s best estimates often require adjustment. See “Cautionary Note Regarding Forward-looking Statements.” For a detailed discussion of our significant accounting policies, see note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” 112 113 The sensitivities in the tables below are changes that we consider to be reasonably possible given historical changes in market conditions and our experience with these products. The impacts are discrete and do not reflect the impact one factor may have on another. In any period and over time, our actual experience may have a positive or negative variance from our long-term assumptions, either singularly or collectively, and these variances may offset each other. Liability for future policy benefits The measurement of the liability for future policy benefits reflects estimates and actuarial assumptions and methodologies which involve the exercise of significant judgment and are inherently uncertain. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Establishing assumptions for the liability for future policy benefits is complex and involves many factors. Any future adverse changes in our assumptions would likely result in the establishment of additional future policy benefit reserves with a corresponding loss recognized in net income (loss). Our future financial results depend significantly upon the extent to which our actual future experience is consistent with the assumptions we have used in determining our liability for future policy benefits. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Moreover, for our long-term care insurance products, we may not be able to mitigate the impact of unexpected adverse experience by increasing premiums and/or other charges to policyholders (where we have the right to do so) or by offering benefit reductions as an alternative to increasing premiums. The liability for future policy benefits is equal to the present value of expected future benefits and claim- related expenses, less the present value of expected future net premiums. Cash flow assumptions, as applicable, used to estimate the liability for future policy benefits include health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates), estimates of future in-force rate actions, which include premium rate increases and benefit reductions associated with our long-term care insurance products. The liability is measured for each group of contracts, or cohorts, using best estimate cash flow assumptions, which are reviewed at least annually in the fourth quarter or more frequently if actual experience indicates a change is required. The change in the liability for future policy benefits, at the locked-in discount rate, resulting from cash flow assumption updates and variances between actual and expected experience is reflected as liability remeasurement (gains) losses in the consolidated statements of income. See notes 2 and 10 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the liability for future policy benefits. Long-term care insurance Key cash flow assumptions used to estimate the liability for future policy benefits for our long-term care insurance products include claim termination rates, incidence and benefit utilization rates, mortality, lapse rates and in-force rate actions. Claim termination rates represent the expected rates at which claims end. Incidence rates represent the likelihood the policyholder will go on claim. Benefit utilization rates represent how much of the available policy benefits are expected to be used. In-force rate actions represent the remaining premium rate increases and associated benefit reductions not yet achieved in our long-term care insurance multi-year in-force rate action plan and are based on our best estimate given our current plans for rate increase filings and our historical experience regarding rate increase approvals. In-force rate actions also include cash payments made to policyholders who elect certain reduced benefit options in connection with legal settlements, referred to as settlement payments. In the fourth quarter of 2023, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $61 million primarily related to updates to our healthy life assumptions to better reflect near-term experience, partially offset by a favorable update to disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. Updates also included favorable assumption updates for future in-force rate action approvals and benefit reductions based on recent favorable rate increase approval experience and feedback from regulators, along with the reflection of the third legal settlement, which had a muted favorable income statement impact in the fourth quarter of 2023 because it primarily impacted profitable uncapped cohorts. In the fourth quarter of 2022, liability remeasurement gains (losses) within net income included favorable cash flow assumption updates of $303 million reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement, which primarily impacted capped cohorts. A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31: (Amounts in millions) 2023 2022 2023 vs. 2022 Present value of expected net premiums (1) . . . . . . . . . . . . . . . . Present value of expected future policy benefits (1) . . . . . . . . . . $15,333 $50,095 $16,691 $50,551 $(1,358) $ (456) (8)% (1)% Increase (decrease) and percentage change The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax (1) At the locked-in discount rate. income for the year ended December 31, 2023: (Amounts in millions) 5% increase in future claim costs (1) . . . . . . . . . . . . . . . . . . . . . Reduction in claim termination rates (2) . . . . . . . . . . . . . . . . . . 10% reduction in benefit of future in-force rate actions (3) . . . . $(1,490) $ (290) $ (175) (1) Reflects the impact of an unfavorable assumption change for claim terminations, incidence or benefit utilization rates (any discrete adverse assumption changes therefrom or in combination with, that results in our future claim costs increasing by 5%). (2) Reflects the impact of a 3% decrease in mortality and 8% decrease in lapse rates. (3) Reflects the impact of an unfavorable change to our assumptions for future premium rate increases and benefit reductions. Life insurance Key cash flow assumptions used to estimate the liability for future policy benefits for our life insurance products include mortality and lapse rates. In the fourth quarter of 2023, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $56 million primarily as a result of updates to our mortality assumptions, including emerging experience related to more modest mortality improvement and an expectation that mortality will continue at elevated levels in the near-term post-COVID-19. There were no cash flow assumption changes for our life insurance products in the fourth quarter of 2022. 114 115 The sensitivities in the tables below are changes that we consider to be reasonably possible given historical changes in market conditions and our experience with these products. The impacts are discrete and do not reflect the impact one factor may have on another. In any period and over time, our actual experience may have a positive or negative variance from our long-term assumptions, either singularly or collectively, and these variances may offset each other. Liability for future policy benefits The measurement of the liability for future policy benefits reflects estimates and actuarial assumptions and methodologies which involve the exercise of significant judgment and are inherently uncertain. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Establishing assumptions for the liability for future policy benefits is complex and involves many factors. Any future adverse changes in our assumptions would likely result in the establishment of additional future policy benefit reserves with a corresponding loss recognized in net income (loss). Our future financial results depend significantly upon the extent to which our actual future experience is consistent with the assumptions we have used in determining our liability for future policy benefits. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Moreover, for our long-term care insurance products, we may not be able to mitigate the impact of unexpected adverse experience by increasing premiums and/or other charges to policyholders (where we have the right to do so) or by offering benefit reductions as an alternative to increasing premiums. The liability for future policy benefits is equal to the present value of expected future benefits and claim- related expenses, less the present value of expected future net premiums. Cash flow assumptions, as applicable, used to estimate the liability for future policy benefits include health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates), estimates of future in-force rate actions, which include premium rate increases and benefit reductions associated with our long-term care insurance products. The liability is measured for each group of contracts, or cohorts, using best estimate cash flow assumptions, which are reviewed at least annually in the fourth quarter or more frequently if actual experience indicates a change is required. The change in the liability for future policy benefits, at the locked-in discount rate, resulting from cash flow assumption updates and variances between actual and expected experience is reflected as liability remeasurement (gains) losses in the consolidated statements of income. See notes 2 and 10 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the liability for future policy benefits. Long-term care insurance Key cash flow assumptions used to estimate the liability for future policy benefits for our long-term care insurance products include claim termination rates, incidence and benefit utilization rates, mortality, lapse rates and in-force rate actions. Claim termination rates represent the expected rates at which claims end. Incidence rates represent the likelihood the policyholder will go on claim. Benefit utilization rates represent how much of the available policy benefits are expected to be used. In-force rate actions represent the remaining premium rate increases and associated benefit reductions not yet achieved in our long-term care insurance multi-year in-force rate action plan and are based on our best estimate given our current plans for rate increase filings and our historical experience regarding rate increase approvals. In-force rate actions also include cash payments made to policyholders who elect certain reduced benefit options in connection with legal settlements, referred to as settlement payments. In the fourth quarter of 2023, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $61 million primarily related to updates to our healthy life assumptions to better reflect near-term experience, partially offset by a favorable update to disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. Updates also included favorable assumption updates for future in-force rate action approvals and benefit reductions based on recent favorable rate increase approval experience and feedback from regulators, along with the reflection of the third legal settlement, which had a muted favorable income statement impact in the fourth quarter of 2023 because it primarily impacted profitable uncapped cohorts. In the fourth quarter of 2022, liability remeasurement gains (losses) within net income included favorable cash flow assumption updates of $303 million reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement, which primarily impacted capped cohorts. A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31: Increase (decrease) and percentage change (Amounts in millions) 2023 2022 2023 vs. 2022 Present value of expected net premiums (1) . . . . . . . . . . . . . . . . Present value of expected future policy benefits (1) . . . . . . . . . . $15,333 $50,095 $16,691 $50,551 $(1,358) $ (456) (8)% (1)% (1) At the locked-in discount rate. The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2023: (Amounts in millions) 5% increase in future claim costs (1) . . . . . . . . . . . . . . . . . . . . . Reduction in claim termination rates (2) . . . . . . . . . . . . . . . . . . 10% reduction in benefit of future in-force rate actions (3) . . . . $(1,490) $ (290) $ (175) (1) Reflects the impact of an unfavorable assumption change for claim terminations, incidence or benefit utilization rates (any discrete adverse assumption changes therefrom or in combination with, that results in our future claim costs increasing by 5%). (2) Reflects the impact of a 3% decrease in mortality and 8% decrease in lapse rates. (3) Reflects the impact of an unfavorable change to our assumptions for future premium rate increases and benefit reductions. Life insurance Key cash flow assumptions used to estimate the liability for future policy benefits for our life insurance products include mortality and lapse rates. In the fourth quarter of 2023, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $56 million primarily as a result of updates to our mortality assumptions, including emerging experience related to more modest mortality improvement and an expectation that mortality will continue at elevated levels in the near-term post-COVID-19. There were no cash flow assumption changes for our life insurance products in the fourth quarter of 2022. 114 115 features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims, commonly referred to as the additional insurance liability. The benefit ratio is equal to the present value of total expected benefit payments over the life of the contract divided by the present value of total expected assessments over the life of the contract, discounted by the projected crediting rate. The assumptions used to calculate the benefit ratio include insured mortality, interest rates and policyholder persistency or lapses, among other assumptions. We perform an annual review of assumptions for our universal and term universal life insurance products in the fourth quarter. Our 2023 review resulted in an expense recorded to pre-tax income of $200 million primarily to reflect unfavorable persistency and mortality assumptions. We made unfavorable updates to our persistency assumptions in our universal life insurance products with secondary guarantees to better reflect emerging experience. We also made unfavorable updates to our mortality assumptions in universal and term universal life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term post-COVID-19. Our 2022 review resulted in a benefit recorded to pre-tax income of $37 million largely associated with higher interest rates. The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2023: (Amounts in millions) 100 basis point decrease in projected crediting rates . . . . . . . . . . 10% increase in persistency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2% higher mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ (50) $(213) $ (42) Liability for policy and contract claims The liability for policy and contract claims represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (i) losses that have been reported to the insurer; (ii) losses related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (iii) loss adjustment expenses. Loss adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust A summary of certain of our significant estimates used in the calculation of our life insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31: Increase (decrease) and percentage change (Amounts in millions) 2023 2022 2023 vs. 2022 Present value of expected net premiums (1) . . . . . . . . . . . . . . . . . . . . Present value of expected future policy benefits (1) . . . . . . . . . . . . . . $1,835 $2,192 $1,573 $2,127 $262 $ 65 17% 3% (1) At the locked-in discount rate and excluding the impacts of flooring adjustments. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information. The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2023: (Amounts in millions) 2% higher mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10% increase in lapses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(20) $(60) Fixed annuities The key cash flow assumption used to estimate the liability for future policy benefits for our fixed annuity products is mortality. In the fourth quarters of 2023 and 2022, our annual review of cash flow assumptions had no impact on liability remeasurement gains (losses) within net income for our fixed annuity products. A summary of certain of our significant estimates and assumptions used in the calculation of our fixed annuities liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31: (Amounts in millions) 2023 2022 2023 vs. 2022 Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future Total present value of expected future policy benefits (1) . . . . . . . . . $2,691 $2,897 $(206) (7)% claims recorded through net income (loss). Increase (decrease) and percentage change claims. (1) At the locked-in discount rate. The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2023: (Amounts in millions) 10% lower mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(60) Policyholder account balances – additional insurance liabilities The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product Mortgage insurance Estimates and actuarial assumptions used for establishing loss reserves involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on Enact’s loss reserves and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, Enact cannot determine with precision the ultimate amounts it will pay for actual claims or the timing of those payments. The sources of uncertainty affecting the estimates are numerous and include factors internal and external to Enact. Internal factors include, but are not limited to, changes in the mix of exposures, loss mitigation activities and claim settlement practices. Significant external influences include changes in home prices, unemployment, government housing policies, state foreclosure timelines, general economic conditions, interest rates, tax policy, credit availability and mortgage products. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on Enact’s reserves, results of operations and financial condition. 116 117 A summary of certain of our significant estimates used in the calculation of our life insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31: Increase (decrease) and percentage change (Amounts in millions) 2023 2022 2023 vs. 2022 Present value of expected net premiums (1) . . . . . . . . . . . . . . . . . . . . Present value of expected future policy benefits (1) . . . . . . . . . . . . . . $1,835 $2,192 $1,573 $2,127 $262 $ 65 17% 3% (1) At the locked-in discount rate and excluding the impacts of flooring adjustments. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information. The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2023: (Amounts in millions) 2% higher mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10% increase in lapses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(20) $(60) Fixed annuities products is mortality. The key cash flow assumption used to estimate the liability for future policy benefits for our fixed annuity In the fourth quarters of 2023 and 2022, our annual review of cash flow assumptions had no impact on liability remeasurement gains (losses) within net income for our fixed annuity products. A summary of certain of our significant estimates and assumptions used in the calculation of our fixed annuities liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31: Increase (decrease) and percentage change The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax (1) At the locked-in discount rate. income for the year ended December 31, 2023: (Amounts in millions) 10% lower mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(60) Policyholder account balances – additional insurance liabilities The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims, commonly referred to as the additional insurance liability. The benefit ratio is equal to the present value of total expected benefit payments over the life of the contract divided by the present value of total expected assessments over the life of the contract, discounted by the projected crediting rate. The assumptions used to calculate the benefit ratio include insured mortality, interest rates and policyholder persistency or lapses, among other assumptions. We perform an annual review of assumptions for our universal and term universal life insurance products in the fourth quarter. Our 2023 review resulted in an expense recorded to pre-tax income of $200 million primarily to reflect unfavorable persistency and mortality assumptions. We made unfavorable updates to our persistency assumptions in our universal life insurance products with secondary guarantees to better reflect emerging experience. We also made unfavorable updates to our mortality assumptions in universal and term universal life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term post-COVID-19. Our 2022 review resulted in a benefit recorded to pre-tax income of $37 million largely associated with higher interest rates. The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2023: (Amounts in millions) 100 basis point decrease in projected crediting rates . . . . . . . . . . 10% increase in persistency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2% higher mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ (50) $(213) $ (42) Liability for policy and contract claims The liability for policy and contract claims represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (i) losses that have been reported to the insurer; (ii) losses related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (iii) loss adjustment expenses. Loss adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims. (Amounts in millions) 2023 2022 2023 vs. 2022 Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future Total present value of expected future policy benefits (1) . . . . . . . . . $2,691 $2,897 $(206) (7)% claims recorded through net income (loss). Mortgage insurance Estimates and actuarial assumptions used for establishing loss reserves involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on Enact’s loss reserves and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, Enact cannot determine with precision the ultimate amounts it will pay for actual claims or the timing of those payments. The sources of uncertainty affecting the estimates are numerous and include factors internal and external to Enact. Internal factors include, but are not limited to, changes in the mix of exposures, loss mitigation activities and claim settlement practices. Significant external influences include changes in home prices, unemployment, government housing policies, state foreclosure timelines, general economic conditions, interest rates, tax policy, credit availability and mortgage products. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on Enact’s reserves, results of operations and financial condition. 116 117 Enact establishes reserves to recognize the estimated liability for losses and loss adjustment expenses related The following tables summarize the primary sources of data considered when determining the fair value of to defaults on insured mortgage loans. Loss reserves are established by estimating the number of loans in the inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. Over time, as the status of the underlying delinquent loans moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase. Enact’s management monitors actual experience, and where circumstances warrant, will revise its assumptions. The liability for loss reserves is reviewed regularly, with changes in estimates of future claims recorded through net income. Estimation of losses is based on historical claim and cure experience and covered exposures and is inherently judgmental. Future developments may result in losses greater or less than the liability for loss reserves provided. Enact’s loss reserves were $518 million and $519 million as of December 31, 2023 and 2022, respectively. In considering the potential sensitivity of the factors underlying Enact’s best estimate of its mortgage insurance reserves, it is possible that even a relatively small change in the estimated claim or severity rate could have a significant impact on loss reserves and, correspondingly, on our results of operations. For example, based on Enact’s actual experience during the three-year period ended December 31, 2023, a quarterly change of 5% in its average claim rate would change the gross loss reserve amount for such quarter by $75 million and a change of 4% in its average severity rate would change the gross loss reserve amount for such quarter by $19 million. Valuation of fixed maturity securities. Our portfolio of fixed maturity securities comprises primarily investment grade securities, which are carried at fair value. The methodologies, estimates and assumptions used in valuing our fixed maturity securities evolve over time and are subject to different interpretations, all of which can lead to materially different estimates of fair value. Additionally, because the valuation is based on market conditions at a specific point in time, the period-to-period changes in fair value may vary significantly due to changing interest rates, as well as external macroeconomic and credit market conditions. For example, widening credit spreads will generally result in a decrease, while tightening credit spreads will generally result in an increase, in the fair value of our fixed maturity securities. Additionally, during periods of increasing interest rates, the market values of lower-yielding assets will decline. See “Item 7A—Quantitative and Qualitative Disclosures About Market Risk—Sensitivity Analysis—Interest Rate Risk” for the impact of hypothetical changes in interest rates on our investments portfolio. Our valuation techniques maximize the use of observable inputs. However, for certain less liquid securities, categorized as Level 3, the valuation inputs and assumptions cannot be corroborated with observable market data and require greater estimation, resulting in values that are less certain. Additionally, the availability of observable market information may change as certain inputs may be more direct drivers of valuation at the time of pricing, or if certain assets previously in active markets become less liquid due to changes in the financial environment. As a result, more securities may be categorized as Level 3 and require more subjectivity and management judgment. As of December 31, 2023, 6% of our total fixed maturity securities related to Level 3 fixed maturity securities valued using internal pricing models. See notes 2, 5 and 21 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the valuation of fixed maturity securities and a description of the fair value measurement estimates and level assignments. fixed maturity securities as of December 31: (Amounts in millions) Fixed maturity securities: 2023 Total Level 1 Level 2 Level 3 Pricing services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $41,311 $ — $41,311 $ — Broker quotes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Internal models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 221 5,249 — — — 2,374 221 2,875 Total fixed maturity securities . . . . . . . . . . . . . . . $46,781 $ — $43,685 $3,096 (Amounts in millions) Fixed maturity securities: Pricing services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $41,113 $ — $41,113 $ — Broker quotes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Internal models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250 5,220 — — — 2,280 250 2,940 Total fixed maturity securities . . . . . . . . . . . . . . . $46,583 $ — $43,393 $3,190 2022 Total Level 1 Level 2 Level 3 Consolidated Balance Sheets Total assets. Total assets increased $1,103 million from $89,714 million as of December 31, 2022 to $90,817 million as of December 31, 2023. • Invested assets increased $803 million primarily attributable to increases of $490 million in limited partnerships, $198 million in fixed maturity securities and $165 million in other invested assets, partially offset by a decrease of $208 million in commercial mortgage loans in 2023. Limited partnerships increased largely from capital calls in 2023. The increase in fixed maturity securities was predominantly related to tightening credit spreads increasing the fair value of our fixed maturity investment portfolio, partially offset by net sales and maturities in 2023. The increase in other invested assets was primarily related to derivatives and bank loan investments. Commercial mortgage loans decreased mostly due to payments outpacing originations in 2023. We continue to monitor macroeconomic trends and rebalance our investment holdings in commercial real estate. • Cash and cash equivalents increased $416 million primarily related to net sales and maturities of fixed maturity securities and commercial mortgage loan payments outpacing originations, partially offset by net withdrawals from our investment contracts and repurchases of Genworth Financial’s common stock in 2023. • Deferred acquisition costs decreased $223 million primarily attributable to amortization in our life and long-term care insurance products in 2023. Total liabilities. Total liabilities increased $1,154 million from $81,328 million as of December 31, 2022 to $82,482 million as of December 31, 2023. • The liability for future policy benefits increased $2,248 million primarily from a decrease in the single-A interest rate used to discount the liability for future policy benefits and aging of our long- term care insurance in-force block, partially offset by the runoff of our life insurance and fixed annuity products. The increase also includes the effects of changes in cash flow assumptions and variances between actual and expected experience. See “—Critical Accounting Estimates— Liability for future policy benefits” for additional information on the impact of changes in cash flow assumptions. 118 119 Enact establishes reserves to recognize the estimated liability for losses and loss adjustment expenses related The following tables summarize the primary sources of data considered when determining the fair value of to defaults on insured mortgage loans. Loss reserves are established by estimating the number of loans in the inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. Over time, as the status of the underlying delinquent loans moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase. Enact’s management monitors actual experience, and where circumstances warrant, will revise its assumptions. The liability for loss reserves is reviewed regularly, with changes in estimates of future claims recorded through net income. Estimation of losses is based on historical claim and cure experience and covered exposures and is inherently judgmental. Future developments may result in losses greater or less than the liability for loss reserves provided. Enact’s loss reserves were $518 million and $519 million as of December 31, 2023 and 2022, respectively. In considering the potential sensitivity of the factors underlying Enact’s best estimate of its mortgage insurance reserves, it is possible that even a relatively small change in the estimated claim or severity rate could have a significant impact on loss reserves and, correspondingly, on our results of operations. For example, based on Enact’s actual experience during the three-year period ended December 31, 2023, a quarterly change of 5% in its average claim rate would change the gross loss reserve amount for such quarter by $75 million and a change of 4% in its average severity rate would change the gross loss reserve amount for such quarter by $19 million. Valuation of fixed maturity securities. Our portfolio of fixed maturity securities comprises primarily investment grade securities, which are carried at fair value. The methodologies, estimates and assumptions used in valuing our fixed maturity securities evolve over time and are subject to different interpretations, all of which can lead to materially different estimates of fair value. Additionally, because the valuation is based on market conditions at a specific point in time, the period-to-period changes in fair value may vary significantly due to changing interest rates, as well as external macroeconomic and credit market conditions. For example, widening credit spreads will generally result in a decrease, while tightening credit spreads will generally result in an increase, in the fair value of our fixed maturity securities. Additionally, during periods of increasing interest rates, the market values of lower-yielding assets will decline. See “Item 7A—Quantitative and Qualitative Disclosures About Market Risk—Sensitivity Analysis—Interest Rate Risk” for the impact of hypothetical changes in interest rates on our investments portfolio. Our valuation techniques maximize the use of observable inputs. However, for certain less liquid securities, categorized as Level 3, the valuation inputs and assumptions cannot be corroborated with observable market data and require greater estimation, resulting in values that are less certain. Additionally, the availability of observable market information may change as certain inputs may be more direct drivers of valuation at the time of pricing, or if certain assets previously in active markets become less liquid due to changes in the financial environment. As a result, more securities may be categorized as Level 3 and require more subjectivity and management judgment. As of December 31, 2023, 6% of our total fixed maturity securities related to Level 3 fixed maturity securities valued using internal pricing models. See notes 2, 5 and 21 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the valuation of fixed maturity securities and a description of the fair value measurement estimates and level assignments. fixed maturity securities as of December 31: (Amounts in millions) Fixed maturity securities: 2023 Total Level 1 Level 2 Level 3 Pricing services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Broker quotes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Internal models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $41,311 221 5,249 $ — — — $41,311 — 2,374 $ — 221 2,875 Total fixed maturity securities . . . . . . . . . . . . . . . $46,781 $ — $43,685 $3,096 (Amounts in millions) Fixed maturity securities: 2022 Total Level 1 Level 2 Level 3 Pricing services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Broker quotes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Internal models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $41,113 250 5,220 $ — — — $41,113 — 2,280 $ — 250 2,940 Total fixed maturity securities . . . . . . . . . . . . . . . $46,583 $ — $43,393 $3,190 Consolidated Balance Sheets Total assets. Total assets increased $1,103 million from $89,714 million as of December 31, 2022 to $90,817 million as of December 31, 2023. • Invested assets increased $803 million primarily attributable to increases of $490 million in limited partnerships, $198 million in fixed maturity securities and $165 million in other invested assets, partially offset by a decrease of $208 million in commercial mortgage loans in 2023. Limited partnerships increased largely from capital calls in 2023. The increase in fixed maturity securities was predominantly related to tightening credit spreads increasing the fair value of our fixed maturity investment portfolio, partially offset by net sales and maturities in 2023. The increase in other invested assets was primarily related to derivatives and bank loan investments. Commercial mortgage loans decreased mostly due to payments outpacing originations in 2023. We continue to monitor macroeconomic trends and rebalance our investment holdings in commercial real estate. • Cash and cash equivalents increased $416 million primarily related to net sales and maturities of fixed maturity securities and commercial mortgage loan payments outpacing originations, partially offset by net withdrawals from our investment contracts and repurchases of Genworth Financial’s common stock in 2023. • Deferred acquisition costs decreased $223 million primarily attributable to amortization in our life and long-term care insurance products in 2023. Total liabilities. Total liabilities increased $1,154 million from $81,328 million as of December 31, 2022 to $82,482 million as of December 31, 2023. • The liability for future policy benefits increased $2,248 million primarily from a decrease in the single-A interest rate used to discount the liability for future policy benefits and aging of our long- term care insurance in-force block, partially offset by the runoff of our life insurance and fixed annuity products. The increase also includes the effects of changes in cash flow assumptions and variances between actual and expected experience. See “—Critical Accounting Estimates— Liability for future policy benefits” for additional information on the impact of changes in cash flow assumptions. 118 119 • Policyholder account balances decreased $1,024 million primarily from surrenders, benefit payments and policy charges in our fixed annuity and universal and term universal life insurance products in 2023, partially offset by an increase in additional insurance liabilities due to changes in cash flow assumptions. See “—Critical Accounting Estimates—Policyholder account balances —additional insurance liabilities” for additional information. • Market risk benefit liabilities decreased $123 million mostly related to favorable equity market performance in 2023. Total equity. Total equity decreased $51 million from $8,386 million as of December 31, 2022 to $8,335 million as of December 31, 2023. • We reported net income available to Genworth Financial, Inc.’s common stockholders of $76 million for the year ended December 31, 2023. • Unrealized gains (losses) on investments increased total equity by $1,277 million primarily from tightening credit spreads in 2023. • Change in the discount rate used to measure future policy benefits decreased total equity by $1,036 million largely attributable to a decrease in the single-A interest rate used to discount the liability for future policy benefits and related reinsurance recoverables (net of deferred taxes) in 2023. • Treasury stock increased $299 million primarily due to the repurchase of Genworth Financial’s common stock, at cost, including excise taxes and other costs paid in connection with acquiring the shares, resulting in a decrease to total equity in 2023. Liquidity and Capital Resources Liquidity and capital resources represent our overall financial strength and our ability to generate cash flows from our businesses, borrow funds at competitive rates and raise new capital to meet our operating and growth needs. Overview of cash flows—Genworth and subsidiaries The following table sets forth our condensed consolidated cash flows for the years ended December 31: (Amounts in millions) 2023 2022 2021 Net cash from operating activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net cash from investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net cash used by financing activities . . . . . . . . . . . . . . . . . . . . . . . . . . $ 597 1,261 (1,443) $ 1,049 733 (1,554) $ 437 896 (2,419) Net increase (decrease) in cash before foreign exchange effect . . . . . $ 415 $ 228 $(1,086) Our principal sources of cash include sales of our products and services, income from our investment portfolio and proceeds from sales of investments. As an insurance business, we typically generate positive cash flows from operating activities, as premiums collected from our insurance products and income received from our investments typically exceed policy acquisition costs, benefits and claims paid, redemptions and operating expenses. Our cash flows from operating activities are affected by the timing of premiums, fees and investment income received and benefits, claims and expenses paid. Positive cash flows from operating activities are then invested to support the obligations of our insurance and investment products and required capital supporting these products. In analyzing our cash flows, we focus on the change in the amount of cash available and used in investing activities. Changes in cash from financing activities primarily relate to deposits to, and redemptions and benefit payments on, universal life insurance and investment contracts; the issuance of debt and equity securities; the repayment or repurchase of borrowings; the repurchase of common stock presented as treasury stock; and other capital transactions. 2023 compared to 2022 Net cash inflows from operating activities were lower primarily due to higher benefit payments in our long- term care insurance business in 2023, partially offset by net cash disbursements in 2022 associated with the return of cash collateral received from counterparties under our derivative contracts. Net cash inflows from investing activities were higher mainly due to commercial mortgage loan payments outpacing originations in 2023 compared to originations outpacing payments in 2022, as well as higher net sales and maturities of fixed maturity securities in 2023. Net cash outflows used by financing activities were lower primarily due to lower repurchases and repayments of Genworth Holdings’ debt in 2023 and a settlement payment related to a Tax Matters Agreement with GE in 2022 that did not recur, partially offset by higher repurchases of Genworth Financial’s common stock in 2023. Genworth—holding company liquidity In consideration of our liquidity, it is important to separate the needs of our holding companies from the needs of their respective subsidiaries. Genworth Financial and Genworth Holdings each act as a holding company for their respective subsidiaries and do not have any significant operations of their own. Genworth Financial’s and Genworth Holdings’ principal sources of cash are derived from dividends and other returns of capital from Enact Holdings. Additional sources of cash have included subsidiary payments to them under tax sharing and expense reimbursement arrangements and proceeds from borrowings or securities issuances. The primary uses of funds at Genworth Financial and Genworth Holdings include payments of principal, interest and other expenses on borrowings or other obligations, payment of holding company general operating expenses (including employee benefits and taxes), payments under guarantees (including guarantees of certain subsidiary obligations), payments to subsidiaries (and, in the case of Genworth Holdings, to Genworth Financial) under tax sharing agreements, contributions to subsidiaries, repurchases of debt securities, repurchases of Genworth Financial’s common stock and, in the case of Genworth Holdings, loans, dividends or other distributions to Genworth Financial. For more information on our tax obligations, refer to note 18 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” Management’s focus is predominantly on Genworth Holdings’ liquidity given it is the issuer of our outstanding public debt. As of December 31, 2023, our principal U.S. life insurance subsidiaries had negative unassigned surplus of approximately $563 million under statutory accounting, and as a result, we do not expect these subsidiaries to pay dividends for the foreseeable future. Therefore, our liquidity at the holding company level is highly dependent on the performance of Enact Holdings and its ability to pay timely dividends and other forms of capital returns to Genworth Holdings as anticipated. Genworth Financial has the right to appoint a majority of directors to the board of directors of Enact Holdings; however, actions taken by Enact Holdings and its board of directors are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. Future dividends will be subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial and will also be dependent on a variety of economic, market and business conditions, among other considerations. Insurance laws and regulations regulate the payment of dividends and other distributions to Genworth Financial and Genworth Holdings by their insurance subsidiaries. See “—Regulated insurance subsidiaries” for additional details. Enact Holdings continues to evaluate its capital allocation strategy to consistently support its existing policyholders, grow its mortgage insurance business, fund attractive new business opportunities and return capital to shareholders. In addition to its quarterly cash dividend program, on November 1, 2022, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings could repurchase up to $75 million of its outstanding common stock, and on August 1, 2023, announced the 120 121 • Policyholder account balances decreased $1,024 million primarily from surrenders, benefit payments and policy charges in our fixed annuity and universal and term universal life insurance products in 2023, partially offset by an increase in additional insurance liabilities due to changes in cash flow assumptions. See “—Critical Accounting Estimates—Policyholder account balances —additional insurance liabilities” for additional information. • Market risk benefit liabilities decreased $123 million mostly related to favorable equity market performance in 2023. Total equity. Total equity decreased $51 million from $8,386 million as of December 31, 2022 to $8,335 million as of December 31, 2023. • We reported net income available to Genworth Financial, Inc.’s common stockholders of $76 million for the year ended December 31, 2023. • Unrealized gains (losses) on investments increased total equity by $1,277 million primarily from tightening credit spreads in 2023. • Change in the discount rate used to measure future policy benefits decreased total equity by $1,036 million largely attributable to a decrease in the single-A interest rate used to discount the liability for future policy benefits and related reinsurance recoverables (net of deferred taxes) in 2023. • Treasury stock increased $299 million primarily due to the repurchase of Genworth Financial’s common stock, at cost, including excise taxes and other costs paid in connection with acquiring the shares, resulting in a decrease to total equity in 2023. Liquidity and Capital Resources Liquidity and capital resources represent our overall financial strength and our ability to generate cash flows from our businesses, borrow funds at competitive rates and raise new capital to meet our operating and growth needs. Overview of cash flows—Genworth and subsidiaries The following table sets forth our condensed consolidated cash flows for the years ended December 31: (Amounts in millions) 2023 2022 2021 Net cash from operating activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 597 $ 1,049 $ Net cash from investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net cash used by financing activities . . . . . . . . . . . . . . . . . . . . . . . . . . 1,261 (1,443) 733 (1,554) (2,419) 437 896 Net increase (decrease) in cash before foreign exchange effect . . . . . $ 415 $ 228 $(1,086) Our principal sources of cash include sales of our products and services, income from our investment portfolio and proceeds from sales of investments. As an insurance business, we typically generate positive cash flows from operating activities, as premiums collected from our insurance products and income received from our investments typically exceed policy acquisition costs, benefits and claims paid, redemptions and operating expenses. Our cash flows from operating activities are affected by the timing of premiums, fees and investment income received and benefits, claims and expenses paid. Positive cash flows from operating activities are then invested to support the obligations of our insurance and investment products and required capital supporting these products. In analyzing our cash flows, we focus on the change in the amount of cash available and used in investing activities. Changes in cash from financing activities primarily relate to deposits to, and redemptions and benefit payments on, universal life insurance and investment contracts; the issuance of debt and equity securities; the repayment or repurchase of borrowings; the repurchase of common stock presented as treasury stock; and other capital transactions. 2023 compared to 2022 Net cash inflows from operating activities were lower primarily due to higher benefit payments in our long- term care insurance business in 2023, partially offset by net cash disbursements in 2022 associated with the return of cash collateral received from counterparties under our derivative contracts. Net cash inflows from investing activities were higher mainly due to commercial mortgage loan payments outpacing originations in 2023 compared to originations outpacing payments in 2022, as well as higher net sales and maturities of fixed maturity securities in 2023. Net cash outflows used by financing activities were lower primarily due to lower repurchases and repayments of Genworth Holdings’ debt in 2023 and a settlement payment related to a Tax Matters Agreement with GE in 2022 that did not recur, partially offset by higher repurchases of Genworth Financial’s common stock in 2023. Genworth—holding company liquidity In consideration of our liquidity, it is important to separate the needs of our holding companies from the needs of their respective subsidiaries. Genworth Financial and Genworth Holdings each act as a holding company for their respective subsidiaries and do not have any significant operations of their own. Genworth Financial’s and Genworth Holdings’ principal sources of cash are derived from dividends and other returns of capital from Enact Holdings. Additional sources of cash have included subsidiary payments to them under tax sharing and expense reimbursement arrangements and proceeds from borrowings or securities issuances. The primary uses of funds at Genworth Financial and Genworth Holdings include payments of principal, interest and other expenses on borrowings or other obligations, payment of holding company general operating expenses (including employee benefits and taxes), payments under guarantees (including guarantees of certain subsidiary obligations), payments to subsidiaries (and, in the case of Genworth Holdings, to Genworth Financial) under tax sharing agreements, contributions to subsidiaries, repurchases of debt securities, repurchases of Genworth Financial’s common stock and, in the case of Genworth Holdings, loans, dividends or other distributions to Genworth Financial. For more information on our tax obligations, refer to note 18 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” Management’s focus is predominantly on Genworth Holdings’ liquidity given it is the issuer of our outstanding public debt. As of December 31, 2023, our principal U.S. life insurance subsidiaries had negative unassigned surplus of approximately $563 million under statutory accounting, and as a result, we do not expect these subsidiaries to pay dividends for the foreseeable future. Therefore, our liquidity at the holding company level is highly dependent on the performance of Enact Holdings and its ability to pay timely dividends and other forms of capital returns to Genworth Holdings as anticipated. Genworth Financial has the right to appoint a majority of directors to the board of directors of Enact Holdings; however, actions taken by Enact Holdings and its board of directors are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. Future dividends will be subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial and will also be dependent on a variety of economic, market and business conditions, among other considerations. Insurance laws and regulations regulate the payment of dividends and other distributions to Genworth Financial and Genworth Holdings by their insurance subsidiaries. See “—Regulated insurance subsidiaries” for additional details. Enact Holdings continues to evaluate its capital allocation strategy to consistently support its existing policyholders, grow its mortgage insurance business, fund attractive new business opportunities and return capital to shareholders. In addition to its quarterly cash dividend program, on November 1, 2022, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings could repurchase up to $75 million of its outstanding common stock, and on August 1, 2023, announced the 120 121 authorization of an additional $100 million of common stock repurchases under a new share repurchase program. Genworth Holdings agreed to participate in order to maintain its overall ownership at its current level. As the majority shareholder, Genworth Holdings received $245 million of capital returns from Enact Holdings in 2023, comprised of quarterly dividends, a special dividend and share repurchases. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Enact Holdings’ stock price and trading volume, and general business and market conditions, among other factors. On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial could repurchase up to $350 million of its outstanding Class A common stock. On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under its existing share repurchase program. Pursuant to the program, during 2023, Genworth Financial repurchased 51,739,098 shares of its common stock at an average price of $5.70 per share for a total of $295 million, excluding excise taxes and other associated costs. In 2024, Genworth Financial also repurchased 4,197,740 shares of its common stock through February 13, 2024 for approximately $25 million, leaving approximately $316 million remaining authorization under the share repurchase program. Further repurchases under the program will continue to be funded from holding company capital, as well as future cash flow generation, including expected future capital returns from Enact Holdings. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions, or by other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time. Our future use of liquidity and capital will prioritize future strategic investments in CareScout and returning capital to Genworth Financial’s shareholders through share repurchases. We expect to continue to provide capital to CareScout to help advance our senior care growth initiatives related to the needs of elderly Americans, as well as their caregivers and families. We may also from time to time seek to repurchase or redeem outstanding debt (with cash on hand, proceeds from the issuance of new debt and/or the proceeds from asset or stock sales) in open market purchases, tender offers, privately negotiated transactions or otherwise. Genworth Holdings had $350 million and $307 million of unrestricted cash and cash equivalents as of December 31, 2023 and 2022, respectively. The increase was principally driven by capital returns from Enact Holdings and intercompany cash tax payments received from Genworth Holdings’ subsidiaries, partially offset by Genworth Financial’s common stock repurchases and debt interest payments in 2023. We believe Genworth Holdings’ unrestricted cash and cash equivalents provide sufficient liquidity to meet its financial obligations over the next twelve months. However, in the third quarter of 2023, we made a federal tax payment based on our projection of current taxable income and utilization of our remaining foreign tax credits, and we expect the amount of intercompany cash tax payments retained by Genworth Holdings from its subsidiaries to be lower starting in 2024 as compared to the amounts received during 2022 and 2023. We also expect Genworth Holdings’ liquidity to continue to be significantly impacted by the amounts and timing of Genworth Financial’s share repurchases as well as future dividends and other forms of capital returns from Enact Holdings. We actively monitor our liquidity position (most notably at Genworth Holdings), liquidity generation options and the credit markets given changing market conditions. Genworth Holdings’ cash management target is to maintain a cash buffer of two times expected annual external debt interest payments. Genworth Holdings may move below or above this targeted cash buffer during any given quarter due to the timing of cash outflows and inflows or from future actions. Management of Genworth Financial continues to evaluate Genworth Holdings’ target level of liquidity as circumstances warrant. conditions, regulatory considerations, the general availability of credit, credit ratings and the performance of and outlook for Enact Holdings and the payment of dividends and other returns of capital therefrom. For a discussion of certain risks associated with our liquidity and dependency on dividends paid by Enact Holdings, see “Item 1A—Risk Factors—Genworth Financial and Genworth Holdings depend on the ability of Enact Holdings and its subsidiaries to pay dividends and make other payments and distributions to each of them and to meet their obligations,” and “Item 1A—Risk Factors—Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms.” These risks may be exacerbated by the economic impact of current elevated interest rates and overall housing trends. During 2023 and 2022, Genworth Holdings repurchased $32 million and $143 million, respectively, principal amount of its debt, and in 2022, early redeemed $152 million of its 4.80% senior notes originally scheduled to mature in February 2024. As of December 31, 2023, Genworth Holdings had $856 million principal of outstanding debt, with no maturities due until June 2034. On October 25, 2023, Genworth Holdings completed a consent solicitation from bondholders representing a majority in principal amount of its 6.50% senior notes due in 2034 (“2034 Notes”) to amend the Replacement Capital Covenant, dated as of November 14, 2006. The amendment permits Genworth Holdings to repay, redeem or repurchase $2,000 principal amount of its floating rate junior subordinated notes due in 2066 (“2066 Notes”) for each $1,000 principal amount of its 2034 Notes repaid, redeemed or repurchased. In December 2022, the Board of Governors of the Federal Reserve System adopted a final rule that established benchmark rates, based on the Secured Overnight Financing Rate (“SOFR”), that replaced the London Interbank Offered Rate (“LIBOR”) after its elimination on June 30, 2023. Pursuant to the final rule, Genworth Holdings’ 2066 Notes, which had an annual interest rate equal to three-month LIBOR plus 2.0025%, transitioned in the third quarter of 2023 to an annual interest rate equal to the three-month Term SOFR Reference Rate, plus a tenor spread adjustment of 0.26161%, plus an additional spread of 2.0025%. We do not expect this change to have a material impact on our results of operations or liquidity. In addition, given the reduction in Genworth Holdings’ debt and corresponding decrease in debt service costs, we do not expect a significant impact on our liquidity from the rise in interest rates in 2022 and 2023. On June 30, 2022, Enact Holdings entered into a credit agreement with a syndicate of lenders that provides for a five-year unsecured revolving credit facility in the initial aggregate principal amount of $200 million, including the ability for Enact Holdings to increase the commitments under the credit facility on an uncommitted basis, by an additional aggregate principal amount of up to $100 million. As of December 31, 2023, Enact Holdings was in compliance with all covenants and the credit facility remained undrawn. Enact Holdings also has $750 million principal amount of senior notes due in August 2025. Enact Holdings continually evaluates opportunities based upon market conditions to further increase its financial flexibility including through raising additional capital, restructuring or refinancing some or all of its outstanding debt or pursuing other options such as reinsurance or credit risk transfer transactions. There can be no guarantee that any such opportunities will be available on favorable terms or at all. Other than its senior notes due in August 2025, Enact Holdings has no material outstanding debt obligations that are expected to affect its liquidity over the next five years. We believe that the operating cash flows generated by Enact Holdings’ mortgage insurance subsidiaries will provide the funds necessary to satisfy its claim payments, operating expenses and taxes. For further information about our borrowings, refer to note 17 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” Capital resources and financing activities Regulated insurance subsidiaries Our current capital resource plans do not include any additional debt offerings or minority sales of Enact Holdings. The availability of additional capital resources will depend on a variety of factors such as market Insurance laws and regulations regulate the payment of dividends and other distributions to us by our insurance subsidiaries. See note 22 in our consolidated financial statements under “Item 8—Financial Statements 122 123 authorization of an additional $100 million of common stock repurchases under a new share repurchase program. Genworth Holdings agreed to participate in order to maintain its overall ownership at its current level. As the majority shareholder, Genworth Holdings received $245 million of capital returns from Enact Holdings in 2023, comprised of quarterly dividends, a special dividend and share repurchases. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Enact Holdings’ stock price and trading volume, and general business and market conditions, among other factors. On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial could repurchase up to $350 million of its outstanding Class A common stock. On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under its existing share repurchase program. Pursuant to the program, during 2023, Genworth Financial repurchased 51,739,098 shares of its common stock at an average price of $5.70 per share for a total of $295 million, excluding excise taxes and other associated costs. In 2024, Genworth Financial also repurchased 4,197,740 shares of its common stock through February 13, 2024 for approximately $25 million, leaving approximately $316 million remaining authorization under the share repurchase program. Further repurchases under the program will continue to be funded from holding company capital, as well as future cash flow generation, including expected future capital returns from Enact Holdings. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions, or by other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time. Our future use of liquidity and capital will prioritize future strategic investments in CareScout and returning capital to Genworth Financial’s shareholders through share repurchases. We expect to continue to provide capital to CareScout to help advance our senior care growth initiatives related to the needs of elderly Americans, as well as their caregivers and families. We may also from time to time seek to repurchase or redeem outstanding debt (with cash on hand, proceeds from the issuance of new debt and/or the proceeds from asset or stock sales) in open market purchases, tender offers, privately negotiated transactions or otherwise. Genworth Holdings had $350 million and $307 million of unrestricted cash and cash equivalents as of December 31, 2023 and 2022, respectively. The increase was principally driven by capital returns from Enact Holdings and intercompany cash tax payments received from Genworth Holdings’ subsidiaries, partially offset by Genworth Financial’s common stock repurchases and debt interest payments in 2023. We believe Genworth Holdings’ unrestricted cash and cash equivalents provide sufficient liquidity to meet its financial obligations over the next twelve months. However, in the third quarter of 2023, we made a federal tax payment based on our projection of current taxable income and utilization of our remaining foreign tax credits, and we expect the amount of intercompany cash tax payments retained by Genworth Holdings from its subsidiaries to be lower starting in 2024 as compared to the amounts received during 2022 and 2023. We also expect Genworth Holdings’ liquidity to continue to be significantly impacted by the amounts and timing of Genworth Financial’s share repurchases as well as future dividends and other forms of capital returns from Enact Holdings. We actively monitor our liquidity position (most notably at Genworth Holdings), liquidity generation options and the credit markets given changing market conditions. Genworth Holdings’ cash management target is to maintain a cash buffer of two times expected annual external debt interest payments. Genworth Holdings may move below or above this targeted cash buffer during any given quarter due to the timing of cash outflows and inflows or from future actions. Management of Genworth Financial continues to evaluate Genworth Holdings’ target level of liquidity as circumstances warrant. conditions, regulatory considerations, the general availability of credit, credit ratings and the performance of and outlook for Enact Holdings and the payment of dividends and other returns of capital therefrom. For a discussion of certain risks associated with our liquidity and dependency on dividends paid by Enact Holdings, see “Item 1A—Risk Factors—Genworth Financial and Genworth Holdings depend on the ability of Enact Holdings and its subsidiaries to pay dividends and make other payments and distributions to each of them and to meet their obligations,” and “Item 1A—Risk Factors—Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms.” These risks may be exacerbated by the economic impact of current elevated interest rates and overall housing trends. During 2023 and 2022, Genworth Holdings repurchased $32 million and $143 million, respectively, principal amount of its debt, and in 2022, early redeemed $152 million of its 4.80% senior notes originally scheduled to mature in February 2024. As of December 31, 2023, Genworth Holdings had $856 million principal of outstanding debt, with no maturities due until June 2034. On October 25, 2023, Genworth Holdings completed a consent solicitation from bondholders representing a majority in principal amount of its 6.50% senior notes due in 2034 (“2034 Notes”) to amend the Replacement Capital Covenant, dated as of November 14, 2006. The amendment permits Genworth Holdings to repay, redeem or repurchase $2,000 principal amount of its floating rate junior subordinated notes due in 2066 (“2066 Notes”) for each $1,000 principal amount of its 2034 Notes repaid, redeemed or repurchased. In December 2022, the Board of Governors of the Federal Reserve System adopted a final rule that established benchmark rates, based on the Secured Overnight Financing Rate (“SOFR”), that replaced the London Interbank Offered Rate (“LIBOR”) after its elimination on June 30, 2023. Pursuant to the final rule, Genworth Holdings’ 2066 Notes, which had an annual interest rate equal to three-month LIBOR plus 2.0025%, transitioned in the third quarter of 2023 to an annual interest rate equal to the three-month Term SOFR Reference Rate, plus a tenor spread adjustment of 0.26161%, plus an additional spread of 2.0025%. We do not expect this change to have a material impact on our results of operations or liquidity. In addition, given the reduction in Genworth Holdings’ debt and corresponding decrease in debt service costs, we do not expect a significant impact on our liquidity from the rise in interest rates in 2022 and 2023. On June 30, 2022, Enact Holdings entered into a credit agreement with a syndicate of lenders that provides for a five-year unsecured revolving credit facility in the initial aggregate principal amount of $200 million, including the ability for Enact Holdings to increase the commitments under the credit facility on an uncommitted basis, by an additional aggregate principal amount of up to $100 million. As of December 31, 2023, Enact Holdings was in compliance with all covenants and the credit facility remained undrawn. Enact Holdings also has $750 million principal amount of senior notes due in August 2025. Enact Holdings continually evaluates opportunities based upon market conditions to further increase its financial flexibility including through raising additional capital, restructuring or refinancing some or all of its outstanding debt or pursuing other options such as reinsurance or credit risk transfer transactions. There can be no guarantee that any such opportunities will be available on favorable terms or at all. Other than its senior notes due in August 2025, Enact Holdings has no material outstanding debt obligations that are expected to affect its liquidity over the next five years. We believe that the operating cash flows generated by Enact Holdings’ mortgage insurance subsidiaries will provide the funds necessary to satisfy its claim payments, operating expenses and taxes. For further information about our borrowings, refer to note 17 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” Capital resources and financing activities Regulated insurance subsidiaries Our current capital resource plans do not include any additional debt offerings or minority sales of Enact Holdings. The availability of additional capital resources will depend on a variety of factors such as market Insurance laws and regulations regulate the payment of dividends and other distributions to us by our insurance subsidiaries. See note 22 in our consolidated financial statements under “Item 8—Financial Statements 122 123 Genworth Holdings provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies in-force prior to the sale date and those written approximately 90 days subsequent to the date of the sale, and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. As of December 31, 2023, the risk in-force of active policies was approximately $893 million. Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding senior and subordinated notes and their respective indentures. Genworth Financial and certain of its holding company subsidiaries also provide guarantees to third parties for the performance of certain obligations of their subsidiaries. We estimate that our potential obligations under such guarantees were $67 million and $69 million as of December 31, 2023 and 2022, respectively. As of December 31, 2023, we were committed to fund $1,530 million in limited partnership investments, $117 million of bank loan investments, $42 million in private placement investments and $13 million in commercial mortgage loan investments. Supplemental Condensed Consolidating Financial Information As discussed above in “—Liquidity and Capital Resources,” Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes (registered securities under the Securities Act of 1933). Genworth Holdings is a direct, 100% owned subsidiary of Genworth Financial. Excluding investments in subsidiaries, the assets, liabilities and results of operations of Genworth Financial and Genworth Holdings, on a combined basis, are not material to the consolidated financial position or the consolidated results of operations of Genworth. In addition, none of Genworth Financial’s direct or indirect subsidiaries, other than Genworth Holdings, are issuers or guarantors of any guaranteed securities. Therefore, in accordance with Rule 13-01 of Regulation S-X, we are permitted, and we elected, to exclude the summarized financial information for both the issuer and guarantor of the registered securities. and Supplementary Data” for additional information regarding the payment of dividends. In general, dividends are required to be submitted to an insurer’s domiciliary department of insurance for review, and distributions from sources other than unassigned surplus require affirmative approval before being paid. Based on estimated statutory results as of December 31, 2023, in accordance with applicable dividend restrictions, Enact Holdings’ U.S. mortgage insurance subsidiaries could pay dividends from unassigned surplus of approximately $336 million in 2024 without affirmative regulatory approval. However, Enact Holdings may choose not to pay dividends in 2024 at this level as it may retain capital for future growth or to meet regulatory or other capital requirements. The liquidity requirements of our regulated insurance subsidiaries principally relate to the liabilities associated with their various insurance and investment products, operating costs and expenses, the payment of dividends to us, contributions to their subsidiaries, payments of principal and interest on their outstanding debt obligations and income taxes. Given the challenging macroeconomic environment in 2022 and 2023, employee costs were higher driven in part by wage inflation, the competitive labor market and low labor participation. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care principally attributable to elevated inflation. These inflationary pressures have not had a significant impact on our liquidity to date; however, if these conditions persist for a long period of time, they could have a material adverse impact on our liquidity, results of operations and financial condition. We will continue to monitor macroeconomic trends, including inflation, to help mitigate any potential adverse impacts to our liquidity. Liabilities arising from insurance and investment products include the payment of benefits and claims, as well as cash payments in connection with policy surrenders and withdrawals, policy loans and obligations to redeem funding agreements. For long-duration coverage products, we generally anticipate a significant amount of claim payments will come due in five or more years from the date of our Annual Report on Form 10-K. For information on discounted and undiscounted expected future benefit payments, see note 10 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Our projected payments are principally associated with our long-term care insurance products, for which we expect overall claim costs to continue to increase as the insured individuals in our two largest blocks approach their peak claim years, which are over a decade away. Actual claims on products that provide long-duration coverage typically emerge over many years, change over time and are difficult to accurately predict. Therefore, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of payments. Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits without forced sales of investments. Products having liabilities with longer durations, such as certain life insurance and long-term care insurance policies, are typically matched with investments having similar duration such as long-term fixed maturity securities and commercial mortgage loans. Shorter-term liabilities are typically matched with fixed maturity securities that have short- and medium-term fixed maturities. In addition, our insurance subsidiaries hold highly liquid, high quality short-term investment securities and other liquid investment grade fixed maturity securities to fund anticipated operating expenses, surrenders and withdrawals. As of December 31, 2023, our total cash, cash equivalents and invested assets were $62.0 billion. Our investments in privately placed fixed maturity securities, commercial mortgage loans, policy loans, bank loans, limited partnership investments and select mortgage-backed and asset-backed securities are relatively illiquid. These asset classes represented approximately 44% of the carrying value of our total cash, cash equivalents and invested assets as of December 31, 2023. Guarantees and other off-balance sheet commitments Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations. 124 125 Genworth Holdings provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies in-force prior to the sale date and those written approximately 90 days subsequent to the date of the sale, and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. As of December 31, 2023, the risk in-force of active policies was approximately $893 million. Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding senior and subordinated notes and their respective indentures. Genworth Financial and certain of its holding company subsidiaries also provide guarantees to third parties for the performance of certain obligations of their subsidiaries. We estimate that our potential obligations under such guarantees were $67 million and $69 million as of December 31, 2023 and 2022, respectively. As of December 31, 2023, we were committed to fund $1,530 million in limited partnership investments, $117 million of bank loan investments, $42 million in private placement investments and $13 million in commercial mortgage loan investments. Supplemental Condensed Consolidating Financial Information As discussed above in “—Liquidity and Capital Resources,” Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes (registered securities under the Securities Act of 1933). Genworth Holdings is a direct, 100% owned subsidiary of Genworth Financial. Excluding investments in subsidiaries, the assets, liabilities and results of operations of Genworth Financial and Genworth Holdings, on a combined basis, are not material to the consolidated financial position or the consolidated results of operations of Genworth. In addition, none of Genworth Financial’s direct or indirect subsidiaries, other than Genworth Holdings, are issuers or guarantors of any guaranteed securities. Therefore, in accordance with Rule 13-01 of Regulation S-X, we are permitted, and we elected, to exclude the summarized financial information for both the issuer and guarantor of the registered securities. and Supplementary Data” for additional information regarding the payment of dividends. In general, dividends are required to be submitted to an insurer’s domiciliary department of insurance for review, and distributions from sources other than unassigned surplus require affirmative approval before being paid. Based on estimated statutory results as of December 31, 2023, in accordance with applicable dividend restrictions, Enact Holdings’ U.S. mortgage insurance subsidiaries could pay dividends from unassigned surplus of approximately $336 million in 2024 without affirmative regulatory approval. However, Enact Holdings may choose not to pay dividends in 2024 at this level as it may retain capital for future growth or to meet regulatory or other capital requirements. The liquidity requirements of our regulated insurance subsidiaries principally relate to the liabilities associated with their various insurance and investment products, operating costs and expenses, the payment of dividends to us, contributions to their subsidiaries, payments of principal and interest on their outstanding debt obligations and income taxes. Given the challenging macroeconomic environment in 2022 and 2023, employee costs were higher driven in part by wage inflation, the competitive labor market and low labor participation. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care principally attributable to elevated inflation. These inflationary pressures have not had a significant impact on our liquidity to date; however, if these conditions persist for a long period of time, they could have a material adverse impact on our liquidity, results of operations and financial condition. We will continue to monitor macroeconomic trends, including inflation, to help mitigate any potential adverse impacts to our liquidity. Liabilities arising from insurance and investment products include the payment of benefits and claims, as well as cash payments in connection with policy surrenders and withdrawals, policy loans and obligations to redeem funding agreements. For long-duration coverage products, we generally anticipate a significant amount of claim payments will come due in five or more years from the date of our Annual Report on Form 10-K. For information on discounted and undiscounted expected future benefit payments, see note 10 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Our projected payments are principally associated with our long-term care insurance products, for which we expect overall claim costs to continue to increase as the insured individuals in our two largest blocks approach their peak claim years, which are over a decade away. Actual claims on products that provide long-duration coverage typically emerge over many years, change over time and are difficult to accurately predict. Therefore, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of payments. Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits without forced sales of investments. Products having liabilities with longer durations, such as certain life insurance and long-term care insurance policies, are typically matched with investments having similar duration such as long-term fixed maturity securities and commercial mortgage loans. Shorter-term liabilities are typically matched with fixed maturity securities that have short- and medium-term fixed maturities. In addition, our insurance subsidiaries hold highly liquid, high quality short-term investment securities and other liquid investment grade fixed maturity securities to fund anticipated operating expenses, surrenders and withdrawals. As of December 31, 2023, our total cash, cash equivalents and invested assets were $62.0 billion. Our investments in privately placed fixed maturity securities, commercial mortgage loans, policy loans, bank loans, limited partnership investments and select mortgage-backed and asset-backed securities are relatively illiquid. These asset classes represented approximately 44% of the carrying value of our total cash, cash equivalents and invested assets as of December 31, 2023. Guarantees and other off-balance sheet commitments Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations. 124 125 Item 7A. Quantitative and Qualitative Disclosures About Market Risk Equity Market Risk Market risk is the risk of the loss of fair value resulting from adverse changes in market rates and prices, such as interest rates, equity prices and foreign currency exchange rates. Market risk is directly influenced by the volatility and liquidity in the markets in which the related underlying financial instruments are traded. While we enter into derivatives to mitigate certain market risks, our agreements with futures commission merchants and derivative counterparties require that we provide securities for initial margin to future commission merchants and securities as collateral to our derivative counterparties to reflect changes in the fair value of our derivatives. We may hold more high-quality securities to ensure we have sufficient collateral to post to derivative counterparties or futures commission merchants in the event of adverse changes in the fair value of our derivative instruments. If we do not have sufficient high-quality securities to provide as collateral, we may need to sell certain other securities to purchase assets that would be eligible for collateral posting, which could adversely impact our future investment income. Interest Rate Risk We enter into market-sensitive instruments primarily for purposes other than trading. The carrying value of our investment portfolio as of December 31, 2023 and 2022 was $59.8 billion and $58.9 billion, of which 78% and 79%, respectively, was invested in fixed maturity securities. The primary market risk to our investment portfolio is interest rate risk associated with investments in fixed maturity securities. During periods of increasing interest rates, market values of lower-yielding assets will decline resulting in unrealized losses on our investment portfolio. In addition, the value of our interest rate hedges will decline during periods of increasing interest rates, requiring us to post/return additional collateral with our derivative counterparties, which could add additional strain to our short-term liquidity. For additional information on interest rate risks associated with our insurance and investment contract liabilities, see “Item 1A—Risk Factors—Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability.” Interest rate fluctuations could also have an adverse effect on the results of our investment portfolio. During periods of declining market interest rates, the interest we receive on variable interest rate investments decreases. In addition, during those periods, we reinvest the cash we receive as interest or return of principal on our investments in lower-yielding high-grade instruments or in lower-credit instruments to maintain comparable returns. Issuers of fixed-income securities or borrowers to our commercial mortgage loans may also decide to prepay their obligations in order to borrow at lower market rates, which exacerbates the risk that we may have to invest the cash proceeds of these securities in lower-yielding or lower-credit instruments. The primary market risk for our long-term borrowings is interest rate risk at the time of maturity or early redemption, when we may be required to refinance these obligations. As of December 31, 2023, Genworth Holdings had outstanding principal of $856 million of long-term debt, with no debt maturities until June 2034, and Enact Holdings had outstanding principal of $750 million of long-term debt due in August 2025. We continue to monitor the interest rate environment and other market influences to evaluate repurchasing Genworth Holdings’ debt prior to maturity. While we are exposed to interest rate risk from Genworth Holdings’ 2066 Notes, we attempt to mitigate the interest rate risk by investing in variable rate assets that back this obligation. We use derivative instruments, such as interest rate swaps, financial futures and option-based financial instruments, as part of our risk management strategy. We use these derivatives to mitigate certain interest rate risk by reducing the risk between the timing of the receipt of cash and its investment in the market and better aligning the duration of assets with the duration of the liabilities. Our exposure to equity market risk within our insurance companies primarily relates to variable annuities and life insurance products and certain equity linked products. Certain fixed and variable annuity products have market risk benefits that expose us to equity market risk if the performance of the underlying investments in the contractholder accounts experiences downturns or volatility for an extended period of time. Additionally, continued equity market volatility could result in additional losses in our variable annuity products and associated hedging program which could lead to increased hedging costs. We are exposed to equity market risk on our holdings of equity securities. We manage equity price risk through industry and issuer diversification, asset allocation techniques and hedging strategies. We also hold limited partnership investments accounted for using net asset value per share (or its equivalent) as a practical expedient to fair value primarily concentrated in private equity investments that are subject to private market exposures and have been excluded from this discussion. Equity exposures associated with limited partnership investments accounted for under the equity method of accounting are excluded from this discussion as they are not considered financial instruments in accordance with U.S. GAAP. We use derivative instruments, such as financial futures and option-based financial instruments, as part of our risk management strategy. We use these derivatives to mitigate equity risk by reducing our exposure to fluctuations in equity market indices that underlie some of our products. Sensitivity Analysis Sensitivity analysis measures the impact of hypothetical changes in interest rates and other market rates or prices on the profitability of market-sensitive financial instruments. The following discussion about the potential effects of changes in interest rates and equity market prices is based on so-called “shock-tests,” which model the effects of interest rate and equity market price shifts on our financial condition and results of operations. Although we believe shock-tests provide the most meaningful analysis permitted by the rules and regulations of the SEC, they are constrained by several factors, including the necessity to conduct the analysis based on a single point in time and by their inability to include the extraordinarily complex market reactions that normally would arise from the market shifts modeled. Although the following results of shock-tests for changes in interest rates and equity market prices may have some limited use as benchmarks, they should not be viewed as forecasts. These forward-looking disclosures also are selective in nature and address only the potential impacts on our financial instruments. In addition, this sensitivity analysis does not include a variety of other potential factors that could affect our business as a result of these changes in interest rates and equity market prices. Interest Rate Risk One means of assessing exposure to interest rate changes is a duration-based analysis that measures the potential changes in fair value resulting from a hypothetical change in interest rates of 100 basis points across all maturities. This is referred to as a parallel shift in the yield curve. Note that all impacts noted below exclude any effects of deferred taxes unless otherwise noted. Under this model, with all other factors constant and assuming no offsetting change in the value of our liabilities, we estimated that such an increase in interest rates would cause the fair value of our fixed maturity securities to decrease by approximately $3.1 billion based on the fair value of our fixed maturity securities as of December 31, 2023, as compared to an estimated decrease of $3.2 billion under this model as of December 31, 2022. As a matter of policy, we have not and will not engage in derivative market-making, speculative derivative trading or other speculative derivative activities. We performed a similar sensitivity analysis on our derivatives portfolio and noted that a 100 basis point increase in interest rates resulted in a decrease in fair value of $655 million based on our derivatives portfolio as 126 127 Item 7A. Quantitative and Qualitative Disclosures About Market Risk Equity Market Risk Market risk is the risk of the loss of fair value resulting from adverse changes in market rates and prices, such as interest rates, equity prices and foreign currency exchange rates. Market risk is directly influenced by the volatility and liquidity in the markets in which the related underlying financial instruments are traded. While we enter into derivatives to mitigate certain market risks, our agreements with futures commission merchants and derivative counterparties require that we provide securities for initial margin to future commission merchants and securities as collateral to our derivative counterparties to reflect changes in the fair value of our derivatives. We may hold more high-quality securities to ensure we have sufficient collateral to post to derivative counterparties or futures commission merchants in the event of adverse changes in the fair value of our derivative instruments. If we do not have sufficient high-quality securities to provide as collateral, we may need to sell certain other securities to purchase assets that would be eligible for collateral posting, which could adversely impact our future investment income. Interest Rate Risk We enter into market-sensitive instruments primarily for purposes other than trading. The carrying value of our investment portfolio as of December 31, 2023 and 2022 was $59.8 billion and $58.9 billion, of which 78% and 79%, respectively, was invested in fixed maturity securities. The primary market risk to our investment portfolio is interest rate risk associated with investments in fixed maturity securities. During periods of increasing interest rates, market values of lower-yielding assets will decline resulting in unrealized losses on our investment portfolio. In addition, the value of our interest rate hedges will decline during periods of increasing interest rates, requiring us to post/return additional collateral with our derivative counterparties, which could add additional strain to our short-term liquidity. For additional information on interest rate risks associated with our insurance and investment contract liabilities, see “Item 1A—Risk Factors—Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability.” Interest rate fluctuations could also have an adverse effect on the results of our investment portfolio. During periods of declining market interest rates, the interest we receive on variable interest rate investments decreases. In addition, during those periods, we reinvest the cash we receive as interest or return of principal on our investments in lower-yielding high-grade instruments or in lower-credit instruments to maintain comparable returns. Issuers of fixed-income securities or borrowers to our commercial mortgage loans may also decide to prepay their obligations in order to borrow at lower market rates, which exacerbates the risk that we may have to invest the cash proceeds of these securities in lower-yielding or lower-credit instruments. The primary market risk for our long-term borrowings is interest rate risk at the time of maturity or early redemption, when we may be required to refinance these obligations. As of December 31, 2023, Genworth Holdings had outstanding principal of $856 million of long-term debt, with no debt maturities until June 2034, and Enact Holdings had outstanding principal of $750 million of long-term debt due in August 2025. We continue to monitor the interest rate environment and other market influences to evaluate repurchasing Genworth Holdings’ debt prior to maturity. While we are exposed to interest rate risk from Genworth Holdings’ 2066 Notes, we attempt to mitigate the interest rate risk by investing in variable rate assets that back this obligation. We use derivative instruments, such as interest rate swaps, financial futures and option-based financial instruments, as part of our risk management strategy. We use these derivatives to mitigate certain interest rate risk by reducing the risk between the timing of the receipt of cash and its investment in the market and better aligning the duration of assets with the duration of the liabilities. Our exposure to equity market risk within our insurance companies primarily relates to variable annuities and life insurance products and certain equity linked products. Certain fixed and variable annuity products have market risk benefits that expose us to equity market risk if the performance of the underlying investments in the contractholder accounts experiences downturns or volatility for an extended period of time. Additionally, continued equity market volatility could result in additional losses in our variable annuity products and associated hedging program which could lead to increased hedging costs. We are exposed to equity market risk on our holdings of equity securities. We manage equity price risk through industry and issuer diversification, asset allocation techniques and hedging strategies. We also hold limited partnership investments accounted for using net asset value per share (or its equivalent) as a practical expedient to fair value primarily concentrated in private equity investments that are subject to private market exposures and have been excluded from this discussion. Equity exposures associated with limited partnership investments accounted for under the equity method of accounting are excluded from this discussion as they are not considered financial instruments in accordance with U.S. GAAP. We use derivative instruments, such as financial futures and option-based financial instruments, as part of our risk management strategy. We use these derivatives to mitigate equity risk by reducing our exposure to fluctuations in equity market indices that underlie some of our products. Sensitivity Analysis Sensitivity analysis measures the impact of hypothetical changes in interest rates and other market rates or prices on the profitability of market-sensitive financial instruments. The following discussion about the potential effects of changes in interest rates and equity market prices is based on so-called “shock-tests,” which model the effects of interest rate and equity market price shifts on our financial condition and results of operations. Although we believe shock-tests provide the most meaningful analysis permitted by the rules and regulations of the SEC, they are constrained by several factors, including the necessity to conduct the analysis based on a single point in time and by their inability to include the extraordinarily complex market reactions that normally would arise from the market shifts modeled. Although the following results of shock-tests for changes in interest rates and equity market prices may have some limited use as benchmarks, they should not be viewed as forecasts. These forward-looking disclosures also are selective in nature and address only the potential impacts on our financial instruments. In addition, this sensitivity analysis does not include a variety of other potential factors that could affect our business as a result of these changes in interest rates and equity market prices. Interest Rate Risk One means of assessing exposure to interest rate changes is a duration-based analysis that measures the potential changes in fair value resulting from a hypothetical change in interest rates of 100 basis points across all maturities. This is referred to as a parallel shift in the yield curve. Note that all impacts noted below exclude any effects of deferred taxes unless otherwise noted. Under this model, with all other factors constant and assuming no offsetting change in the value of our liabilities, we estimated that such an increase in interest rates would cause the fair value of our fixed maturity securities to decrease by approximately $3.1 billion based on the fair value of our fixed maturity securities as of December 31, 2023, as compared to an estimated decrease of $3.2 billion under this model as of December 31, 2022. As a matter of policy, we have not and will not engage in derivative market-making, speculative derivative trading or other speculative derivative activities. We performed a similar sensitivity analysis on our derivatives portfolio and noted that a 100 basis point increase in interest rates resulted in a decrease in fair value of $655 million based on our derivatives portfolio as 126 127 of December 31, 2023, as compared to an estimated decline of $496 million under this model as of December 31, 2022. The estimated decrease in fair value of our derivatives portfolio would also require us to post collateral to certain derivative counterparties of $590 million and would require us to post cash margin related to our cleared swaps and futures contracts of $129 million based on our derivatives portfolio as of December 31, 2023. Of the $655 million estimated decrease in fair value of our derivatives portfolio as of December 31, 2023, $65 million related to non-qualified derivatives used to mitigate interest rate risk associated with our variable annuity market risk benefits. We also performed a similar sensitivity analysis on our variable annuity market risk benefits and noted that a 100 basis point increase in interest rates, with all other factors held constant, would result in a decrease in the fair value of the net liability after reinsurance of approximately $100 million as of December 31, 2023, as compared to a decrease of $120 million as of December 31, 2022. Genworth Holdings’ variable interest rate debt is comprised of junior subordinated notes due in November 2066. In the third quarter of 2023, Genworth Holdings’ 2066 Notes transitioned from an annual interest rate equal to the three-month LIBOR plus 2.0025% to the three-month Term SOFR Reference Rate, plus a tenor spread adjustment of 0.26161%, plus an additional spread of 2.0025%. See note 17 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information. The principal amount, weighted-average interest rate and fair value of Genworth Holdings’ 2066 Notes were as follows as of December 31: (Dollar amounts in millions) 2023 2022 Principal amount . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Weighted-average interest rate . . . . . . . . . . . . . . . . . . . . . . . . . . . Fair value (1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 600 $593 7.27% 3.81% $443 $ 378 (1) The fair value methodology is based on the then-current coupon, revalued based on the three-month Term SOFR Reference Rate or LIBOR, as applicable, set and commercially available data using the current spread assumption. The model is a floating rate coupon model using the risk premium or spread assumption to derive the valuation. Equity Market Risk One means of assessing exposure to changes in equity market prices is to estimate the potential changes in market values on our equity investments resulting from a hypothetical broad-based decline in equity market prices of 10%. Under this model, with all other factors constant, we estimated that such a decline in equity market prices would cause the fair value of our equity investments to decline by approximately $35 million based on our equity positions as of December 31, 2023, as compared to an estimated decline of $26 million under this model as of December 31, 2022. We performed a similar sensitivity analysis on our equity market derivatives and noted that a 10% decline in equity market prices would result in an increase in fair value of $51 million and $54 million based on our equity market derivatives as of December 31, 2023 and 2022, respectively. The estimated increase in fair value primarily relates to non-qualified derivatives used to mitigate equity market risk associated with our variable annuity and fixed indexed annuity liabilities. We also performed a similar sensitivity analysis on our variable annuity market risk benefits and noted that a 10% broad-based decline in equity market prices, with all other factors held constant, would result in an increase in the fair value of the net liability after reinsurance of approximately $70 million as of December 31, 2023, as compared to an increase of approximately $80 million as of December 31, 2022. 128 129 Item 8. Financial Statements and Supplementary Data Genworth Financial, Inc. Index to Consolidated Financial Statements Annual Financial Statements: Report of Independent Registered Public Accounting Firm (KPMG LLP, Richmond, VA, Auditor Firm ID: 185) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130 Financial Statements as of December 31, 2023 and 2022 and for the years ended December 31, 2023, 2022 and 2021: Consolidated Balance Sheets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consolidated Statements of Income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consolidated Statements of Comprehensive Income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consolidated Statements of Changes in Equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consolidated Statements of Cash Flows . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Notes to Consolidated Financial Statements: Note 1 – Nature of Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 2 – Summary of Significant Accounting Policies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 3 – Long-Duration Insurance Contracts Targeted Improvements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 4 – Earnings Per Share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 5 – Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 6 – Derivative Instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 7 – Deferred Acquisition Costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 8 – Intangible Assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 9 – Reinsurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 10 – Future Policy Benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 11 – Policyholder Account Balances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 12 – Additional Insurance Liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 13 – Market Risk Benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 14 – Separate Accounts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 15 – Liability for Policy and Contract Claims . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 16 – Employee Benefit Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 17 – Borrowings and Other Financings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 18 – Income Taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 19 – Supplemental Cash Flow Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 20 – Long-Term Incentive Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 21 – Fair Value of Financial Instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 22 – Insurance Subsidiary Financial Information and Regulatory Matters . . . . . . . . . . . . . . . . . . . . . . . Note 23 – Segment Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 24 – Quarterly Results of Operations (unaudited) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 25 – Commitments and Contingencies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 26 – Changes in Accumulated Other Comprehensive Income (Loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 27 – Noncontrolling Interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 28 – Discontinued Operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Financial Statement Schedules as of December 31, 2023 and 2022 and for the years ended December 31, 2023, 2022 and 2021: Schedule I, Summary of Investments-Other Than Investments in Related Parties . . . . . . . . . . . . . . . . . . . . . Schedule II, Financial Statements of Genworth Financial, Inc. (Parent Only) . . . . . . . . . . . . . . . . . . . . . . . . . Schedule III, Supplemental Insurance Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Page 134 135 136 137 138 139 140 160 165 166 180 185 186 187 191 198 201 202 206 206 209 211 214 217 217 221 241 246 254 257 261 263 265 267 268 275 of December 31, 2023, as compared to an estimated decline of $496 million under this model as of December 31, 2022. The estimated decrease in fair value of our derivatives portfolio would also require us to post collateral to certain derivative counterparties of $590 million and would require us to post cash margin related to our cleared swaps and futures contracts of $129 million based on our derivatives portfolio as of December 31, 2023. Of the $655 million estimated decrease in fair value of our derivatives portfolio as of December 31, 2023, $65 million related to non-qualified derivatives used to mitigate interest rate risk associated with our variable annuity market risk benefits. We also performed a similar sensitivity analysis on our variable annuity market risk benefits and noted that a 100 basis point increase in interest rates, with all other factors held constant, would result in a decrease in the fair value of the net liability after reinsurance of approximately $100 million as of December 31, 2023, as compared to a decrease of $120 million as of December 31, 2022. Genworth Holdings’ variable interest rate debt is comprised of junior subordinated notes due in November 2066. In the third quarter of 2023, Genworth Holdings’ 2066 Notes transitioned from an annual interest rate equal to the three-month LIBOR plus 2.0025% to the three-month Term SOFR Reference Rate, plus a tenor spread adjustment of 0.26161%, plus an additional spread of 2.0025%. See note 17 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information. The principal amount, weighted-average interest rate and fair value of Genworth Holdings’ 2066 Notes were as follows as of December 31: (Dollar amounts in millions) 2023 2022 Principal amount . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $593 $ 600 Weighted-average interest rate . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.27% 3.81% Fair value (1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $443 $ 378 (1) The fair value methodology is based on the then-current coupon, revalued based on the three-month Term SOFR Reference Rate or LIBOR, as applicable, set and commercially available data using the current spread assumption. The model is a floating rate coupon model using the risk premium or spread assumption to derive the valuation. Equity Market Risk One means of assessing exposure to changes in equity market prices is to estimate the potential changes in market values on our equity investments resulting from a hypothetical broad-based decline in equity market prices of 10%. Under this model, with all other factors constant, we estimated that such a decline in equity market prices would cause the fair value of our equity investments to decline by approximately $35 million based on our equity positions as of December 31, 2023, as compared to an estimated decline of $26 million under this model as of December 31, 2022. We performed a similar sensitivity analysis on our equity market derivatives and noted that a 10% decline in equity market prices would result in an increase in fair value of $51 million and $54 million based on our equity market derivatives as of December 31, 2023 and 2022, respectively. The estimated increase in fair value primarily relates to non-qualified derivatives used to mitigate equity market risk associated with our variable annuity and fixed indexed annuity liabilities. We also performed a similar sensitivity analysis on our variable annuity market risk benefits and noted that a 10% broad-based decline in equity market prices, with all other factors held constant, would result in an increase in the fair value of the net liability after reinsurance of approximately $70 million as of December 31, 2023, as compared to an increase of approximately $80 million as of December 31, 2022. Item 8. Financial Statements and Supplementary Data Genworth Financial, Inc. Index to Consolidated Financial Statements Page Annual Financial Statements: Report of Independent Registered Public Accounting Firm (KPMG LLP, Richmond, VA, Auditor Firm ID: 185) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Financial Statements as of December 31, 2023 and 2022 and for the years ended December 31, 2023, 2022 130 and 2021: Consolidated Balance Sheets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consolidated Statements of Income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consolidated Statements of Comprehensive Income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consolidated Statements of Changes in Equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consolidated Statements of Cash Flows . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Notes to Consolidated Financial Statements: Note 1 – Nature of Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 2 – Summary of Significant Accounting Policies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 3 – Long-Duration Insurance Contracts Targeted Improvements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 4 – Earnings Per Share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 5 – Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 6 – Derivative Instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 7 – Deferred Acquisition Costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 8 – Intangible Assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 9 – Reinsurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 10 – Future Policy Benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 11 – Policyholder Account Balances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 12 – Additional Insurance Liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 13 – Market Risk Benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 14 – Separate Accounts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 15 – Liability for Policy and Contract Claims . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 16 – Employee Benefit Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 17 – Borrowings and Other Financings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 18 – Income Taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 19 – Supplemental Cash Flow Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 20 – Long-Term Incentive Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 21 – Fair Value of Financial Instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 22 – Insurance Subsidiary Financial Information and Regulatory Matters . . . . . . . . . . . . . . . . . . . . . . . Note 23 – Segment Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 24 – Quarterly Results of Operations (unaudited) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 25 – Commitments and Contingencies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 26 – Changes in Accumulated Other Comprehensive Income (Loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 27 – Noncontrolling Interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Note 28 – Discontinued Operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Financial Statement Schedules as of December 31, 2023 and 2022 and for the years ended December 31, 2023, 2022 and 2021: 134 135 136 137 138 139 140 160 165 166 180 185 186 187 191 198 201 202 206 206 209 211 214 217 217 221 241 246 254 257 261 263 265 Schedule I, Summary of Investments-Other Than Investments in Related Parties . . . . . . . . . . . . . . . . . . . . . Schedule II, Financial Statements of Genworth Financial, Inc. (Parent Only) . . . . . . . . . . . . . . . . . . . . . . . . . Schedule III, Supplemental Insurance Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 267 268 275 128 129 Report of Independent Registered Public Accounting Firm Liability for future policy benefits for long-term care insurance and life insurance To the Stockholders and Board of Directors Genworth Financial, Inc.: Opinion on the Consolidated Financial Statements We have audited the accompanying consolidated balance sheets of Genworth Financial, Inc. and subsidiaries (the Company) as of December 31, 2023 and 2022, the related consolidated statements of income, comprehensive income, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2023, and the related notes and financial statement schedules I to III (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles. We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 29, 2024 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting. Change in Accounting Principle As discussed in Note 2 to the consolidated financial statements, the Company adopted ASU 2018-12, Targeted Improvements to the Accounting for Long Duration Contracts (LDTI), effective January 1, 2023, with a transition date of January 1, 2021. Basis for Opinion These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. Critical Audit Matters The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate. As discussed in Notes 2 and 10 to the consolidated financial statements, the liability for future policy benefits is equal to the present value of expected future benefits and claim-related expenses, less the present value of expected future net premiums. Cash flow assumptions, as applicable, used to estimate the liability for future policy benefits include health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates), and estimates of future in-force rate actions, which include premium rate increases and benefit reductions associated with long-term care insurance. Estimates of future in-force rate actions include those that are approved or anticipated to be approved, including premium rate increases and associated benefit reductions not yet filed. The Company’s liability for future policy benefits was $57,655 million as of December 31, 2023, of which $43,929 million related to long-term care insurance and $1,698 million related to life insurance. We identified the evaluation of assumptions used in estimating the liability for future policy benefits for long-term care insurance (future in-force rate actions and insured morbidity) and for life insurance (insured mortality and lapses), collectively the key assumptions, as a critical audit matter. Due to the extent of audit effort required for the measurement uncertainty, the evaluation of the key assumptions required especially subjective auditor judgment, and specialized skills and knowledge. The following are the primary procedures we performed to address this critical audit matter. With the assistance of actuarial professionals, we evaluated the design and tested the operating effectiveness of certain internal controls related to the Company’s liability for future policy benefits for long-term care insurance and life insurance. This included controls related to the development of the key assumptions. We also involved actuarial professionals with specialized skills and knowledge, who assisted in: • • • evaluating the actuarial methodologies and key assumptions used to estimate the liability for future policy benefits for long-term care insurance and life insurance for consistency with generally accepted actuarial methodologies and industry practice evaluating certain of the Company’s key assumptions by assessing them in comparison to the Company’s relevant historical experience data and industry data or qualitative factors, and the consistency of the assumptions with each other assessing the reasonableness of estimated future in-force rate action assumptions for long-term care insurance for a selection of estimated rate increases by a) comparing to the Company’s historical regulatory approvals and regulatory information and b) assessing the Company’s ability to achieve the estimated future in-force rate actions by reperforming the Company’s calculations and comparing to the requirements to request a rate action. Additional insurance liabilities for secondary guarantees for universal and term universal contracts As discussed in Notes 2, 11 and 12 to the consolidated financial statements, the additional insurance liabilities consist of secondary guarantees or product features in addition to the policyholder account balance on universal and term universal contracts. The additional insurance liability is equal to the sum of cumulative assessments multiplied by the current benefit ratio plus accrued interest, less excess payments. These additional benefit reserves are included in the liability for policyholder account balances in the consolidated balance sheets. The benefit ratio is equal to the present value of total expected benefit payments over the life of the contract divided by the present value of total expected assessments over the life of the contract, discounted by the projected crediting rate. The assumptions used to calculate the benefit ratio include insured mortality (i.e., life expectancy or longevity), interest rates and policyholder persistency or lapses, among other assumptions. The Company’s total policyholder account balances of $15,540 million as of December 31, 2023, included $2,887 million of additional insurance liabilities related to universal and term universal contracts. 130 131 Report of Independent Registered Public Accounting Firm Liability for future policy benefits for long-term care insurance and life insurance To the Stockholders and Board of Directors Genworth Financial, Inc.: Opinion on the Consolidated Financial Statements We have audited the accompanying consolidated balance sheets of Genworth Financial, Inc. and subsidiaries (the Company) as of December 31, 2023 and 2022, the related consolidated statements of income, comprehensive income, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2023, and the related notes and financial statement schedules I to III (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles. We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 29, 2024 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting. As discussed in Note 2 to the consolidated financial statements, the Company adopted ASU 2018-12, Targeted Improvements to the Accounting for Long Duration Contracts (LDTI), effective January 1, 2023, with a Change in Accounting Principle transition date of January 1, 2021. Basis for Opinion These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. Critical Audit Matters The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate. As discussed in Notes 2 and 10 to the consolidated financial statements, the liability for future policy benefits is equal to the present value of expected future benefits and claim-related expenses, less the present value of expected future net premiums. Cash flow assumptions, as applicable, used to estimate the liability for future policy benefits include health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates), and estimates of future in-force rate actions, which include premium rate increases and benefit reductions associated with long-term care insurance. Estimates of future in-force rate actions include those that are approved or anticipated to be approved, including premium rate increases and associated benefit reductions not yet filed. The Company’s liability for future policy benefits was $57,655 million as of December 31, 2023, of which $43,929 million related to long-term care insurance and $1,698 million related to life insurance. We identified the evaluation of assumptions used in estimating the liability for future policy benefits for long-term care insurance (future in-force rate actions and insured morbidity) and for life insurance (insured mortality and lapses), collectively the key assumptions, as a critical audit matter. Due to the extent of audit effort required for the measurement uncertainty, the evaluation of the key assumptions required especially subjective auditor judgment, and specialized skills and knowledge. The following are the primary procedures we performed to address this critical audit matter. With the assistance of actuarial professionals, we evaluated the design and tested the operating effectiveness of certain internal controls related to the Company’s liability for future policy benefits for long-term care insurance and life insurance. This included controls related to the development of the key assumptions. We also involved actuarial professionals with specialized skills and knowledge, who assisted in: • • • evaluating the actuarial methodologies and key assumptions used to estimate the liability for future policy benefits for long-term care insurance and life insurance for consistency with generally accepted actuarial methodologies and industry practice evaluating certain of the Company’s key assumptions by assessing them in comparison to the Company’s relevant historical experience data and industry data or qualitative factors, and the consistency of the assumptions with each other assessing the reasonableness of estimated future in-force rate action assumptions for long-term care insurance for a selection of estimated rate increases by a) comparing to the Company’s historical regulatory approvals and regulatory information and b) assessing the Company’s ability to achieve the estimated future in-force rate actions by reperforming the Company’s calculations and comparing to the requirements to request a rate action. Additional insurance liabilities for secondary guarantees for universal and term universal contracts As discussed in Notes 2, 11 and 12 to the consolidated financial statements, the additional insurance liabilities consist of secondary guarantees or product features in addition to the policyholder account balance on universal and term universal contracts. The additional insurance liability is equal to the sum of cumulative assessments multiplied by the current benefit ratio plus accrued interest, less excess payments. These additional benefit reserves are included in the liability for policyholder account balances in the consolidated balance sheets. The benefit ratio is equal to the present value of total expected benefit payments over the life of the contract divided by the present value of total expected assessments over the life of the contract, discounted by the projected crediting rate. The assumptions used to calculate the benefit ratio include insured mortality (i.e., life expectancy or longevity), interest rates and policyholder persistency or lapses, among other assumptions. The Company’s total policyholder account balances of $15,540 million as of December 31, 2023, included $2,887 million of additional insurance liabilities related to universal and term universal contracts. 130 131 year-over-year movements of the Company’s recorded mortgage insurance loss reserves within the developed independent range. We have not been able to determine the specific year that we began serving as the Company’s auditor; however we are aware that we have served as the Company’s auditor since at least 1996. /s/ KPMG LLP Richmond, Virginia February 29, 2024 We identified the assessment of the estimate of the additional insurance liabilities related to universal and term universal contracts (secondary guarantees) as a critical audit matter. Specifically, the evaluation of the mortality and lapse assumptions used in the estimation of the additional insurance liabilities required especially subjective auditor judgment. Increased effort and specialized skills were needed to evaluate the Company’s mortality and lapse assumptions and the impact of those assumptions on the additional insurance liabilities. The following are the primary procedures we performed to address this critical audit matter. With the assistance of actuarial professionals, where appropriate, we evaluated the design and tested the operating effectiveness of certain internal controls related to the valuation of the additional insurance liabilities. This included controls related to the development of the mortality and lapse assumptions. We tested the Company’s process to develop the universal and term universal contract additional insurance liabilities through the procedures below. We involved actuarial professionals with specialized skills and knowledge, who assisted in: • • • evaluating the methods and assumptions for consistency with generally accepted actuarial methodologies and industry practice evaluating the Company’s mortality and lapse assumptions by assessing the consistency of the assumptions with the underlying historical claims and lapse experience data and industry data developing an estimate of the additional insurance liabilities for a selection of contracts using the Company’s assumptions and comparing the results to the Company’s recorded additional insurance liabilities for the selected contracts. Mortgage insurance loss reserves As discussed in Notes 2 and 15 to the consolidated financial statements, the Company estimates the liabilities for losses on insured mortgage loans (loss reserves) by estimating the number of loans in their inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. The Company’s Enact segment’s mortgage insurance loss reserves were $518 million of a total liability for policy and contract claims of $652 million as of December 31, 2023. We identified the assessment of the valuation of mortgage insurance loss reserves to be a critical audit matter. The claim severity and claim rate assumptions used to develop reserves were inherently uncertain and involved significant management judgment, which required especially subjective auditor judgment. Additionally, the audit effort to assess the valuation of mortgage insurance loss reserves required the involvement of professionals with specialized knowledge and experience. The following are the primary procedures we performed to address the critical audit matter. We evaluated, with the assistance of actuarial professionals, the design and tested the operating effectiveness of certain internal controls related to the valuation of mortgage insurance loss reserves. This included controls related to the review and approval of the claim severity and claim rate reserve factors used in the estimate for mortgage insurance loss reserves. We involved actuarial professionals with specialized knowledge and experience, who assisted in: • • assessing the Company’s reserving methodology by comparing to accepted actuarial methodologies developing an independent estimate and range for a portion of the mortgage insurance loss reserves, using the Company’s underlying historical claims and delinquency data and independently developed models and assumptions and assessing the position in the range and the 132 133 year-over-year movements of the Company’s recorded mortgage insurance loss reserves within the developed independent range. /s/ KPMG LLP We have not been able to determine the specific year that we began serving as the Company’s auditor; however we are aware that we have served as the Company’s auditor since at least 1996. Richmond, Virginia February 29, 2024 We identified the assessment of the estimate of the additional insurance liabilities related to universal and term universal contracts (secondary guarantees) as a critical audit matter. Specifically, the evaluation of the mortality and lapse assumptions used in the estimation of the additional insurance liabilities required especially subjective auditor judgment. Increased effort and specialized skills were needed to evaluate the Company’s mortality and lapse assumptions and the impact of those assumptions on the additional insurance liabilities. The following are the primary procedures we performed to address this critical audit matter. With the assistance of actuarial professionals, where appropriate, we evaluated the design and tested the operating effectiveness of certain internal controls related to the valuation of the additional insurance liabilities. This included controls related to the development of the mortality and lapse assumptions. We tested the Company’s process to develop the universal and term universal contract additional insurance liabilities through the procedures below. We involved actuarial professionals with specialized skills and knowledge, who assisted in: evaluating the methods and assumptions for consistency with generally accepted actuarial methodologies and industry practice evaluating the Company’s mortality and lapse assumptions by assessing the consistency of the assumptions with the underlying historical claims and lapse experience data and industry data developing an estimate of the additional insurance liabilities for a selection of contracts using the Company’s assumptions and comparing the results to the Company’s recorded additional insurance liabilities for the selected contracts. Mortgage insurance loss reserves As discussed in Notes 2 and 15 to the consolidated financial statements, the Company estimates the liabilities for losses on insured mortgage loans (loss reserves) by estimating the number of loans in their inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. The Company’s Enact segment’s mortgage insurance loss reserves were $518 million of a total liability for policy and contract claims of $652 million as of December 31, 2023. We identified the assessment of the valuation of mortgage insurance loss reserves to be a critical audit matter. The claim severity and claim rate assumptions used to develop reserves were inherently uncertain and involved significant management judgment, which required especially subjective auditor judgment. Additionally, the audit effort to assess the valuation of mortgage insurance loss reserves required the involvement of professionals with specialized knowledge and experience. The following are the primary procedures we performed to address the critical audit matter. We evaluated, with the assistance of actuarial professionals, the design and tested the operating effectiveness of certain internal controls related to the valuation of mortgage insurance loss reserves. This included controls related to the review and approval of the claim severity and claim rate reserve factors used in the estimate for mortgage insurance loss reserves. We involved actuarial professionals with specialized knowledge and experience, who assisted in: methodologies assessing the Company’s reserving methodology by comparing to accepted actuarial developing an independent estimate and range for a portion of the mortgage insurance loss reserves, using the Company’s underlying historical claims and delinquency data and independently developed models and assumptions and assessing the position in the range and the • • • • • 132 133 396 Equity securities, at fair value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4 as of and allowance for credit losses of $7 and $—, respectively, as of December 31, 2023 and 2022) . . . . . . . . . . . . $46,781 $46,583 319 GENWORTH FINANCIAL, INC. CONSOLIDATED BALANCE SHEETS (Amounts in millions, except par value and share amounts) GENWORTH FINANCIAL, INC. CONSOLIDATED STATEMENTS OF INCOME (Amounts in millions, except per share amounts) Assets Investments: Fixed maturity securities available-for-sale, at fair value (amortized cost of $49,365 and $50,834, respectively, December 31, 2023 2022 (As adjusted) December 31, 2023 and 2022) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: Allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,829 (27) 7,032 (22) Commercial mortgage loans, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash, cash equivalents and restricted cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accrued investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred acquisition costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: Allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Reinsurance recoverable, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred tax asset . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Market risk benefit assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Separate account assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,802 2,220 2,821 731 59,751 2,215 647 1,988 198 19,054 (29) 19,025 489 1,952 43 4,509 7,010 2,139 2,331 566 58,948 1,799 643 2,211 203 19,059 (63) 18,996 488 1,983 26 4,417 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $90,817 $89,714 Liabilities and equity Liabilities: Future policy benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $57,655 $55,407 16,564 Policyholder account balances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 748 Market risk benefit liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 683 Liability for policy and contract claims . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203 Unearned premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,687 Other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,611 Long-term borrowings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,417 Separate account liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Liabilities related to discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15,540 625 652 149 1,768 1,584 4,509 — Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82,482 81,328 Income from continuing operations available to Genworth Financial, Inc.’s common Commitments and contingencies (Note 25) Equity: Class A common stock, $0.001 par value; 1,500,000,000 shares authorized; 603,151,611 and 600,036,269 shares issued as of December 31, 2023 and 2022, respectively; 446,823,204 and 495,446,960 shares outstanding as of December 31, 2023 and 2022, respectively . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Additional paid-in capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Retained earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Treasury stock, at cost (156,328,407 and 104,589,309 shares as of December 31, 2023 and 2022, respectively) . . . Total Genworth Financial, Inc.’s stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 11,884 (2,555) 1,213 (3,063) 7,480 855 8,335 1 11,869 (2,614) 1,139 (2,764) 7,631 755 8,386 Total liabilities and equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $90,817 $89,714 See Notes to Consolidated Financial Statements 134 See Notes to Consolidated Financial Statements 135 Years ended December 31, 2023 2022 2021 (As adjusted) (As adjusted) Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,636 $3,680 Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,183 3,146 Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 646 (2) 671 $3,406 3,370 322 724 Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,488 7,495 7,822 Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,783 4,303 Liability remeasurement (gains) losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition and operating expenses, net of deferrals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total benefits and expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,185 6,130 Income from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income from discontinued operations, net of taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to noncontrolling interests . . . . . . Less: net income from discontinued operations attributable to noncontrolling interests . . . . — 587 (12) 503 942 264 118 303 104 199 199 123 (290) (104) 504 1,285 326 106 1,365 319 1,046 — 1,046 130 — 4,575 242 (160) 511 998 384 160 6,710 1,112 248 864 27 891 33 8 Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . $ 76 $ 916 $ 850 Net income available to Genworth Financial, Inc.’s common stockholders: Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 76 $ 916 $ 831 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — 19 Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . $ 76 $ 916 $ 850 stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.82 $ 1.64 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.79 $ 1.61 Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.82 $ 1.68 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.79 $ 1.65 Weighted-average common shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 468.8 504.4 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 474.9 510.9 506.9 514.7 2023 2022 Years ended December 31, 2021 GENWORTH FINANCIAL, INC. CONSOLIDATED STATEMENTS OF INCOME (Amounts in millions, except per share amounts) GENWORTH FINANCIAL, INC. CONSOLIDATED BALANCE SHEETS (Amounts in millions, except par value and share amounts) December 31, 2023 2022 (As adjusted) 7,032 (22) 7,010 2,139 2,331 566 58,948 1,799 643 2,211 203 6,802 2,220 2,821 731 59,751 2,215 647 1,988 198 Assets Investments: Fixed maturity securities available-for-sale, at fair value (amortized cost of $49,365 and $50,834, respectively, and allowance for credit losses of $7 and $—, respectively, as of December 31, 2023 and 2022) . . . . . . . . . . . . $46,781 $46,583 Equity securities, at fair value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 396 319 Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4 as of December 31, 2023 and 2022) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,829 Less: Allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (27) Commercial mortgage loans, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash, cash equivalents and restricted cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accrued investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred acquisition costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19,054 19,059 Less: Allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (29) (63) Reinsurance recoverable, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19,025 18,996 Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred tax asset . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Market risk benefit assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Separate account assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 489 1,952 43 4,509 488 1,983 26 4,417 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $90,817 $89,714 Liabilities and equity Liabilities: Future policy benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $57,655 $55,407 Policyholder account balances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15,540 16,564 Market risk benefit liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Liability for policy and contract claims . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Unearned premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-term borrowings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Separate account liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Liabilities related to discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 625 652 149 1,768 1,584 4,509 — 748 683 203 1,687 1,611 4,417 8 Commitments and contingencies (Note 25) Equity: Class A common stock, $0.001 par value; 1,500,000,000 shares authorized; 603,151,611 and 600,036,269 shares issued as of December 31, 2023 and 2022, respectively; 446,823,204 and 495,446,960 shares outstanding as of December 31, 2023 and 2022, respectively . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Additional paid-in capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Retained earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Treasury stock, at cost (156,328,407 and 104,589,309 shares as of December 31, 2023 and 2022, respectively) . . . (3,063) (2,764) Total Genworth Financial, Inc.’s stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 11,884 (2,555) 1,213 1 11,869 (2,614) 1,139 7,480 855 8,335 7,631 755 8,386 Total liabilities and equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $90,817 $89,714 (As adjusted) (As adjusted) Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,636 3,183 Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 646 Policy fees and other income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,680 3,146 (2) 671 Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,488 7,495 Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Liability remeasurement (gains) losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition and operating expenses, net of deferrals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,783 587 (12) 503 942 264 118 4,303 (290) (104) 504 1,285 326 106 Total benefits and expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,185 6,130 Income from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 303 104 Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 199 Income from discontinued operations, net of taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 199 Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to noncontrolling interests . . . . . . 123 Less: net income from discontinued operations attributable to noncontrolling interests . . . . — 1,365 319 1,046 — 1,046 130 — $3,406 3,370 322 724 7,822 4,575 242 (160) 511 998 384 160 6,710 1,112 248 864 27 891 33 8 Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . $ 76 $ 916 $ 850 Net income available to Genworth Financial, Inc.’s common stockholders: Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 76 $ 916 $ 831 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — 19 Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . $ 76 $ 916 $ 850 Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82,482 81,328 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.82 $ 1.64 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.79 $ 1.61 Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.82 $ 1.68 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.79 $ 1.65 Weighted-average common shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 468.8 504.4 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 474.9 510.9 506.9 514.7 See Notes to Consolidated Financial Statements 134 See Notes to Consolidated Financial Statements 135 GENWORTH FINANCIAL, INC. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Amounts in millions) Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities without an allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net unrealized gains (losses) on securities with an allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derivatives qualifying as hedges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Change in discount rate used to measure future policy benefits . . . . . . Change in instrument-specific credit risk of market risk benefits . . . . . Foreign currency translation and other adjustments . . . . . . . . . . . . . . . . Total other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . Total comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: comprehensive income attributable to noncontrolling interests . . . . . . Total comprehensive income available to Genworth Financial, Inc.’s Years ended December 31, 2023 2022 2021 $ 199 (As adjusted) $ 1,046 (As adjusted) $ 891 1,305 (9,570) (1,759) — (190) (1,036) 2 6 87 286 151 — (825) 13,515 5 30 3,155 4,201 44 6 (186) 3,202 4 148 1,415 2,306 177 common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 135 $ 4,157 $ 2,129 See Notes to Consolidated Financial Statements GENWORTH FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Amounts in millions) Accumulated Additional other Treasury Inc.’s Common stock paid-in capital comprehensive Retained stock, at stockholders’ Noncontrolling income (loss) earnings cost equity interests Total equity Total Genworth Financial, Balances as of December 31, 2020 . . $ 1 $12,008 $ 4,425 $ 1,584 $(2,700) $ 15,318 $ 502 $ 15,820 accounting, net of taxes . . . . . . . . — — (11,533) (2,210) — (13,743) noncontrolling interests . . . . . . . . — (167) (26) — — (193) — 773 (13,743) 580 (657) (657) Cumulative effect of change in Initial sale of subsidiary shares to Sale of business that included noncontrolling interests . . . . . . . . — Comprehensive income: Net income . . . . . . . . . . . . . . . . — Other comprehensive income, net of taxes . . . . . . . . . . . . . . — Total comprehensive income . . . . . . . . . . . . . . . . . Dividends to noncontrolling interests . . . . . . . . . . . . . . . . . . . . — Stock-based compensation expense and exercises and other — Balances as of December 31, 2021 Comprehensive income: Net income . . . . . . . . . . . . . . . . — Other comprehensive income (loss), net of taxes . . . . . . . . — Total comprehensive income . . . . . . . . . . . . . . . . . Treasury stock acquired in connection with share repurchases — Dividends to noncontrolling interests . . . . . . . . . . . . . . . . . . . . — Stock-based compensation expense and exercises and other — Balances as of December 31, 2022 Repurchase of subsidiary shares . . . — Comprehensive income: Net income . . . . . . . . . . . . . . . . — Other comprehensive income, net of taxes . . . . . . . . . . . . . . — Total comprehensive income . . . . . . . . . . . . . . . . . Treasury stock acquired in connection with share repurchases — Dividends to noncontrolling interests . . . . . . . . . . . . . . . . . . . . — Stock-based compensation expense and exercises and other . . . . . . . . — — — — — 17 — — — — 11 — — — — — 15 — 916 — 916 3,241 — — 3,241 (86) 3,155 4,157 4,201 — — — — 850 — — 850 1,279 — — 1,279 — — — — 1 — 2,129 — 18 — — — — — 59 — — — — (64) (64) — — — (2) — 9 — — 76 — — — — — (2) — 7,631 — 76 59 135 — 13 41 136 177 (37) (2) 756 130 44 — (46) 1 755 (16) 123 28 151 (39) 4 891 1,415 2,306 (37) 16 4,285 1,046 (64) (46) 10 8,386 (16) 199 87 286 (39) 17 — (299) (299) — (299) (as adjusted) . . . . . . . . . . . . . . . . . 1 11,858 (5,855) 225 (2,700) 3,529 (as adjusted) . . . . . . . . . . . . . . . . . 1 11,869 (2,614) 1,139 (2,764) 136 Balances as of December 31, 2023 . . $ 1 $11,884 $ (2,555) $ 1,213 $(3,063) $ 7,480 $ 855 $ 8,335 See Notes to Consolidated Financial Statements 137 GENWORTH FINANCIAL, INC. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Amounts in millions) Years ended December 31, 2023 2022 2021 (As adjusted) (As adjusted) Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 199 $ 1,046 $ 891 Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities without an allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,305 (9,570) (1,759) Net unrealized gains (losses) on securities with an allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derivatives qualifying as hedges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — (190) — (825) Change in discount rate used to measure future policy benefits . . . . . . (1,036) 13,515 Change in instrument-specific credit risk of market risk benefits . . . . . Foreign currency translation and other adjustments . . . . . . . . . . . . . . . . Total other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . Total comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: comprehensive income attributable to noncontrolling interests . . . . . . Total comprehensive income available to Genworth Financial, Inc.’s 2 6 87 286 151 5 30 3,155 4,201 44 6 (186) 3,202 4 148 1,415 2,306 177 common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 135 $ 4,157 $ 2,129 See Notes to Consolidated Financial Statements GENWORTH FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Amounts in millions) Common stock Additional paid-in capital Accumulated other comprehensive income (loss) Retained earnings Treasury stock, at cost Total Genworth Financial, Inc.’s stockholders’ equity Noncontrolling interests Total equity Balances as of December 31, 2020 . . $ Cumulative effect of change in 1 $12,008 $ 4,425 $ 1,584 $(2,700) $ 15,318 $ 502 $ 15,820 accounting, net of taxes . . . . . . . . — — (11,533) (2,210) — (13,743) Initial sale of subsidiary shares to noncontrolling interests . . . . . . . . — (167) (26) — — (193) Sale of business that included noncontrolling interests . . . . . . . . — Comprehensive income: Net income . . . . . . . . . . . . . . . . — Other comprehensive income, net of taxes . . . . . . . . . . . . . . — Total comprehensive income . . . . . . . . . . . . . . . . . Dividends to noncontrolling interests . . . . . . . . . . . . . . . . . . . . — Stock-based compensation expense and exercises and other — Balances as of December 31, 2021 — — — — 17 — — — — 850 — — 850 1,279 — — 1,279 — — — — 1 — 2,129 — 18 (as adjusted) . . . . . . . . . . . . . . . . . 1 11,858 (5,855) 225 (2,700) 3,529 Comprehensive income: Net income . . . . . . . . . . . . . . . . — Other comprehensive income (loss), net of taxes . . . . . . . . — Total comprehensive income . . . . . . . . . . . . . . . . . Treasury stock acquired in connection with share repurchases — Dividends to noncontrolling interests . . . . . . . . . . . . . . . . . . . . — Stock-based compensation expense and exercises and other — Balances as of December 31, 2022 — — — — 11 Repurchase of subsidiary shares . . . — Comprehensive income: Net income . . . . . . . . . . . . . . . . — Other comprehensive income, net of taxes . . . . . . . . . . . . . . — Total comprehensive income . . . . . . . . . . . . . . . . . Treasury stock acquired in connection with share repurchases — Dividends to noncontrolling interests . . . . . . . . . . . . . . . . . . . . — Stock-based compensation expense and exercises and other . . . . . . . . — — — — — — 15 — — 59 — — — 4,157 — — — — (64) (64) — — — (2) — 9 — — 76 — — — 7,631 — 76 59 135 (as adjusted) . . . . . . . . . . . . . . . . . 1 11,869 (2,614) 1,139 (2,764) — 773 (13,743) 580 (657) (657) 41 136 177 (37) (2) 756 130 891 1,415 2,306 (37) 16 4,285 1,046 44 — (46) 1 755 (16) 123 28 151 4,201 (64) (46) 10 8,386 (16) 199 87 286 — (299) (299) — (299) — — (2) — — 13 (39) 4 (39) 17 — 916 — 916 3,241 — — 3,241 (86) 3,155 136 Balances as of December 31, 2023 . . $ 1 $11,884 $ (2,555) $ 1,213 $(3,063) $ 7,480 $ 855 $ 8,335 See Notes to Consolidated Financial Statements 137 GENWORTH FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (Amounts in millions) Years ended December 31, 2023 2022 2021 (As adjusted) (As adjusted) (1) Nature of Business GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Cash flows from (used by) operating activities: Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Less income from discontinued operations, net of taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjustments to reconcile net income to net cash from operating activities: 199 $ 1,046 — — $ 891 (27) Amortization of fixed maturity securities discounts and premiums . . . . . . . . . . . . . . . . . . . . . . . . . Net investment (gains) losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . Charges assessed to policyholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition costs deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derivative instruments, limited partnerships and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-term incentive compensation expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Change in certain assets and liabilities: Accrued investment income and other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Insurance reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Current tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other liabilities, policy and contract claims and other policy-related balances . . . . . . . . . . . . . . . . Cash used by operating activities—discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (106) (23) (12) (572) (7) 264 48 (557) 49 (150) 1,500 46 (79) (3) (154) 2 (104) (588) (12) 326 315 (335) 37 (155) 1,055 (1) (352) (31) Net cash from operating activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 597 1,049 (176) (322) (160) (616) (16) 384 275 (359) 40 (134) 1,168 (34) 14 (491) 437 Cash flows from (used by) investing activities: Proceeds from maturities and repayments of investments: Fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships and other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,426 470 202 2,705 759 185 4,162 874 255 Proceeds from sales of investments: Fixed maturity and equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,233 2,658 2,273 Purchases and originations of investments: Fixed maturity and equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships and other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Short-term investments, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy loans, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Proceeds from sale of business, net of cash transferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash used by investing activities—discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (3,217) (273) (586) (12) 73 — (55) — (4,035) (958) (645) 23 41 — — — Net cash from investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,261 733 Cash flows from (used by) financing activities: Deposits to universal life and investment contracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Withdrawals from universal life and investment contracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Repayment and repurchase of long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Proceeds from sale of subsidiary shares to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . Repurchase of subsidiary shares . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Treasury stock acquired in connection with share repurchases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dividends paid to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 566 (1,637) (32) — (16) (296) (39) 11 606 (1,668) (297) — — (64) (46) (85) Net cash used by financing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1,443) (1,554) Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $—, $— and $(1) related to discontinued operations for the years ended December 31, 2023, 2022 and 2021, respectively) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net change in cash, cash equivalents and restricted cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash, cash equivalents and restricted cash at beginning of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash, cash equivalents and restricted cash at end of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less cash, cash equivalents and restricted cash of discontinued operations at end of period . . . . . . . . . . . . . 1 416 1,799 2,215 — — 228 1,571 1,799 — (5,216) (963) (767) 18 57 270 — (67) 896 669 (2,071) (1,541) 529 — — (37) 32 (2,419) 1 (1,085) 2,656 1,571 — Genworth Holdings, Inc. (“Genworth Holdings”) (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an initial public offering (“IPO”) of its common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100% owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, and was renamed Genworth Financial, Inc. (“Genworth Financial”) upon the completion of the reorganization. The accompanying financial statements include on a consolidated basis the accounts of Genworth Financial and its affiliate companies in which it holds a majority voting interest or power to direct activities of certain variable interest entities (“VIEs”), which on a consolidated basis is referred to as “Genworth,” the “Company,” “we,” “us” or “our” unless the context otherwise requires. All intercompany accounts and transactions have been eliminated in consolidation. References to “Genworth Financial” refer solely to Genworth Financial, Inc., and not to any of its consolidated subsidiaries. Beginning in the first quarter of 2023, we changed our operating segments to better align with how we manage our business. The changes allow us to sharpen our focus on common aspects of products within each segment and enhance understanding of business performance. All prior period financial information has been re-presented to reflect the reorganized segment reporting structure. Under the new reporting structure, we operate our business through the following three operating segments: • Enact. Enact Holdings, Inc. (“Enact Holdings”) comprises our Enact segment. Through Enact Holdings, we offer private mortgage insurance products predominantly insuring prime-based, individually underwritten residential mortgage loans at specified coverage percentages (“primary mortgage insurance”). Enact Holdings also selectively enters into insurance transactions with lenders and investors, under which it insures a portfolio of loans at or after origination (“pool mortgage insurance”). • Long-Term Care Insurance. Through our principal U.S. life insurance subsidiaries, we offer long-term care insurance products in the United States. Long-term care insurance products are intended to protect against the significant and escalating costs of long-term care services provided in the insured’s home or assisted living or nursing facilities. • Life and Annuities. We service a variety of protection and retirement income products through our principal U.S. life insurance subsidiaries that are not actively marketed or sold. These products include traditional and non-traditional life insurance (term, universal and term universal life insurance as well as corporate-owned life insurance and funding agreements), fixed annuities and variable annuities. In addition to our three operating segments, we also have Corporate and Other, which includes debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other businesses that are reported outside of our operating segments, such as certain international businesses and discontinued operations. See note 28 for additional information related to discontinued operations. Corporate and Other also includes start-up results of Cash, cash equivalents and restricted cash of continuing operations at end of period . . . . . . . . . . . . . . . . . . . $ 2,215 $ 1,799 $ 1,571 our CareScout business related to our senior care growth initiatives. See Notes to Consolidated Financial Statements 138 139 GENWORTH FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (Amounts in millions) Years ended December 31, 2023 2022 2021 (As adjusted) (As adjusted) Cash flows from (used by) operating activities: Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 199 $ 1,046 $ Less income from discontinued operations, net of taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — Adjustments to reconcile net income to net cash from operating activities: Amortization of fixed maturity securities discounts and premiums . . . . . . . . . . . . . . . . . . . . . . . . . Net investment (gains) losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . Charges assessed to policyholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition costs deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derivative instruments, limited partnerships and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-term incentive compensation expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Change in certain assets and liabilities: Accrued investment income and other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Insurance reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Current tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other liabilities, policy and contract claims and other policy-related balances . . . . . . . . . . . . . . . . Cash used by operating activities—discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (106) (23) (12) (572) (7) 264 48 (557) 49 (150) 1,500 46 (79) (3) (154) 2 (104) (588) (12) 326 315 (335) 37 (155) 1,055 (1) (352) (31) Net cash from operating activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 597 1,049 Cash flows from (used by) investing activities: Proceeds from maturities and repayments of investments: Fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,426 2,705 Commercial mortgage loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships and other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 470 202 759 185 4,162 874 255 Fixed maturity and equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,233 2,658 2,273 Proceeds from sales of investments: Purchases and originations of investments: Fixed maturity and equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (3,217) (4,035) Commercial mortgage loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships and other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Short-term investments, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy loans, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Proceeds from sale of business, net of cash transferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash used by investing activities—discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (273) (586) (12) 73 — (55) — Net cash from investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,261 (958) (645) 23 41 — — — 733 Cash flows from (used by) financing activities: Deposits to universal life and investment contracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 566 Withdrawals from universal life and investment contracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1,637) Repayment and repurchase of long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Proceeds from sale of subsidiary shares to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . Repurchase of subsidiary shares . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Treasury stock acquired in connection with share repurchases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dividends paid to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (32) — (16) (296) (39) 11 606 (1,668) (297) — — (64) (46) (85) Net cash used by financing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1,443) (1,554) (2,419) Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $—, $— and $(1) related to discontinued operations for the years ended December 31, 2023, 2022 and 2021, respectively) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Net change in cash, cash equivalents and restricted cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash, cash equivalents and restricted cash at beginning of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash, cash equivalents and restricted cash at end of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less cash, cash equivalents and restricted cash of discontinued operations at end of period . . . . . . . . . . . . . — 228 1,571 1,799 — 416 1,799 2,215 — Cash, cash equivalents and restricted cash of continuing operations at end of period . . . . . . . . . . . . . . . . . . . $ 2,215 $ 1,799 $ 1,571 891 (27) (176) (322) (160) (616) (16) 384 275 (359) 40 (134) 1,168 (34) 14 (491) 437 (5,216) (963) (767) 18 57 270 — (67) 896 669 (2,071) (1,541) 529 — — (37) 32 1 (1,085) 2,656 1,571 — See Notes to Consolidated Financial Statements 138 GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (1) Nature of Business Genworth Holdings, Inc. (“Genworth Holdings”) (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an initial public offering (“IPO”) of its common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100% owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, and was renamed Genworth Financial, Inc. (“Genworth Financial”) upon the completion of the reorganization. The accompanying financial statements include on a consolidated basis the accounts of Genworth Financial and its affiliate companies in which it holds a majority voting interest or power to direct activities of certain variable interest entities (“VIEs”), which on a consolidated basis is referred to as “Genworth,” the “Company,” “we,” “us” or “our” unless the context otherwise requires. All intercompany accounts and transactions have been eliminated in consolidation. References to “Genworth Financial” refer solely to Genworth Financial, Inc., and not to any of its consolidated subsidiaries. Beginning in the first quarter of 2023, we changed our operating segments to better align with how we manage our business. The changes allow us to sharpen our focus on common aspects of products within each segment and enhance understanding of business performance. All prior period financial information has been re-presented to reflect the reorganized segment reporting structure. Under the new reporting structure, we operate our business through the following three operating segments: • Enact. Enact Holdings, Inc. (“Enact Holdings”) comprises our Enact segment. Through Enact Holdings, we offer private mortgage insurance products predominantly insuring prime-based, individually underwritten residential mortgage loans at specified coverage percentages (“primary mortgage insurance”). Enact Holdings also selectively enters into insurance transactions with lenders and investors, under which it insures a portfolio of loans at or after origination (“pool mortgage insurance”). • Long-Term Care Insurance. Through our principal U.S. life insurance subsidiaries, we offer long-term care insurance products in the United States. Long-term care insurance products are intended to protect against the significant and escalating costs of long-term care services provided in the insured’s home or assisted living or nursing facilities. • Life and Annuities. We service a variety of protection and retirement income products through our principal U.S. life insurance subsidiaries that are not actively marketed or sold. These products include traditional and non-traditional life insurance (term, universal and term universal life insurance as well as corporate-owned life insurance and funding agreements), fixed annuities and variable annuities. In addition to our three operating segments, we also have Corporate and Other, which includes debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other businesses that are reported outside of our operating segments, such as certain international businesses and discontinued operations. See note 28 for additional information related to discontinued operations. Corporate and Other also includes start-up results of our CareScout business related to our senior care growth initiatives. 139 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial could repurchase up to $350 million of its outstanding Class A common stock. On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under the existing share repurchase program. Pursuant to the program, during 2023, Genworth Financial repurchased 51,739,098 shares of its common stock at an average price of $5.70 per share for a total cost of $299 million, including excise taxes and other costs paid in connection with acquiring the shares. The repurchased shares were recorded at cost and presented as treasury stock in a separate caption in equity in our consolidated balance sheets. In 2024, Genworth Financial also authorized share repurchases through a Rule 10b5-1 trading plan under which 4,197,740 shares of its common stock were repurchased through February 13, 2024 for approximately $25 million before excise taxes. Approximately $316 million remained available under the share repurchase program as of February 13, 2024. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions or other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time. (2) Summary of Significant Accounting Policies Our consolidated financial statements have been prepared on the basis of U.S. generally accepted accounting principles (“U.S. GAAP”). Preparing financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year presentation. a) Premiums d) Investment Securities For traditional long-duration insurance contracts, we report premiums as earned when due. For monthly mortgage insurance contracts, we report premiums as revenue over the period that coverage is provided. For single premium mortgage insurance contracts, we report premiums over the estimated policy life in accordance with the expected pattern of risk emergence as further described in our accounting policy for unearned premiums. In addition, we refund post-delinquent premiums received to the insured party if the delinquent loan goes to claim. We record a liability for premiums received on the delinquent loans consistent with our expectations of the rates at which delinquencies go to claim (“claim rates”). Premiums received under annuity contracts without significant mortality risk and premiums received on investment and universal life insurance products are not reported as revenues but rather as deposits and are included in liabilities for policyholder account balances. b) Net Investment Income and Net Investment Gains and Losses Net investment income consists primarily of interest and dividends. Interest is recognized on an accrual basis and reflects amortization of premiums and accretion of discounts on an effective yield basis. Income or loss upon call or prepayment of available-for-sale fixed maturity securities is recognized in net investment income, except for hybrid securities where the income or loss upon call is recognized in net investment gains and losses. 140 141 Investment income on mortgage-backed and asset-backed securities is initially based upon yield, cash flow and prepayment assumptions at the date of purchase. Subsequent revisions in those assumptions are recorded using the retrospective or prospective method. Under the retrospective method used for mortgage-backed and asset-backed securities of high credit quality (ratings equal to or greater than “AA” or that are backed by a U.S. agency), which cannot be contractually prepaid in such a manner that we would not recover a substantial portion of the initial investment, amortized cost of the security is adjusted to the amount that would have existed had the revised assumptions been in place at the date of purchase. The adjustments to amortized cost are recorded as a charge or credit to net investment income. Under the prospective method, which is used for all other mortgage- backed and asset-backed securities, future cash flows are estimated and interest income is recognized going forward using the new internal rate of return. Net investment gains and losses consist primarily of realized gains and losses from the sale of our available-for-sale fixed maturity securities, changes to the allowance for credit losses and unrealized and realized gains and losses from our equity securities, limited partnership investments and derivative instruments. Investment gains and losses are calculated on the basis of specific identification on the trade date. c) Policy Fees and Other Income Policy fees and other income consists primarily of insurance charges assessed on universal and term universal life insurance contracts and fees assessed against customer account values. For universal and term universal life insurance contracts, charges to policyholder accounts for cost of insurance are recognized as revenue when due. Variable product fees are charged to variable annuity contractholders based upon the daily net assets of the contractholder’s and policyholder’s account values and are recognized as revenue when charged. Policy surrender fees are recognized as income when the policy is surrendered. At the time of purchase, we designate our fixed maturity securities as either available-for-sale or trading and report them in our consolidated balance sheets at fair value. Our portfolio of fixed maturity securities comprises primarily investment grade securities. Changes in the fair value of available-for-sale fixed maturity securities, net of the effect on policyholder contract balances and deferred income taxes, are reflected as unrealized investment gains or losses in a separate component of accumulated other comprehensive income (loss). Equity securities are recorded at fair value in our consolidated balance sheets and changes in the fair value are reflected in net investment gains (losses). Allowance for Credit Losses and Write-Downs of Available-For-Sale Fixed Maturity Securities We regularly review securities in an unrealized loss position to determine whether the decline in fair value is related to credit losses or other factors. If we have either (i) the intent to sell the security, or (ii) it is more likely than not that we will be required to sell the security prior to recovering the amortized cost, we record a reduction to the security’s amortized cost and recognize the loss in net investment gains (losses) for the difference between the security’s amortized cost and fair value. If neither of the two preceding conditions exist, we determine whether the decline in fair value is related to credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency/agencies and adverse conditions specifically related to the security, among other factors. If a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security and a credit loss allowance is recognized in net investment GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial could repurchase up to $350 million of its outstanding Class A common stock. On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under the existing share repurchase program. Pursuant to the program, during 2023, Genworth Financial repurchased 51,739,098 shares of its common stock at an average price of $5.70 per share for a total cost of $299 million, including excise taxes and other costs paid in connection with acquiring the shares. The repurchased shares were recorded at cost and presented as treasury stock in a separate caption in equity in our consolidated balance sheets. In 2024, Genworth Financial also authorized share repurchases through a Rule 10b5-1 trading plan under which 4,197,740 shares of its common stock were repurchased through February 13, 2024 for approximately $25 million before excise taxes. Approximately $316 million remained available under the share repurchase program as of February 13, 2024. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions or other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time. (2) Summary of Significant Accounting Policies Our consolidated financial statements have been prepared on the basis of U.S. generally accepted accounting principles (“U.S. GAAP”). Preparing financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year presentation. a) Premiums For traditional long-duration insurance contracts, we report premiums as earned when due. For monthly mortgage insurance contracts, we report premiums as revenue over the period that coverage is provided. For single premium mortgage insurance contracts, we report premiums over the estimated policy life in accordance with the expected pattern of risk emergence as further described in our accounting policy for unearned premiums. In addition, we refund post-delinquent premiums received to the insured party if the delinquent loan goes to claim. We record a liability for premiums received on the delinquent loans consistent with our expectations of the rates at which delinquencies go to claim (“claim rates”). Premiums received under annuity contracts without significant mortality risk and premiums received on investment and universal life insurance products are not reported as revenues but rather as deposits and are included in liabilities for policyholder account balances. b) Net Investment Income and Net Investment Gains and Losses Net investment income consists primarily of interest and dividends. Interest is recognized on an accrual basis and reflects amortization of premiums and accretion of discounts on an effective yield basis. Income or loss upon call or prepayment of available-for-sale fixed maturity securities is recognized in net investment income, except for hybrid securities where the income or loss upon call is recognized in net investment gains and losses. Investment income on mortgage-backed and asset-backed securities is initially based upon yield, cash flow and prepayment assumptions at the date of purchase. Subsequent revisions in those assumptions are recorded using the retrospective or prospective method. Under the retrospective method used for mortgage-backed and asset-backed securities of high credit quality (ratings equal to or greater than “AA” or that are backed by a U.S. agency), which cannot be contractually prepaid in such a manner that we would not recover a substantial portion of the initial investment, amortized cost of the security is adjusted to the amount that would have existed had the revised assumptions been in place at the date of purchase. The adjustments to amortized cost are recorded as a charge or credit to net investment income. Under the prospective method, which is used for all other mortgage- backed and asset-backed securities, future cash flows are estimated and interest income is recognized going forward using the new internal rate of return. Net investment gains and losses consist primarily of realized gains and losses from the sale of our available-for-sale fixed maturity securities, changes to the allowance for credit losses and unrealized and realized gains and losses from our equity securities, limited partnership investments and derivative instruments. Investment gains and losses are calculated on the basis of specific identification on the trade date. c) Policy Fees and Other Income Policy fees and other income consists primarily of insurance charges assessed on universal and term universal life insurance contracts and fees assessed against customer account values. For universal and term universal life insurance contracts, charges to policyholder accounts for cost of insurance are recognized as revenue when due. Variable product fees are charged to variable annuity contractholders based upon the daily net assets of the contractholder’s and policyholder’s account values and are recognized as revenue when charged. Policy surrender fees are recognized as income when the policy is surrendered. d) Investment Securities At the time of purchase, we designate our fixed maturity securities as either available-for-sale or trading and report them in our consolidated balance sheets at fair value. Our portfolio of fixed maturity securities comprises primarily investment grade securities. Changes in the fair value of available-for-sale fixed maturity securities, net of the effect on policyholder contract balances and deferred income taxes, are reflected as unrealized investment gains or losses in a separate component of accumulated other comprehensive income (loss). Equity securities are recorded at fair value in our consolidated balance sheets and changes in the fair value are reflected in net investment gains (losses). Allowance for Credit Losses and Write-Downs of Available-For-Sale Fixed Maturity Securities We regularly review securities in an unrealized loss position to determine whether the decline in fair value is related to credit losses or other factors. If we have either (i) the intent to sell the security, or (ii) it is more likely than not that we will be required to sell the security prior to recovering the amortized cost, we record a reduction to the security’s amortized cost and recognize the loss in net investment gains (losses) for the difference between the security’s amortized cost and fair value. If neither of the two preceding conditions exist, we determine whether the decline in fair value is related to credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency/agencies and adverse conditions specifically related to the security, among other factors. If a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security and a credit loss allowance is recognized in net investment 140 141 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 gains (losses), limited to the amount that the fair value is less than the amortized cost basis. Losses are written off against the allowance when deemed uncollectible or when we intend to sell or expect we will be required to sell a security prior to recovering its amortized cost. When there is an allowance for credit losses, we reassess the credit losses each balance sheet date and subsequent increases or decreases are recorded as an adjustment to the allowance for credit losses, with a corresponding gain or loss recorded in net investment gains (losses). Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with internal assumptions and judgments. When developing the estimate of cash flows expected to be collected at the individual security level, we utilize an analytical model that provides for various loss scenarios and consider the industry sector, current levels of subordination, geographic location and other relevant characteristics of the security or underlying assets, as well as reasonable and supportable forecasts. We regularly monitor our investment portfolio to ensure that securities with a credit loss are identified in a timely manner and any losses are recognized in the proper period. Accrued interest is included in accrued investment income in our consolidated balance sheet and had a carrying value of $504 million and $511 million as of December 31, 2023 and 2022, respectively. We exclude accrued interest related to available-for-sale fixed maturity securities from the estimated allowance for credit losses. Accrued interest on available-for-sale fixed maturity securities is deemed uncollectible and typically written off after 90 days; therefore, we do not measure an allowance for credit losses related to accrued interest. Amounts written off related to accrued interest are recorded as a credit loss expense included in net investment gains (losses). e) Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have fixed maturity securities, equity securities, short-term investments, limited partnerships, derivatives, embedded derivatives, separate account assets and certain other financial instruments, which are carried at fair value. Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. All assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: • Level 1—Quoted prices for identical instruments in active markets. • Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations for which inputs are observable or where those significant value drivers are observable. • Level 3—Instruments for which significant value drivers are unobservable. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as actively traded equity securities and actively traded mutual fund investments. Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs, such as interest rate, credit spread and foreign exchange rates for the underlying financial instruments. All significant inputs are observable, or derived from observable information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include certain public and private corporate fixed maturity and equity securities, government or agency securities, certain mortgage-backed and asset-backed securities, certain non-exchange- traded derivatives such as interest rate or cross currency swaps and short-term investments. Level 3 comprises financial instruments whose fair value is estimated based on industry-standard pricing methodologies and internally developed models utilizing significant inputs not based on, nor corroborated by, readily available market information. In certain instances, this category may also utilize non-binding broker quotes. This category primarily consists of certain less liquid fixed maturity and equity securities, certain derivative instruments or embedded derivatives where we cannot corroborate the significant valuation inputs with market observable data and market risk benefits (“MRBs”). As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability, such as the relative impact on the fair value as a result of including a particular input. We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. See note 21 for additional information related to fair value measurements. f) Commercial Mortgage Loans The carrying value of commercial mortgage loans is stated at principal amounts outstanding, net of unamortized premium or discount, deferred expenses and allowance for credit losses. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. Commercial mortgage loans are considered past due when contractual payments have not been received from the borrower by the required payment date. Loans are placed on non-accrual status when, in management’s opinion, the collection of principal or interest is not probable, typically when the collection of principal or interest is 90 days or more past due. In determining whether it is probable that we will be unable to collect all amounts due, we consider current payment status, debt service coverage ratios, occupancy levels and current loan-to-value. Income on loans on non-accrual status is not recognized until we believe it is probable that we will collect all future contractual principal and interest. Commercial mortgage loans are written off against the allowance to the extent principal or interest is deemed uncollectible. We determine the adequacy of the allowance for credit losses utilizing an analytical model that provides various loss scenarios based on historical experience adjusted for current events, trends, economic conditions and reasonable and supportable forecasts that result in a loss in the loan portfolio over the estimated life of the loans. We revert to historical credit loss experience for periods beyond forecasts that are reasonable and supportable. The allowance for credit losses is measured on a collective basis with consideration for debt service coverage 142 143 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 gains (losses), limited to the amount that the fair value is less than the amortized cost basis. Losses are written off against the allowance when deemed uncollectible or when we intend to sell or expect we will be required to sell a security prior to recovering its amortized cost. When there is an allowance for credit losses, we reassess the credit losses each balance sheet date and subsequent increases or decreases are recorded as an adjustment to the allowance for credit losses, with a corresponding gain or loss recorded in net investment gains (losses). Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with internal assumptions and judgments. When developing the estimate of cash flows expected to be collected at the individual security level, we utilize an analytical model that provides for various loss scenarios and consider the industry sector, current levels of subordination, geographic location and other relevant characteristics of the security or underlying assets, as well as reasonable and supportable forecasts. We regularly monitor our investment portfolio to ensure that securities with a credit loss are identified in a timely manner and any losses are recognized in the proper period. Accrued interest is included in accrued investment income in our consolidated balance sheet and had a carrying value of $504 million and $511 million as of December 31, 2023 and 2022, respectively. We exclude accrued interest related to available-for-sale fixed maturity securities from the estimated allowance for credit losses. Accrued interest on available-for-sale fixed maturity securities is deemed uncollectible and typically written off after 90 days; therefore, we do not measure an allowance for credit losses related to accrued interest. Amounts written off related to accrued interest are recorded as a credit loss expense included in net investment gains (losses). e) Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have fixed maturity securities, equity securities, short-term investments, limited partnerships, derivatives, embedded derivatives, separate account assets and certain other financial instruments, which are carried at fair value. Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. All assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: • Level 1—Quoted prices for identical instruments in active markets. • Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations for which inputs are observable or where those significant value drivers are observable. • Level 3—Instruments for which significant value drivers are unobservable. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as actively traded equity securities and actively traded mutual fund investments. Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs, such as interest rate, credit spread and foreign exchange rates for the underlying financial instruments. All significant inputs are observable, or derived from observable information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include certain public and private corporate fixed maturity and equity securities, government or agency securities, certain mortgage-backed and asset-backed securities, certain non-exchange- traded derivatives such as interest rate or cross currency swaps and short-term investments. Level 3 comprises financial instruments whose fair value is estimated based on industry-standard pricing methodologies and internally developed models utilizing significant inputs not based on, nor corroborated by, readily available market information. In certain instances, this category may also utilize non-binding broker quotes. This category primarily consists of certain less liquid fixed maturity and equity securities, certain derivative instruments or embedded derivatives where we cannot corroborate the significant valuation inputs with market observable data and market risk benefits (“MRBs”). As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability, such as the relative impact on the fair value as a result of including a particular input. We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. See note 21 for additional information related to fair value measurements. f) Commercial Mortgage Loans The carrying value of commercial mortgage loans is stated at principal amounts outstanding, net of unamortized premium or discount, deferred expenses and allowance for credit losses. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. Commercial mortgage loans are considered past due when contractual payments have not been received from the borrower by the required payment date. Loans are placed on non-accrual status when, in management’s opinion, the collection of principal or interest is not probable, typically when the collection of principal or interest is 90 days or more past due. In determining whether it is probable that we will be unable to collect all amounts due, we consider current payment status, debt service coverage ratios, occupancy levels and current loan-to-value. Income on loans on non-accrual status is not recognized until we believe it is probable that we will collect all future contractual principal and interest. Commercial mortgage loans are written off against the allowance to the extent principal or interest is deemed uncollectible. We determine the adequacy of the allowance for credit losses utilizing an analytical model that provides various loss scenarios based on historical experience adjusted for current events, trends, economic conditions and reasonable and supportable forecasts that result in a loss in the loan portfolio over the estimated life of the loans. We revert to historical credit loss experience for periods beyond forecasts that are reasonable and supportable. The allowance for credit losses is measured on a collective basis with consideration for debt service coverage 142 143 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 ratio, debt-to-value, property type and geographic location. Key inputs into the analytical model include exposure, weighted-average life, return, historical loss rates and forecast scenarios. Actual amounts realized over time could differ from the amounts estimated for the allowance for credit losses reported in the consolidated financial statements. Additions and reductions to the allowance through periodic provisions or benefits are recorded in net investment gains (losses). See note 5 for additional disclosures related to commercial mortgage loans. Accrued interest related to commercial mortgage loans is included in accrued investment income in our consolidated balance sheet and had a carrying value of $23 million and $22 million as of December 31, 2023 and 2022, respectively. We do not measure an allowance for credit losses related to accrued interest as uncollectible accrued interest related to our commercial mortgage loans is written off after 90 days and once collectability is determined to be uncertain and not probable. Amounts written off related to accrued interest are recorded as a credit loss expense included in net investment gains (losses). g) Limited Partnerships Limited partnerships are accounted for at fair value when our partnership interest is considered minor (generally less than 3% ownership in the limited partnerships) and we exercise no influence over operating and financial policies. For limited partnerships that do not have a readily determinable fair value, we utilize the net asset value (“NAV”) from the underlying fund statements as a practical expedient for fair value. Changes in the estimated fair value of these investments are included in net investment gains (losses) and income and expenses are reported in net investment income. Investment distributions are evaluated to determine whether the distribution is a return on investment, such as capital gains, interest income and dividend income, or a return of capital. If our ownership percentage exceeds the minor threshold, limited partnerships are accounted for using the equity method of accounting. Our proportionate share of the earnings or losses for limited partnerships accounted for using the equity method of accounting is included in net investment income. In applying either method, we use financial information provided by the investee generally on a one- to three-month lag. However, for limited partnerships measured at fair value, we consider whether an adjustment to the estimated fair value is necessary when the measurement date is not aligned with our reporting date. h) Derivatives Derivative instruments are used to mitigate or reduce our exposure to interest rate, equity market and foreign currency exchange risk associated with assets and liabilities held and forecasted transactions. On the date we enter into a derivative contract, management designates the derivative as a hedge of the identified exposure (cash flow or foreign currency). If a derivative does not qualify for hedge accounting, the changes in its fair value and all scheduled periodic settlement receipts and payments are reported in net income (loss). We formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking various hedge transactions. In this documentation, we specifically identify the asset, liability or forecasted transaction that has been designated as a hedged item, state how the hedging instrument is expected to hedge the risks related to the hedged item and set forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. We generally determine hedge effectiveness based on total changes in fair value of the hedged item attributable to the hedged risk and the total changes in fair value of the derivative instrument. We discontinue hedge accounting prospectively when: (i) it is determined that the derivative is no longer effective in offsetting changes in the cash flows of a hedged item; (ii) the derivative expires or is sold, terminated or exercised; (iii) the derivative is de-designated as a hedge instrument; or (iv) it is no longer probable that the forecasted transaction will occur. For all qualifying and highly effective cash flow hedges, changes in fair value of the derivative instrument are reported as a separate component of accumulated other comprehensive income (loss). When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the derivative continues to be carried in the consolidated balance sheets at its fair value, and gains and losses that were accumulated in other comprehensive income (loss) (“OCI”) are recognized immediately in net income (loss). When the hedged forecasted transaction is no longer probable, but is reasonably possible, the accumulated gain or loss remains in OCI and is recognized when the transaction affects net income (loss); however, prospective hedge accounting for the transaction is terminated. In all other situations in which hedge accounting is discontinued on a cash flow hedge, amounts previously deferred in OCI are reclassified into net income (loss) when net income (loss) is impacted by the variability of the cash flow of the hedged item. We may enter into contracts that are not themselves derivative instruments but contain embedded derivatives. For each contract, we assess whether the economic characteristics of the embedded derivative are clearly and closely related to those of the host contract and determine whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is separated from the host contract and accounted for as a stand-alone derivative. Such embedded derivatives are recorded in the consolidated balance sheets at fair value and are classified consistent with their host contract. Changes in their fair value are recognized in current period net income (loss). If we are unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried in the consolidated balance sheets at fair value, with changes in fair value recognized in current period net income (loss). Changes in the fair value of non-qualifying derivatives, including embedded derivatives, are reported in net investment gains (losses) with the exception of financial futures, which are associated with our MRBs and are reported in changes in fair value of market risk benefits and associated hedges. The majority of our derivative arrangements require the posting of collateral upon meeting certain net exposure thresholds. The amounts recognized for derivative counterparty collateral received by us are recorded in cash, cash equivalents and restricted cash with a corresponding amount recorded in other liabilities to represent our obligation to return the collateral retained by us. As of December 31, 2023 and 2022, the amount of cash collateral received from counterparties was $17 million and $16 million, respectively. We also receive non-cash collateral that is not recognized in our consolidated balance sheet unless we exercise our right to sell or re-pledge the underlying asset. As of December 31, 2023 and 2022, the fair value of non-cash collateral received was $2 million and $5 million, respectively, and the underlying assets were not sold or re-pledged. We pledged $1,100 million and $1,095 million of fixed maturity securities as of December 31, 2023 and 2022, respectively. Fixed maturity securities that we pledge as collateral remain in our consolidated balance sheet within fixed maturity securities available-for-sale. Any cash collateral pledged to a derivative counterparty is derecognized with a receivable recorded in other assets for the right to receive our cash collateral back from the counterparty. Daily changes in the fair value of the derivative contract, commonly referred to as variation margin, for 144 145 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 ratio, debt-to-value, property type and geographic location. Key inputs into the analytical model include exposure, weighted-average life, return, historical loss rates and forecast scenarios. Actual amounts realized over time could differ from the amounts estimated for the allowance for credit losses reported in the consolidated financial statements. Additions and reductions to the allowance through periodic provisions or benefits are recorded in net investment gains (losses). See note 5 for additional disclosures related to commercial mortgage loans. Accrued interest related to commercial mortgage loans is included in accrued investment income in our consolidated balance sheet and had a carrying value of $23 million and $22 million as of December 31, 2023 and 2022, respectively. We do not measure an allowance for credit losses related to accrued interest as uncollectible accrued interest related to our commercial mortgage loans is written off after 90 days and once collectability is determined to be uncertain and not probable. Amounts written off related to accrued interest are recorded as a credit loss expense included in net investment gains (losses). g) Limited Partnerships Limited partnerships are accounted for at fair value when our partnership interest is considered minor (generally less than 3% ownership in the limited partnerships) and we exercise no influence over operating and financial policies. For limited partnerships that do not have a readily determinable fair value, we utilize the net asset value (“NAV”) from the underlying fund statements as a practical expedient for fair value. Changes in the estimated fair value of these investments are included in net investment gains (losses) and income and expenses are reported in net investment income. Investment distributions are evaluated to determine whether the distribution is a return on investment, such as capital gains, interest income and dividend income, or a return of capital. If our ownership percentage exceeds the minor threshold, limited partnerships are accounted for using the equity method of accounting. Our proportionate share of the earnings or losses for limited partnerships accounted for using the equity method of accounting is included in net investment income. In applying either method, we use financial information provided by the investee generally on a one- to three-month lag. However, for limited partnerships measured at fair value, we consider whether an adjustment to the estimated fair value is necessary when the measurement date is not aligned with our reporting date. h) Derivatives Derivative instruments are used to mitigate or reduce our exposure to interest rate, equity market and foreign currency exchange risk associated with assets and liabilities held and forecasted transactions. On the date we enter into a derivative contract, management designates the derivative as a hedge of the identified exposure (cash flow or foreign currency). If a derivative does not qualify for hedge accounting, the changes in its fair value and all scheduled periodic settlement receipts and payments are reported in net income (loss). We formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking various hedge transactions. In this documentation, we specifically identify the asset, liability or forecasted transaction that has been designated as a hedged item, state how the hedging instrument is expected to hedge the risks related to the hedged item and set forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. We generally determine hedge effectiveness based on total changes in fair value of the hedged item attributable to the hedged risk and the total changes in fair value of the derivative instrument. We discontinue hedge accounting prospectively when: (i) it is determined that the derivative is no longer effective in offsetting changes in the cash flows of a hedged item; (ii) the derivative expires or is sold, terminated or exercised; (iii) the derivative is de-designated as a hedge instrument; or (iv) it is no longer probable that the forecasted transaction will occur. For all qualifying and highly effective cash flow hedges, changes in fair value of the derivative instrument are reported as a separate component of accumulated other comprehensive income (loss). When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the derivative continues to be carried in the consolidated balance sheets at its fair value, and gains and losses that were accumulated in other comprehensive income (loss) (“OCI”) are recognized immediately in net income (loss). When the hedged forecasted transaction is no longer probable, but is reasonably possible, the accumulated gain or loss remains in OCI and is recognized when the transaction affects net income (loss); however, prospective hedge accounting for the transaction is terminated. In all other situations in which hedge accounting is discontinued on a cash flow hedge, amounts previously deferred in OCI are reclassified into net income (loss) when net income (loss) is impacted by the variability of the cash flow of the hedged item. We may enter into contracts that are not themselves derivative instruments but contain embedded derivatives. For each contract, we assess whether the economic characteristics of the embedded derivative are clearly and closely related to those of the host contract and determine whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is separated from the host contract and accounted for as a stand-alone derivative. Such embedded derivatives are recorded in the consolidated balance sheets at fair value and are classified consistent with their host contract. Changes in their fair value are recognized in current period net income (loss). If we are unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried in the consolidated balance sheets at fair value, with changes in fair value recognized in current period net income (loss). Changes in the fair value of non-qualifying derivatives, including embedded derivatives, are reported in net investment gains (losses) with the exception of financial futures, which are associated with our MRBs and are reported in changes in fair value of market risk benefits and associated hedges. The majority of our derivative arrangements require the posting of collateral upon meeting certain net exposure thresholds. The amounts recognized for derivative counterparty collateral received by us are recorded in cash, cash equivalents and restricted cash with a corresponding amount recorded in other liabilities to represent our obligation to return the collateral retained by us. As of December 31, 2023 and 2022, the amount of cash collateral received from counterparties was $17 million and $16 million, respectively. We also receive non-cash collateral that is not recognized in our consolidated balance sheet unless we exercise our right to sell or re-pledge the underlying asset. As of December 31, 2023 and 2022, the fair value of non-cash collateral received was $2 million and $5 million, respectively, and the underlying assets were not sold or re-pledged. We pledged $1,100 million and $1,095 million of fixed maturity securities as of December 31, 2023 and 2022, respectively. Fixed maturity securities that we pledge as collateral remain in our consolidated balance sheet within fixed maturity securities available-for-sale. Any cash collateral pledged to a derivative counterparty is derecognized with a receivable recorded in other assets for the right to receive our cash collateral back from the counterparty. Daily changes in the fair value of the derivative contract, commonly referred to as variation margin, for 144 145 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 derivatives cleared through a central clearing party, such as the Chicago Mercantile Exchange are treated as daily settlements of the derivative contract. We test PVFP annually for recoverability as part of premium deficiency testing. See note 8 for additional information related to PVFP including recoverability. i) Cash, Cash Equivalents and Restricted Cash Certificates of deposit, money market funds and other highly liquid investments with original maturities of three months or less are considered cash equivalents in the consolidated balance sheets and consolidated statements of cash flows. Items with maturities greater than three months but less than one year at the time of acquisition are generally considered short-term investments. j) Deferred Acquisition Costs Acquisition costs include costs that are directly related to the successful acquisition of new or renewal of insurance contracts and are capitalized in the period incurred and deferred. Acquisition costs related to our long-duration insurance contracts primarily include commissions in excess of ultimate renewal commissions and for contracts issued, certain other costs such as underwriting, medical inspection, premium taxes and issuance expenses. Deferred acquisition costs (“DAC”) is measured on a grouped basis consistent with cohorts used to estimate the related liability for future policy benefits. DAC is deferred and amortized on a constant level basis for each cohort over the expected term of the related contracts, which approximates straight-line amortization. For our long-term care insurance products, DAC is amortized in proportion to total life count. For our life insurance products, DAC is amortized in proportion to the face amount in-force. For our fixed and variable annuity products, DAC is amortized in proportion to policy count. Assumptions used to amortize DAC are consistent with the assumptions used to estimate the related liability for future policy benefits. Revised assumptions are recognized prospectively over the remaining term of the related contract. The amortization rate is applied at the beginning of the current reporting period and reflects information available through the end of the current reporting period, including assumption updates, if applicable, and actual experience. Policyholders can elect to modify the benefits of certain products. If a contract modification results in substantial changes to the contract, the DAC on the original contract is written off immediately through income and any new deferrable costs associated with the new contract are deferred. If a contract modification does not substantially change the contract, the DAC on the original contract will continue to be amortized and any acquisition costs associated with the related modification are expensed immediately. Acquisition costs related to our mortgage insurance contracts primarily consist of underwriting costs and are amortized in proportion to estimated gross profit to the extent they are recoverable from future profits. k) Intangible Assets Present Value of Future Profits. In conjunction with the acquisition of a block of insurance policies or investment contracts, a portion of the purchase price is assigned to the right to receive future gross profits arising from existing insurance and investment contracts. This intangible asset, called PVFP, represents the actuarially estimated present value of future cash flows from the acquired policies. PVFP is amortized in a manner consistent with the amortization of DAC, which is in proportion to the face amount in-force for life insurance products. Deferred Sales Inducements to Contractholders. We defer sales inducements to contractholders for features on variable annuities that entitle the contractholder to an incremental amount to be credited to the account value upon making a deposit, and for fixed annuities with crediting rates higher than the contract’s expected ongoing crediting rates for periods after the inducement. Deferred sales inducements to contractholders are reported as a separate intangible asset and amortized in benefits and other changes in policy reserves using the same methodology and assumptions used to amortize DAC. Other Intangible Assets. We amortize the costs of other intangibles over their estimated useful lives unless such lives are deemed indefinite. Amortizable intangible assets are tested for impairment based on undiscounted cash flows, which requires the use of estimates and judgment, and are written down to fair value if impaired. Intangible assets with indefinite lives are tested at least annually for impairment using a qualitative or quantitative assessment and are written down to fair value as required. l) Reinsurance Premium revenue, benefits and acquisition and operating expenses, net of deferrals, are reported net of the amounts relating to reinsurance ceded to other companies in the consolidated statements of income. Amounts due from reinsurers for incurred and estimated future claims are reflected in the reinsurance recoverable asset in the consolidated balance sheets. Amounts received from reinsurers that represent recovery of acquisition costs are netted against DAC so that the net amount is capitalized. The cost of reinsurance, or the difference between amounts paid and the liabilities ceded at the inception of the reinsurance agreement, is deferred and amortized in a manner consistent with DAC over the terms of the related reinsurance treaties using the same assumptions as those used to account for the underlying reinsured policies. Premium revenue, benefits and acquisition and operating expenses, net of deferrals, for reinsurance contracts that do not qualify for reinsurance accounting are accounted for under the deposit method of accounting. Allowance for Credit Losses on Reinsurance Recoverables The allowance for credit losses related to reinsurance recoverables is evaluated based on historical loss experience adjusted for current events and reasonable and supportable forecasts from both internal and external sources. The allowance is measured by reinsurer, taking into consideration the reinsured product type and collateral type, and is calculated based on an externally reported probability of default corresponding to the reinsurer’s credit rating and the expected duration of the reinsurer’s contractual obligation to reimburse us for ceded claims on the underlying policies. Our estimate of the allowance reflects consideration for collateral securing the reinsurance agreements and expected recoveries of amounts previously charged off and expected to be charged off. We also consider other credit risk factors, including, among other factors, the historical frequency and severity of the associated insurance claims, aging of recoverables and regulatory, legal and economic factors, to determine if an additional incremental allowance for credit losses is required. No reversion adjustments are necessary as the starting point for our allowance for credit losses reflects historical loss experience covering the expected duration of the reinsurer’s contractual obligation to reimburse us. If available facts and circumstances indicate the reinsurance recoverable does not reflect expectations consistent with the collective analysis, the reinsurance recoverable is assessed on a separate basis. Write-offs are deducted from the allowance in the period the reinsurance recoverable is determined to be uncollectible. 146 147 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 derivatives cleared through a central clearing party, such as the Chicago Mercantile Exchange are treated as daily We test PVFP annually for recoverability as part of premium deficiency testing. See note 8 for additional settlements of the derivative contract. information related to PVFP including recoverability. i) Cash, Cash Equivalents and Restricted Cash Certificates of deposit, money market funds and other highly liquid investments with original maturities of three months or less are considered cash equivalents in the consolidated balance sheets and consolidated statements of cash flows. Items with maturities greater than three months but less than one year at the time of acquisition are generally considered short-term investments. j) Deferred Acquisition Costs Acquisition costs include costs that are directly related to the successful acquisition of new or renewal of insurance contracts and are capitalized in the period incurred and deferred. Acquisition costs related to our long-duration insurance contracts primarily include commissions in excess of ultimate renewal commissions and for contracts issued, certain other costs such as underwriting, medical inspection, premium taxes and issuance expenses. Deferred acquisition costs (“DAC”) is measured on a grouped basis consistent with cohorts used to estimate the related liability for future policy benefits. DAC is deferred and amortized on a constant level basis for each cohort over the expected term of the related contracts, which approximates straight-line amortization. For our long-term care insurance products, DAC is amortized in proportion to total life count. For our life insurance products, DAC is amortized in proportion to the face amount in-force. For our fixed and variable annuity products, DAC is amortized in proportion to policy count. Assumptions used to amortize DAC are consistent with the assumptions used to estimate the related liability for future policy benefits. Revised assumptions are recognized prospectively over the remaining term of the related contract. The amortization rate is applied at the beginning of the current reporting period and reflects information available through the end of the current reporting period, including assumption updates, if applicable, and actual experience. Policyholders can elect to modify the benefits of certain products. If a contract modification results in substantial changes to the contract, the DAC on the original contract is written off immediately through income and any new deferrable costs associated with the new contract are deferred. If a contract modification does not substantially change the contract, the DAC on the original contract will continue to be amortized and any acquisition costs associated with the related modification are expensed immediately. Acquisition costs related to our mortgage insurance contracts primarily consist of underwriting costs and are amortized in proportion to estimated gross profit to the extent they are recoverable from future profits. k) Intangible Assets Present Value of Future Profits. In conjunction with the acquisition of a block of insurance policies or investment contracts, a portion of the purchase price is assigned to the right to receive future gross profits arising from existing insurance and investment contracts. This intangible asset, called PVFP, represents the actuarially estimated present value of future cash flows from the acquired policies. PVFP is amortized in a manner consistent with the amortization of DAC, which is in proportion to the face amount in-force for life insurance products. Deferred Sales Inducements to Contractholders. We defer sales inducements to contractholders for features on variable annuities that entitle the contractholder to an incremental amount to be credited to the account value upon making a deposit, and for fixed annuities with crediting rates higher than the contract’s expected ongoing crediting rates for periods after the inducement. Deferred sales inducements to contractholders are reported as a separate intangible asset and amortized in benefits and other changes in policy reserves using the same methodology and assumptions used to amortize DAC. Other Intangible Assets. We amortize the costs of other intangibles over their estimated useful lives unless such lives are deemed indefinite. Amortizable intangible assets are tested for impairment based on undiscounted cash flows, which requires the use of estimates and judgment, and are written down to fair value if impaired. Intangible assets with indefinite lives are tested at least annually for impairment using a qualitative or quantitative assessment and are written down to fair value as required. l) Reinsurance Premium revenue, benefits and acquisition and operating expenses, net of deferrals, are reported net of the amounts relating to reinsurance ceded to other companies in the consolidated statements of income. Amounts due from reinsurers for incurred and estimated future claims are reflected in the reinsurance recoverable asset in the consolidated balance sheets. Amounts received from reinsurers that represent recovery of acquisition costs are netted against DAC so that the net amount is capitalized. The cost of reinsurance, or the difference between amounts paid and the liabilities ceded at the inception of the reinsurance agreement, is deferred and amortized in a manner consistent with DAC over the terms of the related reinsurance treaties using the same assumptions as those used to account for the underlying reinsured policies. Premium revenue, benefits and acquisition and operating expenses, net of deferrals, for reinsurance contracts that do not qualify for reinsurance accounting are accounted for under the deposit method of accounting. Allowance for Credit Losses on Reinsurance Recoverables The allowance for credit losses related to reinsurance recoverables is evaluated based on historical loss experience adjusted for current events and reasonable and supportable forecasts from both internal and external sources. The allowance is measured by reinsurer, taking into consideration the reinsured product type and collateral type, and is calculated based on an externally reported probability of default corresponding to the reinsurer’s credit rating and the expected duration of the reinsurer’s contractual obligation to reimburse us for ceded claims on the underlying policies. Our estimate of the allowance reflects consideration for collateral securing the reinsurance agreements and expected recoveries of amounts previously charged off and expected to be charged off. We also consider other credit risk factors, including, among other factors, the historical frequency and severity of the associated insurance claims, aging of recoverables and regulatory, legal and economic factors, to determine if an additional incremental allowance for credit losses is required. No reversion adjustments are necessary as the starting point for our allowance for credit losses reflects historical loss experience covering the expected duration of the reinsurer’s contractual obligation to reimburse us. If available facts and circumstances indicate the reinsurance recoverable does not reflect expectations consistent with the collective analysis, the reinsurance recoverable is assessed on a separate basis. Write-offs are deducted from the allowance in the period the reinsurance recoverable is determined to be uncollectible. 146 147 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 m) Separate Accounts Separate account assets represent funds for which the investment income and investment gains and losses accrue directly to the contractholders and are reflected in our consolidated balance sheets at fair value, reported as summary total separate account assets with an equivalent summary total reported for liabilities. Amounts assessed against the contractholders for mortality, administrative and other services are included in revenues. Net investment income and net investment gains (losses) accrue to the benefit of the contractholder and are offset within the same line item in the consolidated statements of income; as a result, there is no impact to net income (loss). There are no gains or losses on transfers of assets from the general account to the separate account. n) Insurance Reserves Future Policy Benefits The liability for future policy benefits is equal to the present value of expected future benefits and claim- related expenses, less the present value of expected future net premiums. Cash flow assumptions, as applicable, used to estimate the liability for future policy benefits include health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and estimates of future in-force rate actions, which include premium rate increases and benefit reductions associated with our long-term care insurance. Estimates of future in-force rate actions include those that are approved or anticipated to be approved, including premium rate increases and associated benefit reductions not yet filed. In addition, we have reached three legal settlements regarding alleged disclosure deficiencies in premium increases for long-term care insurance policies. Benefit reductions include those from in-force rate actions as well as the net impact of legal settlements, which also includes the cash payments made to policyholders who elect certain reduced benefit options in connection with legal settlements, referred to as settlement payments. Claim termination rates for our long-term care insurance represent the expected rates at which claims end, and benefit utilization rates represent the available policy benefits expected to be used. Both claim termination rates and benefit utilization rates are influenced by, among other things, gender, age at claim, diagnosis, type of care needed, benefit period and daily benefit amount. All payments under an insurance contract, including future expected claims and claims incurred, as well as related expenses, are measured together as an integrated reserve. As a result, we elected to present the aggregate liability as one line item within the liability for future policy benefits in our consolidated balance sheets, excluding amounts related to our Enact segment and certain life insurance and fixed annuity products not subject to new accounting guidance adopted on January 1, 2023 related to the recognition and measurement of long- duration insurance contracts, commonly known as long-duration targeted improvements (“LDTI”). The net premium ratio for long-duration traditional and limited-payment contracts is the portion of gross premiums required to provide for all future benefits. The net premium ratio is equal to the present value of actual historical and expected future benefits and expenses divided by the present value of actual historical and expected future gross premiums. For the purposes of calculating the net premium ratio, traditional and limited- payment long-duration insurance contracts are generally grouped into annual calendar-year cohorts based on the contract issue date, product type and company. Limited-payment contracts are grouped into cohorts separately from other traditional products, and riders are combined with the associated base policies. Acquired contracts are grouped by acquisition date, and reinsurance recoverables are grouped by treaty effective date. Cash flow assumptions used to estimate the liability for future policy benefits are monitored quarterly and are updated if emerging experience indicates a change is necessary. As a result, we expect to update the cash flow assumptions related to the implementation timing and approval amounts of in-force rate actions on a quarterly basis. We elected to update the net premium ratio quarterly for actual historical experience; therefore, during interim reporting periods we replace forecasted cash flow assumptions with actual cash flows with any difference recorded in net income (loss). We made an entity-wide election not to update our claim settlement expense assumptions; therefore, these assumptions remain locked-in as of January 1, 2021, the date in which the adoption of LDTI was required to be applied (the “Transition Date”), or if issued after the Transition Date, at the time of contract inception. In addition, all cash flow assumptions are reviewed at least annually in the same period each year. We conduct a formal review and update cash flow assumptions as necessary based on experience studies during the fourth quarter each year. Changes in cash flow assumptions are recorded using a retrospective approach with a cumulative catch-up adjustment by recalculating the net premium ratio using actual historical experience and updated future cash flow estimates over the expected remaining life of the contracts. The liability for future policy benefits is measured using two different discount rates, a current discount rate and a locked-in discount rate. The current discount rate is used to remeasure the liability for future policy benefits recorded in the consolidated balance sheets and is a current upper-medium grade fixed-income instrument yield, commonly interpreted to be a single-A rated bond rate, with the same duration as the corresponding liability. The current discount rate is updated quarterly, and the difference between the liability measured using the locked-in rate and the liability measured using the current rate is recorded in accumulated other comprehensive income (loss). The methodology used to determine the current discount rate assumption maximizes the use of relevant observable inputs and minimizes the use of unobservable inputs. The current discount rate assumption is based on a single-A curve published by a market data service. For cash flows projected beyond the observable curve, we use estimation techniques consistent with Level 3 fair value measurements to interpolate from the last observable rate to an estimated ultimate long-term rate. The locked-in discount rate is used to determine amounts recorded to net income (loss) and is held constant for the purposes of calculating the net premium ratio and interest accretion on the liability for future policy benefits. For policies in-force prior to the Transition Date, the locked-in discount rate is equal to the discount rate used immediately before the Transition Date. For contracts issued on or after the Transition Date, the locked-in discount rate for each issue-year cohort is determined as a single discount rate, calculated as the weighted- average monthly single-A fixed-income instrument forward curves over the calendar year determined using the methodology used for the current discount rate assumption, weighted using annualized premiums, face amounts and monthly premiums for long-term care insurance, life insurance and fixed and variable annuities, respectively. When the net premium ratio is updated, the liability for future policy benefits is remeasured at the beginning of the current reporting period using the updated cash flows and revised net premium ratio discounted by the locked-in discount rate. The remeasured liability for future policy benefits is compared to the liability for future policy benefits as of the prior reporting period using the locked-in discount rate, with any difference recorded as liability remeasurement (gains) losses in current period net income (loss). If the present value of future expected benefits and claim-related expenses exceeds the present value of future expected gross premiums, the net premium ratio is capped at 100% and the liability for future policy benefits is increased with a corresponding adjustment to net income (loss). In the event the liability for future policy benefits is negative as a result of the present value of future net premiums exceeding the present value of future expected benefits, we record a flooring adjustment to ensure the liability for future policy benefits for each cohort is not less than zero. This is 148 149 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 m) Separate Accounts Separate account assets represent funds for which the investment income and investment gains and losses accrue directly to the contractholders and are reflected in our consolidated balance sheets at fair value, reported as summary total separate account assets with an equivalent summary total reported for liabilities. Amounts assessed against the contractholders for mortality, administrative and other services are included in revenues. Net investment income and net investment gains (losses) accrue to the benefit of the contractholder and are offset within the same line item in the consolidated statements of income; as a result, there is no impact to net income (loss). There are no gains or losses on transfers of assets from the general account to the separate account. n) Insurance Reserves Future Policy Benefits The liability for future policy benefits is equal to the present value of expected future benefits and claim- related expenses, less the present value of expected future net premiums. Cash flow assumptions, as applicable, used to estimate the liability for future policy benefits include health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and estimates of future in-force rate actions, which include premium rate increases and benefit reductions associated with our long-term care insurance. Estimates of future in-force rate actions include those that are approved or anticipated to be approved, including premium rate increases and associated benefit reductions not yet filed. In addition, we have reached three legal settlements regarding alleged disclosure deficiencies in premium increases for long-term care insurance policies. Benefit reductions include those from in-force rate actions as well as the net impact of legal settlements, which also includes the cash payments made to policyholders who elect certain reduced benefit options in connection with legal settlements, referred to as settlement payments. Claim termination rates for our long-term care insurance represent the expected rates at which claims end, and benefit utilization rates represent the available policy benefits expected to be used. Both claim termination rates and benefit utilization rates are influenced by, among other things, gender, age at claim, diagnosis, type of care needed, benefit period and daily benefit amount. All payments under an insurance contract, including future expected claims and claims incurred, as well as related expenses, are measured together as an integrated reserve. As a result, we elected to present the aggregate liability as one line item within the liability for future policy benefits in our consolidated balance sheets, excluding amounts related to our Enact segment and certain life insurance and fixed annuity products not subject to new accounting guidance adopted on January 1, 2023 related to the recognition and measurement of long- duration insurance contracts, commonly known as long-duration targeted improvements (“LDTI”). The net premium ratio for long-duration traditional and limited-payment contracts is the portion of gross premiums required to provide for all future benefits. The net premium ratio is equal to the present value of actual historical and expected future benefits and expenses divided by the present value of actual historical and expected future gross premiums. For the purposes of calculating the net premium ratio, traditional and limited- payment long-duration insurance contracts are generally grouped into annual calendar-year cohorts based on the contract issue date, product type and company. Limited-payment contracts are grouped into cohorts separately from other traditional products, and riders are combined with the associated base policies. Acquired contracts are grouped by acquisition date, and reinsurance recoverables are grouped by treaty effective date. Cash flow assumptions used to estimate the liability for future policy benefits are monitored quarterly and are updated if emerging experience indicates a change is necessary. As a result, we expect to update the cash flow assumptions related to the implementation timing and approval amounts of in-force rate actions on a quarterly basis. We elected to update the net premium ratio quarterly for actual historical experience; therefore, during interim reporting periods we replace forecasted cash flow assumptions with actual cash flows with any difference recorded in net income (loss). We made an entity-wide election not to update our claim settlement expense assumptions; therefore, these assumptions remain locked-in as of January 1, 2021, the date in which the adoption of LDTI was required to be applied (the “Transition Date”), or if issued after the Transition Date, at the time of contract inception. In addition, all cash flow assumptions are reviewed at least annually in the same period each year. We conduct a formal review and update cash flow assumptions as necessary based on experience studies during the fourth quarter each year. Changes in cash flow assumptions are recorded using a retrospective approach with a cumulative catch-up adjustment by recalculating the net premium ratio using actual historical experience and updated future cash flow estimates over the expected remaining life of the contracts. The liability for future policy benefits is measured using two different discount rates, a current discount rate and a locked-in discount rate. The current discount rate is used to remeasure the liability for future policy benefits recorded in the consolidated balance sheets and is a current upper-medium grade fixed-income instrument yield, commonly interpreted to be a single-A rated bond rate, with the same duration as the corresponding liability. The current discount rate is updated quarterly, and the difference between the liability measured using the locked-in rate and the liability measured using the current rate is recorded in accumulated other comprehensive income (loss). The methodology used to determine the current discount rate assumption maximizes the use of relevant observable inputs and minimizes the use of unobservable inputs. The current discount rate assumption is based on a single-A curve published by a market data service. For cash flows projected beyond the observable curve, we use estimation techniques consistent with Level 3 fair value measurements to interpolate from the last observable rate to an estimated ultimate long-term rate. The locked-in discount rate is used to determine amounts recorded to net income (loss) and is held constant for the purposes of calculating the net premium ratio and interest accretion on the liability for future policy benefits. For policies in-force prior to the Transition Date, the locked-in discount rate is equal to the discount rate used immediately before the Transition Date. For contracts issued on or after the Transition Date, the locked-in discount rate for each issue-year cohort is determined as a single discount rate, calculated as the weighted- average monthly single-A fixed-income instrument forward curves over the calendar year determined using the methodology used for the current discount rate assumption, weighted using annualized premiums, face amounts and monthly premiums for long-term care insurance, life insurance and fixed and variable annuities, respectively. When the net premium ratio is updated, the liability for future policy benefits is remeasured at the beginning of the current reporting period using the updated cash flows and revised net premium ratio discounted by the locked-in discount rate. The remeasured liability for future policy benefits is compared to the liability for future policy benefits as of the prior reporting period using the locked-in discount rate, with any difference recorded as liability remeasurement (gains) losses in current period net income (loss). If the present value of future expected benefits and claim-related expenses exceeds the present value of future expected gross premiums, the net premium ratio is capped at 100% and the liability for future policy benefits is increased with a corresponding adjustment to net income (loss). In the event the liability for future policy benefits is negative as a result of the present value of future net premiums exceeding the present value of future expected benefits, we record a flooring adjustment to ensure the liability for future policy benefits for each cohort is not less than zero. This is 148 149 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 most prevalent in our term life insurance products due to their product design of a level premium period followed by annual premium rate increases. Impacts for flooring adjustments are recorded to benefits and other changes in policy reserves in current period net income (loss). Estimates and actuarial assumptions used for establishing the liability for future policy benefits involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have, and in the past have had, material impacts on our liability for future policy benefits and net income (loss). Assumptions are based on management’s best estimate and consider a variety of factors including historical and industry experience and trends, as well as market conditions and other factors. Refer to note 10 for additional information related to deviations between actual and expected experience during the period. Deferred Profit Liability We establish a deferred profit liability within the liability for future policy benefits in the consolidated balance sheets for limited-payment products at the time of contract issuance for any amount of gross premiums received in excess of net premiums, which is amortized and recognized in benefits and other changes in policy reserves in net income (loss) in proportion to expected future benefit payments for our fixed annuity products. We accrue interest on the unamortized deferred profit liability balance using the locked-in discount rate for the related liability for future policy benefits. Cash flow assumptions related to the deferred profit liability are consistent with the assumptions used to estimate the related liability for future policy benefits and are updated at the same time as the related liability for future policy benefits. We recalculate the deferred profit liability using updated cash flow assumptions as of the beginning of the current reporting period and compare it to the carrying amount as of the prior reporting period, with any difference recorded as liability remeasurement (gains) losses in current period net income (loss). Policyholder Account Balances The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. Investment-type contracts are broadly defined to include contracts without significant mortality or morbidity risk. Payments received from sales of investment contracts are recorded as deposits to the policyholder account balance. The policyholder account balance liability consists of accumulated account deposits, plus interest credited, less policyholder withdrawals and other charges assessed against the account balance. Interest rates credited to investment contracts are guaranteed for the initial policy term with renewal rates determined as necessary by management. In addition, some indexed crediting features included in our fixed annuity and universal life insurance products are accounted for as embedded derivatives. See notes 6 and 21 for additional information on these embedded derivatives and related fair value measurement disclosures. Additional Insurance Liabilities Additional insurance liabilities consist of secondary guarantees or product features in addition to the policyholder account balance on universal and term universal life insurance contracts that do not meet the criteria to be classified as MRBs or embedded derivatives. The additional insurance liability is equal to cumulative assessments multiplied by the current benefit ratio plus accrued interest, less excess payments. These additional benefit reserves are included in the liability for policyholder account balances in the consolidated balance sheets. The benefit ratio is equal to the present value of total expected benefit payments over the life of the contract divided by the present value of total expected assessments over the life of the contract, discounted by the projected crediting rate. The assumptions used to calculate the benefit ratio include insured mortality (i.e., life expectancy or longevity), interest rates and policyholder persistency or lapses, among other assumptions. The change in the additional insurance liability from the beginning of the current quarterly reporting period to the end of the current quarterly reporting period due to applying a revised benefit ratio is recorded as liability remeasurement (gains) losses in current period net income (loss). The calculation of our additional insurance liabilities includes investment performance. Therefore, we are required to analyze the impacts from net unrealized investment gains and losses on our available for-sale investment securities backing our additional insurance liabilities, as if those unrealized investment gains and losses were realized. These “shadow adjustments” result in the recognition of unrealized gains and losses on our additional insurance liabilities in a manner consistent with unrealized gains and losses on available-for-sale investment securities, which are recorded in accumulated other comprehensive income (loss). Changes to net unrealized investment gains and losses on available-for-sale investment securities backing our additional insurance liabilities may increase or decrease the shadow adjustments recorded within our additional insurance liabilities balance from period to period. Premium Deficiency Testing We conduct annual premium deficiency testing for all reserves related to our universal and term universal life insurance products included in additional insurance liabilities. A premium deficiency exists when the total liability currently established plus the current present value of expected future gross premiums (expected deposits to be paid by the policyholders, including any unearned revenue, and anticipated investment income) is less than the current present value of expected future benefits and settlement costs (including any unamortized PVFP). If it is determined a premium deficiency exists, PVFP is first written off, followed by an accrual for a premium deficiency reserve, if necessary. If a premium deficiency is recorded, PVFP amortization and the associated liabilities are remeasured using updated assumptions. o) Market Risk Benefits MRBs are benefit features associated with our fixed and variable annuity contracts that provide protection to the contractholder from and expose the insurer to other-than-nominal capital market risk. MRBs are measured at fair value using an income-based valuation model. Changes in fair value of market risk benefits, excluding changes attributable to instrument-specific credit risk (or non-performance risk) are reported as changes in fair value of market risk benefits and associated hedges in current period net income (loss). The portion of the change in fair value attributable to instrument-specific credit risk is recognized in accumulated other comprehensive income (loss). We offer certain minimum guarantees associated with our fixed annuity contracts that are classified as MRBs, including living benefits such as a guaranteed minimum withdrawal benefit (“GMWB”). The GMWB allows contractholders to withdraw a pre-defined percentage of account value or benefit base each year, either for a specified period of time or for the contractholders’ lifetime. 150 151 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 most prevalent in our term life insurance products due to their product design of a level premium period followed by annual premium rate increases. Impacts for flooring adjustments are recorded to benefits and other changes in policy reserves in current period net income (loss). Estimates and actuarial assumptions used for establishing the liability for future policy benefits involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have, and in the past have had, material impacts on our liability for future policy benefits and net income (loss). Assumptions are based on management’s best estimate and consider a variety of factors including historical and industry experience and trends, as well as market conditions and other factors. Refer to note 10 for additional information related to deviations between actual and expected experience during the period. Deferred Profit Liability We establish a deferred profit liability within the liability for future policy benefits in the consolidated balance sheets for limited-payment products at the time of contract issuance for any amount of gross premiums received in excess of net premiums, which is amortized and recognized in benefits and other changes in policy reserves in net income (loss) in proportion to expected future benefit payments for our fixed annuity products. We accrue interest on the unamortized deferred profit liability balance using the locked-in discount rate for the related liability for future policy benefits. Cash flow assumptions related to the deferred profit liability are consistent with the assumptions used to estimate the related liability for future policy benefits and are updated at the same time as the related liability for future policy benefits. We recalculate the deferred profit liability using updated cash flow assumptions as of the beginning of the current reporting period and compare it to the carrying amount as of the prior reporting period, with any difference recorded as liability remeasurement (gains) losses in current period net income (loss). Policyholder Account Balances The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. Investment-type contracts are broadly defined to include contracts without significant mortality or morbidity risk. Payments received from sales of investment contracts are recorded as deposits to the policyholder account balance. The policyholder account balance liability consists of accumulated account deposits, plus interest credited, less policyholder withdrawals and other charges assessed against the account balance. Interest rates credited to investment contracts are guaranteed for the initial policy term with renewal rates determined as necessary by management. In addition, some indexed crediting features included in our fixed annuity and universal life insurance products are accounted for as embedded derivatives. See notes 6 and 21 for additional information on these embedded derivatives and related fair value measurement disclosures. Additional Insurance Liabilities Additional insurance liabilities consist of secondary guarantees or product features in addition to the policyholder account balance on universal and term universal life insurance contracts that do not meet the criteria to be classified as MRBs or embedded derivatives. The additional insurance liability is equal to cumulative assessments multiplied by the current benefit ratio plus accrued interest, less excess payments. These additional benefit reserves are included in the liability for policyholder account balances in the consolidated balance sheets. The benefit ratio is equal to the present value of total expected benefit payments over the life of the contract divided by the present value of total expected assessments over the life of the contract, discounted by the projected crediting rate. The assumptions used to calculate the benefit ratio include insured mortality (i.e., life expectancy or longevity), interest rates and policyholder persistency or lapses, among other assumptions. The change in the additional insurance liability from the beginning of the current quarterly reporting period to the end of the current quarterly reporting period due to applying a revised benefit ratio is recorded as liability remeasurement (gains) losses in current period net income (loss). The calculation of our additional insurance liabilities includes investment performance. Therefore, we are required to analyze the impacts from net unrealized investment gains and losses on our available for-sale investment securities backing our additional insurance liabilities, as if those unrealized investment gains and losses were realized. These “shadow adjustments” result in the recognition of unrealized gains and losses on our additional insurance liabilities in a manner consistent with unrealized gains and losses on available-for-sale investment securities, which are recorded in accumulated other comprehensive income (loss). Changes to net unrealized investment gains and losses on available-for-sale investment securities backing our additional insurance liabilities may increase or decrease the shadow adjustments recorded within our additional insurance liabilities balance from period to period. Premium Deficiency Testing We conduct annual premium deficiency testing for all reserves related to our universal and term universal life insurance products included in additional insurance liabilities. A premium deficiency exists when the total liability currently established plus the current present value of expected future gross premiums (expected deposits to be paid by the policyholders, including any unearned revenue, and anticipated investment income) is less than the current present value of expected future benefits and settlement costs (including any unamortized PVFP). If it is determined a premium deficiency exists, PVFP is first written off, followed by an accrual for a premium deficiency reserve, if necessary. If a premium deficiency is recorded, PVFP amortization and the associated liabilities are remeasured using updated assumptions. o) Market Risk Benefits MRBs are benefit features associated with our fixed and variable annuity contracts that provide protection to the contractholder from and expose the insurer to other-than-nominal capital market risk. MRBs are measured at fair value using an income-based valuation model. Changes in fair value of market risk benefits, excluding changes attributable to instrument-specific credit risk (or non-performance risk) are reported as changes in fair value of market risk benefits and associated hedges in current period net income (loss). The portion of the change in fair value attributable to instrument-specific credit risk is recognized in accumulated other comprehensive income (loss). We offer certain minimum guarantees associated with our fixed annuity contracts that are classified as MRBs, including living benefits such as a guaranteed minimum withdrawal benefit (“GMWB”). The GMWB allows contractholders to withdraw a pre-defined percentage of account value or benefit base each year, either for a specified period of time or for the contractholders’ lifetime. 150 151 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 In addition, we offer certain minimum guarantees associated with our variable annuity contracts that are classified as MRBs. Our variable annuity contracts usually contain a basic guaranteed minimum death benefit (“GMDB”) which provides a minimum benefit to be paid upon the annuitant’s death equal to the larger of account value or the return of net deposits. Some variable annuity contracts permit contractholders to purchase through riders, at an additional charge, enhanced death benefits such as the highest contract anniversary value, accumulated net deposits at a stated rate or a combination thereof. Some of our variable annuity contracts provide the contractholder with living benefits such as a GMWB or certain types of guaranteed annuitization benefits. Additionally, some of our variable annuity contracts provide the contractholder with a guaranteed payout annuity floor (“GPAF”), which provides protection to the contractholder from the capital market risk of the variable annuity payment falling below the guaranteed floor. See notes 13 and 21 for additional information related to MRBs and related significant inputs, judgments, valuation methods and assumptions used in the fair value measurement. p) Liability for Policy and Contract Claims The liability for policy and contract claims, or loss reserves, represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (i) losses that have been reported to the insurer; (ii) losses related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (iii) loss adjustment expenses. Loss adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims. As is common accounting practice in the mortgage insurance industry and in accordance with U.S. GAAP, we do not establish loss reserves for future claims on insured loans that are not in default or believed to be in default. Estimates and actuarial assumptions used for establishing the liability for policy and contract claims involve the exercise of significant judgment. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The liabilities for our mortgage insurance policies represent our best estimates of the liabilities at the time based on known facts, trends and other external factors, including home prices, unemployment, government housing policies, state foreclosure timelines, general economic conditions, interest rates, tax policy, credit availability and mortgage products. Reserves for losses and loss adjustment expenses are based on notices of mortgage loan defaults and estimates of defaults that have been incurred but have not been reported by loan servicers. Reserves for losses are established by estimating the number of loans in our inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. Over time, as the status of the underlying delinquent loans moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase. Management considers the liability for policy and contract claims provided to be its best estimate to cover the losses that have occurred. Management monitors actual experience, and where circumstances warrant, will revise its assumptions. Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded in net income (loss). Future developments may result in losses greater or less than the liability for policy and contract claims provided. q) Unearned Premiums For single premium mortgage insurance products, we recognize a portion of the revenue in premiums earned in the current period, while the remaining portion is deferred as unearned premiums and earned over time in accordance with the expected pattern of risk emergence. If single premium policies are cancelled and the premium is non-refundable, then the remaining unearned premium related to each cancelled policy is recognized to earned premiums upon notification of the cancellation. Expected pattern of risk emergence on which we base premium recognition is inherently judgmental and is based on actuarial analysis of historical experience. We periodically review our premium earnings recognition models with any adjustments to the estimates reflected as a cumulative adjustment in current period net income (loss). Our reviews include the consideration of recent and projected loss experience, policy cancellation experience and refinement of actuarial methods. We did not have any adjustments associated with this review in 2023, 2022 or 2021. For share-based equity awards, we determine fair value on the grant date and recognize the related compensation expense, adjusted for expected forfeitures, through the income statement over the respective r) Stock-Based Compensation vesting period of the awards. s) Employee Benefit Plans We provide employees with a defined contribution pension plan and recognize expense throughout the year based on the employee’s age, service and eligible pay. We make an annual contribution to the plan. We also provide employees with defined contribution savings plans. We recognize expense for our contributions to the savings plans at the time employees make contributions to the plans. Some employees participate in defined benefit pension and postretirement benefit plans. We recognize expense for these plans based upon actuarial valuations performed by external experts. We estimate aggregate benefits by using assumptions for employee turnover, future compensation increases, rates of return on pension plan assets and future health care costs. We recognize an expense for differences between actual experience and estimates over the average future service period of participants. We recognize the overfunded or underfunded status of a defined benefit plan as an asset or liability in our consolidated balance sheets and recognize changes in that funded status in the year in which the changes occur through OCI. As of December 31, 2023 and 2022, we recognized a liability for these plans in other liabilities in the consolidated balance sheets. t) Income Taxes We determine deferred tax assets and/or liabilities by multiplying the differences between the financial reporting and tax reporting bases for assets and liabilities by the enacted tax rates expected to be in effect when such differences are recovered or settled if there is no change in law. The effect on deferred taxes of a change in 152 153 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 In addition, we offer certain minimum guarantees associated with our variable annuity contracts that are classified as MRBs. Our variable annuity contracts usually contain a basic guaranteed minimum death benefit (“GMDB”) which provides a minimum benefit to be paid upon the annuitant’s death equal to the larger of account value or the return of net deposits. Some variable annuity contracts permit contractholders to purchase through riders, at an additional charge, enhanced death benefits such as the highest contract anniversary value, accumulated net deposits at a stated rate or a combination thereof. Some of our variable annuity contracts provide the contractholder with living benefits such as a GMWB or certain types of guaranteed annuitization benefits. Additionally, some of our variable annuity contracts provide the contractholder with a guaranteed payout annuity floor (“GPAF”), which provides protection to the contractholder from the capital market risk of the variable annuity payment falling below the guaranteed floor. See notes 13 and 21 for additional information related to MRBs and related significant inputs, judgments, valuation methods and assumptions used in the fair value measurement. p) Liability for Policy and Contract Claims The liability for policy and contract claims, or loss reserves, represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (i) losses that have been reported to the insurer; (ii) losses related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (iii) loss adjustment expenses. Loss adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims. As is common accounting practice in the mortgage insurance industry and in accordance with U.S. GAAP, we do not establish loss reserves for future claims on insured loans that are not in default or believed to be in default. Estimates and actuarial assumptions used for establishing the liability for policy and contract claims involve the exercise of significant judgment. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The liabilities for our mortgage insurance policies represent our best estimates of the liabilities at the time based on known facts, trends and other external factors, including home prices, unemployment, government housing policies, state foreclosure timelines, general economic conditions, interest rates, tax policy, credit availability and mortgage products. Reserves for losses and loss adjustment expenses are based on notices of mortgage loan defaults and estimates of defaults that have been incurred but have not been reported by loan servicers. Reserves for losses are established by estimating the number of loans in our inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. Over time, as the status of the underlying delinquent loans moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase. Management considers the liability for policy and contract claims provided to be its best estimate to cover the losses that have occurred. Management monitors actual experience, and where circumstances warrant, will revise its assumptions. Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded in net income (loss). Future developments may result in losses greater or less than the liability for policy and contract claims provided. q) Unearned Premiums For single premium mortgage insurance products, we recognize a portion of the revenue in premiums earned in the current period, while the remaining portion is deferred as unearned premiums and earned over time in accordance with the expected pattern of risk emergence. If single premium policies are cancelled and the premium is non-refundable, then the remaining unearned premium related to each cancelled policy is recognized to earned premiums upon notification of the cancellation. Expected pattern of risk emergence on which we base premium recognition is inherently judgmental and is based on actuarial analysis of historical experience. We periodically review our premium earnings recognition models with any adjustments to the estimates reflected as a cumulative adjustment in current period net income (loss). Our reviews include the consideration of recent and projected loss experience, policy cancellation experience and refinement of actuarial methods. We did not have any adjustments associated with this review in 2023, 2022 or 2021. r) Stock-Based Compensation For share-based equity awards, we determine fair value on the grant date and recognize the related compensation expense, adjusted for expected forfeitures, through the income statement over the respective vesting period of the awards. s) Employee Benefit Plans We provide employees with a defined contribution pension plan and recognize expense throughout the year based on the employee’s age, service and eligible pay. We make an annual contribution to the plan. We also provide employees with defined contribution savings plans. We recognize expense for our contributions to the savings plans at the time employees make contributions to the plans. Some employees participate in defined benefit pension and postretirement benefit plans. We recognize expense for these plans based upon actuarial valuations performed by external experts. We estimate aggregate benefits by using assumptions for employee turnover, future compensation increases, rates of return on pension plan assets and future health care costs. We recognize an expense for differences between actual experience and estimates over the average future service period of participants. We recognize the overfunded or underfunded status of a defined benefit plan as an asset or liability in our consolidated balance sheets and recognize changes in that funded status in the year in which the changes occur through OCI. As of December 31, 2023 and 2022, we recognized a liability for these plans in other liabilities in the consolidated balance sheets. t) Income Taxes We determine deferred tax assets and/or liabilities by multiplying the differences between the financial reporting and tax reporting bases for assets and liabilities by the enacted tax rates expected to be in effect when such differences are recovered or settled if there is no change in law. The effect on deferred taxes of a change in 152 153 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 tax rates is recognized in net income (loss) in the period that includes the enactment date. Valuation allowances on deferred tax assets are estimated based on our assessment of the realizability of such amounts. fulfill the obligations of the securitization entity. We do not have any additional exposure or guarantees associated with this securitization entity. There was no new asset securitization activity in 2023. Under U.S. GAAP, we are generally required to record U.S. deferred taxes on the anticipated repatriation of foreign income as the income is recognized for financial reporting purposes. An exception under certain accounting guidance permits us not to record a U.S. deferred tax liability for foreign income that we expect to reinvest in our foreign operations and for which remittance will be postponed indefinitely. If it becomes apparent that we cannot positively assert that some or all undistributed income will be reinvested indefinitely, the related deferred taxes are recorded in that period based on the expected form of repatriation (i.e., distribution, loan or sale). In determining indefinite reinvestment, we regularly evaluate the capital needs of our domestic and foreign operations considering all available information, including operating and capital plans, regulatory capital requirements, parent company financing and cash flow needs, as well as the applicable tax laws to which our domestic and foreign subsidiaries are subject. Similarly, under another exception to the recognition of deferred taxes under U.S. GAAP, we do not record deferred taxes on U.S. domestic subsidiary entities for the excess of the financial statement carrying amount over the tax basis in the stock of the subsidiary (commonly referred to as “outside basis difference”) if we have the ability under the tax law and intent to recover the basis difference in a tax-free manner. Deferred taxes would be recognized in the period of a change to our ability or intent. Our companies have elected to file a single U.S. consolidated income tax return (the “life/non-life consolidated return”). All companies domesticated in the United States are included in the life/non-life consolidated return as allowed by the tax law and regulations. We have a tax sharing agreement in place and all intercompany balances related to this agreement are settled at least annually. u) Variable Interest Entities We are involved in certain entities that are considered VIEs as defined under U.S. GAAP, and accordingly, we evaluate the VIE to determine whether we are the primary beneficiary and are required to consolidate the assets and liabilities of the entity. The primary beneficiary of a VIE is the enterprise that has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and has the obligation to absorb losses or receive benefits that could potentially be significant to the VIE. The determination of the primary beneficiary for a VIE can be complex and requires management judgment regarding the expected results of the entity and how those results are absorbed by variable interest holders, as well as which party has the power to direct activities that most significantly impact the performance of the VIEs. Our primary involvement related to VIEs includes securitization transactions, certain investments and reinsurance transactions. We have a beneficial interest in a VIE where we are the servicer and transferor of certain assets that were sold to the VIE. Our primary economic interest in this VIE represents the excess interest of the commercial mortgage loans. This securitization entity was designed to have significant limitations on the types of assets owned, the types and extent of permitted activities and decision making rights and is comprised of an entity backed by commercial mortgage loans. As a result of our involvement in the entity’s design or having certain decision making ability regarding the assets held by the securitization entity, consolidation of the VIE is required. As of December 31, 2023 and 2022, we had $16 million and $21 million, respectively, of total securitized assets required to be consolidated. The assets held by the securitization entity are restricted and can only be used to We have excess of loss reinsurance agreements with entities that are considered VIEs. These entities finance the reinsurance coverage by issuing mortgage insurance-linked notes to unaffiliated investors. The assets of the VIEs are deposited in reinsurance trusts for our benefit that will be the source of reinsurance claim payments. Our involvement with these VIEs represents mortgage insurance claim coverage through excess of loss reinsurance, which includes significant insurance risk and a reasonable possibility of a significant loss but does not result in the unilateral power to direct the activities that most significantly affect the VIEs’ economic performance or result in the obligation to absorb losses or the right to receive benefits. Accordingly, consolidation of the VIEs is not required. Refer to note 9 for additional information related to our reinsurance agreements with entities that are considered VIEs. We hold investments in certain structures that are considered VIEs. Our investments represent beneficial interests that are primarily in the form of structured securities or limited partnership investments. Our involvement in these structures typically represents a passive investment in the returns generated by the VIE and typically does not result in having significant influence over the economic performance of the VIE. Refer to note 5 for additional information related to our limited partnership investments that are considered VIEs. v) Leases We have leased assets predominantly classified as operating leases, which are recognized both as a right-of-use asset and a corresponding lease liability in our consolidated balance sheets. Our leased assets consist of office space in nine locations in the United States and one location in Mexico. Lease payments included in the calculation of our lease liability include fixed amounts contained within each rental agreement and variable lease payments that are based upon an index or rate. We combine lease and non-lease components and as a result, non-lease components are included in the calculation of our lease liability. Our remaining lease terms ranged from less than one year to 15 years and had a weighted-average remaining lease term of eight years as of December 31, 2023. The implicit rate of our lease agreements was not readily determinable; therefore, we utilized our incremental borrowing rate to discount future lease payments. The weighted-average discount rate was 7.2% as of December 31, 2023. The amount of contractual undiscounted lease obligations due in 2024, 2025, 2026, 2027, and 2028 and thereafter is $10 million, $12 million, $10 million, $9 million and $22 million, respectively. As of December 31, 2023, the operating lease liability recorded in other liabilities in our consolidated balance sheet of $48 million was net of imputed interest of $15 million. w) Accounting Changes Long-Duration Targeted Improvements On January 1, 2023, we adopted LDTI, which significantly changed the recognition and measurement of long-duration insurance contracts. This new accounting guidance directly impacted DAC, intangible assets and insurance assets and liabilities in our U.S. life insurance subsidiaries, and also significantly increased our disclosure requirements. The new guidance does not impact our Enact segment and Corporate and Other. We adopted this new accounting guidance using the modified retrospective transition method for all topics except for MRBs, which was required to be applied using the retrospective transition method. The modified retrospective transition method generally results in applying the guidance to contracts on the basis of existing 154 155 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 tax rates is recognized in net income (loss) in the period that includes the enactment date. Valuation allowances on deferred tax assets are estimated based on our assessment of the realizability of such amounts. fulfill the obligations of the securitization entity. We do not have any additional exposure or guarantees associated with this securitization entity. There was no new asset securitization activity in 2023. Under U.S. GAAP, we are generally required to record U.S. deferred taxes on the anticipated repatriation of foreign income as the income is recognized for financial reporting purposes. An exception under certain accounting guidance permits us not to record a U.S. deferred tax liability for foreign income that we expect to reinvest in our foreign operations and for which remittance will be postponed indefinitely. If it becomes apparent that we cannot positively assert that some or all undistributed income will be reinvested indefinitely, the related deferred taxes are recorded in that period based on the expected form of repatriation (i.e., distribution, loan or sale). In determining indefinite reinvestment, we regularly evaluate the capital needs of our domestic and foreign operations considering all available information, including operating and capital plans, regulatory capital requirements, parent company financing and cash flow needs, as well as the applicable tax laws to which our domestic and foreign subsidiaries are subject. Similarly, under another exception to the recognition of deferred taxes under U.S. GAAP, we do not record deferred taxes on U.S. domestic subsidiary entities for the excess of the financial statement carrying amount over the tax basis in the stock of the subsidiary (commonly referred to as “outside basis difference”) if we have the ability under the tax law and intent to recover the basis difference in a tax-free manner. Deferred taxes would be recognized in the period of a change to our ability or intent. Our companies have elected to file a single U.S. consolidated income tax return (the “life/non-life consolidated return”). All companies domesticated in the United States are included in the life/non-life consolidated return as allowed by the tax law and regulations. We have a tax sharing agreement in place and all intercompany balances related to this agreement are settled at least annually. u) Variable Interest Entities We are involved in certain entities that are considered VIEs as defined under U.S. GAAP, and accordingly, we evaluate the VIE to determine whether we are the primary beneficiary and are required to consolidate the assets and liabilities of the entity. The primary beneficiary of a VIE is the enterprise that has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and has the obligation to absorb losses or receive benefits that could potentially be significant to the VIE. The determination of the primary beneficiary for a VIE can be complex and requires management judgment regarding the expected results of the entity and how those results are absorbed by variable interest holders, as well as which party has the power to direct activities that most significantly impact the performance of the VIEs. Our primary involvement related to VIEs includes securitization transactions, certain investments and reinsurance transactions. We have a beneficial interest in a VIE where we are the servicer and transferor of certain assets that were sold to the VIE. Our primary economic interest in this VIE represents the excess interest of the commercial mortgage loans. This securitization entity was designed to have significant limitations on the types of assets owned, the types and extent of permitted activities and decision making rights and is comprised of an entity backed by commercial mortgage loans. As a result of our involvement in the entity’s design or having certain decision making ability regarding the assets held by the securitization entity, consolidation of the VIE is required. As of December 31, 2023 and 2022, we had $16 million and $21 million, respectively, of total securitized assets required to be consolidated. The assets held by the securitization entity are restricted and can only be used to We have excess of loss reinsurance agreements with entities that are considered VIEs. These entities finance the reinsurance coverage by issuing mortgage insurance-linked notes to unaffiliated investors. The assets of the VIEs are deposited in reinsurance trusts for our benefit that will be the source of reinsurance claim payments. Our involvement with these VIEs represents mortgage insurance claim coverage through excess of loss reinsurance, which includes significant insurance risk and a reasonable possibility of a significant loss but does not result in the unilateral power to direct the activities that most significantly affect the VIEs’ economic performance or result in the obligation to absorb losses or the right to receive benefits. Accordingly, consolidation of the VIEs is not required. Refer to note 9 for additional information related to our reinsurance agreements with entities that are considered VIEs. We hold investments in certain structures that are considered VIEs. Our investments represent beneficial interests that are primarily in the form of structured securities or limited partnership investments. Our involvement in these structures typically represents a passive investment in the returns generated by the VIE and typically does not result in having significant influence over the economic performance of the VIE. Refer to note 5 for additional information related to our limited partnership investments that are considered VIEs. v) Leases We have leased assets predominantly classified as operating leases, which are recognized both as a right-of-use asset and a corresponding lease liability in our consolidated balance sheets. Our leased assets consist of office space in nine locations in the United States and one location in Mexico. Lease payments included in the calculation of our lease liability include fixed amounts contained within each rental agreement and variable lease payments that are based upon an index or rate. We combine lease and non-lease components and as a result, non-lease components are included in the calculation of our lease liability. Our remaining lease terms ranged from less than one year to 15 years and had a weighted-average remaining lease term of eight years as of December 31, 2023. The implicit rate of our lease agreements was not readily determinable; therefore, we utilized our incremental borrowing rate to discount future lease payments. The weighted-average discount rate was 7.2% as of December 31, 2023. The amount of contractual undiscounted lease obligations due in 2024, 2025, 2026, 2027, and 2028 and thereafter is $10 million, $12 million, $10 million, $9 million and $22 million, respectively. As of December 31, 2023, the operating lease liability recorded in other liabilities in our consolidated balance sheet of $48 million was net of imputed interest of $15 million. w) Accounting Changes Long-Duration Targeted Improvements On January 1, 2023, we adopted LDTI, which significantly changed the recognition and measurement of long-duration insurance contracts. This new accounting guidance directly impacted DAC, intangible assets and insurance assets and liabilities in our U.S. life insurance subsidiaries, and also significantly increased our disclosure requirements. The new guidance does not impact our Enact segment and Corporate and Other. We adopted this new accounting guidance using the modified retrospective transition method for all topics except for MRBs, which was required to be applied using the retrospective transition method. The modified retrospective transition method generally results in applying the guidance to contracts on the basis of existing 154 155 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 carrying values as of the Transition Date. The new accounting guidance, for all topics, was applied as of the Transition Date with an adjustment to beginning retained earnings and accumulated other comprehensive income (loss). In addition, prior period financial information has been re-presented in accordance with the new accounting standard. As of the Transition Date, we decreased total stockholders’ equity by $13.7 billion after-tax. The total decrease to stockholders’ equity included a reduction to retained earnings of $2.2 billion and a reduction in accumulated other comprehensive income (loss) of $11.5 billion. Our long-term care insurance business was the most significantly impacted from the adoption due to the requirement to remeasure the liability for future policy benefits and related reinsurance recoverables at the single-A bond rate as of the Transition Date, which at that time was materially lower than the locked-in discount rate. Refer to note 3 for further information about the cumulative effect adjustment recorded upon adoption of this new accounting guidance. The following table presents the impacted lines of the consolidated balance sheet reflecting the impact of adopting LDTI on January 1, 2023 as of December 31, 2022: Benefits and expenses: (Amounts in millions) Assets Deferred acquisition costs . . . . . . . . . . . . . . . . Intangible assets . . . . . . . . . . . . . . . . . . . . . . . Reinsurance recoverable . . . . . . . . . . . . . . . . . Less: Allowance for credit losses . . . . . . . . Reinsurance recoverable, net . . . . . . . . . Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred tax asset . . . . . . . . . . . . . . . . . . . . . . Market risk benefit assets . . . . . . . . . . . . . . . . Total assets . . . . . . . . . . . . . . . . . . . . . Liabilities and equity Liabilities: Future policy benefits . . . . . . . . . . . . . . . . . Policyholder account balances . . . . . . . . . . Market risk benefit liabilities . . . . . . . . . . . Liability for policy and contract claims . . . Unearned premiums . . . . . . . . . . . . . . . . . . Other liabilities . . . . . . . . . . . . . . . . . . . . . . Total liabilities . . . . . . . . . . . . . . . . . . Equity: Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . Retained earnings . . . . . . . . . . . . . . . . . . . . Total Genworth Financial, Inc.’s stockholders’ equity . . . . . . . . . . . . Total equity . . . . . . . . . . . . . . . . . . . . . Total liabilities and equity . . . . . . . . . As originally reported Effect of adopting LDTI As adjusted $ 2,200 241 16,495 (60) 16,435 415 1,344 — 86,442 38,064 17,113 — 12,234 584 1,672 75,703 (2,220) 3,098 9,984 10,739 86,442 $ 11 (38) 2,564 (3) 2,561 73 639 26 3,272 17,343 (549) 748 (11,551) (381) 15 5,625 (394) (1,959) (2,353) (2,353) 3,272 $ 2,211 203 19,059 (63) 18,996 488 1,983 26 89,714 55,407 16,564 748 683 203 1,687 81,328 (2,614) 1,139 7,631 8,386 89,714 156 157 The following table presents the impacted lines of the consolidated statements of income reflecting the impact of adopting LDTI on January 1, 2023 for the years ended December 31: 2022 As originally reported Effect of adopting LDTI As As adjusted originally reported 2021 Effect of adopting LDTI As adjusted (Amounts in millions, except per share amounts) Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,719 $ (39) $3,680 $3,435 $ (29) $3,406 Net investment gains (losses) . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . (17) 659 Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . 7,507 15 12 (12) (2) 671 7,495 323 704 7,832 (1) 20 (10) 322 724 7,822 Benefits and other changes in policy reserves . . . . . . Liability remeasurement (gains) losses . . . . . . . . . . . 4,242 — 61 (290) 4,303 (290) 4,383 — 192 242 4,575 242 Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 503 (104) 1 (104) 504 — 508 (160) 3 (160) 511 Acquisition and operating expenses, net of deferrals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,371 (86) 1,285 1,223 (225) 998 Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total benefits and expenses . . . . . . . . . . . . . . . . 307 6,529 19 (399) 326 6,130 978 239 739 739 387 80 307 307 1,365 319 1,046 1,046 377 6,651 1,181 263 918 945 7 59 384 6,710 (69) (15) (54) (54) 1,112 248 864 891 common stockholders . . . . . . . . . . . . . . . . . . . . . . 609 307 916 904 (54) 850 stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 609 307 916 885 (54) 831 common stockholders . . . . . . . . . . . . . . . . . . . . . . 609 307 916 904 (54) 850 Income from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision for income taxes . . . . . . . . . . . . . . . . . . . . Income from continuing operations . . . . . . . . . . . . . Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income available to Genworth Financial, Inc.’s Income from continuing operations available to Genworth Financial, Inc.’s common Net income available to Genworth Financial, Inc.’s Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.21 1.19 0.61 0.60 1.82 1.79 1.75 1.72 (0.11) (0.11) 1.64 1.61 Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.21 1.19 0.61 0.60 1.82 1.79 1.78 1.76 (0.10) (0.11) 1.68 1.65 carrying values as of the Transition Date. The new accounting guidance, for all topics, was applied as of the Transition Date with an adjustment to beginning retained earnings and accumulated other comprehensive income (loss). In addition, prior period financial information has been re-presented in accordance with the new accounting standard. As of the Transition Date, we decreased total stockholders’ equity by $13.7 billion after-tax. The total decrease to stockholders’ equity included a reduction to retained earnings of $2.2 billion and a reduction in accumulated other comprehensive income (loss) of $11.5 billion. Our long-term care insurance business was the most significantly impacted from the adoption due to the requirement to remeasure the liability for future policy benefits and related reinsurance recoverables at the single-A bond rate as of the Transition Date, which at that time was materially lower than the locked-in discount rate. Refer to note 3 for further information about the cumulative effect adjustment recorded upon adoption of this new accounting guidance. The following table presents the impacted lines of the consolidated balance sheet reflecting the impact of adopting LDTI on January 1, 2023 as of December 31, 2022: (Amounts in millions) Assets Deferred acquisition costs . . . . . . . . . . . . . . . . Intangible assets . . . . . . . . . . . . . . . . . . . . . . . Reinsurance recoverable . . . . . . . . . . . . . . . . . Less: Allowance for credit losses . . . . . . . . Reinsurance recoverable, net . . . . . . . . . Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred tax asset . . . . . . . . . . . . . . . . . . . . . . Market risk benefit assets . . . . . . . . . . . . . . . . Total assets . . . . . . . . . . . . . . . . . . . . . Liabilities and equity Liabilities: Equity: Future policy benefits . . . . . . . . . . . . . . . . . Policyholder account balances . . . . . . . . . . Market risk benefit liabilities . . . . . . . . . . . Liability for policy and contract claims . . . Unearned premiums . . . . . . . . . . . . . . . . . . Other liabilities . . . . . . . . . . . . . . . . . . . . . . Total liabilities . . . . . . . . . . . . . . . . . . Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . Retained earnings . . . . . . . . . . . . . . . . . . . . Total Genworth Financial, Inc.’s stockholders’ equity . . . . . . . . . . . . Total equity . . . . . . . . . . . . . . . . . . . . . Total liabilities and equity . . . . . . . . . As originally reported Effect of adopting LDTI As adjusted $ 2,200 241 16,495 (60) 16,435 415 1,344 — 86,442 38,064 17,113 — 12,234 584 1,672 75,703 (2,220) 3,098 9,984 10,739 86,442 $ 11 (38) 2,564 (3) 2,561 73 639 26 3,272 17,343 (549) 748 (11,551) (381) 15 5,625 (394) (1,959) (2,353) (2,353) 3,272 $ 2,211 203 19,059 (63) 18,996 488 1,983 26 89,714 55,407 16,564 748 683 203 1,687 81,328 (2,614) 1,139 7,631 8,386 89,714 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table presents the impacted lines of the consolidated statements of income reflecting the impact of adopting LDTI on January 1, 2023 for the years ended December 31: (Amounts in millions, except per share amounts) Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . Benefits and expenses: Benefits and other changes in policy reserves . . . . . . Liability remeasurement (gains) losses . . . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition and operating expenses, net of 2022 2021 As originally reported Effect of adopting LDTI As adjusted As originally reported Effect of adopting LDTI As adjusted $3,719 (17) 659 7,507 $ (39) $3,680 (2) 671 7,495 15 12 (12) $3,435 323 704 7,832 $ (29) $3,406 322 724 7,822 (1) 20 (10) 4,242 — 61 (290) 4,303 (290) 4,383 — 192 242 4,575 242 — 503 (104) 1 (104) 504 — 508 (160) 3 (160) 511 deferrals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,371 (86) 1,285 1,223 (225) 998 Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total benefits and expenses . . . . . . . . . . . . . . . . 307 6,529 19 (399) 326 6,130 Income from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision for income taxes . . . . . . . . . . . . . . . . . . . . Income from continuing operations . . . . . . . . . . . . . Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income available to Genworth Financial, Inc.’s common stockholders per share: 978 239 739 739 387 80 307 307 1,365 319 1,046 1,046 377 6,651 1,181 263 918 945 7 59 384 6,710 (69) (15) (54) (54) 1,112 248 864 891 609 307 916 904 (54) 850 609 307 916 885 (54) 831 609 307 916 904 (54) 850 1.21 1.19 0.61 0.60 1.82 1.79 1.75 1.72 (0.11) (0.11) 1.64 1.61 Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.21 1.19 0.61 0.60 1.82 1.79 1.78 1.76 (0.10) (0.11) 1.68 1.65 156 157 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table presents the impacted lines of the consolidated statements of cash flows reflecting the Reference Rate Reform impact of adopting LDTI on January 1, 2023 for the years ended December 31: (Amounts in millions) Cash flows from (used by) operating activities: Net income Adjustments to reconcile net income to net cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . from operating activities: Net investment (gains) losses . . . . . . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . Charges assessed to policyholders . . . . . . . . . . Acquisition costs deferred . . . . . . . . . . . . . . . . . Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred income taxes . . . . . . . . . . . . . . . . . . . . Change in certain assets and liabilities: Accrued investment income and other assets . . Insurance reserves . . . . . . . . . . . . . . . . . . . . . . . Other liabilities, policy and contract claims and other policy-related balances . . . . . . . . . . . . . Net cash from operating activities . . . . . . . . . . . . . Troubled Debt Restructurings 2022 2021 As originally reported Effect of adopting LDTI As adjusted As originally reported Effect of adopting LDTI As adjusted $ 739 $ 307 $1,046 $ 945 $ (54) $ 891 17 (15) 2 (323) 1 (322) — (596) — 307 235 (161) 863 19 80 6 192 (104) 8 (12) (104) — (620) (588) (8) (12) 326 315 377 290 (160) 4 (8) 7 (15) (160) (616) (16) 384 275 (155) 1,055 (129) 642 (5) 526 (134) 1,168 129 1,049 (481) — (352) 1,049 310 437 (296) — 14 437 On April 1, 2022, we elected to early adopt new accounting guidance related to troubled debt restructurings and the vintage disclosures included within the accounting guidance for credit losses on financial instruments. The guidance eliminates the recognition and measurement requirements for troubled debt restructurings and requires creditors to instead apply existing guidance related to loan refinancing and restructuring to determine whether a modification results in a new loan or a continuation of an existing loan. The guidance also expands disclosures for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty and requires the presentation of gross write-offs by year of origination. We were permitted to early adopt this new accounting guidance as we adopted the accounting guidance related to credit losses on financial instruments on January 1, 2020. In accordance with the new accounting guidance, we adopted this guidance prospectively as of January 1, 2022, which did not have any impact at adoption. Simplification of Accounting for Income Taxes On January 1, 2021, we adopted new accounting guidance related to simplifying the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. We adopted this new accounting guidance using the retrospective method or modified retrospective method for certain changes and prospective method for all other changes, which did not have a significant impact on our consolidated financial statements and disclosures. 158 159 In March 2020, January 2021 and December 2022, the Financial Accounting Standards Board (the “FASB”) issued new accounting guidance related to reference rate reform, which was effective for us on January 1, 2020. The guidance provides temporary guidance to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform, which includes the transition away from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate. This guidance provides optional practical expedients and exceptions for applying generally accepted accounting principles to investments, derivatives or other transactions affected by reference rate reform such as those that impact the assessment of derivative hedge effectiveness and contract modifications, to include continuing hedge accounting when certain critical terms of a hedging relationship change and modifying certain effectiveness assessments to exclude certain potential sources of ineffectiveness. The guidance was updated to clarify that the optional practical expedients and exceptions can be applied to derivatives that use an interest rate for margining, discounting, or contract price alignment. In addition to the optional practical expedients, the guidance includes a general principle that permits an entity to consider contract modifications due to reference rate reform to be an event that does not require contract remeasurement at the modification date or reassessment of a previous accounting determination. We adopted this guidance prospectively and it did not have a significant impact on our consolidated financial statements or disclosures. x) Accounting Pronouncements Not Yet Adopted In December 2023, the FASB issued new accounting guidance to improve income tax disclosures. The guidance requires annual disclosure of specific categories in the income tax rate reconciliation, separate disclosure of additional information related to reconciling items that meet a quantitative threshold and additional disclosures about income taxes paid, among other qualitative and quantitative disclosure improvements. This guidance is effective for us for annual reporting periods beginning on January 1, 2025 using the prospective method, with early adoption permitted. We are currently evaluating the impact the guidance may have on our processes, controls and disclosures. In November 2023, the FASB issued new accounting guidance to improve segment reporting. The guidance requires annual and interim disclosure of significant segment expenses regularly provided to the Chief Operating Decision Maker (“CODM”) and other segment items. The guidance also requires disclosures about a segment’s profit or loss and assets, currently only required annually, to be disclosed on an interim basis. Under the new accounting guidance, public entities may disclose multiple measures of a segment’s profit or loss, as long as all disclosed measures are used by the CODM for purposes of assessing performance and allocating resources and at least one of the reported measures is that which management believes to be most consistent with U.S. GAAP measurement principles. This guidance is effective for us for annual reporting periods beginning on January 1, 2024 and interim reporting periods beginning on January 1, 2025 using the retrospective method, with early adoption permitted. We are currently evaluating the impact the guidance may have on our processes and disclosures. disclosures. In June 2022, the FASB issued new accounting guidance related to the fair value measurement of equity securities subject to contractual sale restrictions. The guidance clarifies existing fair value guidance on measuring the fair value of an equity security subject to contractual sale restrictions and adds new disclosures related to these securities. We will adopt this guidance prospectively for future reporting periods on the effective date of January 1, 2024. We do not expect any impact from this guidance on our consolidated financial statements and GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table presents the impacted lines of the consolidated statements of cash flows reflecting the Reference Rate Reform impact of adopting LDTI on January 1, 2023 for the years ended December 31: 2022 As originally reported Effect of adopting LDTI As As adjusted originally reported 2021 Effect of adopting LDTI As adjusted Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 739 $ 307 $1,046 $ 945 $ (54) $ 891 Net investment (gains) losses . . . . . . . . . . . . . . 17 (15) 2 (323) 1 (322) (Amounts in millions) Cash flows from (used by) operating activities: Adjustments to reconcile net income to net cash from operating activities: Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . Charges assessed to policyholders . . . . . . . . . . Acquisition costs deferred . . . . . . . . . . . . . . . . . Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred income taxes . . . . . . . . . . . . . . . . . . . . Change in certain assets and liabilities: Accrued investment income and other assets . . Insurance reserves . . . . . . . . . . . . . . . . . . . . . . . Other liabilities, policy and contract claims and other policy-related balances . . . . . . . . . . . . . Net cash from operating activities . . . . . . . . . . . . . Troubled Debt Restructurings — (596) — 307 235 (161) 863 (104) 8 (12) 19 80 6 192 (104) — (160) (588) (12) (620) (8) 326 315 377 290 4 (8) 7 (15) (160) (616) (16) 384 275 (155) 1,055 (129) 642 (5) 526 (134) 1,168 129 1,049 (481) — (352) 1,049 310 437 (296) — 14 437 On April 1, 2022, we elected to early adopt new accounting guidance related to troubled debt restructurings and the vintage disclosures included within the accounting guidance for credit losses on financial instruments. The guidance eliminates the recognition and measurement requirements for troubled debt restructurings and requires creditors to instead apply existing guidance related to loan refinancing and restructuring to determine whether a modification results in a new loan or a continuation of an existing loan. The guidance also expands disclosures for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty and requires the presentation of gross write-offs by year of origination. We were permitted to early adopt this new accounting guidance as we adopted the accounting guidance related to credit losses on financial instruments on January 1, 2020. In accordance with the new accounting guidance, we adopted this guidance prospectively as of January 1, 2022, which did not have any impact at adoption. Simplification of Accounting for Income Taxes On January 1, 2021, we adopted new accounting guidance related to simplifying the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. We adopted this new accounting guidance using the retrospective method or modified retrospective method for certain changes and prospective method for all other changes, which did not have a significant impact on our consolidated financial statements and disclosures. In March 2020, January 2021 and December 2022, the Financial Accounting Standards Board (the “FASB”) issued new accounting guidance related to reference rate reform, which was effective for us on January 1, 2020. The guidance provides temporary guidance to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform, which includes the transition away from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate. This guidance provides optional practical expedients and exceptions for applying generally accepted accounting principles to investments, derivatives or other transactions affected by reference rate reform such as those that impact the assessment of derivative hedge effectiveness and contract modifications, to include continuing hedge accounting when certain critical terms of a hedging relationship change and modifying certain effectiveness assessments to exclude certain potential sources of ineffectiveness. The guidance was updated to clarify that the optional practical expedients and exceptions can be applied to derivatives that use an interest rate for margining, discounting, or contract price alignment. In addition to the optional practical expedients, the guidance includes a general principle that permits an entity to consider contract modifications due to reference rate reform to be an event that does not require contract remeasurement at the modification date or reassessment of a previous accounting determination. We adopted this guidance prospectively and it did not have a significant impact on our consolidated financial statements or disclosures. x) Accounting Pronouncements Not Yet Adopted In December 2023, the FASB issued new accounting guidance to improve income tax disclosures. The guidance requires annual disclosure of specific categories in the income tax rate reconciliation, separate disclosure of additional information related to reconciling items that meet a quantitative threshold and additional disclosures about income taxes paid, among other qualitative and quantitative disclosure improvements. This guidance is effective for us for annual reporting periods beginning on January 1, 2025 using the prospective method, with early adoption permitted. We are currently evaluating the impact the guidance may have on our processes, controls and disclosures. In November 2023, the FASB issued new accounting guidance to improve segment reporting. The guidance requires annual and interim disclosure of significant segment expenses regularly provided to the Chief Operating Decision Maker (“CODM”) and other segment items. The guidance also requires disclosures about a segment’s profit or loss and assets, currently only required annually, to be disclosed on an interim basis. Under the new accounting guidance, public entities may disclose multiple measures of a segment’s profit or loss, as long as all disclosed measures are used by the CODM for purposes of assessing performance and allocating resources and at least one of the reported measures is that which management believes to be most consistent with U.S. GAAP measurement principles. This guidance is effective for us for annual reporting periods beginning on January 1, 2024 and interim reporting periods beginning on January 1, 2025 using the retrospective method, with early adoption permitted. We are currently evaluating the impact the guidance may have on our processes and disclosures. In June 2022, the FASB issued new accounting guidance related to the fair value measurement of equity securities subject to contractual sale restrictions. The guidance clarifies existing fair value guidance on measuring the fair value of an equity security subject to contractual sale restrictions and adds new disclosures related to these securities. We will adopt this guidance prospectively for future reporting periods on the effective date of January 1, 2024. We do not expect any impact from this guidance on our consolidated financial statements and disclosures. 158 159 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (3) Long-Duration Insurance Contracts Targeted Improvements The following table presents the balances of and changes in the consolidated balance sheet on January 1, Transition Disclosures On January 1, 2023, we adopted LDTI using the modified retrospective method for all topics except for MRBs, which was adopted using the retrospective method, as of January 1, 2021 or the Transition Date. When applying the new accounting guidance for MRBs, hindsight was applied where necessary to determine actuarial assumptions for MRBs primarily associated with variable annuities for certain older blocks of business issued before 2003 and certain small runoff blocks of business as observable data was not available. The modified retrospective approach for DAC and balances amortized on a basis consistent with DAC was applied before MRBs were retrospectively measured and, as a result, the historical DAC balances were carried over as of the Transition Date. In the year of adoption only, we have included rollforwards of activity for the year ended December 31, 2021 for DAC, PVFP, the liability for future policy benefits, policyholder account balances, additional insurance liabilities, MRBs and separate account liabilities in notes 7, 8, 10, 11, 12, 13 and 14, respectively, to provide additional information related to comparative post-transition impacts. 160 Total assets . . . . . . . . . . . . . . . . $105,747 $ (79) $ 1,622 $ 14,773 $ 283 $122,346 Total investments . . . . . . . . . . . . . . . . . . $ 74,701 $ — $ — $ — $ — $ 74,701 2021 from the adoption of LDTI: (Amounts in millions) Assets Cash, cash equivalents and restricted cash . . . . . . . . . . . . . . . . . . . . . . . . . . Accrued investment income . . . . . . . . . Deferred acquisition costs . . . . . . . . . . . Intangible assets . . . . . . . . . . . . . . . . . . . Reinsurance recoverable . . . . . . . . . . . . Less: Allowance for credit losses . . . Reinsurance recoverable, net . . . . . Other assets . . . . . . . . . . . . . . . . . . . . . . Deferred tax asset . . . . . . . . . . . . . . . . . Market risk benefit assets . . . . . . . . . . . Separate account assets . . . . . . . . . . . . . Assets related to discontinued operations . . . . . . . . . . . . . . . . . . . . . . Liabilities and equity Liabilities: Future policy benefits . . . . . . . . . . . . Policyholder account balances . . . . . Market risk benefit liabilities . . . . . . . Liability for policy and contract claims . . . . . . . . . . . . . . . . . . . . . . . Unearned premiums . . . . . . . . . . . . . . Other liabilities . . . . . . . . . . . . . . . . . Long-term borrowings . . . . . . . . . . . . Separate account liabilities . . . . . . . . Liabilities related to discontinued operations . . . . . . . . . . . . . . . . . . . . Commitments and contingencies Equity: Class A common stock . . . . . . . . . . . Additional paid-in capital . . . . . . . . . Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . Retained earnings . . . . . . . . . . . . . . . Treasury stock, at cost . . . . . . . . . . . . Total Genworth Financial, Inc.’s stockholders’ equity . . . . . . . . Noncontrolling interests . . . . . . . . . . Total equity . . . . . . . . . . . . . . . . Balances as of December 31, 2020 Effect of adopting LDTI Changes in Eliminate shadow measurement of assets and Change in discount (as reported) adjustments liabilities rate Balances as of January 1, Recognize 2021 MRBs (as adjusted) 2,561 655 1,487 157 16,864 (45) 16,819 404 65 — 6,081 2,817 — — 1,322 114 — — — — — — — (1,515) — — — — 1,214 — 1,214 (89) 497 — — — — — — — — — — — 10,149 (92) — — 10,149 — 4,624 — (92) 248 105 22 — — 2,561 655 2,809 271 28,135 (45) 28,090 563 3,776 22 6,081 — — 2,817 $(4,456) $ 14,654 $ 31,893 $ — $ 84,786 $ 42,695 21,503 — (1,229) — (10,725) (468) — — — — — — — — (641) 1,310 19,633 1,310 — — — — — 4 — — — — — — 761 307 1,618 3,403 6,081 2,370 — — — — — — 1 12,008 — (17,120) (19) (371) — — — (7,108) (626) (2,700) (1,839) — (1,839) (17,120) (390) — — — (1,839) (17,120) (390) 1,575 502 2,077 11,486 775 1,614 3,403 6,081 2,370 89,927 1 12,008 4,425 1,584 (2,700) 15,318 502 15,820 — — — — — — — — 5,606 — — 5,606 — 5,606 161 Total liabilities and equity . . . . . $105,747 $ (79) $ 1,622 $ 14,773 $ 283 $122,346 Total liabilities . . . . . . . . . . . . . . (5,685) 3,461 31,893 673 120,269 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (3) Long-Duration Insurance Contracts Targeted Improvements The following table presents the balances of and changes in the consolidated balance sheet on January 1, 2021 from the adoption of LDTI: (Amounts in millions) Assets Total investments . . . . . . . . . . . . . . . . . . Cash, cash equivalents and restricted cash . . . . . . . . . . . . . . . . . . . . . . . . . . Accrued investment income . . . . . . . . . Deferred acquisition costs . . . . . . . . . . . Intangible assets . . . . . . . . . . . . . . . . . . . Reinsurance recoverable . . . . . . . . . . . . Less: Allowance for credit losses . . . Reinsurance recoverable, net . . . . . Other assets . . . . . . . . . . . . . . . . . . . . . . Deferred tax asset . . . . . . . . . . . . . . . . . Market risk benefit assets . . . . . . . . . . . Separate account assets . . . . . . . . . . . . . Assets related to discontinued operations . . . . . . . . . . . . . . . . . . . . . . Total assets . . . . . . . . . . . . . . . . Liabilities and equity Liabilities: Future policy benefits . . . . . . . . . . . . Policyholder account balances . . . . . Market risk benefit liabilities . . . . . . . Liability for policy and contract claims . . . . . . . . . . . . . . . . . . . . . . . Unearned premiums . . . . . . . . . . . . . . Other liabilities . . . . . . . . . . . . . . . . . Long-term borrowings . . . . . . . . . . . . Separate account liabilities . . . . . . . . Liabilities related to discontinued operations . . . . . . . . . . . . . . . . . . . . Total liabilities . . . . . . . . . . . . . . Commitments and contingencies Equity: Class A common stock . . . . . . . . . . . Additional paid-in capital . . . . . . . . . Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . Retained earnings . . . . . . . . . . . . . . . Treasury stock, at cost . . . . . . . . . . . . Total Genworth Financial, Inc.’s stockholders’ equity . . . . . . . . Noncontrolling interests . . . . . . . . . . Total equity . . . . . . . . . . . . . . . . Total liabilities and equity . . . . . Effect of adopting LDTI Balances as of December 31, 2020 (as reported) Eliminate shadow adjustments Changes in measurement of assets and liabilities Change in discount rate Recognize MRBs Balances as of January 1, 2021 (as adjusted) $ 74,701 $ — $ — $ — $ — $ 74,701 2,561 655 1,487 157 16,864 (45) 16,819 404 65 — 6,081 — — 1,322 114 — — — — (1,515) — — — — — — 1,214 — 1,214 (89) 497 — — 10,149 — — — — — — — — (92) — — 10,149 (92) — 248 4,624 105 22 — — — 2,561 655 2,809 271 28,135 (45) 28,090 563 3,776 22 6,081 2,817 $105,747 — — — (79) $ 1,622 $ 14,773 $ 283 — 2,817 $122,346 $ $ 42,695 21,503 — 11,486 775 1,614 3,403 6,081 2,370 89,927 $(4,456) $ 14,654 $ 31,893 $ — (641) (1,229) 1,310 — — — — — — — — — — (10,725) (468) — — — — — — — — 4 — — — — $ 84,786 19,633 1,310 761 307 1,618 3,403 6,081 — (5,685) — 3,461 — — 673 31,893 2,370 120,269 1 12,008 4,425 1,584 (2,700) — — 5,606 — — — — — — — — 1 12,008 — (1,839) — (19) (17,120) — (371) — — (7,108) (626) (2,700) (17,120) 5,606 — 5,606 (1,839) — (1,839) (390) — — (390) (79) $ 1,622 $ 14,773 $ 283 (17,120) 1,575 502 2,077 $122,346 15,318 502 15,820 $105,747 $ 161 Transition Disclosures On January 1, 2023, we adopted LDTI using the modified retrospective method for all topics except for MRBs, which was adopted using the retrospective method, as of January 1, 2021 or the Transition Date. When applying the new accounting guidance for MRBs, hindsight was applied where necessary to determine actuarial assumptions for MRBs primarily associated with variable annuities for certain older blocks of business issued before 2003 and certain small runoff blocks of business as observable data was not available. The modified retrospective approach for DAC and balances amortized on a basis consistent with DAC was applied before MRBs were retrospectively measured and, as a result, the historical DAC balances were carried over as of the Transition Date. In the year of adoption only, we have included rollforwards of activity for the year ended December 31, 2021 for DAC, PVFP, the liability for future policy benefits, policyholder account balances, additional insurance liabilities, MRBs and separate account liabilities in notes 7, 8, 10, 11, 12, 13 and 14, respectively, to provide additional information related to comparative post-transition impacts. 160 2021 from the adoption of LDTI: (Amounts in millions) Balances as of December 31, 2020 . . . . . . . . . . . . . . . . . . . . . . . $ — $1,316 $ 3 $139 $1,458 Adjustment for removal of related balances in accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . 1,043 185 Adjusted balances as of January 1, 2021 . . . . . . . . . . . . . . . . . . . $1,043 $1,501 Long-term Life Fixed Variable care insurance insurance annuities annuities Total Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred acquisition costs as of January 1, 2021 . . . . . . . . 82 $85 12 $151 1,322 2,780 29 $2,809 The following table summarizes the balances of and changes in intangible assets, including present value of future profits and deferred sales inducements, on January 1, 2021 from the adoption of LDTI: (Amounts in millions) Balances as of December 31, 2020 . . . . . . . . . . . . . . . . . . . . $ 73 Adjustment for removal of related balances in accumulated other comprehensive income (loss) . . . . . Adjusted balances as of January 1, 2021 . . . . . . . . . . . . . . . Life insurance Fixed annuities Variable annuities $ 7 33 $40 $ 3 — $ 3 81 $154 Total $ 83 114 $197 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table summarizes the components of the transition adjustments within stockholders’ equity as The following table summarizes the balances of and changes in deferred acquisition costs on January 1, of January 1, 2021 from the adoption of LDTI: (Amounts in millions) Deferred acquisition costs . . . . . . . . . . . . . . . . . . . Intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . Reinsurance recoverable . . . . . . . . . . . . . . . . . . . . Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Future policy benefits . . . . . . . . . . . . . . . . . . . . . . . Policyholder account balances . . . . . . . . . . . . . . . . Market risk benefits, net . . . . . . . . . . . . . . . . . . . . . Other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accumulated other comprehensive income (loss) $ 1,322 114 10,149 — (27,437) 1,229 (24) — 3,114 $(11,533) Retained earnings $ — — 1,201 156 (3,537) — (623) (4) 597 $(2,210) Total stockholders’ equity $ 1,322 114 11,350 156 (30,974) 1,229 (647) (4) 3,711 $(13,743) The cumulative effect adjustment recorded to accumulated other comprehensive income (loss) for DAC, intangible assets and the liability for policyholder account balances represents the elimination of previously recorded shadow adjustments related to unrealized gains and losses. The cumulative effect adjustment recorded to accumulated other comprehensive income (loss) for the liability for future policy benefits and reinsurance recoverables relates to the higher discount rate in effect immediately prior to adoption compared to the lower single-A rated bond rate as of the Transition Date, partially offset by the elimination of previously recorded shadow adjustments related to unrealized gains and losses. The cumulative effect adjustment recorded to retained earnings for the liability for future policy benefits and reinsurance recoverables relates to cohorts with net premium ratios capped at 100% and single premium fixed payout annuity products with remeasured liability balances in excess of the carryover reserve. Net premium ratios are capped at 100% when gross premiums plus the existing carrying value of reserves are insufficient to cover actual or expected policy and contract benefits at the cohort level, as was the case immediately before the Transition Date for a significant number of issue-year cohorts in our long-term care insurance business. These cohorts are mostly comprised of older blocks, and due to the age of the policies, do not benefit from future in-force rate actions due to limited remaining premium paying periods. Additionally, due to the requirement to group policies by issue-year cohorts, future in-force rate actions related to policies issued in more profitable years cannot subsidize loss generating policies issued in earlier years. The cumulative effect adjustment recorded to accumulated other comprehensive income (loss) for our net MRB liability relates to the cumulative effect of changes in the instrument-specific credit risk between the contract issue date and January 1, 2021. The difference between the fair value and the carrying amount of MRBs as of January 1, 2021, excluding the amounts recorded in accumulated other comprehensive income (loss), was recorded as a cumulative effect adjustment to retained earnings. Transition adjustments related to the recognition of reinsured MRBs are reflected as other assets and other liabilities. 162 163 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table summarizes the components of the transition adjustments within stockholders’ equity as The following table summarizes the balances of and changes in deferred acquisition costs on January 1, of January 1, 2021 from the adoption of LDTI: 2021 from the adoption of LDTI: (Amounts in millions) Balances as of December 31, 2020 . . . . . . . . . . . . . . . . . . . . . . . Adjustment for removal of related balances in accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . Adjusted balances as of January 1, 2021 . . . . . . . . . . . . . . . . . . . Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred acquisition costs as of January 1, 2021 . . . . . . . . Long-term care insurance Life insurance Fixed annuities Variable annuities Total $ — $1,316 $ 3 $139 $1,458 1,043 $1,043 185 $1,501 82 $85 12 $151 1,322 2,780 29 $2,809 The following table summarizes the balances of and changes in intangible assets, including present value of future profits and deferred sales inducements, on January 1, 2021 from the adoption of LDTI: (Amounts in millions) Life insurance Fixed annuities Variable annuities Balances as of December 31, 2020 . . . . . . . . . . . . . . . . . . . . $ 73 Adjustment for removal of related balances in accumulated other comprehensive income (loss) . . . . . Adjusted balances as of January 1, 2021 . . . . . . . . . . . . . . . 81 $154 $ 7 33 $40 $ 3 — $ 3 Total $ 83 114 $197 (Amounts in millions) Deferred acquisition costs . . . . . . . . . . . . . . . . . . . Intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . Reinsurance recoverable . . . . . . . . . . . . . . . . . . . . Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Future policy benefits . . . . . . . . . . . . . . . . . . . . . . . Policyholder account balances . . . . . . . . . . . . . . . . Market risk benefits, net . . . . . . . . . . . . . . . . . . . . . Other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accumulated other comprehensive income (loss) Retained earnings stockholders’ equity $ 1,322 $ — $ 1,322 Total 114 10,149 — (27,437) 1,229 (24) — 3,114 (3,537) (30,974) — 1,201 156 — (623) (4) 597 114 11,350 156 1,229 (647) (4) 3,711 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(11,533) $(2,210) $(13,743) The cumulative effect adjustment recorded to accumulated other comprehensive income (loss) for DAC, intangible assets and the liability for policyholder account balances represents the elimination of previously recorded shadow adjustments related to unrealized gains and losses. The cumulative effect adjustment recorded to accumulated other comprehensive income (loss) for the liability for future policy benefits and reinsurance recoverables relates to the higher discount rate in effect immediately prior to adoption compared to the lower single-A rated bond rate as of the Transition Date, partially offset by the elimination of previously recorded shadow adjustments related to unrealized gains and losses. The cumulative effect adjustment recorded to retained earnings for the liability for future policy benefits and reinsurance recoverables relates to cohorts with net premium ratios capped at 100% and single premium fixed payout annuity products with remeasured liability balances in excess of the carryover reserve. Net premium ratios are capped at 100% when gross premiums plus the existing carrying value of reserves are insufficient to cover actual or expected policy and contract benefits at the cohort level, as was the case immediately before the Transition Date for a significant number of issue-year cohorts in our long-term care insurance business. These cohorts are mostly comprised of older blocks, and due to the age of the policies, do not benefit from future in-force rate actions due to limited remaining premium paying periods. Additionally, due to the requirement to group policies by issue-year cohorts, future in-force rate actions related to policies issued in more profitable years cannot subsidize loss generating policies issued in earlier years. The cumulative effect adjustment recorded to accumulated other comprehensive income (loss) for our net MRB liability relates to the cumulative effect of changes in the instrument-specific credit risk between the contract issue date and January 1, 2021. The difference between the fair value and the carrying amount of MRBs as of January 1, 2021, excluding the amounts recorded in accumulated other comprehensive income (loss), was recorded as a cumulative effect adjustment to retained earnings. Transition adjustments related to the recognition of reinsured MRBs are reflected as other assets and other liabilities. 162 163 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table summarizes the balances of and changes in the liability for future policy benefits on (4) Earnings Per Share January 1, 2021 from the adoption of LDTI: (Amounts in millions) Balances as of December 31, 2020 . . . . . . . . . . . . . Reclassify liability for policy and contract claims, unearned premiums and due premiums(1) . . . . . . . . . . . . . . . . . . . . . . . . . . Change in discount rate assumptions . . . . . . . . Change in cash flow assumptions(2) . . . . . . . . . Change in cash flow assumptions, effect of increase (decrease) of the deferred profit liability(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjustment for removal of related balances in accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjusted balances as of January 1, 2021 . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . Adjusted balances as of January 1, 2021, net of Long-term care insurance Life insurance Fixed annuities Total $28,770 $2,101 $11,824 $42,695 10,918 24,253 3,319 189 361 (2) 10 7,279 264 11,117 31,893 3,581 (173) — 129 (44) (3,716) 63,371 11,476 — 2,649 834 (740) (4,456) 18,766 13,699 84,786 26,009 reinsurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $51,895 $1,815 $ 5,067 $58,777 (1) Upon adopting LDTI, we elected to combine our previously disclosed liability for policy and contract claims, unearned premiums and due premiums, excluding amounts related to mortgage insurance and certain life and annuity products not subject to the new accounting guidance, within the liability for future policy benefits and present the aggregate liability as one line item in our consolidated balance sheets. (2) For limited-payment contracts, if the remeasured liability for future policy benefits under LDTI is (less) greater than the carrying value immediately before the Transition Date, the deferred profit liability is increased (decreased) with a corresponding (decrease) increase to the liability for future policy benefits. The following table summarizes the balances of and changes in the net liability position for MRBs on January 1, 2021 from the adoption of LDTI: (Amounts in millions) Balances as of December 31, 2020 . . . . . . . . . . . . . . . . . . . . Adjustment for the difference between carrying amount and fair value, except for the difference due to instrument-specific credit risk . . . . . . . . . . . . . . . . Adjustment for the cumulative effect of changes in the instrument-specific credit risk since issuance . . . . . . Total adjustment for the difference between carrying amount and fair value . . . . . . . . . . . . . . . . . . . . . . . . Adjusted balances as of January 1, 2021 . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . Adjusted balances as of January 1, 2021, net of Fixed indexed annuities Variable annuities Total $ 71 $ 570 $ 641 39 5 44 115 — 584 623 19 24 603 1,173 244 647 1,288 244 reinsurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $115 $ 929 $1,044 164 165 Basic and diluted earnings per share are calculated by dividing each income category presented below by the weighted-average basic and diluted common shares outstanding for the years ended December 31: (Amounts in millions, except per share amounts) 2023 2022 2021 Weighted-average common shares used in basic earnings per share calculations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 468.8 504.4 506.9 Potentially dilutive securities: Performance stock units, restricted stock units and other equity-based awards . . . . . . . . . . . . . . . . . . 6.1 6.5 7.8 Weighted-average common shares used in diluted earnings per share calculations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 474.9 510.9 514.7 Income from continuing operations: Income from continuing operations . . . . . . . . . . . . . . . . . . . . . $ 199 $1,046 $ 864 Less: net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 130 33 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . $ 76 $ 916 $ 831 Basic per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.82 $ 1.64 Diluted per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.79 $ 1.61 Income from discontinued operations: Income from discontinued operations, net of taxes . . . . . . . . . $ — $ — $ 27 Less: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — 8 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . $ — $ — $ 19 Basic per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — $ — $ 0.04 Diluted per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — $ — $ 0.04 Net income: Income from continuing operations . . . . . . . . . . . . . . . . . . . . . $ 199 $1,046 $ 864 Income from discontinued operations, net of taxes . . . . . . . . . Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income attributable to noncontrolling interests . . . . — 199 123 — 1,046 130 27 891 41 Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 76 $ 916 $ 850 Basic per share(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.82 $ 1.68 Diluted per share(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.79 $ 1.65 (1) May not total due to whole number calculation. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table summarizes the balances of and changes in the liability for future policy benefits on (4) Earnings Per Share Basic and diluted earnings per share are calculated by dividing each income category presented below by the weighted-average basic and diluted common shares outstanding for the years ended December 31: (Amounts in millions, except per share amounts) 2023 2022 2021 Weighted-average common shares used in basic earnings per share calculations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 468.8 504.4 506.9 Potentially dilutive securities: Performance stock units, restricted stock units and other equity-based awards . . . . . . . . . . . . . . . . . . 6.1 6.5 7.8 Weighted-average common shares used in diluted earnings per share calculations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 474.9 510.9 514.7 Income from continuing operations: Income from continuing operations . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to $ 199 $1,046 $ 864 noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 130 33 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . $ 76 $ 916 $ 831 Basic per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.82 $ 1.64 Diluted per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.79 $ 1.61 Income from discontinued operations: Income from discontinued operations, net of taxes . . . . . . . . . Less: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . $ — $ — $ 27 — — 8 $ — $ — $ 19 Basic per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — $ — $ 0.04 Diluted per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — $ — $ 0.04 Net income: Income from continuing operations . . . . . . . . . . . . . . . . . . . . . Income from discontinued operations, net of taxes . . . . . . . . . $ 199 — $1,046 — $ 864 27 Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income attributable to noncontrolling interests . . . . 199 123 1,046 130 891 41 Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 76 $ 916 $ 850 Basic per share(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.82 $ 1.68 Diluted per share(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.16 $ 1.79 $ 1.65 164 165 (1) May not total due to whole number calculation. January 1, 2021 from the adoption of LDTI: (Amounts in millions) Long-term Life care insurance insurance Fixed annuities Total Balances as of December 31, 2020 . . . . . . . . . . . . . $28,770 $2,101 $11,824 $42,695 Reclassify liability for policy and contract claims, unearned premiums and due premiums(1) . . . . . . . . . . . . . . . . . . . . . . . . . . Change in discount rate assumptions . . . . . . . . Change in cash flow assumptions(2) . . . . . . . . . Change in cash flow assumptions, effect of increase (decrease) of the deferred profit liability(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjustment for removal of related balances in accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjusted balances as of January 1, 2021 . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . Adjusted balances as of January 1, 2021, net of 10,918 24,253 3,319 189 361 (2) 10 7,279 264 11,117 31,893 3,581 (173) — 129 (44) (3,716) 63,371 11,476 — 2,649 834 (740) (4,456) 18,766 13,699 84,786 26,009 reinsurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $51,895 $1,815 $ 5,067 $58,777 (1) Upon adopting LDTI, we elected to combine our previously disclosed liability for policy and contract claims, unearned premiums and due premiums, excluding amounts related to mortgage insurance and certain life and annuity products not subject to the new accounting guidance, within the liability for future policy benefits and present the aggregate liability as one line item in our consolidated balance sheets. (2) For limited-payment contracts, if the remeasured liability for future policy benefits under LDTI is (less) greater than the carrying value immediately before the Transition Date, the deferred profit liability is increased (decreased) with a corresponding (decrease) increase to the liability for future policy benefits. The following table summarizes the balances of and changes in the net liability position for MRBs on January 1, 2021 from the adoption of LDTI: (Amounts in millions) Balances as of December 31, 2020 . . . . . . . . . . . . . . . . . . . . $ 71 $ 570 $ 641 Fixed indexed annuities Variable annuities Total Adjustment for the difference between carrying amount and fair value, except for the difference due to instrument-specific credit risk . . . . . . . . . . . . . . . . Adjustment for the cumulative effect of changes in the instrument-specific credit risk since issuance . . . . . . Total adjustment for the difference between carrying amount and fair value . . . . . . . . . . . . . . . . . . . . . . . . Adjusted balances as of January 1, 2021 . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . Adjusted balances as of January 1, 2021, net of 39 5 44 115 — 584 623 19 24 603 1,173 244 647 1,288 244 reinsurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $115 $ 929 $1,044 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (5) Investments (a) Net Investment Income Sources of net investment income were as follows for the years ended December 31: December 31: (Amounts in millions) Fixed maturity securities—taxable . . . . . . . . . . . . . . . . . . . . . Fixed maturity securities—non-taxable . . . . . . . . . . . . . . . . . . Equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage loans . . . . . . . . . . . . . . . . . . . . . . . . . . Policy loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash, cash equivalents, restricted cash and short-term 2023 2022 2021 $2,244 3 11 302 224 117 279 $2,296 5 10 321 211 99 267 $2,411 7 9 376 189 223 241 investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95 20 1 Gross investment income before expenses and fees . . . . Expenses and fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,275 (92) 3,229 (83) 3,457 (87) Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,183 $3,146 $3,370 (b) Net Investment Gains (Losses) The following table sets forth net investment gains (losses) for the years ended December 31: (Amounts in millions) 2023 2022 2021 Realized investment gains (losses): Available-for-sale fixed maturity securities: Realized gains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Realized losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 29 (154) $ 28 (102) $ 67 (10) See note 2 for a discussion of our policy for evaluating and measuring the allowance for credit losses related to our available-for-sale fixed maturity securities. The following tables represent the allowance for credit losses aggregated by security type for available-for-sale fixed maturity securities as of and for the years ended Increase from securities without Increase (decrease) from securities with allowance in allowance in 2023 Decrease due to change in intent or Beginning balance previous periods previous periods Securities requirement Write- sold to sell offs Recoveries Ending balance (Amounts in millions) Fixed maturity securities: Commercial mortgage- Total available-for-sale fixed U.S. corporate . . . . . . . . . . . $— $ 9 $— $ (7) $— $ (2) $— $— backed . . . . . . . . . . . . . . . — 11 — (4) — — — 7 maturity securities . . . . . . . . . . $— $ 20 $— $ (11) $— $ (2) $— $ 7 Increase from securities without Increase (decrease) from securities with allowance in allowance in 2021 Decrease due to change in intent or Beginning balance previous periods previous periods Securities requirement Write- sold to sell offs Recoveries Ending balance (Amounts in millions) Fixed maturity securities: Total available-for-sale fixed Non-U.S. corporate . . . . . . . . . . . $ Commercial mortgage-backed . . 1 3 $— — $ 6 — $ (7) — $— — $— $— $— (3) — — maturity securities . . . . . . . . . . $ 4 $— $ 6 $ (7) $— $ (3) $— $— There was no allowance for credit losses related to our available-for-sale fixed maturity securities as of and for the year ended December 31, 2022. Net realized gains (losses) on available-for-sale fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net realized gains (losses) on equity securities sold . . . . . . . . . Net realized gains (losses) on limited partnerships . . . . . . . . . . (74) (1) — — (125) — Total net realized investment gains (losses) . . . . . . . . . . . . . . . . (126) (74) Net change in allowance for credit losses on available-for-sale fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Write-down of available-for-sale fixed maturity securities(1) . . . . Net unrealized gains (losses) on equity securities still held . . . . . . Net unrealized gains (losses) on limited partnerships . . . . . . . . . . Commercial mortgage loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derivative instruments(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (7) — (2) (1) (35) 53 71 111 4 (5) 32 7 2 (9) 57 (7) 3 53 (6) (1) 1 264 (3) 13 1 Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 23 $ (2) $322 (1) Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis. (2) See note 6 for additional information on the impact of derivative instruments included in net investment gains (losses). 166 167 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 See note 2 for a discussion of our policy for evaluating and measuring the allowance for credit losses related to our available-for-sale fixed maturity securities. The following tables represent the allowance for credit losses aggregated by security type for available-for-sale fixed maturity securities as of and for the years ended December 31: 2023 Increase from securities without allowance in previous periods Increase (decrease) from securities with allowance in previous periods Decrease due to change in intent or requirement to sell Securities sold Beginning balance Write- offs Recoveries Ending balance $— $ 9 $— $ (7) $— $ (2) $— $— (Amounts in millions) Fixed maturity securities: U.S. corporate . . . . . . . . . . . Commercial mortgage- backed . . . . . . . . . . . . . . . — 11 — (4) — — — 7 Total available-for-sale fixed maturity securities . . . . . . . . . . $— $ 20 $— $ (11) $— $ (2) $— $ 7 2021 Increase from securities without allowance in previous periods Increase (decrease) from securities with allowance in previous periods Decrease due to change in intent or requirement to sell Securities sold Beginning balance $ 1 3 $— — $ 6 — $ (7) — $— — (Amounts in millions) Fixed maturity securities: Non-U.S. corporate . . . . . . . . . . . Commercial mortgage-backed . . Total available-for-sale fixed Write- offs Recoveries Ending balance $— $— $— (3) — — maturity securities . . . . . . . . . . $ 4 $— $ 6 $ (7) $— $ (3) $— $— There was no allowance for credit losses related to our available-for-sale fixed maturity securities as of and for the year ended December 31, 2022. 166 167 (5) Investments (a) Net Investment Income Sources of net investment income were as follows for the years ended December 31: (Amounts in millions) 2023 2022 2021 Fixed maturity securities—taxable . . . . . . . . . . . . . . . . . . . . . $2,244 $2,296 $2,411 Fixed maturity securities—non-taxable . . . . . . . . . . . . . . . . . . Equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage loans . . . . . . . . . . . . . . . . . . . . . . . . . . Policy loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash, cash equivalents, restricted cash and short-term investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 11 302 224 117 279 95 5 10 321 211 99 267 20 7 9 376 189 223 241 1 Gross investment income before expenses and fees . . . . Expenses and fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,275 (92) 3,229 (83) 3,457 (87) Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,183 $3,146 $3,370 (b) Net Investment Gains (Losses) The following table sets forth net investment gains (losses) for the years ended December 31: (Amounts in millions) 2023 2022 2021 Realized investment gains (losses): Available-for-sale fixed maturity securities: Realized gains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Realized losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 29 (154) $ 28 (102) $ 67 (10) Net realized gains (losses) on available-for-sale fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (125) (74) Net realized gains (losses) on equity securities sold . . . . . . . . . (1) — Net realized gains (losses) on limited partnerships . . . . . . . . . . Total net realized investment gains (losses) . . . . . . . . . . . . . . . . — (126) — (74) Net change in allowance for credit losses on available-for-sale fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (7) — Write-down of available-for-sale fixed maturity securities(1) . . . . Net unrealized gains (losses) on equity securities still held . . . . . . Net unrealized gains (losses) on limited partnerships . . . . . . . . . . Commercial mortgage loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derivative instruments(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1) 53 111 (5) 7 (9) (2) (35) 71 4 32 2 57 (7) 3 53 (6) (1) 1 264 (3) 13 1 Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 23 $ (2) $322 (1) Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis. (2) See note 6 for additional information on the impact of derivative instruments included in net investment gains (losses). GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (c) Unrealized Investment Gains and Losses (d) Fixed Maturity Securities Net unrealized gains and losses on available-for-sale investment securities reflected as a separate component of accumulated other comprehensive income (loss) were as follows as of December 31: As of December 31, 2023, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows: (Amounts in millions) 2023 2022 2021 Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses . . . . . . . . . . . . . . . $(2,577) $(4,251) $ 7,869 Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses . . . . . . . . . . . . . . . . . Adjustments to policyholder contract balances . . . . . . . . . . Income taxes, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net unrealized investment gains (losses) . . . . . . . . . . . . . . . Less: net unrealized investment gains (losses) attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . Net unrealized investment gains (losses) attributable to — 52 352 — 68 705 — (131) (1,646) (2,173) (3,478) 6,092 (43) (71) 15 Genworth Financial, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . $(2,130) $(3,407) $ 6,077 The change in net unrealized gains (losses) on available-for-sale investment securities reported in accumulated other comprehensive income (loss) was as follows as of and for the years ended December 31: (Amounts in millions) Beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Unrealized gains (losses) arising during the period: Unrealized gains (losses) on fixed maturity 2023 2022 2021 $(3,407) $ 6,077 $ 7,820 securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjustment to policyholder contract balances(1) . . . . Provision for income taxes . . . . . . . . . . . . . . . . . . . . . 1,549 (16) (327) (12,194) 199 2,367 (2,218) 50 466 Change in unrealized gains (losses) on investment securities . . . . . . . . . . . . . . . . . . . 1,206 (9,628) (1,702) Reclassification adjustments to net investment (gains) losses, net of taxes of $(26), $(16) and $14 . . . . . . . . . . 99 58 (51) Change in net unrealized investment gains (losses) . . . . . . Less: change in net unrealized investment gains (losses) 1,305 (9,570) (1,753) attributable to noncontrolling interests . . . . . . . . . . . . . . 28 (86) (10) Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(2,130) $ (3,407) $ 6,077 (1) See note 12 for additional information. Amounts reclassified out of accumulated other comprehensive income (loss) to net investment gains (losses) include realized gains (losses) on sales of securities, which are determined on a specific identification basis. securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $49,365 $986 $(3,563) $ (7) $46,781 168 169 U.S. government, agencies and government-sponsored enterprises . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,588 $121 $ (215) $— $ 3,494 (Amounts in millions) Fixed maturity securities: State and political subdivisions . . . . . . . . . . . . . . . . . . Non-U.S. government . . . . . . . . . . . . . . . . . . . . . . . . . . U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Residential mortgage-backed . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage-backed . . . . . . . . . . . . . . . . . . . . . Other asset-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total available-for-sale fixed maturity Amortized Gross unrealized unrealized gains Gross losses Allowance for credit losses cost or cost Fair value 2,537 703 4,521 2,449 7,813 4,648 3,187 1,294 2,230 1,715 1,187 316 739 1,038 2,041 669 944 829 591 236 369 726 8,182 953 1,714 2,328 24 15 104 66 99 129 75 27 69 30 44 6 1 34 47 8 12 17 8 2 15 18 8 1 6 (259) — (92) — (352) — (143) — (634) — (272) — (239) — (88) — (118) — (96) — (69) — (13) — (55) — (45) — (140) — (61) — (65) — (49) — (38) — (17) — (20) — (43) — (54) — (290) (7) (96) — 2,302 626 4,273 2,372 7,278 4,505 3,023 1,233 2,181 1,649 1,162 309 685 1,027 1,948 616 891 797 561 221 364 701 7,811 907 1,418 2,238 Total U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . 29,360 649 (2,024) — 27,985 Total non-U.S. corporate . . . . . . . . . . . . . . . . . . . . . 162 (533) — GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (c) Unrealized Investment Gains and Losses (d) Fixed Maturity Securities Net unrealized gains and losses on available-for-sale investment securities reflected as a separate component of accumulated other comprehensive income (loss) were as follows as of December 31: As of December 31, 2023, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows: (Amounts in millions) 2023 2022 2021 Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses . . . . . . . . . . . . . . . $(2,577) $(4,251) $ 7,869 Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses . . . . . . . . . . . . . . . . . Adjustments to policyholder contract balances . . . . . . . . . . Income taxes, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 52 352 — 68 705 — (131) (1,646) Net unrealized investment gains (losses) . . . . . . . . . . . . . . . (2,173) (3,478) 6,092 Less: net unrealized investment gains (losses) attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . (43) (71) 15 Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . $(2,130) $(3,407) $ 6,077 The change in net unrealized gains (losses) on available-for-sale investment securities reported in accumulated other comprehensive income (loss) was as follows as of and for the years ended December 31: (Amounts in millions) 2023 2022 2021 Beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(3,407) $ 6,077 $ 7,820 Unrealized gains (losses) arising during the period: Unrealized gains (losses) on fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,549 (12,194) (2,218) Adjustment to policyholder contract balances(1) . . . . Provision for income taxes . . . . . . . . . . . . . . . . . . . . . (16) (327) 199 2,367 50 466 Change in unrealized gains (losses) on investment securities . . . . . . . . . . . . . . . . . . . 1,206 (9,628) (1,702) Reclassification adjustments to net investment (gains) losses, net of taxes of $(26), $(16) and $14 . . . . . . . . . . 99 58 (51) Change in net unrealized investment gains (losses) . . . . . . 1,305 (9,570) (1,753) Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests . . . . . . . . . . . . . . 28 (86) (10) Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(2,130) $ (3,407) $ 6,077 (1) See note 12 for additional information. Amounts reclassified out of accumulated other comprehensive income (loss) to net investment gains (losses) include realized gains (losses) on sales of securities, which are determined on a specific identification basis. (Amounts in millions) Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . State and political subdivisions . . . . . . . . . . . . . . . . . . Non-U.S. government . . . . . . . . . . . . . . . . . . . . . . . . . . U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,521 2,449 7,813 4,648 3,187 1,294 2,230 1,715 1,187 316 Total U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . 29,360 Non-U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total non-U.S. corporate . . . . . . . . . . . . . . . . . . . . . Residential mortgage-backed . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage-backed . . . . . . . . . . . . . . . . . . . . . Other asset-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total available-for-sale fixed maturity 739 1,038 2,041 669 944 829 591 236 369 726 8,182 953 1,714 2,328 Amortized cost or cost Gross unrealized gains Gross unrealized losses Allowance for credit losses Fair value $ 3,588 2,537 703 $121 24 15 $ (215) $— (259) — (92) — $ 3,494 2,302 626 104 66 99 129 75 27 69 30 44 6 649 1 34 47 8 12 17 8 2 15 18 (352) — (143) — (634) — (272) — (239) — (88) — (118) — (96) — (69) — (13) — 4,273 2,372 7,278 4,505 3,023 1,233 2,181 1,649 1,162 309 (2,024) — 27,985 (55) — (45) — (140) — (61) — (65) — (49) — (38) — (17) — (20) — (43) — 162 (533) — 8 1 6 (54) — (290) (7) (96) — 685 1,027 1,948 616 891 797 561 221 364 701 7,811 907 1,418 2,238 securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $49,365 $986 $(3,563) $ (7) $46,781 168 169 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 As of December 31, 2022, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows: (Amounts in millions) Fixed maturity securities: Amortized cost or cost Gross unrealized gains Gross unrealized losses Allowance for credit losses Fair value 2023: The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses had not been recorded, aggregated by investment type and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of December 31, U.S. government, agencies and government-sponsored enterprises . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . State and political subdivisions . . . . . . . . . . . . . . . . . . Non-U.S. government . . . . . . . . . . . . . . . . . . . . . . . . . . U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,446 2,726 731 $ 86 19 15 $ (191) $— (346) — (101) — $ 3,341 2,399 645 4,295 2,450 8,005 4,776 3,265 1,312 2,290 1,758 1,165 325 50 33 59 84 43 15 41 14 32 3 (447) — (221) — (871) — (403) — (361) — (130) — (193) — (155) — (97) — (18) — 3,898 2,262 7,193 4,457 2,947 1,197 2,138 1,617 1,100 310 Total U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . 29,641 374 (2,896) — 27,119 Non-U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total non-U.S. corporate . . . . . . . . . . . . . . . . . . . . . Residential mortgage-backed . . . . . . . . . . . . . . . . . . . . Commercial mortgage-backed . . . . . . . . . . . . . . . . . . . Other asset-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total available-for-sale fixed maturity 817 1,009 2,124 655 997 880 606 308 392 932 8,720 1,059 2,183 2,328 — 19 30 1 4 8 3 — 12 15 92 7 2 1 (77) — (68) — (208) — (90) — (107) — (70) — (63) — (32) — (29) — (58) — (802) — (71) — (277) — (163) — 740 960 1,946 566 894 818 546 276 375 889 8,010 995 1,908 2,166 securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $50,834 $596 $(4,847) $— $46,583 170 171 Less than 12 months 12 months or more Total Fair value Gross Number unrealized of losses securities Fair value Gross Number unrealized of losses securities Fair value Gross Number unrealized of losses securities (Dollar amounts in millions) Description of Securities Fixed maturity securities: U.S. government, agencies and government-sponsored State and political enterprises . . . . . . . . . . . . . . . $ 28 $ (1) 6 $ 1,353 $ (214) 50 $ 1,381 $ (215) 56 subdivisions . . . . . . . . . . . . . . Non-U.S. government . . . . . . . . 121 (2) 18 — — — 1,581 448 (257) (92) 268 67 1,702 448 (259) (92) 286 67 U.S. corporate . . . . . . . . . . . . . . 1,054 (30) 142 17,019 (1,994) 2,164 18,073 (2,024) 2,306 Non-U.S. corporate . . . . . . . . . . Residential mortgage-backed . . . 157 62 (5) (1) 5,180 477 (528) (53) 684 156 5,337 539 (533) (54) 703 187 Commercial mortgage-backed . . . . . . . . . . 37 (1) Other asset-backed . . . . . . . . . . . — — — 1,349 1,624 (289) (96) 224 327 1,386 1,624 (290) (96) 231 327 19 31 7 in an unrealized loss position . . . $1,459 $ (40) 223 $29,031 $(3,523) 3,940 $30,490 $(3,563) 4,163 Total for fixed maturity securities % Below cost: Total for fixed maturity securities <20% Below cost . . . . . . . . . . . . $1,450 $ (37) 221 $26,032 $(2,509) 3,542 $27,482 $(2,546) 3,763 20%-50% Below cost . . . . . . . . . 9 (3) 2 2,999 (1,014) 398 3,008 (1,017) 400 in an unrealized loss position . . . $1,459 $ (40) 223 $29,031 $(3,523) 3,940 $30,490 $(3,563) 4,163 Investment grade . . . . . . . . . . . . . . $1,441 $ (40) 221 $27,804 $(3,394) 3,762 $29,245 $(3,434) 3,983 Below investment grade . . . . . . . . . 18 — 2 1,227 (129) 178 1,245 (129) 180 Total for fixed maturity securities in an unrealized loss position . . . $1,459 $ (40) 223 $29,031 $(3,523) 3,940 $30,490 $(3,563) 4,163 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses had not been recorded, aggregated by investment type and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of December 31, 2023: Less than 12 months 12 months or more Total Fair value Gross unrealized losses Number of securities Fair value Gross unrealized losses Number of securities Fair value Gross unrealized losses Number of securities (Dollar amounts in millions) Description of Securities Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises . . . . . . . . . . . . . . . $ State and political subdivisions . . . . . . . . . . . . . . Non-U.S. government . . . . . . . . U.S. corporate . . . . . . . . . . . . . . Non-U.S. corporate . . . . . . . . . . Residential mortgage-backed . . . Commercial mortgage-backed . . . . . . . . . . Other asset-backed . . . . . . . . . . . Total for fixed maturity securities 28 $ (1) 6 $ 1,353 $ (214) 50 $ 1,381 $ (215) 56 121 18 (2) — — — 142 (30) 19 (5) 31 (1) 1,054 157 62 1,581 448 17,019 5,180 477 (257) (92) 1,702 268 448 67 (1,994) 2,164 18,073 5,337 684 539 156 (528) (53) (259) (92) 286 67 (2,024) 2,306 703 187 (533) (54) 37 7 (1) — — — 1,349 1,624 (289) (96) 224 327 1,386 1,624 (290) (96) 231 327 in an unrealized loss position . . . $1,459 $ (40) 223 $29,031 $(3,523) 3,940 $30,490 $(3,563) 4,163 % Below cost: <20% Below cost . . . . . . . . . . . . $1,450 $ (37) (3) 20%-50% Below cost . . . . . . . . . 9 Total for fixed maturity securities 221 $26,032 $(2,509) 3,542 $27,482 $(2,546) 3,763 400 398 (1,017) (1,014) 3,008 2,999 2 in an unrealized loss position . . . $1,459 $ (40) 223 $29,031 $(3,523) 3,940 $30,490 $(3,563) 4,163 As of December 31, 2022, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows: (Amounts in millions) Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,446 $ 86 $ (191) $— $ 3,341 Amortized Gross unrealized unrealized gains Gross losses Allowance for credit losses cost or cost Fair value Total U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . 29,641 374 (2,896) — 27,119 State and political subdivisions . . . . . . . . . . . . . . . . . . Non-U.S. government . . . . . . . . . . . . . . . . . . . . . . . . . . U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total non-U.S. corporate . . . . . . . . . . . . . . . . . . . . . Residential mortgage-backed . . . . . . . . . . . . . . . . . . . . Commercial mortgage-backed . . . . . . . . . . . . . . . . . . . Other asset-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total available-for-sale fixed maturity 2,726 731 4,295 2,450 8,005 4,776 3,265 1,312 2,290 1,758 1,165 325 817 1,009 2,124 655 997 880 606 308 392 932 8,720 1,059 2,183 2,328 19 15 50 33 59 84 43 15 41 14 32 3 — 19 30 1 4 8 3 — 12 15 92 7 2 1 (346) — (101) — (447) — (221) — (871) — (403) — (361) — (130) — (193) — (155) — (97) — (18) — (77) — (68) — (208) — (90) — (107) — (70) — (63) — (32) — (29) — (58) — (802) — (71) — (277) — (163) — 2,399 645 3,898 2,262 7,193 4,457 2,947 1,197 2,138 1,617 1,100 310 740 960 1,946 566 894 818 546 276 375 889 8,010 995 1,908 2,166 securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $50,834 $596 $(4,847) $— $46,583 in an unrealized loss position . . . $1,459 $ (40) 223 $29,031 $(3,523) 3,940 $30,490 $(3,563) 4,163 170 171 Investment grade . . . . . . . . . . . . . . $1,441 $ (40) 18 — Below investment grade . . . . . . . . . Total for fixed maturity securities 221 $27,804 $(3,394) 3,762 $29,245 $(3,434) 3,983 180 178 1,245 1,227 (129) (129) 2 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses had not been recorded, aggregated by investment type and length of time that individual investment securities had been in a continuous unrealized loss position, based on industry, as of December 31, 2023: The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses had not been recorded, aggregated by investment type and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of December 31, 2022: (Dollar amounts in millions) Description of Securities U.S. corporate: Utilities . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . Finance and insurance . . . . Consumer—non-cyclical . . Technology and communications . . . . . . . Industrial . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . Consumer—cyclical . . . . . . Transportation . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . Subtotal, U.S. corporate Less than 12 months 12 months or more Total Fair value Gross unrealized losses Number of securities Fair value Gross unrealized losses Number of securities Fair value Gross unrealized losses Number of securities Less than 12 months 12 months or more Gross Gross Total Gross Fair value unrealized Number of losses securities Fair value unrealized Number of losses securities Fair value unrealized Number of losses securities $ 177 $ (2) (2) (8) (6) 122 274 173 21 20 42 18 $ 2,129 $ (350) 308 $ 2,306 $ (352) 329 (143) 188 (634) 687 (272) 298 (141) 168 (626) 645 (266) 280 1,465 5,466 2,702 1,343 5,192 2,529 19 (6) 105 6 (1) 50 — — — 11 (1) 88 5 (4) 65 — — — 2,100 702 1,193 1,073 621 137 (233) 269 (87) 96 (118) 150 (95) 148 82 (65) 18 (13) 2,205 752 1,193 1,161 686 137 (239) 288 (88) 102 (118) 150 (96) 159 87 (69) 18 (13) securities . . . . . . . . . . . . . 1,054 (30) 142 17,019 (1,994) 2,164 18,073 (2,024) 2,306 Non-U.S. corporate: Utilities . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . Finance and insurance . . . . Consumer—non-cyclical . . Technology and communications . . . . . . . Industrial . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . Consumer—cyclical . . . . . . Transportation . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . Subtotal, non-U.S. — — — 4 (1) 39 100 10 (2) — — — — — — 5 (2) 18 — — — — — — — — — — — — 609 487 1,358 471 68 (55) 59 (44) (138) 203 55 (61) 659 436 384 188 216 372 (65) (47) (38) (17) (20) (43) 83 61 49 26 30 50 609 526 1,458 471 659 454 384 188 216 372 (55) (45) 68 63 (140) 213 55 (61) (65) (49) (38) (17) (20) (43) 83 66 49 26 30 50 corporate securities . . . . . 157 (5) 19 5,180 (528) 684 5,337 (533) 703 Total for corporate securities in an unrealized loss position . . . $1,211 $ (35) 161 $22,199 $(2,522) 2,848 $23,410 $(2,557) 3,009 We did not recognize an allowance for credit losses on securities in an unrealized loss position included in the tables above. Based on a qualitative and quantitative review of the issuers of the securities, we believe the decline in fair value was largely due to increased interest rates and was not indicative of credit losses. The issuers continue to make timely principal and interest payments. For all securities in an unrealized loss position without an allowance for credit losses, we expect to recover the amortized cost based on our estimate of the amount and timing of cash flows to be collected. We do not intend to sell nor do we expect that we will be required to sell these securities prior to recovering our amortized cost. 172 173 (Dollar amounts in millions) Description of Securities Fixed maturity securities: U.S. government, agencies and government- State and political Residential mortgage- Commercial mortgage- Total for fixed maturity securities in an unrealized % Below cost: Total for fixed maturity securities in an unrealized Total for fixed maturity securities in an unrealized sponsored enterprises . . . $ 1,585 $ (189) 55 $ 17 $ (2) 6 $ 1,602 $ (191) 61 subdivisions . . . . . . . . . . Non-U.S. government . . . . 1,559 351 (269) (54) 258 59 261 152 U.S. corporate . . . . . . . . . . . 18,480 (2,344) 2,452 2,001 Non-U.S. corporate . . . . . . 5,593 (599) 732 748 (77) (47) 66 23 (552) 236 (203) 111 1,820 503 (346) (101) 324 82 20,481 (2,896) 2,688 6,341 (802) 843 backed . . . . . . . . . . . . . . . 569 (51) 192 65 (20) 22 634 (71) 214 backed . . . . . . . . . . . . . . . Other asset-backed . . . . . . . 1,765 1,455 (255) (83) 265 347 88 598 (22) 16 (80) 101 1,853 2,053 (277) (163) 281 448 loss position . . . . . . . . . . . . $31,357 $(3,844) 4,360 $3,930 $(1,003) 581 $35,287 $(4,847) 4,941 <20% Below cost . . . . . . . . $27,596 $(2,587) 3,835 $1,819 $ (291) 310 $29,415 $(2,878) 4,145 20%-50% Below cost . . . . . 3,757 (1,251) 523 2,111 (712) 271 5,868 (1,963) >50% Below cost . . . . . . . . 4 (6) 2 — — — 4 (6) 794 2 loss position . . . . . . . . . . . . $31,357 $(3,844) 4,360 $3,930 $(1,003) 581 $35,287 $(4,847) 4,941 Investment grade . . . . . . . . . . $29,959 $(3,687) 4,158 $3,590 $ (915) 537 $33,549 $(4,602) 4,695 Below investment grade . . . . . 1,398 (157) 202 340 (88) 44 1,738 (245) 246 loss position . . . . . . . . . . . . $31,357 $(3,844) 4,360 $3,930 $(1,003) 581 $35,287 $(4,847) 4,941 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses had not been recorded, aggregated by investment type and length of time that individual investment securities had been in a continuous unrealized loss position, based on industry, as of The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses had not been recorded, aggregated by investment type and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of December 31, 2022: Less than 12 months 12 months or more Total Fair value Gross unrealized losses Number of securities Fair value Gross unrealized losses Number of securities Fair value Gross unrealized losses Number of securities (Dollar amounts in millions) Description of Securities Fixed maturity securities: U.S. government, agencies and government- sponsored enterprises . . . $ 1,585 $ (189) 55 $ 17 $ (2) 6 $ 1,602 $ (191) 61 State and political subdivisions . . . . . . . . . . Non-U.S. government . . . . U.S. corporate . . . . . . . . . . . Non-U.S. corporate . . . . . . Residential mortgage- 1,559 351 18,480 5,593 (269) (54) 258 59 (2,344) 2,452 732 (599) 261 152 2,001 748 (77) (47) 66 23 (552) 236 (203) 111 1,820 503 20,481 6,341 (346) (101) 324 82 (2,896) 2,688 843 (802) backed . . . . . . . . . . . . . . . 569 (51) 192 65 (20) 22 634 (71) 214 Commercial mortgage- backed . . . . . . . . . . . . . . . Other asset-backed . . . . . . . 1,765 1,455 (255) (83) 265 347 88 598 16 (22) (80) 101 1,853 2,053 (277) (163) 281 448 Total for fixed maturity securities in an unrealized loss position . . . . . . . . . . . . $31,357 $(3,844) 4,360 $3,930 $(1,003) 581 $35,287 $(4,847) 4,941 % Below cost: securities . . . . . . . . . . . . . 1,054 (30) 142 17,019 (1,994) 2,164 18,073 (2,024) 2,306 Utilities . . . . . . . . . . . . . . . . $ 177 $ (2) $ 2,129 $ (350) 308 $ 2,306 $ (352) 329 December 31, 2023: (Dollar amounts in millions) Description of Securities U.S. corporate: Energy . . . . . . . . . . . . . . . . . Finance and insurance . . . . Consumer—non-cyclical . . Technology and communications . . . . . . . Industrial . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . Consumer—cyclical . . . . . . Transportation . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . Subtotal, U.S. corporate Utilities . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . Finance and insurance . . . . Consumer—non-cyclical . . Technology and communications . . . . . . . Industrial . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . Consumer—cyclical . . . . . . Transportation . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . Subtotal, non-U.S. Non-U.S. corporate: Total for corporate securities in Less than 12 months 12 months or more Total Fair value Gross Number unrealized of losses securities Fair value Gross Number unrealized of losses securities Fair value Gross Number unrealized of losses securities 21 20 42 18 19 6 11 5 122 274 173 105 50 88 65 (2) (8) (6) (6) (1) (1) (4) — — — — — — 1,343 5,192 2,529 2,100 702 1,193 1,073 621 137 (141) 168 (626) 645 (266) 280 (233) 269 (87) 96 (118) 150 (95) 148 (65) (13) 82 18 1,465 5,466 2,702 2,205 752 1,193 1,161 686 137 (143) 188 (634) 687 (272) 298 (239) 288 (88) 102 (118) 150 (96) 159 (69) (13) 87 18 — — — 39 100 (1) (2) 4 10 — — — — — — 18 (2) 5 — — — — — — — — — — — — 609 487 1,358 471 (55) (44) 68 59 (138) 203 (61) 55 609 526 1,458 471 (55) (45) 68 63 (140) 213 (61) 55 659 436 384 188 216 372 (65) (47) (38) (17) (20) (43) 83 61 49 26 30 50 659 454 384 188 216 372 (65) (49) (38) (17) (20) (43) 83 66 49 26 30 50 corporate securities . . . . . 157 (5) 19 5,180 (528) 684 5,337 (533) 703 We did not recognize an allowance for credit losses on securities in an unrealized loss position included in the tables above. Based on a qualitative and quantitative review of the issuers of the securities, we believe the decline in fair value was largely due to increased interest rates and was not indicative of credit losses. The issuers continue to make timely principal and interest payments. For all securities in an unrealized loss position without an allowance for credit losses, we expect to recover the amortized cost based on our estimate of the amount and timing of cash flows to be collected. We do not intend to sell nor do we expect that we will be required to sell these securities prior to recovering our amortized cost. an unrealized loss position . . . $1,211 $ (35) 161 $22,199 $(2,522) 2,848 $23,410 $(2,557) 3,009 Total for fixed maturity securities in an unrealized loss position . . . . . . . . . . . . $31,357 $(3,844) 4,360 $3,930 $(1,003) 581 $35,287 $(4,847) 4,941 172 173 Total for fixed maturity securities in an unrealized loss position . . . . . . . . . . . . $31,357 $(3,844) 4,360 $3,930 $(1,003) 581 $35,287 $(4,847) 4,941 <20% Below cost . . . . . . . . $27,596 $(2,587) 3,835 $1,819 $ (291) 310 (712) 271 20%-50% Below cost . . . . . 2 — — — >50% Below cost . . . . . . . . (1,251) (6) 3,757 4 Investment grade . . . . . . . . . . $29,959 $(3,687) 4,158 $3,590 $ (915) 537 44 Below investment grade . . . . . $29,415 $(2,878) 4,145 794 2 (1,963) (6) 5,868 4 $33,549 $(4,602) 4,695 246 1,398 2,111 1,738 (245) (157) (88) 202 523 340 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses had not been recorded, aggregated by investment type and length of time that individual investment securities had been in a continuous unrealized loss position, based on industry, as of December 31, 2022: (Dollar amounts in millions) Description of Securities U.S. corporate: Utilities . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . Finance and Less than 12 months 12 months or more Fair value Gross unrealized losses Number of securities Fair value Gross unrealized losses Number of securities Fair value Total Gross unrealized losses Number of securities $ 2,447 $ (398) (187) 1,538 345 226 $ 187 $ (49) (34) 144 37 14 $ 2,634 $ (447) (221) 1,682 382 240 insurance . . . . . . . . . . 5,250 (668) 696 706 (203) 74 5,956 (871) 770 Consumer— non-cyclical . . . . . . . . 2,805 (342) 317 201 (61) 22 3,006 (403) 339 Technology and communications . . . . Industrial . . . . . . . . . . . . Capital goods . . . . . . . . Consumer—cyclical . . . Transportation . . . . . . . . Other . . . . . . . . . . . . . . . . . Subtotal, U.S. corporate 2,259 829 1,332 1,138 746 136 (273) (105) (153) (108) (93) (17) 304 104 169 173 95 23 271 110 148 194 21 19 (88) (25) (40) (47) (4) (1) 32 13 16 22 5 1 2,530 939 1,480 1,332 767 155 (361) (130) (193) (155) (97) (18) 336 117 185 195 100 24 securities . . . . . . . . . . . . . . 18,480 (2,344) 2,452 2,001 (552) 236 20,481 (2,896) 2,688 Non-U.S. corporate: Utilities . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . Finance and 640 604 (63) (61) 66 69 57 40 (14) (7) 9 5 697 644 (77) (68) 75 74 The scheduled maturity distribution of fixed maturity securities as of December 31, 2023 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties. (Amounts in millions) Amortized cost or cost Fair value Due one year or less . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1,384 $ 1,372 Due after one year through five years . . . . . . . . . . . . . . . . . Due after five years through ten years . . . . . . . . . . . . . . . . Due after ten years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Subtotal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Residential mortgage-backed . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage-backed . . . . . . . . . . . . . . . . . . . . . . Other asset-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,418 12,751 21,817 44,370 953 1,714 2,328 8,205 12,114 20,527 42,218 907 1,418 2,238 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $49,365 $46,781 As of December 31, 2023, securities issued by finance and insurance, consumer—non-cyclical, utilities and technology and communications industry groups represented approximately 26%, 14%, 14% and 11%, respectively, of our domestic and foreign corporate fixed maturity securities portfolio. No other industry group comprised more than 10% of our investment portfolio. As of December 31, 2023, we did not hold any fixed maturity securities in any single issuer, other than securities issued or guaranteed by the U.S. government, which exceeded 10% of stockholders’ equity. As of December 31, 2023 and 2022, securities of $43 million and $42 million, respectively, were on deposit with various state government insurance departments in order to comply with relevant insurance regulations. (e) Commercial Mortgage Loans insurance . . . . . . . . . . 1,310 (122) 204 296 (86) 42 1,606 (208) 246 Consumer— Our mortgage loans are collateralized by commercial properties, including multi-family residential buildings. The carrying value of commercial mortgage loans is stated at original cost net of principal payments, non-cyclical . . . . . . . . 491 (74) 56 54 (16) 11 545 (90) 67 amortization and allowance for credit losses. Technology and communications . . . . Industrial . . . . . . . . . . . . Capital goods . . . . . . . . Consumer—cyclical . . . Transportation . . . . . . . . Other . . . . . . . . . . . . . . . Subtotal, non-U.S. corporate securities . . . . . . . . . . . . . . Total for corporate securities in an unrealized loss position . . . . . . . . . . . . . . . 740 480 394 241 180 513 (96) (45) (46) (28) (21) (43) 93 71 52 31 26 64 39 105 62 23 29 43 (11) (25) (17) (4) (8) (15) 8 13 6 6 5 6 779 585 456 264 209 556 (107) (70) (63) (32) (29) (58) 101 84 58 37 31 70 5,593 (599) 732 748 (203) 111 6,341 (802) 843 $24,073 $(2,943) 3,184 $2,749 $(755) 347 $26,822 $(3,698) 3,531 174 175 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The scheduled maturity distribution of fixed maturity securities as of December 31, 2023 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties. (Amounts in millions) Due one year or less . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Due after one year through five years . . . . . . . . . . . . . . . . . Due after five years through ten years . . . . . . . . . . . . . . . . Due after ten years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Subtotal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Residential mortgage-backed . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage-backed . . . . . . . . . . . . . . . . . . . . . . Other asset-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortized cost or cost Fair value $ 1,384 8,418 12,751 21,817 44,370 953 1,714 2,328 $ 1,372 8,205 12,114 20,527 42,218 907 1,418 2,238 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $49,365 $46,781 As of December 31, 2023, securities issued by finance and insurance, consumer—non-cyclical, utilities and technology and communications industry groups represented approximately 26%, 14%, 14% and 11%, respectively, of our domestic and foreign corporate fixed maturity securities portfolio. No other industry group comprised more than 10% of our investment portfolio. As of December 31, 2023, we did not hold any fixed maturity securities in any single issuer, other than securities issued or guaranteed by the U.S. government, which exceeded 10% of stockholders’ equity. As of December 31, 2023 and 2022, securities of $43 million and $42 million, respectively, were on deposit with various state government insurance departments in order to comply with relevant insurance regulations. (e) Commercial Mortgage Loans insurance . . . . . . . . . . 1,310 (122) 204 296 (86) 42 1,606 (208) 246 non-cyclical . . . . . . . . 491 (74) 56 54 (16) 11 545 (90) 67 Our mortgage loans are collateralized by commercial properties, including multi-family residential buildings. The carrying value of commercial mortgage loans is stated at original cost net of principal payments, amortization and allowance for credit losses. 174 175 The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses had not been recorded, aggregated by investment type and length of time that individual investment securities had been in a continuous unrealized loss position, based on industry, as of December 31, 2022: Less than 12 months 12 months or more Gross Gross Total Gross Fair value unrealized Number of losses securities Fair value unrealized Number of losses securities Fair value unrealized Number of losses securities Utilities . . . . . . . . . . . . . $ 2,447 $ (398) Energy . . . . . . . . . . . . . . 1,538 (187) 345 226 $ 187 $ (49) 144 (34) 37 14 $ 2,634 $ (447) 1,682 (221) 382 240 insurance . . . . . . . . . . 5,250 (668) 696 706 (203) 74 5,956 (871) 770 non-cyclical . . . . . . . . 2,805 (342) 317 201 (61) 22 3,006 (403) 339 2,259 829 1,332 1,138 746 136 (273) (105) (153) (108) (93) (17) 304 104 169 173 95 23 271 110 148 194 21 19 (88) (25) (40) (47) (4) (1) 32 13 16 22 5 1 2,530 939 1,480 1,332 767 155 (361) (130) (193) (155) (97) (18) 336 117 185 195 100 24 securities . . . . . . . . . . . . . . 18,480 (2,344) 2,452 2,001 (552) 236 20,481 (2,896) 2,688 Utilities . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . 640 604 (63) (61) 66 69 57 40 (14) (7) 9 5 697 644 (77) (68) 75 74 740 480 394 241 180 513 (96) (45) (46) (28) (21) (43) 93 71 52 31 26 64 39 105 62 23 29 43 (11) (25) (17) (4) (8) (15) 8 13 6 6 5 6 779 585 456 264 209 556 (107) 101 (70) (63) (32) (29) (58) 84 58 37 31 70 securities . . . . . . . . . . . . . . 5,593 (599) 732 748 (203) 111 6,341 (802) 843 position . . . . . . . . . . . . . . . $24,073 $(2,943) 3,184 $2,749 $(755) 347 $26,822 $(3,698) 3,531 (Dollar amounts in millions) Description of Securities U.S. corporate: Finance and Consumer— Technology and communications . . . . Industrial . . . . . . . . . . . . Capital goods . . . . . . . . Consumer—cyclical . . . Transportation . . . . . . . . Other . . . . . . . . . . . . . . . . . Subtotal, U.S. corporate Non-U.S. corporate: Finance and Consumer— Technology and communications . . . . Industrial . . . . . . . . . . . . Capital goods . . . . . . . . Consumer—cyclical . . . Transportation . . . . . . . . Other . . . . . . . . . . . . . . . Subtotal, non-U.S. corporate Total for corporate securities in an unrealized loss GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 We diversify our commercial mortgage loans by both property type and geographic region. The following tables set forth the distribution across property type and geographic region for commercial mortgage loans as of December 31: (Amounts in millions) Property type: Retail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Apartments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mixed use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2023 2022 Carrying value % of total Carrying value % of total $2,858 1,481 1,440 522 371 157 42% $2,916 1,579 22 1,456 21 561 8 371 5 149 2 42% 22 21 8 5 2 Subtotal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,829 100% 7,032 100% Allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . (27) Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $6,802 (22) $7,010 (Amounts in millions) Geographic region: South Atlantic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Pacific . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mountain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Middle Atlantic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . West South Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . East North Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . West North Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . East South Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . New England . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2023 2022 Carrying value % of total Carrying value % of total $1,803 1,281 1,029 925 553 445 404 206 183 26% $1,809 1,340 19 1,023 15 988 14 578 8 454 6 438 6 218 3 184 3 26% 19 15 14 8 6 6 3 3 Subtotal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,829 100% 7,032 100% Allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . (27) Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $6,802 (22) $7,010 As of December 31, 2023 and 2022, we had no commercial mortgage loans past due or on non-accrual status. For a discussion of our policy related to placing commercial mortgage loans on non-accrual status, see note 2. During the years ended December 31, 2023 and 2022, we did not have any loan modifications or extensions associated with borrowers experiencing financial difficulty that resulted in the consideration of whether to establish a new loan or to continue accounting for the modification or extension under the existing loan. The following table sets forth the allowance for credit losses related to commercial mortgage loans as of and for the years ended December 31: (Amounts in millions) Allowance for credit losses: 2023 2022 2021 Beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 22 $ 26 $ 31 Provision . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 (5) Write-offs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — 3 (8) Recoveries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 1 — Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 27 $ 22 $ 26 In evaluating the credit quality of commercial mortgage loans, we assess the performance of the underlying loans using both quantitative and qualitative criteria. Certain risks associated with commercial mortgage loans can be evaluated by reviewing both the debt-to-value and debt service coverage ratio to understand both the probability of the borrower not being able to make the necessary loan payments as well as the ability to sell the underlying property for an amount that would enable us to recover our unpaid principal balance in the event of default by the borrower. The average debt-to-value ratio is based on our most recent estimate of the fair value for the underlying property which is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. A lower debt-to-value indicates that our loan value is more likely to be recovered in the event of default by the borrower if the property were sold. The debt service coverage ratio is based on “normalized” annual income of the property compared to the payments required under the terms of the loan. Normalization allows for the removal of annual one-time events such as capital expenditures, prepaid or late real estate tax payments or non-recurring third-party fees (such as legal, consulting or contract fees). This ratio is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. A higher debt service coverage ratio indicates the borrower is less likely to default on the loan. The debt service coverage ratio is not used without considering other factors associated with the borrower, such as the borrower’s liquidity or access to other resources that may result in our expectation that the borrower will continue to make the future scheduled payments. The following tables set forth commercial mortgage loans by year of origination and credit quality indicator as of December 31, 2023: (Amounts in millions) Debt-to-value: 2023 2022 2021 2020 2019 Total 2018 and prior 0%–50% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 19 $ 75 $ 86 $115 $127 $1,946 $2,368 51%–60% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61%–75% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 229 84 771 220 599 76%–100% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — 86 275 4 154 388 23 Greater than 100% . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — 826 756 23 — 1,393 3,018 50 — Total amortized cost . . . . . . . . . . . . . . . . . . . . . . . $271 $930 $905 $480 $692 $3,551 $6,829 Debt service coverage ratio: Less than 1.00 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $— $ 17 $ 3 $ 18 $ 31 $ 196 $ 265 1.00–1.25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.26–1.50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.51–2.00 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Greater than 2.00 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 172 65 20 38 223 396 256 9 104 422 367 19 67 205 171 36 159 261 205 147 471 1,262 1,475 263 1,196 2,611 2,494 Total amortized cost . . . . . . . . . . . . . . . . . . . . . . . $271 $930 $905 $480 $692 $3,551 $6,829 176 177 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table sets forth the allowance for credit losses related to commercial mortgage loans as of and for the years ended December 31: (Amounts in millions) Allowance for credit losses: Beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Write-offs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Recoveries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2023 2022 2021 $ 22 5 $ 26 (5) — — — $ 27 $ 31 3 (8) 1 — $ 26 $ 22 In evaluating the credit quality of commercial mortgage loans, we assess the performance of the underlying loans using both quantitative and qualitative criteria. Certain risks associated with commercial mortgage loans can be evaluated by reviewing both the debt-to-value and debt service coverage ratio to understand both the probability of the borrower not being able to make the necessary loan payments as well as the ability to sell the underlying property for an amount that would enable us to recover our unpaid principal balance in the event of default by the borrower. The average debt-to-value ratio is based on our most recent estimate of the fair value for the underlying property which is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. A lower debt-to-value indicates that our loan value is more likely to be recovered in the event of default by the borrower if the property were sold. The debt service coverage ratio is based on “normalized” annual income of the property compared to the payments required under the terms of the loan. Normalization allows for the removal of annual one-time events such as capital expenditures, prepaid or late real estate tax payments or non-recurring third-party fees (such as legal, consulting or contract fees). This ratio is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. A higher debt service coverage ratio indicates the borrower is less likely to default on the loan. The debt service coverage ratio is not used without considering other factors associated with the borrower, such as the borrower’s liquidity or access to other resources that may result in our expectation that the borrower will continue to make the future scheduled payments. The following tables set forth commercial mortgage loans by year of origination and credit quality indicator as of December 31, 2023: (Amounts in millions) Debt-to-value: 2023 2022 2021 2020 2019 2018 and prior Total We diversify our commercial mortgage loans by both property type and geographic region. The following tables set forth the distribution across property type and geographic region for commercial mortgage loans as of December 31: (Amounts in millions) Property type: 2023 2022 Carrying value % of total Carrying value % of total Retail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Apartments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mixed use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,858 1,481 1,440 522 371 157 42% $2,916 42% 22 21 8 5 2 1,579 1,456 561 371 149 22 21 8 5 2 Subtotal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,829 100% 7,032 100% Allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . (27) Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $6,802 (22) $7,010 2023 2022 Carrying value % of total Carrying value % of total 26% $1,809 26% (Amounts in millions) Geographic region: South Atlantic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Pacific . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mountain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Middle Atlantic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . West South Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . East North Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . West North Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . East South Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . New England . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,803 1,281 1,029 925 553 445 404 206 183 19 15 14 8 6 6 3 3 Subtotal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,829 100% 7,032 100% Allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . (27) Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $6,802 As of December 31, 2023 and 2022, we had no commercial mortgage loans past due or on non-accrual status. For a discussion of our policy related to placing commercial mortgage loans on non-accrual status, see note 2. During the years ended December 31, 2023 and 2022, we did not have any loan modifications or extensions associated with borrowers experiencing financial difficulty that resulted in the consideration of whether to establish a new loan or to continue accounting for the modification or extension under the existing loan. 19 15 14 8 6 6 3 3 1,340 1,023 988 578 454 438 218 184 (22) $7,010 0%–50% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154 220 51%–60% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 388 61%–75% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 599 76%–100% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — 23 Greater than 100% . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — $ 19 $ 75 $ 86 $115 $127 $1,946 $2,368 1,393 86 3,018 275 50 4 — $271 $930 $905 $480 $692 $3,551 $6,829 826 756 23 — Total amortized cost . . . . . . . . . . . . . . . . . . . . . . . Debt service coverage ratio: Less than 1.00 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.00–1.25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.26–1.50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.51–2.00 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Greater than 2.00 . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total amortized cost . . . . . . . . . . . . . . . . . . . . . . . 176 177 $— $ 17 $ 14 172 65 20 3 $ 18 $ 31 $ 196 $ 265 263 9 19 1,196 104 67 2,611 422 205 2,494 367 171 $271 $930 $905 $480 $692 $3,551 $6,829 147 471 1,262 1,475 38 223 396 256 36 159 261 205 23 229 84 771 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following tables set forth the debt-to-value of commercial mortgage loans by property type as of The following tables set forth the debt service coverage ratio for fixed rate commercial mortgage loans by December 31: (Amounts in millions) Property type: 0%–50% 51%–60% 61%–75% 76%–100% Greater than 100% Total 2023 Less than 1.00 1.00–1.25 1.26–1.50 1.51–2.00 Greater than 2.00 Total 2023 Retail . . . . . . . . . . . . . . . . . . . . . . . . . . . . Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . Apartments . . . . . . . . . . . . . . . . . . . . . . . . Mixed use . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 945 350 670 194 120 89 $ 686 325 250 61 61 10 $1,227 771 520 259 183 58 Total amortized cost . . . . . . . . . . . . . . . . $2,368 $1,393 $3,018 $ — 35 — 8 7 — $ 50 $— — — — — — $— $2,858 1,481 1,440 522 371 157 $6,829 % of total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35% 20% 44% 1% — % 100% % of total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4% 4% Weighted-average debt service coverage ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.42 1.87 1.66 0.87 — 1.96 (Amounts in millions) Property type: 0%–50% 51%–60% 61%–75% 76%–100% Greater than 100% Total 2022 (Amounts in millions) Property type: Retail . . . . . . . . . . . . . . . . . . . . . . . . . . . . Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . Apartments . . . . . . . . . . . . . . . . . . . . . . . . Mixed use . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 907 445 668 184 93 88 $ 649 272 243 90 79 9 $1,332 848 545 279 199 52 Total amortized cost . . . . . . . . . . . . . . . . $2,385 $1,342 $3,255 $ 28 14 — 8 — — $ 50 $— — — — — — $— $2,916 1,579 1,456 561 371 149 $7,032 % of total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34% 19% 46% 1% — % 100% Weighted-average debt service coverage ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.35 1.95 1.63 1.34 — 1.93 property type as of December 31: (Amounts in millions) Property type: Retail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 54 105 Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Apartments . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mixed use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 12 27 24 $105 $ 583 $1,142 $ 974 $2,858 48 30 51 14 15 244 181 86 80 22 615 471 187 164 32 469 715 186 86 64 1,481 1,440 522 371 157 Total amortized cost . . . . . . . . . . . . . . . . . . . . . $265 $263 $1,196 $2,611 $2,494 $6,829 Weighted-average debt-to-value . . . . . . . . . . . . . . . . 64% 63% 17% 65% 38% 58% 37% 100% 46% 55% Less than 1.00 1.00–1.25 1.26–1.50 1.51–2.00 Greater than 2.00 Total 2022 Retail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 88 $ 560 $1,380 $ 820 $2,916 Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Apartments . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mixed use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81 20 14 25 42 $ 68 131 44 11 16 2 155 194 150 50 9 666 574 242 190 33 546 624 144 90 63 1,579 1,456 561 371 149 Total amortized cost . . . . . . . . . . . . . . . . . . . . . $270 $272 $1,118 $3,085 $2,287 $7,032 % of total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4% 4% Weighted-average debt-to-value . . . . . . . . . . . . . . . . 61% 62% 16% 63% 44% 60% 32% 100% 44% 56% (f) Limited Partnerships or Similar Entities Investments in limited partnerships or similar entities are generally considered VIEs when the equity group lacks sufficient financial control. Generally, these investments are limited partner or non-managing member equity investments in a widely held fund that is sponsored and managed by a reputable asset manager. We are not the primary beneficiary of any VIE investment in a limited partnership or similar entity. As of December 31, 2023 and 2022, the total carrying value of these investments was $2,667 million and $2,230 million, respectively. Our maximum exposure to loss is equal to the outstanding carrying value and future funding commitments. We have not contributed, and do not plan to contribute, any additional financial or other support outside of what is contractually obligated. 178 179 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following tables set forth the debt-to-value of commercial mortgage loans by property type as of The following tables set forth the debt service coverage ratio for fixed rate commercial mortgage loans by December 31: (Amounts in millions) Property type: 0%–50% 51%–60% 61%–75% 76%–100% than 100% Total 2023 Greater Retail . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 945 $ 686 $1,227 $ — $— $2,858 Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . Apartments . . . . . . . . . . . . . . . . . . . . . . . . Mixed use . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . 350 670 194 120 89 325 250 61 61 10 771 520 259 183 58 35 — 8 7 — — — — — — 1,481 1,440 522 371 157 Total amortized cost . . . . . . . . . . . . . . . . $2,368 $1,393 $3,018 $ 50 $— $6,829 property type as of December 31: (Amounts in millions) Property type: Less than 1.00 1.00–1.25 1.26–1.50 1.51–2.00 Greater than 2.00 Total 2023 Retail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Apartments . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mixed use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total amortized cost . . . . . . . . . . . . . . . . . . . . . $ 54 105 43 12 27 24 $265 $105 48 30 51 14 15 $263 $ 583 244 181 86 80 22 $1,142 615 471 187 164 32 $ 974 $2,858 1,481 1,440 522 371 157 469 715 186 86 64 $1,196 $2,611 $2,494 $6,829 % of total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35% 20% 44% 1% — % 100% % of total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4% 4% Weighted-average debt service coverage ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.42 1.87 1.66 0.87 — 1.96 Weighted-average debt-to-value . . . . . . . . . . . . . . . . 64% 63% 17% 65% 38% 58% 37% 100% 46% 55% 0%–50% 51%–60% 61%–75% 76%–100% than 100% Total 2022 Greater (Amounts in millions) Property type: Less than 1.00 1.00–1.25 1.26–1.50 1.51–2.00 Greater than 2.00 Total 2022 Retail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Apartments . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mixed use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total amortized cost . . . . . . . . . . . . . . . . . . . . . $ 88 81 20 14 25 42 $270 $ 68 131 44 11 16 2 $272 $ 560 155 194 150 50 9 $1,380 666 574 242 190 33 $ 820 $2,916 1,579 1,456 561 371 149 546 624 144 90 63 $1,118 $3,085 $2,287 $7,032 % of total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4% 4% Weighted-average debt-to-value . . . . . . . . . . . . . . . . 61% 62% 16% 63% 44% 60% 32% 100% 44% 56% (f) Limited Partnerships or Similar Entities Investments in limited partnerships or similar entities are generally considered VIEs when the equity group lacks sufficient financial control. Generally, these investments are limited partner or non-managing member equity investments in a widely held fund that is sponsored and managed by a reputable asset manager. We are not the primary beneficiary of any VIE investment in a limited partnership or similar entity. As of December 31, 2023 and 2022, the total carrying value of these investments was $2,667 million and $2,230 million, respectively. Our maximum exposure to loss is equal to the outstanding carrying value and future funding commitments. We have not contributed, and do not plan to contribute, any additional financial or other support outside of what is contractually obligated. 178 179 (Amounts in millions) Property type: Retail . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 907 $ 649 $1,332 $ 28 $— $2,916 Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . Apartments . . . . . . . . . . . . . . . . . . . . . . . . Mixed use . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . 445 668 184 93 88 272 243 90 79 9 848 545 279 199 52 14 — 8 — — — — — — — 1,579 1,456 561 371 149 Total amortized cost . . . . . . . . . . . . . . . . $2,385 $1,342 $3,255 $ 50 $— $7,032 % of total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34% 19% 46% 1% — % 100% Weighted-average debt service coverage ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.35 1.95 1.63 1.34 — 1.93 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (6) Derivative Instruments Our business activities routinely deal with fluctuations in interest rates, equity prices, currency exchange rates and other asset and liability prices. We use derivative instruments to mitigate or reduce some of these risks. We have established policies for managing each of these risks, including prohibitions on derivatives market- making and other speculative derivatives activities. These policies require the use of derivative instruments in concert with other techniques to reduce or mitigate these risks. While we use derivatives to mitigate or reduce risks, certain derivatives do not meet the accounting requirements to be designated as hedging instruments and are denoted as “derivatives not designated as hedges” in the following disclosures. For derivatives that meet the accounting requirements to be designated as hedges, the following disclosures for these derivatives are denoted as “derivatives designated as hedges,” which include cash flow hedges. The following table sets forth our positions in derivative instruments as of December 31: (Amounts in millions) Derivatives designated as hedges Cash flow hedges: Derivative assets Derivative liabilities Balance sheet classification Fair value 2023 2022 Balance sheet classification Fair value 2023 2022 Interest rate swaps . . . . . . . . . . . . . . . Other invested assets $ 55 $ 24 Other liabilities Foreign currency swaps . . . . . . . . . . . Other invested assets 20 Other liabilities Forward bond purchase 10 $490 $522 2 — commitments . . . . . . . . . . . . . . . . . Other invested assets 51 — Other liabilities — — Total cash flow hedges . . . . . . . . . . . . Total derivatives designated as hedges . . . . . . . . . . . . . . . . . . . . . . . 116 44 116 44 492 522 492 522 Derivatives not designated as hedges Equity index options . . . . . . . . . . . . . . . . . Other invested assets 6 Other liabilities — — Financial futures(1) . . . . . . . . . . . . . . . . . . . Other invested assets — — Other liabilities — — 9 — Forward bond purchase commitments . . . . Other invested assets — — Other liabilities Fixed indexed annuity embedded Policyholder 15 Indexed universal life embedded derivatives . . . . . . . . . . . . . . . . . . . . . . . Other assets Reinsurance recoverable derivatives . . . . . . . . . . . . . . . . . . . . . . . Total derivatives not designated as hedges . . . . . . . . . . . . . . . . . . . . . . . Total derivatives . . . . . . . . . . . . . . . . . — — account balances(2) 165 202 Policyholder — — account balances(3) 15 15 15 6 $131 $ 50 189 217 $681 $739 (1) The period end valuations of financial futures were zero as a result of settling the margins on these contracts on a daily basis. (2) Represents the embedded derivatives associated with our fixed indexed annuity liabilities. (3) Represents the embedded derivatives associated with our indexed universal life liabilities. The fair value of derivative positions presented above was not offset by the respective collateral amounts received or provided under these agreements. 180 181 The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for fixed indexed annuity embedded derivatives and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated: Measurement 2022 Additions December 31, Maturities/ terminations December 31, 2023 (Notional in millions) Derivatives designated as hedges Cash flow hedges: Interest rate swaps . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . . . . . . . Forward bond purchase commitments . . . Notional Notional Notional Total cash flow hedges . . . . . . . . . . . . . . . Total derivatives designated as hedges . . . . . . . . . . . . . . . . . . . . . . Derivatives not designated as hedges $ 8,542 $1,857 $(1,424) $ 8,975 144 — 8,686 — 1,075 2,932 (13) — 131 1,075 (1,437) 10,181 8,686 2,932 (1,437) 10,181 Equity index options . . . . . . . . . . . . . . . . . . . . . Financial futures . . . . . . . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . Notional Notional Notional 936 1,403 — 729 5,488 500 (963) (5,640) — 702 1,251 500 Total derivatives not designated as hedges . . . . . . . . . . . . . . . . . . . . . . 2,339 6,717 (6,603) 2,453 Total derivatives . . . . . . . . . . . . . . $11,025 $9,649 $(8,040) $12,634 Measurement 2022 Additions December 31, Maturities/ terminations December 31, 2023 derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . Policies 7,315 (1,489) 5,826 derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . Policies 771 (22) 749 — — (Number of policies) Derivatives not designated as hedges Fixed indexed annuity embedded Indexed universal life embedded Cash Flow Hedges Certain derivative instruments are designated as cash flow hedges. The changes in fair value of these instruments are recorded as a component of OCI. We designate and account for the following as cash flow hedges when they have met the effectiveness requirements: (i) various types of interest rate swaps to convert floating rate investments to fixed rate investments; (ii) various types of interest rate swaps to convert floating rate liabilities into fixed rate liabilities; (iii) receive U.S. dollar fixed on foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated investments; (iv) forward starting interest rate swaps to hedge against changes in interest rates associated with future fixed rate bond purchases and/or interest income; (v) forward bond purchase commitments to hedge against the variability in the anticipated cash flows required to purchase future fixed rate bonds; and (vi) other instruments to hedge the cash flows of various forecasted transactions. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (6) Derivative Instruments Our business activities routinely deal with fluctuations in interest rates, equity prices, currency exchange rates and other asset and liability prices. We use derivative instruments to mitigate or reduce some of these risks. We have established policies for managing each of these risks, including prohibitions on derivatives market- making and other speculative derivatives activities. These policies require the use of derivative instruments in concert with other techniques to reduce or mitigate these risks. While we use derivatives to mitigate or reduce risks, certain derivatives do not meet the accounting requirements to be designated as hedging instruments and are denoted as “derivatives not designated as hedges” in the following disclosures. For derivatives that meet the accounting requirements to be designated as hedges, the following disclosures for these derivatives are denoted as “derivatives designated as hedges,” which include cash flow hedges. The following table sets forth our positions in derivative instruments as of December 31: Derivative assets Derivative liabilities Balance sheet classification Fair value 2023 2022 Balance sheet classification Fair value 2023 2022 (Amounts in millions) Derivatives designated as hedges Cash flow hedges: Forward bond purchase Total cash flow hedges . . . . . . . . . . . . Total derivatives designated as hedges . . . . . . . . . . . . . . . . . . . . . . . Derivatives not designated as hedges Interest rate swaps . . . . . . . . . . . . . . . Other invested assets $ 55 $ 24 Other liabilities $490 $522 Foreign currency swaps . . . . . . . . . . . Other invested assets 10 20 Other liabilities 2 — commitments . . . . . . . . . . . . . . . . . Other invested assets 51 — Other liabilities — — 116 44 116 44 492 522 492 522 Equity index options . . . . . . . . . . . . . . . . . Other invested assets 15 6 Other liabilities — — Financial futures(1) . . . . . . . . . . . . . . . . . . . Other invested assets — — Other liabilities — — Forward bond purchase commitments . . . . Other invested assets — — Other liabilities 9 — Fixed indexed annuity embedded derivatives . . . . . . . . . . . . . . . . . . . . . . . Other assets — — account balances(2) 165 202 Indexed universal life embedded Reinsurance derivatives . . . . . . . . . . . . . . . . . . . . . . . recoverable — — account balances(3) 15 15 Policyholder Policyholder Total derivatives not designated as hedges . . . . . . . . . . . . . . . . . . . . . . . Total derivatives . . . . . . . . . . . . . . . . . 15 6 $131 $ 50 189 217 $681 $739 (1) The period end valuations of financial futures were zero as a result of settling the margins on these contracts on a daily basis. (2) Represents the embedded derivatives associated with our fixed indexed annuity liabilities. (3) Represents the embedded derivatives associated with our indexed universal life liabilities. The fair value of derivative positions presented above was not offset by the respective collateral amounts received or provided under these agreements. The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for fixed indexed annuity embedded derivatives and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated: (Notional in millions) Derivatives designated as hedges Cash flow hedges: Measurement December 31, 2022 Additions Maturities/ terminations December 31, 2023 Interest rate swaps . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . . . . . . . Forward bond purchase commitments . . . Notional Notional Notional $ 8,542 144 — $1,857 — 1,075 $(1,424) (13) — $ 8,975 131 1,075 Total cash flow hedges . . . . . . . . . . . . . . . 8,686 2,932 (1,437) 10,181 Total derivatives designated as hedges . . . . . . . . . . . . . . . . . . . . . . Derivatives not designated as hedges Equity index options . . . . . . . . . . . . . . . . . . . . . Financial futures . . . . . . . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . Total derivatives not designated as hedges . . . . . . . . . . . . . . . . . . . . . . 8,686 2,932 (1,437) 10,181 Notional Notional Notional 936 1,403 — 729 5,488 500 (963) (5,640) — 702 1,251 500 2,339 6,717 (6,603) 2,453 Total derivatives . . . . . . . . . . . . . . $11,025 $9,649 $(8,040) $12,634 (Number of policies) Derivatives not designated as hedges Fixed indexed annuity embedded Measurement December 31, 2022 Additions Maturities/ terminations December 31, 2023 derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . Policies 7,315 Indexed universal life embedded derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . Policies 771 — — (1,489) 5,826 (22) 749 Cash Flow Hedges Certain derivative instruments are designated as cash flow hedges. The changes in fair value of these instruments are recorded as a component of OCI. We designate and account for the following as cash flow hedges when they have met the effectiveness requirements: (i) various types of interest rate swaps to convert floating rate investments to fixed rate investments; (ii) various types of interest rate swaps to convert floating rate liabilities into fixed rate liabilities; (iii) receive U.S. dollar fixed on foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated investments; (iv) forward starting interest rate swaps to hedge against changes in interest rates associated with future fixed rate bond purchases and/or interest income; (v) forward bond purchase commitments to hedge against the variability in the anticipated cash flows required to purchase future fixed rate bonds; and (vi) other instruments to hedge the cash flows of various forecasted transactions. 180 181 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table provides information about the pre-tax income effects of cash flow hedges for the year The following table provides information about the pre-tax income effects of cash flow hedges for the year ended December 31, 2023: (Amounts in millions) Interest rate swaps hedging Gain (loss) recognized in OCI Gain (loss) reclassified into net income from OCI Classification of gain (loss) reclassified into net income Gain (loss) recognized in net income assets . . . . . . . . . . . . . . . . . . . . $ (92) $220 Interest rate swaps hedging assets . . . . . . . . . . . . . . . . . . . . Interest rate swaps hedging liabilities . . . . . . . . . . . . . . . . . . Interest rate swaps hedging liabilities . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . . . . . . . . — — — 51 10 (3) 1 1 Foreign currency swaps . . . . . . . . (10) — Foreign currency swaps . . . . . . . . — Total . . . . . . . . . . . . . . . . . . . $ (51) 2 $231 Net investment income Net investment gains (losses) Interest expense Net investment gains (losses) Net investment gains (losses) Net investment income Net investment gains (losses) $— — — — — — — $— The following table provides information about the pre-tax income effects of cash flow hedges for the year ended December 31, 2022: (Amounts in millions) Interest rate swaps hedging Gain (loss) recognized in OCI Gain (loss) reclassified into net income from OCI Classification of gain (loss) reclassified into net income Gain (loss) recognized in net income assets . . . . . . . . . . . . . . . . . . . . $(854) $225 Interest rate swaps hedging assets . . . . . . . . . . . . . . . . . . . . Interest rate swaps hedging liabilities . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . — — 15 Total . . . . . . . . . . . . . . . . . . . $(839) 9 (3) — $231 Net investment income Net investment gains (losses) Interest expense Net investment income $— — — — $— Classification of gain (loss) recognized in net income Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Classification of gain (loss) recognized in net income Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) ended December 31, 2021: (Amounts in millions) Interest rate swaps hedging Gain (loss) recognized in OCI Gain (loss) reclassified into net income from OCI Classification of gain (loss) reclassified into net income Gain (loss) recognized in net income assets . . . . . . . . . . . . . . . . . . . . $(100) $217 income $— Interest rate swaps hedging assets . . . . . . . . . . . . . . . . . . . . — Interest rate swaps hedging liabilities . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . Total . . . . . . . . . . . . . . . . . . . $ (57) 36 7 1 (1) — $217 Net investment Net investment gains (losses) Interest expense Net investment income — — — $— Classification of gain (loss) recognized in net income Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) The following table provides a reconciliation of current period changes, net of applicable income taxes, for these designated derivatives presented in the separate component of stockholders’ equity labeled “derivatives qualifying as hedges,” as of and for the years ended December 31: (Amounts in millions) 2023 2022 2021 Derivatives qualifying as effective accounting hedges as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,200 $2,025 $2,211 Current period increases (decreases) in fair value, net of deferred taxes of $12, $165 and $12 . . . . . . . . . . . . . . . . . . (39) (674) (45) Reclassification to net (income), net of deferred taxes of $80, $80 and $76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (151) (151) (141) Derivatives qualifying as effective accounting hedges as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,010 $1,200 $2,025 The total of derivatives designated as cash flow hedges of $1,010 million, net of taxes, recorded in stockholders’ equity as of December 31, 2023 is expected to be reclassified to net income (loss) in the future, concurrently with and primarily offsetting changes in interest expense and interest income on floating rate instruments and interest income on future fixed rate bond purchases. Of this amount, $136 million, net of taxes, is expected to be reclassified to net income (loss) in the next 12 months. Actual amounts may vary from this amount as a result of market conditions. All forecasted transactions associated with qualifying cash flow hedges are expected to occur by 2057. During the years ended December 31, 2023, 2022 and 2021, we reclassified $10 million, $11 million and $10 million, respectively, to net income in connection with forecasted transactions that were no longer considered reasonably possible of occurring. Derivatives Not Designated As Hedges We enter into certain non-qualifying derivative instruments such as equity index options and financial futures to mitigate the risks associated with liabilities that have guaranteed minimum benefits, fixed indexed annuities and indexed universal life. Our fixed indexed annuity and indexed universal life insurance products 182 183 ended December 31, 2023: (Amounts in millions) Interest rate swaps hedging Interest rate swaps hedging assets . . . . . . . . . . . . . . . . . . . . Interest rate swaps hedging liabilities . . . . . . . . . . . . . . . . . . Interest rate swaps hedging liabilities . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . . . . . . . . Gain (loss) recognized in OCI Gain (loss) reclassified into net income from OCI Classification of gain (loss) reclassified into net income Gain (loss) recognized in net income — — — 51 10 (3) 1 1 Net investment Net investment gains (losses) Interest expense Net investment gains (losses) Net investment gains (losses) Net investment Net investment gains (losses) Foreign currency swaps . . . . . . . . (10) — income Foreign currency swaps . . . . . . . . — Total . . . . . . . . . . . . . . . . . . . $ (51) 2 $231 The following table provides information about the pre-tax income effects of cash flow hedges for the year ended December 31, 2022: Gain (loss) recognized in OCI Gain (loss) reclassified into net income from OCI Classification of gain (loss) reclassified into net income Gain (loss) recognized in net income assets . . . . . . . . . . . . . . . . . . . . $(854) $225 income $— (Amounts in millions) Interest rate swaps hedging Interest rate swaps hedging assets . . . . . . . . . . . . . . . . . . . . Interest rate swaps hedging liabilities . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . Total . . . . . . . . . . . . . . . . . . . $(839) Net investment Net investment gains (losses) Interest expense Net investment income — — 15 9 (3) — $231 Classification of gain (loss) recognized in net income Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Classification of gain (loss) recognized in net income Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) — — — — — — $— — — — $— GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table provides information about the pre-tax income effects of cash flow hedges for the year The following table provides information about the pre-tax income effects of cash flow hedges for the year assets . . . . . . . . . . . . . . . . . . . . $ (92) $220 income $— assets . . . . . . . . . . . . . . . . . . . . $(100) $217 Interest rate swaps hedging assets . . . . . . . . . . . . . . . . . . . . — Interest rate swaps hedging liabilities . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . 36 7 Total . . . . . . . . . . . . . . . . . . . $ (57) 1 (1) — $217 ended December 31, 2021: (Amounts in millions) Interest rate swaps hedging Gain (loss) recognized in OCI Gain (loss) reclassified into net income from OCI Classification of gain (loss) reclassified into net income Gain (loss) recognized in net income Classification of gain (loss) recognized in net income Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment gains (losses) Net investment income Net investment gains (losses) Interest expense Net investment income $— — — — $— The following table provides a reconciliation of current period changes, net of applicable income taxes, for these designated derivatives presented in the separate component of stockholders’ equity labeled “derivatives qualifying as hedges,” as of and for the years ended December 31: (Amounts in millions) 2023 2022 2021 Derivatives qualifying as effective accounting hedges as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,200 $2,025 $2,211 Current period increases (decreases) in fair value, net of deferred taxes of $12, $165 and $12 . . . . . . . . . . . . . . . . . . (39) (674) (45) Reclassification to net (income), net of deferred taxes of $80, $80 and $76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (151) (151) (141) Derivatives qualifying as effective accounting hedges as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,010 $1,200 $2,025 The total of derivatives designated as cash flow hedges of $1,010 million, net of taxes, recorded in stockholders’ equity as of December 31, 2023 is expected to be reclassified to net income (loss) in the future, concurrently with and primarily offsetting changes in interest expense and interest income on floating rate instruments and interest income on future fixed rate bond purchases. Of this amount, $136 million, net of taxes, is expected to be reclassified to net income (loss) in the next 12 months. Actual amounts may vary from this amount as a result of market conditions. All forecasted transactions associated with qualifying cash flow hedges are expected to occur by 2057. During the years ended December 31, 2023, 2022 and 2021, we reclassified $10 million, $11 million and $10 million, respectively, to net income in connection with forecasted transactions that were no longer considered reasonably possible of occurring. Derivatives Not Designated As Hedges We enter into certain non-qualifying derivative instruments such as equity index options and financial futures to mitigate the risks associated with liabilities that have guaranteed minimum benefits, fixed indexed annuities and indexed universal life. Our fixed indexed annuity and indexed universal life insurance products 182 183 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 with certain features are required to be bifurcated as embedded derivatives. Additionally, we have forward bond purchase commitments to hedge against the variability in the anticipated cash flows required to purchase future fixed rate bonds. The following table provides the pre-tax gain (loss) recognized in net income for the effects of derivatives not designated as hedges for the years ended December 31: (Amounts in millions) 2023 2022 2021 Classification of gain (loss) recognized in net income Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Equity index options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — $— $ 6 (20) 2 Net investment gains (losses) 18 Net investment gains (losses) Financial futures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . . . . . . . . . Fixed indexed annuity embedded derivatives . . . . . . . . . . Indexed universal life embedded derivatives . . . . . . . . . . (108) (81) (123) Changes in fair value of market risk benefits and associated hedges (9) — — Net investment gains (losses) (32) Net investment gains (losses) (18) 24 Net investment gains (losses) 14 16 27 Total derivatives not designated as hedges . . . . . . . . $(115) $ (58) $(111) (Amounts in millions) Derivative Counterparty Credit Risk Most of our derivative arrangements with counterparties require the posting of collateral upon meeting certain net exposure thresholds. The following table presents additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of December 31: (Amounts in millions) Amounts presented in the balance sheet: Gross amounts recognized . . . . . . . . . Gross amounts offset in the balance 2023 2022 Derivative assets (1) Derivative liabilities (1) Net derivatives Derivative assets(1) Derivative liabilities (1) Net derivatives $131 $ 501 $ (370) $ 50 $ 522 $ (472) (Amounts in millions) sheet . . . . . . . . . . . . . . . . . . . . . . . . — — — — — — Net amounts presented in the balance sheet . . . . . . . . . . . . . . . . . . . . . . . . Gross amounts not offset in the balance sheet: 131 501 (370) 50 522 (472) Financial instruments(2) . . . . . . . . . . . Collateral received . . . . . . . . . . . . . . . Collateral pledged . . . . . . . . . . . . . . . . Over collateralization . . . . . . . . . . . . . . . . . (59) (19) — — (59) — (1,100) 658 — (19) 1,100 (658) (25) (21) — — (25) — (1,095) 598 — (21) 1,095 (598) Net amount . . . . . . . . . . . . . . . . . . . . . . . . . $ 53 $ — $ 53 $ 4 $ — $ 4 (1) Does not include amounts related to embedded derivatives as of December 31, 2023 and 2022. (2) Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty. (7) Deferred Acquisition Costs periods indicated: (Amounts in millions) The following tables present the balances of and changes in deferred acquisition costs as of and for the $935 1 (57) $879 $989 6 (60) $935 December 31, 2023 Long-term Life Fixed care insurance insurance annuities Variable annuities Total Balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . Costs deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,080 $ 57 $113 $2,185 — (139) — (12) — (15) 1 (223) Balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . $ 941 $ 45 $ 98 1,963 Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred acquisition costs . . . . . . . . . . . . . . . . . . . . . December 31, 2022 Long-term Life Fixed care insurance insurance annuities Variable annuities Total Balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . Costs deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,271 $ 70 $131 $2,461 — (191) — (13) — (18) 6 (282) Balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . $1,080 $ 57 $113 2,185 Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred acquisition costs . . . . . . . . . . . . . . . . . . . . . December 31, 2021 Long-term Life Fixed care insurance insurance annuities Variable annuities Total Balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,043 $1,501 $ 85 $151 $2,780 Costs deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 (63) — (230) — (15) — (20) 9 (328) Balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . $ 989 $1,271 $ 70 $131 2,461 Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred acquisition costs . . . . . . . . . . . . . . . . . . . . . 25 $1,988 26 $2,211 27 $2,488 184 185 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (7) Deferred Acquisition Costs The following tables present the balances of and changes in deferred acquisition costs as of and for the Total derivatives not designated as hedges . . . . . . . . $(115) $ (58) $(111) (Amounts in millions) December 31, 2022 Long-term care insurance Life insurance Fixed annuities Variable annuities periods indicated: (Amounts in millions) December 31, 2023 Long-term care insurance Life insurance Fixed annuities Variable annuities Balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . Costs deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . $935 1 (57) $879 Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred acquisition costs . . . . . . . . . . . . . . . . . . . . . $1,080 — (139) $ 57 — (12) $113 — (15) $ 941 $ 45 $ 98 1,963 Balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . Costs deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . $989 6 (60) $935 Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred acquisition costs . . . . . . . . . . . . . . . . . . . . . $1,271 — (191) $ 70 — (13) $131 — (18) $1,080 $ 57 $113 2,185 (Amounts in millions) December 31, 2021 Long-term care insurance Life insurance Fixed annuities Variable annuities Balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . Costs deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,043 9 (63) $1,501 — (230) $ 85 — (15) $151 — (20) Total $2,185 1 (223) 25 $1,988 Total $2,461 6 (282) 26 $2,211 Total $2,780 9 (328) Balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . $ 989 $1,271 $ 70 $131 2,461 Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred acquisition costs . . . . . . . . . . . . . . . . . . . . . 27 $2,488 184 185 with certain features are required to be bifurcated as embedded derivatives. Additionally, we have forward bond purchase commitments to hedge against the variability in the anticipated cash flows required to purchase future fixed rate bonds. The following table provides the pre-tax gain (loss) recognized in net income for the effects of derivatives not designated as hedges for the years ended December 31: (Amounts in millions) 2023 2022 2021 Classification of gain (loss) recognized in net income Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — $— $ 2 Net investment gains (losses) Equity index options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 (20) 18 Net investment gains (losses) Financial futures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (108) (81) (123) associated hedges Forward bond purchase commitments . . . . . . . . . . . . . . . (9) — — Net investment gains (losses) Fixed indexed annuity embedded derivatives . . . . . . . . . . Indexed universal life embedded derivatives . . . . . . . . . . (18) 14 16 27 (32) Net investment gains (losses) 24 Net investment gains (losses) Changes in fair value of market risk benefits and Derivative Counterparty Credit Risk Most of our derivative arrangements with counterparties require the posting of collateral upon meeting certain net exposure thresholds. The following table presents additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of December 31: 2023 2022 Derivative assets (1) Derivative liabilities (1) Net derivatives Derivative assets(1) Derivative liabilities (1) Net derivatives (Amounts in millions) Amounts presented in the balance sheet: Gross amounts offset in the balance Net amounts presented in the balance Gross amounts not offset in the balance sheet: Gross amounts recognized . . . . . . . . . $131 $ 501 $ (370) $ 50 $ 522 $ (472) sheet . . . . . . . . . . . . . . . . . . . . . . . . — — — — — — sheet . . . . . . . . . . . . . . . . . . . . . . . . 131 501 (370) 50 522 (472) Financial instruments(2) . . . . . . . . . . . Collateral received . . . . . . . . . . . . . . . Collateral pledged . . . . . . . . . . . . . . . . Over collateralization . . . . . . . . . . . . . . . . . (59) (19) — — (59) — (1,100) 658 — (19) 1,100 (658) (25) (21) — — (25) — (1,095) 598 — (21) 1,095 (598) Net amount . . . . . . . . . . . . . . . . . . . . . . . . . $ 53 $ — $ 53 $ 4 $ — $ 4 (1) Does not include amounts related to embedded derivatives as of December 31, 2023 and 2022. (2) Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (8) Intangible Assets The following table presents our intangible assets as of December 31: (Amounts in millions) PVFP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capitalized software . . . . . . . . . . . . . . . . . . . . . . . . Deferred sales inducements to contractholders . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2023 2022 Gross carrying amount $2,146 517 317 6 Accumulated amortization $(2,038) (449) (297) (4) Gross carrying amount $2,146 482 317 6 Accumulated amortization $(2,026) (427) (291) (4) Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,986 $(2,788) $2,951 $(2,748) Amortization expense related to PVFP and capitalized software was $34 million, $38 million and $47 million for the years ended December 31, 2023, 2022 and 2021, respectively. Amortization expense related to deferred sales inducements of $6 million, $8 million and $9 million for the years ended December 31, 2023, 2022 and 2021, respectively, was included in benefits and other changes in policy reserves. Present Value of Future Profits The following table presents the balances of and changes in PVFP as of and for the years ended December 31: (Amounts in millions) 2023 2022 2021 Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . Costs deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $154 $134 $120 — — — (20) (14) (12) Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $108 $120 $134 We test PVFP for recoverability as part of annual premium deficiency testing. As of December 31, 2023, 2022 and 2021, all our businesses had sufficient future income and we did not recognize a premium deficiency reserve; therefore, the related PVFP was deemed recoverable. The percentage of the PVFP balance estimated to be amortized over each of the next five years is as follows: As of December 31, 2023 and 2022, our reinsurance recoverable related to UFLIC at the locked-in discount 2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2027 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2028 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.3% 10.2% 10.1% 10.1% 10.1% 186 187 (9) Reinsurance We reinsure a portion of our policy risks to other insurance companies in order to reduce our ultimate losses, diversify our exposures and provide capital flexibility. We also assume certain policy risks written by other insurance companies. Reinsurance accounting is followed for assumed and ceded transactions when there is adequate insurance risk transfer. Otherwise, the deposit method of accounting is followed. Reinsurance does not relieve us from our obligations to policyholders. In the event that the reinsurers are unable to meet their obligations, we remain liable for the reinsured claims. We monitor both the financial condition of individual reinsurers and risk concentrations arising from similar geographic regions, activities and economic characteristics of reinsurers to lessen the risk of default by such reinsurers. Other than the relationship discussed below with Union Fidelity Life Insurance Company (“UFLIC”), we do not have significant concentrations of reinsurance with any one reinsurer that could have a material impact on our financial position. U.S. Life Insurance Subsidiaries As of December 31, 2023, the maximum amount of individual ordinary life insurance normally retained by us on any one individual life policy was $5 million. We have several significant reinsurance transactions (“Reinsurance Transactions”) with UFLIC, an affiliate of General Electric Company (“GE”). In the Reinsurance Transactions, we ceded to UFLIC in-force blocks of structured settlements issued prior to 2004, substantially all of our in-force blocks of variable annuities issued prior to 2004 and a block of long-term care insurance policies that we reinsured in 2000 from legal entities now a part of Brighthouse Life Insurance Company. Although we remain directly liable under these contracts and policies as the ceding insurer, the Reinsurance Transactions have the effect of transferring the financial results of the reinsured blocks to UFLIC. To secure the payment of its obligations to us under the reinsurance agreements governing the Reinsurance Transactions, UFLIC has established trust accounts to maintain an aggregate amount of assets with a statutory book value at least equal to the statutory general account reserves attributable to the reinsured business less an amount required to be held in certain claims-paying accounts. A trustee administers the trust accounts and we are permitted to withdraw from the trust accounts amounts due to us pursuant to the terms of the reinsurance agreements that are not otherwise paid by UFLIC. In addition, pursuant to a Capital Maintenance Agreement, GE is obligated to maintain sufficient capital in UFLIC to maintain UFLIC’s risk-based capital (“RBC”) at not less than 150% of its company action level, as defined by the National Association of Insurance Commissioners (“NAIC”). rate was $13,020 million and $13,503 million, respectively. Under the terms of certain reinsurance agreements that our life insurance subsidiaries have with external parties, we pledged assets, including cash, in either separate portfolios or trusts for the benefit of external reinsurers. These assets support the reserves ceded to those external reinsurers. We have pledged fixed maturity securities, commercial mortgage loans and cash of $9,683 million, $489 million and $39 million, respectively, as of December 31, 2023 and $10,218 million, $576 million and $105 million, respectively, as of December 31, 2022 in connection with these reinsurance agreements. However, we maintain the ability to substitute these pledged assets for other qualified collateral, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. (8) Intangible Assets The following table presents our intangible assets as of December 31: 2023 2022 Gross carrying amount Accumulated amortization Gross carrying amount Accumulated amortization (Amounts in millions) PVFP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,146 $(2,038) $2,146 $(2,026) Capitalized software . . . . . . . . . . . . . . . . . . . . . . . . Deferred sales inducements to contractholders . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 517 317 6 (449) (297) (4) 482 317 6 (427) (291) (4) Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,986 $(2,788) $2,951 $(2,748) Amortization expense related to PVFP and capitalized software was $34 million, $38 million and $47 million for the years ended December 31, 2023, 2022 and 2021, respectively. Amortization expense related to deferred sales inducements of $6 million, $8 million and $9 million for the years ended December 31, 2023, 2022 and 2021, respectively, was included in benefits and other changes in policy reserves. Present Value of Future Profits December 31: The following table presents the balances of and changes in PVFP as of and for the years ended (Amounts in millions) 2023 2022 2021 Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . $120 $134 $154 Costs deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (12) (14) (20) Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $108 $120 $134 We test PVFP for recoverability as part of annual premium deficiency testing. As of December 31, 2023, 2022 and 2021, all our businesses had sufficient future income and we did not recognize a premium deficiency reserve; therefore, the related PVFP was deemed recoverable. 2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2027 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2028 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.3% 10.2% 10.1% 10.1% 10.1% GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (9) Reinsurance We reinsure a portion of our policy risks to other insurance companies in order to reduce our ultimate losses, diversify our exposures and provide capital flexibility. We also assume certain policy risks written by other insurance companies. Reinsurance accounting is followed for assumed and ceded transactions when there is adequate insurance risk transfer. Otherwise, the deposit method of accounting is followed. Reinsurance does not relieve us from our obligations to policyholders. In the event that the reinsurers are unable to meet their obligations, we remain liable for the reinsured claims. We monitor both the financial condition of individual reinsurers and risk concentrations arising from similar geographic regions, activities and economic characteristics of reinsurers to lessen the risk of default by such reinsurers. Other than the relationship discussed below with Union Fidelity Life Insurance Company (“UFLIC”), we do not have significant concentrations of reinsurance with any one reinsurer that could have a material impact on our financial position. U.S. Life Insurance Subsidiaries As of December 31, 2023, the maximum amount of individual ordinary life insurance normally retained by us on any one individual life policy was $5 million. We have several significant reinsurance transactions (“Reinsurance Transactions”) with UFLIC, an affiliate of General Electric Company (“GE”). In the Reinsurance Transactions, we ceded to UFLIC in-force blocks of structured settlements issued prior to 2004, substantially all of our in-force blocks of variable annuities issued prior to 2004 and a block of long-term care insurance policies that we reinsured in 2000 from legal entities now a part of Brighthouse Life Insurance Company. Although we remain directly liable under these contracts and policies as the ceding insurer, the Reinsurance Transactions have the effect of transferring the financial results of the reinsured blocks to UFLIC. To secure the payment of its obligations to us under the reinsurance agreements governing the Reinsurance Transactions, UFLIC has established trust accounts to maintain an aggregate amount of assets with a statutory book value at least equal to the statutory general account reserves attributable to the reinsured business less an amount required to be held in certain claims-paying accounts. A trustee administers the trust accounts and we are permitted to withdraw from the trust accounts amounts due to us pursuant to the terms of the reinsurance agreements that are not otherwise paid by UFLIC. In addition, pursuant to a Capital Maintenance Agreement, GE is obligated to maintain sufficient capital in UFLIC to maintain UFLIC’s risk-based capital (“RBC”) at not less than 150% of its company action level, as defined by the National Association of Insurance Commissioners (“NAIC”). The percentage of the PVFP balance estimated to be amortized over each of the next five years is as follows: As of December 31, 2023 and 2022, our reinsurance recoverable related to UFLIC at the locked-in discount rate was $13,020 million and $13,503 million, respectively. Under the terms of certain reinsurance agreements that our life insurance subsidiaries have with external parties, we pledged assets, including cash, in either separate portfolios or trusts for the benefit of external reinsurers. These assets support the reserves ceded to those external reinsurers. We have pledged fixed maturity securities, commercial mortgage loans and cash of $9,683 million, $489 million and $39 million, respectively, as of December 31, 2023 and $10,218 million, $576 million and $105 million, respectively, as of December 31, 2022 in connection with these reinsurance agreements. However, we maintain the ability to substitute these pledged assets for other qualified collateral, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. 186 187 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table sets forth net domestic life insurance in-force as of December 31: (Amounts in millions) 2023 2022 2021 Direct life insurance in-force . . . . . . . . . . . . . . . . . . Amounts assumed from other companies . . . . . . . . Amounts ceded to other companies(1) . . . . . . . . . . . $ 397,276 487 (352,901) $ 430,151 527 (383,350) $ 471,147 573 (427,464) Net life insurance in-force . . . . . . . . . . . . . . . . . . . . $ 44,862 $ 47,328 $ 44,256 Percentage of amount assumed to net . . . . . . . . . . . 1% 1% 1% (1) Includes amounts accounted for under the deposit method. Enact Enact Holdings, through Enact Mortgage Insurance Corporation (“EMICO”), its principal U.S. mortgage insurance subsidiary, cedes a portion of its mortgage insurance risk in order to obtain credit towards the financial requirements of the government-sponsored enterprises’ (“GSEs”) private mortgage insurer eligibility requirements (“PMIERs”). EMICO engages in excess of loss transactions either through a panel of traditional reinsurance providers or through collateralized reinsurance with unaffiliated special purpose insurers that are considered VIEs. The excess of loss transactions generally cover a subset of loans in a given book year where typically both the attachment and detachment points of the ceded risk tier are within the PMIERs capital requirements at inception. Each reinsurance treaty has a term of ten years or more and grants EMICO a unilateral right to commute the treaty prior to the full term, subject to certain performance triggers. EMICO retains the first layer of aggregate loss exposure on covered policies while the reinsurer provides the second layer of coverage, up to the defined reinsurance coverage amount, and EMICO retains losses in excess of the reinsurance coverage amount. Traditional reinsurance providers collateralize a portion of their coverage by holding funds in reinsurance trust accounts, and the VIEs fully collateralize the reinsurance coverage by issuing mortgage insurance-linked notes to unaffiliated investors. The notes are non-recourse to EMICO, and to Genworth Financial and its affiliates. In 2023, EMICO executed an excess of loss reinsurance transaction with a panel of reinsurers that provides up to approximately $180 million of reinsurance coverage on a portion of new insurance written in 2023. During 2023, EMICO also obtained approximately $248 million of excess of loss reinsurance coverage from certain special purpose insurers. In 2022, EMICO executed three excess of loss reinsurance transactions with a panel of reinsurers that provide up to approximately $422 million of reinsurance coverage on a portion of new insurance written for its 2022 book year and up to approximately $325 million of reinsurance coverage on a portfolio of mortgage insurance policies written during the second half of 2021. EMICO also engages in quota share reinsurance transactions under which the reinsurer receives a premium in exchange for covering an agreed-upon portion of incurred losses. EMICO executed a quota share reinsurance agreement in 2023 with a panel of third-party reinsurers under which it ceded 16.125% of a portion of new insurance written for its 2023 book year. EMICO has the right to terminate the reinsurance agreement upon the occurrence of certain events. On January 3, 2024, EMICO entered into a quota share reinsurance agreement under which it will cede approximately 21% of a portion of new insurance written for its 2024 book year. On January 30, 2024, EMICO NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 executed an excess of loss reinsurance transaction which provides up to $255 million of reinsurance coverage on a portion of current and expected new insurance written for the 2024 book year, effective January 1, 2024. Premiums Written and Earned The following table sets forth the effects of reinsurance on premiums written and earned for the years ended Written Earned 2023 2022 2021 2023 2022 2021 December 31: (Amounts in millions) Direct: Assumed: Ceded: Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . $ 699 $ 738 $ 774 $ 699 $ 738 $ 775 Accident and health insurance(1) . . . . . . . . . . . . Mortgage insurance . . . . . . . . . . . . . . . . . . . . . . Total direct . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,712 995 4,406 2,739 979 4,456 2,802 990 4,566 2,712 1,049 4,460 2,739 1,023 4,500 2,802 1,050 4,627 Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . Accident and health insurance(1) . . . . . . . . . . . . Mortgage insurance . . . . . . . . . . . . . . . . . . . . . . Total assumed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 288 1 4 293 294 1 3 298 302 2 3 307 288 1 4 293 294 1 3 298 302 2 3 307 Life insurance(2) . . . . . . . . . . . . . . . . . . . . . . . . . Accident and health insurance(1) . . . . . . . . . . . . Mortgage insurance . . . . . . . . . . . . . . . . . . . . . . (493) (537) (87) (505) (533) (80) (913) (543) (72) (493) (537) (87) (505) (533) (80) (913) (543) (72) Total ceded . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1,117) (1,118) (1,528) (1,117) (1,118) (1,528) Net premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,582 $ 3,636 $ 3,345 $ 3,636 $ 3,680 $ 3,406 Percentage of amount assumed to net . . . . . . . . . . . . 8% 8% 9% (1) Accident and health insurance is comprised of our long-term care insurance products. (2) Effective December 1, 2021 and included in the year ended December 31, 2021, we entered into a reinsurance agreement with SCOR Global Life USA Reinsurance Company, under which we ceded premiums of $360 million associated with certain term life insurance policies. Reinsurance recoveries recognized as a reduction of benefits and other changes in policy reserves amounted to $2,702 million, $2,746 million and $2,979 million during 2023, 2022 and 2021, respectively. 188 189 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table sets forth net domestic life insurance in-force as of December 31: (Amounts in millions) 2023 2022 2021 Direct life insurance in-force . . . . . . . . . . . . . . . . . . $ 397,276 $ 430,151 $ 471,147 Amounts assumed from other companies . . . . . . . . 487 527 573 Amounts ceded to other companies(1) . . . . . . . . . . . (352,901) (383,350) (427,464) Net life insurance in-force . . . . . . . . . . . . . . . . . . . . $ 44,862 $ 47,328 $ 44,256 Percentage of amount assumed to net . . . . . . . . . . . 1% 1% 1% (1) Includes amounts accounted for under the deposit method. Enact Enact Holdings, through Enact Mortgage Insurance Corporation (“EMICO”), its principal U.S. mortgage insurance subsidiary, cedes a portion of its mortgage insurance risk in order to obtain credit towards the financial requirements of the government-sponsored enterprises’ (“GSEs”) private mortgage insurer eligibility requirements (“PMIERs”). EMICO engages in excess of loss transactions either through a panel of traditional reinsurance providers or through collateralized reinsurance with unaffiliated special purpose insurers that are considered VIEs. The excess of loss transactions generally cover a subset of loans in a given book year where typically both the attachment and detachment points of the ceded risk tier are within the PMIERs capital requirements at inception. Each reinsurance treaty has a term of ten years or more and grants EMICO a unilateral right to commute the treaty prior to the full term, subject to certain performance triggers. EMICO retains the first layer of aggregate loss exposure on covered policies while the reinsurer provides the second layer of coverage, up to the defined reinsurance coverage amount, and EMICO retains losses in excess of the reinsurance coverage amount. Traditional reinsurance providers collateralize a portion of their coverage by holding funds in reinsurance trust accounts, and the VIEs fully collateralize the reinsurance coverage by issuing mortgage insurance-linked notes to unaffiliated investors. The notes are non-recourse to EMICO, and to Genworth Financial and its affiliates. In 2023, EMICO executed an excess of loss reinsurance transaction with a panel of reinsurers that provides up to approximately $180 million of reinsurance coverage on a portion of new insurance written in 2023. During 2023, EMICO also obtained approximately $248 million of excess of loss reinsurance coverage from certain special purpose insurers. In 2022, EMICO executed three excess of loss reinsurance transactions with a panel of reinsurers that provide up to approximately $422 million of reinsurance coverage on a portion of new insurance written for its 2022 book year and up to approximately $325 million of reinsurance coverage on a portfolio of mortgage insurance policies written during the second half of 2021. EMICO also engages in quota share reinsurance transactions under which the reinsurer receives a premium in exchange for covering an agreed-upon portion of incurred losses. EMICO executed a quota share reinsurance agreement in 2023 with a panel of third-party reinsurers under which it ceded 16.125% of a portion of new insurance written for its 2023 book year. EMICO has the right to terminate the reinsurance agreement upon the occurrence of certain events. On January 3, 2024, EMICO entered into a quota share reinsurance agreement under which it will cede approximately 21% of a portion of new insurance written for its 2024 book year. On January 30, 2024, EMICO NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 executed an excess of loss reinsurance transaction which provides up to $255 million of reinsurance coverage on a portion of current and expected new insurance written for the 2024 book year, effective January 1, 2024. Premiums Written and Earned The following table sets forth the effects of reinsurance on premiums written and earned for the years ended December 31: (Amounts in millions) Direct: Written Earned 2023 2022 2021 2023 2022 2021 Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . Accident and health insurance(1) . . . . . . . . . . . . Mortgage insurance . . . . . . . . . . . . . . . . . . . . . . Total direct . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 699 $ 738 $ 774 $ 699 $ 738 $ 2,712 995 4,406 2,739 979 4,456 2,802 990 4,566 2,712 1,049 4,460 2,739 1,023 4,500 Assumed: Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . Accident and health insurance(1) . . . . . . . . . . . . Mortgage insurance . . . . . . . . . . . . . . . . . . . . . . Total assumed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 288 4 293 1 294 3 298 2 302 3 307 1 288 4 293 1 294 3 298 775 2,802 1,050 4,627 2 302 3 307 Ceded: Life insurance(2) . . . . . . . . . . . . . . . . . . . . . . . . . Accident and health insurance(1) . . . . . . . . . . . . Mortgage insurance . . . . . . . . . . . . . . . . . . . . . . (493) (537) (87) (505) (533) (80) (913) (543) (72) (493) (537) (87) (505) (533) (80) (913) (543) (72) Total ceded . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1,117) (1,118) (1,528) (1,117) (1,118) (1,528) Net premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,582 $ 3,636 $ 3,345 $ 3,636 $ 3,680 $ 3,406 Percentage of amount assumed to net . . . . . . . . . . . . 8% 8% 9% (1) Accident and health insurance is comprised of our long-term care insurance products. (2) Effective December 1, 2021 and included in the year ended December 31, 2021, we entered into a reinsurance agreement with SCOR Global Life USA Reinsurance Company, under which we ceded premiums of $360 million associated with certain term life insurance policies. Reinsurance recoveries recognized as a reduction of benefits and other changes in policy reserves amounted to $2,702 million, $2,746 million and $2,979 million during 2023, 2022 and 2021, respectively. 188 189 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Allowance for Credit Losses on Reinsurance Recoverables The following table sets forth the changes in the allowance for credit losses related to reinsurance recoverables as of and for the years ended December 31: (Amounts in millions) Allowance for credit losses: 2023 2022 2021 Beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Write-offs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Recoveries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 45 $ 58 $ 63 35 13 5 (69) — — — — — Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 29 $ 63 $ 58 Our policy for evaluating and measuring the allowance for credit losses related to reinsurance recoverables utilizes the reinsurer’s credit rating, updated quarterly, to assess the credit quality of reinsurance recoverables. The following tables set forth A.M. Best Company, Inc.’s credit ratings related to our reinsurance recoverables at the locked-in discount rate, gross of the allowance for credit losses, as of December 31: (Amounts in millions) Credit rating: Collateralized Non-collateralized Total 2023 A++ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A+ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Not rated(1) . . . . . . . . . . . . . . . . . . . . . . . . Total reinsurance recoverable . . . . . $ — 1,322 33 13,021 $14,376 $ 666 3,041 383 13,037 $17,127 $ 666 1,719 350 16 $2,751 2022 (Amounts in millions) Credit rating: Collateralized Non-collateralized Total A++ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A+ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Not rated(1) . . . . . . . . . . . . . . . . . . . . . . . . Total reinsurance recoverable . . . . . $ — 1,268 20 13,506 $14,794 $ 626 2,050 33 86 $2,795 $ 626 3,318 53 13,592 $17,589 (1) Primarily relates to amounts associated with UFLIC, which is not rated. However, UFLIC has trust accounts and a guarantee from its parent, as discussed above, and is sufficiently collateralized and fully collectible; accordingly, no allowance for credit losses was recorded as of December 31, 2023 and 2022. Reinsurance recoverables are considered past due when contractual payments have not been received from the reinsurer by the required payment date. Claims submitted for payment are generally due in less than one year. As of December 31, 2023, we did not have any reinsurance recoverables past due. As of December 31, 2022, the reinsurance recoverable related to Scottish Re US Inc. (“Scottish Re”), a reinsurance company domiciled in Delaware, was past due. In 2019, Scottish Re was ordered into receivership for the purposes of rehabilitation. In May 2023, the Receiver concluded that Scottish Re should be liquidated based upon adverse changes in its financial condition subsequent to the filing of the proposed and subsequently amended Plan of Rehabilitation. In July 2023, Scottish Re’s board of directors consented to the liquidation order, which was made final by the Court shortly thereafter. In addition, the Court’s liquidation order mandated all reinsurance agreements in-force with Scottish Re be terminated (or expire) by no later than September 30, 2023. We previously established an allowance for credit losses of $36 million related to the reinsurance recoverable due from Scottish Re. In the third quarter of 2023, we determined that the reinsurance recoverable was uncollectible. As a result, we recorded an additional credit loss of $33 million and wrote off the entire reinsurance recoverable of $69 million against the allowance for credit losses. We also recaptured all our life insurance policies from Scottish Re in the third quarter of 2023, which did not have a significant impact on our earnings for the year ended December 31, 2023, as the credit loss recognized during 2023 was offset by the derecognition of ceded premiums payable of approximately $33 million where we have the right of offset for the amounts owed to us by Scottish Re. Effective December 31, 2023, we entered into a binding letter of intent with a third party to cede, on a yearly renewable term basis, certain term and universal life insurance products recaptured from Scottish Re, as well as some smaller blocks. This transaction resulted in a gain of $34 million that was deferred as cost of reinsurance and recorded as part of the reinsurance recoverable balance as of December 31, 2023; therefore, there was no impact to net income (loss). The final treaties were executed and signed on January 30, 2024, with no changes to the terms outlined in the letter of intent. (10) Future Policy Benefits The following table sets forth our liability for future policy benefits as of December 31: (Amounts in millions) 2023 2022 Long-term care insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . $43,929 $41,457 Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,698 11,829 1,820 11,923 Total long-duration insurance contracts . . . . . . . . . . . . 57,456 55,200 Deferred profit liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cost of reinsurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128 71 115 92 Total future policy benefits . . . . . . . . . . . . . . . . . . . . . . $57,655 $55,407 190 191 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Allowance for Credit Losses on Reinsurance Recoverables The following table sets forth the changes in the allowance for credit losses related to reinsurance recoverables as of and for the years ended December 31: (Amounts in millions) Allowance for credit losses: 2023 2022 2021 Beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 63 $ 58 $ 45 Provision . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 5 13 Write-offs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Recoveries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (69) — — — — — Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 29 $ 63 $ 58 Our policy for evaluating and measuring the allowance for credit losses related to reinsurance recoverables utilizes the reinsurer’s credit rating, updated quarterly, to assess the credit quality of reinsurance recoverables. The following tables set forth A.M. Best Company, Inc.’s credit ratings related to our reinsurance recoverables at the locked-in discount rate, gross of the allowance for credit losses, as of December 31: (Amounts in millions) Credit rating: Collateralized Non-collateralized Total A++ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A+ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Not rated(1) . . . . . . . . . . . . . . . . . . . . . . . . $ — 1,322 33 13,021 Total reinsurance recoverable . . . . . $14,376 (Amounts in millions) Credit rating: Collateralized Non-collateralized Total A++ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A+ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Not rated(1) . . . . . . . . . . . . . . . . . . . . . . . . $ — 1,268 20 13,506 Total reinsurance recoverable . . . . . $14,794 $2,795 2023 $ 666 1,719 350 16 $2,751 2022 $ 626 2,050 33 86 $ 666 3,041 383 13,037 $17,127 $ 626 3,318 53 13,592 $17,589 (1) Primarily relates to amounts associated with UFLIC, which is not rated. However, UFLIC has trust accounts and a guarantee from its parent, as discussed above, and is sufficiently collateralized and fully collectible; accordingly, no allowance for credit losses was recorded as of December 31, 2023 and 2022. Reinsurance recoverables are considered past due when contractual payments have not been received from the reinsurer by the required payment date. Claims submitted for payment are generally due in less than one year. As of December 31, 2023, we did not have any reinsurance recoverables past due. As of December 31, 2022, the reinsurance recoverable related to Scottish Re US Inc. (“Scottish Re”), a reinsurance company domiciled in Delaware, was past due. In 2019, Scottish Re was ordered into receivership for the purposes of rehabilitation. In May 2023, the Receiver concluded that Scottish Re should be liquidated based upon adverse changes in its financial condition subsequent to the filing of the proposed and subsequently amended Plan of Rehabilitation. In July 2023, Scottish Re’s board of directors consented to the liquidation order, which was made final by the Court shortly thereafter. In addition, the Court’s liquidation order mandated all reinsurance agreements in-force with Scottish Re be terminated (or expire) by no later than September 30, 2023. We previously established an allowance for credit losses of $36 million related to the reinsurance recoverable due from Scottish Re. In the third quarter of 2023, we determined that the reinsurance recoverable was uncollectible. As a result, we recorded an additional credit loss of $33 million and wrote off the entire reinsurance recoverable of $69 million against the allowance for credit losses. We also recaptured all our life insurance policies from Scottish Re in the third quarter of 2023, which did not have a significant impact on our earnings for the year ended December 31, 2023, as the credit loss recognized during 2023 was offset by the derecognition of ceded premiums payable of approximately $33 million where we have the right of offset for the amounts owed to us by Scottish Re. Effective December 31, 2023, we entered into a binding letter of intent with a third party to cede, on a yearly renewable term basis, certain term and universal life insurance products recaptured from Scottish Re, as well as some smaller blocks. This transaction resulted in a gain of $34 million that was deferred as cost of reinsurance and recorded as part of the reinsurance recoverable balance as of December 31, 2023; therefore, there was no impact to net income (loss). The final treaties were executed and signed on January 30, 2024, with no changes to the terms outlined in the letter of intent. (10) Future Policy Benefits The following table sets forth our liability for future policy benefits as of December 31: (Amounts in millions) 2023 2022 Long-term care insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $43,929 1,698 11,829 $41,457 1,820 11,923 Total long-duration insurance contracts . . . . . . . . . . . . 57,456 55,200 Deferred profit liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cost of reinsurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128 71 115 92 Total future policy benefits . . . . . . . . . . . . . . . . . . . . . . $57,655 $55,407 190 191 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following tables present the balances of and changes in the liability for future policy benefits as of and for the years ended December 31: (Dollar amounts in millions) Present value of expected net premiums: 2023 Long-term care insurance Life insurance Fixed annuities Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance, at original discount rate . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in cash flow assumptions . . . . . . . . . . . . . . . . . . . Effect of actual variances from expected experience . . . . . . . . . . . . Adjusted beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net premiums collected(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance, at original discount rate . . . . . . . . . . . . . . . . . Effect of changes in discount rate assumptions . . . . . . . . . . . . . . . . $19,895 $19,959 (276) (365) 19,318 2 994 (1,968) — — 18,346 304 $4,083 $3,922 180 38 $ — $ — — — 4,140 — 217 (439) — — 3,918 262 — 42 — (42) — — — — Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $18,650 $4,180 $ — Present value of expected future policy benefits: Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance, at original discount rate . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in cash flow assumptions . . . . . . . . . . . . . . . . . . . Effect of actual variances from expected experience . . . . . . . . . . . . Adjusted beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance, at original discount rate . . . . . . . . . . . . . . . . . Effect of changes in discount rate assumptions . . . . . . . . . . . . . . . . $61,352 $61,148 (292) (50) 60,806 2 3,327 (3,621) — (1) 60,513 2,066 $5,556 $5,374 261 61 $11,923 $10,300 (33) (30) 5,696 — 281 (823) — (8) 5,146 266 10,237 35 663 (1,016) — 1 9,920 1,909 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $62,579 $5,412 $11,829 Net liability for future policy benefits, before flooring adjustments . . . . . . . . $41,457 $1,473 $11,923 Net liability for future policy benefits, before flooring adjustments . . . . . . . . Flooring adjustments(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net liability for future policy benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $43,929 — 43,929 7,572 $1,232 466 $11,829 — 1,698 852 11,829 9,008 Net liability for future policy benefits, net of reinsurance recoverable . . . . . . $36,357 $ 846 $ 2,821 Weighted-average liability duration (years) . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.5 6.0 10.9 Weighted-average liability duration (years) . . . . . . . . . . . . . . . . . . . . . . . . . . . 13.7 5.9 11.1 (1) Net premiums collected represents the portion of gross premiums collected from policyholders that is used (1) Net premiums collected represents the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. (2) See note 2 for a discussion of flooring adjustments. 192 to fund expected benefit payments. (2) Related to a third-party recapture of certain single premium immediate annuity contracts in 2022. (3) See note 2 for a discussion of flooring adjustments. 193 2022 Long-term Life Fixed care insurance insurance annuities (Dollar amounts in millions) Present value of expected net premiums: Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance, at original discount rate . . . . . . . . . . . . . . . . . . . . . . . $25,247 $20,717 $5,414 $4,086 $ — $ — Effect of changes in cash flow assumptions . . . . . . . . . . . . . . . . . . . Effect of actual variances from expected experience . . . . . . . . . . . . 102 82 — 69 Adjusted beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . 20,901 4,155 Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net premiums collected(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 1,061 (2,011) — — Ending balance, at original discount rate . . . . . . . . . . . . . . . . . 19,959 Effect of changes in discount rate assumptions . . . . . . . . . . . . . . . . (64) — 226 (459) — — 3,922 161 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $19,895 $4,083 $ — Present value of expected future policy benefits: Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance, at original discount rate . . . . . . . . . . . . . . . . . . . . . . . $85,338 $61,146 $7,157 $5,814 $17,039 $11,012 Effect of changes in cash flow assumptions . . . . . . . . . . . . . . . . . . . Effect of actual variances from expected experience . . . . . . . . . . . . Adjusted beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . . . . . . . . . . . . . . Reinsurance transactions(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (251) (31) 60,864 10 3,364 (3,090) — — — 5,920 10,988 (851) (1,072) — 106 — 304 — — 1 Ending balance, at original discount rate . . . . . . . . . . . . . . . . . Effect of changes in discount rate assumptions . . . . . . . . . . . . . . . . 61,148 204 5,374 182 10,300 1,623 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $61,352 $5,556 $11,923 — — — 50 — (50) — — — — — (24) 43 690 — (352) 3 Flooring adjustments(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net liability for future policy benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 41,457 7,270 347 1,820 873 — 11,923 8,957 Net liability for future policy benefits, net of reinsurance recoverable . . . . . . $34,187 $ 947 $ 2,966 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following tables present the balances of and changes in the liability for future policy benefits as of and for the years ended December 31: 2023 Long-term Life Fixed care insurance insurance annuities (Dollar amounts in millions) Present value of expected net premiums: Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance, at original discount rate . . . . . . . . . . . . . . . . . . . . . . . $19,895 $19,959 $4,083 $3,922 $ — $ — Effect of changes in cash flow assumptions . . . . . . . . . . . . . . . . . . . Effect of actual variances from expected experience . . . . . . . . . . . . (276) (365) 180 38 Adjusted beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . 19,318 4,140 Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net premiums collected(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1,968) Derecognition (lapses and withdrawals) . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 994 — — Ending balance, at original discount rate . . . . . . . . . . . . . . . . . Effect of changes in discount rate assumptions . . . . . . . . . . . . . . . . 18,346 304 — 217 (439) — — 3,918 262 — — — 42 — (42) — — — — Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $18,650 $4,180 $ — Present value of expected future policy benefits: Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance, at original discount rate . . . . . . . . . . . . . . . . . . . . . . . $61,352 $61,148 $5,556 $5,374 $11,923 $10,300 Effect of changes in cash flow assumptions . . . . . . . . . . . . . . . . . . . Effect of actual variances from expected experience . . . . . . . . . . . . (292) (50) Adjusted beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . 60,806 5,696 10,237 Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance, at original discount rate . . . . . . . . . . . . . . . . . Effect of changes in discount rate assumptions . . . . . . . . . . . . . . . . 2 3,327 (3,621) — (1) 60,513 2,066 261 61 — 281 (823) — (8) (33) (30) (1,016) 35 663 — 1 5,146 266 9,920 1,909 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $62,579 $5,412 $11,829 Net liability for future policy benefits, before flooring adjustments . . . . . . . . $43,929 $1,232 $11,829 Flooring adjustments(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net liability for future policy benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 43,929 7,572 466 1,698 852 — 11,829 9,008 (Dollar amounts in millions) Present value of expected net premiums: 2022 Long-term care insurance Life insurance Fixed annuities Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance, at original discount rate . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in cash flow assumptions . . . . . . . . . . . . . . . . . . . Effect of actual variances from expected experience . . . . . . . . . . . . $25,247 $20,717 102 82 $5,414 $4,086 — 69 $ — $ — — — Adjusted beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net premiums collected(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance, at original discount rate . . . . . . . . . . . . . . . . . Effect of changes in discount rate assumptions . . . . . . . . . . . . . . . . 20,901 8 1,061 (2,011) — — 19,959 (64) 4,155 — 226 (459) — — 3,922 161 — 50 — (50) — — — — Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $19,895 $4,083 $ — Present value of expected future policy benefits: Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance, at original discount rate . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in cash flow assumptions . . . . . . . . . . . . . . . . . . . Effect of actual variances from expected experience . . . . . . . . . . . . $85,338 $61,146 (251) (31) $7,157 $5,814 — 106 $17,039 $11,012 — (24) Adjusted beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . . . . . . . . . . . . . . Reinsurance transactions(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance, at original discount rate . . . . . . . . . . . . . . . . . Effect of changes in discount rate assumptions . . . . . . . . . . . . . . . . 60,864 10 3,364 (3,090) — — — 61,148 204 5,920 — 304 (851) — — 1 5,374 182 10,988 43 690 (1,072) — (352) 3 10,300 1,623 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $61,352 $5,556 $11,923 Net liability for future policy benefits, before flooring adjustments . . . . . . . . Flooring adjustments(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net liability for future policy benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $41,457 — 41,457 7,270 $1,473 347 $11,923 — 1,820 873 11,923 8,957 Net liability for future policy benefits, net of reinsurance recoverable . . . . . . $34,187 $ 947 $ 2,966 Net liability for future policy benefits, net of reinsurance recoverable . . . . . . $36,357 $ 846 $ 2,821 Weighted-average liability duration (years) . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.5 6.0 10.9 Weighted-average liability duration (years) . . . . . . . . . . . . . . . . . . . . . . . . . . . 13.7 5.9 11.1 (1) Net premiums collected represents the portion of gross premiums collected from policyholders that is used (1) Net premiums collected represents the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. (2) See note 2 for a discussion of flooring adjustments. 192 to fund expected benefit payments. (2) Related to a third-party recapture of certain single premium immediate annuity contracts in 2022. (3) See note 2 for a discussion of flooring adjustments. 193 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (Dollar amounts in millions) Present value of expected net premiums: 2021 Long-term care insurance Life insurance Fixed annuities Long-term care insurance Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance, at original discount rate . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in cash flow assumptions . . . . . . . . . . . . . . . . . . . Effect of actual variances from expected experience . . . . . . . . . . . . $26,283 $20,600 1,615 (444) $ 5,451 $ — $ 3,916 $ — — — 228 165 Adjusted beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net premiums collected(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance, at original discount rate . . . . . . . . . . . . . . . . . Effect of changes in discount rate assumptions . . . . . . . . . . . . . . . . 21,771 23 1,053 (2,130) — — 20,717 4,530 4,309 — 221 (444) — — 4,086 1,328 — 47 — (47) — — — — Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $25,247 $ 5,414 $ — Present value of expected future policy benefits: Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance, at original discount rate . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in cash flow assumptions . . . . . . . . . . . . . . . . . . . Effect of actual variances from expected experience . . . . . . . . . . . . $89,645 $59,709 1,678 (565) $ 7,821 $18,637 $ 6,062 $11,358 27 (24) 252 190 Adjusted beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance, at original discount rate . . . . . . . . . . . . . . . . . Effect of changes in discount rate assumptions . . . . . . . . . . . . . . . . 60,822 23 3,309 (3,006) — (2) 61,146 24,192 6,504 — 322 (1,013) — 1 5,814 1,343 11,361 46 728 (1,119) — (4) 11,012 6,027 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $85,338 $ 7,157 $17,039 Net liability for future policy benefits, before flooring adjustments . . . . . . . . Flooring adjustments(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net liability for future policy benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $60,091 — 60,091 10,557 $ 1,743 $17,039 — 423 2,166 1,040 17,039 12,583 Net liability for future policy benefits, net of reinsurance recoverable . . . . . . $49,534 $ 1,126 $ 4,456 Weighted-average liability duration (years) . . . . . . . . . . . . . . . . . . . . . . . . . . . 16.9 7.0 13.6 (1) Net premiums collected represents the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. (2) See note 2 for a discussion on flooring adjustments. 194 195 In the fourth quarter of 2023, we completed our annual review of cash flow assumptions including expected claim incidence and terminations, expenses, interest rates, benefit utilization trend and in-force rate actions, among other assumptions. The impact of changes in cash flow assumptions in 2023 resulted in a decrease of $16 million in the liability for future policy benefits primarily as a result of a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. This was partially offset by unfavorable updates to our healthy life assumptions to better reflect near-term experience for cost of care, mortality, incidence and lapse rates. We also evaluated our assumptions regarding expectations of future premium rate increase approvals and benefit reductions and did not make significant changes to our multi-year in-force rate action plan. However, we did increase our assumption for future approvals and benefit reductions given our current plans for rate increase filings and our historical experience regarding approvals and regulatory support, as well as benefit reductions and legal settlement results. The impact of actual versus expected experience in 2023 resulted in an increase of $315 million in the liability for future policy benefits primarily driven by higher claims and unfavorable timing impacts related to a second legal settlement. In the fourth quarter of 2022, we refined several assumptions, including reducing our lapse assumption in light of favorable experience from our long-term care insurance legal settlement elections and benefit reductions and updating our interest rate assumption to reflect the impact of the higher interest rate environment. The favorable impacts from both the effect of changes in cash flow assumptions and actual versus expected experience were mainly attributable to the inclusion of a second legal settlement. We also evaluated our assumptions regarding expectations of future premium rate increase approvals and benefit reductions and did not make significant changes to our multi-year in-force rate action plan. However, we did increase our assumption for future approvals and benefit reductions given our current plans for rate increase filings and our historical experience regarding approvals and regulatory support, as well as benefit reductions and legal settlement results. In the fourth quarter of 2021, we reviewed our assumptions including expected claim incidence and terminations, expenses, interest rates, benefit utilization trend and in-force rate actions, among other assumptions. The most significant update to our long-term care insurance assumptions included an unfavorable update to the benefit utilization trend, which drove significant updates to our in-force rate action plan, and related assumptions. Given the expected future increases in cost of care, we expected our long-term benefit utilization to trend higher than previously assumed. Prior to this update, we had assumed that the long-term benefit utilization would improve over time. Based on our experience, it did not improve as much as we predicted, largely due to cost of care growth driven by both broad-based inflation and minimum wage increases in some large states, among other factors. Therefore, we increased the outlook for our future benefit utilization trend. Life insurance In the fourth quarter of 2023, we completed our annual review of cash flow assumptions and increased our liability for future policy benefits by $81 million primarily as a result of unfavorable updates to our mortality assumptions to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term post-COVID-19. The impact of actual versus expected experience in 2023 resulted in an increase of $23 million in the liability for future policy benefits primarily driven by unfavorable mortality experience. There were no cash flow assumption changes for our life insurance products in the fourth quarter of 2022. The effect of actual versus expected experience in 2022 resulted in an increase of $37 million in the liability for GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (Dollar amounts in millions) Present value of expected net premiums: Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance, at original discount rate . . . . . . . . . . . . . . . . . . . . . . . $26,283 $20,600 $ 5,451 $ — $ 3,916 $ — 2021 Long-term Life Fixed care insurance insurance annuities Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $25,247 $ 5,414 $ — Present value of expected future policy benefits: Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance, at original discount rate . . . . . . . . . . . . . . . . . . . . . . . $89,645 $59,709 $ 7,821 $18,637 $ 6,062 $11,358 Effect of changes in cash flow assumptions . . . . . . . . . . . . . . . . . . . Effect of actual variances from expected experience . . . . . . . . . . . . Adjusted beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net premiums collected(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance, at original discount rate . . . . . . . . . . . . . . . . . Effect of changes in discount rate assumptions . . . . . . . . . . . . . . . . Effect of changes in cash flow assumptions . . . . . . . . . . . . . . . . . . . Effect of actual variances from expected experience . . . . . . . . . . . . Adjusted beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance, at original discount rate . . . . . . . . . . . . . . . . . Effect of changes in discount rate assumptions . . . . . . . . . . . . . . . . 1,615 (444) 21,771 23 1,053 (2,130) — — 20,717 4,530 1,678 (565) 60,822 23 3,309 (3,006) — (2) 61,146 24,192 228 165 4,309 — 221 (444) — — 4,086 1,328 — — — 47 — (47) — — — — 27 (24) 46 728 — (4) 252 190 — 322 — 1 6,504 11,361 (1,013) (1,119) 5,814 1,343 11,012 6,027 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $85,338 $ 7,157 $17,039 Net liability for future policy benefits, before flooring adjustments . . . . . . . . $60,091 $ 1,743 $17,039 Flooring adjustments(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net liability for future policy benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 60,091 10,557 423 2,166 1,040 — 17,039 12,583 Net liability for future policy benefits, net of reinsurance recoverable . . . . . . $49,534 $ 1,126 $ 4,456 Weighted-average liability duration (years) . . . . . . . . . . . . . . . . . . . . . . . . . . . 16.9 7.0 13.6 (1) Net premiums collected represents the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. (2) See note 2 for a discussion on flooring adjustments. Long-term care insurance In the fourth quarter of 2023, we completed our annual review of cash flow assumptions including expected claim incidence and terminations, expenses, interest rates, benefit utilization trend and in-force rate actions, among other assumptions. The impact of changes in cash flow assumptions in 2023 resulted in a decrease of $16 million in the liability for future policy benefits primarily as a result of a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. This was partially offset by unfavorable updates to our healthy life assumptions to better reflect near-term experience for cost of care, mortality, incidence and lapse rates. We also evaluated our assumptions regarding expectations of future premium rate increase approvals and benefit reductions and did not make significant changes to our multi-year in-force rate action plan. However, we did increase our assumption for future approvals and benefit reductions given our current plans for rate increase filings and our historical experience regarding approvals and regulatory support, as well as benefit reductions and legal settlement results. The impact of actual versus expected experience in 2023 resulted in an increase of $315 million in the liability for future policy benefits primarily driven by higher claims and unfavorable timing impacts related to a second legal settlement. In the fourth quarter of 2022, we refined several assumptions, including reducing our lapse assumption in light of favorable experience from our long-term care insurance legal settlement elections and benefit reductions and updating our interest rate assumption to reflect the impact of the higher interest rate environment. The favorable impacts from both the effect of changes in cash flow assumptions and actual versus expected experience were mainly attributable to the inclusion of a second legal settlement. We also evaluated our assumptions regarding expectations of future premium rate increase approvals and benefit reductions and did not make significant changes to our multi-year in-force rate action plan. However, we did increase our assumption for future approvals and benefit reductions given our current plans for rate increase filings and our historical experience regarding approvals and regulatory support, as well as benefit reductions and legal settlement results. In the fourth quarter of 2021, we reviewed our assumptions including expected claim incidence and terminations, expenses, interest rates, benefit utilization trend and in-force rate actions, among other assumptions. The most significant update to our long-term care insurance assumptions included an unfavorable update to the benefit utilization trend, which drove significant updates to our in-force rate action plan, and related assumptions. Given the expected future increases in cost of care, we expected our long-term benefit utilization to trend higher than previously assumed. Prior to this update, we had assumed that the long-term benefit utilization would improve over time. Based on our experience, it did not improve as much as we predicted, largely due to cost of care growth driven by both broad-based inflation and minimum wage increases in some large states, among other factors. Therefore, we increased the outlook for our future benefit utilization trend. Life insurance In the fourth quarter of 2023, we completed our annual review of cash flow assumptions and increased our liability for future policy benefits by $81 million primarily as a result of unfavorable updates to our mortality assumptions to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term post-COVID-19. The impact of actual versus expected experience in 2023 resulted in an increase of $23 million in the liability for future policy benefits primarily driven by unfavorable mortality experience. There were no cash flow assumption changes for our life insurance products in the fourth quarter of 2022. The effect of actual versus expected experience in 2022 resulted in an increase of $37 million in the liability for 194 195 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 future policy benefits. The increase was primarily driven by unfavorable mortality from COVID-19 and elevated death claims in a single cohort in 2022. The following table sets forth the amount of undiscounted and discounted expected future gross premiums and expected future benefit payments as December 31: In the fourth quarter of 2021, we completed our annual review of cash flow assumptions and recorded an increase to our liability for future policy benefits of $24 million principally due to unfavorable pre-COVID-19 mortality. The effect of actual versus expected experience in 2021 resulted in an increase of $25 million to our liability for future policy benefits primarily from unfavorable mortality due to COVID-19. Fixed annuities The impact of changes in cash flow assumptions and actual versus expected experience in 2023 resulted in decreases of $33 million and $30 million, respectively, in the liability for future policy benefits, primarily from favorable mortality. The impact of actual versus expected experience in 2022 resulted in a decrease of $24 million in the liability payments . . . . . . . . . . . . . . $ 7,524 $ 5,412 $ 7,924 $ 5,556 $ 8,652 $ 7,157 for future policy benefits due principally to favorable mortality. Due to emerging experience on our structured settlements, we revised the mortality assumption to reflect unfavorable mortality rates, resulting in an increase of $27 million, partially offset by a favorable actual to expected experience adjustment of $24 million in 2021. premiums . . . . . . . . . . . . . . $ — $ — $ — $ — $ — $ — payments . . . . . . . . . . . . . . $ 23,903 $11,829 $ 24,924 $11,923 $ 26,473 $17,039 The following table provides the weighted-average interest rates for the liability for future policy benefits as of December 31: During 2023 and 2022, we recorded a charge of $6 million and $16 million, respectively, to net income due to net premiums exceeding gross premiums for our life insurance products primarily due to higher claim severity. 2023 2022 2021 Long-term care insurance Interest accretion (locked-in) rate . . . . . . . . . . . . . . . . . . . . . . . . . Current discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5.8% 5.8% 5.8% 5.1% 5.4% 2.8% Life insurance Interest accretion (locked-in) rate . . . . . . . . . . . . . . . . . . . . . . . . . Current discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5.8% 5.8% 5.8% 4.8% 5.2% 2.4% Fixed annuities Interest accretion (locked-in) rate . . . . . . . . . . . . . . . . . . . . . . . . . Current discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6.7% 6.7% 6.7% 5.0% 5.3% 2.8% See note 2 for additional information related to the discount rate used to measure the liability for future policy benefits. (Amounts in millions) Undiscounted Discounted Undiscounted Discounted Undiscounted Discounted 2023 2022 2021 premiums . . . . . . . . . . . . . . $ 38,279 $26,341 $ 42,329 $28,278 $ 45,334 $36,642 payments . . . . . . . . . . . . . . $124,594 $62,579 $130,315 $61,352 $133,974 $85,338 premiums . . . . . . . . . . . . . . $ 10,693 $ 6,278 $ 11,541 $ 6,559 $ 12,266 $ 8,853 Long-term care insurance Expected future gross Expected future benefit Life insurance Expected future gross Expected future benefit Fixed annuities Expected future gross Expected future benefit During 2021, we recorded a charge of $8 million to net income due to net premiums exceeding gross premiums for our life insurance products principally from higher claim frequency due to unfavorable mortality attributable to COVID-19. The following table sets forth the amount of revenue and interest accretion (expense) recognized in net income related to our liability for future policy benefits for the years ended December 31: (Amounts in millions) 2023 2022 2021 Gross Interest Gross Interest Gross Interest premiums accretion(1) premiums accretion(1) premiums accretion(1) Long-term care insurance . . . . . . . . . . . . . . . $2,713 $2,333 $2,769 $2,303 $2,847 $2,256 Life insurance . . . . . . . . . . . . . . . . . . . . . . . . Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . 688 — 64 663 725 — 78 690 759 — 101 728 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,401 $3,060 $3,494 $3,071 $3,606 $3,085 (1) Amounts for interest accretion are included in benefits and other changes in policy reserves in the consolidated statements of income. 196 197 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 future policy benefits. The increase was primarily driven by unfavorable mortality from COVID-19 and elevated The following table sets forth the amount of undiscounted and discounted expected future gross premiums death claims in a single cohort in 2022. and expected future benefit payments as December 31: In the fourth quarter of 2021, we completed our annual review of cash flow assumptions and recorded an increase to our liability for future policy benefits of $24 million principally due to unfavorable pre-COVID-19 mortality. The effect of actual versus expected experience in 2021 resulted in an increase of $25 million to our liability for future policy benefits primarily from unfavorable mortality due to COVID-19. Fixed annuities favorable mortality. (Amounts in millions) Undiscounted Discounted Undiscounted Discounted Undiscounted Discounted 2023 2022 2021 Long-term care insurance Expected future gross premiums . . . . . . . . . . . . . . $ 38,279 $26,341 $ 42,329 $28,278 $ 45,334 $36,642 Expected future benefit payments . . . . . . . . . . . . . . $124,594 $62,579 $130,315 $61,352 $133,974 $85,338 The impact of changes in cash flow assumptions and actual versus expected experience in 2023 resulted in decreases of $33 million and $30 million, respectively, in the liability for future policy benefits, primarily from Life insurance Expected future gross The impact of actual versus expected experience in 2022 resulted in a decrease of $24 million in the liability payments . . . . . . . . . . . . . . $ 7,524 $ 5,412 $ 7,924 $ 5,556 $ 8,652 $ 7,157 for future policy benefits due principally to favorable mortality. Fixed annuities Expected future gross Due to emerging experience on our structured settlements, we revised the mortality assumption to reflect unfavorable mortality rates, resulting in an increase of $27 million, partially offset by a favorable actual to expected experience adjustment of $24 million in 2021. premiums . . . . . . . . . . . . . . $ — $ — $ — $ — $ — $ — Expected future benefit payments . . . . . . . . . . . . . . $ 23,903 $11,829 $ 24,924 $11,923 $ 26,473 $17,039 The following table provides the weighted-average interest rates for the liability for future policy benefits as of December 31: During 2023 and 2022, we recorded a charge of $6 million and $16 million, respectively, to net income due to net premiums exceeding gross premiums for our life insurance products primarily due to higher claim severity. premiums . . . . . . . . . . . . . . $ 10,693 $ 6,278 $ 11,541 $ 6,559 $ 12,266 $ 8,853 Expected future benefit Long-term care insurance Interest accretion (locked-in) rate . . . . . . . . . . . . . . . . . . . . . . . . . 5.8% 5.8% 5.8% Current discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5.1% 5.4% 2.8% 2023 2022 2021 Life insurance Fixed annuities Interest accretion (locked-in) rate . . . . . . . . . . . . . . . . . . . . . . . . . 5.8% 5.8% 5.8% Current discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.8% 5.2% 2.4% Interest accretion (locked-in) rate . . . . . . . . . . . . . . . . . . . . . . . . . 6.7% 6.7% 6.7% Current discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5.0% 5.3% 2.8% See note 2 for additional information related to the discount rate used to measure the liability for future policy benefits. During 2021, we recorded a charge of $8 million to net income due to net premiums exceeding gross premiums for our life insurance products principally from higher claim frequency due to unfavorable mortality attributable to COVID-19. The following table sets forth the amount of revenue and interest accretion (expense) recognized in net income related to our liability for future policy benefits for the years ended December 31: (Amounts in millions) 2023 2022 2021 Gross premiums Interest accretion(1) Gross premiums Interest accretion(1) Gross premiums Interest accretion(1) Long-term care insurance . . . . . . . . . . . . . . . Life insurance . . . . . . . . . . . . . . . . . . . . . . . . Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . $2,713 688 — $2,333 64 663 $2,769 725 — $2,303 78 690 $2,847 759 — $2,256 101 728 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,401 $3,060 $3,494 $3,071 $3,606 $3,085 (1) Amounts for interest accretion are included in benefits and other changes in policy reserves in the consolidated statements of income. 196 197 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (11) Policyholder Account Balances The following table sets forth our liabilities for policyholder account balances as of December 31: (Dollar amounts in millions) (Amounts in millions) Life insurance(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Variable annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fixed indexed annuity embedded derivatives(2) . . . . . . . . . . Indexed universal life embedded derivatives(2) . . . . . . . . . . . Additional insurance liabilities(3) . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total policyholder account balances . . . . . . . . . . . . . . . 2023 2022 $ 7,460 4,479 529 165 15 2,887 5 $15,540 $ 7,694 5,477 610 202 15 2,566 — $16,564 Includes funding agreements. (1) (2) See note 6 for additional information. (3) Represents additional liabilities related to death or other insurance benefits that are recorded within policyholder account balances and are considered long-duration insurance contracts. See note 12 for additional information. The contracts underlying the minimum guarantees, such as GMWB and guaranteed annuitization benefits, are considered “in the money” if the present value of the contractholder’s benefits is greater than the account value, or commonly referred to as the net amount at risk. For GMWBs and guaranteed annuitization benefits, the only way the contractholder can monetize the excess of the benefits over the account value of the contract is through lifetime withdrawals or lifetime income payments after annuitization. For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The following tables present the balances of and changes in policyholder account balances as of and for the years ended December 31: (Dollar amounts in millions) Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Premiums received . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Surrenders and withdrawals . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net transfers from separate accounts . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . Life insurance $ 7,694 — 500 (614) (272) (215) — 388 (21) $ 7,460 2023 Fixed annuities $5,477 — 20 (6) (842) (387) — 160 57 $4,479 Variable annuities $610 — 14 (6) (66) (80) 1 4 52 $529 Weighted-average crediting rate . . . . . . . . . . . . . . . . . . . . . Net amount at risk(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash surrender value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.9% $42,754 $ 4,336 2.8% $ 33 $3,519 3.3% $479 $529 (1) The net amount at risk presented for fixed and variable annuity products contains both general and separate accounts, including amounts related to annuitization and other insurance benefits classified as MRBs. 198 199 Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . $ 7,835 $6,595 Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Premiums received . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Surrenders and withdrawals . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net transfers from separate accounts . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2022 Life insurance Fixed annuities Variable annuities — 518 (632) (177) (210) — 381 (21) — 23 (6) (908) (475) — 173 75 $652 — 21 (8) (48) (69) 11 4 47 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . $ 7,694 $5,477 $610 Weighted-average crediting rate . . . . . . . . . . . . . . . . . . . . . 3.9% 2.4% 3.3% Net amount at risk(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash surrender value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $44,113 $ 4,415 $ 21 $4,449 $661 $610 (1) The net amount at risk presented for fixed and variable annuity products contains both general and separate accounts, including amounts related to annuitization and other insurance benefits classified as MRBs. (Dollar amounts in millions) Life insurance Fixed annuities Variable annuities Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . $ 8,105 $ 7,892 Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Premiums received . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Surrenders and withdrawals . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net transfers from separate accounts . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 558 (644) (298) (233) — 365 (18) 2021 — 36 (7) (1,153) (508) — 199 136 $689 — 24 (8) (43) (58) 5 5 38 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . $ 7,835 $ 6,595 $652 Weighted-average crediting rate . . . . . . . . . . . . . . . . . . . . . 3.9% Net amount at risk(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash surrender value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $46,613 $ 4,411 $ $ 5,471 2.3% 98 3.2% $648 $652 (1) The net amount at risk presented for fixed and variable annuity products contains both general and separate accounts, including amounts related to annuitization and other insurance benefits classified as MRBs. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (11) Policyholder Account Balances The following table sets forth our liabilities for policyholder account balances as of December 31: (Dollar amounts in millions) 2022 Life insurance Fixed annuities Variable annuities (Amounts in millions) Life insurance(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7,460 $ 7,694 Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Variable annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fixed indexed annuity embedded derivatives(2) . . . . . . . . . . Indexed universal life embedded derivatives(2) . . . . . . . . . . . Additional insurance liabilities(3) . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2023 2022 4,479 5,477 529 165 15 2,887 5 610 202 15 2,566 — Total policyholder account balances . . . . . . . . . . . . . . . $15,540 $16,564 (1) Includes funding agreements. (2) See note 6 for additional information. (3) Represents additional liabilities related to death or other insurance benefits that are recorded within policyholder account balances and are considered long-duration insurance contracts. See note 12 for additional information. The contracts underlying the minimum guarantees, such as GMWB and guaranteed annuitization benefits, are considered “in the money” if the present value of the contractholder’s benefits is greater than the account value, or commonly referred to as the net amount at risk. For GMWBs and guaranteed annuitization benefits, the only way the contractholder can monetize the excess of the benefits over the account value of the contract is through lifetime withdrawals or lifetime income payments after annuitization. For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The following tables present the balances of and changes in policyholder account balances as of and for the years ended December 31: (Dollar amounts in millions) Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . $ 7,694 $5,477 Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Premiums received . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Surrenders and withdrawals . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net transfers from separate accounts . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2023 Life insurance Fixed annuities Variable annuities — 500 (614) (272) (215) — 388 (21) — 20 (6) (842) (387) — 160 57 $610 — 14 (6) (66) (80) 1 4 52 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . $ 7,460 $4,479 $529 Weighted-average crediting rate . . . . . . . . . . . . . . . . . . . . . Net amount at risk(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash surrender value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.9% 2.8% 3.3% $42,754 $ 4,336 $ 33 $3,519 $479 $529 (1) The net amount at risk presented for fixed and variable annuity products contains both general and separate accounts, including amounts related to annuitization and other insurance benefits classified as MRBs. Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Premiums received . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Surrenders and withdrawals . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net transfers from separate accounts . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7,835 — 518 (632) (177) (210) — 381 (21) $6,595 — 23 (6) (908) (475) — 173 75 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . $ 7,694 $5,477 $652 — 21 (8) (48) (69) 11 4 47 $610 Weighted-average crediting rate . . . . . . . . . . . . . . . . . . . . . Net amount at risk(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash surrender value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.9% $44,113 $ 4,415 2.4% $ 21 $4,449 3.3% $661 $610 (1) The net amount at risk presented for fixed and variable annuity products contains both general and separate accounts, including amounts related to annuitization and other insurance benefits classified as MRBs. (Dollar amounts in millions) Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Premiums received . . . . . . . . . . . . . . . . . . . . . . . . . . . Policy charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Surrenders and withdrawals . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net transfers from separate accounts . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2021 Life insurance Fixed annuities Variable annuities $ 8,105 — 558 (644) (298) (233) — 365 (18) $ 7,892 — 36 (7) (1,153) (508) — 199 136 $689 — 24 (8) (43) (58) 5 5 38 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . $ 7,835 $ 6,595 $652 Weighted-average crediting rate . . . . . . . . . . . . . . . . . . . . . Net amount at risk(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash surrender value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.9% $46,613 $ 4,411 2.3% $ 98 $ 5,471 3.2% $648 $652 (1) The net amount at risk presented for fixed and variable annuity products contains both general and separate accounts, including amounts related to annuitization and other insurance benefits classified as MRBs. 198 199 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following tables present policyholder account balances by range of guaranteed minimum crediting rate (12) Additional Insurance Liabilities and the related range of the difference between rates being credited to policyholders and the respective guaranteed minimums as of December 31: 2023 (Amounts in millions) At guaranteed minimum 1–50 basis points above 51–150 basis points above Less than 2.00% . . . . . . . . . . . . . . . . . . . . . . . . . . 2.00%–2.99% . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.00%–3.99% . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.00% and greater . . . . . . . . . . . . . . . . . . . . . . . . . Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 121 1,201 1,732 2,479 $5,533 $ 97 81 699 16 $893 $ 39 — 1,155 10 $1,204 Greater than 150 basis points above Total(1) $— — 31 — $ 31 $ 257 1,282 3,617 2,505 $7,661 (1) Excludes universal life insurance and investment contracts of approximately $4,807 million that have a market component to their crediting strategy. 2022 (Amounts in millions) At guaranteed minimum 1–50 basis points above 51–150 basis points above Less than 2.00% . . . . . . . . . . . . . . . . . . . . . . . . . . 2.00%–2.99% . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.00%–3.99% . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.00% and greater . . . . . . . . . . . . . . . . . . . . . . . . . Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,065 947 1,928 2,649 $6,589 $ 42 2 774 12 $830 $ 2 — 1,156 1 $1,159 Greater than 150 basis points above Total(1) $— — 1 — $ 1 $1,109 949 3,859 2,662 $8,579 (1) Excludes universal life insurance and investment contracts of approximately $5,202 million that have a market component to their crediting strategy. Certain of our U.S. life insurance subsidiaries are members of the Federal Home Loan Bank (“FHLB”) system in their respective regions. As of December 31, 2023 and 2022, we held $24 million and $25 million, respectively, of FHLB common stock related to those memberships, which was included in equity securities. The FHLBs have been granted a lien on certain of our invested assets to collateralize our obligations; however, we maintain the ability to substitute these pledged assets for other qualified collateral, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by us, the FHLB’s recovery on the collateral is limited to the amount of our funding agreement liabilities to the FHLB. These funding agreements as of December 31, 2023 and 2022 were collateralized by fixed maturity securities with a fair value of $359 million and $520 million, respectively. The amount of funding agreements outstanding with the FHLBs was $100 million and $200 million as of December 31, 2023 and 2022, respectively, which was included in policyholder account balances. The following table presents the balances of and changes in additional liabilities related to death or other insurance benefits that are included within policyholder account balances related to universal and term universal life insurance products as of and for the years ended December 31: (Dollar amounts in millions) 2023 2022 2021 Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . $2,566 $2,656 $2,524 Beginning balance before shadow accounting adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,634 $2,523 $2,341 Effect of changes in cash flow assumptions . . . . . . 200 (37) Effect of actual variances from expected experience . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (3) 33 Adjusted beginning balance . . . . . . . . . . . . . . . 2,831 2,519 2,466 Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . (222) (215) Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . Assessments collected . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . Other (flooring adjustment) . . . . . . . . . . . . . . . . . . . Ending balance before shadow accounting — 90 240 — — — 85 245 — — adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . 2,939 2,634 Effect of shadow accounting adjustments . . . . . . . . (52) (68) Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . 2,887 — 2,566 — 85 40 — 77 253 (282) — 9 2,523 133 2,656 — Additional insurance liabilities, net of reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,887 $2,566 $2,656 Weighted-average liability duration (years) . . . . . . . . . . . . . . . 18.9 20.8 22.6 In the fourth quarter of 2023, as part of our annual review of assumptions, we increased our additional insurance liabilities primarily to reflect unfavorable updates to our persistency and mortality assumptions to better reflect emerging experience. Our mortality assumption updates included more modest mortality improvement and reflected an expectation that mortality will continue at elevated levels in the near term post- COVID-19. In the fourth quarter of 2022, as part of our annual review of assumptions, we decreased our additional insurance liabilities primarily related to higher interest rates. In the fourth quarter of 2021, as part of our annual review of assumptions, we increased our additional insurance liabilities primarily driven by unfavorable pre-COVID-19 mortality. unfavorable mortality experience. The increase from the effect of actual versus expected experience in 2022 and 2021 was primarily due to 200 201 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following tables present policyholder account balances by range of guaranteed minimum crediting rate (12) Additional Insurance Liabilities 2023 $ 39 — 1,155 10 $1,204 2022 $ 2 — 1,156 1 $1,159 Greater than 150 basis points above Total(1) $— $ 257 — 31 — 1,282 3,617 2,505 $ 31 $7,661 Greater than 150 basis points above Total(1) $— — 1 — $ 1 $1,109 949 3,859 2,662 $8,579 and the related range of the difference between rates being credited to policyholders and the respective guaranteed minimums as of December 31: (Amounts in millions) At guaranteed minimum 1–50 basis points above 51–150 basis points above Less than 2.00% . . . . . . . . . . . . . . . . . . . . . . . . . . $ 121 2.00%–2.99% . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.00%–3.99% . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.00% and greater . . . . . . . . . . . . . . . . . . . . . . . . . 1,201 1,732 2,479 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $5,533 $ 97 81 699 16 $893 (1) Excludes universal life insurance and investment contracts of approximately $4,807 million that have a market component to their crediting strategy. (Amounts in millions) At guaranteed minimum 1–50 basis points above 51–150 basis points above Less than 2.00% . . . . . . . . . . . . . . . . . . . . . . . . . . $1,065 2.00%–2.99% . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.00%–3.99% . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.00% and greater . . . . . . . . . . . . . . . . . . . . . . . . . 947 1,928 2,649 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $6,589 $ 42 2 774 12 $830 (1) Excludes universal life insurance and investment contracts of approximately $5,202 million that have a market component to their crediting strategy. Certain of our U.S. life insurance subsidiaries are members of the Federal Home Loan Bank (“FHLB”) system in their respective regions. As of December 31, 2023 and 2022, we held $24 million and $25 million, respectively, of FHLB common stock related to those memberships, which was included in equity securities. The FHLBs have been granted a lien on certain of our invested assets to collateralize our obligations; however, we maintain the ability to substitute these pledged assets for other qualified collateral, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by us, the FHLB’s recovery on the collateral is limited to the amount of our funding agreement liabilities to the FHLB. These funding agreements as of December 31, 2023 and 2022 were collateralized by fixed maturity securities with a fair value of $359 million and $520 million, respectively. The amount of funding agreements outstanding with the FHLBs was $100 million and $200 million as of December 31, 2023 and 2022, respectively, which was included in policyholder account balances. The following table presents the balances of and changes in additional liabilities related to death or other insurance benefits that are included within policyholder account balances related to universal and term universal life insurance products as of and for the years ended December 31: (Dollar amounts in millions) 2023 2022 2021 Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . $2,566 $2,656 $2,524 Beginning balance before shadow accounting adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in cash flow assumptions Effect of actual variances from expected $2,634 200 $2,523 (37) $2,341 85 experience . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (3) 33 40 Adjusted beginning balance . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . Assessments collected . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition (lapses and withdrawals) . . . . . . . . . Other (flooring adjustment) . . . . . . . . . . . . . . . . . . . Ending balance before shadow accounting adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of shadow accounting adjustments . . . . . . . . Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . Additional insurance liabilities, net of reinsurance 2,831 — 90 240 (222) — — 2,939 (52) 2,887 — 2,519 — 85 245 (215) — — 2,634 (68) 2,566 — 2,466 — 77 253 (282) — 9 2,523 133 2,656 — recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,887 $2,566 $2,656 Weighted-average liability duration (years) . . . . . . . . . . . . . . . 18.9 20.8 22.6 In the fourth quarter of 2023, as part of our annual review of assumptions, we increased our additional insurance liabilities primarily to reflect unfavorable updates to our persistency and mortality assumptions to better reflect emerging experience. Our mortality assumption updates included more modest mortality improvement and reflected an expectation that mortality will continue at elevated levels in the near term post- COVID-19. In the fourth quarter of 2022, as part of our annual review of assumptions, we decreased our additional insurance liabilities primarily related to higher interest rates. In the fourth quarter of 2021, as part of our annual review of assumptions, we increased our additional insurance liabilities primarily driven by unfavorable pre-COVID-19 mortality. The increase from the effect of actual versus expected experience in 2022 and 2021 was primarily due to unfavorable mortality experience. 200 201 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table provides the weighted-average interest rates for our additional insurance liabilities as of The following tables present the balances of and changes in market risk benefits as of and for the years December 31: Interest accretion rate(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Projected crediting rate(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.2% 3.3% 3.2% 3.8% 3.8% 3.6% 2023 2022 2021 (1) The interest accretion rate is determined by using the weighted-average policyholder crediting rates for the underlying policies over the period in-force, and based on the adjusted beginning balance, is used to measure the amount of interest accretion. (2) The projected crediting rate is determined by using a future crediting rate curve that utilizes a portfolio approach reflecting anticipated reinvestment activity and runoff of existing assets over the projection period. The projected crediting rate is used to discount future assessments and excess benefits. The following table sets forth the amount of revenue and interest accretion (expense) recognized in net income related to additional insurance liabilities for years ended December 31: (Amounts in millions) 2023 2022 2021 Gross assessments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion (1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $539 $ 90 $559 $ 85 $592 $ 77 (1) Amounts for interest accretion are included in benefits and other changes in policy reserves in the consolidated statements of income. (13) Market Risk Benefits The following table sets forth our market risk benefits by asset and liability position as of December 31: (Amounts in millions) Asset Liability Net liability Asset Liability Net liability Fixed indexed annuities . . . . . . . . . . . . . . . . . . . . . . . . Variable annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . $— 43 $ 55 570 Total market risk benefits . . . . . . . . . . . . . . . . . . $ 43 $625 $ 55 527 $582 $— 26 $ 52 696 $ 26 $748 $ 52 670 $722 2023 2022 Market risk benefits, net of reinsurance recoverable . . . . . . . . . . . . . . . . . . Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 52 $ 670 $158 ended December 31: (Dollar amounts in millions) Beginning balance before effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Attributed fees collected . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in interest rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in equity markets . . . . . . . . . . . . . . . . . . . . . . . . . . . Actual policyholder behavior different from expected behavior . . . . . Effect of changes in future expected policyholder behavior . . . . . . . . . Effect of changes in other future expected assumptions . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance before effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Weighted-average attained age of contractholders . . . . . . . . . . . . . . . . . . . . Net amount at risk(2) (1) Represents the net reinsured asset related to our variable annuity MRBs. (2) See note 11 for additional information on the net amount at risk. 2023 Fixed indexed annuities Variable annuities Reinsurance recoverable(1) $ 50 — 3 5 — (2) (2) (2) — — — 52 3 55 — $ 55 73 $ 660 — $158 — 9 8 (15) (5) (31) 5 11 — — 140 — $140 34 37 (35) (33) (157) 8 11 — (5) 520 7 527 140 $ 387 76 202 203 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table provides the weighted-average interest rates for our additional insurance liabilities as of The following tables present the balances of and changes in market risk benefits as of and for the years December 31: Interest accretion rate(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.2% 3.3% 3.2% Projected crediting rate(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.8% 3.8% 3.6% 2023 2022 2021 (1) The interest accretion rate is determined by using the weighted-average policyholder crediting rates for the underlying policies over the period in-force, and based on the adjusted beginning balance, is used to measure the amount of interest accretion. (2) The projected crediting rate is determined by using a future crediting rate curve that utilizes a portfolio approach reflecting anticipated reinvestment activity and runoff of existing assets over the projection period. The projected crediting rate is used to discount future assessments and excess benefits. The following table sets forth the amount of revenue and interest accretion (expense) recognized in net income related to additional insurance liabilities for years ended December 31: (Amounts in millions) 2023 2022 2021 Gross assessments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion (1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $539 $ 90 $559 $ 85 $592 $ 77 (1) Amounts for interest accretion are included in benefits and other changes in policy reserves in the consolidated statements of income. (13) Market Risk Benefits The following table sets forth our market risk benefits by asset and liability position as of December 31: (Amounts in millions) Asset Liability Net liability Asset Liability Net liability Fixed indexed annuities . . . . . . . . . . . . . . . . . . . . . . . . $— Variable annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 $ 55 570 Total market risk benefits . . . . . . . . . . . . . . . . . . $ 43 $625 $ 55 527 $582 $— 26 $ 52 696 $ 26 $748 $ 52 670 $722 ended December 31: (Dollar amounts in millions) Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance before effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Attributed fees collected . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in interest rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in equity markets . . . . . . . . . . . . . . . . . . . . . . . . . . . Actual policyholder behavior different from expected behavior . . . . . Effect of changes in future expected policyholder behavior . . . . . . . . . Effect of changes in other future expected assumptions . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance before effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2023 Fixed indexed annuities Variable annuities Reinsurance recoverable(1) $ 52 $ 670 $158 $158 — 9 8 (15) (5) (31) 5 11 — — 140 — $140 $ 50 — 3 5 — (2) (2) (2) — — — 52 3 55 — $ 55 73 $ 660 — 34 37 (35) (33) (157) 8 11 — (5) 520 7 527 140 $ 387 76 2023 2022 Market risk benefits, net of reinsurance recoverable . . . . . . . . . . . . . . . . . . Weighted-average attained age of contractholders . . . . . . . . . . . . . . . . . . . . Net amount at risk(2) (1) Represents the net reinsured asset related to our variable annuity MRBs. (2) See note 11 for additional information on the net amount at risk. 202 203 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (Dollar amounts in millions) Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance before effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Attributed fees collected . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in interest rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in equity markets . . . . . . . . . . . . . . . . . . . . . . . . . . Actual policyholder behavior different from expected behavior . . . . Effect of changes in future expected policyholder behavior . . . . . . . . Effect of changes in other future expected assumptions . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance before effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Market risk benefits, net of reinsurance recoverable . . . . . . . . . . . . . . . . . Weighted-average attained age of contractholders . . . . . . . . . . . . . . . . . . . Net amount at risk(2) 2022 Fixed indexed annuities Variable annuities Reinsurance recoverable(1) $ 94 $ 855 $193 $193 — 4 9 (16) (74) 39 3 — — — 158 — $158 $ 90 — 1 5 — (51) 5 (2) — — 2 50 2 52 — $ 52 72 $ 840 6 18 42 (28) (513) 286 8 — — 1 660 10 670 158 $ 512 76 (1) Represents the net reinsured asset related to our variable annuity MRBs. (2) See note 11 for additional information on the net amount at risk. (Dollar amounts in millions) Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $115 $1,173 $244 Beginning balance before effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $110 $1,154 2021 Fixed indexed annuities Variable annuities Reinsurance recoverable(1) Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Attributed fees collected . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in interest rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in equity markets . . . . . . . . . . . . . . . . . . . . . . . . . . . Actual policyholder behavior different from expected behavior . . . . . Effect of changes in future expected policyholder behavior . . . . . . . . . Effect of changes in other future expected assumptions . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance before effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Market risk benefits, net of reinsurance recoverable . . . . . . . . . . . . . . . . . . Weighted-average attained age of contractholders . . . . . . . . . . . . . . . . . . . . Net amount at risk(2) (1) Represents the net reinsured asset related to our variable annuity MRBs. (2) See note 11 for additional information on the net amount at risk. $244 — 1 11 (13) (21) (42) 13 — — — 193 — $193 — — 6 — (10) (7) (7) — — (2) 90 4 94 — $ 94 71 3 4 48 (23) (115) (267) 36 — — — 840 15 855 193 $ 662 75 During the year ended December 31, 2023, equity market performance was favorable, resulting in a decrease in the net MRB liability of our variable annuity products. During the year ended December 31, 2022, risk-free interest rates increased, resulting in a decrease in the net MRB liability of our fixed indexed and variable annuity products. In our variable annuity products, this was partially offset by unfavorable equity market performance, which increased our net MRB liability. During the year ended December 31, 2021, equity market performance was favorable and risk-free interest rates increased, resulting in a decrease in our net MRB liability of our fixed indexed and variable annuity products. 204 205 Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 94 $ 855 $193 Beginning balance before effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Attributed fees collected . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in interest rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in equity markets . . . . . . . . . . . . . . . . . . . . . . . . . . Actual policyholder behavior different from expected behavior . . . . Effect of changes in future expected policyholder behavior . . . . . . . . Effect of changes in other future expected assumptions . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance before effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Market risk benefits, net of reinsurance recoverable . . . . . . . . . . . . . . . . . Weighted-average attained age of contractholders . . . . . . . . . . . . . . . . . . . Net amount at risk(2) $ 90 — 1 5 — (51) 5 (2) — — 2 50 2 52 — $ 52 72 (1) Represents the net reinsured asset related to our variable annuity MRBs. (2) See note 11 for additional information on the net amount at risk. 2022 $ 840 6 18 42 (28) (513) 286 8 — — 1 660 10 670 158 $ 512 76 $193 — 4 9 (16) (74) 39 3 — — — 158 — $158 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (Dollar amounts in millions) Fixed indexed annuities Variable annuities Reinsurance recoverable(1) (Dollar amounts in millions) Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beginning balance before effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest accretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Attributed fees collected . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in interest rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in equity markets . . . . . . . . . . . . . . . . . . . . . . . . . . . Actual policyholder behavior different from expected behavior . . . . . Effect of changes in future expected policyholder behavior . . . . . . . . . Effect of changes in other future expected assumptions . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ending balance before effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effect of changes in instrument-specific credit risk . . . . . . . . . . . . . . . . . . . Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Market risk benefits, net of reinsurance recoverable . . . . . . . . . . . . . . . . . . Weighted-average attained age of contractholders . . . . . . . . . . . . . . . . . . . . Net amount at risk(2) 2021 Fixed indexed annuities Variable annuities Reinsurance recoverable(1) $115 $1,173 $244 $244 — 1 11 (13) (21) (42) 13 — — — 193 — $193 $110 — — 6 — (10) (7) (7) — — (2) 90 4 94 — $ 94 71 $1,154 3 4 48 (23) (115) (267) 36 — — — 840 15 855 193 $ 662 75 (1) Represents the net reinsured asset related to our variable annuity MRBs. (2) See note 11 for additional information on the net amount at risk. During the year ended December 31, 2023, equity market performance was favorable, resulting in a decrease in the net MRB liability of our variable annuity products. During the year ended December 31, 2022, risk-free interest rates increased, resulting in a decrease in the net MRB liability of our fixed indexed and variable annuity products. In our variable annuity products, this was partially offset by unfavorable equity market performance, which increased our net MRB liability. During the year ended December 31, 2021, equity market performance was favorable and risk-free interest rates increased, resulting in a decrease in our net MRB liability of our fixed indexed and variable annuity products. 204 205 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (14) Separate Accounts The following table sets forth changes in our liability for policy and contract claims as of December 31: The following table presents the balances of and changes in separate account liabilities, which are primarily comprised of variable annuity products, as of and for the periods indicated: December 31, 2023 December 31, 2022 December 31, 2021 (Amounts in millions) Beginning balance as of January 1 . . . . . . . . . . Premiums and deposits . . . . . . . . . . . . . . . Policy charges . . . . . . . . . . . . . . . . . . . . . . Surrenders and withdrawals . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . Investment performance . . . . . . . . . . . . . . Net transfers to general account . . . . . . . . Other charges . . . . . . . . . . . . . . . . . . . . . . . Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . $4,417 35 (104) (361) (190) 716 (1) (3) $4,509 Cash surrender value(1) . . . . . . . . . . . . . . . . . . . $4,506 $6,066 48 (115) (352) (226) (991) (11) (2) $4,417 $4,414 $6,081 47 (136) (506) (266) 852 (5) (1) $6,066 $6,065 (1) Cash surrender value represents the amount of the contractholders’ account balances that was distributable less certain surrender charges. Separate Account Assets The following table presents the aggregate fair value of assets, by major investment asset category, supporting separate accounts as of the dates indicated: (Amounts in millions) December 31, 2023 December 31, 2022 Equity funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Balanced funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Bond funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Money market funds . . . . . . . . . . . . . . . . . . . . . . . . . Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,018 1,927 320 244 $4,509 $1,866 1,962 332 257 $4,417 (15) Liability for Policy and Contract Claims The following table sets forth our liability for policy and contract claims as of December 31: (Amounts in millions) Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Life and Annuities segment(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other mortgage insurance business . . . . . . . . . . . . . . . . . . . . . . . . . 2023 2022 $518 126 8 $519 158 6 Total liability for policy and contract claims . . . . . . . . . . . . . $652 $683 (1) Primarily includes balances related to our universal and term universal life insurance products. 206 207 (Amounts in millions) 2023 2022 2021 Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . $ 683 $ 819 $ 761 Less reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (23) 660 (26) 793 (32) 729 Incurred related to insured events of: Current year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Prior years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 885 (239) 879 (310) Total incurred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 646 569 881 10 891 Paid related to insured events of: Current year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Prior years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (557) (114) (578) (124) (688) (139) Total paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (671) (702) (827) Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Add reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 636 16 — 660 23 — 793 26 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . $ 652 $ 683 $ 819 The liability for policy and contract claims represents our current best estimate; however, there may be future adjustments to this estimate and related assumptions. Such adjustments, reflecting any variety of new and adverse trends, could be significant, and result in increases in reserves by an amount that could be material to our results of operations and financial condition and liquidity. In addition, loss reserves recorded on new delinquencies in our Enact segment have a high degree of estimation, particularly due to the uncertain macroeconomic environment, including whether the U.S. economy will experience a recession in 2024, and the level of uncertainty regarding whether borrowers in forbearance will ultimately cure or result in a claim payment, as well as the timing and severity of those payments. Given the extended period of time that may exist between the reporting of a delinquency and the claim payment, and changes in economic conditions and the real estate market, significant uncertainty and variability exist on amounts actually paid. The favorable development related to insured events of prior years for the year ended December 31, 2023 was predominantly associated with $241 million of reserve releases in our Enact segment primarily related to favorable cure performance on delinquencies from 2022 and earlier, including those related to COVID-19. Cure performance on delinquencies from 2022 has not been negatively impacted by uncertainty in the economic environment to the extent initially expected. The favorable development related to insured events of prior years for the year ended December 31, 2022 was largely attributable to $314 million of favorable reserve adjustments primarily driven by favorable cure performance on 2020 and 2021 COVID-19 delinquencies in our Enact segment. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (14) Separate Accounts The following table sets forth changes in our liability for policy and contract claims as of December 31: The following table presents the balances of and changes in separate account liabilities, which are primarily comprised of variable annuity products, as of and for the periods indicated: (Amounts in millions) Beginning balance as of January 1 . . . . . . . . . . $4,417 December 31, December 31, December 31, 2022 $6,066 2021 $6,081 Premiums and deposits . . . . . . . . . . . . . . . Policy charges . . . . . . . . . . . . . . . . . . . . . . Surrenders and withdrawals . . . . . . . . . . . Benefit payments . . . . . . . . . . . . . . . . . . . . Investment performance . . . . . . . . . . . . . . Net transfers to general account . . . . . . . . Other charges . . . . . . . . . . . . . . . . . . . . . . . 2023 35 (104) (361) (190) 716 (1) (3) 48 (115) (352) (226) (991) (11) (2) 47 (136) (506) (266) 852 (5) (1) Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . Cash surrender value(1) . . . . . . . . . . . . . . . . . . . $4,509 $4,506 $4,417 $4,414 $6,066 $6,065 (1) Cash surrender value represents the amount of the contractholders’ account balances that was distributable less certain surrender charges. Separate Account Assets The following table presents the aggregate fair value of assets, by major investment asset category, supporting separate accounts as of the dates indicated: (Amounts in millions) Equity funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Balanced funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Bond funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Money market funds . . . . . . . . . . . . . . . . . . . . . . . . . December 31, December 31, 2023 $2,018 1,927 320 244 2022 $1,866 1,962 332 257 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $4,509 $4,417 (15) Liability for Policy and Contract Claims The following table sets forth our liability for policy and contract claims as of December 31: (Amounts in millions) Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Life and Annuities segment(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other mortgage insurance business . . . . . . . . . . . . . . . . . . . . . . . . . 2023 2022 $518 126 8 $519 158 6 Total liability for policy and contract claims . . . . . . . . . . . . . $652 $683 (1) Primarily includes balances related to our universal and term universal life insurance products. (Amounts in millions) 2023 2022 2021 Beginning balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . Less reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 683 (23) $ 819 (26) $ 761 (32) Net beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 660 793 729 Incurred related to insured events of: Current year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Prior years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 885 (239) 879 (310) Total incurred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 646 569 881 10 891 Paid related to insured events of: Current year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Prior years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (557) (114) (578) (124) (688) (139) Total paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (671) (702) (827) Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Add reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 636 16 — 660 23 — 793 26 Ending balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . $ 652 $ 683 $ 819 The liability for policy and contract claims represents our current best estimate; however, there may be future adjustments to this estimate and related assumptions. Such adjustments, reflecting any variety of new and adverse trends, could be significant, and result in increases in reserves by an amount that could be material to our results of operations and financial condition and liquidity. In addition, loss reserves recorded on new delinquencies in our Enact segment have a high degree of estimation, particularly due to the uncertain macroeconomic environment, including whether the U.S. economy will experience a recession in 2024, and the level of uncertainty regarding whether borrowers in forbearance will ultimately cure or result in a claim payment, as well as the timing and severity of those payments. Given the extended period of time that may exist between the reporting of a delinquency and the claim payment, and changes in economic conditions and the real estate market, significant uncertainty and variability exist on amounts actually paid. The favorable development related to insured events of prior years for the year ended December 31, 2023 was predominantly associated with $241 million of reserve releases in our Enact segment primarily related to favorable cure performance on delinquencies from 2022 and earlier, including those related to COVID-19. Cure performance on delinquencies from 2022 has not been negatively impacted by uncertainty in the economic environment to the extent initially expected. The favorable development related to insured events of prior years for the year ended December 31, 2022 was largely attributable to $314 million of favorable reserve adjustments primarily driven by favorable cure performance on 2020 and 2021 COVID-19 delinquencies in our Enact segment. 206 207 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table sets forth information about incurred claims, net of reinsurance, as well as cumulative number of reported delinquencies and the total of incurred but not reported (“IBNR”) liabilities plus expected development on reported claims included within the net incurred claims amounts for our Enact segment as of December 31, 2023. The information about the incurred claims development for the years ended December 31, 2014 to 2022 and the historical reported delinquencies as of December 31, 2022 and prior are presented as supplementary information. Incurred claims and allocated claim adjustment expenses, net of reinsurance (Dollar amounts in millions) For the years ended December 31, Accident year (1) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Unaudited 2014 . . . . . . . . . . $328 $288 $269 $261 $259 $258 $259 $259 $258 $ 257 178 2015 . . . . . . . . . . — 235 208 187 181 180 180 179 179 134 2016 . . . . . . . . . . — — 198 160 138 136 137 136 135 99 2017 . . . . . . . . . . — — — 171 121 102 105 104 102 69 73 2018 . . . . . . . . . . — — — — 117 84 59 2019 . . . . . . . . . . — — — — — 106 111 71 49 2020 . . . . . . . . . . — — — — — — 365 362 107 37 2021 . . . . . . . . . . — — — — — — — 141 119 137 2022 . . . . . . . . . . — — — — — — — — 220 275 2023 . . . . . . . . . . — — — — — — — — — 78 98 84 Total of IBNR liabilities including expected development on reported claims as of December 31, 2023 Number of reported delinquencies (2) $— — — — — — — — — 27 17,809 15,400 13,970 15,097 11,269 11,883 38,863 12,585 14,329 15,851 (1) Represents the year in which first monthly mortgage payments have been missed by the borrower. (2) Represents reported and outstanding delinquencies less actual cures as of December 31 for each respective accident year. Total incurred . . . . $1,294 208 209 The following table sets forth paid claims development, net of reinsurance, for our Enact segment for the year ended December 31, 2023. The information about paid claims development for the years ended December 31, 2014 to 2022 is presented as supplementary information. (Amounts in millions) Accident year (1) Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Unaudited 2014 . . . . . . . . . . . . . . . . . . . . . . . . . $ 22 $127 $195 $233 $247 $253 $254 $255 $255 $ 256 2015 . . . . . . . . . . . . . . . . . . . . . . . . . — 12 2016 . . . . . . . . . . . . . . . . . . . . . . . . . — — 85 10 2017 . . . . . . . . . . . . . . . . . . . . . . . . . — — — 145 64 6 2018 . . . . . . . . . . . . . . . . . . . . . . . . . — — — — 167 110 46 3 2019 . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — 173 124 77 32 2 2020 . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — — 175 127 87 48 18 1 176 128 90 55 31 8 2021 . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — — — — 2022 . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — — — — — 2023 . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — — — — — — Total paid . . . . . . . . . . . . . . . $ 793 Total incurred . . . . . . . . . . . . . . . . . . . . . . $1,294 Total paid . . . . . . . . . . . . . . . . . . . . . . . . . All outstanding liabilities before 2014 . . . . . . . . . . . . . . . . . . . . . Reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Liability for policy and contract claims . . . . . . . . . . . . . . . . . . . . $ 518 177 129 92 59 38 13 2 177 131 94 62 43 19 7 4 793 15 2 (1) Represents the year in which first monthly mortgage payments have been missed by the borrower. The following table sets forth our average payout of incurred claims by age for our Enact segment as of December 31, 2023: Years 1 2 3 4 5 6 7 8 9 10 Average annual percentage payout of incurred claims by age Unaudited Percentage of payout . . . . . . . . . . . . . . . . 3.9% 28.1% 24.6% 12.0% 4.6% 2.1% 0.9% 0.6% 0.2% 0.2% (16) Employee Benefit Plans (a) Pension and Retiree Health and Life Insurance Benefit Plans Essentially all of our employees are enrolled in a qualified defined contribution pension plan. The plan is 100% funded by Genworth. We make annual contributions to each employee’s pension plan account based on the employee’s age, service and eligible pay. Employees are vested in the plan after three years of service. As of December 31, 2023 and 2022, we recorded a liability related to these benefits of $8 million. In addition, certain employees also participate in non-qualified defined contribution plans and in qualified and non-qualified defined benefit pension plans. The plan assets and pension liabilities, including the projected and accumulated benefit obligations of these plans, were not material to our consolidated financial statements individually or in the aggregate. As of December 31, 2023 and 2022, we recorded a liability related to these plans of GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table sets forth paid claims development, net of reinsurance, for our Enact segment for the year ended December 31, 2023. The information about paid claims development for the years ended December 31, 2014 to 2022 is presented as supplementary information. (Amounts in millions) Accident year (1) Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Unaudited 2014 . . . . . . . . . . . . . . . . . . . . . . . . . 177 176 173 167 145 2015 . . . . . . . . . . . . . . . . . . . . . . . . . — 12 85 129 128 124 110 64 10 2016 . . . . . . . . . . . . . . . . . . . . . . . . . — — 92 90 77 46 2017 . . . . . . . . . . . . . . . . . . . . . . . . . — — — 6 59 55 32 2018 . . . . . . . . . . . . . . . . . . . . . . . . . — — — — 3 38 31 2019 . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — 2 13 8 2020 . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — — 2021 . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — — — — 2 2022 . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — — — — — 2023 . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — — — — — $ 22 $127 $195 $233 $247 $253 $254 $255 $255 $ 256 177 131 94 62 43 19 7 4 — 175 127 87 48 18 1 Total paid . . . . . . . . . . . . . . . $ 793 Total incurred . . . . . . . . . . . . . . . . . . . . . . Total paid . . . . . . . . . . . . . . . . . . . . . . . . . All outstanding liabilities before 2014 . . . . . . . . . . . . . . . . . . . . . Reinsurance recoverable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,294 793 15 2 Liability for policy and contract claims . . . . . . . . . . . . . . . . . . . . $ 518 (1) Represents the year in which first monthly mortgage payments have been missed by the borrower. The following table sets forth our average payout of incurred claims by age for our Enact segment as of December 31, 2023: The following table sets forth information about incurred claims, net of reinsurance, as well as cumulative number of reported delinquencies and the total of incurred but not reported (“IBNR”) liabilities plus expected development on reported claims included within the net incurred claims amounts for our Enact segment as of December 31, 2023. The information about the incurred claims development for the years ended December 31, 2014 to 2022 and the historical reported delinquencies as of December 31, 2022 and prior are presented as supplementary information. Total of IBNR liabilities including expected on reported claims as of December 31, reported Number of Incurred claims and allocated claim adjustment expenses, net of reinsurance development (Dollar amounts in millions) For the years ended December 31, Accident year (1) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2023 delinquencies (2) Unaudited 2014 . . . . . . . . . . $328 $288 $269 $261 $259 $258 $259 $259 $258 $ 257 2015 . . . . . . . . . . — 235 208 187 181 180 180 179 179 2016 . . . . . . . . . . — — 198 160 138 136 137 136 135 2017 . . . . . . . . . . — — — 171 121 102 105 104 102 2018 . . . . . . . . . . — — — — 117 84 84 2019 . . . . . . . . . . — — — — — 106 111 78 98 73 71 2020 . . . . . . . . . . — — — — — — 365 362 107 2021 . . . . . . . . . . — — — — — — — 141 119 2022 . . . . . . . . . . — — — — — — — — 220 $— — — — — — — — — 178 134 99 69 59 49 37 137 275 17,809 15,400 13,970 15,097 11,269 11,883 38,863 12,585 14,329 2023 . . . . . . . . . . — — — — — — — — — 27 15,851 Total incurred . . . . $1,294 (1) Represents the year in which first monthly mortgage payments have been missed by the borrower. (2) Represents reported and outstanding delinquencies less actual cures as of December 31 for each respective accident year. Average annual percentage payout of incurred claims by age 9 2 Years 1 10 8 3 4 6 5 7 Percentage of payout . . . . . . . . . . . . . . . . 3.9% 28.1% 24.6% 12.0% 4.6% 2.1% 0.9% 0.6% 0.2% 0.2% Unaudited (16) Employee Benefit Plans (a) Pension and Retiree Health and Life Insurance Benefit Plans Essentially all of our employees are enrolled in a qualified defined contribution pension plan. The plan is 100% funded by Genworth. We make annual contributions to each employee’s pension plan account based on the employee’s age, service and eligible pay. Employees are vested in the plan after three years of service. As of December 31, 2023 and 2022, we recorded a liability related to these benefits of $8 million. In addition, certain employees also participate in non-qualified defined contribution plans and in qualified and non-qualified defined benefit pension plans. The plan assets and pension liabilities, including the projected and accumulated benefit obligations of these plans, were not material to our consolidated financial statements individually or in the aggregate. As of December 31, 2023 and 2022, we recorded a liability related to these plans of 208 209 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 $49 million and $47 million, respectively, which we accrued in other liabilities in the consolidated balance sheets. In 2023 and 2022, we recognized a decrease of $2 million and an increase of $26 million, respectively, in OCI. and 2021. Our cost associated with these plans was $13 million for each of the years ended December 31, 2023, 2022 Prior to the third quarter of 2022, the First Colony Life Insurance Company Pension Plan (“FCL Plan”) was one of our defined benefit pension plans available to certain of our employees. The First Colony Life Insurance Pension Plan Committee (“FCL Committee”), as the appointed delegate by Genworth Financial’s Board of Directors, adopted resolutions to terminate the FCL Plan in a standard termination effective December 31, 2021. The Internal Revenue Service (“IRS”) was notified of the intent to terminate the FCL Plan and subsequently issued a favorable determination letter to the FCL Committee on June 22, 2022. As permitted by the IRS determination letter, the FCL Plan settled the projected benefit obligation during 2022 by distributing FCL Plan assets to FCL Plan participants in the form of a lump sum distribution, an individual retirement account rollover to another qualified plan or by purchasing a non-participating annuity contract from a third-party insurer to cover vested benefits. The FCL Plan was fully funded and did not require any additional cash contributions to terminate. As of and for the year ended December 31, 2022, we completed the termination of the FCL Plan and incurred $8 million of pre-tax termination costs associated with the recognition of actuarial losses previously deferred in accumulated other comprehensive income (loss). We provide retiree health benefits to domestic employees hired prior to January 1, 2005 who meet certain service requirements. Under this plan, retirees over 65 years of age receive a subsidy towards the purchase of a Medigap policy, and retirees under 65 years of age receive medical benefits similar to our employees’ medical benefits. In December 2009, we announced that eligibility for retiree medical benefits would be limited to associates who were within 10 years of retirement eligibility as of January 1, 2010. We also provide retiree life and long-term care insurance benefits. The plans are funded as claims are incurred. As of December 31, 2023 and 2022, the accumulated postretirement benefit obligation associated with these benefits was $53 million and $50 million, respectively, which we accrued in other liabilities in the consolidated balance sheets. In 2023 and 2022, we recognized a decrease of $3 million and an increase of $18 million, respectively, in OCI. The increase in our pension and postretirement benefit obligations and corresponding decrease in OCI for the year ended December 31, 2023 was principally due to lower interest rates used to measure our pension and postretirement liabilities. Our cost associated with our pension, retiree health and life insurance benefit plans was $12 million, $22 million and $18 million for the years ended December 31, 2023, 2022 and 2021, respectively. (b) Savings Plans Our domestic employees participate in qualified and non-qualified defined contribution savings plans that allow employees to contribute a portion of their pay to the plan on a pre-tax basis. We make matching contributions equal to 100% of the first 4% of pay deferred by an employee and 50% of the next 2% of pay deferred by an employee so that our matching contribution does not exceed 5% of an employee’s pay. Employees do not vest immediately in Genworth matching contributions but fully vest in the matching contributions after two complete years of service. One option available to employees in the defined contribution savings plan is the ClearCourse® variable annuity option offered by certain of our life insurance subsidiaries. The amount of deposits recorded by our life insurance subsidiaries in 2023 and 2022 in relation to this plan option was less than $1 million for each year. (c) Health and Welfare Benefits for Active Employees We provide health and welfare benefits to our employees, including health, life, disability, dental and long- term care insurance, among others. Our long-term care insurance is provided through our group long-term care insurance products. The premiums recorded by this business related to these benefits were insignificant during 2023, 2022 and 2021. (17) Borrowings and Other Financings (a) Long-Term Borrowings The following table sets forth total long-term borrowings as of December 31: (Amounts in millions) Genworth Holdings 6.50% Senior Notes, due 2034 . . . . . . . . . . . . . . . . . . . . . $ 262 $ 285 Floating Rate Junior Subordinated Notes, due 2066 . . . . . Subtotal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Bond consent fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred borrowing charges . . . . . . . . . . . . . . . . . . . . . . . Total Genworth Holdings . . . . . . . . . . . . . . . . . . . . . . . . . Enact Holdings 6.50% Senior Notes, due 2025 . . . . . . . . . . . . . . . . . . . . . Deferred borrowing charges . . . . . . . . . . . . . . . . . . . . . . . Total Enact Holdings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,584 $1,611 2023 2022 592 854 (9) (6) 839 750 (5) 745 599 884 (10) (6) 868 750 (7) 743 Genworth Holdings Long-Term Senior Notes As of December 31, 2023, Genworth Holdings had outstanding fixed rate senior notes with a principal balance of $263 million and a discount of $1 million, with an interest rate of 6.50% due in June 2034 (“2034 Notes”). The senior notes are Genworth Holdings’ direct, unsecured obligations and rank equally in right of payment with all its existing and future unsecured and unsubordinated obligations. Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior notes and the holders of the senior notes, on an unsecured unsubordinated basis, of the full and punctual payment of the principal of, premium, if any, interest on, and all other amounts payable under, the senior notes and the respective senior notes indenture. Genworth Holdings has the option to redeem all or a portion of the senior notes at any time with notice to the noteholders at a price equal to the greater of 100% of principal or the sum of the present value of the remaining scheduled payments of principal and interest discounted at the then-current treasury rate plus an applicable spread. During the year ended December 31, 2023, in addition to amounts repurchased in connection 210 211 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 $49 million and $47 million, respectively, which we accrued in other liabilities in the consolidated balance sheets. In 2023 and 2022, we recognized a decrease of $2 million and an increase of $26 million, respectively, in OCI. Our cost associated with these plans was $13 million for each of the years ended December 31, 2023, 2022 and 2021. Prior to the third quarter of 2022, the First Colony Life Insurance Company Pension Plan (“FCL Plan”) was one of our defined benefit pension plans available to certain of our employees. The First Colony Life Insurance Pension Plan Committee (“FCL Committee”), as the appointed delegate by Genworth Financial’s Board of Directors, adopted resolutions to terminate the FCL Plan in a standard termination effective December 31, 2021. The Internal Revenue Service (“IRS”) was notified of the intent to terminate the FCL Plan and subsequently issued a favorable determination letter to the FCL Committee on June 22, 2022. As permitted by the IRS determination letter, the FCL Plan settled the projected benefit obligation during 2022 by distributing FCL Plan assets to FCL Plan participants in the form of a lump sum distribution, an individual retirement account rollover to another qualified plan or by purchasing a non-participating annuity contract from a third-party insurer to cover vested benefits. The FCL Plan was fully funded and did not require any additional cash contributions to terminate. As of and for the year ended December 31, 2022, we completed the termination of the FCL Plan and incurred $8 million of pre-tax termination costs associated with the recognition of actuarial losses previously deferred in accumulated other comprehensive income (loss). We provide retiree health benefits to domestic employees hired prior to January 1, 2005 who meet certain service requirements. Under this plan, retirees over 65 years of age receive a subsidy towards the purchase of a Medigap policy, and retirees under 65 years of age receive medical benefits similar to our employees’ medical benefits. In December 2009, we announced that eligibility for retiree medical benefits would be limited to associates who were within 10 years of retirement eligibility as of January 1, 2010. We also provide retiree life and long-term care insurance benefits. The plans are funded as claims are incurred. As of December 31, 2023 and 2022, the accumulated postretirement benefit obligation associated with these benefits was $53 million and $50 million, respectively, which we accrued in other liabilities in the consolidated balance sheets. In 2023 and 2022, we recognized a decrease of $3 million and an increase of $18 million, respectively, in OCI. The increase in our pension and postretirement benefit obligations and corresponding decrease in OCI for the year ended December 31, 2023 was principally due to lower interest rates used to measure our pension and postretirement liabilities. Our cost associated with our pension, retiree health and life insurance benefit plans was $12 million, $22 million and $18 million for the years ended December 31, 2023, 2022 and 2021, respectively. (b) Savings Plans Our domestic employees participate in qualified and non-qualified defined contribution savings plans that allow employees to contribute a portion of their pay to the plan on a pre-tax basis. We make matching contributions equal to 100% of the first 4% of pay deferred by an employee and 50% of the next 2% of pay deferred by an employee so that our matching contribution does not exceed 5% of an employee’s pay. Employees do not vest immediately in Genworth matching contributions but fully vest in the matching contributions after two complete years of service. One option available to employees in the defined contribution savings plan is the ClearCourse® variable annuity option offered by certain of our life insurance subsidiaries. The amount of deposits recorded by our life insurance subsidiaries in 2023 and 2022 in relation to this plan option was less than $1 million for each year. (c) Health and Welfare Benefits for Active Employees We provide health and welfare benefits to our employees, including health, life, disability, dental and long- term care insurance, among others. Our long-term care insurance is provided through our group long-term care insurance products. The premiums recorded by this business related to these benefits were insignificant during 2023, 2022 and 2021. (17) Borrowings and Other Financings (a) Long-Term Borrowings The following table sets forth total long-term borrowings as of December 31: (Amounts in millions) Genworth Holdings 2023 2022 6.50% Senior Notes, due 2034 . . . . . . . . . . . . . . . . . . . . . Floating Rate Junior Subordinated Notes, due 2066 . . . . . $ 262 592 $ 285 599 Subtotal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Bond consent fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred borrowing charges . . . . . . . . . . . . . . . . . . . . . . . Total Genworth Holdings . . . . . . . . . . . . . . . . . . . . . . . . . Enact Holdings 6.50% Senior Notes, due 2025 . . . . . . . . . . . . . . . . . . . . . Deferred borrowing charges . . . . . . . . . . . . . . . . . . . . . . . Total Enact Holdings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 854 (9) (6) 839 750 (5) 745 884 (10) (6) 868 750 (7) 743 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,584 $1,611 Genworth Holdings Long-Term Senior Notes As of December 31, 2023, Genworth Holdings had outstanding fixed rate senior notes with a principal balance of $263 million and a discount of $1 million, with an interest rate of 6.50% due in June 2034 (“2034 Notes”). The senior notes are Genworth Holdings’ direct, unsecured obligations and rank equally in right of payment with all its existing and future unsecured and unsubordinated obligations. Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior notes and the holders of the senior notes, on an unsecured unsubordinated basis, of the full and punctual payment of the principal of, premium, if any, interest on, and all other amounts payable under, the senior notes and the respective senior notes indenture. Genworth Holdings has the option to redeem all or a portion of the senior notes at any time with notice to the noteholders at a price equal to the greater of 100% of principal or the sum of the present value of the remaining scheduled payments of principal and interest discounted at the then-current treasury rate plus an applicable spread. During the year ended December 31, 2023, in addition to amounts repurchased in connection 210 211 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 with a completed bondholder consent solicitation to amend the Replacement Capital Covenant as discussed below, Genworth Holdings repurchased $11 million principal amount of its 2034 Notes for a pre-tax gain of $1 million and paid accrued interest thereon. Long-Term Junior Subordinated Notes As of December 31, 2023, Genworth Holdings had outstanding floating rate junior notes having an aggregate principal amount of $593 million and a discount of $1 million, with interest payable quarterly until the notes mature in November 2066 (“2066 Notes”). The 2066 Notes previously had an annual interest rate equal to three-month LIBOR plus 2.0025%. The United Kingdom Financial Conduct Authority eliminated the use of three-month LIBOR effective June 30, 2023. In December 2022, the Board of Governors of the Federal Reserve System adopted a final rule that established benchmark rates, based on the Secured Overnight Financing Rate (“SOFR”), that replaced LIBOR after its elimination. Pursuant to the final rule, Genworth Holdings’ 2066 Notes transitioned in the third quarter of 2023 to an annual interest rate equal to the three-month Term SOFR Reference Rate, plus a tenor spread adjustment of 0.26161%, plus an additional spread of 2.0025%. Term SOFR is published by CME Group Inc. and is a forward-looking rate that is based on SOFR futures trading. Subject to certain conditions, Genworth Holdings has the right, on one or more occasions, to defer the payment of interest on the 2066 Notes during any period of up to 10 years without giving rise to an event of default and without permitting acceleration under the terms of the 2066 Notes. Genworth Holdings will not be required to settle deferred interest payments until it has deferred interest for five years or made a payment of current interest. In the event of our bankruptcy, holders will have a limited claim for deferred interest. In connection with the issuance of the 2066 Notes, we entered into a Replacement Capital Covenant, whereby we agreed, for the benefit of holders of Genworth Holdings’ 2034 Notes, that Genworth Holdings would not repay, redeem or repurchase all or any part of the 2066 Notes on or before November 15, 2046, unless such repayment, redemption or repurchase was made from the proceeds of the issuance of certain replacement capital securities and pursuant to the other terms and conditions set forth in the Replacement Capital Covenant. On October 25, 2023, Genworth Holdings completed a consent solicitation from bondholders representing a majority in principal amount of its 2034 Notes to amend the Replacement Capital Covenant. The amendment permits Genworth Holdings to repay, redeem or repurchase $2,000 principal amount of its 2066 Notes for each $1,000 principal amount of its 2034 Notes repaid, redeemed or repurchased. In connection with this transaction, Genworth Holdings repurchased approximately $14 million principal of its 2034 Notes at prices negotiated with the noteholders below par value, which was accounted for as a debt modification with the difference in the par value and principal amount repurchased deferred as a change to the carrying value of the 2034 Notes. In addition, Genworth Holdings subsequently repurchased $7 million of its 2066 Notes for a pre-tax gain of $1 million. During the 180-day period prior to November 15, 2036, the “scheduled redemption date,” Genworth Holdings must use its commercially reasonable efforts, subject to certain conditions, to raise sufficient net proceeds from the sale of certain qualifying capital securities to redeem the 2066 Notes on the scheduled redemption date. If Genworth Holdings has not raised sufficient net proceeds to repay the 2066 Notes in full on the scheduled redemption date, it shall repay the Notes in part on such date and on each quarterly interest payment date thereafter to the extent that it has received net proceeds from the sale of such qualifying capital securities, until the 2066 Notes have been redeemed in full. Genworth Holdings may otherwise redeem the 2066 Notes at any time in whole or in part at their principal amount plus accrued and unpaid interest to the date of redemption, subject to compliance with the Replacement Capital Covenant. The 2066 Notes will be subordinated to all existing and future senior, subordinated and junior subordinated debt of Genworth Holdings, except for any future debt that by its terms is not superior in right of payment, and will be effectively subordinated to all liabilities of our subsidiaries. Genworth Financial provides a full and unconditional guarantee to the trustee of the 2066 Notes and the holders of the 2066 Notes, on an unsecured subordinated basis, of the full and punctual payment of the principal of, premium, if any, interest on, and all other amounts payable under, the outstanding 2066 Notes and the respective 2066 Notes indenture. Enact Holdings As of December 31, 2023, Enact Holdings had $750 million principal amount of 6.50% senior notes due in 2025. Interest on the notes is payable semi-annually in arrears on February 15 and August 15 of each year. The notes mature on August 15, 2025. Enact Holdings may redeem the notes, in whole or in part, at any time prior to February 15, 2025 at its option, by paying a make-whole premium, plus accrued and unpaid interest, if any. At any time on or after February 15, 2025, Enact Holdings may redeem the notes, in whole or in part, at its option, at 100% of the principal amount, plus accrued and unpaid interest. The notes contain customary events of default, which subject to certain notice and cure conditions, can result in the acceleration of the principal and accrued interest on the outstanding notes if Enact Holdings breaches the terms of the indenture. (b) Revolving Credit Facility Enact Holdings On June 30, 2022, Enact Holdings entered into a credit agreement with a syndicate of lenders that provides for a five-year unsecured revolving credit facility in the initial aggregate principal amount of $200 million, including the ability for Enact Holdings to increase the commitments under the credit facility on an uncommitted basis, by an additional aggregate principal amount of up to $100 million. Any borrowings under Enact Holdings’ credit facility will bear interest at a per annum rate equal to a floating rate tied to a standard short-term borrowing index selected at Enact Holdings’ option, plus an applicable margin, pursuant to the terms of the credit agreement. The applicable margin is based on Enact Holdings’ ratings established by certain debt rating agencies for its outstanding debt. Enact Holdings’ credit facility includes customary representations, warranties, covenants, terms and conditions. As of December 31, 2023, Enact Holdings was in compliance with all covenants and the credit facility remained undrawn. (c) Liquidity Principal amounts under our long-term borrowings by maturity were as follows as of December 31, 2023: (Amounts in millions) 2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2027 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2028 and thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 750 — — 856 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,606 212 213 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 with a completed bondholder consent solicitation to amend the Replacement Capital Covenant as discussed below, Genworth Holdings repurchased $11 million principal amount of its 2034 Notes for a pre-tax gain of $1 million and paid accrued interest thereon. Long-Term Junior Subordinated Notes As of December 31, 2023, Genworth Holdings had outstanding floating rate junior notes having an aggregate principal amount of $593 million and a discount of $1 million, with interest payable quarterly until the notes mature in November 2066 (“2066 Notes”). The 2066 Notes previously had an annual interest rate equal to three-month LIBOR plus 2.0025%. The United Kingdom Financial Conduct Authority eliminated the use of three-month LIBOR effective June 30, 2023. In December 2022, the Board of Governors of the Federal Reserve System adopted a final rule that established benchmark rates, based on the Secured Overnight Financing Rate (“SOFR”), that replaced LIBOR after its elimination. Pursuant to the final rule, Genworth Holdings’ 2066 Notes transitioned in the third quarter of 2023 to an annual interest rate equal to the three-month Term SOFR Reference Rate, plus a tenor spread adjustment of 0.26161%, plus an additional spread of 2.0025%. Term SOFR is published by CME Group Inc. and is a forward-looking rate that is based on SOFR futures trading. Subject to certain conditions, Genworth Holdings has the right, on one or more occasions, to defer the payment of interest on the 2066 Notes during any period of up to 10 years without giving rise to an event of default and without permitting acceleration under the terms of the 2066 Notes. Genworth Holdings will not be required to settle deferred interest payments until it has deferred interest for five years or made a payment of current interest. In the event of our bankruptcy, holders will have a limited claim for deferred interest. In connection with the issuance of the 2066 Notes, we entered into a Replacement Capital Covenant, whereby we agreed, for the benefit of holders of Genworth Holdings’ 2034 Notes, that Genworth Holdings would not repay, redeem or repurchase all or any part of the 2066 Notes on or before November 15, 2046, unless such repayment, redemption or repurchase was made from the proceeds of the issuance of certain replacement capital securities and pursuant to the other terms and conditions set forth in the Replacement Capital Covenant. On October 25, 2023, Genworth Holdings completed a consent solicitation from bondholders representing a majority in principal amount of its 2034 Notes to amend the Replacement Capital Covenant. The amendment permits Genworth Holdings to repay, redeem or repurchase $2,000 principal amount of its 2066 Notes for each $1,000 principal amount of its 2034 Notes repaid, redeemed or repurchased. In connection with this transaction, Genworth Holdings repurchased approximately $14 million principal of its 2034 Notes at prices negotiated with the noteholders below par value, which was accounted for as a debt modification with the difference in the par value and principal amount repurchased deferred as a change to the carrying value of the 2034 Notes. In addition, Genworth Holdings subsequently repurchased $7 million of its 2066 Notes for a pre-tax gain of $1 million. During the 180-day period prior to November 15, 2036, the “scheduled redemption date,” Genworth Holdings must use its commercially reasonable efforts, subject to certain conditions, to raise sufficient net proceeds from the sale of certain qualifying capital securities to redeem the 2066 Notes on the scheduled redemption date. If Genworth Holdings has not raised sufficient net proceeds to repay the 2066 Notes in full on the scheduled redemption date, it shall repay the Notes in part on such date and on each quarterly interest payment date thereafter to the extent that it has received net proceeds from the sale of such qualifying capital securities, until the 2066 Notes have been redeemed in full. Genworth Holdings may otherwise redeem the 2066 Notes at any time in whole or in part at their principal amount plus accrued and unpaid interest to the date of redemption, subject to compliance with the Replacement Capital Covenant. The 2066 Notes will be subordinated to all existing and future senior, subordinated and junior subordinated debt of Genworth Holdings, except for any future debt that by its terms is not superior in right of payment, and will be effectively subordinated to all liabilities of our subsidiaries. Genworth Financial provides a full and unconditional guarantee to the trustee of the 2066 Notes and the holders of the 2066 Notes, on an unsecured subordinated basis, of the full and punctual payment of the principal of, premium, if any, interest on, and all other amounts payable under, the outstanding 2066 Notes and the respective 2066 Notes indenture. Enact Holdings As of December 31, 2023, Enact Holdings had $750 million principal amount of 6.50% senior notes due in 2025. Interest on the notes is payable semi-annually in arrears on February 15 and August 15 of each year. The notes mature on August 15, 2025. Enact Holdings may redeem the notes, in whole or in part, at any time prior to February 15, 2025 at its option, by paying a make-whole premium, plus accrued and unpaid interest, if any. At any time on or after February 15, 2025, Enact Holdings may redeem the notes, in whole or in part, at its option, at 100% of the principal amount, plus accrued and unpaid interest. The notes contain customary events of default, which subject to certain notice and cure conditions, can result in the acceleration of the principal and accrued interest on the outstanding notes if Enact Holdings breaches the terms of the indenture. (b) Revolving Credit Facility Enact Holdings On June 30, 2022, Enact Holdings entered into a credit agreement with a syndicate of lenders that provides for a five-year unsecured revolving credit facility in the initial aggregate principal amount of $200 million, including the ability for Enact Holdings to increase the commitments under the credit facility on an uncommitted basis, by an additional aggregate principal amount of up to $100 million. Any borrowings under Enact Holdings’ credit facility will bear interest at a per annum rate equal to a floating rate tied to a standard short-term borrowing index selected at Enact Holdings’ option, plus an applicable margin, pursuant to the terms of the credit agreement. The applicable margin is based on Enact Holdings’ ratings established by certain debt rating agencies for its outstanding debt. Enact Holdings’ credit facility includes customary representations, warranties, covenants, terms and conditions. As of December 31, 2023, Enact Holdings was in compliance with all covenants and the credit facility remained undrawn. (c) Liquidity Principal amounts under our long-term borrowings by maturity were as follows as of December 31, 2023: (Amounts in millions) 2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2027 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2028 and thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — 750 — — 856 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,606 212 213 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (18) Income Taxes Income from continuing operations before income taxes included the following components for the years ended December 31: (Amounts in millions) 2023 2022 2021 Domestic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $301 $1,365 $1,115 (3) Foreign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 — Income from continuing operations before income taxes . . . . . . . $303 $1,365 $1,112 The total provision for income taxes was as follows for the years ended December 31: (Amounts in millions) 2023 2022 2021 Current federal income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred federal income taxes $ 50 49 $— 320 $ (32) 273 Total federal income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99 320 241 Current state income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred state income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total state income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 (1) 5 4 (6) (2) 5 2 7 Current foreign income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred foreign income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — 1 — — Total foreign income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 1 — Total provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . $104 $319 $248 Our current income tax receivable (payable) was $(43) million and $3 million as of December 31, 2023 and 2022, respectively. The reconciliation of the federal statutory tax rate to the effective income tax rate was as follows for the years ended December 31: Statutory U.S. federal income tax rate . . . . . . . . . . . . . . . . . . . . . . . . . Increase (reduction) in rate resulting from: 2023 2022 2021 21.0% 21.0% 21.0% Tax on income from terminated swaps . . . . . . . . . . . . . . . . . . . . 2.3 Reduction in uncertain tax positions . . . . . . . . . . . . . . . . . . . . . . — — 0.2 Non-deductible expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.0 1.4 State income tax, net of federal income tax effect . . . . . . . . . . . . (0.1) (0.1) — Other, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.0 2.6 (1.9) 0.4 0.5 (0.3) Effective rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34.3% 23.4% 22.3% The effective tax rate for the years ended December 31, 2023, 2022 and 2021 was above the statutory U.S. federal income tax rate of 21% largely due to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income. The effective tax rate for the year ended December 31, 2023 increased compared to the year ended December 31, 2022 primarily attributable to higher tax expense on certain forward starting swap gains in relation to pre-tax income in 2023. The effective tax rate for the year ended December 31, 2022 increased compared to the year ended December 31, 2021 primarily attributable to a reduction in uncertain tax positions due to the expiration of certain statute of limitations in 2021 that did not recur. The components of our deferred income taxes were as follows as of December 31: (Amounts in millions) Assets: 2023 2022 Foreign tax credit carryforwards . . . . . . . . . . . . . . . . . . . . $ — $ 156 Net operating loss carryforwards . . . . . . . . . . . . . . . . . . . Capital loss carryforwards . . . . . . . . . . . . . . . . . . . . . . . . . State income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Insurance reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . DAC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accrued commission and general expenses . . . . . . . . . . . Liabilities associated with discontinued operations . . . . . Net unrealized losses on investment securities . . . . . . . . . Net unrealized losses on derivatives . . . . . . . . . . . . . . . . . Net effect of change in discount rate for future policy benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net effect of change in fair value of MRBs attributable to instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Gross deferred income tax assets . . . . . . . . . . . . . . . Valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . 2,656 (542) 2,754 (583) Total deferred income tax assets . . . . . . . . . . . . . . . . 2,114 2,171 Liabilities: DAC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . PVFP and other intangibles . . . . . . . . . . . . . . . . . . . . . . . . Insurance reserves transition adjustment . . . . . . . . . . . . . Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred income tax liabilities . . . . . . . . . . . . . 162 188 Net deferred income tax asset . . . . . . . . . . . . . . . . . . $1,952 $1,983 3 138 370 910 18 75 121 539 81 391 2 8 — 27 49 67 19 4 146 407 732 — 70 122 892 102 110 3 10 40 31 74 20 23 The $3 million of net operating loss (“NOL”) carryfowards relate to foreign jurisdictions and are fully offset by a valuation allowance. Capital loss carryforwards amounted to $656 million as of December 31, 2023, and, if unused, will expire in 2026. 214 215 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (18) Income Taxes ended December 31: Income from continuing operations before income taxes included the following components for the years (Amounts in millions) 2023 2022 2021 Domestic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $301 $1,365 $1,115 Foreign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 — (3) Income from continuing operations before income taxes . . . . . . . $303 $1,365 $1,112 The total provision for income taxes was as follows for the years ended December 31: (Amounts in millions) Current federal income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 50 Deferred federal income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total federal income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . Current state income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred state income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total state income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2023 2022 2021 $— 320 320 $ (32) 273 241 4 (6) (2) 5 2 7 49 99 6 (1) 5 Current foreign income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — Deferred foreign income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total foreign income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — 1 — 1 — Total provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . $104 $319 $248 Our current income tax receivable (payable) was $(43) million and $3 million as of December 31, 2023 and 2022, respectively. years ended December 31: The reconciliation of the federal statutory tax rate to the effective income tax rate was as follows for the 2023 2022 2021 Statutory U.S. federal income tax rate . . . . . . . . . . . . . . . . . . . . . . . . . 21.0% 21.0% 21.0% Increase (reduction) in rate resulting from: Tax on income from terminated swaps . . . . . . . . . . . . . . . . . . . . 10.0 2.3 Reduction in uncertain tax positions . . . . . . . . . . . . . . . . . . . . . . — — Non-deductible expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . State income tax, net of federal income tax effect . . . . . . . . . . . . 2.0 1.4 0.2 (0.1) 2.6 (1.9) 0.4 0.5 Other, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (0.1) — (0.3) Effective rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34.3% 23.4% 22.3% The effective tax rate for the years ended December 31, 2023, 2022 and 2021 was above the statutory U.S. federal income tax rate of 21% largely due to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income. The effective tax rate for the year ended December 31, 2023 increased compared to the year ended December 31, 2022 primarily attributable to higher tax expense on certain forward starting swap gains in relation to pre-tax income in 2023. The effective tax rate for the year ended December 31, 2022 increased compared to the year ended December 31, 2021 primarily attributable to a reduction in uncertain tax positions due to the expiration of certain statute of limitations in 2021 that did not recur. The components of our deferred income taxes were as follows as of December 31: (Amounts in millions) Assets: Foreign tax credit carryforwards . . . . . . . . . . . . . . . . . . . . Net operating loss carryforwards . . . . . . . . . . . . . . . . . . . Capital loss carryforwards . . . . . . . . . . . . . . . . . . . . . . . . . State income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Insurance reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . DAC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accrued commission and general expenses . . . . . . . . . . . Liabilities associated with discontinued operations . . . . . Net unrealized losses on investment securities . . . . . . . . . Net unrealized losses on derivatives . . . . . . . . . . . . . . . . . Net effect of change in discount rate for future policy benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net effect of change in fair value of MRBs attributable to instrument-specific credit risk . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2023 2022 $ — 3 138 370 910 18 75 121 539 81 $ 156 4 146 407 732 — 70 122 892 102 391 110 2 8 3 10 Gross deferred income tax assets . . . . . . . . . . . . . . . Valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . 2,656 (542) 2,754 (583) Total deferred income tax assets . . . . . . . . . . . . . . . . 2,114 2,171 Liabilities: DAC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . PVFP and other intangibles . . . . . . . . . . . . . . . . . . . . . . . . Insurance reserves transition adjustment . . . . . . . . . . . . . Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred income tax liabilities . . . . . . . . . . . . . — 27 49 67 19 162 40 31 74 20 23 188 Net deferred income tax asset . . . . . . . . . . . . . . . . . . $1,952 $1,983 The $3 million of net operating loss (“NOL”) carryfowards relate to foreign jurisdictions and are fully offset by a valuation allowance. Capital loss carryforwards amounted to $656 million as of December 31, 2023, and, if unused, will expire in 2026. 214 215 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Our valuation allowance as of December 31, 2023 and 2022 was $542 million and $583 million, respectively. Given the change in our unrealized gains (losses) on our fixed maturity securities and forward starting swaps in 2022 due to rising interest rates and the corresponding reduction in the amount of unrealized capital gains expected to be available in the future to offset our capital loss carryforwards and other capital deferred tax assets, we recorded a valuation allowance of $200 million during 2022 through accumulated other comprehensive income (loss) related to deferred tax assets that would produce capital losses. There was no change in this valuation allowance in 2023 based upon the amounts and characteristics of our deferred tax assets and liabilities and our assessment of the risks associated with the recoverability of our deferred tax assets. The remainder of the valuation allowance as of December 31, 2023 and 2022 is related to state deferred tax assets and foreign net operating losses. The state deferred tax assets related primarily to the future deductions associated with the Section 338 elections and non-insurance NOL carryforwards. Our ability to realize our net deferred tax asset of $1,952 million, which includes deferred tax assets related to capital loss and NOL carryforwards, is primarily dependent upon generating sufficient taxable income and capital gains in future years. We have net deferred tax assets of $879 million that have or will produce capital losses. As part of the assessment of the amount of the valuation allowance, management has asserted that it has the ability and intent to execute tax planning strategies including holding certain investment assets with unrealized losses to recovery or maturity or realizing gains on certain investment assets with unrealized gains to the extent necessary to ensure realization of the capital related deferred tax assets, net of the $200 million valuation allowance. We have net deferred tax assets of $1,073 million that will produce ordinary income (loss) in future years. Management has concluded that there is sufficient positive evidence to support the expected realization of these deferred tax assets for U.S. federal income tax purposes. This positive evidence includes the fact that: (i) we are currently in a cumulative three-year income position, and (ii) our U.S. operating forecasts are profitable, which include in-force premium rate increases and associated benefit reductions already obtained in our long-term care insurance business. After consideration of all available evidence, we have concluded that it is more likely than not that our deferred tax assets, with the exception of capital loss carryforwards, other capital deferred tax assets, state deferred tax assets and certain foreign net operating losses for which a valuation allowance has been established, will be realized. If our actual results do not validate the current projections of pre-tax income, we may be required to record an additional valuation allowance that could have a material impact on our consolidated financial statements in future periods. As a consequence of our separation from GE and our joint election with GE to treat that separation as an asset sale under Section 338 of the Internal Revenue Code, we became entitled to additional tax deductions in post IPO periods. We were obligated, pursuant to our Tax Matters Agreement with GE, to make fixed payments to GE on an after-tax basis and subject to a cumulative maximum of $640 million, which was 80% of the projected tax savings associated with the Section 338 deductions. During 2022, we made a $55 million payment to GE to satisfy our remaining obligation under the Tax Matters Agreement. A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: (Amounts in millions) 2023 2022 2021 Balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 33 $ 40 $ 62 Tax positions related to the current period: Gross additions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — Gross reductions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (3) (3) (3) Tax positions related to the prior years: Gross additions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — Gross reductions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — (4) (19) Balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 30 $ 33 $ 40 The total amount of unrecognized tax benefits was $30 million as of December 31, 2023, which if recognized would affect the effective tax rate on continuing operations by $21 million. We believe it is reasonably possible that if the uncertain tax positions were resolved in 2024, approximately $18 million of the unrecognized tax benefits would be recognized. We recognize accrued interest and penalties related to unrecognized tax benefits as components of income tax expense. We recorded $—, $— and $2 million of benefit in 2023, 2022 and 2021, respectively. Our companies have elected to file a single U.S. consolidated income tax return (the “life/non-life consolidated return”). All companies domesticated in the United States are included in the life/non-life consolidated return as allowed by the tax law and regulations. We have a tax sharing agreement in place and all intercompany balances related to this agreement are settled at least annually. We are not currently subject to any significant examinations by federal or state income tax authorities. Generally, we are no longer subject to federal or state income tax examinations for years prior to 2020. (19) Supplemental Cash Flow Information Net cash paid for taxes was $10 million, $5 million and $7 million and cash paid for interest was $110 million, $101 million and $186 million for the years ended December 31, 2023, 2022 and 2021, respectively. (20) Long-Term Incentive Compensation Genworth Financial Prior to May 2012, we granted share-based awards to employees and directors, including stock appreciation rights (“SARs”), restricted stock units (“RSUs”), deferred stock units (“DSUs”) and performance stock units (“PSUs”) under the 2004 Genworth Financial, Inc. Omnibus Incentive Plan (the “2004 Omnibus Incentive Plan”). In May 2012, the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (the “2012 Omnibus Incentive Plan”) was approved by stockholders. Under the 2012 Omnibus Incentive Plan, we were authorized to grant 16 million equity awards, plus a number of additional shares not to exceed 25 million underlying awards outstanding under the 2004 Omnibus Incentive Plan. In December 2018, the 2018 Genworth Financial, Inc. Omnibus Incentive Plan (the “2018 Omnibus Incentive Plan”) was approved by stockholders. Under the 2018 Omnibus Incentive Plan, we were authorized to grant 25 million equity awards, plus a number of additional shares not to exceed 20 million underlying awards outstanding 216 217 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Our valuation allowance as of December 31, 2023 and 2022 was $542 million and $583 million, respectively. Given the change in our unrealized gains (losses) on our fixed maturity securities and forward starting swaps in 2022 due to rising interest rates and the corresponding reduction in the amount of unrealized capital gains expected to be available in the future to offset our capital loss carryforwards and other capital deferred tax assets, we recorded a valuation allowance of $200 million during 2022 through accumulated other comprehensive income (loss) related to deferred tax assets that would produce capital losses. There was no change in this valuation allowance in 2023 based upon the amounts and characteristics of our deferred tax assets and liabilities and our assessment of the risks associated with the recoverability of our deferred tax assets. The remainder of the valuation allowance as of December 31, 2023 and 2022 is related to state deferred tax assets and foreign net operating losses. The state deferred tax assets related primarily to the future deductions associated with the Section 338 elections and non-insurance NOL carryforwards. Our ability to realize our net deferred tax asset of $1,952 million, which includes deferred tax assets related to capital loss and NOL carryforwards, is primarily dependent upon generating sufficient taxable income and capital gains in future years. We have net deferred tax assets of $879 million that have or will produce capital losses. As part of the assessment of the amount of the valuation allowance, management has asserted that it has the ability and intent to execute tax planning strategies including holding certain investment assets with unrealized losses to recovery or maturity or realizing gains on certain investment assets with unrealized gains to the extent necessary to ensure realization of the capital related deferred tax assets, net of the $200 million valuation allowance. We have net deferred tax assets of $1,073 million that will produce ordinary income (loss) in future years. Management has concluded that there is sufficient positive evidence to support the expected realization of these deferred tax assets for U.S. federal income tax purposes. This positive evidence includes the fact that: (i) we are currently in a cumulative three-year income position, and (ii) our U.S. operating forecasts are profitable, which include in-force premium rate increases and associated benefit reductions already obtained in our long-term care insurance business. After consideration of all available evidence, we have concluded that it is more likely than not that our deferred tax assets, with the exception of capital loss carryforwards, other capital deferred tax assets, state deferred tax assets and certain foreign net operating losses for which a valuation allowance has been established, will be realized. If our actual results do not validate the current projections of pre-tax income, we may be required to record an additional valuation allowance that could have a material impact on our consolidated financial statements in future periods. As a consequence of our separation from GE and our joint election with GE to treat that separation as an asset sale under Section 338 of the Internal Revenue Code, we became entitled to additional tax deductions in post IPO periods. We were obligated, pursuant to our Tax Matters Agreement with GE, to make fixed payments to GE on an after-tax basis and subject to a cumulative maximum of $640 million, which was 80% of the projected tax savings associated with the Section 338 deductions. During 2022, we made a $55 million payment to GE to satisfy our remaining obligation under the Tax Matters Agreement. A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: (Amounts in millions) Balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tax positions related to the current period: 2023 2022 2021 $ 33 $ 40 $ 62 Gross additions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Gross reductions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — (3) (3) (3) Tax positions related to the prior years: Gross additions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Gross reductions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — (19) (4) — Balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 30 $ 33 $ 40 The total amount of unrecognized tax benefits was $30 million as of December 31, 2023, which if recognized would affect the effective tax rate on continuing operations by $21 million. We believe it is reasonably possible that if the uncertain tax positions were resolved in 2024, approximately $18 million of the unrecognized tax benefits would be recognized. We recognize accrued interest and penalties related to unrecognized tax benefits as components of income tax expense. We recorded $—, $— and $2 million of benefit in 2023, 2022 and 2021, respectively. Our companies have elected to file a single U.S. consolidated income tax return (the “life/non-life consolidated return”). All companies domesticated in the United States are included in the life/non-life consolidated return as allowed by the tax law and regulations. We have a tax sharing agreement in place and all intercompany balances related to this agreement are settled at least annually. We are not currently subject to any significant examinations by federal or state income tax authorities. Generally, we are no longer subject to federal or state income tax examinations for years prior to 2020. (19) Supplemental Cash Flow Information Net cash paid for taxes was $10 million, $5 million and $7 million and cash paid for interest was $110 million, $101 million and $186 million for the years ended December 31, 2023, 2022 and 2021, respectively. (20) Long-Term Incentive Compensation Genworth Financial Prior to May 2012, we granted share-based awards to employees and directors, including stock appreciation rights (“SARs”), restricted stock units (“RSUs”), deferred stock units (“DSUs”) and performance stock units (“PSUs”) under the 2004 Genworth Financial, Inc. Omnibus Incentive Plan (the “2004 Omnibus Incentive Plan”). In May 2012, the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (the “2012 Omnibus Incentive Plan”) was approved by stockholders. Under the 2012 Omnibus Incentive Plan, we were authorized to grant 16 million equity awards, plus a number of additional shares not to exceed 25 million underlying awards outstanding under the 2004 Omnibus Incentive Plan. In December 2018, the 2018 Genworth Financial, Inc. Omnibus Incentive Plan (the “2018 Omnibus Incentive Plan”) was approved by stockholders. Under the 2018 Omnibus Incentive Plan, we were authorized to grant 25 million equity awards, plus a number of additional shares not to exceed 20 million underlying awards outstanding 216 217 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 under the prior Plans. In May 2021, the 2021 Genworth Financial, Inc. Omnibus Incentive Plan (the “2021 Omnibus Incentive Plan”) was approved by stockholders. Under the 2021 Omnibus Incentive Plan, we are authorized to grant 25 million equity awards, plus a number of additional shares not to exceed 20 million underlying awards outstanding under the prior Plans. The 2004 Omnibus Incentive Plan together with the 2012, 2018 and 2021 Omnibus Incentive Plans are referred to collectively as the “Omnibus Incentive Plans.” We recorded long-term incentive compensation expense under the Omnibus Incentive Plans of $34 million, $27 million and $38 million, respectively, for the years ended December 31, 2023, 2022 and 2021, which included stock-based compensation expense of $29 million, $19 million and $21 million, respectively. Long-term incentive compensation expense was recognized evenly on a straight-line attribution method over the awards’ respective vesting period. During 2023, 2022 and 2021, we issued RSUs with average restriction periods of three years and a fair value measured at the market price of a share of our Class A Common Stock on the grant date. During 2023, 2022 and 2021, we granted PSUs with a fair value as described in further detail below as of the approval date by Genworth Financial’s Board of Directors. PSUs may be earned over a three-year period based upon the achievement of certain performance goals. The PSUs granted in 2023 have a three-year measurement period starting on January 1, 2023 going through December 31, 2025. The performance metric is based on our Enact segment’s adjusted operating income (loss), consolidated statutory pre-tax income of our U.S. life insurance subsidiaries and Genworth’s total shareholder return over the three-year measurement period compared to certain of its peer companies established as of the grant date. See note 23 for our definition of adjusted operating income (loss). The grant-date fair value based on market price as of the approval date for the adjusted operating income (loss) and consolidated statutory pre-tax income performance measures was $6.21. The grant-date fair value for the total relative shareholder return performance metric was $8.82, which was calculated using the Monte Carlo simulation. The PSUs granted in 2022 have a three-year measurement period starting on January 1, 2022 going through December 31, 2024. The performance metric is based on our Enact segment’s adjusted operating income (loss), consolidated statutory net income of our U.S. life insurance subsidiaries and Genworth’s total shareholder return over the three-year measurement period compared to certain of its peer companies established as of the grant date. The grant-date fair value based on market price as of the approval date for the adjusted operating income (loss) and consolidated statutory net income performance measures was $4.27. The grant-date fair value for the total relative shareholder return performance metric was $5.30, which was calculated using the Monte Carlo simulation. The PSUs granted in 2021 have a three-year measurement period starting on January 1, 2021 going through December 31, 2023. The performance metric is based on Genworth’s consolidated adjusted operating income and its total shareholder return relative to certain of its peer companies as of the grant date. The grant-date fair value based on market price as of the approval date for the adjusted operating income performance measure was $3.31. The grant-date fair value for the total relative shareholder return performance metric was $4.18, which was calculated using the Monte Carlo simulation. The valuation assumptions used in the Monte Carlo simulation to calculate the total relative shareholder return performance metric for the PSUs granted in 2023, 2022 and 2021 were as follows: 2023 2022 2021 Valuation-date stock price . . . . . $ Volatility . . . . . . . . . . . . . . . . . . . Dividend yield . . . . . . . . . . . . . . Risk-free rate . . . . . . . . . . . . . . . 6.21 $ 55.4% — % 4.3% 4.27 $ 64.6% — % 1.8% 3.31 65.0% — % 0.3% Valuation maximum . . . . . . . . . . 800% of grant- 800% of grant- 800% of grant- date stock price date stock price date stock price For all PSU awards granted, the compensation committee of our Board of Directors determines and approves no later than March 15, following the end of the three-year performance period for each applicable performance period, the number of units earned and vested for each distinct performance period. For the years ended December 31, 2023, 2022 and 2021, we recorded $9 million, $3 million and $16 million, respectively, of expense associated with our PSUs. The following tables summarize the status of our equity-based awards as of December 31, 2023 and 2022: RSUs PSUs DSUs SARs Weighted- Weighted- Number average Number Weighted- Number Weighted- Number average of awards grant date fair value of average of average of awards fair value awards fair value awards grant date fair value (Awards in thousands) Balance as of January 1, 2022 . . . . . . . . . . . . . Granted . . . . . . . . . . . . . . . . . . . . . . . . . . 2,317 1,105 Performance adjustment(1) . . . . . . . . . . . . — Exercised . . . . . . . . . . . . . . . . . . . . . . . . . (1,004) Terminated . . . . . . . . . . . . . . . . . . . . . . . . (299) Balance as of January 1, 2023 . . . . . . . . . . . . . 2,119 Granted . . . . . . . . . . . . . . . . . . . . . . . . . . 974 Performance adjustment(1) . . . . . . . . . . . . — Exercised . . . . . . . . . . . . . . . . . . . . . . . . . (1,261) Terminated . . . . . . . . . . . . . . . . . . . . . . . . (103) $3.38 $4.25 $ — $3.39 $3.52 $3.81 $6.05 $ — $3.69 $4.27 7,505 2,182 2,308 (4,616) (718) 6,661 1,418 1,807 (3,883) — $3.70 $4.47 $4.61 $4.61 $3.55 $3.65 $6.76 $3.03 $3.03 $ — 1,837 281 — (954) — 1,164 94 — (140) — $3.42 $2.51 $ — $4.02 $ — $2.44 $3.66 $ — $2.43 $ — 6,195 — — — (2,295) 3,900 — — — (2,308) $3.36 $ — $ — $ — $2.52 $3.85 $ — $ — $ — $5.87 Balance as of December 31, 2023 . . . . . . . . . . 1,729 $5.13 6,003 $4.60 1,118 $3.00 1,592 $3.22 (1) The performance adjustment relates to additional awards expected to be earned through the achievement of certain performance metrics. As of December 31, 2023 and 2022, total unrecognized stock-based compensation expense related to non-vested non-cash awards not yet recognized was $17 million and $16 million, respectively. This expense is expected to be recognized over a weighted-average period of approximately two years. The actual tax benefit realized for the tax deductions from the exercise of share-based awards was $4 million and $5 million for the years ended December 31, 2023 and 2022, respectively. 218 219 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 under the prior Plans. In May 2021, the 2021 Genworth Financial, Inc. Omnibus Incentive Plan (the “2021 Omnibus Incentive Plan”) was approved by stockholders. Under the 2021 Omnibus Incentive Plan, we are authorized to grant 25 million equity awards, plus a number of additional shares not to exceed 20 million underlying awards outstanding under the prior Plans. The 2004 Omnibus Incentive Plan together with the 2012, 2018 and 2021 Omnibus Incentive Plans are referred to collectively as the “Omnibus Incentive Plans.” We recorded long-term incentive compensation expense under the Omnibus Incentive Plans of $34 million, $27 million and $38 million, respectively, for the years ended December 31, 2023, 2022 and 2021, which included stock-based compensation expense of $29 million, $19 million and $21 million, respectively. Long-term incentive compensation expense was recognized evenly on a straight-line attribution method over the awards’ respective vesting period. During 2023, 2022 and 2021, we issued RSUs with average restriction periods of three years and a fair value measured at the market price of a share of our Class A Common Stock on the grant date. During 2023, 2022 and 2021, we granted PSUs with a fair value as described in further detail below as of the approval date by Genworth Financial’s Board of Directors. PSUs may be earned over a three-year period based upon the achievement of certain performance goals. The PSUs granted in 2023 have a three-year measurement period starting on January 1, 2023 going through December 31, 2025. The performance metric is based on our Enact segment’s adjusted operating income (loss), consolidated statutory pre-tax income of our U.S. life insurance subsidiaries and Genworth’s total shareholder return over the three-year measurement period compared to certain of its peer companies established as of the grant date. See note 23 for our definition of adjusted operating income (loss). The grant-date fair value based on market price as of the approval date for the adjusted operating income (loss) and consolidated statutory pre-tax income performance measures was $6.21. The grant-date fair value for the total relative shareholder return performance metric was $8.82, which was calculated using the Monte Carlo simulation. The PSUs granted in 2022 have a three-year measurement period starting on January 1, 2022 going through December 31, 2024. The performance metric is based on our Enact segment’s adjusted operating income (loss), consolidated statutory net income of our U.S. life insurance subsidiaries and Genworth’s total shareholder return over the three-year measurement period compared to certain of its peer companies established as of the grant date. The grant-date fair value based on market price as of the approval date for the adjusted operating income (loss) and consolidated statutory net income performance measures was $4.27. The grant-date fair value for the total relative shareholder return performance metric was $5.30, which was calculated using the Monte Carlo simulation. The PSUs granted in 2021 have a three-year measurement period starting on January 1, 2021 going through December 31, 2023. The performance metric is based on Genworth’s consolidated adjusted operating income and its total shareholder return relative to certain of its peer companies as of the grant date. The grant-date fair value based on market price as of the approval date for the adjusted operating income performance measure was $3.31. The grant-date fair value for the total relative shareholder return performance metric was $4.18, which was calculated using the Monte Carlo simulation. The valuation assumptions used in the Monte Carlo simulation to calculate the total relative shareholder return performance metric for the PSUs granted in 2023, 2022 and 2021 were as follows: Valuation-date stock price . . . . . Volatility . . . . . . . . . . . . . . . . . . . Dividend yield . . . . . . . . . . . . . . Risk-free rate . . . . . . . . . . . . . . . Valuation maximum . . . . . . . . . . 2023 2022 2021 $ $ 6.21 55.4% — % 4.3% $ 4.27 64.6% — % 1.8% 3.31 65.0% — % 0.3% 800% of grant- date stock price 800% of grant- date stock price 800% of grant- date stock price For all PSU awards granted, the compensation committee of our Board of Directors determines and approves no later than March 15, following the end of the three-year performance period for each applicable performance period, the number of units earned and vested for each distinct performance period. For the years ended December 31, 2023, 2022 and 2021, we recorded $9 million, $3 million and $16 million, respectively, of expense associated with our PSUs. The following tables summarize the status of our equity-based awards as of December 31, 2023 and 2022: (Awards in thousands) RSUs PSUs DSUs SARs Number of awards Weighted- average grant date fair value Number of awards Weighted- average fair value Number of awards Weighted- average fair value Number of awards Weighted- average grant date fair value 2,317 Balance as of January 1, 2022 . . . . . . . . . . . . . 1,105 Granted . . . . . . . . . . . . . . . . . . . . . . . . . . Performance adjustment(1) . . . . . . . . . . . . — (1,004) Exercised . . . . . . . . . . . . . . . . . . . . . . . . . (299) Terminated . . . . . . . . . . . . . . . . . . . . . . . . Balance as of January 1, 2023 . . . . . . . . . . . . . 2,119 974 Granted . . . . . . . . . . . . . . . . . . . . . . . . . . Performance adjustment(1) . . . . . . . . . . . . — (1,261) Exercised . . . . . . . . . . . . . . . . . . . . . . . . . (103) Terminated . . . . . . . . . . . . . . . . . . . . . . . . $3.38 $4.25 $ — $3.39 $3.52 $3.81 $6.05 $ — $3.69 $4.27 7,505 2,182 2,308 (4,616) (718) 6,661 1,418 1,807 (3,883) — $3.70 $4.47 $4.61 $4.61 $3.55 $3.65 $6.76 $3.03 $3.03 $ — 1,837 281 — (954) — 1,164 94 — (140) — $3.42 $2.51 $ — $4.02 $ — $2.44 $3.66 $ — $2.43 $ — 6,195 — — — (2,295) 3,900 — — — (2,308) $3.36 $ — $ — $ — $2.52 $3.85 $ — $ — $ — $5.87 Balance as of December 31, 2023 . . . . . . . . . . 1,729 $5.13 6,003 $4.60 1,118 $3.00 1,592 $3.22 (1) The performance adjustment relates to additional awards expected to be earned through the achievement of certain performance metrics. As of December 31, 2023 and 2022, total unrecognized stock-based compensation expense related to non-vested non-cash awards not yet recognized was $17 million and $16 million, respectively. This expense is expected to be recognized over a weighted-average period of approximately two years. The actual tax benefit realized for the tax deductions from the exercise of share-based awards was $4 million and $5 million for the years ended December 31, 2023 and 2022, respectively. 218 219 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 During 2023 and 2022, we issued cash settled RSUs with average restriction periods of three years and a fair The following table summarizes the status of Enact Holdings’ equity-based awards as of December 31, 2023 value measured at the market price of a share of our Class A Common Stock on the grant date. The RSUs will vest as a cash payment equal to one share of our Class A Common Stock using the average closing sales prices on the 20 trading days immediately preceding the vesting date. In 2022 and 2021, we granted time-based cash awards with a fair value of $1.00 per award and that vest over three years, with a third of the payout occurring per year as determined by the vesting period, beginning on the first anniversary of the grant date. The following table summarizes cash award activity as of December 31, 2023 and 2022: Cash settled RSUs Number of awards Weighted- average fair value (Awards in thousands) Balance as of January 1, 2022 . . . . . . . . . . . . . . . . . . . Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Performance adjustment . . . . . . . . . . . . . . . . . . . Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Balance as of January 1, 2023 . . . . . . . . . . . . . . . . . . . Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Performance adjustment . . . . . . . . . . . . . . . . . . . Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 2,957 — (23) (180) 2,754 2,211 — (1,108) (93) Balance as of December 31, 2023 . . . . . . . . . . . . . . . . 3,764 $ — $4.27 $ — $4.17 $4.31 $4.27 $6.18 $ — $5.97 $5.84 $6.15 Time-based cash awards Number of awards 27,696 208 — (13,992) (1,020) 12,892 — — (8,511) (175) 4,206 Enact Holdings In connection with the minority IPO of Enact Holdings, Genworth Financial’s indirect subsidiary, Enact Holdings granted equity-based awards to its employees and directors, including RSUs, PSUs and DSUs. Additionally, in 2021, the Enact Holdings, Inc. 2021 Omnibus Incentive Plan was adopted and approved by Enact Holdings’ shareholders. Under the Enact Holdings, Inc. 2021 Omnibus Incentive Plan, Enact Holdings is authorized to issue up to four million equity awards. During 2023, 2022, and 2021 Enact Holdings granted RSUs with average restriction periods of three years and a fair value measured at the fair value of a share of Enact Holdings’ Class A Common Stock on the grant date. During 2023 and 2022, Enact Holdings granted PSUs with a three-year measurement period starting on January 1, 2023 going through December 31, 2025 for those granted in 2023 and starting on January 1, 2022 going through December 31, 2024 for those granted in 2022. The performance metrics are based on the standalone results of Enact Holdings and are measured by the growth in consolidated book value per share over the three-year measurement period, calculated as the increase in book value divided by the average number of shares outstanding from January 1, 2023 to December 31, 2025 for the PSUs granted in 2023 and from January 1, 2022 to December 31, 2024 for the PSUs granted in 2022. The PSUs were granted at market price as of the approval date by Enact Holdings’ Board of Directors. 220 221 and 2022: (Awards in thousands) RSUs PSUs DSUs Number of awards Weighted- average fair value Number of awards Weighted- average fair value Number of awards Weighted- average fair value Balance as of January 1, 2022 . . . . . . . . . . . . . . . . Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dividend equivalents . . . . . . . . . . . . . . . . . . . Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 654 322 62 (3) $19.02 — $22.18 $24.00 156 10 $19.00 — Terminated . . . . . . . . . . . . . . . . . . . . . . . . . . . (26) $19.73 — $ — $22.15 $24.00 17 78 5 $ — — $ — — Balance as of January 1, 2023 . . . . . . . . . . . . . . . . 1,009 Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dividend equivalents . . . . . . . . . . . . . . . . . . . Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Terminated . . . . . . . . . . . . . . . . . . . . . . . . . . . 294 59 (125) (23) $20.07 $24.26 $26.82 166 157 16 $22.15 $24.23 $26.82 100 58 8 $21.84 — $20.61 — $ — — $ — — Balance as of December 31, 2023 . . . . . . . . . . . . . 1,214 $20.94 339 $23.16 166 $20.87 $22.02 $24.00 $ — $ — $21.81 $23.80 $26.97 $ — $ — $22.54 For the years ended December 31, 2023, 2022 and 2021, and in accordance with our majority ownership, we recorded $15 million, $10 million and $2 million, respectively, of stock-based compensation expense. As of December 31, 2023 and 2022, total estimated unrecognized expense related to these awards was $13 million. This expense is expected to be recognized over a weighted-average period of approximately two years. The actual tax benefit realized for the tax deductions from the exercise of share-based awards was less than $1 million for both the years ended December 31, 2023 and 2022. (21) Fair Value of Financial Instruments Recurring Fair Value Measurements We have fixed maturity securities, equity securities, limited partnerships, derivatives, short-term investments, embedded derivatives, separate account assets, MRBs and certain other financial instruments, which are carried at fair value. Below is a description of the valuation techniques and inputs used to determine fair value by class of instrument. Fixed maturity securities, equity securities and short-term investments The fair value of fixed maturity securities, equity securities and short-term investments is estimated primarily based on information derived from third-party pricing services (“pricing services”), internal models and/or broker quotes, which may use a market approach, income approach or a combination of the market and income approach depending on the type of instrument and availability of information. In general, a market approach is utilized if there is readily available and relevant market activity for an individual security. In certain cases where market information is not available for a specific security but is available for similar securities, that security is valued using market information for similar securities, which is also a market approach. When market information is not available for a specific security (or similar securities) or is available but such information is less relevant or reliable, an income approach or a combination of a market and income approach is utilized. For GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 During 2023 and 2022, we issued cash settled RSUs with average restriction periods of three years and a fair The following table summarizes the status of Enact Holdings’ equity-based awards as of December 31, 2023 value measured at the market price of a share of our Class A Common Stock on the grant date. The RSUs will vest as a cash payment equal to one share of our Class A Common Stock using the average closing sales prices on the 20 trading days immediately preceding the vesting date. In 2022 and 2021, we granted time-based cash awards with a fair value of $1.00 per award and that vest over three years, with a third of the payout occurring per year as determined by the vesting period, beginning on the first anniversary of the grant date. The following table summarizes cash award activity as of December 31, 2023 and 2022: Cash settled RSUs Number of awards Weighted- average fair value (Awards in thousands) Balance as of January 1, 2022 . . . . . . . . . . . . . . . . . . . Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Performance adjustment . . . . . . . . . . . . . . . . . . . Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Balance as of January 1, 2023 . . . . . . . . . . . . . . . . . . . Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Performance adjustment . . . . . . . . . . . . . . . . . . . Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 2,957 — (23) (180) 2,754 2,211 — (1,108) (93) Balance as of December 31, 2023 . . . . . . . . . . . . . . . . 3,764 $ — $4.27 $ — $4.17 $4.31 $4.27 $6.18 $ — $5.97 $5.84 $6.15 Time-based cash awards Number of awards 27,696 208 — (13,992) (1,020) 12,892 — — (8,511) (175) 4,206 Enact Holdings In connection with the minority IPO of Enact Holdings, Genworth Financial’s indirect subsidiary, Enact Holdings granted equity-based awards to its employees and directors, including RSUs, PSUs and DSUs. Additionally, in 2021, the Enact Holdings, Inc. 2021 Omnibus Incentive Plan was adopted and approved by Enact Holdings’ shareholders. Under the Enact Holdings, Inc. 2021 Omnibus Incentive Plan, Enact Holdings is authorized to issue up to four million equity awards. During 2023, 2022, and 2021 Enact Holdings granted RSUs with average restriction periods of three years and a fair value measured at the fair value of a share of Enact Holdings’ Class A Common Stock on the grant date. During 2023 and 2022, Enact Holdings granted PSUs with a three-year measurement period starting on January 1, 2023 going through December 31, 2025 for those granted in 2023 and starting on January 1, 2022 going through December 31, 2024 for those granted in 2022. The performance metrics are based on the standalone results of Enact Holdings and are measured by the growth in consolidated book value per share over the three-year measurement period, calculated as the increase in book value divided by the average number of shares outstanding from January 1, 2023 to December 31, 2025 for the PSUs granted in 2023 and from January 1, 2022 to December 31, 2024 for the PSUs granted in 2022. The PSUs were granted at market price as of the approval date by Enact Holdings’ Board of Directors. and 2022: (Awards in thousands) RSUs PSUs DSUs Number of awards Weighted- average fair value Number of awards Weighted- average fair value Number of awards Weighted- average fair value Balance as of January 1, 2022 . . . . . . . . . . . . . . . . Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dividend equivalents . . . . . . . . . . . . . . . . . . . Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Terminated . . . . . . . . . . . . . . . . . . . . . . . . . . . Balance as of January 1, 2023 . . . . . . . . . . . . . . . . Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dividend equivalents . . . . . . . . . . . . . . . . . . . Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Terminated . . . . . . . . . . . . . . . . . . . . . . . . . . . 654 322 62 (3) (26) 1,009 294 59 (125) (23) $19.02 — 156 $22.18 10 $24.00 $19.00 — $19.73 — 166 $20.07 157 $24.26 $26.82 16 $21.84 — $20.61 — 17 $ — 78 $22.15 5 $24.00 $ — — $ — — 100 $22.15 58 $24.23 $26.82 8 $ — — $ — — Balance as of December 31, 2023 . . . . . . . . . . . . . 1,214 $20.94 339 $23.16 166 $20.87 $22.02 $24.00 $ — $ — $21.81 $23.80 $26.97 $ — $ — $22.54 For the years ended December 31, 2023, 2022 and 2021, and in accordance with our majority ownership, we recorded $15 million, $10 million and $2 million, respectively, of stock-based compensation expense. As of December 31, 2023 and 2022, total estimated unrecognized expense related to these awards was $13 million. This expense is expected to be recognized over a weighted-average period of approximately two years. The actual tax benefit realized for the tax deductions from the exercise of share-based awards was less than $1 million for both the years ended December 31, 2023 and 2022. (21) Fair Value of Financial Instruments Recurring Fair Value Measurements We have fixed maturity securities, equity securities, limited partnerships, derivatives, short-term investments, embedded derivatives, separate account assets, MRBs and certain other financial instruments, which are carried at fair value. Below is a description of the valuation techniques and inputs used to determine fair value by class of instrument. Fixed maturity securities, equity securities and short-term investments The fair value of fixed maturity securities, equity securities and short-term investments is estimated primarily based on information derived from third-party pricing services (“pricing services”), internal models and/or broker quotes, which may use a market approach, income approach or a combination of the market and income approach depending on the type of instrument and availability of information. In general, a market approach is utilized if there is readily available and relevant market activity for an individual security. In certain cases where market information is not available for a specific security but is available for similar securities, that security is valued using market information for similar securities, which is also a market approach. When market information is not available for a specific security (or similar securities) or is available but such information is less relevant or reliable, an income approach or a combination of a market and income approach is utilized. For 220 221 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 securities with optionality, such as call or prepayment features (including mortgage-backed or asset-backed securities), an income approach may be used. These valuation techniques may change from period to period, based on the relevance and availability of market data. Further, while we consider the valuations provided by pricing services and broker quotes to be of high quality, management determines the fair value of our investment securities after considering all relevant and available information. In general, we first obtain valuations from pricing services. If prices are unavailable for public securities, we obtain broker quotes. For all securities, excluding certain private fixed maturity securities, if neither a pricing service nor broker quotes valuation is available, we determine fair value using internal models. For certain private fixed maturity securities where we do not obtain valuations from pricing services, we utilize an internal model to determine fair value since transactions for similar securities are not readily observable and these securities are not typically valued by pricing services. Given our understanding of the pricing methodologies and procedures of pricing services, the securities valued by pricing services are typically classified as Level 2 unless we determine the valuation process for a security or group of securities utilizes significant unobservable inputs, which would result in the valuation being classified as Level 3. Broker quotes may be utilized when pricing services data is not available and are typically classified as Level 3 due to the use of significant unobservable inputs. For private fixed maturity securities, we utilize an income approach where we obtain public bond spreads and utilize those in an internal model to determine fair value. Other inputs to the model include rating and weighted-average life, as well as sector which is used to assign the spread. We then add an additional premium, which represents an unobservable input, to the public bond spread to adjust for the liquidity and other features of our private placements. We utilize the estimated market yield to discount the expected cash flows of the security to determine fair value. We utilize price caps for securities where the estimated market yield results in a valuation that may exceed the amount that would be received in a market transaction. When a security does not have an external rating, we assign the security an internal rating to determine the appropriate public bond spread that should be utilized in the valuation. While we generally consider the public bond spreads by sector and maturity to be observable inputs, we evaluate the similarities of our private placements with the public bonds, price caps, liquidity premiums applied, and whether external ratings are available for our private placements to determine whether the spreads utilized would be considered observable inputs. We classify private securities without an external rating or public bond spread as Level 3. In general, a significant increase (decrease) in credit spreads would have resulted in a significant decrease (increase) in the fair value for our fixed maturity securities as of December 31, 2023. For remaining securities priced using internal models, we determine fair value using an income approach. We maximize the use of observable inputs but typically utilize significant unobservable inputs to determine fair value. Accordingly, the valuations are typically classified as Level 3. Our assessment of whether or not there were significant unobservable inputs related to fixed maturity securities was based on our observations obtained through the course of managing our investment portfolio, including interaction with other market participants, observations related to the availability and consistency of pricing and/or rating, and understanding of general market activity such as new issuance and the level of secondary market trading for a class of securities. Additionally, we considered data obtained from pricing services to determine whether our estimated values incorporate significant unobservable inputs that would result in the valuation being classified as Level 3. A summary of the inputs used for our financial instruments carried at fair value based on the level in which instruments are classified is included below. We have combined certain classes of instruments together as the Equity securities. The primary inputs to the valuation of exchange-traded equity securities include quoted Separate account assets. The fair value of separate account assets is based on the quoted prices of the underlying fund investments and, therefore, represents Level 1 pricing. nature of the inputs is similar. Level 1 measurements prices for the identical instrument. Level 2 measurements Fixed maturity securities • Third-party pricing services: In estimating the fair value of fixed maturity securities, 88% of our portfolio was priced using third-party pricing services as of December 31, 2023. These pricing services utilize industry-standard valuation techniques that include market-based approaches, income-based approaches, a combination of market-based and income-based approaches or other proprietary, internally generated models as part of the valuation processes. These third-party pricing vendors maximize the use of publicly available data inputs to generate valuations for each asset class. Priority and type of inputs used may change frequently as certain inputs may be more direct drivers of valuation at the time of pricing. Examples of significant inputs incorporated by pricing services may include sector and issuer spreads, seasoning, capital structure, security optionality, collateral data, prepayment assumptions, default assumptions, delinquencies, debt covenants, benchmark yields, trade data, dealer quotes, credit ratings, maturity and weighted-average life. We conduct regular meetings with our pricing services for the purpose of understanding the methodologies, techniques and inputs used by the third-party pricing providers. 222 223 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 securities with optionality, such as call or prepayment features (including mortgage-backed or asset-backed securities), an income approach may be used. These valuation techniques may change from period to period, based on the relevance and availability of market data. Further, while we consider the valuations provided by pricing services and broker quotes to be of high quality, management determines the fair value of our investment securities after considering all relevant and available information. In general, we first obtain valuations from pricing services. If prices are unavailable for public securities, we obtain broker quotes. For all securities, excluding certain private fixed maturity securities, if neither a pricing service nor broker quotes valuation is available, we determine fair value using internal models. For certain private fixed maturity securities where we do not obtain valuations from pricing services, we utilize an internal model to determine fair value since transactions for similar securities are not readily observable and these securities are not typically valued by pricing services. Given our understanding of the pricing methodologies and procedures of pricing services, the securities valued by pricing services are typically classified as Level 2 unless we determine the valuation process for a security or group of securities utilizes significant unobservable inputs, which would result in the valuation being classified as Level 3. Broker quotes may be utilized when pricing services data is not available and are typically classified as Level 3 due to the use of significant unobservable inputs. For private fixed maturity securities, we utilize an income approach where we obtain public bond spreads and utilize those in an internal model to determine fair value. Other inputs to the model include rating and weighted-average life, as well as sector which is used to assign the spread. We then add an additional premium, which represents an unobservable input, to the public bond spread to adjust for the liquidity and other features of our private placements. We utilize the estimated market yield to discount the expected cash flows of the security to determine fair value. We utilize price caps for securities where the estimated market yield results in a valuation that may exceed the amount that would be received in a market transaction. When a security does not have an external rating, we assign the security an internal rating to determine the appropriate public bond spread that should be utilized in the valuation. While we generally consider the public bond spreads by sector and maturity to be observable inputs, we evaluate the similarities of our private placements with the public bonds, price caps, liquidity premiums applied, and whether external ratings are available for our private placements to determine whether the spreads utilized would be considered observable inputs. We classify private securities without an external rating or public bond spread as Level 3. In general, a significant increase (decrease) in credit spreads would have resulted in a significant decrease (increase) in the fair value for our fixed maturity securities as of December 31, 2023. For remaining securities priced using internal models, we determine fair value using an income approach. We maximize the use of observable inputs but typically utilize significant unobservable inputs to determine fair value. Accordingly, the valuations are typically classified as Level 3. Our assessment of whether or not there were significant unobservable inputs related to fixed maturity securities was based on our observations obtained through the course of managing our investment portfolio, including interaction with other market participants, observations related to the availability and consistency of pricing and/or rating, and understanding of general market activity such as new issuance and the level of secondary market trading for a class of securities. Additionally, we considered data obtained from pricing services to determine whether our estimated values incorporate significant unobservable inputs that would result in the valuation being classified as Level 3. A summary of the inputs used for our financial instruments carried at fair value based on the level in which instruments are classified is included below. We have combined certain classes of instruments together as the nature of the inputs is similar. Level 1 measurements Equity securities. The primary inputs to the valuation of exchange-traded equity securities include quoted prices for the identical instrument. Separate account assets. The fair value of separate account assets is based on the quoted prices of the underlying fund investments and, therefore, represents Level 1 pricing. Level 2 measurements Fixed maturity securities • Third-party pricing services: In estimating the fair value of fixed maturity securities, 88% of our portfolio was priced using third-party pricing services as of December 31, 2023. These pricing services utilize industry-standard valuation techniques that include market-based approaches, income-based approaches, a combination of market-based and income-based approaches or other proprietary, internally generated models as part of the valuation processes. These third-party pricing vendors maximize the use of publicly available data inputs to generate valuations for each asset class. Priority and type of inputs used may change frequently as certain inputs may be more direct drivers of valuation at the time of pricing. Examples of significant inputs incorporated by pricing services may include sector and issuer spreads, seasoning, capital structure, security optionality, collateral data, prepayment assumptions, default assumptions, delinquencies, debt covenants, benchmark yields, trade data, dealer quotes, credit ratings, maturity and weighted-average life. We conduct regular meetings with our pricing services for the purpose of understanding the methodologies, techniques and inputs used by the third-party pricing providers. 222 223 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table presents a summary of the significant inputs used by our pricing services for certain fair value measurements of fixed maturity securities that are classified as Level 2 as of December 31, 2023: (Amounts in millions) Fair value Primary methodologies Significant inputs U.S. government, agencies and government- sponsored enterprises . . . . . . . . . . . . . . . . . . $ 3,494 State and political subdivisions . . . . . . . . . . . . $ 2,242 Non-U.S. government . . . . . . . . . . . . . . . . . . . . $ 626 Price quotes from trading desk, broker feeds Multi-dimensional attribute-based modeling systems, third-party pricing vendors Bid side prices, trade prices, Option Adjusted Spread (“OAS”) to swap curve, Bond Market Association OAS, Treasury Curve, Agency Bullet Curve, maturity to issuer spread Trade prices, material event notices, Municipal Market Data benchmark yields, broker quotes Matrix pricing, spread priced to benchmark curves, price quotes from market makers Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . . $24,317 Non-U.S. corporate . . . . . . . . . . . . . . . . . . . . . . $ 6,185 Residential mortgage-backed . . . . . . . . . . . . . . $ 904 Commercial mortgage-backed . . . . . . . . . . . . . $ 1,407 Other asset-backed . . . . . . . . . . . . . . . . . . . . . . $ 2,136 Multi-dimensional attribute-based modeling systems, broker quotes, price quotes from market makers, OAS-based models Multi-dimensional attribute-based modeling systems, OAS-based models, price quotes from market makers OAS-based models, single factor binomial models, internally priced Multi-dimensional attribute-based modeling systems, pricing matrix, spread matrix priced to swap curves, Trepp commercial mortgage- backed securities analytics model Multi-dimensional attribute-based modeling systems, spread matrix priced to swap curves, price quotes from market makers 224 Bid side prices to Treasury Curve, Issuer Curve, which includes sector, quality, duration, OAS percentage and change for spread matrix, trade prices, comparative transactions, Trade Reporting and Compliance Engine (“TRACE”) reports Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources Prepayment and default assumptions, aggregation of bonds with similar characteristics, including collateral type, vintage, tranche type, weighted-average life, weighted-average loan age, issuer program and delinquency ratio, pay up and pay down factors, TRACE reports Credit risk, interest rate risk, prepayment speeds, new issue data, collateral performance, origination year, tranche type, original credit ratings, weighted-average life, cash flows, spreads derived from broker quotes, bid side prices, spreads to daily updated swap curves, TRACE reports Spreads to daily updated swap curves, spreads derived from trade prices and broker quotes, bid side prices, new issue data, collateral performance, analysis of prepayment speeds, cash flows, collateral loss analytics, historical issue analysis, trade data from market makers, TRACE reports • Internal models: A portion of our U.S. corporate and non-U.S. corporate securities are valued using internal models. The fair value of these fixed maturity securities was $1,578 million and $796 million, respectively, as of December 31, 2023. Internally modeled securities are primarily private fixed maturity securities where we use market observable inputs such as an interest rate yield curve, published credit spreads for similar securities based on the external ratings of the instrument and related industry sector of the issuer. Additionally, we may apply certain price caps and liquidity premiums in the valuation of private fixed maturity securities. Price caps and liquidity premiums are established using inputs from market participants. Equity securities. The primary inputs to the valuation include quoted prices for identical assets, or similar assets in markets that are not active. Short-term investments. The fair value of short-term investments classified as Level 2 is determined after considering prices obtained by pricing services. Level 3 measurements Fixed maturity securities • Broker quotes: A portion of our state and political subdivisions, U.S. corporate, non-U.S. corporate, residential mortgage-backed, commercial mortgage-backed and other asset-backed securities are valued using broker quotes. Broker quotes are obtained from third-party providers that have current market knowledge to provide a reasonable price for securities not routinely priced by pricing services. Brokers utilized for valuation of assets are reviewed annually. The fair value of our Level 3 fixed maturity securities priced by broker quotes was $221 million as of December 31, 2023. • Internal models: A portion of our state and political subdivisions, U.S. corporate, non-U.S. corporate, residential mortgage-backed and other asset-backed securities are valued using internal models. The primary inputs to the valuation of the bond population include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, duration, call provisions, issuer rating, benchmark yields and credit spreads. Certain private fixed maturity securities are valued using an internal model using market observable inputs such as the interest rate yield curve, as well as published credit spreads for similar securities, which includes significant unobservable inputs. Additionally, we may apply certain price caps and liquidity premiums in the valuation of private fixed maturity securities. Price caps are established using inputs from market participants. For structured securities, the primary inputs to the valuation include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, weighted-average coupon, weighted- average maturity, issuer rating, structure of the security, expected prepayment speeds and volumes, collateral type, current and forecasted loss severity, average delinquency rates, vintage of the loans, geographic region, debt service coverage ratios, payment priority with the tranche, benchmark yields and credit spreads. The fair value of our Level 3 fixed maturity securities priced using internal models was $2,875 million as of December 31, 2023. Equity securities. The primary inputs to the valuation include broker quotes where the underlying inputs are unobservable and for internal models, structure of the security and issuer rating. 225 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table presents a summary of the significant inputs used by our pricing services for certain fair value measurements of fixed maturity securities that are classified as Level 2 as of December 31, 2023: (Amounts in millions) Fair value Primary methodologies Significant inputs U.S. government, agencies and government- sponsored enterprises . . . . . . . . . . . . . . . . . . $ 3,494 feeds issuer spread State and political subdivisions . . . . . . . . . . . . $ 2,242 vendors broker quotes Matrix pricing, spread Benchmark yields, trade prices, broker Non-U.S. government . . . . . . . . . . . . . . . . . . . . $ 626 Price quotes from trading desk, broker Multi-dimensional attribute-based modeling systems, third-party pricing priced to benchmark curves, price quotes from market makers Multi-dimensional attribute-based modeling systems, broker quotes, price quotes from market makers, OAS-based Multi-dimensional attribute-based modeling systems, OAS-based models, price quotes from Bid side prices, trade prices, Option Adjusted Spread (“OAS”) to swap curve, Bond Market Association OAS, Treasury Curve, Agency Bullet Curve, maturity to Trade prices, material event notices, Municipal Market Data benchmark yields, quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources Bid side prices to Treasury Curve, Issuer Curve, which includes sector, quality, duration, OAS percentage and change for spread matrix, trade prices, comparative transactions, Trade Reporting and Compliance Engine (“TRACE”) reports Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources Prepayment and default assumptions, aggregation of bonds with similar characteristics, including collateral type, vintage, tranche type, weighted-average OAS-based models, single factor binomial life, weighted-average loan age, issuer models, internally program and delinquency ratio, pay up and Multi-dimensional attribute-based modeling systems, pricing matrix, spread matrix priced to swap curves, Trepp Credit risk, interest rate risk, prepayment speeds, new issue data, collateral performance, origination year, tranche type, original credit ratings, weighted-average commercial mortgage- life, cash flows, spreads derived from backed securities analytics model broker quotes, bid side prices, spreads to daily updated swap curves, TRACE reports Multi-dimensional attribute-based modeling systems, Spreads to daily updated swap curves, spreads derived from trade prices and broker quotes, bid side prices, new issue data, collateral performance, analysis of spread matrix priced to prepayment speeds, cash flows, collateral swap curves, price quotes from market loss analytics, historical issue analysis, trade data from market makers, TRACE U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . . $24,317 models Non-U.S. corporate . . . . . . . . . . . . . . . . . . . . . . $ 6,185 market makers Residential mortgage-backed . . . . . . . . . . . . . . $ 904 priced pay down factors, TRACE reports Commercial mortgage-backed . . . . . . . . . . . . . $ 1,407 • Internal models: A portion of our U.S. corporate and non-U.S. corporate securities are valued using internal models. The fair value of these fixed maturity securities was $1,578 million and $796 million, respectively, as of December 31, 2023. Internally modeled securities are primarily private fixed maturity securities where we use market observable inputs such as an interest rate yield curve, published credit spreads for similar securities based on the external ratings of the instrument and related industry sector of the issuer. Additionally, we may apply certain price caps and liquidity premiums in the valuation of private fixed maturity securities. Price caps and liquidity premiums are established using inputs from market participants. Equity securities. The primary inputs to the valuation include quoted prices for identical assets, or similar assets in markets that are not active. Short-term investments. The fair value of short-term investments classified as Level 2 is determined after considering prices obtained by pricing services. Level 3 measurements Fixed maturity securities • Broker quotes: A portion of our state and political subdivisions, U.S. corporate, non-U.S. corporate, residential mortgage-backed, commercial mortgage-backed and other asset-backed securities are valued using broker quotes. Broker quotes are obtained from third-party providers that have current market knowledge to provide a reasonable price for securities not routinely priced by pricing services. Brokers utilized for valuation of assets are reviewed annually. The fair value of our Level 3 fixed maturity securities priced by broker quotes was $221 million as of December 31, 2023. • Internal models: A portion of our state and political subdivisions, U.S. corporate, non-U.S. corporate, residential mortgage-backed and other asset-backed securities are valued using internal models. The primary inputs to the valuation of the bond population include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, duration, call provisions, issuer rating, benchmark yields and credit spreads. Certain private fixed maturity securities are valued using an internal model using market observable inputs such as the interest rate yield curve, as well as published credit spreads for similar securities, which includes significant unobservable inputs. Additionally, we may apply certain price caps and liquidity premiums in the valuation of private fixed maturity securities. Price caps are established using inputs from market participants. For structured securities, the primary inputs to the valuation include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, weighted-average coupon, weighted- average maturity, issuer rating, structure of the security, expected prepayment speeds and volumes, collateral type, current and forecasted loss severity, average delinquency rates, vintage of the loans, geographic region, debt service coverage ratios, payment priority with the tranche, benchmark yields and credit spreads. The fair value of our Level 3 fixed maturity securities priced using internal models was $2,875 million as of December 31, 2023. Equity securities. The primary inputs to the valuation include broker quotes where the underlying inputs are unobservable and for internal models, structure of the security and issuer rating. Other asset-backed . . . . . . . . . . . . . . . . . . . . . . $ 2,136 makers reports 224 225 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Limited partnerships. The fair value of limited partnerships classified as Level 3 is determined based on third-party valuation sources that utilize unobservable inputs, such as a reference to public market or private transactions, valuations for comparable companies or assets, discounted cash flows and/or recent transactions. Short-term investments. The primary inputs to the valuation include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, duration, call provisions, issuer rating, benchmark yields and credit spreads. Certain securities are valued using an internal model using market observable inputs such as the interest rate yield curve, as well as published credit spreads for similar securities, which include significant unobservable inputs. Net asset value Limited partnerships. Limited partnerships are valued based on comparable market transactions, discounted future cash flows, quoted market prices and/or estimates using the most recent data available for the underlying instrument. We utilize the NAV from the underlying fund statements as a practical expedient for fair value. Market risk benefits MRBs are contracts or contract features that provide protection to the contractholder from and expose us to other-than-nominal capital market risk. MRBs include certain contract features on fixed and variable annuity products that provide minimum guarantees, in addition to the policyholder account balance, such as GMDBs, GMWBs and GPAFs. MRBs are measured at fair value using an income-based valuation model based on current net amounts at risk, market data, experience and other factors. See note 2 for a discussion of our policy for recording changes in fair value of MRBs. MRB assets and liabilities for minimum guarantees are valued and presented separately from the related separate account and policyholder account balances. Fixed indexed annuities The valuation of fixed indexed annuities MRBs, which includes GMWB features, is based on an income approach that incorporates inputs such as policyholder behavior (GMWB utilization, lapses and mortality), equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance risk and risk margins. Our discount rate used to determine fair value of our fixed indexed annuities MRBs includes market credit spreads above U.S. Treasury rates to reflect an adjustment for the non-performance risk of the fixed indexed annuities MRBs. We determine fair value using an internal model based on the various inputs noted above. As a result of our assumptions for GMWB utilization, expected future interest credited and non-performance risk being considered significant unobservable inputs, we classify these instruments as Level 3. As expected future interest credited decreases or GMWB utilization increases, the value of our fixed indexed annuities MRB liability will increase. Any increase in non-performance risk would increase the discount rate and would decrease the fair value of the liability. As of December 31, 2023, a significant change in the unobservable inputs discussed above would have resulted in a significantly lower or higher fair value measurement. Refer to note 13 for additional details related to the changes in the fair value measurement of fixed indexed annuities MRBs as of December 31, 2023 and 2022. Variable annuities The valuation of our variable annuities MRBs, which includes GMWB, GMDB and GPAF features, is based on an income approach that incorporates inputs such as policyholder behavior (GMWB utilization, lapses and mortality), equity index volatility, interest rates, equity index and fund correlation and an adjustment to the discount rate to incorporate non-performance risk and risk margins. Our discount rate used to determine fair value of our variable annuities MRBs includes market credit spreads above U.S. Treasury rates to reflect an adjustment for the non-performance risk of the variable annuities MRBs. We determine fair value using an internal model based on the various inputs noted above. We classify the variable annuities MRBs valuation as Level 3 based on having significant unobservable inputs, with policyholder behavior (GMWB utilization and lapses), equity index volatility and non-performance risk being considered the more significant unobservable inputs. As equity index volatility increases, the fair value of the variable annuities MRBs will increase. An increase in our lapse assumption would decrease the fair value of the variable annuities MRBs, whereas an increase in our GMWB utilization rate would increase the fair value. Any increase in non-performance risk would increase the discount rate and would decrease the fair value of the liability. As of December 31, 2023, a significant change in the unobservable inputs discussed above would have resulted in a significantly lower or higher fair value measurement. Refer to note 13 for additional details related to the changes in the fair value measurement of variable annuities MRBs as of December 31, 2023 and 2022. Derivatives We consider counterparty collateral arrangements and rights of set-off when evaluating our net credit risk exposure to our derivative counterparties. Accordingly, we are permitted to include consideration of these arrangements when determining whether any incremental adjustment should be made for both the counterparty’s and our non-performance risk in measuring fair value for our derivative instruments. As a result of these counterparty arrangements, we determined that any adjustment for credit risk would not be material and we have not recorded any incremental adjustment for our non-performance risk or the non-performance risk of the derivative counterparty for our derivative assets or liabilities. Interest rate swaps. The valuation of interest rate swaps is determined using an income approach. The primary input into the valuation represents the forward interest rate swap curve, which is generally considered an observable input, and results in the derivative being classified as Level 2. For certain interest rate swaps, the inputs into the valuation also include the total returns of certain bonds that would primarily be considered an observable input and result in the derivative being classified as Level 2. Foreign currency swaps. The valuation of foreign currency swaps is determined using an income approach. The primary inputs into the valuation represent the forward interest rate swap curve and foreign currency exchange rates, both of which are considered observable inputs, and results in the derivative being classified as Level 2. Equity index options. We have equity index options associated with various equity indices. The valuation of equity index options is determined using an income approach. The primary inputs into the valuation represent forward interest rates, equity index volatility, equity index and time value component associated with the optionality in the derivative. The equity index volatility surface is determined based on market information that is not readily observable and is developed based upon inputs received from several third-party sources. Accordingly, these options are classified as Level 3. As of December 31, 2023, a significant increase (decrease) in the equity index volatility discussed above would have resulted in a significantly higher (lower) fair value measurement. 226 227 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Limited partnerships. The fair value of limited partnerships classified as Level 3 is determined based on third-party valuation sources that utilize unobservable inputs, such as a reference to public market or private transactions, valuations for comparable companies or assets, discounted cash flows and/or recent transactions. Short-term investments. The primary inputs to the valuation include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, duration, call provisions, issuer rating, benchmark yields and credit spreads. Certain securities are valued using an internal model using market observable inputs such as the interest rate yield curve, as well as published credit spreads for similar securities, which include significant unobservable inputs. Limited partnerships. Limited partnerships are valued based on comparable market transactions, discounted future cash flows, quoted market prices and/or estimates using the most recent data available for the underlying instrument. We utilize the NAV from the underlying fund statements as a practical expedient for fair value. Net asset value Market risk benefits MRBs are contracts or contract features that provide protection to the contractholder from and expose us to other-than-nominal capital market risk. MRBs include certain contract features on fixed and variable annuity products that provide minimum guarantees, in addition to the policyholder account balance, such as GMDBs, GMWBs and GPAFs. MRBs are measured at fair value using an income-based valuation model based on current net amounts at risk, market data, experience and other factors. See note 2 for a discussion of our policy for recording changes in fair value of MRBs. MRB assets and liabilities for minimum guarantees are valued and presented separately from the related separate account and policyholder account balances. Fixed indexed annuities The valuation of fixed indexed annuities MRBs, which includes GMWB features, is based on an income approach that incorporates inputs such as policyholder behavior (GMWB utilization, lapses and mortality), equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance risk and risk margins. Our discount rate used to determine fair value of our fixed indexed annuities MRBs includes market credit spreads above U.S. Treasury rates to reflect an adjustment for the non-performance risk of the fixed indexed annuities MRBs. We determine fair value using an internal model based on the various inputs noted above. As a result of our assumptions for GMWB utilization, expected future interest credited and non-performance risk being considered significant unobservable inputs, we classify these instruments as Level 3. As expected future interest credited decreases or GMWB utilization increases, the value of our fixed indexed annuities MRB liability will increase. Any increase in non-performance risk would increase the discount rate and would decrease the fair value of the liability. As of December 31, 2023, a significant change in the unobservable inputs discussed above would have resulted in a significantly lower or higher fair value measurement. Refer to note 13 for additional details related to the changes in the fair value measurement of fixed indexed annuities MRBs as of December 31, 2023 and 2022. Variable annuities The valuation of our variable annuities MRBs, which includes GMWB, GMDB and GPAF features, is based on an income approach that incorporates inputs such as policyholder behavior (GMWB utilization, lapses and mortality), equity index volatility, interest rates, equity index and fund correlation and an adjustment to the discount rate to incorporate non-performance risk and risk margins. Our discount rate used to determine fair value of our variable annuities MRBs includes market credit spreads above U.S. Treasury rates to reflect an adjustment for the non-performance risk of the variable annuities MRBs. We determine fair value using an internal model based on the various inputs noted above. We classify the variable annuities MRBs valuation as Level 3 based on having significant unobservable inputs, with policyholder behavior (GMWB utilization and lapses), equity index volatility and non-performance risk being considered the more significant unobservable inputs. As equity index volatility increases, the fair value of the variable annuities MRBs will increase. An increase in our lapse assumption would decrease the fair value of the variable annuities MRBs, whereas an increase in our GMWB utilization rate would increase the fair value. Any increase in non-performance risk would increase the discount rate and would decrease the fair value of the liability. As of December 31, 2023, a significant change in the unobservable inputs discussed above would have resulted in a significantly lower or higher fair value measurement. Refer to note 13 for additional details related to the changes in the fair value measurement of variable annuities MRBs as of December 31, 2023 and 2022. Derivatives We consider counterparty collateral arrangements and rights of set-off when evaluating our net credit risk exposure to our derivative counterparties. Accordingly, we are permitted to include consideration of these arrangements when determining whether any incremental adjustment should be made for both the counterparty’s and our non-performance risk in measuring fair value for our derivative instruments. As a result of these counterparty arrangements, we determined that any adjustment for credit risk would not be material and we have not recorded any incremental adjustment for our non-performance risk or the non-performance risk of the derivative counterparty for our derivative assets or liabilities. Interest rate swaps. The valuation of interest rate swaps is determined using an income approach. The primary input into the valuation represents the forward interest rate swap curve, which is generally considered an observable input, and results in the derivative being classified as Level 2. For certain interest rate swaps, the inputs into the valuation also include the total returns of certain bonds that would primarily be considered an observable input and result in the derivative being classified as Level 2. Foreign currency swaps. The valuation of foreign currency swaps is determined using an income approach. The primary inputs into the valuation represent the forward interest rate swap curve and foreign currency exchange rates, both of which are considered observable inputs, and results in the derivative being classified as Level 2. Equity index options. We have equity index options associated with various equity indices. The valuation of equity index options is determined using an income approach. The primary inputs into the valuation represent forward interest rates, equity index volatility, equity index and time value component associated with the optionality in the derivative. The equity index volatility surface is determined based on market information that is not readily observable and is developed based upon inputs received from several third-party sources. Accordingly, these options are classified as Level 3. As of December 31, 2023, a significant increase (decrease) in the equity index volatility discussed above would have resulted in a significantly higher (lower) fair value measurement. 226 227 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Financial futures. The fair value of financial futures is based on the closing exchange prices. Accordingly, these financial futures are classified as Level 1. The period end valuation is zero as a result of settling the margins on these contracts on a daily basis. Forward bond purchase commitments. The valuation of forward bond purchase commitments is determined using an income approach. The primary inputs into the valuation represent current bond prices and interest rates, as well as an estimate of the cost of counterparty financing to acquire and carry the bond during the forward period. The estimated cost of counterparty financing is not readily observable and is developed based upon an assumed spread; accordingly, these derivatives are classified as Level 3. Fixed indexed annuity and indexed universal life embedded derivatives We have fixed indexed annuity and indexed universal life insurance products where interest is credited to the policyholder’s account balance based on equity index changes. This feature is required to be bifurcated as an embedded derivative and recorded at fair value. Fair value is determined using an income approach where the present value of the excess cash flows above the guaranteed cash flows is used to determine the value attributed to the equity index feature. The inputs used in determining the fair value include policyholder behavior (lapses and withdrawals), near-term equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance risk and risk margins. As a result of our assumptions for expected future interest credited being considered significant unobservable inputs, we classify these instruments as Level 3. As expected future interest credited decreases, the value of our embedded derivative liability will decrease. As of December 31, 2023, a significant change in the unobservable inputs discussed above would have resulted in a significantly lower or higher fair value measurement. The following tables set forth our assets by class of instrument that are measured at fair value on a recurring basis as of December 31: (Amounts in millions) Assets Investments: Fixed maturity securities: Total U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27,985 25,895 2,090 U.S. government, agencies and government-sponsored enterprises . . . . . $ 3,494 $ — $ 3,494 $ — $ — State and political subdivisions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-U.S. government . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total non-U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Residential mortgage-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other asset-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other invested assets: Derivative assets: Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Equity index options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . . . . . . . . . . . . . . . . . . Total derivative assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Short-term investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2023 Total Level 1 Level 2 Level 3 NAV(1) 2,302 626 4,273 2,372 7,278 4,505 3,023 1,233 2,181 1,649 1,162 309 685 1,027 1,948 616 891 797 561 221 364 701 7,811 907 1,418 2,238 55 10 15 51 131 27 158 — — — — — — — — — — — — — — — — — — — — — — — — — — — — 321 — — — — — — — — 2,242 626 3,392 2,312 6,561 4,436 3,011 1,210 2,146 1,527 1,140 160 416 896 1,814 535 867 734 508 220 342 649 6,981 904 1,407 2,136 43 — 55 10 — — 65 20 85 60 — 881 60 717 69 12 23 35 122 22 149 269 131 134 81 24 63 53 1 22 52 830 3 11 102 — — 15 51 66 7 73 — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — Total fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46,781 43,685 3,096 Equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 396 2,193 32 20 — 2,173 Separate account assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,509 4,509 — — Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $54,037 $4,830 $43,813 $3,221 $2,173 (1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. 228 229 Financial futures. The fair value of financial futures is based on the closing exchange prices. Accordingly, these financial futures are classified as Level 1. The period end valuation is zero as a result of settling the margins on these contracts on a daily basis. Forward bond purchase commitments. The valuation of forward bond purchase commitments is determined using an income approach. The primary inputs into the valuation represent current bond prices and interest rates, as well as an estimate of the cost of counterparty financing to acquire and carry the bond during the forward period. The estimated cost of counterparty financing is not readily observable and is developed based upon an assumed spread; accordingly, these derivatives are classified as Level 3. Fixed indexed annuity and indexed universal life embedded derivatives We have fixed indexed annuity and indexed universal life insurance products where interest is credited to the policyholder’s account balance based on equity index changes. This feature is required to be bifurcated as an embedded derivative and recorded at fair value. Fair value is determined using an income approach where the present value of the excess cash flows above the guaranteed cash flows is used to determine the value attributed to the equity index feature. The inputs used in determining the fair value include policyholder behavior (lapses and withdrawals), near-term equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance risk and risk margins. As a result of our assumptions for expected future interest credited being considered significant unobservable inputs, we classify these instruments as Level 3. As expected future interest credited decreases, the value of our embedded derivative liability will decrease. As of December 31, 2023, a significant change in the unobservable inputs discussed above would have resulted in a significantly lower or higher fair value measurement. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following tables set forth our assets by class of instrument that are measured at fair value on a recurring basis as of December 31: (Amounts in millions) Assets Investments: Fixed maturity securities: 2023 Total Level 1 Level 2 Level 3 NAV(1) U.S. government, agencies and government-sponsored enterprises . . . . . State and political subdivisions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-U.S. government . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U.S. corporate: $ 3,494 2,302 626 $ — — — $ 3,494 2,242 626 $ — 60 — $ — — — Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,273 2,372 7,278 4,505 3,023 1,233 2,181 1,649 1,162 309 Total U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27,985 Non-U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total non-U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Residential mortgage-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other asset-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 685 1,027 1,948 616 891 797 561 221 364 701 7,811 907 1,418 2,238 Total fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46,781 Equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other invested assets: Derivative assets: Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Equity index options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . . . . . . . . . . . . . . . . . . Total derivative assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Short-term investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 396 2,193 55 10 15 51 131 27 158 — — — — — — — — — — — — — — — — — — — — — — — — — — 321 — — — — — — — — 3,392 2,312 6,561 4,436 3,011 1,210 2,146 1,527 1,140 160 881 60 717 69 12 23 35 122 22 149 25,895 2,090 416 896 1,814 535 867 734 508 220 342 649 6,981 904 1,407 2,136 269 131 134 81 24 63 53 1 22 52 830 3 11 102 43,685 3,096 — — — — — — — — — — — — — — — — — — — — — — — — — — 32 20 — 2,173 43 — 55 10 — — 65 20 85 — — 15 51 66 7 73 — — — — — — — — 228 229 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $54,037 $4,830 $43,813 $3,221 $2,173 (1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. Separate account assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,509 4,509 — — GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (Amounts in millions) Assets Investments: Fixed maturity securities: 2022 Total Level 1 Level 2 Level 3 NAV(1) The following tables present additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of and for the dates indicated: U.S. government, agencies and government-sponsored enterprises . . . . . State and political subdivisions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-U.S. government . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U.S. corporate: $ 3,341 2,399 645 $ — — — $ 3,341 2,344 645 $ — 55 — $ — — — Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,898 2,262 7,193 4,457 2,947 1,197 2,138 1,617 1,100 310 Total U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27,119 Non-U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total non-U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Residential mortgage-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other asset-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 740 960 1,946 566 894 818 546 276 375 889 8,010 995 1,908 2,166 Total fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46,583 Equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other invested assets: Derivative assets: 319 1,816 Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Equity index options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total derivative assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Short-term investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 20 6 50 3 53 — — — — — — — — — — — — — — — — — — — — — — — — — — 239 — — — — — — — 3,056 2,146 6,506 4,375 2,923 1,175 2,104 1,504 1,057 151 842 116 687 82 24 22 34 113 43 159 24,997 2,122 445 842 1,821 493 868 770 451 212 355 868 7,125 973 1,896 2,072 295 118 125 73 26 48 95 64 20 21 885 22 12 94 43,393 3,190 — — — — — — — — — — — — — — — — — — — — — — — — — — 46 — 24 20 — 44 3 47 34 24 — 1,792 — — 6 6 — 6 — — — — — — — — Separate account assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,417 4,417 — Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $53,188 $4,656 $43,486 $3,254 $1,792 Total Level 3 assets . . . . . . . . . . . . . $3,254 $13 $165 $292 $(66) $— $(334) $(170) $3,221 $143 (1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. 230 Total U.S. corporate . . . . . 2,122 — 75 179 (41) — (139) (130) 2,090 61 Beginning balance as of January 1, 2023 Total realized and unrealized gains (losses) Included in net income Included in OCI Purchases Sales Issuances Settlements Level 3(1) Level 3(1) 2023 Transfer Transfer into out of balance as of December 31, Ending Total gains (losses) attributable to assets still held Included in net income Included in OCI subdivisions . . . . . . . . . . . . . Non-U.S. government . . . . . . . . $55 $4 — — $1 — $— $— $— — — — $— (1) $— 1 $— — (Amounts in millions) Fixed maturity securities: State and political U.S. corporate: Utilities . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . Finance and insurance . . . Consumer—non-cyclical . Technology and communications . . . . . Industrial . . . . . . . . . . . . . Capital goods . . . . . . . . . . Consumer—cyclical . . . . . Transportation . . . . . . . . . Other . . . . . . . . . . . . . . . . Non-U.S. corporate: Utilities . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . Finance and insurance . . . Consumer—non-cyclical . Technology and communications . . . . . Industrial . . . . . . . . . . . . . Capital goods . . . . . . . . . . Consumer—cyclical . . . . . Transportation . . . . . . . . . Other . . . . . . . . . . . . . . . . Total non-U.S. 842 — 116 — 687 — 82 — 24 — 22 — 34 — 113 — 43 — 159 — 295 — 118 — 125 5 73 — 26 — 48 — 95 1 64 — 20 — 21 — corporate . . . . . . . . . . . 885 6 Residential mortgage-backed . . 22 — Commercial mortgage-backed . . . . . . . . . Other asset-backed . . . . . . . . . . 12 — 94 — Total fixed maturity securities . . . . . . . . . . . . . . . 3,190 10 Equity securities . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . 34 — 24 (3) Other invested assets: Derivative assets: Equity index options . . . . Forward bond purchase commitments . . . . . . . . Total derivative assets . . . Short-term investments . . . . . . . Total other invested assets . . . . 6 6 6 6 6 6 — — 33 4 28 2 — 1 1 4 1 1 6 4 4 2 4 5 7 1 3 — 36 1 (1) 2 114 — — — 51 51 — 51 (16) (3) (64) (15) — — — (8) (22) (11) (58) (2) — (1) (2) (15) (37) (64) — — (179) (1) — (4) (324) — (1) (9) — (9) — (9) 11 — — — — — — 13 — — 24 30 11 — — — 1 — — — — 42 — — — 67 — — — — — — — $67 (36) (56) (26) — (12) — — — — — (8) — — — — — — — — — (8) (19) — (13) — — — — — — — $60 — 881 60 717 69 12 23 35 122 22 149 269 131 134 81 24 63 53 1 22 52 830 3 11 102 32 20 15 51 66 7 73 $1 — 24 3 24 2 — 1 1 4 1 1 5 4 4 2 4 3 2 1 3 — 28 — — 2 92 — — — 51 51 — 51 $4 — — — — — — — — — — — — — — 5 — — — — — — — 5 — — — 9 — (3) 3 — 3 — 3 $9 (170) 3,096 87 — (40) — (1) — 92 — — — — — — — — — — — — — — — — — — — — — — — 4 — — — — — — — — 7 — — — — — 25 — — 1 — (12) — (6) — 1 — — 28 — — 66 (18) — — — — — — — 23 — — 268 (59) — 5 (7) — — — — 12 — — 12 — — 7 — — 19 — — 231 — — — — — (Amounts in millions) Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises . . . . . $ 3,341 $ — $ 3,341 $ — $ — Total U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27,119 24,997 2,122 State and political subdivisions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-U.S. government . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-U.S. corporate: Utilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finance and insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—non-cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Technology and communications . . . . . . . . . . . . . . . . . . . . . . . . . . . Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Capital goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consumer—cyclical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total non-U.S. corporate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Residential mortgage-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other asset-backed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other invested assets: Derivative assets: Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Equity index options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total derivative assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Short-term investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,399 645 3,898 2,262 7,193 4,457 2,947 1,197 2,138 1,617 1,100 310 740 960 1,946 566 894 818 546 276 375 889 8,010 995 1,908 2,166 319 1,816 24 20 6 50 3 53 — — — — — — — — — — — — — — — — — — — — — — — — — — — — 239 — — — — — — — 2,344 645 3,056 2,146 6,506 4,375 2,923 1,175 2,104 1,504 1,057 151 445 842 1,821 493 868 770 451 212 355 868 7,125 973 1,896 2,072 46 — 24 20 — 44 3 47 Total fixed maturity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46,583 43,393 3,190 55 — 842 116 687 82 24 22 34 113 43 159 295 118 125 73 26 48 95 64 20 21 885 22 12 94 34 24 — — 6 6 6 — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — 1,792 Separate account assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,417 4,417 — — Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $53,188 $4,656 $43,486 $3,254 $1,792 (1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 2022 Total Level 1 Level 2 Level 3 NAV(1) The following tables present additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of and for the dates indicated: Beginning balance as of January 1, 2023 Total realized and unrealized gains (losses) Included in net income Included in OCI Purchases Sales Issuances Settlements Transfer into Level 3(1) Transfer out of Level 3(1) Ending balance as of December 31, 2023 Total gains (losses) attributable to assets still held Included in net income Included in OCI $55 $4 — — $1 — $— $— $— — — — $— (1) $— 1 $— — (Amounts in millions) Fixed maturity securities: State and political subdivisions . . . . . . . . . . . . . Non-U.S. government . . . . . . . . U.S. corporate: Utilities . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . Finance and insurance . . . Consumer—non-cyclical . Technology and communications . . . . . Industrial . . . . . . . . . . . . . Capital goods . . . . . . . . . . Consumer—cyclical . . . . . Transportation . . . . . . . . . Other . . . . . . . . . . . . . . . . 842 — 116 — 687 — 82 — 24 — 22 — 34 — 113 — 43 — 159 — Total U.S. corporate . . . . . 2,122 — Non-U.S. corporate: Utilities . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . Finance and insurance . . . Consumer—non-cyclical . Technology and communications . . . . . Industrial . . . . . . . . . . . . . Capital goods . . . . . . . . . . Consumer—cyclical . . . . . Transportation . . . . . . . . . Other . . . . . . . . . . . . . . . . Total non-U.S. 295 — 118 — 5 125 73 — 26 — 48 — 95 1 64 — 20 — 21 — corporate . . . . . . . . . . . 885 6 Residential mortgage-backed . . Commercial mortgage-backed . . . . . . . . . Other asset-backed . . . . . . . . . . Total fixed maturity 22 — 12 — 94 — securities . . . . . . . . . . . . . . . 3,190 10 Equity securities . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . Other invested assets: Derivative assets: Equity index options . . . . Forward bond purchase commitments . . . . . . . . Total derivative assets . . . Short-term investments . . . . . . . 34 — (3) 24 6 6 — — 6 6 — — Total other invested assets . . . . 6 Total Level 3 assets . . . . . . . . . . . . . $3,254 6 $13 33 4 28 2 — 1 1 4 1 1 75 6 4 4 2 — 4 5 7 1 3 36 1 (1) 2 114 — — — 51 51 — 51 87 — (40) — (1) — 92 — — — — — — — — — — — — — — — — — — — — — — — (16) (3) (64) (15) — — — (8) (22) (11) 179 (41) — (139) 4 — — — — — — — — 7 — — — — — 25 — — (12) — 1 (6) — — 1 — — 28 — — 66 (18) — — — — — — — 23 — — 268 (59) — 5 (7) — — — — 12 — — — — — 12 — — 7 — — 19 — — (58) (2) — (1) (2) (15) (37) (64) — — (179) (1) — (4) (324) — (1) (9) — (9) — (9) $165 $292 $(66) $— $(334) 11 — — — — — — 13 — — 24 30 11 — — — 1 — — — — 42 — — — 67 — — — — — — — $67 $60 — 881 60 717 69 12 23 35 122 22 149 (36) (56) (26) — (12) — — — — — (130) 2,090 (8) — — — — — — — — — (8) (19) — (13) 269 131 134 81 24 63 53 1 22 52 830 3 11 102 (170) 3,096 — — — — — — — 32 20 15 51 66 7 73 $(170) $3,221 $4 — — — — — — — — — — — — — — 5 — — — — — — — 5 — — — 9 — (3) 3 — 3 — 3 $9 $1 — 24 3 24 2 — 1 1 4 1 1 61 5 4 4 2 — 4 3 2 1 3 28 — — 2 92 — — — 51 51 — 51 $143 230 231 (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Total realized and unrealized gains (losses) Included in net income Included in OCI Purchases Sales Issuances Settlements Transfer into Level 3(1) Transfer out of Level 3(1) Ending balance as of December 31, 2022 Total gains (losses) attributable to assets still held Included in net income Included in OCI $— 2 $— $— (3) — $— (1) $— — $— — (Amounts in millions) Fixed maturity securities: State and political subdivisions . . . . . . . . . . . . . Non-U.S. government . . . . . . . . U.S. corporate: Utilities . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . Finance and insurance . . . Consumer—non-cyclical . Technology and communications . . . . . . Industrial . . . . . . . . . . . . . Capital goods . . . . . . . . . . Consumer—cyclical . . . . . Transportation . . . . . . . . . Other . . . . . . . . . . . . . . . . Beginning balance as of January 1, 2022 $82 2 950 76 685 104 29 37 45 137 64 254 Total U.S. corporate . . . . . 2,381 Non-U.S. corporate: Utilities . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . Finance and insurance . . . Consumer—non-cyclical . Technology and communications . . . . . . Industrial . . . . . . . . . . . . . Capital goods . . . . . . . . . . Consumer—cyclical . . . . . Transportation . . . . . . . . . Other . . . . . . . . . . . . . . . . Total non-U.S. 345 145 160 63 28 93 173 76 53 26 $3 — — — — — — — — — — — — — — 5 — — — — — — — $(30) — (211) (19) (147) (13) (5) (4) (7) (18) (8) (27) 130 — — — — — 216 — — — — — — — — — — — — — — — — — 5 — — (41) — — (459) 351 (41) — (56) (15) (40) (8) (2) (33) (16) (15) (3) (5) 24 — — 13 (21) — — — — 9 — — — — — 22 — — — (10) — — — — — — — — — — (19) (9) (19) (9) — (11) (4) (6) (5) (10) (92) (18) (24) — — — (20) (52) — (30) — corporate . . . . . . . . . . . 1,162 5 (193) 68 (31) — (144) Residential mortgage-backed Commercial . . mortgage-backed . . . . . . . . . Other asset-backed . . . . . . . . . . Total fixed maturity 27 — (8) 14 — — 16 138 — — (5) (15) — — — (6) — 77 (2) — (7) securities . . . . . . . . . . . . . . . 3,808 8 (710) 512 (81) — (246) Equity securities . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . Other invested assets: Derivative assets: Equity index options . . . . . Total derivative assets . . . Total other invested assets . . . . . 37 26 42 42 42 — (2) (20) (20) (20) — — — — — 1 (3) — — — — 13 — — 13 — — 13 — — — — (29) (29) (29) $55 — 842 116 687 82 24 22 34 113 43 159 2,122 295 118 125 73 26 48 95 64 20 21 885 22 12 94 $3 — — — — — — — — — — — — — — 5 — — — — — — — $(31) — (210) (20) (141) (13) (5) (4) (7) (18) (7) (28) (453) (55) (15) (41) (8) (2) (31) (16) (16) (3) (4) 5 (191) — — — (6) (6) (13) (11) — (56) — — — — — (13) (17) (97) — — — (9) — (14) — (14) — — (37) (13) — (93) (240) 3,190 8 (700) (1) — — — — 34 24 6 6 6 — (2) (7) (7) (7) — — — — — 3 68 8 — — — — — — — 79 — 20 — 18 — — — 17 — — 55 4 1 — 139 — — — — — NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Beginning balance as of January 1, 2021 Total realized and unrealized gains (losses) Included in net income Included in OCI Purchases Sales Issuances Settlements Level 3 (1) Level 3 (1) 2021 Transfer Transfer into out of balance as of December 31, Ending Total gains (losses) attributable to assets still held Included in net income Included in OCI Total U.S. corporate . . 2,272 430 — — (153) (289) 2,381 (Amounts in millions) Fixed maturity securities: State and political subdivisions . . . . . . . . . . . Non-U.S. government . . . . . U.S. corporate: Non-U.S. corporate: Utilities . . . . . . . . . . . . Energy . . . . . . . . . . . . Finance and insurance . . . . . . . . . Consumer—non- cyclical . . . . . . . . . . Technology and communications . . . Industrial . . . . . . . . . . . Capital goods . . . . . . . Consumer—cyclical . . Transportation . . . . . . . Other . . . . . . . . . . . . . . Utilities . . . . . . . . . . . . Energy . . . . . . . . . . . . Finance and insurance . . . . . . . . . Consumer—non- cyclical . . . . . . . . . . Technology and communications . . . Industrial . . . . . . . . . . . Capital goods . . . . . . . Consumer—cyclical . . Transportation . . . . . . . Other . . . . . . . . . . . . . . Total non-U.S. Residential mortgage-backed . . . . . . . Commercial mortgage- backed . . . . . . . . . . . . . . . Other asset-backed . . . . . . . . Total fixed maturity securities . . . . . . . . . . . . . 4,089 Equity securities . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . Other invested assets: Derivative assets: Equity index options . . Total derivative assets . . . . . . . . . . . Total other invested assets . . $66 — 842 128 607 109 47 40 60 150 70 219 352 245 305 67 28 95 178 146 109 83 14 20 109 51 17 63 63 63 $3 — — — — — — — — — — — — — — 3 1 — 2 — — 3 6 — — — 18 — 1 18 18 18 (1) — (1) — (1) (1) (17) (5) 7 (1) (2) — (4) 1 — (3) (3) — (2) — (16) — — — — — $13 — $— $— $— 2 — — $— — $— — 3 4 118 — — 50 — — (18) 233 — — (2) — — — 12 — — 17 — — — — — — — — — — — — — — 30 — — — — — 1 (2) — 8 — — — — — 14 — — 25 — — 17 — — — — — — — — (18) (10) (46) (3) — (20) (14) (5) (5) (32) (8) (28) (62) (14) — (14) — — (49) (45) $— — (13) (104) (108) (3) (33) — — (8) — (20) (24) (79) (84) — — — (31) (87) (7) (15) — — (50) (666) — — 18 8 17 3 4 — — — — 88 138 — — — 3 — — — — — — 10 — 35 186 — — $82 2 950 76 685 104 29 37 45 137 64 254 345 145 160 63 28 93 173 76 53 26 27 16 138 3,808 37 26 42 42 42 5 (14) $3 — — — — — — — — — — — — — — — — — — — — — — 1 — 9 — 1 10 10 10 $13 — 4 1 (16) (2) (1) (1) (2) — (1) 1 (17) (6) 3 (2) (1) (2) — — — (1) — (2) — (29) — — — — — 5 — — 1 — — 69 — — 602 — (2) — (9) — 8 — — (2) (3) (25) (403) (5) — 31 — — (70) — — 31 — — 31 — — (70) (70) — — — — corporate . . . . . . . . . 1,608 15 (10) 95 (2) — (220) 3 (327) 1,162 5 (23) Total Level 3 assets . . . . . . . . . . . . . . $3,913 $(14) $(710) $526 $(84) $— $(275) $139 $(241) $3,254 $(1) $(700) Total Level 3 assets . . . . . . . . . . . $4,220 $37 $(16) $641 $(11) $— $(478) $186 $(666) $3,913 $20 $(29) (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. 232 233 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Beginning balance as of January 1, 2022 Total realized and unrealized gains (losses) Included in net income Included in OCI Purchases Sales Issuances Settlements Level 3(1) Level 3(1) 2022 Transfer Transfer into out of balance as of December 31, Ending Total gains (losses) attributable to assets still held Included in net income Included in OCI $— $— $— 2 (3) — $— (1) $— — $— — (Amounts in millions) Fixed maturity securities: State and political subdivisions . . . . . . . . . . . . . Non-U.S. government . . . . . . . . U.S. corporate: Utilities . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . Finance and insurance . . . Consumer—non-cyclical . Technology and communications . . . . . . Industrial . . . . . . . . . . . . . Capital goods . . . . . . . . . . Consumer—cyclical . . . . . Transportation . . . . . . . . . Other . . . . . . . . . . . . . . . . Utilities . . . . . . . . . . . . . . Energy . . . . . . . . . . . . . . . Finance and insurance . . . Consumer—non-cyclical . Technology and communications . . . . . . Industrial . . . . . . . . . . . . . Capital goods . . . . . . . . . . Consumer—cyclical . . . . . Transportation . . . . . . . . . Other . . . . . . . . . . . . . . . . Total non-U.S. Total U.S. corporate . . . . . 2,381 Non-U.S. corporate: $82 2 950 76 685 104 29 37 45 137 64 254 345 145 160 63 28 93 173 76 53 26 $3 — — — — — — — — — — — — — — 5 — — — — — — — $(30) — (211) (19) (147) (13) (5) (4) (7) (18) (8) (27) (459) (56) (15) (40) (8) (2) (33) (16) (15) (3) (5) 130 — — — — — 216 — — — — — — — — — — — — — — — — — 5 — — — 351 (41) — (41) — 24 — — 13 (21) — — — — 9 — — — — — 22 — — — (10) — — — — — — — — — — Residential mortgage-backed . . 27 — (8) 14 — — mortgage-backed . . . . . . . . . Other asset-backed . . . . . . . . . . 16 138 — — (5) (15) — — — 77 (6) — Commercial Total fixed maturity Equity securities . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . Other invested assets: Derivative assets: Equity index options . . . . . Total derivative assets . . . Total other invested assets . . . . . 37 26 42 42 42 — (2) (20) (20) (20) — — — — — 1 (3) — — — — 13 — — 13 — — 13 — — (19) (9) (19) (9) — (11) (4) (6) (5) (10) (92) (18) (24) — — — (20) (52) — (30) — (2) — (7) — — (29) (29) (29) 3 68 8 — — — — — — — 79 — 20 — 18 — — — 17 — — 55 4 1 — 139 — — — — — (11) — (56) — — — — — (13) (17) (97) — — — (9) — (14) — (14) — — (37) (13) — (93) (1) — — — — 2,122 $55 — 842 116 687 82 24 22 34 113 43 159 295 118 125 73 26 48 95 64 20 21 885 22 12 94 34 24 6 6 6 $3 — — — — — — — — — — — — — — 5 — — — — — — — — — — — (2) (7) (7) (7) $(31) — (210) (20) (141) (13) (5) (4) (7) (18) (7) (28) (453) (55) (15) (41) (8) (2) (31) (16) (16) (3) (4) (6) (6) (13) — — — — — securities . . . . . . . . . . . . . . . 3,808 8 (710) 512 (81) — (246) (240) 3,190 8 (700) corporate . . . . . . . . . . . 1,162 5 (193) 68 (31) — (144) 5 (191) Total Level 3 assets . . . . . . . . . . . . . . $3,913 $(14) $(710) $526 $(84) $— $(275) $139 $(241) $3,254 $(1) $(700) (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (Amounts in millions) Fixed maturity securities: State and political subdivisions . . . . . . . . . . . Non-U.S. government . . . . . U.S. corporate: Utilities . . . . . . . . . . . . Energy . . . . . . . . . . . . Finance and insurance . . . . . . . . . Consumer—non- cyclical . . . . . . . . . . Technology and communications . . . Industrial . . . . . . . . . . . Capital goods . . . . . . . Consumer—cyclical . . Transportation . . . . . . . Other . . . . . . . . . . . . . . Beginning balance as of January 1, 2021 $66 — 842 128 607 109 47 40 60 150 70 219 Total U.S. corporate . . 2,272 Non-U.S. corporate: Utilities . . . . . . . . . . . . Energy . . . . . . . . . . . . Finance and insurance . . . . . . . . . Consumer—non- cyclical . . . . . . . . . . Technology and communications . . . Industrial . . . . . . . . . . . Capital goods . . . . . . . Consumer—cyclical . . Transportation . . . . . . . Other . . . . . . . . . . . . . . Total non-U.S. 352 245 305 67 28 95 178 146 109 83 $3 — — — — — — — — — — — — — — 3 1 — 2 — — 3 6 Total realized and unrealized gains (losses) Included in net income Included in OCI Purchases Sales Issuances Settlements Transfer into Level 3 (1) Transfer out of Level 3 (1) Ending balance as of December 31, 2021 Total gains (losses) attributable to assets still held Included in net income Included in OCI $— $— $— 2 — — $— — $— — $13 — 3 4 (1) — (1) — (1) (1) (17) (5) 7 (1) (2) — (4) 1 — (3) (3) 118 — — 50 — — (18) 233 — — (2) — — — (18) (10) (46) (3) — (20) (14) (5) (5) (32) 12 — — 17 — — — — — — — — — — — — — — 430 — — (153) 30 — — — — — 1 (2) — 8 — — — — — 14 — — 25 — — 17 — — — — — — — — (8) (28) (62) (14) — (14) — — (49) (45) $— — (13) (104) (108) (3) (33) — — (8) — (20) $82 2 950 76 685 104 29 37 45 137 64 254 (289) 2,381 (24) (79) (84) — — — (31) (87) (7) (15) 345 145 160 63 28 93 173 76 53 26 $3 — — — — — — — — — — — — — — $13 — 4 1 (16) (2) (1) (1) (2) — (1) 1 (17) (6) 3 5 (14) — — — — — — — (2) (1) (2) — — — (1) 18 8 17 3 4 — — — — 88 138 — — — 3 — — — — — — corporate . . . . . . . . . 1,608 15 (10) 95 (2) — (220) 3 (327) 1,162 5 (23) Residential mortgage-backed . . . . . . . Commercial mortgage- backed . . . . . . . . . . . . . . . Other asset-backed . . . . . . . . 14 20 109 Total fixed maturity securities . . . . . . . . . . . . . 4,089 Equity securities . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . Other invested assets: Derivative assets: Equity index options . . Total derivative assets . . . . . . . . . . . Total other invested assets . . 51 17 63 63 63 — — — 18 — 1 18 18 18 — (2) — (16) — — — — — 5 — — 1 — — 69 — — 602 (2) — — (9) — 8 — — (2) (3) (25) (403) (5) — 10 — 35 186 — — 31 — — (70) — 31 — — 31 — — (70) (70) — — — — (50) (666) — — — — — 27 16 138 3,808 37 26 42 42 42 — 1 — 9 — 1 10 10 10 — (2) — (29) — — — — — Total Level 3 assets . . . . . . . . . . . $4,220 $37 $(16) $641 $(11) $— $(478) $186 $(666) $3,913 $20 $(29) (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. 232 233 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table presents the gains and losses included in net income from assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: (Amounts in millions) 2023 2022 2021 Total realized and unrealized gains (losses) included in net income: Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 10 3 $ 8 (22) $19 18 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 13 $(14) $37 Total gains (losses) included in net income attributable to assets still held: Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 9 — $ 8 (9) $ 9 11 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 9 $ (1) $20 The amount presented for net investment income relates to fixed maturity securities and primarily represents amortization and accretion of premiums and discounts on certain fixed maturity securities. The following table presents a summary of the significant unobservable inputs used for certain asset fair value measurements that are based on internal models and classified as Level 3 as of December 31, 2023: (Amounts in millions) Valuation technique Fair value Unobservable input Range Weighted-average(1) Fixed maturity securities: U.S. corporate: Finance and Consumer—non- Technology and Utilities . . . . . . . . . . Internal models $ 851 Energy . . . . . . . . . . . Internal models 46 Credit spreads Credit spreads 58bps - 194bps 113bps - 218bps 136bps 163bps insurance . . . . . . . Internal models 707 Credit spreads 14bps - 248bps 168bps cyclical . . . . . . . . . Internal models Credit spreads 79bps - 224bps 138bps communications . . Internal models Industrial . . . . . . . . . Internal models Capital goods . . . . . . Internal models Consumer—cyclical . . Internal models Transportation . . . . . Internal models Other . . . . . . . . . . . . Internal models Credit spreads Credit spreads Credit spreads Credit spreads Credit spreads Credit spreads 65bps - 88bps 98bps - 181bps 85bps - 160bps 79bps - 171bps 44bps - 138bps 79bps - 115bps 74bps 125bps 131bps 123bps 98bps 90bps Total U.S. Non-U.S. corporate: Finance and Consumer—non- Technology and corporate . . . . . . . Internal models $1,988 Credit spreads 14bps - 248bps 144bps Utilities . . . . . . . . . . Internal models $ 214 Energy . . . . . . . . . . . Internal models Credit spreads Credit spreads 74bps - 194bps 88bps - 183bps 129bps 129bps insurance . . . . . . . Internal models Credit spreads 115bps - 197bps 132bps cyclical . . . . . . . . . Internal models Credit spreads 65bps - 146bps 101bps Credit spreads Credit spreads Credit spreads Credit spreads Credit spreads 98bps - 128bps 107bps - 183bps 65bps - 218bps 113bps - 146bps 58bps - 136bps 108bps 146bps 118bps 119bps 112bps communications . . Internal models Industrial . . . . . . . . . Internal models Capital goods . . . . . . Internal models Transportation . . . . . Internal models Other . . . . . . . . . . . . Internal models Total non-U.S. Derivative assets: Discounted cash corporate . . . . . . . Internal models $ 761 Credit spreads 58bps - 218bps 110bps Equity index options . . . . flows 15 Equity index volatility 6% - 24% 19% Forward bond purchase Discounted cash Counterparty financing commitments . . . . . . . . flows 51 $ $ spreads Lapse rate 35bps 2% - 10% Non-performance risk (counterparty credit risk) 42bps - 83bps Not applicable 5% 69bps 22% Other assets(2) . . . . . . . . . . . . . . Cash flow model $ 140 Equity index volatility 13% - 30% (1) Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities, notional for derivative assets and the policyholder account balances associated with the instrument for the net reinsured portion of our variable annuity MRBs. (2) Represents the net reinsured portion of our variable annuity MRBs. 69 12 23 35 122 22 101 125 134 79 24 61 52 20 52 234 235 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table presents the gains and losses included in net income from assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: The following table presents a summary of the significant unobservable inputs used for certain asset fair value measurements that are based on internal models and classified as Level 3 as of December 31, 2023: (Amounts in millions) Valuation technique Fair value Unobservable input Range Weighted-average(1) (Amounts in millions) 2023 2022 2021 Total realized and unrealized gains (losses) included in net income: Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 10 $ 8 Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 (22) $19 18 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 13 $(14) $37 Total gains (losses) included in net income attributable to assets still held: Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 $ 8 Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . — (9) $ 9 11 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 $ (1) $20 $ $ The amount presented for net investment income relates to fixed maturity securities and primarily represents amortization and accretion of premiums and discounts on certain fixed maturity securities. Fixed maturity securities: U.S. corporate: Utilities . . . . . . . . . . Energy . . . . . . . . . . . Finance and Internal models Internal models $ 851 46 Credit spreads Credit spreads 58bps - 194bps 113bps - 218bps 136bps 163bps insurance . . . . . . . Internal models 707 Credit spreads 14bps - 248bps 168bps Consumer—non- cyclical . . . . . . . . . Internal models 69 Credit spreads 79bps - 224bps 138bps Technology and communications . . Industrial . . . . . . . . . Capital goods . . . . . . Consumer—cyclical . . Transportation . . . . . Other . . . . . . . . . . . . Total U.S. Internal models Internal models Internal models Internal models Internal models Internal models 12 23 35 122 22 101 Credit spreads Credit spreads Credit spreads Credit spreads Credit spreads Credit spreads 65bps - 88bps 98bps - 181bps 85bps - 160bps 79bps - 171bps 44bps - 138bps 79bps - 115bps 74bps 125bps 131bps 123bps 98bps 90bps corporate . . . . . . . Internal models $1,988 Credit spreads 14bps - 248bps 144bps Non-U.S. corporate: Utilities . . . . . . . . . . Energy . . . . . . . . . . . Finance and Internal models Internal models $ 214 125 Credit spreads Credit spreads 74bps - 194bps 88bps - 183bps 129bps 129bps insurance . . . . . . . Internal models 134 Credit spreads 115bps - 197bps 132bps Consumer—non- cyclical . . . . . . . . . Internal models Technology and communications . . Industrial . . . . . . . . . Capital goods . . . . . . Transportation . . . . . Other . . . . . . . . . . . . Total non-U.S. Internal models Internal models Internal models Internal models Internal models 79 24 61 52 20 52 Credit spreads 65bps - 146bps 101bps Credit spreads Credit spreads Credit spreads Credit spreads Credit spreads 98bps - 128bps 107bps - 183bps 65bps - 218bps 113bps - 146bps 58bps - 136bps 108bps 146bps 118bps 119bps 112bps corporate . . . . . . . Internal models $ 761 Credit spreads 58bps - 218bps 110bps Derivative assets: Equity index options . . . . Forward bond purchase commitments . . . . . . . . Discounted cash flows Discounted cash flows $ $ 15 51 Other assets(2) . . . . . . . . . . . . . . Cash flow model $ 140 Equity index volatility Counterparty financing spreads Lapse rate Non-performance risk 6% - 24% 19% 35bps 2% - 10% Not applicable 5% (counterparty credit risk) 42bps - 83bps Equity index volatility 13% - 30% 69bps 22% (1) Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities, notional for derivative assets and the policyholder account balances associated with the instrument for the net reinsured portion of our variable annuity MRBs. (2) Represents the net reinsured portion of our variable annuity MRBs. 234 235 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Certain classes of instruments classified as Level 3 are excluded above as a result of not being material or due to limitations in being able to obtain the underlying inputs used by certain third-party sources, such as broker quotes, used as an input in determining fair value. The following tables present additional information about liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of and for the dates indicated: The following tables set forth our liabilities by class of instrument that are measured at fair value on a recurring basis as of December 31: (Amounts in millions) Liabilities Policyholder account balances: 2023 Total Level 1 Level 2 Level 3 Fixed indexed annuity embedded derivatives . . . . . . . . Indexed universal life embedded derivatives . . . . . . . . $165 $— 15 — Total policyholder account balances . . . . . . . . . . . . . . . 180 — Derivative liabilities: Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . . . . . . . . 490 — 2 — 9 — Total derivative liabilities . . . . . . . . . . . . . . . . . . . . . . . 501 — $— — — $165 15 180 490 2 — 492 — — 9 9 Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . $681 $— $492 $189 (Amounts in millions) Liabilities Policyholder account balances: 2022 Total Level 1 Level 2 Level 3 Fixed indexed annuity embedded derivatives . . . . . . . . Indexed universal life embedded derivatives . . . . . . . . $202 $— 15 — Total policyholder account balances . . . . . . . . . . . . . . . 217 — Derivative liabilities: Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 522 — Total derivative liabilities . . . . . . . . . . . . . . . . . . . . . . . 522 — $— — — 522 522 $202 15 217 — — Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . $739 $— $522 $217 Total (gains) losses attributable to liabilities still held 4 9 9 — — — Total (gains) losses attributable to liabilities still held Total realized and unrealized (gains) losses Beginning balance January 1, as of 2023 Included in net Included (income) in OCI Purchases Sales Issuances Settlements Level 3 Ending balance as of Transfer Transfer Included into out of Level 3 December 31, 2023 in net Included (income) in OCI (Amounts in millions) Policyholder account balances: Fixed indexed annuity embedded Indexed universal life embedded Total policyholder Derivative liabilities: Forward bond purchase commitments . . . . . . . . . . . Total derivative liabilities . . . . — — 4 9 9 derivatives . . . . . . . . . $202 $ 18 $— $— $— $— $ (52) $— $ (3) $165 $ 18 $— derivatives . . . . . . . . . 15 (14) — — — 14 — — — 15 (14) — account balances . . . . . 217 — — — 14 (52) — (3) 180 Total Level 3 liabilities . . . . . . . . . . $217 $ 13 $— $— $— $ 14 $ (52) $— $ (3) $189 $ 13 $— — — — — — — — — — — — — — — 9 9 Total realized and unrealized (gains) losses Beginning balance as of Included January 1, in net Included (Amounts in millions) 2022 (income) in OCI Purchases Sales Issuances Settlements Level 3 Ending balance as of Transfer Transfer Included into out of Level 3 December 31, in net Included 2022 (income) in OCI Policyholder account balances: Fixed indexed annuity embedded Indexed universal life embedded Total policyholder derivatives . . . . . . . $294 $(16) $— $— $— $— $ (73) $— $ (3) $202 $(16) $— derivatives . . . . . . . 25 (27) — — — 17 — — — 15 (27) — account balances . . 319 (43) — — — 17 (73) — (3) 217 (43) — Total Level 3 liabilities . . . $319 $(43) $— $— $— $ 17 $ (73) $— $ (3) $217 $(43) $— 236 237 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Certain classes of instruments classified as Level 3 are excluded above as a result of not being material or due to limitations in being able to obtain the underlying inputs used by certain third-party sources, such as broker quotes, used as an input in determining fair value. The following tables present additional information about liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of and for the dates indicated: The following tables set forth our liabilities by class of instrument that are measured at fair value on a recurring basis as of December 31: 2023 Total Level 1 Level 2 Level 3 (Amounts in millions) Liabilities Policyholder account balances: Fixed indexed annuity embedded derivatives . . . . . . . . $165 $— Indexed universal life embedded derivatives . . . . . . . . 15 — Total policyholder account balances . . . . . . . . . . . . . . . 180 — Derivative liabilities: Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 490 — Foreign currency swaps . . . . . . . . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . . . . . . . . 2 — 9 — Total derivative liabilities . . . . . . . . . . . . . . . . . . . . . . . 501 — $— — — $165 15 180 490 2 — 492 — — 9 9 Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . $681 $— $492 $189 (Amounts in millions) Liabilities Policyholder account balances: 2022 Total Level 1 Level 2 Level 3 Fixed indexed annuity embedded derivatives . . . . . . . . $202 $— Indexed universal life embedded derivatives . . . . . . . . 15 — Total policyholder account balances . . . . . . . . . . . . . . . 217 — Derivative liabilities: Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 522 — Total derivative liabilities . . . . . . . . . . . . . . . . . . . . . . . 522 — $— — — 522 522 $202 15 217 — — Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . $739 $— $522 $217 Total realized and unrealized (gains) losses Included in net (income) Included in OCI Beginning balance as of January 1, 2023 Purchases Sales Issuances Settlements Transfer into Level 3 Transfer out of Level 3 Ending balance as of December 31, 2023 Total (gains) losses attributable to liabilities still held Included in net (income) Included in OCI $202 $ 18 $— $— $— $— $ (52) $— $ (3) $165 $ 18 $— 15 (14) — — — 14 — — — 15 (14) — (Amounts in millions) Policyholder account balances: Fixed indexed annuity embedded derivatives . . . . . . . . . Indexed universal life embedded derivatives . . . . . . . . . Total policyholder account balances . . . . . 217 Derivative liabilities: Forward bond purchase commitments . . . . . . . . . . . Total derivative liabilities . . . . — — 4 9 9 — — — 14 (52) — (3) 180 — — — — — — — — — — — — — — 9 9 4 9 9 — — — Total Level 3 liabilities . . . . . . . . . . $217 $ 13 $— $— $— $ 14 $ (52) $— $ (3) $189 $ 13 $— Total realized and unrealized (gains) losses Included in net (income) Included in OCI Beginning balance as of January 1, 2022 Total (gains) losses attributable to liabilities still held Included in net (income) Included in OCI Transfer into Level 3 Transfer out of Level 3 Ending balance as of December 31, 2022 Purchases Sales Issuances Settlements $294 $(16) $— $— $— $— $ (73) $— $ (3) $202 $(16) $— 25 (27) — — — 17 — — — 15 (27) — (Amounts in millions) Policyholder account balances: Fixed indexed annuity embedded derivatives . . . . . . . Indexed universal life embedded derivatives . . . . . . . Total policyholder account balances . . 319 (43) — — — 17 (73) — (3) 217 (43) — Total Level 3 liabilities . . . $319 $(43) $— $— $— $ 17 $ (73) $— $ (3) $217 $(43) $— 236 237 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Total realized and unrealized (gains) losses Included in net (income) Included in OCI Beginning balance as of January 1, 2021 Total (gains) losses attributable to liabilities still held Included in net (income) Included in OCI Transfer into Level 3 Transfer out of Level 3 Ending balance as of December 31, 2021 Purchases Sales Issuances Settlements $399 $ 32 $— $— $— $— $(136) $— $ (1) $294 $ 32 $— 26 (24) — — — 23 — — — 25 (24) — (Amounts in millions) Policyholder account balances: Fixed indexed annuity embedded derivatives . . . . . . . Indexed universal life embedded derivatives . . . . . . . Total policyholder embedded derivative instrument with all remaining changes in the fair value of these embedded derivative instruments being shown separately in the category labeled “included in net (income)” in the tables presented above. The following table presents a summary of the significant unobservable inputs used for certain liability fair value measurements that are based on internal models and classified as Level 3 as of December 31, 2023: (Amounts in millions) Policyholder account balances: Valuation technique Fair value Unobservable input Range Weighted- average(1) Fixed indexed annuity embedded Option budget Expected future derivatives . . . . . . . . . . . . . . . . . . . method $165 interest credited 1% - 3% Indexed universal life embedded Option budget Expected future derivatives . . . . . . . . . . . . . . . . . . . method $ 15 interest credited 3% - 12% 2% 5% account balances . . 425 8 — — — 23 (136) — (1) 319 8 — Market risk benefits(2): Total Level 3 liabilities . . . $425 $ 8 $— $— $— $ 23 $(136) $— $ (1) $319 $ 8 $— The following table presents the gains and losses included in net (income) from liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: Fixed indexed annuities . . . . . . . . . . . model $ 55 interest credited Cash flow Expected future (Amounts in millions) 2023 2022 2021 Total realized and unrealized (gains) losses included in net (income): Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment (gains) losses . . . . . . . . . . . . . . . . . . . . . . . . . . $— 13 $— (43) $— 8 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 13 $ (43) $ 8 Total (gains) losses included in net (income) attributable to liabilities still held: Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment (gains) losses . . . . . . . . . . . . . . . . . . . . . . . . . . $— 13 $— (43) $— 8 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 13 $ (43) $ 8 Purchases, sales, issuances and settlements represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases, sales and settlements of fixed maturity and equity securities and purchases, issuances and settlements of derivative instruments. Issuances for fixed indexed annuity and indexed universal life embedded derivative liabilities represent the amount of the premium received that is attributed to the value of the embedded derivative. Settlements of embedded derivatives are characterized as the change in fair value upon exercising the embedded derivative instrument, effectively representing a settlement of the embedded derivative instrument. We have shown these changes in fair value separately based on the classification of this activity as effectively issuing and settling the 238 239 utilization rate —% - 68% 53% 42bps - 83bps 69bps 1% - 3% 2% - 11% 2% 5% utilization rate 63% - 89% 78% GMWB Non-performance risk (credit spreads) Lapse rate GMWB Non-performance risk (credit spreads) Equity index Variable annuities . . . . . . . . . . . . . . . model $527 volatility 13% - 30% 22% Cash flow 42bps - 83bps 69bps Derivative liabilities: Forward bond purchase Discounted Counterparty commitments . . . . . . . . . . . . . . . . . cash flows $ 9 financing spreads 35bps Not applicable (1) Unobservable inputs weighted by the policyholder account balances associated with the instrument. (2) Refer to note 13 for additional details related to MRBs. Assets and Liabilities Not Required to Be Carried at Fair Value Assets and liabilities that are reflected in the accompanying consolidated financial statements at fair value are not included in the following disclosure of fair value. Such items include cash and cash equivalents, short- term investments, investment securities, MRBs, separate accounts and derivative instruments. Apart from certain of our borrowings and certain marketable securities, few of the instruments are actively traded and their fair values must often be determined using internal models. The fair value estimates are made at a specific point in time, based upon available market information and judgments about the financial instruments, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such estimates do not reflect any premium or discount that could result from offering for sale at one time our entire GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Total realized and unrealized (gains) losses Beginning balance as of Included January 1, in net Included Total (gains) losses attributable to liabilities still held Ending balance as of Transfer Transfer Included into out of Level 3 December 31, in net Included 2021 (income) in OCI (Amounts in millions) 2021 (income) in OCI Purchases Sales Issuances Settlements Level 3 Policyholder account balances: Fixed indexed annuity embedded Indexed universal life embedded Total policyholder derivatives . . . . . . . $399 $ 32 $— $— $— $— $(136) $— $ (1) $294 $ 32 $— derivatives . . . . . . . 26 (24) — — — 23 — — — 25 (24) — embedded derivative instrument with all remaining changes in the fair value of these embedded derivative instruments being shown separately in the category labeled “included in net (income)” in the tables presented above. The following table presents a summary of the significant unobservable inputs used for certain liability fair value measurements that are based on internal models and classified as Level 3 as of December 31, 2023: (Amounts in millions) Policyholder account balances: Valuation technique Fair value Unobservable input Range Weighted- average(1) Fixed indexed annuity embedded derivatives . . . . . . . . . . . . . . . . . . . Indexed universal life embedded derivatives . . . . . . . . . . . . . . . . . . . Option budget method Option budget method $165 $ 15 Expected future interest credited Expected future interest credited 1% - 3% 3% - 12% 2% 5% account balances . . 425 8 — — — 23 (136) — (1) 319 8 — Market risk benefits(2): Total Level 3 liabilities . . . $425 $ 8 $— $— $— $ 23 $(136) $— $ (1) $319 $ 8 $— The following table presents the gains and losses included in net (income) from liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: Fixed indexed annuities . . . . . . . . . . . Cash flow model $ 55 (Amounts in millions) 2023 2022 2021 Total realized and unrealized (gains) losses included in net (income): Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $— $— $— Net investment (gains) losses . . . . . . . . . . . . . . . . . . . . . . . . . . 13 (43) Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 13 $ (43) $ Total (gains) losses included in net (income) attributable to liabilities still held: Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $— $— $— Net investment (gains) losses . . . . . . . . . . . . . . . . . . . . . . . . . . 13 (43) Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 13 $ (43) $ 8 8 8 8 Purchases, sales, issuances and settlements represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases, sales and settlements of fixed maturity and equity securities and purchases, issuances and settlements of derivative instruments. Issuances for fixed indexed annuity and indexed universal life embedded derivative liabilities represent the amount of the premium received that is attributed to the value of the embedded derivative. Settlements of embedded derivatives are characterized as the change in fair value upon exercising the embedded derivative instrument, effectively representing a settlement of the embedded derivative instrument. We have shown these changes in fair value separately based on the classification of this activity as effectively issuing and settling the Variable annuities . . . . . . . . . . . . . . . Derivative liabilities: Forward bond purchase commitments . . . . . . . . . . . . . . . . . Cash flow model $527 Discounted cash flows $ Counterparty financing spreads 9 35bps Not applicable (1) Unobservable inputs weighted by the policyholder account balances associated with the instrument. (2) Refer to note 13 for additional details related to MRBs. Assets and Liabilities Not Required to Be Carried at Fair Value Assets and liabilities that are reflected in the accompanying consolidated financial statements at fair value are not included in the following disclosure of fair value. Such items include cash and cash equivalents, short- term investments, investment securities, MRBs, separate accounts and derivative instruments. Apart from certain of our borrowings and certain marketable securities, few of the instruments are actively traded and their fair values must often be determined using internal models. The fair value estimates are made at a specific point in time, based upon available market information and judgments about the financial instruments, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such estimates do not reflect any premium or discount that could result from offering for sale at one time our entire 238 239 GMWB utilization rate —% - 68% 53% Non-performance risk (credit spreads) Expected future interest credited Lapse rate GMWB utilization rate Non-performance risk (credit spreads) Equity index volatility 42bps - 83bps 69bps 1% - 3% 2% - 11% 2% 5% 63% - 89% 78% 42bps - 83bps 69bps 13% - 30% 22% GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value estimates cannot be substantiated by comparison to independent markets. The following represents our estimated fair value of financial assets and liabilities that are not required to be carried at fair value as of December 31: (Amounts in millions) Assets: Notional amount Carrying amount 2023 Fair value Total Level 1 Level 2 Level 3 Commercial mortgage loans, net . . . . . . . . . . . . . . . Bank loan investments . . . . . . . . . . . . . . . . . . . . . . . Liabilities: Long-term borrowings(2) . . . . . . . . . . . . . . . . . . . . . Investment contracts . . . . . . . . . . . . . . . . . . . . . . . . Commitments to fund investments: (1) (1) (1) (1) $6,802 $6,291 $— $ — $6,291 520 520 — 529 — 1,584 5,346 1,413 — 5,372 — 1,413 — — 5,372 (Amounts in millions) Limited partnerships accounted for at NAV: Bank loan investments . . . . . . . . . . . . . . . . . . . . . . . Private placement investments . . . . . . . . . . . . . . . . . Commercial mortgage loans . . . . . . . . . . . . . . . . . . $117 42 13 — — — — — — — — — — — — — — — (1) These financial instruments do not have notional amounts. (2) See note 17 for additional information related to borrowings. (Amounts in millions) Assets: Notional amount Carrying amount 2022 Fair value Total Level 1 Level 2 Level 3 Commercial mortgage loans, net . . . . . . . . . . . . . . . Bank loan investments . . . . . . . . . . . . . . . . . . . . . . . Liabilities: Long-term borrowings(2) . . . . . . . . . . . . . . . . . . . . . Investment contracts . . . . . . . . . . . . . . . . . . . . . . . . Commitments to fund investments: (1) (1) (1) (1) $7,010 $6,345 $— $ — $6,345 474 474 — — 467 1,611 6,794 1,346 — 7,171 — 1,346 — — 7,171 Bank loan investments . . . . . . . . . . . . . . . . . . . . . . . Private placement investments . . . . . . . . . . . . . . . . . Commercial mortgage loans . . . . . . . . . . . . . . . . . . $70 19 5 — — — — — — — — — — — — — — — (1) These financial instruments do not have notional amounts. (2) See note 17 for additional information related to borrowings. As of December 31, 2023 and 2022, we also had $23 million and $26 million, respectively, of real estate owned assets included in other invested assets in our consolidated balance sheets, which are initially recorded at fair value less estimated selling costs (the carrying value) and are subsequently valued at the lower of the carrying value or current fair value less estimated selling costs. As of December 31, 2023 and 2022, these properties were adjusted to fair value less estimated selling costs, which was less than the carrying value. These amounts represented the fair value as of December 31, 2023 and 2022. The fair value of the real estate owned assets is classified as Level 2. 240 241 Assets Measured Using Net Asset Value Limited partnerships include partnership interests accounted for using NAV per share (or its equivalent) or fair value for those interests considered minor and partnership interests accounted for under the equity method of accounting for those interests exceeding the minor threshold. Our limited partnership interests accounted for using NAV per share (or its equivalent) are generally not redeemable by the investees and generally cannot be sold without approval of the general partner. We receive distributions of income and proceeds from the liquidation of the underlying assets of the investees, which usually takes place in years five to ten of the typical contractual life of ten to 12 years. The following table presents the carrying value of limited partnerships and commitments to fund as of December 31: 2023 2022 Carrying Commitments Carrying Commitments value to fund value to fund Private equity funds(1) . . . . . . . . . . . . . . . . . $1,948 $1,203 $1,647 $1,107 Real estate funds(2) . . . . . . . . . . . . . . . . . . . . Infrastructure funds(3) . . . . . . . . . . . . . . . . . 123 102 87 160 Total limited partnerships accounted for at NAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,173 1,450 1,792 1,215 Limited partnerships accounted for at fair value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships accounted for under the equity method of accounting . . . . . . . . . . . . . . 20 628 1 79 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,821 $1,530 $2,331 $1,365 82 63 24 515 79 29 1 149 (1) This class employs various investment strategies such as leveraged buyout, growth equity, venture capital and mezzanine financing, generally investing in debt or equity positions directly in companies or assets of various sizes across diverse industries globally, primarily concentrated in North America. (2) This class invests in real estate in North America, Europe and Asia via direct property ownership, joint ventures, mortgages and investments in debt and equity instruments. (3) This class invests in the debt or equity of cash flow generating assets diversified across a variety of industries, including transportation, energy infrastructure, renewable power, social infrastructure, power generation, water, telecommunications and other regulated entities globally. (22) Insurance Subsidiary Financial Information and Regulatory Matters Dividends Our insurance subsidiaries are subject to oversight by applicable insurance laws and regulations as to the amount of dividends they may pay to their parent in any year, the purpose of which is to protect affected insurance policyholders or contractholders, not stockholders. In general, dividends and distributions are required to be submitted to an insurer’s domiciliary department of insurance for review, and the payment of any dividend or distribution from a source other than unassigned surplus requires prior written regulatory approval. Enact Holdings’ ability to pay dividends is limited in part by such regulatory restrictions on its insurance subsidiaries. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value estimates cannot be substantiated by comparison to independent markets. The following represents our estimated fair value of financial assets and liabilities that are not required to be carried at fair value as of December 31: Notional amount Carrying amount Total Level 1 Level 2 Level 3 2023 Fair value (Amounts in millions) Assets: Liabilities: Commercial mortgage loans, net . . . . . . . . . . . . . . . Bank loan investments . . . . . . . . . . . . . . . . . . . . . . . $6,802 $6,291 $— $ — $6,291 529 520 — — 520 Long-term borrowings(2) . . . . . . . . . . . . . . . . . . . . . Investment contracts . . . . . . . . . . . . . . . . . . . . . . . . 1,584 5,346 1,413 — 5,372 — 1,413 — — 5,372 Commitments to fund investments: Bank loan investments . . . . . . . . . . . . . . . . . . . . . . . $117 Private placement investments . . . . . . . . . . . . . . . . . Commercial mortgage loans . . . . . . . . . . . . . . . . . . 42 13 — — — — — — — — — — — — — — — (1) These financial instruments do not have notional amounts. (2) See note 17 for additional information related to borrowings. Notional amount Carrying amount Total Level 1 Level 2 Level 3 2022 Fair value (Amounts in millions) Assets: Liabilities: Commercial mortgage loans, net . . . . . . . . . . . . . . . Bank loan investments . . . . . . . . . . . . . . . . . . . . . . . $7,010 $6,345 $— $ — $6,345 467 474 — — 474 Long-term borrowings(2) . . . . . . . . . . . . . . . . . . . . . Investment contracts . . . . . . . . . . . . . . . . . . . . . . . . 1,611 6,794 1,346 — 7,171 — 1,346 — — 7,171 Commitments to fund investments: Bank loan investments . . . . . . . . . . . . . . . . . . . . . . . Private placement investments . . . . . . . . . . . . . . . . . Commercial mortgage loans . . . . . . . . . . . . . . . . . . $70 19 5 — — — — — — — — — — — — — — — (1) These financial instruments do not have notional amounts. (2) See note 17 for additional information related to borrowings. As of December 31, 2023 and 2022, we also had $23 million and $26 million, respectively, of real estate owned assets included in other invested assets in our consolidated balance sheets, which are initially recorded at fair value less estimated selling costs (the carrying value) and are subsequently valued at the lower of the carrying value or current fair value less estimated selling costs. As of December 31, 2023 and 2022, these properties were adjusted to fair value less estimated selling costs, which was less than the carrying value. These amounts represented the fair value as of December 31, 2023 and 2022. The fair value of the real estate owned assets is classified as Level 2. (1) (1) (1) (1) (1) (1) (1) (1) Assets Measured Using Net Asset Value Limited partnerships include partnership interests accounted for using NAV per share (or its equivalent) or fair value for those interests considered minor and partnership interests accounted for under the equity method of accounting for those interests exceeding the minor threshold. Our limited partnership interests accounted for using NAV per share (or its equivalent) are generally not redeemable by the investees and generally cannot be sold without approval of the general partner. We receive distributions of income and proceeds from the liquidation of the underlying assets of the investees, which usually takes place in years five to ten of the typical contractual life of ten to 12 years. The following table presents the carrying value of limited partnerships and commitments to fund as of December 31: (Amounts in millions) Limited partnerships accounted for at NAV: 2023 2022 Carrying value Commitments to fund Carrying value Commitments to fund Private equity funds(1) . . . . . . . . . . . . . . . . . Real estate funds(2) . . . . . . . . . . . . . . . . . . . . Infrastructure funds(3) . . . . . . . . . . . . . . . . . $1,948 123 102 $1,203 87 160 $1,647 82 63 $1,107 79 29 Total limited partnerships accounted for at NAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships accounted for at fair value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships accounted for under the equity method of accounting . . . . . . . . . . . . . . 2,173 1,450 1,792 1,215 20 628 1 79 24 515 1 149 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,821 $1,530 $2,331 $1,365 (1) This class employs various investment strategies such as leveraged buyout, growth equity, venture capital and mezzanine financing, generally investing in debt or equity positions directly in companies or assets of various sizes across diverse industries globally, primarily concentrated in North America. (2) This class invests in real estate in North America, Europe and Asia via direct property ownership, joint ventures, mortgages and investments in debt and equity instruments. (3) This class invests in the debt or equity of cash flow generating assets diversified across a variety of industries, including transportation, energy infrastructure, renewable power, social infrastructure, power generation, water, telecommunications and other regulated entities globally. (22) Insurance Subsidiary Financial Information and Regulatory Matters Dividends Our insurance subsidiaries are subject to oversight by applicable insurance laws and regulations as to the amount of dividends they may pay to their parent in any year, the purpose of which is to protect affected insurance policyholders or contractholders, not stockholders. In general, dividends and distributions are required to be submitted to an insurer’s domiciliary department of insurance for review, and the payment of any dividend or distribution from a source other than unassigned surplus requires prior written regulatory approval. Enact Holdings’ ability to pay dividends is limited in part by such regulatory restrictions on its insurance subsidiaries. 240 241 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Based on estimated statutory results as of December 31, 2023, in accordance with applicable dividend restrictions, Enact Holdings’ U.S. mortgage insurance subsidiaries could pay dividends from unassigned surplus of approximately $336 million in 2024 without affirmative regulatory approval, although notice of the intent to pay must be provided to the state insurance commissioner 30 days in advance thereof, during which time the commissioner may review the dividend pursuant to statutory standards. Even though the approximately $336 million is considered unrestricted, Enact Holdings may choose not to pay dividends in 2024 at this level as it may retain capital for future growth or to meet regulatory or other capital requirements. Our U.S. life insurance subsidiaries had negative unassigned surplus of $563 million under statutory accounting as of December 31, 2023 and as a result, cannot pay dividends to us in 2024 or in the foreseeable future. As of December 31, 2023, Genworth Financial’s and Genworth Holdings’ consolidated subsidiaries had restricted net assets of $7.2 billion and $7.6 billion, respectively. As the majority shareholder, Genworth Holdings received $174 million, $205 million and $163 million, respectively, of dividends in 2023, 2022 and 2021 from Enact Holdings. Future dividends paid by Enact Holdings are subject to quarterly review and approval by its board of directors and Genworth Financial, and will also be dependent on a variety of economic, market and business conditions. Our principal U.S. life insurance subsidiaries did not pay any dividends in 2023, 2022 or 2021. In the first quarter of 2021, our international subsidiaries paid a dividend of $370 million to Genworth Holdings from the net proceeds of the Genworth Mortgage Insurance Australia Limited (“Genworth Australia”) sale. U.S. domiciled insurance subsidiaries—statutory financial information Our U.S. domiciled insurance subsidiaries file financial statements with state insurance regulatory authorities and the NAIC that are prepared on an accounting basis either prescribed or permitted by such authorities. Statutory accounting practices differ from U.S. GAAP in several respects, causing differences in reported net income (loss) and stockholders’ equity. Permitted statutory accounting practices encompass all accounting practices not so prescribed but that have been specifically allowed by individual state insurance authorities. Our U.S. domiciled insurance subsidiaries have no material permitted accounting practices, except for River Lake Insurance Company VI (“River Lake VI”) and River Lake Insurance Company X (“River Lake X”). The permitted practices of River Lake VI and River Lake X were an essential element of their design and were expressly included in their plans of operation and in the licensing orders issued by their domiciliary state regulators, and without those permitted accounting practices, these entities could be subject to regulatory action. Accordingly, we believe that the permitted accounting practices will remain in effect for so long as we maintain these entities. The material permitted accounting practices were as follows: • • In 2023 and 2022, River Lake VI had a permitted accounting practice from the State of Delaware to carry its excess of loss reinsurance agreements with The Canada Life Assurance Company for its universal and term life insurance business assumed from Genworth Life and Annuity Insurance Company (“GLAIC”) as an admitted asset. In 2023 and 2022, River Lake X had a permitted accounting practice from the State of Vermont to carry its excess of loss reinsurance agreement with Hannover Life Reassurance Company of America for its term life insurance business assumed from GLAIC as an admitted asset. The impact of these permitted accounting practices of River Lake VI and River Lake X on our combined U.S. domiciled life insurance subsidiaries’ statutory capital and surplus was zero as of December 31, 2023 and 2022. If these permitted accounting practices had not been used, no regulatory event would have been triggered. For regulatory purposes, our U.S. mortgage insurers are required to establish a special statutory contingency reserve. Annual additions to the statutory contingency reserve must be at least 50% of net earned premiums, as defined by state insurance laws and regulations. These contingency reserves generally are held until the earlier of (i) the time that loss ratios exceed 35% or (ii) 10 years. However, approval by the North Carolina Department of Insurance (“NCDOI”) is required for contingency reserve releases when loss ratios exceed 35%. The statutory contingency reserve for our U.S. mortgage insurers was approximately $4.0 billion and $3.6 billion, respectively, as of December 31, 2023 and 2022 and is included in the table below containing combined statutory capital and surplus balances. The tables below include the combined statutory net income and statutory capital and surplus for our U.S. domiciled insurance subsidiaries for the periods indicated: (Amounts in millions) Combined statutory net income (loss): Life insurance subsidiaries, excluding captive life Years ended December 31, 2023 2022 2021 reinsurance subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . Mortgage insurance subsidiaries . . . . . . . . . . . . . . . . . . . . $193 665 $ 276 $ 747 654 593 Combined statutory net income, excluding captive reinsurance subsidiaries . . . . . . . . . . . . . . . . . . . . . Captive life reinsurance subsidiaries . . . . . . . . . . . . . . . . . 858 94 1,023 253 1,247 (1,351) Combined statutory net income (loss) . . . . . . . . . . . . $952 $1,276 $ (104) (Amounts in millions) Combined statutory capital and surplus: Life insurance subsidiaries, excluding captive life reinsurance subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mortgage insurance subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,369 5,044 $3,082 4,687 Combined statutory capital and surplus . . . . . . . . . . . . . . . . . . $8,413 $7,769 As of December 31, 2023 2022 The statutory net income (loss) from our captive life reinsurance subsidiaries, River Lake VI and River Lake X, relates to the reinsurance of term and universal life insurance statutory reserves assumed from GLAIC. These reserves are, in turn, secured by excess of loss reinsurance treaties with third parties. Additionally, the life insurance subsidiaries’ combined statutory net income (loss) and distributable income are not affected by the statutory net income (loss) of the captives, except to the extent dividends are received from the captives. The combined statutory capital and surplus of our life insurance subsidiaries does not include the capital and surplus of our captive life reinsurance subsidiaries of $97 million and $96 million as of December 31, 2023 and 2022, respectively. 242 243 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Based on estimated statutory results as of December 31, 2023, in accordance with applicable dividend restrictions, Enact Holdings’ U.S. mortgage insurance subsidiaries could pay dividends from unassigned surplus of approximately $336 million in 2024 without affirmative regulatory approval, although notice of the intent to pay must be provided to the state insurance commissioner 30 days in advance thereof, during which time the commissioner may review the dividend pursuant to statutory standards. Even though the approximately $336 million is considered unrestricted, Enact Holdings may choose not to pay dividends in 2024 at this level as it may retain capital for future growth or to meet regulatory or other capital requirements. Our U.S. life insurance subsidiaries had negative unassigned surplus of $563 million under statutory accounting as of December 31, 2023 and as a result, cannot pay dividends to us in 2024 or in the foreseeable future. As of December 31, 2023, Genworth Financial’s and Genworth Holdings’ consolidated subsidiaries had restricted net assets of $7.2 billion and $7.6 billion, respectively. As the majority shareholder, Genworth Holdings received $174 million, $205 million and $163 million, respectively, of dividends in 2023, 2022 and 2021 from Enact Holdings. Future dividends paid by Enact Holdings are subject to quarterly review and approval by its board of directors and Genworth Financial, and will also be dependent on a variety of economic, market and business conditions. Our principal U.S. life insurance subsidiaries did not pay any dividends in 2023, 2022 or 2021. In the first quarter of 2021, our international subsidiaries paid a dividend of $370 million to Genworth Holdings from the net proceeds of the Genworth Mortgage Insurance Australia Limited (“Genworth Australia”) sale. U.S. domiciled insurance subsidiaries—statutory financial information Our U.S. domiciled insurance subsidiaries file financial statements with state insurance regulatory authorities and the NAIC that are prepared on an accounting basis either prescribed or permitted by such authorities. Statutory accounting practices differ from U.S. GAAP in several respects, causing differences in reported net income (loss) and stockholders’ equity. Permitted statutory accounting practices encompass all accounting practices not so prescribed but that have been specifically allowed by individual state insurance authorities. Our U.S. domiciled insurance subsidiaries have no material permitted accounting practices, except for River Lake Insurance Company VI (“River Lake VI”) and River Lake Insurance Company X (“River Lake X”). The permitted practices of River Lake VI and River Lake X were an essential element of their design and were expressly included in their plans of operation and in the licensing orders issued by their domiciliary state regulators, and without those permitted accounting practices, these entities could be subject to regulatory action. Accordingly, we believe that the permitted accounting practices will remain in effect for so long as we maintain these entities. The material permitted accounting practices were as follows: • In 2023 and 2022, River Lake VI had a permitted accounting practice from the State of Delaware to carry its excess of loss reinsurance agreements with The Canada Life Assurance Company for its universal and term life insurance business assumed from Genworth Life and Annuity Insurance Company (“GLAIC”) as an admitted asset. • In 2023 and 2022, River Lake X had a permitted accounting practice from the State of Vermont to carry its excess of loss reinsurance agreement with Hannover Life Reassurance Company of America for its term life insurance business assumed from GLAIC as an admitted asset. The impact of these permitted accounting practices of River Lake VI and River Lake X on our combined U.S. domiciled life insurance subsidiaries’ statutory capital and surplus was zero as of December 31, 2023 and 2022. If these permitted accounting practices had not been used, no regulatory event would have been triggered. For regulatory purposes, our U.S. mortgage insurers are required to establish a special statutory contingency reserve. Annual additions to the statutory contingency reserve must be at least 50% of net earned premiums, as defined by state insurance laws and regulations. These contingency reserves generally are held until the earlier of (i) the time that loss ratios exceed 35% or (ii) 10 years. However, approval by the North Carolina Department of Insurance (“NCDOI”) is required for contingency reserve releases when loss ratios exceed 35%. The statutory contingency reserve for our U.S. mortgage insurers was approximately $4.0 billion and $3.6 billion, respectively, as of December 31, 2023 and 2022 and is included in the table below containing combined statutory capital and surplus balances. The tables below include the combined statutory net income and statutory capital and surplus for our U.S. domiciled insurance subsidiaries for the periods indicated: (Amounts in millions) Combined statutory net income (loss): Life insurance subsidiaries, excluding captive life Years ended December 31, 2023 2022 2021 reinsurance subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . Mortgage insurance subsidiaries . . . . . . . . . . . . . . . . . . . . $193 665 $ 276 747 $ 654 593 Combined statutory net income, excluding captive reinsurance subsidiaries . . . . . . . . . . . . . . . . . . . . . Captive life reinsurance subsidiaries . . . . . . . . . . . . . . . . . 858 94 1,023 253 1,247 (1,351) Combined statutory net income (loss) . . . . . . . . . . . . $952 $1,276 $ (104) (Amounts in millions) Combined statutory capital and surplus: As of December 31, 2023 2022 Life insurance subsidiaries, excluding captive life reinsurance subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mortgage insurance subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,369 5,044 $3,082 4,687 Combined statutory capital and surplus . . . . . . . . . . . . . . . . . . $8,413 $7,769 The statutory net income (loss) from our captive life reinsurance subsidiaries, River Lake VI and River Lake X, relates to the reinsurance of term and universal life insurance statutory reserves assumed from GLAIC. These reserves are, in turn, secured by excess of loss reinsurance treaties with third parties. Additionally, the life insurance subsidiaries’ combined statutory net income (loss) and distributable income are not affected by the statutory net income (loss) of the captives, except to the extent dividends are received from the captives. The combined statutory capital and surplus of our life insurance subsidiaries does not include the capital and surplus of our captive life reinsurance subsidiaries of $97 million and $96 million as of December 31, 2023 and 2022, respectively. 242 243 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Capital Requirements of U.S. Life Insurers The NAIC has adopted RBC requirements to evaluate the adequacy of statutory capital and surplus in relation to risks associated with: (i) asset risk; (ii) insurance risk; (iii) interest rate risk; and (iv) business risk. The RBC formula is designated as an early warning tool for the states to identify possible weakly capitalized companies for purposes of initiating further regulatory action. In the course of operations, we periodically monitor the RBC level of each of our life insurance subsidiaries. As of December 31, 2023 and 2022, each of our life insurance subsidiaries exceeded the minimum required RBC levels in their respective domiciliary state. The consolidated RBC ratio of our U.S. domiciled life insurance subsidiaries, which is representative of the RBC ratio on a company action level basis of Genworth Life Insurance Company (“GLIC”), the parent of our U.S. life insurance subsidiaries, was approximately 303% and 291% as of December 31, 2023 and 2022, respectively. In 2023 and 2022, we released $99 million and $199 million, respectively, of statutory reserves resulting from updates to our universal and term universal life insurance products with secondary guarantees as part of Actuarial Guideline 38 8D (“AG 38 8D”) in our Virginia and Delaware licensed life insurance subsidiaries. In 2021, we established $231 million of additional AG 38 8D statutory reserves. As a part of our cash flow testing process for our U.S. life insurance subsidiaries, we consider incremental benefits from expected future in-force rate actions in our long-term care insurance products that would help mitigate the impact of deteriorating experience. The New York State Department of Financial Services (“NYDFS”), which regulates Genworth Life Insurance Company of New York (“GLICNY”), requires specific adequacy testing scenarios that are generally more severe than those deemed acceptable in other states. Moreover, the required testing scenarios by the NYDFS have a disproportionate impact on our long-term care insurance products. In addition, we use New York specific experience for setting assumptions in our long-term care insurance products in GLICNY. While the NYDFS generally does not permit in-force rate increases for long-term care insurance to be used in asset adequacy analysis until such increases have been approved, it has allowed GLICNY to incorporate recently filed in-force rate actions in its asset adequacy analysis prior to approval in the past. As a result, after discussions with the NYDFS and through the exercise of professional actuarial judgment, GLICNY incorporated in its 2023 and 2022 asset adequacy analysis assumptions for future in-force rate actions for long-term care insurance products to offset the emerging adverse experience for these products. With these assumption updates, GLICNY’s 2023 and 2022 asset adequacy analysis produced a negative margin. To address the negative margin, GLICNY recorded an incremental $87 million and $98 million of additional statutory reserves in 2023 and 2022, respectively. As a result of the 2023 and 2022 activity, the aggregate amount of statutory reserves established by GLICNY for asset adequacy deficits increased to $792 million ($757 million related to long-term care insurance and $35 million related to variable annuities) and $705 million ($670 million related to long-term care insurance and $35 million related to variable annuities) as of December 31, 2023 and 2022, respectively. Capital Requirements of U.S. Mortgage Insurers Mortgage insurers are not subject to the NAIC’s RBC requirements, but certain states and other regulators impose another form of capital requirement on mortgage insurers requiring maintenance of a risk-to-capital ratio not to exceed 25:1. Fifteen other states maintain similar risk-to-capital requirements. As of December 31, 2023 and 2022, the risk-to-capital ratio of Enact Holdings’ combined insurance subsidiaries was approximately 11.6:1 and 12.8:1, respectively, under the current regulatory framework as established under North Carolina law and enforced by the NCDOI, Enact Holdings’ insurance subsidiaries’ domestic insurance regulator. Each of Enact Holdings’ insurance subsidiaries met its respective capital requirements as of December 31, 2023 and 2022. Private mortgage insurers must meet the operational and financial requirements under PMIERs as set forth by the GSEs in order to remain eligible to insure loans that are purchased by the GSEs. Each approved mortgage insurer is required to provide the GSEs with an annual certification and a quarterly report evidencing its compliance with PMIERs. In September 2020, subsequent to the issuance of Enact Holdings’ senior notes due in 2025, the GSEs imposed certain restrictions (the “GSE Restrictions”) on Enact with respect to capital. In May 2021, in connection with their conditional approval of the partial sale of Enact Holdings, the GSEs confirmed the GSE Restrictions would remain in effect until certain conditions (the “GSE Conditions”) were met for two consecutive quarters. These conditions were met as of December 31, 2022, and in March 2023, the GSEs confirmed that Enact is no longer subject to the GSE Restrictions and the GSE Conditions. Enact has met all PMIERs reporting requirements as required by the GSEs. As of December 31, 2023 and 2022, Enact had estimated available assets of $5,006 million and $5,206 million, respectively, against $3,119 million and $3,156 million, respectively, net required assets under PMIERs. The sufficiency ratio as of December 31, 2023 was 161%, or $1,887 million above the PMIERs requirements, compared to 165%, or $2,050 million above the PMIERs requirements as of December 31, 2022. PMIERs sufficiency as of December 31, 2022 was based on the published requirements applicable to private mortgage insurers and did not give effect to the GSE Restrictions imposed on Enact as of December 31, 2022. Securities on deposit Certain of our insurance subsidiaries have securities on deposit with various state or foreign government insurance departments in order to comply with relevant insurance regulations. See note 5(d) for additional information related to these deposits. Additionally, under the terms of certain reinsurance agreements that our life insurance subsidiaries have with external parties, we pledged assets in either separate portfolios or in trust for the benefit of external reinsurers. These assets support the reserves ceded to those external reinsurers. See note 9 for additional information related to these pledged assets under reinsurance agreements. Certain of our U.S. life insurance subsidiaries are also members of regional Federal Home Loan Banks (“FHLBs”) and the FHLBs have been granted a lien on certain of our invested assets to collateralize our obligations. See note 11 for additional information related to these pledged assets with the FHLBs. Guarantees of obligations In addition to the commitments discussed in note 25, Genworth Financial and certain of its holding company subsidiaries provide guarantees to third parties for the performance of certain obligations of their subsidiaries. We estimate that our potential obligations under such guarantees were $67 million and $69 million as of December 31, 2023 and 2022, respectively. Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations. 244 245 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Capital Requirements of U.S. Life Insurers The NAIC has adopted RBC requirements to evaluate the adequacy of statutory capital and surplus in relation to risks associated with: (i) asset risk; (ii) insurance risk; (iii) interest rate risk; and (iv) business risk. The RBC formula is designated as an early warning tool for the states to identify possible weakly capitalized companies for purposes of initiating further regulatory action. In the course of operations, we periodically monitor the RBC level of each of our life insurance subsidiaries. As of December 31, 2023 and 2022, each of our life insurance subsidiaries exceeded the minimum required RBC levels in their respective domiciliary state. The consolidated RBC ratio of our U.S. domiciled life insurance subsidiaries, which is representative of the RBC ratio on a company action level basis of Genworth Life Insurance Company (“GLIC”), the parent of our U.S. life insurance subsidiaries, was approximately 303% and 291% as of December 31, 2023 and 2022, respectively. In 2023 and 2022, we released $99 million and $199 million, respectively, of statutory reserves resulting from updates to our universal and term universal life insurance products with secondary guarantees as part of Actuarial Guideline 38 8D (“AG 38 8D”) in our Virginia and Delaware licensed life insurance subsidiaries. In 2021, we established $231 million of additional AG 38 8D statutory reserves. As a part of our cash flow testing process for our U.S. life insurance subsidiaries, we consider incremental benefits from expected future in-force rate actions in our long-term care insurance products that would help mitigate the impact of deteriorating experience. The New York State Department of Financial Services (“NYDFS”), which regulates Genworth Life Insurance Company of New York (“GLICNY”), requires specific adequacy testing scenarios that are generally more severe than those deemed acceptable in other states. Moreover, the required testing scenarios by the NYDFS have a disproportionate impact on our long-term care insurance products. In addition, we use New York specific experience for setting assumptions in our long-term care insurance products in GLICNY. While the NYDFS generally does not permit in-force rate increases for long-term care insurance to be used in asset adequacy analysis until such increases have been approved, it has allowed GLICNY to incorporate recently filed in-force rate actions in its asset adequacy analysis prior to approval in the past. As a result, after discussions with the NYDFS and through the exercise of professional actuarial judgment, GLICNY incorporated in its 2023 and 2022 asset adequacy analysis assumptions for future in-force rate actions for long-term care insurance products to offset the emerging adverse experience for these products. With these assumption updates, GLICNY’s 2023 and 2022 asset adequacy analysis produced a negative margin. To address the negative margin, GLICNY recorded an incremental $87 million and $98 million of additional statutory reserves in 2023 and 2022, respectively. As a result of the 2023 and 2022 activity, the aggregate amount of statutory reserves established by GLICNY for asset adequacy deficits increased to $792 million ($757 million related to long-term care insurance and $35 million related to variable annuities) and $705 million ($670 million related to long-term care insurance and $35 million related to variable annuities) as of December 31, 2023 and 2022, respectively. Capital Requirements of U.S. Mortgage Insurers Mortgage insurers are not subject to the NAIC’s RBC requirements, but certain states and other regulators impose another form of capital requirement on mortgage insurers requiring maintenance of a risk-to-capital ratio not to exceed 25:1. Fifteen other states maintain similar risk-to-capital requirements. As of December 31, 2023 and 2022, the risk-to-capital ratio of Enact Holdings’ combined insurance subsidiaries was approximately 11.6:1 and 12.8:1, respectively, under the current regulatory framework as established under North Carolina law and enforced by the NCDOI, Enact Holdings’ insurance subsidiaries’ domestic insurance regulator. Each of Enact Holdings’ insurance subsidiaries met its respective capital requirements as of December 31, 2023 and 2022. Private mortgage insurers must meet the operational and financial requirements under PMIERs as set forth by the GSEs in order to remain eligible to insure loans that are purchased by the GSEs. Each approved mortgage insurer is required to provide the GSEs with an annual certification and a quarterly report evidencing its compliance with PMIERs. In September 2020, subsequent to the issuance of Enact Holdings’ senior notes due in 2025, the GSEs imposed certain restrictions (the “GSE Restrictions”) on Enact with respect to capital. In May 2021, in connection with their conditional approval of the partial sale of Enact Holdings, the GSEs confirmed the GSE Restrictions would remain in effect until certain conditions (the “GSE Conditions”) were met for two consecutive quarters. These conditions were met as of December 31, 2022, and in March 2023, the GSEs confirmed that Enact is no longer subject to the GSE Restrictions and the GSE Conditions. Enact has met all PMIERs reporting requirements as required by the GSEs. As of December 31, 2023 and 2022, Enact had estimated available assets of $5,006 million and $5,206 million, respectively, against $3,119 million and $3,156 million, respectively, net required assets under PMIERs. The sufficiency ratio as of December 31, 2023 was 161%, or $1,887 million above the PMIERs requirements, compared to 165%, or $2,050 million above the PMIERs requirements as of December 31, 2022. PMIERs sufficiency as of December 31, 2022 was based on the published requirements applicable to private mortgage insurers and did not give effect to the GSE Restrictions imposed on Enact as of December 31, 2022. Securities on deposit Certain of our insurance subsidiaries have securities on deposit with various state or foreign government insurance departments in order to comply with relevant insurance regulations. See note 5(d) for additional information related to these deposits. Additionally, under the terms of certain reinsurance agreements that our life insurance subsidiaries have with external parties, we pledged assets in either separate portfolios or in trust for the benefit of external reinsurers. These assets support the reserves ceded to those external reinsurers. See note 9 for additional information related to these pledged assets under reinsurance agreements. Certain of our U.S. life insurance subsidiaries are also members of regional Federal Home Loan Banks (“FHLBs”) and the FHLBs have been granted a lien on certain of our invested assets to collateralize our obligations. See note 11 for additional information related to these pledged assets with the FHLBs. Guarantees of obligations In addition to the commitments discussed in note 25, Genworth Financial and certain of its holding company subsidiaries provide guarantees to third parties for the performance of certain obligations of their subsidiaries. We estimate that our potential obligations under such guarantees were $67 million and $69 million as of December 31, 2023 and 2022, respectively. Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations. 244 245 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 While some of these items may be significant components of net income (loss) available to Genworth Financial, Inc.’s common stockholders in accordance with U.S. GAAP, we believe that adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders, and measures that are derived from or incorporate adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders, among other key performance indicators, as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders is not a substitute for net income (loss) available to Genworth Financial, Inc.’s common stockholders determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders may differ from the definitions used by other companies. Adjustments to reconcile net income (loss) available to Genworth Financial, Inc.’s common stockholders to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments. Genworth Holdings also provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies in-force prior to the sale date and those written approximately 90 days subsequent to the date of the sale, and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. As of December 31, 2023, the risk in-force of active policies was approximately $893 million. (23) Segment Information (a) Operating Segment Information We have the following three operating segments: Enact; Long-Term Care Insurance; and Life and Annuities. The products in the Life and Annuities segment include traditional and non-traditional life insurance (term, universal and term universal life insurance as well as corporate-owned life insurance and funding agreements), fixed annuities and variable annuities, none of which are actively marketed or sold. In addition to our three operating segments, we also have Corporate and Other, which includes debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter- segment transactions and the results of other businesses that are reported outside of our operating segments, such as certain international businesses and discontinued operations. Corporate and Other also includes start-up results of our CareScout business related to our senior care growth initiatives. We tax our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other. We use the same accounting policies and procedures to measure segment income (loss) and assets as our consolidated net income and assets. Management evaluates performance and allocates resources on the basis of “adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders.” We define adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders as income (loss) from continuing operations excluding the after-tax effects of income (loss) from continuing operations attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. We exclude net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders because, in our opinion, they are not indicative of overall operating performance. 246 247 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 While some of these items may be significant components of net income (loss) available to Genworth Financial, Inc.’s common stockholders in accordance with U.S. GAAP, we believe that adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders, and measures that are derived from or incorporate adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders, among other key performance indicators, as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders is not a substitute for net income (loss) available to Genworth Financial, Inc.’s common stockholders determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders may differ from the definitions used by other companies. Adjustments to reconcile net income (loss) available to Genworth Financial, Inc.’s common stockholders to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments. Genworth Holdings also provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies in-force prior to the sale date and those written approximately 90 days subsequent to the date of the sale, and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. As of December 31, 2023, the risk in-force of active policies was approximately $893 million. (23) Segment Information (a) Operating Segment Information We have the following three operating segments: Enact; Long-Term Care Insurance; and Life and Annuities. The products in the Life and Annuities segment include traditional and non-traditional life insurance (term, universal and term universal life insurance as well as corporate-owned life insurance and funding agreements), fixed annuities and variable annuities, none of which are actively marketed or sold. In addition to our three operating segments, we also have Corporate and Other, which includes debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter- segment transactions and the results of other businesses that are reported outside of our operating segments, such as certain international businesses and discontinued operations. Corporate and Other also includes start-up results of our CareScout business related to our senior care growth initiatives. We tax our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other. We use the same accounting policies and procedures to measure segment income (loss) and assets as our consolidated net income and assets. Management evaluates performance and allocates resources on the basis of “adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders.” We define adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders as income (loss) from continuing operations excluding the after-tax effects of income (loss) from continuing operations attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. We exclude net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders because, in our opinion, they are not indicative of overall operating performance. 246 247 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following is a summary of our segments and Corporate and Other as of and for the years ended December 31: (Amounts in millions) 2023 Long-Term Care Insurance Enact Life and Annuities Corporate and Other Total Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . . . . . . $ 957 208 (14) 2 $ 2,463 1,914 114 — Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,153 4,491 $ $ 207 1,042 (49) 646 1,846 9 19 (28) (2) (2) $ 3,636 3,183 23 646 7,488 Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . . . . . Liability remeasurement (gains) losses . . . . . . . . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition and operating expenses, net of deferrals . . . . . Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total benefits and expenses . . . . . . . . . . . . . . . . . Income (loss) from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision (benefit) for income taxes . . . . . . . . . . . . . . . . . . Income (loss) from continuing operations . . . . . . . . . . . . . . Income from discontinued operations, net of taxes . . . . . . . Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . Net income (loss) available to Genworth Financial, Inc.’s 27 — — — 212 11 52 302 851 186 665 — 665 123 — 3,802 321 — — 452 71 — 4,646 (155) (3) (152) — (152) — — 963 266 (12) 503 213 181 — 2,114 (268) (59) (209) — (209) — — (9) — 4,783 587 — — 65 1 66 123 (125) (20) (105) — (105) — — (12) 503 942 264 118 7,185 303 104 199 — 199 123 — common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 542 $ (152) $ (209) $ (105) $ 76 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income (loss) available to Genworth Financial, $ 542 $ (152) $ (209) $ (105) $ 76 — — — — — Inc.’s common stockholders . . . . . . . . . . . . . . . . . . $ 542 $ (152) $ (209) $ (105) $ 76 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $6,193 $46,195 $36,517 $1,912 $90,817 Long-Term Care Enact Insurance Life and Annuities Corporate and Other Total 2022 234 1,083 (4) 669 1,982 620 27 (104) 504 604 240 — 91 16 75 — 75 — — $ 6 8 $ 3,680 3,146 (15) — (1) (11) — — — 41 — 54 84 (85) (16) (69) — (69) — — (2) 671 7,495 4,303 (290) (104) 504 1,285 326 106 6,130 1,365 319 1,046 — 1,046 130 — Total benefits and expenses . . . . . . . . . . . . . . . . . 3,958 1,891 (Amounts in millions) Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 940 $ 2,500 $ Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . . . . . . 155 (2) 2 Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,095 1,900 19 — 4,419 Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . . . . . Liability remeasurement (gains) losses . . . . . . . . . . . . . . . . (94) — 3,788 (317) — — 227 12 52 197 898 194 704 — 704 130 — — — 413 74 — 461 125 336 — 336 — — Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition and operating expenses, net of deferrals . . . . . Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income (loss) from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision (benefit) for income taxes . . . . . . . . . . . . . . . . . . Income (loss) from continuing operations . . . . . . . . . . . . . . Income from discontinued operations, net of taxes . . . . . . . Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . Net income (loss) available to Genworth Financial, Inc.’s Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 574 $ 336 $ 75 $ (69) $ 916 stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — Net income (loss) available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . $ 574 $ 336 $ 75 $ (69) $ 916 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $5,712 $44,156 $37,975 $1,871 $89,714 common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 574 $ 336 $ 75 $ (69) $ 916 248 249 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Total benefits and expenses . . . . . . . . . . . . . . . . . 4,646 2,114 The following is a summary of our segments and Corporate and Other as of and for the years ended December 31: (Amounts in millions) Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 957 $ 2,463 $ $ Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . . . . . . 208 (14) 2 Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,153 Long-Term Care Enact Insurance Life and Annuities Corporate and Other Total 2023 207 1,042 (49) 646 1,846 963 266 (12) 503 213 181 — (268) (59) (209) — (209) — — 9 19 (28) (2) (2) $ 3,636 3,183 23 646 7,488 (9) — 4,783 587 — — 65 1 66 123 (125) (20) (105) — (105) — — (12) 503 942 264 118 7,185 303 104 199 — 199 123 — 1,914 114 — 4,491 3,802 321 — — 452 71 — (155) (3) (152) — (152) — — 27 — — — 212 11 52 302 851 186 665 — 665 123 — Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . . . . . Liability remeasurement (gains) losses . . . . . . . . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition and operating expenses, net of deferrals . . . . . Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income (loss) from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision (benefit) for income taxes . . . . . . . . . . . . . . . . . . Income (loss) from continuing operations . . . . . . . . . . . . . . Income from discontinued operations, net of taxes . . . . . . . Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . Net income (loss) available to Genworth Financial, Inc.’s Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common Income from discontinued operations available to Genworth Financial, Inc.’s common common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 542 $ (152) $ (209) $ (105) $ 76 stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 542 $ (152) $ (209) $ (105) $ 76 stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — — — Net income (loss) available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . $ 542 $ (152) $ (209) $ (105) $ 76 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $6,193 $46,195 $36,517 $1,912 $90,817 (Amounts in millions) Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . . . . . . Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . . . . . Liability remeasurement (gains) losses . . . . . . . . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition and operating expenses, net of deferrals . . . . . Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total benefits and expenses . . . . . . . . . . . . . . . . . Income (loss) from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision (benefit) for income taxes . . . . . . . . . . . . . . . . . . Income (loss) from continuing operations . . . . . . . . . . . . . . Income from discontinued operations, net of taxes . . . . . . . Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . Net income (loss) available to Genworth Financial, Inc.’s 2022 Long-Term Care Insurance Enact Life and Annuities Corporate and Other Total $ $ 940 155 (2) 2 1,095 $ 2,500 1,900 19 — 4,419 $ 234 1,083 (4) 669 1,982 (94) — 3,788 (317) — — 227 12 52 197 898 194 704 — 704 130 — — — 413 74 — 3,958 461 125 336 — 336 — — 620 27 (104) 504 604 240 — 1,891 91 16 75 — 75 — — 6 8 (15) — (1) (11) — — — 41 — 54 84 (85) (16) (69) — (69) — — $ 3,680 3,146 (2) 671 7,495 4,303 (290) (104) 504 1,285 326 106 6,130 1,365 319 1,046 — 1,046 130 — common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 574 $ 336 $ 75 $ (69) $ 916 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income (loss) available to Genworth Financial, $ 574 $ 336 $ 75 $ (69) $ 916 — — — — — Inc.’s common stockholders . . . . . . . . . . . . . . . . . . $ 574 $ 336 $ 75 $ (69) $ 916 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $5,712 $44,156 $37,975 $1,871 $89,714 248 249 The following is a summary of revenues of major product groups for our segments and Corporate and Other (b) Revenues of Major Product Groups for the years ended December 31: (Amounts in millions) Revenues: 2023 2022 2021 Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance segment . . . . . . . . . . . . . . . . . . . . $1,153 4,491 $1,095 4,419 $1,118 4,846 Life and Annuities segment: Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Variable annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,394 1,443 1,172 313 139 389 150 505 174 Life and Annuities segment . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,846 1,982 1,851 Corporate and Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (2) (1) 7 Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $7,488 $7,495 $7,822 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (Amounts in millions) 2021 Long-Term Care Insurance Enact Life and Annuities Corporate and Other Total Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . . . . . . . $ 975 141 (2) 4 $2,561 2,027 257 1 $ (136) 1,195 74 718 $ Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,118 4,846 1,851 Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . . . . . . Liability remeasurement (gains) losses . . . . . . . . . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition and operating expenses, net of deferrals . . . . . . Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125 — — — 230 15 51 3,808 68 — — 451 76 — 648 174 (160) 511 233 291 — Total benefits and expenses . . . . . . . . . . . . . . . . . . 421 4,403 1,697 Income (loss) from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision (benefit) for income taxes . . . . . . . . . . . . . . . . . . . Income (loss) from continuing operations . . . . . . . . . . . . . . . Income from discontinued operations, net of taxes . . . . . . . . Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . Net income (loss) available to Genworth Financial, Inc.’s 697 148 549 — 549 33 — 443 123 320 — 320 — — 154 30 124 — 124 — — 6 7 (7) 1 7 $3,406 3,370 322 724 7,822 (6) — 4,575 242 — — 84 2 109 189 (182) (53) (129) 27 (102) — 8 (160) 511 998 384 160 6,710 1,112 248 864 27 891 33 8 common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 516 $ 320 $ 124 $(110) $ 850 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . $ 516 $ 320 $ 124 $(129) $ 831 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . — — — 19 19 Net income (loss) available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . $ 516 $ 320 $ 124 $(110) $ 850 250 251 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 2021 Long-Term Care Enact Insurance Life and Annuities Corporate and Other Total (b) Revenues of Major Product Groups The following is a summary of revenues of major product groups for our segments and Corporate and Other for the years ended December 31: (Amounts in millions) 2023 2022 2021 Revenues: Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance segment . . . . . . . . . . . . . . . . . . . . Life and Annuities segment: Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Variable annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Life and Annuities segment . . . . . . . . . . . . . . . . . . . . . . . . . . . Corporate and Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,153 4,491 $1,095 4,419 $1,118 4,846 1,394 313 139 1,846 (2) $7,488 1,443 389 150 1,982 (1) $7,495 1,172 505 174 1,851 7 $7,822 (Amounts in millions) Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 975 $ (136) $ Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . Policy fees and other income . . . . . . . . . . . . . . . . . . . . . . . . . $2,561 2,027 257 1 141 (2) 4 1,195 74 718 Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,118 4,846 1,851 Total benefits and expenses . . . . . . . . . . . . . . . . . . 421 4,403 1,697 Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . . . . . . Liability remeasurement (gains) losses . . . . . . . . . . . . . . . . . Changes in fair value of market risk benefits and associated hedges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest credited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisition and operating expenses, net of deferrals . . . . . . Amortization of deferred acquisition costs and intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income (loss) from continuing operations before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision (benefit) for income taxes . . . . . . . . . . . . . . . . . . . Income (loss) from continuing operations . . . . . . . . . . . . . . . Income from discontinued operations, net of taxes . . . . . . . . Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Less: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . — Net income (loss) available to Genworth Financial, Inc.’s Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to 125 — — — 230 15 51 697 148 549 — 549 3,808 68 — — 451 76 — 443 123 320 — 320 — — 648 174 (160) 511 233 291 — 154 30 124 — 124 — — (7) 6 7 1 7 $3,406 3,370 322 724 7,822 (6) — 4,575 242 — — 84 2 109 189 (182) (53) (129) 27 (102) — 8 (160) 511 998 384 160 6,710 1,112 248 864 27 891 33 8 common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 516 $ 320 $ 124 $(110) $ 850 Genworth Financial, Inc.’s common stockholders . . . $ 516 $ 320 $ 124 $(129) $ 831 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . — — — 19 19 Net income (loss) available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . $ 516 $ 320 $ 124 $(110) $ 850 250 251 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (c) Reconciliations The following tables present the reconciliation of net income available to Genworth Financial, Inc.’s common stockholders to adjusted operating income available to Genworth Financial, Inc.’s common stockholders and a summary of adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for our segments and Corporate and Other for the years ended December 31: (Amounts in millions) 2023 2022 2021 Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 76 $ 916 $ 850 Add: net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 130 33 Add: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: income from discontinued operations, net of taxes . . . . . . . Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to — 199 — 199 — 1,046 — 1,046 8 891 27 864 noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 130 33 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: Net investment (gains) losses, net(1) . . . . . . . . . . . . . . . . . . . . . . . Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges(2) . . . . . . . (Gains) losses on early extinguishment of debt(3) . . . . . . . . . . . . . Expenses related to restructuring . . . . . . . . . . . . . . . . . . . . . . . . . Pension plan termination costs . . . . . . . . . . . . . . . . . . . . . . . . . . . Taxes on adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjusted operating income available to Genworth Financial, 76 916 831 The following is a summary of geographic region activity as of and for the years ended December 31: (25) (22) (2) 4 — 10 2 (322) (142) 6 2 8 26 (210) 45 34 — 96 Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 41 $ 818 $ 474 (Amounts in millions) United States International (1) Total (1) For the year ended December 31, 2023, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $2 million. (2) Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(10) million, $(38) million and $(50) million for the years ended December 31, 2023, 2022 and 2021, respectively. (3) See note 17 for additional information on (gains) losses on early extinguishment of debt during 2023 and 2022. During 2021, we paid pre-tax make-whole premiums of $26 million and incurred pre-tax losses of $19 million in connection with the early redemption and repurchase of certain of Genworth Holdings’ senior notes. 252 (1) Predominantly comprised of operations in Mexico. 253 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (Amounts in millions) 2023 2022 2021 Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance segment . . . . . . . . . . . . . . . . . . . . . . . $ 552 (242) $ 578 320 $ 520 126 Life and Annuities segment: Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Variable annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Life and Annuities segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Corporate and Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjusted operating income available to Genworth Financial, (275) (111) (201) 50 37 (188) (81) 62 21 (28) (52) 83 22 (96) (76) Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 41 $ 818 $ 474 Other than pension plan termination costs incurred in 2022 related to one of our defined benefit pension plans, there were no infrequent or unusual items excluded from adjusted operating income during the periods presented. (d) Geographic Segment Information (Amounts in millions) United States International (1) Total Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7,476 12 $ 7,488 Income from continuing operations . . . . . . . . . . . Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ $ 197 197 2 2 $ $ 199 199 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $90,767 50 $90,817 Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7,487 Income from continuing operations . . . . . . . . . . . $ 1,046 Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1,046 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $89,672 $ 7,495 $ 1,046 $ 1,046 $89,714 (Amounts in millions) United States International (1) Total Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income (loss) from continuing operations . . . . . . . Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . $7,815 $ 867 $ 894 $ $ $ 7 (3) (3) $7,822 $ 864 $ 891 2023 $ $ $ $ 2022 $ 8 $— $— $ 42 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (c) Reconciliations The following tables present the reconciliation of net income available to Genworth Financial, Inc.’s common stockholders to adjusted operating income available to Genworth Financial, Inc.’s common stockholders and a summary of adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for our segments and Corporate and Other for the years ended December 31: (Amounts in millions) 2023 2022 2021 Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 76 $ 916 $ 850 Add: net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 130 33 Add: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: income from discontinued operations, net of taxes . . . . . . . Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . . Less: net income from continuing operations attributable to — 199 — 199 — 1,046 — 1,046 8 891 27 864 noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 130 33 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . 76 916 831 Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: Net investment (gains) losses, net(1) . . . . . . . . . . . . . . . . . . . . . . . (25) 2 (322) Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges(2) . . . . . . . (142) (210) (Gains) losses on early extinguishment of debt(3) . . . . . . . . . . . . . Expenses related to restructuring . . . . . . . . . . . . . . . . . . . . . . . . . Pension plan termination costs . . . . . . . . . . . . . . . . . . . . . . . . . . . Taxes on adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjusted operating income available to Genworth Financial, (22) (2) 4 — 10 6 2 8 26 45 34 — 96 (1) For the year ended December 31, 2023, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $2 million. (2) Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(10) million, $(38) million and $(50) million for the years ended December 31, 2023, 2022 and 2021, respectively. (3) See note 17 for additional information on (gains) losses on early extinguishment of debt during 2023 and 2022. During 2021, we paid pre-tax make-whole premiums of $26 million and incurred pre-tax losses of $19 million in connection with the early redemption and repurchase of certain of Genworth Holdings’ senior notes. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (Amounts in millions) 2023 2022 2021 Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: Enact segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance segment . . . . . . . . . . . . . . . . . . . . . . . Life and Annuities segment: Life insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fixed annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Variable annuities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Life and Annuities segment Corporate and Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adjusted operating income available to Genworth Financial, $ 552 (242) $ 578 320 $ 520 126 (275) 50 37 (188) (81) (111) 62 21 (28) (52) (201) 83 22 (96) (76) Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 41 $ 818 $ 474 Other than pension plan termination costs incurred in 2022 related to one of our defined benefit pension plans, there were no infrequent or unusual items excluded from adjusted operating income during the periods presented. (d) Geographic Segment Information The following is a summary of geographic region activity as of and for the years ended December 31: (Amounts in millions) United States International (1) Total Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7,476 Income from continuing operations . . . . . . . . . . . Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ $ 197 197 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $90,767 $ $ $ $ 12 $ 7,488 2 2 $ $ 199 199 50 $90,817 2023 2022 Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 41 $ 818 $ 474 (Amounts in millions) United States International (1) Total Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7,487 Income from continuing operations . . . . . . . . . . . $ 1,046 Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1,046 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $89,672 $ 7,495 $ 1,046 $ 1,046 $89,714 $ 8 $— $— $ 42 2021 (Amounts in millions) United States International (1) Total Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income (loss) from continuing operations . . . . . . . Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . $7,815 $ 867 $ 894 $ $ $ 7 (3) (3) $7,822 $ 864 $ 891 252 (1) Predominantly comprised of operations in Mexico. 253 (2) In the fourth quarter of 2023, our long-term care insurance business had a pre-tax liability remeasurement loss of $188 million that included adverse pre-tax cash flow assumption updates of $61 million driven mostly by unfavorable updates to our healthy life assumptions to better reflect near-term experience related to cost of care, mortality, incidence and lapse, partially offset by a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post COVID-19. The liability remeasurement loss also included pre-tax unfavorable actual versus expected experience of $127 million due primarily to higher claims and unfavorable timing impacts related (3) In the fourth quarter of 2023, our life insurance products included adverse pre-tax cash flow assumption updates of $226 million reflecting unfavorable persistency and mortality assumption updates. (4) In the fourth quarter of 2023, our Enact segment recorded a favorable pre-tax reserve release of $53 million primarily related to cure performance on delinquencies from 2022 and earlier, including those related to COVID-19. (5) Under applicable accounting guidance, companies in a loss position are required to use basic weighted- average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended December 31, 2023, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share as the inclusion of shares for PSUs, RSUs and other equity-based awards of 6.3 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended December 31, 2023, dilutive potential weighted-average common shares outstanding would have been 455.7 million. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (24) Quarterly Results of Operations (unaudited) Our unaudited quarterly results of operations for the year ended December 31, 2023 are summarized in the table below. (Amounts in millions, except per share amounts) Three months ended March 31, 2023 June 30, 2023 September 30, 2023 December 31, 2023 Total revenues(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,854 $1,892 $1,831 $1,911 to a second legal settlement. Total benefits and expenses(2), (3), (4) . . . . . . . . . . . . . . . . . . . . $1,645 $1,671 $1,741 $2,128 Income (loss) from continuing operations(1), (2), (3), (4) . . . . . . $ 154 $ 166 $ 60 $ (181) Income (loss) from discontinued operations, net of taxes . . $ — $ 2 $ — $ (2) Net income (loss)(1), (2), (3), (4) . . . . . . . . . . . . . . . . . . . . . . . . . $ 154 $ 168 Net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 32 $ 31 $ $ 60 $ (183) 31 $ 29 Net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — $ — $ — $ — Net income (loss) available to Genworth Financial, Inc.’s common stockholders(1), (2), (3), (4) . . . . . . . . . . . . . . . . . . . . $ 122 $ 137 $ 29 $ (212) Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders . . $ 122 $ 135 $ 29 $ (210) Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income (loss) available to Genworth Financial, — 2 — (2) Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . $ 122 $ 137 $ 29 $ (212) Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.25 $ 0.28 $ 0.06 $ (0.47) Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.24 $ 0.28 $ 0.06 $ (0.47) Net income (loss) available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.25 $ 0.29 $ 0.06 $ (0.47) Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.24 $ 0.29 $ 0.06 $ (0.47) Weighted-average common shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Diluted(5) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 492.3 500.1 473.2 478.1 460.5 466.0 449.4 449.4 (1) Pre-tax net investment gains of $90 million associated with limited partnerships and changes in the fair value of equity securities resulted in an increase in total revenues in the fourth quarter of 2023. 254 255 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (2) (3) (4) In the fourth quarter of 2023, our long-term care insurance business had a pre-tax liability remeasurement loss of $188 million that included adverse pre-tax cash flow assumption updates of $61 million driven mostly by unfavorable updates to our healthy life assumptions to better reflect near-term experience related to cost of care, mortality, incidence and lapse, partially offset by a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post COVID-19. The liability remeasurement loss also included pre-tax unfavorable actual versus expected experience of $127 million due primarily to higher claims and unfavorable timing impacts related to a second legal settlement. In the fourth quarter of 2023, our life insurance products included adverse pre-tax cash flow assumption updates of $226 million reflecting unfavorable persistency and mortality assumption updates. In the fourth quarter of 2023, our Enact segment recorded a favorable pre-tax reserve release of $53 million primarily related to cure performance on delinquencies from 2022 and earlier, including those related to COVID-19. (5) Under applicable accounting guidance, companies in a loss position are required to use basic weighted- average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended December 31, 2023, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share as the inclusion of shares for PSUs, RSUs and other equity-based awards of 6.3 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended December 31, 2023, dilutive potential weighted-average common shares outstanding would have been 455.7 million. (24) Quarterly Results of Operations (unaudited) Our unaudited quarterly results of operations for the year ended December 31, 2023 are summarized in the table below. Three months ended March 31, June 30, September 30, December 31, 2023 2023 2023 2023 (Amounts in millions, except per share amounts) Total revenues(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,854 $1,892 $1,831 $1,911 Total benefits and expenses(2), (3), (4) . . . . . . . . . . . . . . . . . . . . $1,645 $1,671 $1,741 $2,128 Income (loss) from continuing operations(1), (2), (3), (4) . . . . . . $ 154 $ 166 60 $ (181) Income (loss) from discontinued operations, net of taxes . . $ — $ 2 $ — $ (2) Net income (loss)(1), (2), (3), (4) . . . . . . . . . . . . . . . . . . . . . . . . . $ 154 $ 168 60 $ (183) Net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 32 $ 31 31 $ 29 Net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — $ — $ — $ — Net income (loss) available to Genworth Financial, Inc.’s common stockholders(1), (2), (3), (4) . . . . . . . . . . . . . . . . . . . . $ 122 $ 137 $ 29 $ (212) $ $ $ Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common Genworth Financial, Inc.’s common stockholders . . $ 122 $ 135 $ 29 $ (210) stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 2 — (2) Net income (loss) available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . $ 122 $ 137 $ 29 $ (212) Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.25 $ 0.28 $ 0.06 $ (0.47) Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.24 $ 0.28 $ 0.06 $ (0.47) Net income (loss) available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.25 $ 0.29 $ 0.06 $ (0.47) Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.24 $ 0.29 $ 0.06 $ (0.47) Weighted-average common shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Diluted(5) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 492.3 500.1 473.2 478.1 460.5 466.0 449.4 449.4 (1) Pre-tax net investment gains of $90 million associated with limited partnerships and changes in the fair value of equity securities resulted in an increase in total revenues in the fourth quarter of 2023. 254 255 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Our unaudited quarterly results of operations for the year ended December 31, 2022 are summarized in the table below. (Amounts in millions, except per share amounts) Three months ended March 31, 2022 June 30, 2022 September 30, 2022 December 31, 2022 Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,893 $1,887 $1,848 Total benefits and expenses(1), (2) . . . . . . . . . . . . . . . . . . . . . $1,537 $1,627 $1,628 Income from continuing operations(1), (2) . . . . . . . . . . . . . . . $ 272 $ 198 $ 166 $1,867 $1,338 $ 410 Income (loss) from discontinued operations, net of taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ (2) $ (1) $ 5 $ (2) Net income(1), (2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 270 $ 197 $ 171 $ 408 Net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . $ 30 $ 38 $ 35 $ 27 Net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . $ — $ — $ — $ — Net income available to Genworth Financial, Inc.’s common stockholders(1), (2) . . . . . . . . . . . . . . . . . . . . . . . . $ 240 $ 159 $ 136 $ 381 Net income available to Genworth Financial, Inc.’s common stockholders: Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 242 $ 160 $ 131 $ 383 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net income available to Genworth Financial, Inc.’s (2) (1) 5 (2) common stockholders . . . . . . . . . . . . . . . . . . . . . . . $ 240 $ 159 $ 136 $ 381 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.48 $ 0.32 $ 0.26 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.47 $ 0.31 $ 0.26 Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.47 $ 0.31 $ 0.27 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.46 $ 0.31 $ 0.27 $ 0.77 $ 0.76 $ 0.77 $ 0.76 Weighted-average common shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 508.3 517.4 508.9 514.1 503.8 509.3 496.5 502.9 (1) In the fourth quarter of 2022, our long-term care insurance business had a pre-tax liability remeasurement gain of $255 million primarily from favorable pre-tax cash flow assumption updates of $303 million, which reflected an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of a second legal settlement. This settlement primarily impacted older, unprofitable capped cohorts. (2) In the fourth quarter of 2022, our Enact segment recorded a net favorable pre-tax reserve release of $42 million primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations. (25) Commitments and Contingencies (a) Litigation and Regulatory Matters We face the risk of litigation and regulatory investigations and actions in the ordinary course of operating our businesses, including the risk of class action lawsuits. Our pending legal and regulatory actions include proceedings specific to us and others generally applicable to business practices in the industries in which we operate. In our insurance operations, we are, have been, or may become subject to class actions and individual suits alleging, among other things, issues relating to sales or underwriting practices, increases to in-force long- term care insurance premiums, payment of contingent or other sales commissions, claims payments and procedures, product design, product disclosure, product administration, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, recommending unsuitable products to customers, our pricing structures and business practices in our mortgage insurance subsidiaries, such as captive reinsurance arrangements with lenders and contract underwriting services, violations of the Real Estate Settlement and Procedures Act of 1974 or related state anti- inducement laws, and mortgage insurance policy rescissions and curtailments, and breaching fiduciary or other duties to customers, including but not limited to cybersecurity breaches of customer information. Plaintiffs in class action and other lawsuits against us may seek very large or indeterminate amounts which may remain unknown for substantial periods of time. In our investment-related operations, we are subject to litigation involving commercial disputes with counterparties. We are also subject to litigation arising out of our general business activities such as our contractual and employment relationships, including claims under the Employee Retirement Income Security Act of 1974, post-closing obligations associated with previous dispositions and securities lawsuits. In addition, we are also subject to various regulatory inquiries, such as information requests, subpoenas, books and record examinations and market conduct and financial examinations from state, federal and international regulators and other authorities. A substantial legal liability or a significant regulatory action against us could have an adverse effect on our business, financial condition and results of operations. Moreover, even if we ultimately prevail in the litigation, regulatory action or investigation, we could suffer significant reputational harm, which could have an adverse effect on our business, financial condition or results of operations. In September 2018, GLAIC, our indirect wholly-owned subsidiary, was named as a defendant in a putative class action lawsuit pending in the United States District Court for the Eastern District of Virginia captioned TVPX ARX INC., as Securities Intermediary for Consolidated Wealth Management, LTD. on behalf of itself and all others similarly situated v. Genworth Life and Annuity Insurance Company. Plaintiff alleges unlawful and excessive cost of insurance charges were imposed on policyholders. The complaint asserts claims for breach of contract, alleging that Genworth improperly considered non-mortality factors when calculating cost of insurance rates and failed to decrease cost of insurance charges in light of improved expectations of future mortality, and seeks unspecified compensatory damages, costs, and equitable relief. On October 29, 2018, we filed a motion to enjoin the case in the Middle District of Georgia, and a motion to dismiss and motion to stay in the Eastern District of Virginia. We moved to enjoin the prosecution of the Eastern District of Virginia action on the basis that it involves claims released in a prior nationwide class action settlement (the “McBride settlement”) that was approved by the Middle District of Georgia. Plaintiff filed an amended complaint on November 13, 2018. On December 6, 2018, we moved the Middle District of Georgia for leave to file our counterclaim, which alleges 256 257 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 Our unaudited quarterly results of operations for the year ended December 31, 2022 are summarized in the table below. (2) In the fourth quarter of 2022, our Enact segment recorded a net favorable pre-tax reserve release of $42 million primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations. (25) Commitments and Contingencies (a) Litigation and Regulatory Matters We face the risk of litigation and regulatory investigations and actions in the ordinary course of operating our businesses, including the risk of class action lawsuits. Our pending legal and regulatory actions include proceedings specific to us and others generally applicable to business practices in the industries in which we operate. In our insurance operations, we are, have been, or may become subject to class actions and individual suits alleging, among other things, issues relating to sales or underwriting practices, increases to in-force long- term care insurance premiums, payment of contingent or other sales commissions, claims payments and procedures, product design, product disclosure, product administration, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, recommending unsuitable products to customers, our pricing structures and business practices in our mortgage insurance subsidiaries, such as captive reinsurance arrangements with lenders and contract underwriting services, violations of the Real Estate Settlement and Procedures Act of 1974 or related state anti- inducement laws, and mortgage insurance policy rescissions and curtailments, and breaching fiduciary or other duties to customers, including but not limited to cybersecurity breaches of customer information. Plaintiffs in class action and other lawsuits against us may seek very large or indeterminate amounts which may remain unknown for substantial periods of time. In our investment-related operations, we are subject to litigation involving commercial disputes with counterparties. We are also subject to litigation arising out of our general business activities such as our contractual and employment relationships, including claims under the Employee Retirement Income Security Act of 1974, post-closing obligations associated with previous dispositions and securities lawsuits. In addition, we are also subject to various regulatory inquiries, such as information requests, subpoenas, books and record examinations and market conduct and financial examinations from state, federal and international regulators and other authorities. A substantial legal liability or a significant regulatory action against us could have an adverse effect on our business, financial condition and results of operations. Moreover, even if we ultimately prevail in the litigation, regulatory action or investigation, we could suffer significant reputational harm, which could have an adverse effect on our business, financial condition or results of operations. In September 2018, GLAIC, our indirect wholly-owned subsidiary, was named as a defendant in a putative class action lawsuit pending in the United States District Court for the Eastern District of Virginia captioned TVPX ARX INC., as Securities Intermediary for Consolidated Wealth Management, LTD. on behalf of itself and all others similarly situated v. Genworth Life and Annuity Insurance Company. Plaintiff alleges unlawful and excessive cost of insurance charges were imposed on policyholders. The complaint asserts claims for breach of contract, alleging that Genworth improperly considered non-mortality factors when calculating cost of insurance rates and failed to decrease cost of insurance charges in light of improved expectations of future mortality, and seeks unspecified compensatory damages, costs, and equitable relief. On October 29, 2018, we filed a motion to enjoin the case in the Middle District of Georgia, and a motion to dismiss and motion to stay in the Eastern District of Virginia. We moved to enjoin the prosecution of the Eastern District of Virginia action on the basis that it involves claims released in a prior nationwide class action settlement (the “McBride settlement”) that was approved by the Middle District of Georgia. Plaintiff filed an amended complaint on November 13, 2018. On December 6, 2018, we moved the Middle District of Georgia for leave to file our counterclaim, which alleges 256 257 Three months ended March 31, June 30, September 30, December 31, 2022 2022 2022 (Amounts in millions, except per share amounts) Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,893 $1,887 $1,848 Total benefits and expenses(1), (2) . . . . . . . . . . . . . . . . . . . . . $1,537 $1,627 $1,628 Income from continuing operations(1), (2) . . . . . . . . . . . . . . . $ 272 $ 198 $ 166 2022 $1,867 $1,338 $ 410 Income (loss) from discontinued operations, net of taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ (2) $ (1) $ 5 $ (2) Net income(1), (2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 270 $ 197 $ 171 $ 408 Net income from continuing operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . $ 30 $ 38 $ 35 $ 27 Net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . $ — $ — $ — $ — Net income available to Genworth Financial, Inc.’s common stockholders(1), (2) . . . . . . . . . . . . . . . . . . . . . . . . $ 240 $ 159 $ 136 $ 381 Net income available to Genworth Financial, Inc.’s common stockholders: Income from continuing operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 242 $ 160 $ 131 $ 383 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (2) (1) 5 (2) Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . $ 240 $ 159 $ 136 $ 381 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.48 $ 0.32 $ 0.26 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.47 $ 0.31 $ 0.26 Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.47 $ 0.31 $ 0.27 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.46 $ 0.31 $ 0.27 $ 0.77 $ 0.76 $ 0.77 $ 0.76 Weighted-average common shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 508.3 517.4 508.9 514.1 503.8 509.3 496.5 502.9 (1) In the fourth quarter of 2022, our long-term care insurance business had a pre-tax liability remeasurement gain of $255 million primarily from favorable pre-tax cash flow assumption updates of $303 million, which reflected an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of a second legal settlement. This settlement primarily impacted older, unprofitable capped cohorts. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 that plaintiff breached the covenant not to sue contained in the prior settlement agreement by filing its current action. On March 15, 2019, the Middle District of Georgia granted our motion to enjoin and denied our motion for leave to file our counterclaim. As such, plaintiff is enjoined from pursuing its class action in the Eastern District of Virginia. On March 29, 2019, plaintiff filed a notice of appeal in the Middle District of Georgia, notifying the Court of its appeal to the United States Court of Appeals for the Eleventh Circuit from the order granting our motion to enjoin. On March 29, 2019, we filed our notice of cross-appeal in the Middle District of Georgia, notifying the Court of our cross-appeal to the Eleventh Circuit from the portion of the order denying our motion for leave to file our counterclaim. On April 8, 2019, the Eastern District of Virginia dismissed the case without prejudice, with leave for plaintiff to refile an amended complaint only if a final appellate Court decision vacates the injunction and reverses the Middle District of Georgia’s opinion. On May 21, 2019, plaintiff filed its appeal and memorandum in support in the Eleventh Circuit. We filed our response to plaintiff’s appeal memorandum on July 3, 2019. The Eleventh Circuit Court of Appeals heard oral argument on plaintiff’s appeal and our cross-appeal on April 21, 2020. On May 26, 2020, the Eleventh Circuit Court of Appeals vacated the Middle District of Georgia’s order enjoining plaintiff’s class action and remanded the case back to the Middle District of Georgia for further factual development as to whether Genworth has altered how it calculates or charges cost of insurance since the McBride settlement. The Eleventh Circuit Court of Appeals did not reach a decision on Genworth’s counterclaim. On June 30, 2021, we filed in the Middle District of Georgia our renewed motion to enforce the class action settlement and release and renewed our motion for leave to file a counterclaim. The briefing on both motions concluded in October 2021. On March 24, 2022, the Court denied our motions. On April 11, 2022, we filed an appeal of the Court’s denial to the United States Court of Appeals for the Eleventh Circuit. On June 22, 2022, we filed our opening brief in support of the appeal. Plaintiff filed its respondent’s brief on September 20, 2022, and we filed our reply brief on November 10, 2022. The appeal was orally argued on August 17, 2023, and we are awaiting a decision from the Eleventh Circuit. We intend to continue to vigorously defend this action. In September 2018, Genworth Financial, Genworth Holdings, Genworth North America Corporation, Genworth Financial International Holdings, LLC (“GFIH”) and GLIC were named as defendants in a putative class action lawsuit pending in the Court of Chancery of the State of Delaware captioned Richard F. Burkhart, William E. Kelly, Richard S. Lavery, Thomas R. Pratt, Gerald Green, individually and on behalf of all other persons similarly situated v. Genworth et al. Plaintiffs allege that GLIC paid dividends to its parent and engaged in certain reinsurance transactions causing it to maintain inadequate capital capable of meeting its obligations to GLIC policyholders and agents. The complaint alleges causes of action for intentional fraudulent transfer and constructive fraudulent transfer and seeks injunctive relief. We moved to dismiss this action in December 2018. On January 29, 2019, plaintiffs exercised their right to amend their complaint. On March 12, 2019, we moved to dismiss plaintiffs’ amended complaint. On April 26, 2019, plaintiffs filed a memorandum in opposition to our motion to dismiss, which we replied to on June 14, 2019. On August 7, 2019, plaintiffs filed a motion seeking to prevent proceeds that GFIH expected to receive from the then planned sale of its shares in Genworth MI Canada Inc. (“Genworth Canada”) from being transferred out of GFIH. On September 11, 2019, plaintiffs filed a renewed motion seeking the same relief as their August 7, 2019 motion with an exception that allowed GFIH to transfer $450 million of expected proceeds from the sale of Genworth Canada through a dividend to Genworth Holdings to allow the pay-off of a senior secured term loan facility dated March 7, 2018 among Genworth Holdings as the borrower, GFIH as the limited guarantor and the lending parties thereto. Oral arguments on our motion to dismiss and plaintiffs’ motion occurred on October 21, 2019, and plaintiffs’ motion was denied. On January 31, 2020, the Court granted in part our motion to dismiss, dismissing claims relating to $395 million in dividends GLIC paid to its parent from 2012 to 2014 (out of the $410 million in total dividends subject to plaintiffs’ claims). The Court denied the balance of the motion to dismiss leaving a claim relating to $15 million in dividends and unquantified claims relating to the 2016 termination of a reinsurance transaction. On March 27, 2020, we filed our answer to plaintiffs’ amended complaint. On May 26, 2021, the plaintiffs filed a second amended and supplemental class action complaint adding additional factual allegations and three new causes of action. On July 26, 2021, we moved to dismiss the three new causes of action and answered the balance of the second amended and supplemental class action complaint. Plaintiffs filed an opposition to our motion to dismiss on September 30, 2021. The Court heard oral arguments on the motion on December 7, 2021 and ordered each party to file supplemental submissions, which were filed on January 28, 2022. On May 10, 2022, the Court granted our motion to dismiss the three new causes of action. On January 27, 2022, plaintiffs filed a motion for a preliminary injunction seeking to enjoin GFIH from transferring any assets to any affiliate, including paying any dividends to Genworth Holdings and to enjoin Genworth Holdings and Genworth Financial from transferring or distributing any value to Genworth Financial’s shareholders. On June 2, 2022, plaintiffs withdrew their motion for a preliminary injunction. On January 12, 2024, plaintiffs moved for class certification. We filed our opposition papers on February 23, 2024 and intend to continue to vigorously defend this action. In January 2021, GLAIC was named as a defendant in a putative class action lawsuit pending in the United States District Court for the District of Oregon captioned Patsy H. McMillan, individually and on behalf of all others similarly situated, v. Genworth Life and Annuity Insurance Company. Plaintiff sought to represent life insurance policyholders, alleging that GLAIC impermissibly calculated cost of insurance rates to be higher than permitted by her policy. The complaint asserted claims for breach of contract, conversion, and declaratory and injunctive relief, and sought damages in excess of $5 million. On February 10, 2023, the parties reached an agreement in principle to settle the action for an immaterial amount. On April 14, 2023, the action was dismissed on stipulation. On August 11, 2021, GLIC and GLICNY received a request for pre-suit mediation related to a potential class action lawsuit that may have been brought by five long-term care insurance policyholders, who sought to represent a nationwide class alleging that the defendants made misleading and inadequate disclosures regarding premium increases for long-term care insurance policies. The draft complaint asserted claims for breach of contract, conversion, and declaratory and injunctive relief, and sought damages in excess of $5 million. Genworth participated in pre-suit mediation in November 2021 and January 2022. On January 15, 2022, the parties reached an agreement in principle to settle the dispute on a nationwide basis, subject to the negotiation and execution of a final settlement agreement, and Court approval thereof. On January 28, 2022, the complaint was filed in the United States District Court for the Eastern District of Virginia captioned Fred Haney, Marsha Merrill, Sylvia Swanson, and Alan Wooten, individually, and on behalf of all others similarly situated v. Genworth Life Insurance Company and Genworth Life Insurance Company of New York. The parties executed a settlement agreement consistent with the agreement in principle signed on January 15, 2022. On May 2, 2022, the Court preliminarily approved the settlement. The final approval hearing commenced on November 17, 2022 and the Court entered judgment finally approving the settlement on February 15, 2023. Pursuant to its terms, the settlement became final on March 27, 2023. We began implementation of the settlement in the second quarter of 2023 and expect an overall net favorable economic impact to our long-term care insurance business from the settlement of this case. On August 1, 2022, a putative class action was filed in the United States District Court for the Eastern District of Virginia by two former Genworth employees against Genworth Financial, its Board of Directors and the Fiduciary and Investments Committee of Genworth Financial’s Retirement and Savings Plan (“Savings Plan”). Plaintiffs purport to act on behalf of the Savings Plan and all similarly simulated participants and beneficiaries of the Savings Plan. The complaint asserts that the defendants breached their fiduciary duties under the Employee Retirement Income Security Act of 1974 by imprudently offering and inadequately monitoring a suite of BlackRock Target Date Funds as a retirement investment option for Genworth employees. Plaintiffs seek 258 259 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 that plaintiff breached the covenant not to sue contained in the prior settlement agreement by filing its current action. On March 15, 2019, the Middle District of Georgia granted our motion to enjoin and denied our motion for leave to file our counterclaim. As such, plaintiff is enjoined from pursuing its class action in the Eastern District of Virginia. On March 29, 2019, plaintiff filed a notice of appeal in the Middle District of Georgia, notifying the Court of its appeal to the United States Court of Appeals for the Eleventh Circuit from the order granting our motion to enjoin. On March 29, 2019, we filed our notice of cross-appeal in the Middle District of Georgia, notifying the Court of our cross-appeal to the Eleventh Circuit from the portion of the order denying our motion for leave to file our counterclaim. On April 8, 2019, the Eastern District of Virginia dismissed the case without prejudice, with leave for plaintiff to refile an amended complaint only if a final appellate Court decision vacates the injunction and reverses the Middle District of Georgia’s opinion. On May 21, 2019, plaintiff filed its appeal and memorandum in support in the Eleventh Circuit. We filed our response to plaintiff’s appeal memorandum on July 3, 2019. The Eleventh Circuit Court of Appeals heard oral argument on plaintiff’s appeal and our cross-appeal on April 21, 2020. On May 26, 2020, the Eleventh Circuit Court of Appeals vacated the Middle District of Georgia’s order enjoining plaintiff’s class action and remanded the case back to the Middle District of Georgia for further factual development as to whether Genworth has altered how it calculates or charges cost of insurance since the McBride settlement. The Eleventh Circuit Court of Appeals did not reach a decision on Genworth’s counterclaim. On June 30, 2021, we filed in the Middle District of Georgia our renewed motion to enforce the class action settlement and release and renewed our motion for leave to file a counterclaim. The briefing on both motions concluded in October 2021. On March 24, 2022, the Court denied our motions. On April 11, 2022, we filed an appeal of the Court’s denial to the United States Court of Appeals for the Eleventh Circuit. On June 22, 2022, we filed our opening brief in support of the appeal. Plaintiff filed its respondent’s brief on September 20, 2022, and we filed our reply brief on November 10, 2022. The appeal was orally argued on August 17, 2023, and we are awaiting a decision from the Eleventh Circuit. We intend to continue to vigorously defend this action. In September 2018, Genworth Financial, Genworth Holdings, Genworth North America Corporation, Genworth Financial International Holdings, LLC (“GFIH”) and GLIC were named as defendants in a putative class action lawsuit pending in the Court of Chancery of the State of Delaware captioned Richard F. Burkhart, William E. Kelly, Richard S. Lavery, Thomas R. Pratt, Gerald Green, individually and on behalf of all other persons similarly situated v. Genworth et al. Plaintiffs allege that GLIC paid dividends to its parent and engaged in certain reinsurance transactions causing it to maintain inadequate capital capable of meeting its obligations to GLIC policyholders and agents. The complaint alleges causes of action for intentional fraudulent transfer and constructive fraudulent transfer and seeks injunctive relief. We moved to dismiss this action in December 2018. On January 29, 2019, plaintiffs exercised their right to amend their complaint. On March 12, 2019, we moved to dismiss plaintiffs’ amended complaint. On April 26, 2019, plaintiffs filed a memorandum in opposition to our motion to dismiss, which we replied to on June 14, 2019. On August 7, 2019, plaintiffs filed a motion seeking to prevent proceeds that GFIH expected to receive from the then planned sale of its shares in Genworth MI Canada Inc. (“Genworth Canada”) from being transferred out of GFIH. On September 11, 2019, plaintiffs filed a renewed motion seeking the same relief as their August 7, 2019 motion with an exception that allowed GFIH to transfer $450 million of expected proceeds from the sale of Genworth Canada through a dividend to Genworth Holdings to allow the pay-off of a senior secured term loan facility dated March 7, 2018 among Genworth Holdings as the borrower, GFIH as the limited guarantor and the lending parties thereto. Oral arguments on our motion to dismiss and plaintiffs’ motion occurred on October 21, 2019, and plaintiffs’ motion was denied. On January 31, 2020, the Court granted in part our motion to dismiss, dismissing claims relating to $395 million in dividends GLIC paid to its parent from 2012 to 2014 (out of the $410 million in total dividends subject to plaintiffs’ claims). The Court denied the balance of the motion to dismiss leaving a claim relating to $15 million in dividends and unquantified claims relating to the 2016 termination of a reinsurance transaction. On March 27, 2020, we filed our answer to plaintiffs’ amended complaint. On May 26, 2021, the plaintiffs filed a second amended and supplemental class action complaint adding additional factual allegations and three new causes of action. On July 26, 2021, we moved to dismiss the three new causes of action and answered the balance of the second amended and supplemental class action complaint. Plaintiffs filed an opposition to our motion to dismiss on September 30, 2021. The Court heard oral arguments on the motion on December 7, 2021 and ordered each party to file supplemental submissions, which were filed on January 28, 2022. On May 10, 2022, the Court granted our motion to dismiss the three new causes of action. On January 27, 2022, plaintiffs filed a motion for a preliminary injunction seeking to enjoin GFIH from transferring any assets to any affiliate, including paying any dividends to Genworth Holdings and to enjoin Genworth Holdings and Genworth Financial from transferring or distributing any value to Genworth Financial’s shareholders. On June 2, 2022, plaintiffs withdrew their motion for a preliminary injunction. On January 12, 2024, plaintiffs moved for class certification. We filed our opposition papers on February 23, 2024 and intend to continue to vigorously defend this action. In January 2021, GLAIC was named as a defendant in a putative class action lawsuit pending in the United States District Court for the District of Oregon captioned Patsy H. McMillan, individually and on behalf of all others similarly situated, v. Genworth Life and Annuity Insurance Company. Plaintiff sought to represent life insurance policyholders, alleging that GLAIC impermissibly calculated cost of insurance rates to be higher than permitted by her policy. The complaint asserted claims for breach of contract, conversion, and declaratory and injunctive relief, and sought damages in excess of $5 million. On February 10, 2023, the parties reached an agreement in principle to settle the action for an immaterial amount. On April 14, 2023, the action was dismissed on stipulation. On August 11, 2021, GLIC and GLICNY received a request for pre-suit mediation related to a potential class action lawsuit that may have been brought by five long-term care insurance policyholders, who sought to represent a nationwide class alleging that the defendants made misleading and inadequate disclosures regarding premium increases for long-term care insurance policies. The draft complaint asserted claims for breach of contract, conversion, and declaratory and injunctive relief, and sought damages in excess of $5 million. Genworth participated in pre-suit mediation in November 2021 and January 2022. On January 15, 2022, the parties reached an agreement in principle to settle the dispute on a nationwide basis, subject to the negotiation and execution of a final settlement agreement, and Court approval thereof. On January 28, 2022, the complaint was filed in the United States District Court for the Eastern District of Virginia captioned Fred Haney, Marsha Merrill, Sylvia Swanson, and Alan Wooten, individually, and on behalf of all others similarly situated v. Genworth Life Insurance Company and Genworth Life Insurance Company of New York. The parties executed a settlement agreement consistent with the agreement in principle signed on January 15, 2022. On May 2, 2022, the Court preliminarily approved the settlement. The final approval hearing commenced on November 17, 2022 and the Court entered judgment finally approving the settlement on February 15, 2023. Pursuant to its terms, the settlement became final on March 27, 2023. We began implementation of the settlement in the second quarter of 2023 and expect an overall net favorable economic impact to our long-term care insurance business from the settlement of this case. On August 1, 2022, a putative class action was filed in the United States District Court for the Eastern District of Virginia by two former Genworth employees against Genworth Financial, its Board of Directors and the Fiduciary and Investments Committee of Genworth Financial’s Retirement and Savings Plan (“Savings Plan”). Plaintiffs purport to act on behalf of the Savings Plan and all similarly simulated participants and beneficiaries of the Savings Plan. The complaint asserts that the defendants breached their fiduciary duties under the Employee Retirement Income Security Act of 1974 by imprudently offering and inadequately monitoring a suite of BlackRock Target Date Funds as a retirement investment option for Genworth employees. Plaintiffs seek 258 259 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 declaratory and injunctive relief, monetary damages, and attorney’s fees. By stipulation entered September 6, 2022, the complaint was dismissed, without prejudice, against the Board of Directors and the Fiduciary and Investments Committee of Genworth Financial’s Savings Plan. On October 17, 2022, we moved to dismiss the complaint against the sole remaining defendant, Genworth Financial. Plaintiffs filed opposition papers on November 10, 2022, and we filed our reply papers on November 16, 2022. By order dated January 20, 2023, the Court granted plaintiffs’ motion to serve an amended complaint, rendering our initial motion to dismiss moot. On January 20, 2023, plaintiffs filed an amended complaint, and on February 2, 2023, we filed a motion to dismiss the amended complaint. On March 16, 2023, the Court directed plaintiffs to file a second amended complaint and denied as moot our motion to dismiss the amended complaint. Plaintiffs filed the second amended complaint on April 17, 2023. On May 15, 2023, we answered and moved to dismiss the second amended complaint. On September 13, 2023, the Court granted in part and denied in part our motion to dismiss the second amended complaint. Plaintiffs moved for class certification on October 16, 2023, and we filed opposition papers on December 4, 2023. Oral argument on plaintiffs’ class certification motion was heard on February 12, 2024, and we are awaiting the Court’s ruling. On February 20, 2024, we moved for summary judgment dismissing the claims. Trial is scheduled for May 20, 2024. We intend to continue to vigorously defend this action. On December 16, 2022, Blue Cross Blue Shield of Nebraska (“BCBSNE”) served an arbitration demand on GLIC in relation to BCBSNE’s stated intent to recapture a block of long-term care insurance policies for which the risk was partly ceded to GLIC. In its arbitration demand, BCBSNE alleges that GLIC breached the governing reinsurance agreement by refusing to agree to transfer assets equal to the fair value of the liabilities being recaptured. BCBSNE asserts it has satisfied all of its obligations under the reinsurance agreement and is seeking to recapture the ceded block of reinsurance. BCBSNE seeks damages equal to the fair value of the recaptured liabilities, plus interest and other damages, including attorneys’ fees and costs. The arbitration panel has been appointed and an organizational meeting was held on August 30, 2023. The trial is scheduled for September and October of 2024. We intend to vigorously defend this arbitration proceeding. Starting in June 2023, various Genworth entities (including Genworth Financial, GLIC and GLAIC) have been named as defendants in certain of ten putative class action lawsuits in the United States District Courts for the Eastern District of Virginia and the District of Massachusetts. These cases are captioned as follows: King v. Genworth Financial, Inc.; Anastasio v. Genworth Financial, Inc. et al; Hauser v. Genworth Life Insurance Company; Smith v. Genworth Financial, Inc.; Behrens v. Genworth Life Insurance Company; Hale et al v. Genworth Financial, Inc.; Burkett, Jr. v. Genworth Life and Annuity Insurance Company; Manar v. Genworth Financial, Inc.; Kennedy v. Genworth Financial, Inc.; and Bailey v. Genworth Financial, Inc. The actions relate to the data security events involving the MOVEit file transfer system (“MOVEit Cybersecurity Incident”), which PBI Research Services (“PBI”), a third-party vendor, uses in the performance of its services. Our life insurance subsidiaries use PBI to, among other things, satisfy applicable regulatory obligations to search various databases to identify the deaths of insured persons under life insurance policies, and to identify the deaths of long-term care insurance and annuity policies which can impact premium payment obligations and benefit eligibility. Plaintiffs seek to represent various classes and subclasses of Genworth long-term care insurance policyholders and agents whose data was accessed or potentially accessed by the MOVEit Cybersecurity Incident, alleging that Genworth breached its purported duty to safeguard their sensitive data from cybercriminals. The complaints assert claims for, inter alia, negligence, negligence per se, breach of contract, unjust enrichment, and violations of various consumer protection and privacy statutes, and they seek, inter alia, declaratory and injunctive relief, compensatory and punitive damages, restitution, attorneys’ fees and costs. On October 4, 2023, the Joint Panel on Multidistrict Litigation issued an order consolidating all actions relating to the MOVEit Cybersecurity Incident before a single federal judge in the United States District Court for the District of Massachusetts. We intend to vigorously defend these actions. On October 20, 2023, GLIC was named as the defendant in a putative class action lawsuit in the United States District Court for the Eastern District of Virginia captioned Martin Silverstein, on behalf of himself and all others similarly situated v. Genworth Life Insurance Company. The complaint alleges that GLIC subjected universal life insurance policyholders to impermissible increases in cost of insurance charges, thereby breaching the underlying contracts. The complaint seeks, among other things, monetary damages and reinstatement of any lapsed policies. We intend to vigorously defend this action. At this time, we cannot determine or predict the ultimate outcome of any of the pending legal and regulatory matters specifically identified above or the likelihood of potential future legal and regulatory matters against us. In addition, we are not able to provide an estimate or range of reasonably possible losses related to these matters. Therefore, we cannot ensure that the current investigations and proceedings will not have a material adverse effect on our business, financial condition or results of operations. In addition, it is possible that related investigations and proceedings may be commenced in the future, and we could become subject to additional unrelated investigations and lawsuits. Increased regulatory scrutiny and any resulting investigations or proceedings could result in new legal precedents and industry-wide regulations or practices that could adversely affect our business, financial condition and results of operations. (b) Commitments See note 21 for amounts we were committed to fund related to our investments as of December 31, 2023. (26) Changes in Accumulated Other Comprehensive Income (Loss) The following tables show the changes in accumulated other comprehensive income (loss), net of taxes, by component as of and for the periods indicated: Net unrealized investment gains (losses) Derivatives qualifying as hedges (1) Change in the discount rate used to measure future policy benefits Change in instrument- specific credit risk of market risk benefits Foreign currency translation and other adjustments (Amounts in millions) Balances as of January 1, 2023 . . . . . . $(3,407) $1,200 $ (10) $ $(2,614) OCI before reclassifications . . . . . . Amounts reclassified from OCI . . . Current period OCI . . . . . . . . . . . . . 1,206 99 1,305 (39) (151) (190) $ (403) (1,036) — (1,036) 2 — 2 Total 137 (50) 87 6 4 2 6 Balances as of December 31, 2023 Less: change in OCI attributable to before noncontrolling interests . . . . (2,102) 1,010 (1,439) (8) 12 (2,527) noncontrolling interests . . . . . . . . . 28 — — — — 28 Balances as of December 31, 2023 . . . $(2,130) $1,010 $(1,439) $ (8) $ 12 $(2,555) (1) See note 6 for additional information. 260 261 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 On October 20, 2023, GLIC was named as the defendant in a putative class action lawsuit in the United States District Court for the Eastern District of Virginia captioned Martin Silverstein, on behalf of himself and all others similarly situated v. Genworth Life Insurance Company. The complaint alleges that GLIC subjected universal life insurance policyholders to impermissible increases in cost of insurance charges, thereby breaching the underlying contracts. The complaint seeks, among other things, monetary damages and reinstatement of any lapsed policies. We intend to vigorously defend this action. At this time, we cannot determine or predict the ultimate outcome of any of the pending legal and regulatory matters specifically identified above or the likelihood of potential future legal and regulatory matters against us. In addition, we are not able to provide an estimate or range of reasonably possible losses related to these matters. Therefore, we cannot ensure that the current investigations and proceedings will not have a material adverse effect on our business, financial condition or results of operations. In addition, it is possible that related investigations and proceedings may be commenced in the future, and we could become subject to additional unrelated investigations and lawsuits. Increased regulatory scrutiny and any resulting investigations or proceedings could result in new legal precedents and industry-wide regulations or practices that could adversely affect our business, financial condition and results of operations. (b) Commitments See note 21 for amounts we were committed to fund related to our investments as of December 31, 2023. (26) Changes in Accumulated Other Comprehensive Income (Loss) The following tables show the changes in accumulated other comprehensive income (loss), net of taxes, by component as of and for the periods indicated: (Amounts in millions) Balances as of January 1, 2023 . . . . . . OCI before reclassifications . . . . . . Amounts reclassified from OCI . . . Net unrealized investment gains (losses) $(3,407) 1,206 99 Current period OCI . . . . . . . . . . . . . 1,305 (190) (1,036) Balances as of December 31, 2023 before noncontrolling interests . . . . (2,102) 1,010 (1,439) Less: change in OCI attributable to Change in the discount rate used to measure future policy benefits Change in instrument- specific credit risk of market risk benefits Foreign currency translation and other adjustments Derivatives qualifying as hedges (1) $1,200 (39) (151) $ (403) (1,036) — $ (10) 2 — 2 (8) Total $(2,614) 137 (50) 87 $ 6 4 2 6 12 (2,527) noncontrolling interests . . . . . . . . . 28 — — — — 28 Balances as of December 31, 2023 . . . $(2,130) $1,010 $(1,439) $ (8) $ 12 $(2,555) (1) See note 6 for additional information. 260 261 declaratory and injunctive relief, monetary damages, and attorney’s fees. By stipulation entered September 6, 2022, the complaint was dismissed, without prejudice, against the Board of Directors and the Fiduciary and Investments Committee of Genworth Financial’s Savings Plan. On October 17, 2022, we moved to dismiss the complaint against the sole remaining defendant, Genworth Financial. Plaintiffs filed opposition papers on November 10, 2022, and we filed our reply papers on November 16, 2022. By order dated January 20, 2023, the Court granted plaintiffs’ motion to serve an amended complaint, rendering our initial motion to dismiss moot. On January 20, 2023, plaintiffs filed an amended complaint, and on February 2, 2023, we filed a motion to dismiss the amended complaint. On March 16, 2023, the Court directed plaintiffs to file a second amended complaint and denied as moot our motion to dismiss the amended complaint. Plaintiffs filed the second amended complaint on April 17, 2023. On May 15, 2023, we answered and moved to dismiss the second amended complaint. On September 13, 2023, the Court granted in part and denied in part our motion to dismiss the second amended complaint. Plaintiffs moved for class certification on October 16, 2023, and we filed opposition papers on December 4, 2023. Oral argument on plaintiffs’ class certification motion was heard on February 12, 2024, and we are awaiting the Court’s ruling. On February 20, 2024, we moved for summary judgment dismissing the claims. Trial is scheduled for May 20, 2024. We intend to continue to vigorously defend this action. On December 16, 2022, Blue Cross Blue Shield of Nebraska (“BCBSNE”) served an arbitration demand on GLIC in relation to BCBSNE’s stated intent to recapture a block of long-term care insurance policies for which the risk was partly ceded to GLIC. In its arbitration demand, BCBSNE alleges that GLIC breached the governing reinsurance agreement by refusing to agree to transfer assets equal to the fair value of the liabilities being recaptured. BCBSNE asserts it has satisfied all of its obligations under the reinsurance agreement and is seeking to recapture the ceded block of reinsurance. BCBSNE seeks damages equal to the fair value of the recaptured liabilities, plus interest and other damages, including attorneys’ fees and costs. The arbitration panel has been appointed and an organizational meeting was held on August 30, 2023. The trial is scheduled for September and October of 2024. We intend to vigorously defend this arbitration proceeding. Starting in June 2023, various Genworth entities (including Genworth Financial, GLIC and GLAIC) have been named as defendants in certain of ten putative class action lawsuits in the United States District Courts for the Eastern District of Virginia and the District of Massachusetts. These cases are captioned as follows: King v. Genworth Financial, Inc.; Anastasio v. Genworth Financial, Inc. et al; Hauser v. Genworth Life Insurance Company; Smith v. Genworth Financial, Inc.; Behrens v. Genworth Life Insurance Company; Hale et al v. Genworth Financial, Inc.; Burkett, Jr. v. Genworth Life and Annuity Insurance Company; Manar v. Genworth Financial, Inc.; Kennedy v. Genworth Financial, Inc.; and Bailey v. Genworth Financial, Inc. The actions relate to the data security events involving the MOVEit file transfer system (“MOVEit Cybersecurity Incident”), which PBI Research Services (“PBI”), a third-party vendor, uses in the performance of its services. Our life insurance subsidiaries use PBI to, among other things, satisfy applicable regulatory obligations to search various databases to identify the deaths of insured persons under life insurance policies, and to identify the deaths of long-term care insurance and annuity policies which can impact premium payment obligations and benefit eligibility. Plaintiffs seek to represent various classes and subclasses of Genworth long-term care insurance policyholders and agents whose data was accessed or potentially accessed by the MOVEit Cybersecurity Incident, alleging that Genworth breached its purported duty to safeguard their sensitive data from cybercriminals. The complaints assert claims for, inter alia, negligence, negligence per se, breach of contract, unjust enrichment, and violations of various consumer protection and privacy statutes, and they seek, inter alia, declaratory and injunctive relief, compensatory and punitive damages, restitution, attorneys’ fees and costs. On October 4, 2023, the Joint Panel on Multidistrict Litigation issued an order consolidating all actions relating to the MOVEit Cybersecurity Incident before a single federal judge in the United States District Court for the District of Massachusetts. We intend to vigorously defend these actions. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 (Amounts in millions) Balances as of January 1, 2022 . . . . . OCI before reclassifications . . . . . . Amounts reclassified from OCI . . . Net unrealized investment gains (losses) $ 6,077 (9,628) 58 Change in the discount rate used to measure future policy benefits Change in instrument- specific credit risk of market risk benefits Foreign currency translation and other adjustments Derivatives qualifying as hedges (1) $2,025 (674) (151) $(13,918) 13,515 — $ (15) 5 — 5 Total $(5,855) 3,255 (100) $ (24) 37 (7) 30 3,155 Current period OCI . . . . . . . . . . . . (9,570) (825) 13,515 Balances as of December 31, 2022 before noncontrolling interests . . . . (3,493) 1,200 (403) (10) 6 (2,700) Less: change in OCI attributable to noncontrolling interests . . . . . . . . . (86) — — — — (86) Balances as of December 31, 2022 . . $(3,407) $1,200 $ (403) $ (10) $ 6 $(2,614) (1) See note 6 for additional information. (Amounts in millions) Balances as of January 1, 2021 . . . . . OCI before reclassifications . . . . . . Amounts reclassified from OCI . . . Net unrealized investment gains (losses) $ 7,820 (1,702) (51) Change in the discount rate used to measure future policy benefits Change in instrument- specific credit risk of market risk benefits Foreign currency translation and other adjustments Derivatives qualifying as hedges (1) $2,211 (45) (141) $(17,120) 3,202 — $ (19) 4 — 4 $— 148 — 148 Total $(7,108) 1,607 (192) 1,415 Current period OCI . . . . . . . . . . . . (1,753) (186) 3,202 Balances as of December 31, 2021 before noncontrolling interests . . . . 6,067 2,025 (13,918) (15) 148 (5,693) Less: change in OCI attributable to noncontrolling interests . . . . . . . . . (10) — — — 172 162 Balances as of December 31, 2021 . . $ 6,077 $2,025 $(13,918) $ (15) $ (24) $(5,855) (1) See note 6 for additional information. As of December 31, 2023, 2022 and 2021, the balances of the change in the discount rate used to measure future policy benefits were net of taxes of $391 million, $110 million and $3,758 million, respectively, and the balances of the change in instrument-specific credit risk of MRBs were net of taxes of $2 million, $2 million and $4 million, respectively. The foreign currency translation and other adjustments balance in the charts above included $30 million, $34 million and $(1) million, respectively, net of taxes of $(7) million, $(8) million and $1 million, respectively, related to a net unrecognized postretirement benefit obligation as of December 31, 2023, 2022 and 2021. The balance also included taxes of $2 million related to foreign currency translation adjustments as of December 31, 2022. Amounts reclassified from foreign currency translation and other adjustments in 2022 related to the after-tax recognition of actuarial losses in connection with the termination of one of our defined benefit pension plans that was recorded to acquisition and operating expenses, net of deferrals, in our consolidated statements of income. See note 16 for additional information. 262 263 The following table shows reclassifications from accumulated other comprehensive income (loss), net of taxes, for the periods presented: (Amounts in millions) Net unrealized investment (gains) losses: Unrealized (gains) losses on investments . . . . . . . . . . . . . . . . . . Income taxes . . . . . . . . . . . . . . . . . . . Total . . . . . . . . . . . . . . . . . . . . . . . . . . Derivatives designated as hedges: Amount reclassified from accumulated other comprehensive income (loss) Years ended December 31, 2023 2022 2021 Affected line item in the consolidated statements of income $ 99 26 $ 125 $ 74 (16) $ 58 $ (51) $ (65) Net investment (gains) losses 14 Provision for income taxes Interest rate swaps hedging assets . . . Interest rate swaps hedging assets . . . $(220) (10) $(225) (9) $(217) Net investment income (1) Net investment (gains) losses Interest rate swaps hedging liabilities . . . . . . . . . . . . . . . . . . . . . Interest rate swaps hedging liabilities . . . . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . . . . Income taxes . . . . . . . . . . . . . . . . . . . 3 (1) (1) (2) 80 3 — — — 80 1 Interest expense — Net investment (gains) losses — — 76 Net investment (gains) losses Net investment (gains) losses Provision for income taxes Total . . . . . . . . . . . . . . . . . . . . . . . . . . $(151) $(151) $(141) (27) Noncontrolling Interests On September 15, 2021, Enact Holdings, Genworth Financial’s indirect subsidiary, priced the IPO of its common shares. All of the shares were offered by the selling stockholder, Genworth Holdings, Genworth Financial’s wholly owned subsidiary, with the net proceeds from the IPO retained by Genworth Holdings. Genworth Holdings sold 13,310,400 of Enact Holdings’ common shares at an IPO price of $19.00 per common share. In addition to the shares sold in the IPO, 14,655,600 common shares were sold in a concurrent private sale (“Private Sale”) at a price per share of $17.86, which was equal to the IPO price less the underwriting discount per share. Genworth Holdings also granted the underwriters a 30-day option to purchase up to an additional 1,996,560 common shares (“Over-Allotment Option”) of Enact Holdings at the IPO price less the underwriting discount. On September 16, 2021, the underwriters exercised their option to purchase all 1,996,560 common shares permitted under the terms of the underwriting agreement. The IPO, Private Sale and Over-Allotment Option (collectively the “Offering”) closed on September 20, 2021. Following the completion of the Offering and as of December 31, 2023, we beneficially owned approximately 81.6% of the common shares of Enact Holdings. The gross proceeds of the Offering, before payment of underwriter fees and other expenses, were $553 million. Costs directly related to the Offering, including underwriter fees and other expenses, were $24 million. Consistent with applicable accounting guidance, changes in the ownership of a subsidiary that do not result in a loss of control are accounted for as equity transactions with no gain or loss recognized through earnings. Any GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 The following table shows reclassifications from accumulated other comprehensive income (loss), net of taxes, for the periods presented: (Amounts in millions) Net unrealized investment (gains) losses: Unrealized (gains) losses on investments . . . . . . . . . . . . . . . . . . Income taxes . . . . . . . . . . . . . . . . . . . Total . . . . . . . . . . . . . . . . . . . . . . . . . . Derivatives designated as hedges: Interest rate swaps hedging assets . . . Interest rate swaps hedging assets . . . Interest rate swaps hedging liabilities . . . . . . . . . . . . . . . . . . . . . Interest rate swaps hedging liabilities . . . . . . . . . . . . . . . . . . . . . Forward bond purchase commitments . . . . . . . . . . . . . . . . . Foreign currency swaps . . . . . . . . . . . Income taxes . . . . . . . . . . . . . . . . . . . Amount reclassified from accumulated other comprehensive income (loss) Years ended December 31, 2023 2022 2021 Affected line item in the consolidated statements of income $ 99 26 $ 125 $ 74 (16) $ 58 $ (65) Net investment (gains) losses Provision for income taxes 14 $ (51) $(220) (10) $(225) (9) $(217) Net investment income (1) Net investment (gains) losses 3 (1) (1) (2) 80 3 — — — 80 1 Interest expense — Net investment (gains) losses — — 76 Net investment (gains) losses Net investment (gains) losses Provision for income taxes Total . . . . . . . . . . . . . . . . . . . . . . . . . . $(151) $(151) $(141) before noncontrolling interests . . . . 6,067 2,025 (13,918) (15) 148 (5,693) (27) Noncontrolling Interests On September 15, 2021, Enact Holdings, Genworth Financial’s indirect subsidiary, priced the IPO of its common shares. All of the shares were offered by the selling stockholder, Genworth Holdings, Genworth Financial’s wholly owned subsidiary, with the net proceeds from the IPO retained by Genworth Holdings. Genworth Holdings sold 13,310,400 of Enact Holdings’ common shares at an IPO price of $19.00 per common share. In addition to the shares sold in the IPO, 14,655,600 common shares were sold in a concurrent private sale (“Private Sale”) at a price per share of $17.86, which was equal to the IPO price less the underwriting discount per share. Genworth Holdings also granted the underwriters a 30-day option to purchase up to an additional 1,996,560 common shares (“Over-Allotment Option”) of Enact Holdings at the IPO price less the underwriting discount. On September 16, 2021, the underwriters exercised their option to purchase all 1,996,560 common shares permitted under the terms of the underwriting agreement. The IPO, Private Sale and Over-Allotment Option (collectively the “Offering”) closed on September 20, 2021. Following the completion of the Offering and as of December 31, 2023, we beneficially owned approximately 81.6% of the common shares of Enact Holdings. The gross proceeds of the Offering, before payment of underwriter fees and other expenses, were $553 million. Costs directly related to the Offering, including underwriter fees and other expenses, were $24 million. Consistent with applicable accounting guidance, changes in the ownership of a subsidiary that do not result in a loss of control are accounted for as equity transactions with no gain or loss recognized through earnings. Any 262 263 Net unrealized investment gains (losses) Derivatives qualifying as hedges (1) Change in the discount rate used to measure future policy benefits Change in instrument- specific credit risk of market Foreign currency translation and other risk benefits adjustments Total (Amounts in millions) Balances as of January 1, 2022 . . . . . $ 6,077 $2,025 $(13,918) $ (15) $ (24) $(5,855) OCI before reclassifications . . . . . . (9,628) Amounts reclassified from OCI . . . 58 Current period OCI . . . . . . . . . . . . (9,570) (674) (151) (825) 13,515 — 13,515 — 5 5 37 (7) 30 3,255 (100) 3,155 Balances as of December 31, 2022 Less: change in OCI attributable to before noncontrolling interests . . . . (3,493) 1,200 (403) (10) 6 (2,700) noncontrolling interests . . . . . . . . . (86) — — — — (86) Balances as of December 31, 2022 . . $(3,407) $1,200 $ (403) $ (10) $ 6 $(2,614) (1) See note 6 for additional information. Net unrealized investment gains (losses) Derivatives qualifying as hedges (1) Change in the discount rate used to measure future policy benefits Change in instrument- specific credit risk of market Foreign currency translation and other risk benefits adjustments Total (Amounts in millions) Balances as of January 1, 2021 . . . . . $ 7,820 $2,211 $(17,120) $ (19) $— $(7,108) OCI before reclassifications . . . . . . (1,702) Amounts reclassified from OCI . . . (51) Current period OCI . . . . . . . . . . . . (1,753) (45) (141) (186) 3,202 — 3,202 4 — 4 148 — 148 1,607 (192) 1,415 Balances as of December 31, 2021 Less: change in OCI attributable to (1) See note 6 for additional information. noncontrolling interests . . . . . . . . . (10) — — — 172 162 Balances as of December 31, 2021 . . $ 6,077 $2,025 $(13,918) $ (15) $ (24) $(5,855) As of December 31, 2023, 2022 and 2021, the balances of the change in the discount rate used to measure future policy benefits were net of taxes of $391 million, $110 million and $3,758 million, respectively, and the balances of the change in instrument-specific credit risk of MRBs were net of taxes of $2 million, $2 million and $4 million, respectively. The foreign currency translation and other adjustments balance in the charts above included $30 million, $34 million and $(1) million, respectively, net of taxes of $(7) million, $(8) million and $1 million, respectively, related to a net unrecognized postretirement benefit obligation as of December 31, 2023, 2022 and 2021. The balance also included taxes of $2 million related to foreign currency translation adjustments as of December 31, 2022. Amounts reclassified from foreign currency translation and other adjustments in 2022 related to the after-tax recognition of actuarial losses in connection with the termination of one of our defined benefit pension plans that was recorded to acquisition and operating expenses, net of deferrals, in our consolidated statements of income. See note 16 for additional information. GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 difference between the carrying value and the fair value related to the change in ownership is recorded as an adjustment to stockholders’ equity. A summary of these changes in ownership interests and the effect on stockholders’ equity was as follows for the year ended December 31, 2021: (Amounts in millions) Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 850 Transfers to noncontrolling interests: Decrease in Genworth Financial, Inc.’s additional paid-in capital for initial sale of Enact Holdings shares to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . Net transfers to noncontrolling interests . . . . . . . . . . . . . . . (167) (167) Change from net income available to Genworth Financial, Inc.’s common stockholders and transfers to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 683 On November 1, 2022, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings could repurchase up to $75 million of its outstanding common stock, and it began share repurchases under the program in the fourth quarter of 2022. On August 1, 2023, Enact Holdings announced the authorization of an additional $100 million of common stock repurchases under a new share repurchase program. Pursuant to these programs, Enact Holdings repurchased 3,520,052 shares of its common stock in 2023. As the majority shareholder, Genworth Holdings participated in order to maintain its overall ownership of approximately 81.6% and received $71 million in cash. Dividends of $39 million, $46 million and $37 million were paid to owners of noncontrolling interests of Enact Holdings in 2023, 2022 and 2021, respectively. (28) Discontinued Operations On March 3, 2021, we completed the sale of our entire ownership interest of approximately 52% in Genworth Australia through an underwriting agreement and received approximately AUD483 million ($370 million) of net cash proceeds. The following table provides a summary of the gain (loss) on sale associated with the disposition of Genworth Australia for the year ended December 31, 2021: (Amounts in millions) Net cash proceeds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 370 Add: carrying value of noncontrolling interests(1) . . . . . . . . . . . 657 Total adjusted consideration(2) . . . . . . . . . . . . . . . . . . . . . . . . . . 1,027 Carrying value of the disposal group before accumulated other comprehensive (income) loss . . . . . . . . . . . . . . . . . . . . . . . . . 1,040 Add: total accumulated other comprehensive (income) loss of disposal group(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109 Total adjusted carrying value of the disposal group . . . . . . . . . Pre-tax loss on sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tax benefit on sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,149 (122) 122 After-tax gain (loss) on sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — (1) In accordance with accounting guidance on the deconsolidation of a subsidiary or group of assets, the carrying amount of any noncontrolling interests in the subsidiary sold (adjusted to reflect amounts in accumulated other comprehensive income (loss) recognized upon final disposition) is added to the total fair value of the consideration received. (2) Represents the aggregate of the net cash proceeds received upon sale closing plus the adjusted carrying amount of noncontrolling interests in the subsidiary sold. (3) Amount consists of $160 million of cumulative losses on foreign currency translation adjustments, partially offset by cumulative unrealized investment gains of $29 million and deferred tax gains of $22 million. 264 265 GENWORTH FINANCIAL, INC. GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 difference between the carrying value and the fair value related to the change in ownership is recorded as an adjustment to stockholders’ equity. A summary of these changes in ownership interests and the effect on stockholders’ equity was as follows for the year ended December 31, 2021: (28) Discontinued Operations On March 3, 2021, we completed the sale of our entire ownership interest of approximately 52% in Genworth Australia through an underwriting agreement and received approximately AUD483 million ($370 million) of net cash proceeds. The following table provides a summary of the gain (loss) on sale associated with the disposition of Genworth Australia for the year ended December 31, 2021: (Amounts in millions) Net cash proceeds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Add: carrying value of noncontrolling interests(1) . . . . . . . . . . . Total adjusted consideration(2) . . . . . . . . . . . . . . . . . . . . . . . . . . Carrying value of the disposal group before accumulated other comprehensive (income) loss . . . . . . . . . . . . . . . . . . . . . . . . . Add: total accumulated other comprehensive (income) loss of disposal group(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total adjusted carrying value of the disposal group . . . . . . . . . Pre-tax loss on sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tax benefit on sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 370 657 1,027 1,040 109 1,149 (122) 122 After-tax gain (loss) on sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — (1) In accordance with accounting guidance on the deconsolidation of a subsidiary or group of assets, the carrying amount of any noncontrolling interests in the subsidiary sold (adjusted to reflect amounts in accumulated other comprehensive income (loss) recognized upon final disposition) is added to the total fair value of the consideration received. (2) Represents the aggregate of the net cash proceeds received upon sale closing plus the adjusted carrying amount of noncontrolling interests in the subsidiary sold. (3) Amount consists of $160 million of cumulative losses on foreign currency translation adjustments, partially offset by cumulative unrealized investment gains of $29 million and deferred tax gains of $22 million. (Amounts in millions) Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 850 Transfers to noncontrolling interests: Decrease in Genworth Financial, Inc.’s additional paid-in capital for initial sale of Enact Holdings shares to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . Net transfers to noncontrolling interests . . . . . . . . . . . . . . . (167) (167) Change from net income available to Genworth Financial, Inc.’s common stockholders and transfers to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 683 On November 1, 2022, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings could repurchase up to $75 million of its outstanding common stock, and it began share repurchases under the program in the fourth quarter of 2022. On August 1, 2023, Enact Holdings announced the authorization of an additional $100 million of common stock repurchases under a new share repurchase program. Pursuant to these programs, Enact Holdings repurchased 3,520,052 shares of its common stock in 2023. As the majority shareholder, Genworth Holdings participated in order to maintain its overall ownership of approximately 81.6% and received $71 million in cash. Dividends of $39 million, $46 million and $37 million were paid to owners of noncontrolling interests of Enact Holdings in 2023, 2022 and 2021, respectively. 264 265 GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 A summary of operating results related to Genworth Australia reported as discontinued operations was as follows for the year ended December 31, 2021: (Amounts in millions) Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 51 4 (5) Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . . . . . . . . . Acquisition and operating expenses, net of deferrals . . . . . . . . . . Amortization of deferred acquisition costs and intangibles . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total benefits and expenses . . . . . . . . . . . . . . . . . . . . . . . . . . Income before income taxes and gain (loss) on sale(1) . . . . . . . . . Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income before gain (loss) on sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Gain (loss) on sale, net of taxes Income from discontinued operations, net of taxes . . . . . . . . . . . 50 11 7 6 1 25 25 8 17 — 17 Less: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . $ 9 (1) The year ended December 31, 2021 included pre-tax income from discontinued operations available to Genworth Financial, Inc.’s common stockholders of $13 million. In addition, we recorded an after-tax favorable adjustment of $10 million for the year ended December 31, 2021 associated with a refinement to our tax matters agreement liability related to discontinued operations. Schedule I Genworth Financial, Inc. Summary of Investments—Other Than Investments in Related Parties (Amounts in millions) As of December 31, 2023, the amortized cost or cost, fair value and carrying value of our invested assets were as follows: Amortized cost or cost (1) Fair value Carrying value Type of investment Fixed maturity securities: Bonds: U.S. government, agencies and authorities . . . . . . . . . . . . . . . . . . . . . . . . $ 3,588 $ 3,494 $ 3,494 State and political subdivisions . . . . . . . . . Non-U.S. government . . . . . . . . . . . . . . . . . Public utilities . . . . . . . . . . . . . . . . . . . . . . . All other corporate bonds . . . . . . . . . . . . . . Equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage loans, net . . . . . . . . . . . . . . . . Policy loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . . . . . . . . . . . . . . Other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . 2,537 703 5,260 37,277 49,365 365 6,802 2,220 2,000 613 2,302 626 4,958 35,401 396 xxxxx xxxxx xxxxx xxxxx 2,302 626 4,958 35,401 396 6,802 2,220 2,821 731 Total fixed maturity securities . . . . . . 46,781 46,781 Total investments . . . . . . . . . . . . . . . . $61,365 xxxxx $59,751 (1) Amortized cost for fixed maturity securities and short-term investments, which are included in other invested assets, represents original cost reduced by repayments and adjusted for amortization of premium or accretion of discount. Cost for equity securities represents original cost, and cost for limited partnerships represents original cost adjusted for distributions. Cost for derivatives, which are included in other invested assets, represents the original cost of the positions. See Report of Independent Registered Public Accounting Firm 266 267 GENWORTH FINANCIAL, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2023, 2022 and 2021 A summary of operating results related to Genworth Australia reported as discontinued operations was as follows for the year ended December 31, 2021: (Amounts in millions) Revenues: Premiums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 51 Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net investment gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Benefits and expenses: Benefits and other changes in policy reserves . . . . . . . . . . . . . . . Acquisition and operating expenses, net of deferrals . . . . . . . . . . Amortization of deferred acquisition costs and intangibles . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total benefits and expenses . . . . . . . . . . . . . . . . . . . . . . . . . . Income before income taxes and gain (loss) on sale(1) . . . . . . . . . Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Income before gain (loss) on sale . . . . . . . . . . . . . . . . . . . . . . . . . Gain (loss) on sale, net of taxes . . . . . . . . . . . . . . . . . . . . . . . . . . Income from discontinued operations, net of taxes . . . . . . . . . . . Less: net income from discontinued operations attributable to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . $ 9 4 (5) 50 11 7 6 1 25 25 8 17 — 17 (1) The year ended December 31, 2021 included pre-tax income from discontinued operations available to Genworth Financial, Inc.’s common stockholders of $13 million. In addition, we recorded an after-tax favorable adjustment of $10 million for the year ended December 31, 2021 associated with a refinement to our tax matters agreement liability related to discontinued operations. Schedule I Genworth Financial, Inc. Summary of Investments—Other Than Investments in Related Parties (Amounts in millions) As of December 31, 2023, the amortized cost or cost, fair value and carrying value of our invested assets were as follows: Type of investment Fixed maturity securities: Bonds: U.S. government, agencies and authorities . . . . . . . . . . . . . . . . . . . . . . . . State and political subdivisions . . . . . . . . . Non-U.S. government . . . . . . . . . . . . . . . . . Public utilities . . . . . . . . . . . . . . . . . . . . . . . All other corporate bonds . . . . . . . . . . . . . . Total fixed maturity securities . . . . . . Equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commercial mortgage loans, net . . . . . . . . . . . . . . . . Policy loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Limited partnerships . . . . . . . . . . . . . . . . . . . . . . . . . . Other invested assets . . . . . . . . . . . . . . . . . . . . . . . . . Amortized cost or cost (1) Fair value Carrying value $ 3,588 2,537 703 5,260 37,277 49,365 365 6,802 2,220 2,000 613 $ 3,494 2,302 626 4,958 35,401 46,781 396 xxxxx xxxxx xxxxx xxxxx $ 3,494 2,302 626 4,958 35,401 46,781 396 6,802 2,220 2,821 731 Total investments . . . . . . . . . . . . . . . . $61,365 xxxxx $59,751 (1) Amortized cost for fixed maturity securities and short-term investments, which are included in other invested assets, represents original cost reduced by repayments and adjusted for amortization of premium or accretion of discount. Cost for equity securities represents original cost, and cost for limited partnerships represents original cost adjusted for distributions. Cost for derivatives, which are included in other invested assets, represents the original cost of the positions. See Report of Independent Registered Public Accounting Firm 266 267 Schedule II Genworth Financial, Inc. (Parent Company Only) Balance Sheets (Amounts in millions) December 31, 2023 2022 (As adjusted) Assets: Investments in subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred tax asset . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7,517 $ 7,655 6 3 3 3 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7,523 $ 7,664 Liabilities and stockholders’ equity Liabilities: Other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Intercompany notes payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 $ 31 43 7 26 33 Commitments and contingencies Stockholders’ equity: Common stock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Additional paid-in capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . Retained earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Treasury stock, at cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 11,884 (2,555) 1,213 (3,063) 1 11,869 (2,614) 1,139 (2,764) Total Genworth Financial, Inc.’s stockholders’ equity . . . . . . . . . . . . . . . . . . . 7,480 7,631 Total liabilities and stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7,523 $ 7,664 See Notes to Schedule II See Report of Independent Registered Public Accounting Firm Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Income (Amounts in millions) Years ended December 31, 2023 2022 2021 (As adjusted) (As adjusted) Revenues: Expenses: Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $— Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — Acquisition and operating expenses, net of deferrals . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Loss before income taxes and equity in income of subsidiaries . . . . . . . . . . . . . Benefit from income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Equity in income of subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 7 42 (42) (4) 114 $— — 31 — 31 (31) (3) 944 $ (3) (3) 25 (1) 24 (27) (1) 876 Net income available to Genworth Financial, Inc.’s common stockholders . . . $ 76 $916 $850 See Notes to Schedule II See Report of Independent Registered Public Accounting Firm 268 269 Schedule II Genworth Financial, Inc. (Parent Company Only) Balance Sheets (Amounts in millions) Assets: Investments in subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7,517 $ 7,655 Deferred tax asset . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 3 6 3 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7,523 $ 7,664 December 31, 2023 2022 (As adjusted) Other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 12 $ Intercompany notes payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 43 7 26 33 Liabilities and stockholders’ equity Liabilities: Commitments and contingencies Stockholders’ equity: Common stock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 Additional paid-in capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,884 11,869 Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . (2,555) (2,614) Retained earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,213 1,139 Treasury stock, at cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (3,063) (2,764) Total Genworth Financial, Inc.’s stockholders’ equity . . . . . . . . . . . . . . . . . . . 7,480 7,631 Total liabilities and stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7,523 $ 7,664 See Notes to Schedule II See Report of Independent Registered Public Accounting Firm Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Income (Amounts in millions) Years ended December 31, 2023 2022 2021 (As adjusted) (As adjusted) Revenues: Net investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $— Total revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — Expenses: Acquisition and operating expenses, net of deferrals . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Loss before income taxes and equity in income of subsidiaries . . . . . . . . . . . . . Benefit from income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Equity in income of subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 7 42 (42) (4) 114 $— — 31 — 31 (31) (3) 944 $ (3) (3) 25 (1) 24 (27) (1) 876 Net income available to Genworth Financial, Inc.’s common stockholders . . . $ 76 $916 $850 See Notes to Schedule II See Report of Independent Registered Public Accounting Firm 268 269 Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Comprehensive Income (Amounts in millions) Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Cash Flows (Amounts in millions) Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 76 $ 916 $ 850 Cash flows from (used by) operating activities: Net income available to Genworth Financial, Inc.’s common Years ended December 31, 2023 2022 2021 (As adjusted) (As adjusted) Years ended December 31, 2023 2022 2021 (As adjusted) (As adjusted) Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities without an allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net unrealized gains (losses) on securities with an allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derivatives qualifying as hedges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Change in discount rate used to measure future policy benefits . . . . . . Change in instrument-specific credit risk of market risk benefits . . . . . Foreign currency translation and other adjustments . . . . . . . . . . . . . . . . 1,277 (9,484) (1,723) — (190) (1,036) 2 6 — (825) 13,515 5 30 6 (186) 3,202 4 (24) 1,279 Total other comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59 3,241 Total comprehensive income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 135 $ 4,157 $ 2,129 See Notes to Schedule II See Report of Independent Registered Public Accounting Firm 270 271 stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 76 $ 916 $ 850 Adjustments to reconcile net income available to Genworth Financial, Inc.’s common stockholders to net cash from (used by) operating activities: Equity in income from subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . . (114) (944) Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-term incentive compensation expense . . . . . . . . . . . . . . . . . . . Change in certain assets and liabilities: Accrued investment income and other assets . . . . . . . . . . . . . . . . . . — Current tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net cash from (used by) operating activities . . . . . . . . . . . . . . . . . . . . . . . Cash flows used by investing activities: Capital contributions paid to subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . Net cash used by investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash flows from (used by) financing activities: Intercompany notes payable, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Treasury stock acquired in connection with share repurchases . . . . . . . . Other, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net cash from (used by) financing activities . . . . . . . . . . . . . . . . . . . . . . . Effect of exchange rate changes on cash, cash equivalents and restricted cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — Net change in cash, cash equivalents and restricted cash . . . . . . . . . . . . . — Cash, cash equivalents and restricted cash at beginning of year . . . . . . . . . . . . — (4) 34 (1) 14 5 (3) (3) 307 (296) (13) (2) (6) 27 2 2 15 12 (3) (3) 64 (64) (9) (9) — — — (876) — 40 (1) (5) (13) (5) (2) (2) 12 — (5) 7 — — — Cash, cash equivalents and restricted cash at end of year . . . . . . . . . . . . . . . . . $ — $ — $ — See Notes to Schedule II See Report of Independent Registered Public Accounting Firm Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Comprehensive Income (Amounts in millions) Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Cash Flows (Amounts in millions) Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 76 $ 916 $ 850 Cash flows from (used by) operating activities: Net income available to Genworth Financial, Inc.’s common Years ended December 31, 2023 2022 2021 (As adjusted) (As adjusted) Years ended December 31, 2023 2022 2021 (As adjusted) (As adjusted) Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities without an allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,277 (9,484) (1,723) Net unrealized gains (losses) on securities with an allowance for credit losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derivatives qualifying as hedges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — (190) — (825) Change in discount rate used to measure future policy benefits . . . . . . (1,036) 13,515 Change in instrument-specific credit risk of market risk benefits . . . . . Foreign currency translation and other adjustments . . . . . . . . . . . . . . . . Total other comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 6 59 5 30 3,241 6 (186) 3,202 4 (24) 1,279 Total comprehensive income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 135 $ 4,157 $ 2,129 See Notes to Schedule II See Report of Independent Registered Public Accounting Firm stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 76 $ 916 $ 850 Adjustments to reconcile net income available to Genworth Financial, Inc.’s common stockholders to net cash from (used by) operating activities: Equity in income from subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-term incentive compensation expense . . . . . . . . . . . . . . . . . . . (114) (4) 34 (944) (6) 27 (876) — 40 Change in certain assets and liabilities: Accrued investment income and other assets . . . . . . . . . . . . . . . . . . — (1) Current tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net cash from (used by) operating activities . . . . . . . . . . . . . . . . . . . . . . . 5 Cash flows used by investing activities: Capital contributions paid to subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . Net cash used by investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash flows from (used by) financing activities: Intercompany notes payable, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Treasury stock acquired in connection with share repurchases . . . . . . . . Other, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net cash from (used by) financing activities . . . . . . . . . . . . . . . . . . . . . . . (3) (3) 307 (296) (13) (2) Effect of exchange rate changes on cash, cash equivalents and restricted cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — Net change in cash, cash equivalents and restricted cash . . . . . . . . . . . . . — Cash, cash equivalents and restricted cash at beginning of year . . . . . . . . . . . . — 2 2 15 12 (3) (3) 64 (64) (9) (9) — — — (1) (5) (13) (5) (2) (2) 12 — (5) 7 — — — Cash, cash equivalents and restricted cash at end of year . . . . . . . . . . . . . . . . . $ — $ — $ — See Notes to Schedule II See Report of Independent Registered Public Accounting Firm 270 271 Schedule II Genworth Financial, Inc. (Parent Company Only) Notes to Schedule II Years Ended December 31, 2023, 2022 and 2021 (1) Organization and Basis of Presentation Genworth Holdings (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an IPO of its common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100% owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, and was renamed Genworth Financial upon the completion of the reorganization. Genworth Financial is a holding company whose subsidiaries offer mortgage and long-term care insurance adopting LDTI on January 1, 2023 as of December 31, 2022: products and service life insurance and annuity products. The parent company financial information reflects Genworth Financial’s direct subsidiaries using the equity method of accounting. Under this method, investments in subsidiaries are recorded at cost and adjusted for the subsidiaries’ cumulative results of operations, capital contributions and distributions, and other changes in equity. The parent company financial statements should be read in conjunction with the consolidated financial statements of Genworth Financial and its subsidiaries and the notes thereto. On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial could repurchase up to $350 million of its outstanding Class A common stock. On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under the existing share repurchase program. Pursuant to the program, during 2023, Genworth Financial repurchased 51,739,098 shares of its common stock at an average price of $5.70 per share for a total cost of $299 million, including excise taxes and other costs paid in connection with acquiring the shares. The repurchased shares were recorded at cost and presented as treasury stock in a separate caption in equity in the parent company balance sheets. In 2024, Genworth Financial also authorized share repurchases through a Rule 10b5-1 trading plan under which 4,197,740 shares of its common stock were repurchased through February 13, 2024 for approximately $25 million before excise taxes. Approximately $316 million remained available under the share repurchase program as of February 13, 2024. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions or other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time. (2) Accounting Changes On January 1, 2023, Genworth Financial adopted LDTI, which significantly changed the recognition and measurement of long-duration insurance contracts. This new accounting guidance directly impacted DAC, intangible assets and insurance assets and liabilities of Genworth Financial’s U.S. life insurance subsidiaries. Genworth Financial adopted this new accounting guidance using the modified retrospective transition method for all topics except for MRBs, which was required to be applied using the retrospective transition method. The modified retrospective transition method generally results in applying the guidance to contracts on the basis of existing carrying values as of the Transition Date. The new accounting guidance, for all topics, was applied as of 272 273 Schedule II Genworth Financial, Inc. (Parent Company Only) Notes to Schedule II Years Ended December 31, 2023, 2022 and 2021 the Transition Date with an adjustment to beginning retained earnings and accumulated other comprehensive income (loss). In addition, prior period financial information has been re-presented in accordance with the new accounting standard. As of the Transition Date, Genworth Financial’s total stockholders’ equity decreased by $13.7 billion after-tax, which included a reduction to retained earnings of $2.2 billion and a reduction in accumulated other comprehensive income (loss) of $11.5 billion. For a discussion of accounting policies related to insurance assets and liabilities associated with long-duration insurance contracts, see note 2 in the consolidated financial statements of Genworth Financial and its subsidiaries. The following table presents the impacted lines of the parent company balance sheet reflecting the impact of As originally reported Effect of adopting LDTI As adjusted (Amounts in millions) Assets: Equity: Investments in subsidiaries . . . . . . . . . . . . . Total assets . . . . . . . . . . . . . . . . . . . . . . . . . $10,008 $10,017 $(2,353) $(2,353) $ 7,655 $ 7,664 Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . Retained earnings . . . . . . . . . . . . . . . . . . . . Total Genworth Financial, Inc.’s $ (2,220) $ 3,098 $ (394) $(1,959) $(2,614) $ 1,139 stockholders’ equity . . . . . . . . . . . . . . . . $ 9,984 $(2,353) $ 7,631 The following table presents the impacted lines of the parent company statements of income reflecting the impact of adopting LDTI on January 1, 2023 for the years ended December 31: (Amounts in millions) As originally Effect of As originally Effect of reported adopting LDTI As adjusted reported adopting LDTI As adjusted Equity in income of subsidiaries . . . . $637 $307 $944 $930 $(54) $876 2022 2021 Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . $609 $307 $916 $904 $(54) $850 The following table presents the impacted lines of the parent company statements of cash flows reflecting the impact of adopting LDTI on January 1, 2023 for the years ended December 31: 2022 2021 As originally Effect of As originally Effect of reported adopting LDTI As adjusted reported adopting LDTI As adjusted (Amounts in millions) Cash flows from (used by) operating activities: Net income available to Genworth Financial, Inc.’s Equity in income from common stockholders . . . . . . . $ 609 $ 307 $ 916 $ 904 $(54) $ 850 subsidiaries . . . . . . . . . . . . . . . $(637) $(307) $(944) $(930) $ 54 $(876) Schedule II Genworth Financial, Inc. (Parent Company Only) Notes to Schedule II Years Ended December 31, 2023, 2022 and 2021 Schedule II Genworth Financial, Inc. (Parent Company Only) Notes to Schedule II Years Ended December 31, 2023, 2022 and 2021 (1) Organization and Basis of Presentation Genworth Holdings (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an IPO of its common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100% owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, and was renamed Genworth Financial upon the completion of the reorganization. the Transition Date with an adjustment to beginning retained earnings and accumulated other comprehensive income (loss). In addition, prior period financial information has been re-presented in accordance with the new accounting standard. As of the Transition Date, Genworth Financial’s total stockholders’ equity decreased by $13.7 billion after-tax, which included a reduction to retained earnings of $2.2 billion and a reduction in accumulated other comprehensive income (loss) of $11.5 billion. For a discussion of accounting policies related to insurance assets and liabilities associated with long-duration insurance contracts, see note 2 in the consolidated financial statements of Genworth Financial and its subsidiaries. The following table presents the impacted lines of the parent company balance sheet reflecting the impact of Genworth Financial is a holding company whose subsidiaries offer mortgage and long-term care insurance adopting LDTI on January 1, 2023 as of December 31, 2022: products and service life insurance and annuity products. (Amounts in millions) Assets: As originally reported Effect of adopting LDTI As adjusted Investments in subsidiaries . . . . . . . . . . . . . Total assets . . . . . . . . . . . . . . . . . . . . . . . . . $10,008 $10,017 $(2,353) $(2,353) $ 7,655 $ 7,664 Equity: Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . Retained earnings . . . . . . . . . . . . . . . . . . . . Total Genworth Financial, Inc.’s $ (2,220) $ 3,098 $ (394) $(1,959) $(2,614) $ 1,139 stockholders’ equity . . . . . . . . . . . . . . . . $ 9,984 $(2,353) $ 7,631 The following table presents the impacted lines of the parent company statements of income reflecting the impact of adopting LDTI on January 1, 2023 for the years ended December 31: (Amounts in millions) Equity in income of subsidiaries Net income available to Genworth . . . . Financial, Inc.’s common stockholders . . . . . . . . . . . . . . . . . . As originally reported 2022 Effect of adopting LDTI As adjusted As originally reported 2021 Effect of adopting LDTI As adjusted $637 $307 $944 $930 $(54) $876 $609 $307 $916 $904 $(54) $850 The following table presents the impacted lines of the parent company statements of cash flows reflecting the impact of adopting LDTI on January 1, 2023 for the years ended December 31: (Amounts in millions) Cash flows from (used by) operating activities: Net income available to Genworth Financial, Inc.’s common stockholders . . . . . . . Equity in income from As originally reported 2022 Effect of adopting LDTI As adjusted As originally reported 2021 Effect of adopting LDTI As adjusted $ 609 $ 307 $ 916 $ 904 $(54) $ 850 subsidiaries . . . . . . . . . . . . . . . $(637) $(307) $(944) $(930) $ 54 $(876) 272 273 The parent company financial information reflects Genworth Financial’s direct subsidiaries using the equity method of accounting. Under this method, investments in subsidiaries are recorded at cost and adjusted for the subsidiaries’ cumulative results of operations, capital contributions and distributions, and other changes in equity. The parent company financial statements should be read in conjunction with the consolidated financial statements of Genworth Financial and its subsidiaries and the notes thereto. On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial could repurchase up to $350 million of its outstanding Class A common stock. On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under the existing share repurchase program. Pursuant to the program, during 2023, Genworth Financial repurchased 51,739,098 shares of its common stock at an average price of $5.70 per share for a total cost of $299 million, including excise taxes and other costs paid in connection with acquiring the shares. The repurchased shares were recorded at cost and presented as treasury stock in a separate caption in equity in the parent company balance sheets. In 2024, Genworth Financial also authorized share repurchases through a Rule 10b5-1 trading plan under which 4,197,740 shares of its common stock were repurchased through February 13, 2024 for approximately $25 million before excise taxes. Approximately $316 million remained available under the share repurchase program as of February 13, 2024. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions or other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time. (2) Accounting Changes On January 1, 2023, Genworth Financial adopted LDTI, which significantly changed the recognition and measurement of long-duration insurance contracts. This new accounting guidance directly impacted DAC, intangible assets and insurance assets and liabilities of Genworth Financial’s U.S. life insurance subsidiaries. Genworth Financial adopted this new accounting guidance using the modified retrospective transition method for all topics except for MRBs, which was required to be applied using the retrospective transition method. The modified retrospective transition method generally results in applying the guidance to contracts on the basis of existing carrying values as of the Transition Date. The new accounting guidance, for all topics, was applied as of Schedule II Genworth Financial, Inc. (Parent Company Only) Notes to Schedule II Years Ended December 31, 2023, 2022 and 2021 On January 1, 2021, Genworth Financial adopted new accounting guidance related to simplifying the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. Genworth Financial adopted this new accounting guidance using the retrospective method or modified retrospective method for certain changes and prospective method for all other changes, which did not have a significant impact on Genworth Financial’s financial statements and disclosures. (3) Commitments Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior and subordinated notes and the holders of the senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any, and interest on, and all other amounts payable under, the outstanding senior and subordinated notes and their respective indentures. (4) Income Taxes As of December 31, 2023 and 2022, Genworth Financial had a deferred tax asset of $3 million and $6 million, respectively, primarily comprised of share-based compensation. As of December 31, 2023 and 2022, Genworth Financial had a current income tax receivable of $2 million and $—, respectively. Net cash paid for taxes was $1 million, $1 million and $4 million for the years ended December 31, 2023, 2022 and 2021, respectively. (5) Supplemental Cash Flow Information In 2023 and 2022, Genworth Holdings forgave intercompany loans of $302 million and $50 million, respectively, due from Genworth Financial. The extinguishment of the loans between the related parties was treated as non-cash deemed dividends to Genworth Financial and accordingly had no impact on Genworth Financial’s cash flows for the years ended December 31, 2023 and 2022. Schedule III Genworth Financial, Inc. Supplemental Insurance Information (Amounts in millions) Segment December 31, 2023 Enact . . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance . . . . Life and Annuities . . . . . . . . . . . Corporate and Other . . . . . . . . . December 31, 2022 Enact . . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance . . . . Life and Annuities . . . . . . . . . . . Corporate and Other . . . . . . . . . Deferred Future Policy Acquisition Costs Benefits Liability for Policy and Contract Claims Unearned Premiums Policyholder Account Balances $ 25 879 1,084 — $1,988 $ 26 935 1,250 — $2,211 $ — 43,929 13,726 — $ — — 15,540 — $ — 41,457 13,950 — $ — — 16,564 — $518 — 126 8 $652 $519 — 158 6 $683 $149 — — — $149 $203 — — — $203 Total . . . . . . . . . . . . . . . . . $57,655 $15,540 Total . . . . . . . . . . . . . . . . . $55,407 $16,564 See Report of Independent Registered Public Accounting Firm 274 275 Schedule II Genworth Financial, Inc. (Parent Company Only) Notes to Schedule II Years Ended December 31, 2023, 2022 and 2021 On January 1, 2021, Genworth Financial adopted new accounting guidance related to simplifying the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. Genworth Financial adopted this new accounting guidance using the retrospective method or modified retrospective method for certain changes and prospective method for all other changes, which did not have a significant impact on Genworth Financial’s financial statements and disclosures. (3) Commitments Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior and subordinated notes and the holders of the senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any, and interest on, and all other amounts payable under, the outstanding senior and subordinated notes and their respective indentures. (4) Income Taxes respectively. (5) Supplemental Cash Flow Information As of December 31, 2023 and 2022, Genworth Financial had a deferred tax asset of $3 million and $6 million, respectively, primarily comprised of share-based compensation. As of December 31, 2023 and 2022, Genworth Financial had a current income tax receivable of $2 million and $—, respectively. Net cash paid for taxes was $1 million, $1 million and $4 million for the years ended December 31, 2023, 2022 and 2021, In 2023 and 2022, Genworth Holdings forgave intercompany loans of $302 million and $50 million, respectively, due from Genworth Financial. The extinguishment of the loans between the related parties was treated as non-cash deemed dividends to Genworth Financial and accordingly had no impact on Genworth Financial’s cash flows for the years ended December 31, 2023 and 2022. Schedule III Genworth Financial, Inc. Supplemental Insurance Information (Amounts in millions) Segment December 31, 2023 Enact . . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance . . . . Life and Annuities . . . . . . . . . . . Corporate and Other . . . . . . . . . Total . . . . . . . . . . . . . . . . . December 31, 2022 Enact . . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance . . . . Life and Annuities . . . . . . . . . . . Corporate and Other . . . . . . . . . Total . . . . . . . . . . . . . . . . . Deferred Acquisition Costs Future Policy Benefits Policyholder Account Balances Liability for Policy and Contract Claims Unearned Premiums $ 25 879 1,084 — $1,988 $ 26 935 1,250 — $2,211 $ — 43,929 13,726 — $ — — 15,540 — $57,655 $15,540 $ — 41,457 13,950 — $ — — 16,564 — $55,407 $16,564 $518 — 126 8 $652 $519 — 158 6 $683 $149 — — — $149 $203 — — — $203 See Report of Independent Registered Public Accounting Firm 274 275 Schedule III—Continued Genworth Financial, Inc. Supplemental Insurance Information (Amounts in millions) Segment Year ended December 31, 2023 Premium Revenue Net Investment Income Interest Credited and Benefits and Other Changes in Policy Reserves(1) Amortization of Deferred Acquisition Costs Other Operating Expenses Premiums Written Enact . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance . . . Life and Annuities . . . . . . . . . . Corporate and Other . . . . . . . . $ 957 2,463 207 9 $ 208 1,914 1,042 19 Total . . . . . . . . . . . . . . . . . $3,636 $3,183 Year ended December 31, 2022 Enact . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance . . . Life and Annuities . . . . . . . . . . Corporate and Other . . . . . . . . $ 940 2,500 234 6 $ 155 1,900 1,083 8 Total . . . . . . . . . . . . . . . . . $3,680 $3,146 Year ended December 31, 2021 Enact . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance . . . Life and Annuities . . . . . . . . . . Corporate and Other . . . . . . . . $ 975 2,561 (136) 6 $ 141 2,027 1,195 7 Total . . . . . . . . . . . . . . . . . $3,406 $3,370 $ 27 4,123 1,732 (9) $5,873 $ (94) 3,471 1,151 (11) $4,517 $ 125 3,876 1,333 (6) $5,328 $ 7 57 166 — $230 $ 8 60 222 — $290 $ 9 63 265 — $337 $ 268 466 228 132 $ 904 2,463 207 8 $1,094 $3,582 $ 283 427 622 95 $ 896 2,500 234 6 $1,427 $3,636 $ 287 464 259 195 $ 914 2,561 (137) 7 $1,205 $3,345 (1) Interest credited and benefits and other changes in policy reserves includes changes in policy reserves resulting from liability remeasurement (gains) losses and excludes changes in fair value of market risk benefits and associated hedges of $(12) million, $(104) million and $(160) million for the years ended December 31, 2023, 2022 and 2021, respectively. See Report of Independent Registered Public Accounting Firm Item 9. Changes In and Disagreements With Accountants On Accounting and Financial Disclosure None. Item 9A. Controls and Procedures Evaluation of Disclosure Controls and Procedures As of December 31, 2023, an evaluation was conducted under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934). Based on this evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2023. Management’s Annual Report On Internal Control Over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting for our company. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework and criteria established in Internal Control—Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, our management has concluded that our internal control over financial reporting was effective as of December 31, 2023. Our independent auditor, KPMG LLP, a registered public accounting firm, has issued an attestation report on the effectiveness of our internal control over financial reporting. This attestation report appears below. /s/ Thomas J. McInerney Thomas J. McInerney President and Chief Executive Officer (Principal Executive Officer) /s/ Jerome T. Upton Jerome T. Upton Executive Vice President and Chief Financial Officer (Principal Financial Officer) February 29, 2024 276 277 Schedule III—Continued Genworth Financial, Inc. Supplemental Insurance Information (Amounts in millions) Net Premium Revenue Investment Income Interest Credited and Benefits and Other Changes in Policy Reserves(1) Amortization of Deferred Acquisition Costs Other Operating Expenses Premiums Written Total . . . . . . . . . . . . . . . . . $3,636 $3,183 $5,873 Segment Year ended December 31, 2023 Enact . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance . . . $ 957 2,463 Life and Annuities . . . . . . . . . . Corporate and Other . . . . . . . . 207 9 $ 208 1,914 1,042 19 Year ended December 31, 2022 Enact . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance . . . $ 940 2,500 Life and Annuities . . . . . . . . . . Corporate and Other . . . . . . . . 234 6 $ 155 1,900 1,083 8 Total . . . . . . . . . . . . . . . . . $3,680 $3,146 Year ended December 31, 2021 Enact . . . . . . . . . . . . . . . . . . . . Long-Term Care Insurance . . . $ 975 2,561 Life and Annuities . . . . . . . . . . (136) Corporate and Other . . . . . . . . 6 $ 141 2,027 1,195 7 $ 27 4,123 1,732 (9) $ (94) 3,471 1,151 (11) $4,517 $ 125 3,876 1,333 (6) Total . . . . . . . . . . . . . . . . . $3,406 $3,370 $5,328 $ 7 57 166 — $230 $ 8 60 222 — $290 $ 9 63 265 — $337 $ 268 466 228 132 $ 904 2,463 207 8 $1,094 $3,582 $ 283 427 622 95 $ 896 2,500 234 6 $1,427 $3,636 $ 287 464 259 195 $ 914 2,561 (137) 7 $1,205 $3,345 (1) Interest credited and benefits and other changes in policy reserves includes changes in policy reserves resulting from liability remeasurement (gains) losses and excludes changes in fair value of market risk benefits and associated hedges of $(12) million, $(104) million and $(160) million for the years ended December 31, 2023, 2022 and 2021, respectively. See Report of Independent Registered Public Accounting Firm Item 9. Changes In and Disagreements With Accountants On Accounting and Financial Disclosure None. Item 9A. Controls and Procedures Evaluation of Disclosure Controls and Procedures As of December 31, 2023, an evaluation was conducted under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934). Based on this evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2023. Management’s Annual Report On Internal Control Over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting for our company. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework and criteria established in Internal Control—Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, our management has concluded that our internal control over financial reporting was effective as of December 31, 2023. Our independent auditor, KPMG LLP, a registered public accounting firm, has issued an attestation report on the effectiveness of our internal control over financial reporting. This attestation report appears below. /s/ Thomas J. McInerney Thomas J. McInerney President and Chief Executive Officer (Principal Executive Officer) /s/ Jerome T. Upton Jerome T. Upton Executive Vice President and Chief Financial Officer (Principal Financial Officer) February 29, 2024 276 277 Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. /s/ KPMG LLP Richmond, Virginia February 29, 2024 Report of Independent Registered Public Accounting Firm To the Stockholders and Board of Directors Genworth Financial, Inc.: Opinion on Internal Control Over Financial Reporting We have audited Genworth Financial, Inc. and subsidiaries’ (the Company) internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2023 and 2022, the related consolidated statements of income, comprehensive income, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2023, and the related notes and financial statement schedules I to III (collectively, the consolidated financial statements), and our report dated February 29, 2024 expressed an unqualified opinion on those consolidated financial statements. Basis for Opinion The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report On Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. Definition and Limitations of Internal Control Over Financial Reporting A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements. 278 279 Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. /s/ KPMG LLP Richmond, Virginia February 29, 2024 Report of Independent Registered Public Accounting Firm To the Stockholders and Board of Directors Genworth Financial, Inc.: Opinion on Internal Control Over Financial Reporting We have audited Genworth Financial, Inc. and subsidiaries’ (the Company) internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2023 and 2022, the related consolidated statements of income, comprehensive income, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2023, and the related notes and financial statement schedules I to III (collectively, the consolidated financial statements), and our report dated February 29, 2024 expressed an unqualified opinion on those consolidated financial statements. Basis for Opinion The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report On Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. Definition and Limitations of Internal Control Over Financial Reporting A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements. 278 279 Changes in Internal Control Over Financial Reporting During the Quarter Ended December 31, 2023 There were no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Item 9B. Other Information During the three months ended December 31, 2023, no directors or officers of Genworth adopted or terminated any contract, instruction or written plan for the purchase or sale of Genworth’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a “Rule 10b5-1 trading arrangement”) or any “non- Rule 10b5-1 trading arrangement” as defined under the securities laws. Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections None. Item 10. Directors, Executive Officers and Corporate Governance PART III The following table sets forth certain information concerning our executive officers: Name Age Positions Thomas J. McInerney . . . . . . . . . . . . 67 President and Chief Executive Officer Jerome T. Upton . . . . . . . . . . . . . . . . 60 Executive Vice President and Chief Financial Officer Jamala M. Arland . . . . . . . . . . . . . . . 42 Executive Vice President—U.S. Life Insurance Rohit Gupta . . . . . . . . . . . . . . . . . . . . 49 President and Chief Executive Officer, Enact Melissa Hagerman . . . . . . . . . . . . . . 56 Executive Vice President and Chief Human Resources Officer Mark Blakeley Hodges . . . . . . . . . . . 44 Executive Vice President and Chief Risk Officer Gregory S. Karawan . . . . . . . . . . . . . 59 Executive Vice President and General Counsel Kelly Saltzgaber . . . . . . . . . . . . . . . . 59 Executive Vice President and Chief Investment Officer Andrea Lynn White . . . . . . . . . . . . . . 58 Executive Vice President—CareScout Insurance G. Kent Conrad . . . . . . . . . . . . . . . . . 75 Director, member of Nominating and Corporate Governance and Karen E. Dyson . . . . . . . . . . . . . . . . . 64 Director, member of Audit and Management Development and Risk Committees Compensation Committees Jill R. Goodman . . . . . . . . . . . . . . . . 57 Director, member of Management Development and Compensation Melina E. Higgins . . . . . . . . . . . . . . . 56 Non-Executive Chair of the Board, member of Audit and and Nominating and Corporate Governance Committees Howard D. Mills, III . . . . . . . . . . . . . 59 Director, member of Nominating and Corporate Governance and Management Development and Compensation Committees Robert P. Restrepo Jr. . . . . . . . . . . . . 73 Director, member of Audit and Management Development and Elaine A. Sarsynski . . . . . . . . . . . . . . 68 Director, member of Audit and Risk Committees Ramsey D. Smith . . . . . . . . . . . . . . . 56 Director, member of Nominating and Corporate Governance and Risk Committees Compensation Committees Risk Committees Executive Officers and Directors listed above. The following sets forth certain biographical information with respect to our executive officers and directors Thomas J. McInerney has been our President and Chief Executive Officer and a director since January 2013. Before joining our Company, Mr. McInerney had served as a Senior Advisor to the Boston Consulting Group from June 2011 to December 2012, providing consulting and advisory services to leading insurance and financial services companies in the United States and Canada. From October 2009 to December 2010, Mr. McInerney was a member of ING Groep’s Management Board for Insurance, where he was the Chief Operating Officer of ING’s insurance and investment management business worldwide. Prior to that, he served in a variety of senior roles with ING Groep NV after serving in many leadership positions with Aetna, where he began his career as an insurance underwriter in June 1978. Mr. McInerney has served as a director of Enact Holdings, a majority owned subsidiary of Genworth Financial, since its IPO in September 2021. He is also on the boards of United Way Worldwide, Virginia Learns, Global Research Institute at the College of William & Mary and Virginia Ready, where he serves as Chair of the Board. Mr. McInerney is a member of the American Council of Life Insurers and serves, and has served, on its CEO Steering Committees and Board. Mr. McInerney received a B.A. in Economics with Honors from Colgate University and an M.B.A. from the Tuck School of Business at Dartmouth College. 280 281 Changes in Internal Control Over Financial Reporting During the Quarter Ended December 31, 2023 There were no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal Item 10. Directors, Executive Officers and Corporate Governance PART III control over financial reporting. Item 9B. Other Information During the three months ended December 31, 2023, no directors or officers of Genworth adopted or terminated any contract, instruction or written plan for the purchase or sale of Genworth’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a “Rule 10b5-1 trading arrangement”) or any “non- Rule 10b5-1 trading arrangement” as defined under the securities laws. Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections None. The following table sets forth certain information concerning our executive officers: Name Age Positions Thomas J. McInerney . . . . . . . . . . . . Jerome T. Upton . . . . . . . . . . . . . . . . Jamala M. Arland . . . . . . . . . . . . . . . Rohit Gupta . . . . . . . . . . . . . . . . . . . . Melissa Hagerman . . . . . . . . . . . . . . Mark Blakeley Hodges . . . . . . . . . . . Gregory S. Karawan . . . . . . . . . . . . . Kelly Saltzgaber . . . . . . . . . . . . . . . . Andrea Lynn White . . . . . . . . . . . . . . G. Kent Conrad . . . . . . . . . . . . . . . . . 67 President and Chief Executive Officer 60 Executive Vice President and Chief Financial Officer 42 Executive Vice President—U.S. Life Insurance 49 President and Chief Executive Officer, Enact 56 Executive Vice President and Chief Human Resources Officer 44 Executive Vice President and Chief Risk Officer 59 Executive Vice President and General Counsel 59 Executive Vice President and Chief Investment Officer 58 Executive Vice President—CareScout Insurance 75 Director, member of Nominating and Corporate Governance and Risk Committees Karen E. Dyson . . . . . . . . . . . . . . . . . 64 Director, member of Audit and Management Development and Compensation Committees Jill R. Goodman . . . . . . . . . . . . . . . . 57 Director, member of Management Development and Compensation Melina E. Higgins . . . . . . . . . . . . . . . Howard D. Mills, III . . . . . . . . . . . . . and Nominating and Corporate Governance Committees 56 Non-Executive Chair of the Board, member of Audit and Management Development and Compensation Committees 59 Director, member of Nominating and Corporate Governance and Risk Committees Robert P. Restrepo Jr. . . . . . . . . . . . . 73 Director, member of Audit and Management Development and Compensation Committees Elaine A. Sarsynski . . . . . . . . . . . . . . Ramsey D. Smith . . . . . . . . . . . . . . . 68 Director, member of Audit and Risk Committees 56 Director, member of Nominating and Corporate Governance and Risk Committees Executive Officers and Directors The following sets forth certain biographical information with respect to our executive officers and directors listed above. Thomas J. McInerney has been our President and Chief Executive Officer and a director since January 2013. Before joining our Company, Mr. McInerney had served as a Senior Advisor to the Boston Consulting Group from June 2011 to December 2012, providing consulting and advisory services to leading insurance and financial services companies in the United States and Canada. From October 2009 to December 2010, Mr. McInerney was a member of ING Groep’s Management Board for Insurance, where he was the Chief Operating Officer of ING’s insurance and investment management business worldwide. Prior to that, he served in a variety of senior roles with ING Groep NV after serving in many leadership positions with Aetna, where he began his career as an insurance underwriter in June 1978. Mr. McInerney has served as a director of Enact Holdings, a majority owned subsidiary of Genworth Financial, since its IPO in September 2021. He is also on the boards of United Way Worldwide, Virginia Learns, Global Research Institute at the College of William & Mary and Virginia Ready, where he serves as Chair of the Board. Mr. McInerney is a member of the American Council of Life Insurers and serves, and has served, on its CEO Steering Committees and Board. Mr. McInerney received a B.A. in Economics with Honors from Colgate University and an M.B.A. from the Tuck School of Business at Dartmouth College. 280 281 Jerome T. Upton has been our Executive Vice President and Chief Financial Officer (“CFO”) since March 1, 2023 and is designated as the Company’s Principal Financial Officer. Prior to that, he served as our Senior Vice President, Deputy CFO and Controller from April 2022 to March 2023. From June 2010 to April 2022, Mr. Upton served as Vice President of the Company (during which time he also served as Deputy CFO from August 2020 to April 2022, as interim CFO of the Company’s U.S. Life Insurance business from August 2019 to August 2020, as the Chief Financial and Operations Officer of the Company’s Global Mortgage Insurance businesses from May 2012 to August 2019, and Senior Vice President and Chief Operating Officer of the international mortgage insurance businesses of the Company from June 2010 to May 2012). Prior to joining the Company’s predecessor in 1998, Mr. Upton was with KPMG Peat Marwick, where he served in accounting positions of increasing authority before attaining the position of Senior Manager – Insurance. Prior thereto, Mr. Upton was the Controller and Director of Financial Reporting for Century American Insurance Company and obtained the status of Certified Public Accountant. Mr. Upton received a Bachelor of Science Degree in Accounting from the University of North Carolina at Pembroke. Jamala M. Arland has been our Executive Vice President—U.S. Life Insurance since January 2024. Prior to that, she served as Senior Vice President—Long-Term Care Insurance In-Force since May 2022 with oversight responsibilities of the Company’s in-force long-term care insurance products. From January 2019 through May 2022, she served as a Vice President in Long-Term Care In-Force leading the execution of the Company’s multi- year rate action plan. Ms. Arland joined the Company in May 2005 and has held various actuarial roles at the Company in life valuation and annuity product development. She is the industry representative to the California Long-Term Care Taskforce, as appointed by the state Senate Rules Committee. Ms. Arland is a Fellow in the Society of Actuaries, a member of the American Academy of Actuaries (“AAA”), previously serving as chair of the AAA LTC Reform Subcommittee, and is a charterholder in the CFA Institute. Ms. Arland received a Bachelor of Mathematics (Actuarial Science and Statistics) degree from the University of Waterloo. Rohit Gupta has served as the President and Chief Executive Officer of Enact Holdings, a majority-owned subsidiary of Genworth Financial, and as a Director of Enact Holdings since its IPO in September 2021. While Mr. Gupta is President and Chief Executive Officer of Enact Holdings, he is not an officer of Genworth Financial. Mr. Gupta has also served as President and Chief Executive Officer of the Company’s U.S. mortgage insurance business since May 2012. Mr. Gupta also served as the Company’s Executive Vice President—Enact from May 2021 to September 2021, the Company’s Executive Vice President—U.S. Mortgage Insurance from February 2021 to May 2021, and as a Vice President of the Company from April 2013 to February 2021. Prior to that he held positions of Chief Commercial Officer from September 2009 to May 2012 and Senior Vice President, Products, Intelligence and Strategy from October 2007 to September 2009 in the Company’s U.S. mortgage insurance business. He also held various management positions with GE Mortgage Insurance beginning in 2003 and was a product manager for GE Capital. Mr. Gupta began his career with FedEx Corporation in Strategic Marketing, where he was responsible for competitive intelligence and market analysis supporting FedEx senior management. Mr. Gupta serves on the Mortgage Bankers Association board of directors and the Housing Policy Executive Council. He also served as Chairman and remains a board member of the U.S. Mortgage Insurers trade association. Mr. Gupta served on the board of Genworth MI Canada Inc. from June 2016 to December 2019. He also served on the board of Aqua Finance from 2021 to July 2022 and on the Mortgage Bankers Association Residential Board of Governors from 2017 through 2022. Mr. Gupta received an undergraduate degree in Computer Science & Technology from Indian Institute of Technology and received an M.B.A. in Finance from University of Illinois at Urbana Champaign. Melissa Hagerman has been our Executive Vice President and Chief Human Resources Officer since January 2022. Prior to that, she served as a Human Resources leader for the Company’s corporate and investment functions since February 2018. Ms. Hagerman previously served as Director, Human Resources for the Company’s U.S. Life Insurance segment and corporate finance function from June 2014 to January 2018, as Director, Human Resources for the corporate finance and global risk functions from July 2011 to March 2013, and as a senior client manager from March 2010 to July 2011. Ms. Hagerman has also held human resources positions at Carmax from March 2013 to June 2014 and Circuit City from July 2007 to February 2009. Ms. Hagerman received a B.S. in Human Resources Management from the University of Richmond and graduated from the Tuck Global Leadership Program through Dartmouth College in 2019. Mark Blakeley Hodges has been our Executive Vice President and Chief Risk Officer since May 2022. Prior to that he served as Senior Vice President and Chief Risk Officer since March 2022 and as Interim Chief Risk Officer from November 2021 to March 2022. Mr. Hodges previously served as Chief Operational Risk Officer for the Company and its U.S. Life Insurance segment from July 2015 until November 2021. From July 2002 through July 2015, Mr. Hodges served in various capacities with the Company and/or its predecessor including roles with responsibilities for oversight of Enterprise Risk Management (ERM) programs, financial reporting systems, operational and technology platforms, and testing and quality assurance programs. Mr. Hodges received a B.S. in Decision Support Systems from Virginia Polytechnic Institute (Virginia Tech) and graduated from the Tuck Global Executive Leadership Program through Dartmouth in 2020. Gregory S. Karawan has been our Executive Vice President and General Counsel since January 2022. Prior to that, he served as a Vice President of the Company since June 2008 and as General Counsel of our U.S. Life Insurance segment since January 2007. Mr. Karawan joined the Company in 2000 as global chief litigation counsel, a position he held intermittently and then continuously after January 2008. Prior to joining the Company, Mr. Karawan worked at the law firm of Sonnenschein Nath and Rosenthal. Mr. Karawan received a B.A. in economics from State University of New York Binghamton and a J.D. from Fordham Law School. Kelly Saltzgaber has been our Executive Vice President and Chief Investment Officer since March 1, 2023. She previously served as the Head of the Portfolio Management team from January 2018 to March 2023, having been Interim Head since mid-2017 after moving to Portfolio Management in November 2016, and as a Senior Credit Trader from 2013 to 2016. Prior to joining the Company in 2013, Ms. Saltzgaber had 27 years of combined experience in Institutional Credit Sales at Goldman Sachs, Barclays and Cambridge International and as an analyst in the Asset-Backed Securities group at Merrill Lynch. Ms. Saltzgaber received a B.A. in Economics Modified with Mathematics from Dartmouth College and an M.B.A. in Finance from New York University’s Stern School of Business. Andrea Lynn White has been our Executive Vice President—CareScout Insurance since October 1, 2023. She previously served as Executive Vice President—Government Relations from May 2022 to September 2023, while maintaining her title of Chief of Staff, a role to which she was appointed in December 2017. Ms. White served as our Senior Vice President—Government Relations from May 2021 to May 2022. In addition, Ms. White held positions in the Company’s Government Relations department from July 2015 to December 2017 and served as the Company’s Corporate Ombudsperson, with responsibility of implementing the Company’s code of ethics programs, from May 2005 to July 2015. From February 2001 to May 2005, Ms. White served in various capacities within the Company and/or its predecessor, including roles in the Human Resources department. Prior to joining the Company, Ms. White held various roles at Aetna Life Insurance and was an Associate with the law firm of LeClair Ryan. Ms. White received a B.BA., summa cum laude, in Finance from Howard University and a J.D. from the University of Virginia. G. Kent Conrad has served as a member of our board of directors since March 2013. Sen. Conrad served as a U.S. Senator representing the State of North Dakota from January 1987 to January 2013. He served as Chairman or Ranking Member of the Senate Budget Committee for 12 years. Prior to serving in the U.S. Senate, Sen. Conrad served as the Tax Commissioner for the State of North Dakota from 1981 to 1986 and as Assistant Tax Commissioner from 1974 to 1980. Sen. Conrad currently serves as a Strategic Advisor to Molina Healthcare, as co-chair of the Economic Advisory Committee for American Edge, as a member of the board of directors of the Committee for a Responsible Federal Budget, as a Senior Fellow for The Bipartisan Policy Center and as an advisor to the CEO of the Baltimore Orioles. Sen. Conrad received an A.B. in Political Science from Stanford University and an M.B.A. from George Washington University. Karen E. Dyson has served as a member of our board of directors since December 2020. Lt. Gen. Dyson was the first female finance officer to achieve three-star general officer rank in August 2014. She retired as 282 283 Jerome T. Upton has been our Executive Vice President and Chief Financial Officer (“CFO”) since March 1, 2023 and is designated as the Company’s Principal Financial Officer. Prior to that, he served as our Senior Vice President, Deputy CFO and Controller from April 2022 to March 2023. From June 2010 to April 2022, Mr. Upton served as Vice President of the Company (during which time he also served as Deputy CFO from August 2020 to April 2022, as interim CFO of the Company’s U.S. Life Insurance business from August 2019 to August 2020, as the Chief Financial and Operations Officer of the Company’s Global Mortgage Insurance businesses from May 2012 to August 2019, and Senior Vice President and Chief Operating Officer of the international mortgage insurance businesses of the Company from June 2010 to May 2012). Prior to joining the Company’s predecessor in 1998, Mr. Upton was with KPMG Peat Marwick, where he served in accounting positions of increasing authority before attaining the position of Senior Manager – Insurance. Prior thereto, Mr. Upton was the Controller and Director of Financial Reporting for Century American Insurance Company and obtained the status of Certified Public Accountant. Mr. Upton received a Bachelor of Science Degree in Accounting from the University of North Carolina at Pembroke. Jamala M. Arland has been our Executive Vice President—U.S. Life Insurance since January 2024. Prior to that, she served as Senior Vice President—Long-Term Care Insurance In-Force since May 2022 with oversight responsibilities of the Company’s in-force long-term care insurance products. From January 2019 through May 2022, she served as a Vice President in Long-Term Care In-Force leading the execution of the Company’s multi- year rate action plan. Ms. Arland joined the Company in May 2005 and has held various actuarial roles at the Company in life valuation and annuity product development. She is the industry representative to the California Long-Term Care Taskforce, as appointed by the state Senate Rules Committee. Ms. Arland is a Fellow in the Society of Actuaries, a member of the American Academy of Actuaries (“AAA”), previously serving as chair of the AAA LTC Reform Subcommittee, and is a charterholder in the CFA Institute. Ms. Arland received a Bachelor of Mathematics (Actuarial Science and Statistics) degree from the University of Waterloo. Rohit Gupta has served as the President and Chief Executive Officer of Enact Holdings, a majority-owned subsidiary of Genworth Financial, and as a Director of Enact Holdings since its IPO in September 2021. While Mr. Gupta is President and Chief Executive Officer of Enact Holdings, he is not an officer of Genworth Financial. Mr. Gupta has also served as President and Chief Executive Officer of the Company’s U.S. mortgage insurance business since May 2012. Mr. Gupta also served as the Company’s Executive Vice President—Enact from May 2021 to September 2021, the Company’s Executive Vice President—U.S. Mortgage Insurance from February 2021 to May 2021, and as a Vice President of the Company from April 2013 to February 2021. Prior to that he held positions of Chief Commercial Officer from September 2009 to May 2012 and Senior Vice President, Products, Intelligence and Strategy from October 2007 to September 2009 in the Company’s U.S. mortgage insurance business. He also held various management positions with GE Mortgage Insurance beginning in 2003 and was a product manager for GE Capital. Mr. Gupta began his career with FedEx Corporation in Strategic Marketing, where he was responsible for competitive intelligence and market analysis supporting FedEx senior management. Mr. Gupta serves on the Mortgage Bankers Association board of directors and the Housing Policy Executive Council. He also served as Chairman and remains a board member of the U.S. Mortgage Insurers trade association. Mr. Gupta served on the board of Genworth MI Canada Inc. from June 2016 to December 2019. He also served on the board of Aqua Finance from 2021 to July 2022 and on the Mortgage Bankers Association Residential Board of Governors from 2017 through 2022. Mr. Gupta received an undergraduate degree in Computer Science & Technology from Indian Institute of Technology and received an M.B.A. in Finance from University of Illinois at Urbana Champaign. Melissa Hagerman has been our Executive Vice President and Chief Human Resources Officer since January 2022. Prior to that, she served as a Human Resources leader for the Company’s corporate and investment functions since February 2018. Ms. Hagerman previously served as Director, Human Resources for the Company’s U.S. Life Insurance segment and corporate finance function from June 2014 to January 2018, as Director, Human Resources for the corporate finance and global risk functions from July 2011 to March 2013, and as a senior client manager from March 2010 to July 2011. Ms. Hagerman has also held human resources positions at Carmax from March 2013 to June 2014 and Circuit City from July 2007 to February 2009. Ms. Hagerman received a B.S. in Human Resources Management from the University of Richmond and graduated from the Tuck Global Leadership Program through Dartmouth College in 2019. Mark Blakeley Hodges has been our Executive Vice President and Chief Risk Officer since May 2022. Prior to that he served as Senior Vice President and Chief Risk Officer since March 2022 and as Interim Chief Risk Officer from November 2021 to March 2022. Mr. Hodges previously served as Chief Operational Risk Officer for the Company and its U.S. Life Insurance segment from July 2015 until November 2021. From July 2002 through July 2015, Mr. Hodges served in various capacities with the Company and/or its predecessor including roles with responsibilities for oversight of Enterprise Risk Management (ERM) programs, financial reporting systems, operational and technology platforms, and testing and quality assurance programs. Mr. Hodges received a B.S. in Decision Support Systems from Virginia Polytechnic Institute (Virginia Tech) and graduated from the Tuck Global Executive Leadership Program through Dartmouth in 2020. Gregory S. Karawan has been our Executive Vice President and General Counsel since January 2022. Prior to that, he served as a Vice President of the Company since June 2008 and as General Counsel of our U.S. Life Insurance segment since January 2007. Mr. Karawan joined the Company in 2000 as global chief litigation counsel, a position he held intermittently and then continuously after January 2008. Prior to joining the Company, Mr. Karawan worked at the law firm of Sonnenschein Nath and Rosenthal. Mr. Karawan received a B.A. in economics from State University of New York Binghamton and a J.D. from Fordham Law School. Kelly Saltzgaber has been our Executive Vice President and Chief Investment Officer since March 1, 2023. She previously served as the Head of the Portfolio Management team from January 2018 to March 2023, having been Interim Head since mid-2017 after moving to Portfolio Management in November 2016, and as a Senior Credit Trader from 2013 to 2016. Prior to joining the Company in 2013, Ms. Saltzgaber had 27 years of combined experience in Institutional Credit Sales at Goldman Sachs, Barclays and Cambridge International and as an analyst in the Asset-Backed Securities group at Merrill Lynch. Ms. Saltzgaber received a B.A. in Economics Modified with Mathematics from Dartmouth College and an M.B.A. in Finance from New York University’s Stern School of Business. Andrea Lynn White has been our Executive Vice President—CareScout Insurance since October 1, 2023. She previously served as Executive Vice President—Government Relations from May 2022 to September 2023, while maintaining her title of Chief of Staff, a role to which she was appointed in December 2017. Ms. White served as our Senior Vice President—Government Relations from May 2021 to May 2022. In addition, Ms. White held positions in the Company’s Government Relations department from July 2015 to December 2017 and served as the Company’s Corporate Ombudsperson, with responsibility of implementing the Company’s code of ethics programs, from May 2005 to July 2015. From February 2001 to May 2005, Ms. White served in various capacities within the Company and/or its predecessor, including roles in the Human Resources department. Prior to joining the Company, Ms. White held various roles at Aetna Life Insurance and was an Associate with the law firm of LeClair Ryan. Ms. White received a B.BA., summa cum laude, in Finance from Howard University and a J.D. from the University of Virginia. G. Kent Conrad has served as a member of our board of directors since March 2013. Sen. Conrad served as a U.S. Senator representing the State of North Dakota from January 1987 to January 2013. He served as Chairman or Ranking Member of the Senate Budget Committee for 12 years. Prior to serving in the U.S. Senate, Sen. Conrad served as the Tax Commissioner for the State of North Dakota from 1981 to 1986 and as Assistant Tax Commissioner from 1974 to 1980. Sen. Conrad currently serves as a Strategic Advisor to Molina Healthcare, as co-chair of the Economic Advisory Committee for American Edge, as a member of the board of directors of the Committee for a Responsible Federal Budget, as a Senior Fellow for The Bipartisan Policy Center and as an advisor to the CEO of the Baltimore Orioles. Sen. Conrad received an A.B. in Political Science from Stanford University and an M.B.A. from George Washington University. Karen E. Dyson has served as a member of our board of directors since December 2020. Lt. Gen. Dyson was the first female finance officer to achieve three-star general officer rank in August 2014. She retired as 282 283 Military Deputy to the Assistant Secretary of the Army for Financial Management and Comptroller in August 2017. During her career, she led efforts building, executing, and reporting on the Army’s multi-appropriation budget; commanded units and led troops in war operations; and led strategic transformation initiatives. Lt. Gen. Dyson is a strategic leader with board experience in corporate governance, finance and audit committees, risk oversight, and management development and compensation. She currently serves on the boards of USAA Federal Savings Bank since October 2017 (serving as nominations and governance committee chair); CALIBRE Systems, Inc. since October 2018 (serving as audit committee chair); and Army Emergency Relief Organization since 2020. Lt. Gen. Dyson received a B.S. in Business Management from Missouri State University, an M.B.A. from Austin Peay State University and an M.S. in National Resource Strategy from the Eisenhower School of National Security and Resources Strategy. Lt. Gen. Dyson is National Association of Corporate Directors (“NACD”) Directorship Certified. Jill R. Goodman has served as a member of our board of directors since March 2021. Ms. Goodman is currently Managing Director of Foros Advisors LLC, a strategic financial and mergers and acquisitions advisory firm, a position she has held since November 2013. Ms. Goodman advises companies and special committees with regard to mergers and acquisitions. Previously, she served as a Managing Director and Head, Special Committee and Fiduciary Practice—U.S. at Rothschild from 2010 to October 2013. From 1998 to 2010, Ms. Goodman was with Lazard in the Mergers & Acquisitions and Strategic Advisory Group, most recently as Managing Director. Ms. Goodman has served as a director of Cboe Global Markets, a leading provider of trading, clearing and investment solutions to market participants around the world, since 2012 (serving as finance and strategy chair and as a member of the executive and nominating and governance committees). She has also served as a director of Cover Genius, a private global insurance technology company, since February 2022. Ms. Goodman graduated magna cum laude from Rice University with a B.A. degree. She received her J.D. degree, with honors, from the University of Chicago Law School. Melina E. Higgins has served as a member of our board of directors since September 2013 and Non- Executive Chair of the Board since May 2021. Ms. Higgins retired in 2010 from a nearly 20-year career at The Goldman Sachs Group Inc., where she served as a Managing Director from 2001 and a Partner from 2002. During her tenure at Goldman Sachs, Ms. Higgins served as Head of the Americas for Private Debt and Co- Chairperson of the Investment Advisory Committee for the GS Mezzanine Partners funds. She also served as a member of the Investment Committee for the Principal Investment Area, which oversaw and approved global private equity and private debt investments. Goldman’s Principal Investment Area was one of the largest alternative asset managers in the world. Ms. Higgins has served as a director of Viatris Inc. since November 2020 (serving as chair of the board, executive committee chair and finance committee chair). She previously served on the boards of Mylan N.V. from February 2013 to November 2020 and NextGen Acquisition Corp. II from March 2021 to December 2021. Ms. Higgins has also served as Non- Executive Chair of the board of Antares Midco, Inc. since January 2016 and is a member of the Women’s Leadership Board of Harvard University’s John F. Kennedy School of Government. Ms. Higgins received a B.A. in Economics and Spanish from Colgate University and an M.B.A. from Harvard Business School. Howard D. Mills, III has served as a member of our board of directors since March 2021. Mr. Mills is currently Executive Vice President of Business Development and External Affairs of beeXact, a geospatial data management/EngineeringTech company that designs and permits fiber optic networks. He also currently serves as a Senior Advisor to McKinsey & Company, where he advises boards and executives in the areas of regulatory and reputational risk, executive positioning, strategy, environmental, social, and governance (ESG) matters, financial communications, crisis management, mergers and acquisitions and public policy. Mr. Mills had a 12- year career at Deloitte LLP, where he served as Managing Director and Global Insurance Regulatory Leader from 2007 to May 2019. During his tenure at Deloitte, Mr. Mills served Deloitte’s largest U.S. and global insurance clients. Prior to his management consulting career, Mr. Mills was the Superintendent of the New York State Insurance Department from 2005 to 2006. Mr. Mills served three terms in the New York State Assembly from 1999 to 2004, where he was an active member of the National Council of Insurance Legislators. Mr. Mills has served as a director of The Doctors Company since May 2019, the largest physician-owned medical liability insurer in the U.S. (serving as a member of the audit committee). Mr. Mills previously served on the board of directors of Ensight, a cloud-based insurance sales platform from June 2019 to January 2022. Mr. Mills currently serves as President and a Director of the Insurance Federation of New York and as a Trustee of The Institutes Griffith Insurance Education Foundation. Mr. Mills received a B.A. in political science from Marist College and an M.A. in public administration from The American University. Mr. Mills is a NACD Governance Fellow. Robert P. Restrepo Jr. has served as a member of our board of directors since December 2016. Mr. Restrepo retired from State Auto Financial Corporation in 2015, having served as its Chairman from 2006 to December 2015 and as its President and Chief Executive Officer from 2006 to May 2015. Mr. Restrepo has over 40 years of insurance industry experience, having held executive roles at Main Street America Group, Hanover Insurance Group Inc. (formerly Allmerica Financial Corp), Travelers and Aetna. Mr. Restrepo has served as a director of RLI Corp., a property and casualty insurance company, since July 2016 (serving as chair of the nominating/governance committee and as a member of the finance and investment committee) and of Enact Holdings, a majority-owned subsidiary of Genworth Financial, since its IPO in September 2021 (serving as a member of the audit and nominating and corporate governance committees). Mr. Restrepo also currently serves on the board of directors of The Larry H. Miller Group of Companies. He also previously served as a director of Majesco, a provider of insurance software and consulting services, from August 2015 to September 2020. Mr. Restrepo received a B.A. in English from Yale University. Mr. Restrepo is NACD Directorship Certified and has obtained the Professional Director – Public Company credential from the American College of Corporate Directors. Elaine A. Sarsynski has served as a member of our board of directors since March 2022. Ms. Sarsynski was Chairwoman, Chief Executive Officer and President of MassMutual International, an insurance company, until her retirement in 2017. She joined Mass Mutual Life Insurance Company in 2005 as Managing Director at Babson Capital Management LLC, a MassMutual subsidiary. She became Executive Vice President, Chief Administrative Officer, Chief Executive Officer and President of MassMutual International in 2006 and Executive Vice President, member of the Office of the Chief Executive Officer and President of MassMutual Retirement Services, as well as Chairwoman of MassMutual International, in 2008. Prior to joining Babson Capital, she served two elected terms as First Selectman for the town of Suffield, Connecticut. In 1998, she founded Sun Consulting Group LLC, offering consulting services to the real estate industry. Ms. Sarsynski previously spent 17 years at Aetna, where she held multiple senior management positions overseeing segments of the company’s Investments Division and leading the Corporate Finance Department. She currently serves on the board of directors of TI Fluid Systems PLC, Horizon Technology Finance Corporation and Horace Mann Educators Corporation. Ms. Sarsynski previously served on the board of directors of AXA S.A. from 2018 to 2021. Ms. Sarsynski received a B.A. from Smith College and an M.B.A. from Columbia University. Ramsey D. Smith has served as a member of our board of directors since March 2021. Mr. Smith is the founder and CEO of ALEX.fyi, a retirement solutions company, and is a founding partner of ALEXIncome, a retirement consulting company. Before founding ALEX.fyi in 2016, Mr. Smith spent over two decades at Goldman Sachs, most recently as Managing Director, Equity Derivative Sales, Head of Insurance. Mr. Smith built out the Life Insurance business at Goldman Sachs from 2007 to 2016. Prior to his tenure at Goldman Sachs, Mr. Smith worked as an analyst at Credit Suisse from 1990 to 1993. Mr. Smith is active in philanthropic activities, including serving on the Board of Sponsors for Educational Opportunity. Mr. Smith received an A.B. degree in Romance Languages and Literature from Princeton University and an M.B.A. from Harvard Business From time to time, we or our subsidiaries are subject to court orders, judgments or decrees enjoining us or the subsidiaries from engaging in certain business practices, and sometimes such orders, judgments or decrees are also applicable to our affiliates, officers, employees and certain other related parties, including certain of our School. executive officers. Other Information We will provide the remaining information that is responsive to this Item 10 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year 284 285 Military Deputy to the Assistant Secretary of the Army for Financial Management and Comptroller in August 2017. During her career, she led efforts building, executing, and reporting on the Army’s multi-appropriation budget; commanded units and led troops in war operations; and led strategic transformation initiatives. Lt. Gen. Dyson is a strategic leader with board experience in corporate governance, finance and audit committees, risk oversight, and management development and compensation. She currently serves on the boards of USAA Federal Savings Bank since October 2017 (serving as nominations and governance committee chair); CALIBRE Systems, Inc. since October 2018 (serving as audit committee chair); and Army Emergency Relief Organization since 2020. Lt. Gen. Dyson received a B.S. in Business Management from Missouri State University, an M.B.A. from Austin Peay State University and an M.S. in National Resource Strategy from the Eisenhower School of National Security and Resources Strategy. Lt. Gen. Dyson is National Association of Corporate Directors (“NACD”) Directorship Certified. Jill R. Goodman has served as a member of our board of directors since March 2021. Ms. Goodman is currently Managing Director of Foros Advisors LLC, a strategic financial and mergers and acquisitions advisory firm, a position she has held since November 2013. Ms. Goodman advises companies and special committees with regard to mergers and acquisitions. Previously, she served as a Managing Director and Head, Special Committee and Fiduciary Practice—U.S. at Rothschild from 2010 to October 2013. From 1998 to 2010, Ms. Goodman was with Lazard in the Mergers & Acquisitions and Strategic Advisory Group, most recently as Managing Director. Ms. Goodman has served as a director of Cboe Global Markets, a leading provider of trading, clearing and investment solutions to market participants around the world, since 2012 (serving as finance and strategy chair and as a member of the executive and nominating and governance committees). She has also served as a director of Cover Genius, a private global insurance technology company, since February 2022. Ms. Goodman graduated magna cum laude from Rice University with a B.A. degree. She received her J.D. degree, with honors, from the University of Chicago Law School. Melina E. Higgins has served as a member of our board of directors since September 2013 and Non- Executive Chair of the Board since May 2021. Ms. Higgins retired in 2010 from a nearly 20-year career at The Goldman Sachs Group Inc., where she served as a Managing Director from 2001 and a Partner from 2002. During her tenure at Goldman Sachs, Ms. Higgins served as Head of the Americas for Private Debt and Co- Chairperson of the Investment Advisory Committee for the GS Mezzanine Partners funds. She also served as a member of the Investment Committee for the Principal Investment Area, which oversaw and approved global private equity and private debt investments. Goldman’s Principal Investment Area was one of the largest alternative asset managers in the world. Ms. Higgins has served as a director of Viatris Inc. since November 2020 (serving as chair of the board, executive committee chair and finance committee chair). She previously served on the boards of Mylan N.V. from February 2013 to November 2020 and NextGen Acquisition Corp. II from March 2021 to December 2021. Ms. Higgins has also served as Non- Executive Chair of the board of Antares Midco, Inc. since January 2016 and is a member of the Women’s Leadership Board of Harvard University’s John F. Kennedy School of Government. Ms. Higgins received a B.A. in Economics and Spanish from Colgate University and an M.B.A. from Harvard Business School. Howard D. Mills, III has served as a member of our board of directors since March 2021. Mr. Mills is currently Executive Vice President of Business Development and External Affairs of beeXact, a geospatial data management/EngineeringTech company that designs and permits fiber optic networks. He also currently serves as a Senior Advisor to McKinsey & Company, where he advises boards and executives in the areas of regulatory and reputational risk, executive positioning, strategy, environmental, social, and governance (ESG) matters, financial communications, crisis management, mergers and acquisitions and public policy. Mr. Mills had a 12- year career at Deloitte LLP, where he served as Managing Director and Global Insurance Regulatory Leader from 2007 to May 2019. During his tenure at Deloitte, Mr. Mills served Deloitte’s largest U.S. and global insurance clients. Prior to his management consulting career, Mr. Mills was the Superintendent of the New York State Insurance Department from 2005 to 2006. Mr. Mills served three terms in the New York State Assembly from 1999 to 2004, where he was an active member of the National Council of Insurance Legislators. Mr. Mills has served as a director of The Doctors Company since May 2019, the largest physician-owned medical liability insurer in the U.S. (serving as a member of the audit committee). Mr. Mills previously served on the board of directors of Ensight, a cloud-based insurance sales platform from June 2019 to January 2022. Mr. Mills currently serves as President and a Director of the Insurance Federation of New York and as a Trustee of The Institutes Griffith Insurance Education Foundation. Mr. Mills received a B.A. in political science from Marist College and an M.A. in public administration from The American University. Mr. Mills is a NACD Governance Fellow. Robert P. Restrepo Jr. has served as a member of our board of directors since December 2016. Mr. Restrepo retired from State Auto Financial Corporation in 2015, having served as its Chairman from 2006 to December 2015 and as its President and Chief Executive Officer from 2006 to May 2015. Mr. Restrepo has over 40 years of insurance industry experience, having held executive roles at Main Street America Group, Hanover Insurance Group Inc. (formerly Allmerica Financial Corp), Travelers and Aetna. Mr. Restrepo has served as a director of RLI Corp., a property and casualty insurance company, since July 2016 (serving as chair of the nominating/governance committee and as a member of the finance and investment committee) and of Enact Holdings, a majority-owned subsidiary of Genworth Financial, since its IPO in September 2021 (serving as a member of the audit and nominating and corporate governance committees). Mr. Restrepo also currently serves on the board of directors of The Larry H. Miller Group of Companies. He also previously served as a director of Majesco, a provider of insurance software and consulting services, from August 2015 to September 2020. Mr. Restrepo received a B.A. in English from Yale University. Mr. Restrepo is NACD Directorship Certified and has obtained the Professional Director – Public Company credential from the American College of Corporate Directors. Elaine A. Sarsynski has served as a member of our board of directors since March 2022. Ms. Sarsynski was Chairwoman, Chief Executive Officer and President of MassMutual International, an insurance company, until her retirement in 2017. She joined Mass Mutual Life Insurance Company in 2005 as Managing Director at Babson Capital Management LLC, a MassMutual subsidiary. She became Executive Vice President, Chief Administrative Officer, Chief Executive Officer and President of MassMutual International in 2006 and Executive Vice President, member of the Office of the Chief Executive Officer and President of MassMutual Retirement Services, as well as Chairwoman of MassMutual International, in 2008. Prior to joining Babson Capital, she served two elected terms as First Selectman for the town of Suffield, Connecticut. In 1998, she founded Sun Consulting Group LLC, offering consulting services to the real estate industry. Ms. Sarsynski previously spent 17 years at Aetna, where she held multiple senior management positions overseeing segments of the company’s Investments Division and leading the Corporate Finance Department. She currently serves on the board of directors of TI Fluid Systems PLC, Horizon Technology Finance Corporation and Horace Mann Educators Corporation. Ms. Sarsynski previously served on the board of directors of AXA S.A. from 2018 to 2021. Ms. Sarsynski received a B.A. from Smith College and an M.B.A. from Columbia University. Ramsey D. Smith has served as a member of our board of directors since March 2021. Mr. Smith is the founder and CEO of ALEX.fyi, a retirement solutions company, and is a founding partner of ALEXIncome, a retirement consulting company. Before founding ALEX.fyi in 2016, Mr. Smith spent over two decades at Goldman Sachs, most recently as Managing Director, Equity Derivative Sales, Head of Insurance. Mr. Smith built out the Life Insurance business at Goldman Sachs from 2007 to 2016. Prior to his tenure at Goldman Sachs, Mr. Smith worked as an analyst at Credit Suisse from 1990 to 1993. Mr. Smith is active in philanthropic activities, including serving on the Board of Sponsors for Educational Opportunity. Mr. Smith received an A.B. degree in Romance Languages and Literature from Princeton University and an M.B.A. from Harvard Business School. From time to time, we or our subsidiaries are subject to court orders, judgments or decrees enjoining us or the subsidiaries from engaging in certain business practices, and sometimes such orders, judgments or decrees are also applicable to our affiliates, officers, employees and certain other related parties, including certain of our executive officers. Other Information We will provide the remaining information that is responsive to this Item 10 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year 284 285 covered by this Annual Report, in either case under the captions “Election of Directors,” “Corporate Governance,” “Board of Directors and Committees,” “Section 16(a) Beneficial Ownership Reporting Compliance,” and possibly elsewhere therein. That information is incorporated into this Item 10 by reference. Item 15. Exhibits and Financial Statement Schedules PART IV Item 11. Executive Compensation We will provide information that is responsive to this Item 11 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report, in either case under the captions “Board of Directors and Committees,” “Compensation Discussion and Analysis,” “Report of the Management Development and Compensation Committee” (which report shall be deemed furnished with this Form 10-K, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934), “Executive Compensation,” and possibly elsewhere therein. That information is incorporated into this Item 11 by reference. Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters We will provide information that is responsive to this Item 12 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report, in either case under the caption “Information Relating to Directors, Director Nominees, Executive Officers and Significant Stockholders,” “Equity Compensation Plans” and possibly elsewhere therein. That information is incorporated into this Item 12 by reference. Item 13. Certain Relationships and Related Transactions, and Director Independence We will provide information that is responsive to this Item 13 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report, in either case under the captions “Corporate Governance,” “Certain Relationships and Transactions,” and possibly elsewhere therein. That information is incorporated into this Item 13 by reference. Item 14. Principal Accountant Fees and Services We will provide information that is responsive to this Item 14 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report, in either case under the caption “Independent Registered Public Accounting Firm,” and possibly elsewhere therein. That information is incorporated into this Item 14 by reference. a. Documents filed as part of this report. 1. Financial Statements (see Item 8. Financial Statements and Supplementary Data) Report of KPMG LLP, Independent Registered Public Accounting Firm Consolidated Balance Sheets as of December 31, 2023 and 2022 Consolidated Statements of Income for the years ended December 31, 2023, 2022 and 2021 Consolidated Statements of Comprehensive Income for the years ended December 31, 2023, 2022 and 2021 Consolidated Statements of Changes in Equity for the years ended December 31, 2023, 2022 and 2021 Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021 Notes to Consolidated Financial Statements 2. Financial Statement Schedules Schedule I—Summary of Investments—Other Than Investments in Related Parties Schedule II—Financial Statements of Genworth Financial, Inc. (Parent Only) Schedule III—Supplemental Insurance Information 286 287 covered by this Annual Report, in either case under the captions “Election of Directors,” “Corporate Governance,” “Board of Directors and Committees,” “Section 16(a) Beneficial Ownership Reporting PART IV Compliance,” and possibly elsewhere therein. That information is incorporated into this Item 10 by reference. Item 15. Exhibits and Financial Statement Schedules Item 11. Executive Compensation We will provide information that is responsive to this Item 11 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report, in either case under the captions “Board of Directors and Committees,” “Compensation Discussion and Analysis,” “Report of the Management Development and Compensation Committee” (which report shall be deemed furnished with this Form 10-K, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934), “Executive Compensation,” and possibly elsewhere therein. That information is incorporated into this Item 11 by reference. Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters We will provide information that is responsive to this Item 12 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report, in either case under the caption “Information Relating to Directors, Director Nominees, Executive Officers and Significant Stockholders,” “Equity Compensation Plans” and possibly elsewhere therein. That information is incorporated into this Item 12 by reference. Item 13. Certain Relationships and Related Transactions, and Director Independence We will provide information that is responsive to this Item 13 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report, in either case under the captions “Corporate Governance,” “Certain Relationships and Transactions,” and possibly elsewhere therein. That information is incorporated into this Item 13 by reference. Item 14. Principal Accountant Fees and Services We will provide information that is responsive to this Item 14 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report, in either case under the caption “Independent Registered Public Accounting Firm,” and possibly elsewhere therein. That information is incorporated into this Item 14 by reference. a. Documents filed as part of this report. 1. Financial Statements (see Item 8. Financial Statements and Supplementary Data) Report of KPMG LLP, Independent Registered Public Accounting Firm Consolidated Balance Sheets as of December 31, 2023 and 2022 Consolidated Statements of Income for the years ended December 31, 2023, 2022 and 2021 Consolidated Statements of Comprehensive Income for the years ended December 31, 2023, 2022 and 2021 Consolidated Statements of Changes in Equity for the years ended December 31, 2023, 2022 and 2021 Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021 Notes to Consolidated Financial Statements 2. Financial Statement Schedules Schedule I—Summary of Investments—Other Than Investments in Related Parties Schedule II—Financial Statements of Genworth Financial, Inc. (Parent Only) Schedule III—Supplemental Insurance Information 286 287 3. Exhibits Number Description 2.1 3.1 3.2 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 Agreement and Plan of Merger, dated as of April 1, 2013, among Genworth Financial, Inc. (renamed Genworth Holdings, Inc.), Sub XLVI, Inc. (renamed Genworth Financial, Inc.) and Sub XLII, Inc. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed on April 1, 2013) Amended and Restated Certificate of Incorporation of Genworth Financial, Inc., dated as of April 1, 2013 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on April 1, 2013) Amended and Restated Bylaws of Genworth Financial, Inc., dated as of October 19, 2022 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on October 21, 2022) Specimen Class A Common Stock certificate (incorporated by reference to Exhibit 4.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2012) Indenture, dated as of November 14, 2006, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on November 14, 2006) First Supplemental Indenture, dated as of November 14, 2006, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on November 14, 2006) Second Supplemental Indenture, dated as of April 1, 2013, among Genworth Holdings, Inc., Genworth Financial, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on April 1, 2013) Third Supplemental Indenture, dated as of March 18, 2016, among Genworth Holdings, Inc., Genworth Financial, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee, amending the Indenture, dated as of November 14, 2006, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on March 22, 2016) Indenture, dated as of June 15, 2004, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and The Bank of New York (successor to JPMorgan Chase Bank), as Trustee (incorporated by reference to Exhibit 4.10 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2004) Supplemental Indenture No. 1, dated as of June 15, 2004, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and The Bank of New York (successor to JPMorgan Chase Bank), as Trustee (incorporated by reference to Exhibit 4.11 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2004) Supplemental Indenture No. 9, dated as of April 1, 2013, among Genworth Holdings, Inc., Genworth Financial, Inc., as guarantor, and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on April 1, 2013) Supplemental Indenture No. 12, dated as of March 18, 2016, among Genworth Holdings, Inc., Genworth Financial, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee, amending the Indenture, dated as of June 15, 2004, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and JPMorgan Chase Bank, N.A. (succeeded by The Bank of New York Mellon Trust Company, N.A.), as Trustee (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on March 22, 2016) Number Description 4.10 Supplemental Indenture No. 13, dated as of October 3, 2018, among Genworth Holdings, Inc., Genworth Financial, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee, amending the Indenture, dated as of June 15, 2004, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and JPMorgan Chase Bank, N.A. (succeeded by The Bank of New York Mellon Trust Company, N.A.), as Trustee (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on October 4, 2018) 4.11 Description of Registrant’s Capital Stock (incorporated by reference to Exhibit 4.15 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2019) 10.1 Coinsurance Agreement, dated as of April 15, 2004, by and between GE Life and Annuity Assurance Company (now known as Genworth Life and Annuity Insurance Company) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.11 to the Registration Statement on Form S-1 (No. 333-112009) (the “Registration Statement”)) 10.1.1 Amendments to Coinsurance Agreement (incorporated by reference to Exhibit 10.6.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) 10.2 Coinsurance Agreement, dated as of April 15, 2004, by and between Federal Home Life Insurance Company (merged with and into Genworth Life and Annuity Insurance Company effective January 1, 2007) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.12 to the Registration Statement) 10.2.1 Amendments to Coinsurance Agreement (incorporated by reference to Exhibit 10.7.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) 10.3 Coinsurance Agreement, dated as of April 15, 2004, by and between General Electric Capital Assurance Company (now known as Genworth Life Insurance Company) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.13 to the Registration Statement) 10.3.1 Amendments to Coinsurance Agreement (incorporated by reference to Exhibit 10.8.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) 10.4 Coinsurance Agreement, dated as of April 15, 2004, by and between GE Capital Life Assurance Company of New York (now known as Genworth Life Insurance Company of New York) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.14 to the Registration Statement) 10.4.1 Amendments to Coinsurance Agreement (incorporated by reference to Exhibit 10.9.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) 10.4.2 Third Amendment to Coinsurance Agreement (incorporated by reference to Exhibit 10.11.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2009) 10.5 Coinsurance Agreement, dated as of April 15, 2004, by and between American Mayflower Life Insurance Company of New York (merged with and into Genworth Life Insurance Company of New York effective January 1, 2007) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.15 to the Registration Statement) 10.5.1 Amendments to Coinsurance Agreement (incorporated by reference to Exhibit 10.10.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) 10.5.2 Third Amendment to Coinsurance Agreement (incorporated by reference to Exhibit 10.12.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2009) 10.6 Coinsurance Agreement, dated as of April 15, 2004, between First Colony Life Insurance Company (merged with and into Genworth Life and Annuity Insurance Company, effective January 1, 2007) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.54 to the Registration Statement) 288 289 3. Exhibits Number Description 2.1 Agreement and Plan of Merger, dated as of April 1, 2013, among Genworth Financial, Inc. (renamed Genworth Holdings, Inc.), Sub XLVI, Inc. (renamed Genworth Financial, Inc.) and Sub XLII, Inc. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed on April 1, 2013) 3.1 Amended and Restated Certificate of Incorporation of Genworth Financial, Inc., dated as of April 1, 2013 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on 3.2 Amended and Restated Bylaws of Genworth Financial, Inc., dated as of October 19, 2022 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on October 21, April 1, 2013) 2022) 4.1 Specimen Class A Common Stock certificate (incorporated by reference to Exhibit 4.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2012) 4.2 Indenture, dated as of November 14, 2006, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on November 14, 2006) 4.3 First Supplemental Indenture, dated as of November 14, 2006, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on November 14, 2006) 4.4 Second Supplemental Indenture, dated as of April 1, 2013, among Genworth Holdings, Inc., Genworth Financial, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on April 1, 2013) 4.5 Third Supplemental Indenture, dated as of March 18, 2016, among Genworth Holdings, Inc., Genworth Financial, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee, amending the Indenture, dated as of November 14, 2006, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on March 22, 2016) 4.6 Indenture, dated as of June 15, 2004, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and The Bank of New York (successor to JPMorgan Chase Bank), as Trustee (incorporated by reference to Exhibit 4.10 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2004) 4.7 Supplemental Indenture No. 1, dated as of June 15, 2004, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and The Bank of New York (successor to JPMorgan Chase Bank), as Trustee (incorporated by reference to Exhibit 4.11 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2004) 4.8 Supplemental Indenture No. 9, dated as of April 1, 2013, among Genworth Holdings, Inc., Genworth Financial, Inc., as guarantor, and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on April 1, 2013) 4.9 Supplemental Indenture No. 12, dated as of March 18, 2016, among Genworth Holdings, Inc., Genworth Financial, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee, amending the Indenture, dated as of June 15, 2004, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and JPMorgan Chase Bank, N.A. (succeeded by The Bank of New York Mellon Trust Company, N.A.), as Trustee (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on March 22, 2016) Number 4.10 4.11 10.1 10.1.1 10.2 10.2.1 10.3 10.3.1 10.4 10.4.1 10.4.2 10.5 10.5.1 10.5.2 10.6 Description Supplemental Indenture No. 13, dated as of October 3, 2018, among Genworth Holdings, Inc., Genworth Financial, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee, amending the Indenture, dated as of June 15, 2004, between Genworth Financial, Inc. (renamed Genworth Holdings, Inc.) and JPMorgan Chase Bank, N.A. (succeeded by The Bank of New York Mellon Trust Company, N.A.), as Trustee (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on October 4, 2018) Description of Registrant’s Capital Stock (incorporated by reference to Exhibit 4.15 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2019) Coinsurance Agreement, dated as of April 15, 2004, by and between GE Life and Annuity Assurance Company (now known as Genworth Life and Annuity Insurance Company) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.11 to the Registration Statement on Form S-1 (No. 333-112009) (the “Registration Statement”)) Amendments to Coinsurance Agreement (incorporated by reference to Exhibit 10.6.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) Coinsurance Agreement, dated as of April 15, 2004, by and between Federal Home Life Insurance Company (merged with and into Genworth Life and Annuity Insurance Company effective January 1, 2007) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.12 to the Registration Statement) Amendments to Coinsurance Agreement (incorporated by reference to Exhibit 10.7.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) Coinsurance Agreement, dated as of April 15, 2004, by and between General Electric Capital Assurance Company (now known as Genworth Life Insurance Company) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.13 to the Registration Statement) Amendments to Coinsurance Agreement (incorporated by reference to Exhibit 10.8.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) Coinsurance Agreement, dated as of April 15, 2004, by and between GE Capital Life Assurance Company of New York (now known as Genworth Life Insurance Company of New York) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.14 to the Registration Statement) Amendments to Coinsurance Agreement (incorporated by reference to Exhibit 10.9.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) Third Amendment to Coinsurance Agreement (incorporated by reference to Exhibit 10.11.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2009) Coinsurance Agreement, dated as of April 15, 2004, by and between American Mayflower Life Insurance Company of New York (merged with and into Genworth Life Insurance Company of New York effective January 1, 2007) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.15 to the Registration Statement) Amendments to Coinsurance Agreement (incorporated by reference to Exhibit 10.10.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) Third Amendment to Coinsurance Agreement (incorporated by reference to Exhibit 10.12.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2009) Coinsurance Agreement, dated as of April 15, 2004, between First Colony Life Insurance Company (merged with and into Genworth Life and Annuity Insurance Company, effective January 1, 2007) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.54 to the Registration Statement) 288 289 Number 10.6.1 10.7 10.7.1 10.8 10.8.1 10.8.2 10.9 10.9.1 10.9.2 10.10 10.10.1 10.10.2 10.10.3 10.11 10.12 10.13 Description Description Amendments to Coinsurance Agreement (incorporated by reference to Exhibit 10.11.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) Retrocession Agreement, dated as of April 15, 2004, by and between General Electric Capital Assurance Company (now known as Genworth Life Insurance Company) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.16 to the Registration Statement) Amendments to Retrocession Agreement (incorporated by reference to Exhibit 10.12.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) Retrocession Agreement, dated as of April 15, 2004, by and between GE Capital Life Assurance Company of New York (now known as Genworth Life Insurance Company of New York) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.17 to the Registration Statement) Amendments to Retrocession Agreement (incorporated by reference to Exhibit 10.13.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) Third Amendment to Retrocession Agreement (incorporated by reference to Exhibit 10.15.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2009) Reinsurance Agreement, dated as of April 15, 2004, by and between GE Life and Annuity Assurance Company (now known as Genworth Life and Annuity Insurance Company) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.18 to the Registration Statement) First Amendment to Reinsurance Agreement (incorporated by reference to Exhibit 10.14.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) Second Amendment to Reinsurance Agreement (incorporated by reference to Exhibit 10.15.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2012) Reinsurance Agreement, dated as of April 15, 2004, by and between GE Capital Life Assurance Company of New York (now known as Genworth Life Insurance Company of New York) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.19 to the Registration Statement) First Amendment to Reinsurance Agreement (incorporated by reference to Exhibit 10.15.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) Second Amendment to Reinsurance Agreement (incorporated by reference to Exhibit 10.17.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2009) Third Amendment to Reinsurance Agreement (incorporated by reference to Exhibit 10.16.3 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2012) Trust Agreement, dated as of April 15, 2004, among Union Fidelity Life Insurance Company, General Electric Capital Assurance Company (now known as Genworth Life Insurance Company) and The Bank of New York (incorporated by reference to Exhibit 10.48 to the Registration Statement) Trust Agreement, dated as of April 15, 2004, among Union Fidelity Life Insurance Company, Federal Home Life Insurance Company (merged with and into Genworth Life and Annuity Insurance Company, effective January 1, 2007) and The Bank of New York (incorporated by reference to Exhibit 10.51 to the Registration Statement) Trust Agreement, dated as of April 15, 2004, among Union Fidelity Life Insurance Company, First Colony Life Insurance Company (merged with and into Genworth Life and Annuity Insurance Company, effective January 1, 2007) and The Bank of New York (incorporated by reference to Exhibit 10.53 to the Registration Statement) 290 291 Number 10.14 Trust Agreement, dated as of April 15, 2004, among Union Fidelity Insurance Company, American Mayflower Life Insurance Company of New York (merged with and into Genworth Life Insurance Company of New York, effective January 1, 2007) and The Bank of New York (incorporated by reference to Exhibit 10.49 to the Registration Statement) 10.15 Trust Agreement, dated as of April 15, 2004, among Union Fidelity Life Insurance Company, GE Life and Annuity Assurance Company (now known as Genworth Life and Annuity Insurance Company) and The Bank of New York (incorporated by reference to Exhibit 10.50 to the Registration Statement) 10.16 Trust Agreement, dated as of April 15, 2004, among Union Fidelity Life Insurance Company, GE Capital Life Assurance Company of New York (now known as Genworth Life Insurance Company of New York) and The Bank of New York (incorporated by reference to Exhibit 10.52 to the Registration Statement) 10.17 Trust Agreement, dated as of December 1, 2009, among Union Fidelity Life Insurance Company, Genworth Life Insurance Company of New York and Deutsche Bank Trust Company Americas (incorporated by reference to Exhibit 10.24 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2009) 10.18 Capital Maintenance Agreement, dated as of January 1, 2004, by and between Union Fidelity Life Insurance Company and General Electric Capital Corporation (incorporated by reference to Exhibit 10.21 to the Registration Statement) 10.18.1 Amendment No. 1 to Capital Maintenance Agreement, dated as of December 1, 2013, by and between General Electric Capital Corporation and Union Fidelity Life Insurance Company (received by Genworth Financial, Inc. with all required signatures for effectiveness from General Electric Capital Corporation and Union Fidelity Life Insurance Company in February 2015) (incorporated by reference to Exhibit 10.27.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2014 10.19 Replacement Capital Covenant, dated November 14, 2006 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on November 14, 2006) 10.19.1 Amendment No. 1 to Replacement Capital Covenant, dated as of October 18, 2023 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on October 19, 2023) 10.20 Assignment and Assumption Agreement, dated as of April 1, 2013, between Genworth Holdings, Inc. and Genworth Financial, Inc. (incorporated by reference to Exhibit 10.1 to the Current Report 10.21§ 2004 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.56 on Form 8-K filed on April 1, 2013) to the Registration Statement) 10.21.1§ First Amendment to the Genworth Financial, Inc. 2004 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the period ended September 30, 2007) 10.21.2§ Second Amendment to the Genworth Financial, Inc. 2004 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on May 18, 2009) 10.22§ 2012 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on May 21, 2012) 10.22.1§ First Amendment to the 2012 Genworth Financial, Inc. Omnibus Incentive Plan, dated as of December 12, 2017 (incorporated by reference to Exhibit 10.34.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2017) Number Description 10.6.1 Amendments to Coinsurance Agreement (incorporated by reference to Exhibit 10.11.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) 10.7 Retrocession Agreement, dated as of April 15, 2004, by and between General Electric Capital Assurance Company (now known as Genworth Life Insurance Company) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.16 to the Registration Statement) 10.7.1 Amendments to Retrocession Agreement (incorporated by reference to Exhibit 10.12.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) 10.8 Retrocession Agreement, dated as of April 15, 2004, by and between GE Capital Life Assurance Company of New York (now known as Genworth Life Insurance Company of New York) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.17 to the Registration Statement) 10.8.1 Amendments to Retrocession Agreement (incorporated by reference to Exhibit 10.13.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) 10.8.2 Third Amendment to Retrocession Agreement (incorporated by reference to Exhibit 10.15.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2009) 10.9 Reinsurance Agreement, dated as of April 15, 2004, by and between GE Life and Annuity Assurance Company (now known as Genworth Life and Annuity Insurance Company) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.18 to the Registration Statement) 10.9.1 First Amendment to Reinsurance Agreement (incorporated by reference to Exhibit 10.14.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) 10.9.2 Second Amendment to Reinsurance Agreement (incorporated by reference to Exhibit 10.15.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2012) 10.10 Reinsurance Agreement, dated as of April 15, 2004, by and between GE Capital Life Assurance Company of New York (now known as Genworth Life Insurance Company of New York) and Union Fidelity Life Insurance Company (incorporated by reference to Exhibit 10.19 to the Registration Statement) 10.10.1 First Amendment to Reinsurance Agreement (incorporated by reference to Exhibit 10.15.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) 10.10.2 Second Amendment to Reinsurance Agreement (incorporated by reference to Exhibit 10.17.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2009) 10.10.3 Third Amendment to Reinsurance Agreement (incorporated by reference to Exhibit 10.16.3 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2012) 10.11 Trust Agreement, dated as of April 15, 2004, among Union Fidelity Life Insurance Company, General Electric Capital Assurance Company (now known as Genworth Life Insurance Company) and The Bank of New York (incorporated by reference to Exhibit 10.48 to the Registration Statement) 10.12 Trust Agreement, dated as of April 15, 2004, among Union Fidelity Life Insurance Company, Federal Home Life Insurance Company (merged with and into Genworth Life and Annuity Insurance Company, effective January 1, 2007) and The Bank of New York (incorporated by reference to Exhibit 10.51 to the Registration Statement) 10.13 Trust Agreement, dated as of April 15, 2004, among Union Fidelity Life Insurance Company, First Colony Life Insurance Company (merged with and into Genworth Life and Annuity Insurance Company, effective January 1, 2007) and The Bank of New York (incorporated by reference to Exhibit 10.53 to the Registration Statement) Number 10.14 10.15 10.16 10.17 10.18 10.18.1 10.19 10.19.1 10.20 10.21§ 10.21.1§ Description Trust Agreement, dated as of April 15, 2004, among Union Fidelity Insurance Company, American Mayflower Life Insurance Company of New York (merged with and into Genworth Life Insurance Company of New York, effective January 1, 2007) and The Bank of New York (incorporated by reference to Exhibit 10.49 to the Registration Statement) Trust Agreement, dated as of April 15, 2004, among Union Fidelity Life Insurance Company, GE Life and Annuity Assurance Company (now known as Genworth Life and Annuity Insurance Company) and The Bank of New York (incorporated by reference to Exhibit 10.50 to the Registration Statement) Trust Agreement, dated as of April 15, 2004, among Union Fidelity Life Insurance Company, GE Capital Life Assurance Company of New York (now known as Genworth Life Insurance Company of New York) and The Bank of New York (incorporated by reference to Exhibit 10.52 to the Registration Statement) Trust Agreement, dated as of December 1, 2009, among Union Fidelity Life Insurance Company, Genworth Life Insurance Company of New York and Deutsche Bank Trust Company Americas (incorporated by reference to Exhibit 10.24 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2009) Capital Maintenance Agreement, dated as of January 1, 2004, by and between Union Fidelity Life Insurance Company and General Electric Capital Corporation (incorporated by reference to Exhibit 10.21 to the Registration Statement) Amendment No. 1 to Capital Maintenance Agreement, dated as of December 1, 2013, by and between General Electric Capital Corporation and Union Fidelity Life Insurance Company (received by Genworth Financial, Inc. with all required signatures for effectiveness from General Electric Capital Corporation and Union Fidelity Life Insurance Company in February 2015) (incorporated by reference to Exhibit 10.27.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2014 Replacement Capital Covenant, dated November 14, 2006 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on November 14, 2006) Amendment No. 1 to Replacement Capital Covenant, dated as of October 18, 2023 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on October 19, 2023) Assignment and Assumption Agreement, dated as of April 1, 2013, between Genworth Holdings, Inc. and Genworth Financial, Inc. (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on April 1, 2013) 2004 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.56 to the Registration Statement) First Amendment to the Genworth Financial, Inc. 2004 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the period ended September 30, 2007) 10.21.2§ Second Amendment to the Genworth Financial, Inc. 2004 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on May 18, 2009) 10.22§ 10.22.1§ 2012 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on May 21, 2012) First Amendment to the 2012 Genworth Financial, Inc. Omnibus Incentive Plan, dated as of December 12, 2017 (incorporated by reference to Exhibit 10.34.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2017) 290 291 Number 10.22.2§ 10.22.3§ 10.22.4§ 10.23§ 10.24§ 10.25§ 10.25.1§ 10.25.2§ 10.26§ 10.27§ 10.28§ 10.29§ 10.30§ 10.30.1§ 10.30.2§ 10.31§ Description Description Form of Deferred Stock Unit Award Agreement under the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.6 to the Quarterly Report on Form 10-Q for the period ended June 30, 2012) Form of Stock Appreciation Rights with a Maximum Share Value—Executive Officer Retention Agreement under the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed on November 1, 2012) Form of Stock Appreciation Rights with a Maximum Share Value Award Agreement under the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q for the period ended June 30, 2015) Amendment to Stock Options and Stock Appreciation Rights under the 2004 Genworth Financial, Inc. Omnibus Incentive Plan and the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.7 to the Quarterly Report on Form 10-Q for the period ended June 30, 2013) Policy Regarding Personal Use of Non-Commercial Aircraft by Executive Officers (incorporated by reference to Exhibit 10 to the Current Report on Form 8-K filed on July 21, 2006) Genworth Financial, Inc. Executive Life Program (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on September 6, 2005) Amendment to the Genworth Financial, Inc. Executive Life Program (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q for the period ended March 31, 2007) Amendment to the Genworth Financial, Inc. Executive Life Program (incorporated by reference to Exhibit 10.38.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) Amendment to Stock Options and Stock Appreciation Rights under the 2004 Genworth Financial, Inc. Omnibus Incentive Plan and the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the period ended June 30, 2015) Amended and Restated Genworth Financial, Inc. Supplemental Executive Retirement Plan (incorporated by reference to Exhibit 10.47 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2015) Amended and Restated Genworth Financial, Inc. Retirement and Savings Restoration Plan (incorporated by reference to Exhibit 10.48 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2015) Amended and Restated Genworth Financial, Inc. Deferred Compensation Plan (incorporated by reference to Exhibit 10.49 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2015) 2018 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Quarterly report filed on Form 10-Q for the period ended June 30, 2019) Form of Restricted Stock Award Agreement under the 2018 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.3 to the Quarterly report filed on Form 10- Q for the period ended June 30, 2019) Form of Cash-Based Award Agreement under the 2018 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.4 to the Quarterly report filed on Form 10- Q for the period ended June 30, 2019) Amended and Restated Genworth Financial, Inc. Leadership Life Insurance Plan (incorporated by reference to Exhibit 10.48 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2020) 292 293 Number 10.32§ 2021 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the period ended June 30, 2021) 10.33§ Amended and Restated Genworth Financial, Inc. 2014 Change of Control Plan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the period ended September 10.34§ Amended and Restated Genworth Financial, Inc. Senior Executive Severance Plan (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q for the period ended September 30, 2022) 30, 2022) 10.35§ Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on July 26, 2021) 10.36§ Transition, Severance & Release Agreement, dated February 22, 2023, between Genworth Financial, Inc. and Daniel Sheehan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the period ended March 31, 2023) 10.37§ Form of 2023-2025 Restricted Stock Unit Award Agreement under the 2021 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q for the period ended March 31, 2023) 10.38§ Form of 2023-2025 Performance Stock Unit Award Agreement under the 2021 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q for the period ended March 31, 2023) 10.39§ Form of 2023 Director Restricted Stock Unit Award Agreement under the 2021 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the period ended June 30, 2023) Genworth Financial, Inc. Split-Dollar Leadership Life Insurance Plan (filed herewith) Amended and Restated Indemnification Agreement, dated as of February 26, 2024, by and between Genworth Financial, Inc. and Rohit Gupta (filed herewith) Subsidiaries of the registrant (filed herewith) Consent of KPMG LLP (filed herewith) Powers of Attorney (filed herewith) (filed herewith) herewith) 31.1 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002—Thomas J. McInerney 31.2 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002—Jerome T. Upton (filed 10.40§ 10.41§ 21 23 24 32.1 Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code— 32.2 Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code— Thomas J. McInerney (filed herewith) Jerome T. Upton (filed herewith) 97 Genworth Financial, Inc. Incentive-Based Compensation Recovery Policy (filed herewith ) 101.INS Inline XBRL Instance Document 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document Number Description 10.22.2§ Form of Deferred Stock Unit Award Agreement under the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.6 to the Quarterly Report on Form 10-Q for the period ended June 30, 2012) 10.22.3§ Form of Stock Appreciation Rights with a Maximum Share Value—Executive Officer Retention Agreement under the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed on November 1, 2012) 10.22.4§ Form of Stock Appreciation Rights with a Maximum Share Value Award Agreement under the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q for the period ended June 30, 2015) 10.23§ Amendment to Stock Options and Stock Appreciation Rights under the 2004 Genworth Financial, Inc. Omnibus Incentive Plan and the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.7 to the Quarterly Report on Form 10-Q for the period ended June 30, 2013) 10.24§ Policy Regarding Personal Use of Non-Commercial Aircraft by Executive Officers (incorporated by reference to Exhibit 10 to the Current Report on Form 8-K filed on July 21, 2006) 10.25§ Genworth Financial, Inc. Executive Life Program (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on September 6, 2005) 10.25.1§ Amendment to the Genworth Financial, Inc. Executive Life Program (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q for the period ended March 31, 2007) 10.25.2§ Amendment to the Genworth Financial, Inc. Executive Life Program (incorporated by reference to Exhibit 10.38.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2008) 10.26§ Amendment to Stock Options and Stock Appreciation Rights under the 2004 Genworth Financial, Inc. Omnibus Incentive Plan and the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the period 10.27§ Amended and Restated Genworth Financial, Inc. Supplemental Executive Retirement Plan (incorporated by reference to Exhibit 10.47 to the Annual Report on Form 10-K for the fiscal year 10.28§ Amended and Restated Genworth Financial, Inc. Retirement and Savings Restoration Plan (incorporated by reference to Exhibit 10.48 to the Annual Report on Form 10-K for the fiscal year 10.29§ Amended and Restated Genworth Financial, Inc. Deferred Compensation Plan (incorporated by reference to Exhibit 10.49 to the Annual Report on Form 10-K for the fiscal year ended ended June 30, 2015) ended December 31, 2015) ended December 31, 2015) December 31, 2015) 10.30§ 2018 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Quarterly report filed on Form 10-Q for the period ended June 30, 2019) 10.30.1§ Form of Restricted Stock Award Agreement under the 2018 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.3 to the Quarterly report filed on Form 10- Q for the period ended June 30, 2019) 10.30.2§ Form of Cash-Based Award Agreement under the 2018 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.4 to the Quarterly report filed on Form 10- Q for the period ended June 30, 2019) 10.31§ Amended and Restated Genworth Financial, Inc. Leadership Life Insurance Plan (incorporated by reference to Exhibit 10.48 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2020) Number 10.32§ 10.33§ 10.34§ 10.35§ 10.36§ 10.37§ 10.38§ 10.39§ 10.40§ 10.41§ 21 23 24 31.1 31.2 32.1 32.2 Description 2021 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the period ended June 30, 2021) Amended and Restated Genworth Financial, Inc. 2014 Change of Control Plan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the period ended September 30, 2022) Amended and Restated Genworth Financial, Inc. Senior Executive Severance Plan (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q for the period ended September 30, 2022) Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on July 26, 2021) Transition, Severance & Release Agreement, dated February 22, 2023, between Genworth Financial, Inc. and Daniel Sheehan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the period ended March 31, 2023) Form of 2023-2025 Restricted Stock Unit Award Agreement under the 2021 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q for the period ended March 31, 2023) Form of 2023-2025 Performance Stock Unit Award Agreement under the 2021 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q for the period ended March 31, 2023) Form of 2023 Director Restricted Stock Unit Award Agreement under the 2021 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the period ended June 30, 2023) Genworth Financial, Inc. Split-Dollar Leadership Life Insurance Plan (filed herewith) Amended and Restated Indemnification Agreement, dated as of February 26, 2024, by and between Genworth Financial, Inc. and Rohit Gupta (filed herewith) Subsidiaries of the registrant (filed herewith) Consent of KPMG LLP (filed herewith) Powers of Attorney (filed herewith) Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002—Thomas J. McInerney (filed herewith) Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002—Jerome T. Upton (filed herewith) Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code— Thomas J. McInerney (filed herewith) Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code— Jerome T. Upton (filed herewith) 97 Genworth Financial, Inc. Incentive-Based Compensation Recovery Policy (filed herewith ) 101.INS Inline XBRL Instance Document 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 292 293 Number Description 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 104 The cover page for the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, has been formatted in Inline XBRL § Management contract or compensatory plan or arrangement. Neither Genworth Financial, Inc., nor any of its consolidated subsidiaries, has outstanding any instrument with respect to its long-term debt, other than those filed as an exhibit to this Annual Report, under which the total amount of securities authorized exceeds 10% of the total assets of Genworth Financial, Inc. and its subsidiaries on a consolidated basis. Genworth Financial, Inc. hereby agrees to furnish to the U.S. Securities and Exchange Commission, upon request, a copy of each instrument that defines the rights of holders of such long-term debt that is not filed or incorporated by reference as an exhibit to this Annual Report. Genworth Financial, Inc. will furnish any exhibit upon the payment of a reasonable fee, which fee shall be limited to Genworth Financial, Inc.’s reasonable expenses in furnishing such exhibit. Dated: February 29, 2024 Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SIGNATURES Dated: February 29, 2024 GENWORTH FINANCIAL, INC. By: Name: /s/ Thomas J. McInerney Thomas J. McInerney Title: President and Chief Executive Officer; Director (Principal Executive Officer) Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated. President and Chief Executive Officer; Director (Principal Executive Officer) Executive Vice President and Chief Financial Officer (Principal Financial Officer) Vice President and Controller (Principal Accounting Officer) /s/ Thomas J. McInerney Thomas J. McInerney /s/ Jerome T. Upton Jerome T. Upton /s/ Darren W. Woodell Darren W. Woodell * * * * * * * * G. Kent Conrad Karen E. Dyson Jill R. Goodman Howard D. Mills, III Robert P. Restrepo Jr. Elaine A. Sarsynski Ramsey D. Smith Melina E. Higgins Director Director Director Director Director Director Director Director **By /s/ Thomas J. McInerney Thomas J. McInerney Attorney-in-Fact 294 295 Number Description 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 104 The cover page for the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, has been formatted in Inline XBRL § Management contract or compensatory plan or arrangement. Neither Genworth Financial, Inc., nor any of its consolidated subsidiaries, has outstanding any instrument with respect to its long-term debt, other than those filed as an exhibit to this Annual Report, under which the total amount of securities authorized exceeds 10% of the total assets of Genworth Financial, Inc. and its subsidiaries on a consolidated basis. Genworth Financial, Inc. hereby agrees to furnish to the U.S. Securities and Exchange Commission, upon request, a copy of each instrument that defines the rights of holders of such long-term debt that is not filed or incorporated by reference as an exhibit to this Annual Report. Genworth Financial, Inc. will furnish any exhibit upon the payment of a reasonable fee, which fee shall be limited to Genworth Financial, Inc.’s reasonable expenses in furnishing such exhibit. Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SIGNATURES Dated: February 29, 2024 GENWORTH FINANCIAL, INC. By: Name: Title: President and Chief Executive Officer; Director /s/ Thomas J. McInerney Thomas J. McInerney (Principal Executive Officer) Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated. Dated: February 29, 2024 /s/ Thomas J. McInerney Thomas J. McInerney /s/ Jerome T. Upton Jerome T. Upton /s/ Darren W. Woodell Darren W. Woodell * G. Kent Conrad * Karen E. Dyson * Jill R. Goodman * Howard D. Mills, III * Robert P. Restrepo Jr. * Elaine A. Sarsynski * Ramsey D. Smith * Melina E. Higgins President and Chief Executive Officer; Director (Principal Executive Officer) Executive Vice President and Chief Financial Officer (Principal Financial Officer) Vice President and Controller (Principal Accounting Officer) Director Director Director Director Director Director Director Director 294 295 **By /s/ Thomas J. McInerney Thomas J. McInerney Attorney-in-Fact Exhibit 21 Exhibit 23 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the registration statements (No. 333-255187) on Form S-3 and (Nos. 333-256459, 333-115825, 333- 127474, 333-168961, 333-181607 and 333-231538) on Form S-8 of our reports dated February 29, 2024, with respect to the consolidated financial statements of Genworth Financial, Inc. and the effectiveness of internal control over financial reporting. /s/ KPMG LLP Richmond, Virginia February 29, 2024 Genworth Financial, Inc.’s subsidiaries as of December 31, 2023 are listed below. Except where noted below, Genworth Financial, Inc. owns, directly or indirectly, 100% of the outstanding shares or other equity interests of these companies (including, with respect to certain companies, shares in names of nominees and qualifying shares in names of directors). (cid:31) Name Assigned Settlement, Inc. Capital Brokerage Corporation CareScout, LLC CareScout Holdings, Inc. Enact Financial Assurance Corporation(1) Enact Financial Services, Inc.(1) Enact Holdings, Inc.(1) Enact Mortgage Holdings, LLC(1) Enact Mortgage Insurance Corporation(1) Enact Mortgage Insurance Corporation of North Carolina(1) Enact Mortgage Reinsurance Corporation(1) Enact Mortgage Services, LLC(1) Enact Re Ltd.(1) Genworth Annuity Service Corporation Genworth Financial Agency, Inc. Genworth Financial Asia Limited Genworth Financial India Private Limited Genworth Financial International Holdings, LLC Genworth Financial Mauritius Holdings Limited(1) Genworth Holdings, Inc. Genworth Insurance Company Genworth Life and Annuity Insurance Company Genworth Life Insurance Company (dba GLIC in New York) Genworth Life Insurance Company of New York Genworth North America Corporation Genworth Seguros de Credito a la Vivienda, S.A. de C.V. Genworth Servicios, S. de R. L. de C. V. Genworth (Shanghai) Health Consulting Services Company Limited GFCM LLC GLIC Real Estate Holding, LLC GLICNY Real Estate Holding, LLC GNWLAAC Real Estate Holding, LLC HGI Annuity Service Corporation Jamestown Assignment Company, Inc. Mayflower Assignment Corporation Monument Lane PCC, Inc.(1) Monument Lane IC 1, Inc.(1) Monument Lane IC 2, Inc.(1) Newco Properties, Inc. River Lake Insurance Company VI River Lake Insurance Company X Sponsored Captive Re, Inc.(1) United Pacific Structured Settlement Company (cid:31) (1) Genworth Financial, Inc. beneficially owns 81.6% of the shares. Domicile Virginia Washington Delaware Delaware North Carolina Delaware Delaware North Carolina North Carolina North Carolina North Carolina North Carolina Bermuda Delaware Virginia Hong Kong India Delaware Mauritius Delaware North Carolina Virginia Delaware New York Washington Mexico Mexico China Delaware Delaware Delaware Delaware Delaware Virginia New York Virginia Delaware Vermont North Carolina Florida Washington, D.C. Washington, D.C. Washington, D.C. Genworth Financial, Inc.’s subsidiaries as of December 31, 2023 are listed below. Except where noted below, Genworth Financial, Inc. owns, directly or indirectly, 100% of the outstanding shares or other equity interests of these companies (including, with respect to certain companies, shares in names of nominees and qualifying shares in names of directors). Exhibit 21 Exhibit 23 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the registration statements (No. 333-255187) on Form S-3 and (Nos. 333-256459, 333-115825, 333- 127474, 333-168961, 333-181607 and 333-231538) on Form S-8 of our reports dated February 29, 2024, with respect to the consolidated financial statements of Genworth Financial, Inc. and the effectiveness of internal control over financial reporting. /s/ KPMG LLP Richmond, Virginia February 29, 2024 (cid:31) Name Assigned Settlement, Inc. Capital Brokerage Corporation CareScout, LLC CareScout Holdings, Inc. Enact Financial Assurance Corporation(1) Enact Financial Services, Inc.(1) Enact Holdings, Inc.(1) Enact Mortgage Holdings, LLC(1) Enact Mortgage Insurance Corporation(1) Enact Mortgage Insurance Corporation of North Carolina(1) Enact Mortgage Reinsurance Corporation(1) Enact Mortgage Services, LLC(1) Enact Re Ltd.(1) Genworth Annuity Service Corporation Genworth Financial Agency, Inc. Genworth Financial Asia Limited Genworth Financial India Private Limited Genworth Financial International Holdings, LLC Genworth Financial Mauritius Holdings Limited(1) Genworth Holdings, Inc. Genworth Insurance Company Genworth Life and Annuity Insurance Company Genworth Life Insurance Company (dba GLIC in New York) Genworth Life Insurance Company of New York Genworth North America Corporation Genworth Seguros de Credito a la Vivienda, S.A. de C.V. Genworth Servicios, S. de R. L. de C. V. Genworth (Shanghai) Health Consulting Services Company Limited GFCM LLC GLIC Real Estate Holding, LLC GLICNY Real Estate Holding, LLC GNWLAAC Real Estate Holding, LLC HGI Annuity Service Corporation Jamestown Assignment Company, Inc. Mayflower Assignment Corporation Monument Lane PCC, Inc.(1) Monument Lane IC 1, Inc.(1) Monument Lane IC 2, Inc.(1) Newco Properties, Inc. River Lake Insurance Company VI River Lake Insurance Company X Sponsored Captive Re, Inc.(1) United Pacific Structured Settlement Company (cid:31) (1) Genworth Financial, Inc. beneficially owns 81.6% of the shares. Domicile Virginia Washington Delaware Delaware North Carolina Delaware Delaware North Carolina North Carolina North Carolina North Carolina North Carolina Bermuda Delaware Virginia Hong Kong India Delaware Mauritius Delaware North Carolina Virginia Delaware New York Washington Mexico Mexico China Delaware Delaware Delaware Delaware Delaware Virginia New York Washington, D.C. Washington, D.C. Washington, D.C. Virginia Delaware Vermont North Carolina Florida Exhibit 24 Exhibit 31.1 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that each of the undersigned, being a director of Genworth Financial, Inc., a Delaware corporation (the “Company”), hereby severally constitutes and appoints Thomas J. McInerney, Jerome T. Upton and Gregory S. Karawan and each of them individually, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead in any and all capacities, to sign the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, or on such other form as such attorneys-in-fact, or any of them, may deem necessary or desirable and any amendments thereto, in such form as they or any one of them may approve, and to file the same with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them individually, full power and authority to do and perform each and every act and thing requisite and necessary to be done so that such Annual Report and any such amendments shall comply with the Securities Exchange Act of 1934, as amended, and the applicable Rules and Regulations adopted or issued pursuant thereto, as fully and to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their substitute or resubstitute, may lawfully do or cause to be done by virtue hereof. IN WITNESS WHEREOF, each of the undersigned has hereunto set his or her hand on the date indicated below. 15d-15(f)) for the registrant and have: (cid:31) /s/ MELINA E. HIGGINS Melina E. Higgins Non-Executive Chair of the Board /s/ G. KENT CONRAD G. Kent Conrad Director /s/ KAREN E. DYSON Karen E. Dyson Director /s/ JILL R. GOODMAN Jill R. Goodman Director /s/ HOWARD D. MILLS, III Howard D. Mills, III Director /s/ ROBERT P. RESTREPO JR. Robert P. Restrepo Jr. Director /s/ ELAINE A. SARSYNSKI Elaine A. Sarsynski Director /s/ RAMSEY D. SMITH Ramsey D. Smith Director February 27, 2024 February 27, 2024 February 27, 2024 February 27, 2024 February 27, 2024 February 27, 2024 February 27, 2024 February 27, 2024 I, Thomas J. McInerney, certify that: 1. I have reviewed this annual report on Form 10-K of Genworth Financial, Inc.; CERTIFICATIONS 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. Dated: February 29, 2024 (cid:31) /s/ Thomas J. McInerney Thomas J. McInerney President and Chief Executive Officer (Principal Executive Officer) POWER OF ATTORNEY I, Thomas J. McInerney, certify that: CERTIFICATIONS KNOW ALL PERSONS BY THESE PRESENTS, that each of the undersigned, being a director of Genworth Financial, Inc., a Delaware corporation (the “Company”), hereby severally constitutes and appoints Thomas J. McInerney, Jerome T. Upton and Gregory S. Karawan and each of 1. I have reviewed this annual report on Form 10-K of Genworth Financial, Inc.; them individually, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead in any and all capacities, to sign the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, or 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make on such other form as such attorneys-in-fact, or any of them, may deem necessary or desirable and any amendments thereto, in such form as they or any one of them may approve, and to file the same with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them individually, full power and authority to do and perform each and every the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; act and thing requisite and necessary to be done so that such Annual Report and any such amendments shall comply with the Securities Exchange Act of 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects 1934, as amended, and the applicable Rules and Regulations adopted or issued pursuant thereto, as fully and to all intents and purposes as he or she the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; Exhibit 24 Exhibit 31.1 might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their substitute or resubstitute, may lawfully do or cause to be done by virtue hereof. IN WITNESS WHEREOF, each of the undersigned has hereunto set his or her hand on the date indicated below. (cid:31) /s/ MELINA E. HIGGINS Melina E. Higgins Non-Executive Chair of the Board February 27, 2024 February 27, 2024 February 27, 2024 February 27, 2024 February 27, 2024 February 27, 2024 /s/ G. KENT CONRAD G. Kent Conrad Director /s/ KAREN E. DYSON Karen E. Dyson Director /s/ JILL R. GOODMAN Jill R. Goodman Director /s/ HOWARD D. MILLS, III Howard D. Mills, III Director Robert P. Restrepo Jr. Director Elaine A. Sarsynski Director /s/ RAMSEY D. SMITH Ramsey D. Smith Director 4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal /s/ ROBERT P. RESTREPO JR. February 27, 2024 /s/ ELAINE A. SARSYNSKI February 27, 2024 control over financial reporting. Dated: February 29, 2024 (cid:31) /s/ Thomas J. McInerney Thomas J. McInerney President and Chief Executive Officer (Principal Executive Officer) Exhibit 31.2 Exhibit 32.1 I, Jerome T. Upton, certify that: (AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002) CERTIFICATIONS CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 1. I have reviewed this annual report on Form 10-K of Genworth Financial, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; the Company. 4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined Dated: February 29, 2024 in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (cid:31) (cid:31) (cid:31) I, Thomas J. McInerney, as President and Chief Executive Officer of Genworth Financial, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), that to my knowledge: (1) the accompanying Annual Report on Form 10-K of the Company for the year ended December 31, 2023 (the “Report”), filed with the U.S. Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. Dated: February 29, 2024 (cid:31) /s/ Jerome T. Upton Jerome T. Upton Executive Vice President and Chief Financial Officer (Principal Financial Officer) /s/ Thomas J. McInerney Thomas J. McInerney President and Chief Executive Officer (Principal Executive Officer) CERTIFICATIONS CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 Exhibit 31.2 Exhibit 32.1 I, Jerome T. Upton, certify that: (AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002) 1. I have reviewed this annual report on Form 10-K of Genworth Financial, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; I, Thomas J. McInerney, as President and Chief Executive Officer of Genworth Financial, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), that to my knowledge: (cid:31) (1) (2) (cid:31) the accompanying Annual Report on Form 10-K of the Company for the year ended December 31, 2023 (the “Report”), filed with the U.S. Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and Dated: February 29, 2024 (cid:31) 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. Dated: February 29, 2024 (cid:31) /s/ Jerome T. Upton Jerome T. Upton Executive Vice President and Chief Financial Officer (Principal Financial Officer) /s/ Thomas J. McInerney Thomas J. McInerney President and Chief Executive Officer (Principal Executive Officer) CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 Exhibit 32.2 (AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002) I, Jerome T. Upton, as Executive Vice President and Chief Financial Officer of Genworth Financial, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), that to my knowledge: (cid:31) (1) (2) (cid:31) the accompanying Annual Report on Form 10-K of the Company for the year ended December 31, 2023 (the “Report”), filed with the U.S. Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: February 29, 2024 (cid:31) /s/ Jerome T. Upton Jerome T. Upton Executive Vice President and Chief Financial Officer (Principal Financial Officer) Stockholder Information Corporate Headquarters(cid:1) Genworth Financial, Inc. 6620 West Broad Street Richmond, VA 23230 e-mail: contactus@genworth.com 804 484.3821(cid:1)(cid:1) Toll free in the U.S.: 1 888 GENWORTH 1 888 436.9678 Stock Exchange Listing(cid:1) Genworth Class A Common Stock is listed on the New York Stock Exchange (Ticker symbol: GNW) Transfer Agent Computershare Tel: 1 866 229.8413 Tel: 1 800 231.5469 (hearing impaired) Tel: 1 201 680. and Canada) Tel: 1 201 680.6610 (hearing impaired outside the U.S. and Canada) (outside the U.S. 6685 Address Genworth Stockholder Inquiries to: Computershare P.O. Box 430 Providence, RI 02940-30 www.computershare.com/investor 78 78 Stock Purchase and Sale Plan(cid:1) The Computershare CIP plan provides shareholders of record and new investors with a convenient way to make cash purchases of Genworth’s common stock and to automatically reinvest dividends, when paid. Inquiries should be made directly to Computershare. Contacts Board of Directors For reporting complaints about Genworth’s accounting, internal accounting controls or auditing matters or any other concerns to the Board of Directors or the Audit Committee, you may write to or call: To obtain plan enrollment materials, please call 1 866 229.8413 or visit www.computershare.com/investor Independent Registered Public Accounting Firm KPMG LLP Suite 2000 1021 East Cary Street Richmond, VA 23219-4023 Tel: 804 782.4200 Fax: 804 782.4300 Board of Directors Genworth Financial, Inc. c/o Corporate Secretary 6620 West Broad Street Richmond, VA 23230 1 866 717.3594 e-mail: directors@genworth.com Corporate Ombudsperson To report concerns related to compliance with the law, Genworth policies or government contracting requirements, contact: Genworth Ombudsperson 6620 West Broad Street Richmond, VA 23230 1 888 251.4332 e-mail: ombudsoffice.genworth@ genworth.com Investor Relations e-mail: investorinfo@genworth.com investor. genworth.com Product/Service Information(cid:1) For information about products offered by Genworth Financial companies, visit genworth.com. This Annual Report is also available online at genworth.com. Genworth Financial, Inc. 6620 West Broad Street Richmond, Virginia 23230 genworth.com ©202 4 Genworth Financial, Inc. All rights reserved. 

Continue reading text version or see original annual report in PDF format above